<SEC-DOCUMENT>0001099800-24-000039.txt : 20240429
<SEC-HEADER>0001099800-24-000039.hdr.sgml : 20240429
<ACCEPTANCE-DATETIME>20240429160619
ACCESSION NUMBER:		0001099800-24-000039
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		99
CONFORMED PERIOD OF REPORT:	20240331
FILED AS OF DATE:		20240429
DATE AS OF CHANGE:		20240429

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Edwards Lifesciences Corp
		CENTRAL INDEX KEY:			0001099800
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				364316614
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15525
		FILM NUMBER:		24890637

	BUSINESS ADDRESS:	
		STREET 1:		ONE EDWARDS WAY
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614
		BUSINESS PHONE:		9492502500

	MAIL ADDRESS:	
		STREET 1:		ONE EDWARDS WAY
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EDWARDS LIFESCIENCES CORP.
		DATE OF NAME CHANGE:	20090225

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EDWARDS LIFESCIENCES CORP
		DATE OF NAME CHANGE:	20000203

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVG CONTROLLED INC
		DATE OF NAME CHANGE:	19991126
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>ew-20240331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:1b5f1024-67d5-4c23-ba5b-277a92b54967,g:71cdffb8-b576-4b3a-8b78-825fbaff5436,d:141c83fee5da4f43b6493ac7539be527-->
<html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ew="http://www.edwards.com/20240331" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:srt="http://fasb.org/srt/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>ew-20240331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-25">0001099800</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="f-26">12/31</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-27">2024</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-28">Q1</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-29">false</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" id="f-670">http://fasb.org/us-gaap/2023#BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</ix:nonNumeric><ix:nonNumeric contextRef="c-5" name="us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" id="f-680">http://fasb.org/us-gaap/2023#BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</ix:nonNumeric><ix:nonNumeric contextRef="c-3" name="us-gaap:DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" id="f-695">http://fasb.org/us-gaap/2023#OtherAssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-4" name="us-gaap:DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" id="f-696">http://fasb.org/us-gaap/2023#OtherAssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-4" name="us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" id="f-701">http://www.edwards.com/20240331#AccruedAndOtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-3" name="us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" id="f-702">http://www.edwards.com/20240331#AccruedAndOtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-248" name="ecd:TrdArrDuration" format="ixt-sec:durday" id="f-1031">324</ix:nonNumeric><ix:nonNumeric contextRef="c-250" name="ecd:TrdArrDuration" format="ixt-sec:durday" id="f-1032">353</ix:nonNumeric><ix:nonNumeric contextRef="c-252" name="ecd:TrdArrDuration" format="ixt-sec:durday" id="f-1033">202</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="ew-20240331.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-04-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-12</xbrli:startDate><xbrli:endDate>2023-04-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ew:MedtronicIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-12</xbrli:startDate><xbrli:endDate>2023-04-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ew:MedtronicIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ew:MedtronicIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ew:MedtronicIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ew:NewMarketsTaxCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:LimitedLiabilityCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:LimitedLiabilityCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ew:MedicalDeviceCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ew:MedicalDeviceCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ew:MedicalDeviceCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ew:MedicalDeviceCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ew:MedicalDeviceCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ew:MedicalDeviceCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ew:ConvertiblePromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ew:MeasurementInputProbabilityOfMilestoneAchievementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ew:ContingentConsiderationLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ew:ContingentConsiderationLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ew:ContingentConsiderationLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ew:ContingentConsiderationLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ew:ContingentConsiderationLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ew:ContingentConsiderationLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ew:ContingentConsiderationLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ew:ContingentConsiderationLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ew:SeparationCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ew:SeparationCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ew:EmployeeAndNonemployeeStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ew:EmployeeAndNonemployeeStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">ew:InitialDeliveryOfSharesSettledFebruary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">ew:InitialDeliveryOfSharesSettledFebruary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-01</xbrli:startDate><xbrli:endDate>2023-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">ew:February2023StockRepurchaseProgramSharesSoldInMarch2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="lawsuit"><xbrli:measure>ew:lawsuit</xbrli:measure></xbrli:unit><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="agreement"><xbrli:measure>ew:agreement</xbrli:measure></xbrli:unit><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:IsraelTaxAuthorityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:JapanSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:JapanSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ew:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ew:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:TranscatheterAorticValveReplacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:TranscatheterAorticValveReplacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:TranscatheterMitralAndTricuspidTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:TranscatheterMitralAndTricuspidTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:SurgicalHeartValveTherapyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:SurgicalHeartValveTherapyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:CriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-247"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:CriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">ew:MichaelA.MussallemMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-249"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">ew:MichaelA.MussallemMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-250"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">ew:ScottB.UllemMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-251"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">ew:ScottB.UllemMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-252"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">ew:BernardJ.ZovighianMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-253"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">ew:BernardJ.ZovighianMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i141c83fee5da4f43b6493ac7539be527_1"></div><div style="min-height:36pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:29.239%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-Q</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:2.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.947%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="f-2">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION&#160;13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF&#160;1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the Quarterly Period Ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3">March&#160;31, 2024</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">or</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:2.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.947%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-4">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF&#160;1934</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">1-15525</ix:nonNumeric> </span></div><div style="margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:29.239%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-6">EDWARDS LIFESCIENCES CORPORATION</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:49.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.264%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-7">Delaware</ix:nonNumeric></span></div></td><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-8">36-4316614</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></div></td><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></div></td><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-9">One Edwards Way</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-10">Irvine</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-11">California</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-12">92614</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices and zip code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-13">949</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-14">250-2500</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">(Registrant's telephone number, including area code)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:29.239%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:6pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.473%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-15">Common Stock, par value $1.00 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-16">EW</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-17">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-18">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T (&#167;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files).&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-19">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule&#160;12b-2 of the Exchange Act.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:16.030%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.812%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.289%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.129%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.293%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-20">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="f-21">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-22">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).&#160;Yes&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-23">&#9746;</ix:nonNumeric></span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The number of shares outstanding of the registrant's common stock, $1.00 par value, as of April&#160;25, 2024 was <ix:nonFraction unitRef="shares" contextRef="c-2" decimals="-5" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="f-24">602.6</ix:nonFraction> million.</span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.760%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:24.75pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i141c83fee5da4f43b6493ac7539be527_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EDWARDS LIFESCIENCES CORPORATION</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM 10-Q</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended March&#160;31, 2024 </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:83.819%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.782%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Number</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_13">Part&#160;I.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_13">FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_16">Item&#160;1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_16">Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_16">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_19">Consolidated Condensed Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_19">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_22">Consolidated Condensed Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_22">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_25">Consolidated Condensed Statements of Comprehensive Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_25">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_28">Consolidated Condensed Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_28">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_31">Consolidated Condensed Statements of Stockholders' Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_31">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_34">Notes to Consolidated Condensed Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_34">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_85">Item&#160;2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_85">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_85">26</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_103">Item&#160;3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_103">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_103">36</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_106">Item&#160;4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_106">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_106">37</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_109">Part&#160;II.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_109">OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_112">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_112">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_112">38</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_115">Item&#160;1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_115">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_115">38</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_118">Item&#160;2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_118">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_118">38</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_121">Item 5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_121">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_121">38</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Item&#160;6.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_127">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_127">39</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_130">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i141c83fee5da4f43b6493ac7539be527_130">40</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i141c83fee5da4f43b6493ac7539be527_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NOTE REGARDING FORWARD-LOOKING STATEMENTS </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This report contains forward-looking statements within the meaning of Section&#160;27A of the Securities Act of 1933 and Section&#160;21E of the Securities Exchange Act of 1934. We intend the forward-looking statements contained in this report to be covered by the safe harbor provisions of such Acts. Statements other than statements of historical or current fact in this report or referred to or incorporated by reference into this report are "forward-looking statements" for purposes of these safe harbor provisions. These statements can sometimes be identified by the use of the forward-looking words such as "may," "believe," "will," "expect," "project," "estimate," "should," "anticipate," "plan," "goal," "continue," "seek," "pro forma," "forecast," "intend," "guidance," "optimistic," "aspire," "confident," other forms of these words or similar words or expressions or the negatives thereof. Statements regarding past performance, efforts, or results about which inferences or assumptions may be made can also be forward-looking statements and are not indicative of future performance or results; these statements can be identified by the use of words such as "preliminary," "initial," "potential," "possible," "diligence," "industry-leading," "compliant," "indications," or "early feedback" or other forms of these words or similar words or expressions or the negatives thereof.  These forward-looking statements are subject to substantial risks and uncertainties that could cause our results or future business, financial condition, results of operations or performance to differ materially from our historical results or experiences or those expressed or implied in any forward-looking statements contained in this report.  These risks and uncertainties include, but are not limited to: the spin-off of our critical care product group, our ability to develop new products and avoid manufacturing and quality issues; clinical trial or commercial results or new product approvals and therapy adoption; the impact of domestic and global conditions; competition in the markets in which we operate; our reliance on vendors, suppliers, and other third parties; damage, failure or interruption of our information technology systems; the impact of public health crises; consolidation in the healthcare industry; our ability to protect our intellectual property; our compliance with applicable regulations; our exposure to product liability claims; use of our products in unapproved circumstances; changes to reimbursement for our products; the impact of currency exchange rates; unanticipated actions by the United States Food and Drug Administration and other regulatory agencies; changes to tax laws; unexpected impacts or expenses of litigation or internal or government investigations; and other risks detailed under &#8220;Risk Factors&#8221; in our annual report on Form&#160;10-K for the year ended December&#160;31, 2023, as such risks and uncertainties may be amended, supplemented or superseded from time to time by our subsequent reports on Forms&#160;10-Q and 8-K we file with the United States Securities and Exchange Commission. These forward-looking statements speak only as of the date on which they are made and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of the statement. If we do update or correct one or more of these statements, investors and others should not conclude that we will make additional updates or corrections.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise indicated or otherwise required by the context, the terms "we," "our," "it," "its," "Company," "Edwards," and "Edwards Lifesciences" refer to Edwards Lifesciences Corporation and its subsidiaries.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i141c83fee5da4f43b6493ac7539be527_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="margin-bottom:11pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Part&#160;I. Financial Information</span></div><div id="i141c83fee5da4f43b6493ac7539be527_16"></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item&#160;1.&#160;&#160;&#160;&#160;Financial Statements</span></div><div id="i141c83fee5da4f43b6493ac7539be527_19"></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">EDWARDS LIFESCIENCES CORPORATION</span></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED CONDENSED BALANCE SHEETS</span></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(in millions, except par value; unaudited)</span></div><div style="margin-top:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:73.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.364%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="f-30">1,224.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="f-31">1,144.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term investments (Note&#160;5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:ShortTermInvestments" scale="6" id="f-32">473.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ShortTermInvestments" scale="6" id="f-33">500.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable, net of allowances of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="f-34">13.5</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="f-35">8.3</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="f-36">817.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="f-37">775.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherReceivablesNetCurrent" scale="6" id="f-38">59.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherReceivablesNetCurrent" scale="6" id="f-39">61.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories (Note&#160;2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="f-40">1,207.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="f-41">1,168.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="f-42">138.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="f-43">146.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherAssetsCurrent" scale="6" id="f-44">250.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherAssetsCurrent" scale="6" id="f-45">239.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-46">4,170.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-47">4,035.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term investments (Note&#160;5)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LongTermInvestments" scale="6" id="f-48">455.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LongTermInvestments" scale="6" id="f-49">583.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="f-50">1,767.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="f-51">1,749.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-52">98.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-53">94.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-54">1,252.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-55">1,253.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="f-56">446.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="f-57">428.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="f-58">776.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="f-59">754.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets (Note 2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="f-60">767.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="f-61">463.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-62">9,736.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-63">9,363.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="f-64">212.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="f-65">201.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued and other liabilities (Note 2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="ew:AccruedAndOtherLiabilitiesCurrent" scale="6" id="f-66">873.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="ew:AccruedAndOtherLiabilitiesCurrent" scale="6" id="f-67">969.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-68">24.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-69">24.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-70">1,110.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-71">1,195.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="f-72">597.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="f-73">597.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:TaxesPayableCurrentAndNoncurrent" scale="6" id="f-74">79.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:TaxesPayableCurrentAndNoncurrent" scale="6" id="f-75">80.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-76">77.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-77">73.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Uncertain tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LiabilityForUncertainTaxPositionsNoncurrent" scale="6" id="f-78">336.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LiabilityForUncertainTaxPositionsNoncurrent" scale="6" id="f-79">339.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Litigation settlement accrual</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LitigationReserveNoncurrent" scale="6" id="f-80">82.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LitigationReserveNoncurrent" scale="6" id="f-81">94.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="f-82">266.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="f-83">264.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-84">2,549.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-85">2,643.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commitments and contingencies (Note&#160;11)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-3" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-86"/></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-4" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-87"/></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stockholders' equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-88"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-89">0.01</ix:nonFraction></ix:nonFraction> par value, authorized <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="f-90"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="f-91">50.0</ix:nonFraction></ix:nonFraction> shares, <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="f-92"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="f-93">no</ix:nonFraction></ix:nonFraction> shares outstanding&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="f-94">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="f-95">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-96"><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-97">1.00</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="f-98"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="f-99">1,050.0</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="f-100">651.8</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="f-101">650.5</ix:nonFraction> shares issued, and <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-102">602.4</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-103">601.1</ix:nonFraction> shares outstanding, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="f-104">651.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="f-105">650.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-106">2,379.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-107">2,274.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="f-108">9,344.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="f-109">8,992.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss (Note 12)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-110">233.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-111">242.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury stock, at cost, <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-112">49.4</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-113">49.4</ix:nonFraction> shares, respectively </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="6" id="f-114">5,024.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="6" id="f-115">5,024.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Edwards Lifesciences Corporation stockholders' equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-116">7,117.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-117">6,650.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:MinorityInterest" scale="6" id="f-118">68.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:MinorityInterest" scale="6" id="f-119">69.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stockholders' equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-120">7,186.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-121">6,719.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities and equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-122">9,736.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-123">9,363.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">consolidated condensed financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i141c83fee5da4f43b6493ac7539be527_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">EDWARDS LIFESCIENCES CORPORATION</span></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS</span></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(in millions, except per share information; unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.578%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.697%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-124">1,598.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-125">1,459.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-126">385.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-127">329.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-128">1,212.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-129">1,130.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-130">489.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-131">436.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-132">285.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-133">261.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intellectual property agreement and certain litigation expenses (Note 3)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:LitigationSettlementExpense" scale="6" id="f-134">8.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:LitigationSettlementExpense" scale="6" id="f-135">43.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities (Note 7)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:fixed-zero" scale="6" id="f-136">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="f-137">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separation costs (Note&#160;4)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherNonrecurringIncomeExpense" scale="6" id="f-138">41.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherNonrecurringIncomeExpense" format="ixt:fixed-zero" scale="6" id="f-139">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-140">387.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-141">388.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="f-142">16.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="f-143">8.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-144">5.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-145">1.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before provision for income taxes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-146">409.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-147">398.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-148">58.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-149">58.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-150">351.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-151">340.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to noncontrolling interest</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="f-152">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="f-153">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Edwards Lifesciences Corporation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-154">351.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-155">340.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Share information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (Note 13)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-156">0.58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-157">0.56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-158">0.58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-159">0.56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-160">601.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-161">607.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-162">604.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-163">610.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">consolidated condensed financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i141c83fee5da4f43b6493ac7539be527_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">EDWARDS LIFESCIENCES CORPORATION</span></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(in millions; unaudited)</span></div><div style="margin-bottom:4pt;margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.654%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.159%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-164">351.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-165">340.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax (Note&#160;12):</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="f-166">26.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="f-167">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain (loss) on hedges</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="f-168">26.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="f-169">17.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized pension credits (costs)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="f-170">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="f-171">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain on available-for-sale investments</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="f-172">8.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="f-173">13.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-174">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-175">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-176">360.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-177">340.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss attributable to noncontrolling interest</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="f-178">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="f-179">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to Edwards Lifesciences Corporation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-180">361.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-181">340.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">consolidated condensed financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i141c83fee5da4f43b6493ac7539be527_28"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">EDWARDS LIFESCIENCES CORPORATION</span></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS</span></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(in millions; unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-182">351.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-183">340.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash (used in) provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-184">38.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-185">35.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash operating lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="6" id="f-186">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="6" id="f-187">6.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation (Note&#160;9)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-188">44.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-189">38.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="f-190">35.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="f-191">51.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="f-192">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="f-193">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts and other receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables" scale="6" id="f-194">55.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables" scale="6" id="f-195">77.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="f-196">69.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="f-197">32.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="f-198">89.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="f-199">45.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="f-200">263.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="f-201">87.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="f-202">27.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="f-203">23.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intellectual property agreement accrual</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="ew:IncreaseDecreaseInLegalSettlementAccrual" scale="6" id="f-204">5.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="ew:IncreaseDecreaseInLegalSettlementAccrual" scale="6" id="f-205">29.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="f-206">4.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="f-207">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in) provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-208">53.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-209">314.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="f-210">65.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="f-211">61.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of held-to-maturity investments (Note 5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsToAcquireHeldToMaturitySecurities" scale="6" id="f-212">0.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PaymentsToAcquireHeldToMaturitySecurities" scale="6" id="f-213">12.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from held-to-maturity investments (Note 5)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" scale="6" id="f-214">9.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" scale="6" id="f-215">80.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of available-for-sale investments (Note 5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="6" id="f-216">1.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="6" id="f-217">3.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from available-for-sale investments (Note 5)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" scale="6" id="f-218">157.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" scale="6" id="f-219">183.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="6" id="f-220">20.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="6" id="f-221">13.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business combination, net of cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="ew:PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions" format="ixt:fixed-zero" scale="6" id="f-222">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="ew:PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions" scale="6" id="f-223">141.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment for acquisition options (Note 6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherPaymentsToAcquireBusinesses" scale="6" id="f-224">10.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherPaymentsToAcquireBusinesses" scale="6" id="f-225">15.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuances of notes receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsToAcquireReceivables" scale="6" id="f-226">2.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PaymentsToAcquireReceivables" scale="6" id="f-227">15.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="f-228">2.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="f-229">1.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-230">63.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-231">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="f-232">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="f-233">249.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProceedsFromStockPlans" scale="6" id="f-234">62.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ProceedsFromStockPlans" scale="6" id="f-235">41.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="f-236">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="f-237">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-238">61.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-239">206.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-240">9.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-241">4.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-242">81.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-243">103.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-244">1,148.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-245">772.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash at end of period (Note 2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-246">1,229.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-247">876.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">consolidated condensed financial statements.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i141c83fee5da4f43b6493ac7539be527_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">EDWARDS LIFESCIENCES CORPORATION</span></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY</span></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(in millions; unaudited)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.134%"><tr><td style="width:1.0%"/><td style="width:26.956%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.266%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.345%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.345%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.345%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.013%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.345%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.122%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.345%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.904%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.345%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.633%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.345%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.179%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.345%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.633%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.345%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Edwards Lifesciences Corporation Stockholders' Equity</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling Interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Stockholders' Equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-248">650.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-249">650.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-250">49.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-251">5,024.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-252">2,274.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-253">8,992.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-254">242.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-255">6,650.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-256">69.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-257">6,719.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-258">351.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-259">351.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="f-260">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-261">351.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-262">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-263">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-264">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued under stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-19" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="f-265">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-266">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-267">60.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-268">62.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-269">62.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-270">44.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-271">44.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-272">44.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-273">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-274">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-275">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at March 31, 2024</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-22" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-276">651.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-277">651.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-23" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-278">49.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-279">5,024.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-280">2,379.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-281">9,344.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-282">233.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-283">7,117.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-284">68.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-285">7,186.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">consolidated condensed financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:38.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">EDWARDS LIFESCIENCES CORPORATION</span></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY</span></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(in millions; unaudited)</span></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.458%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.872%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.170%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.772%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.461%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.560%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.340%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.754%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Edwards Lifesciences, Inc. Stockholders' Equity</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling Interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Stockholders' Equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-29" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-286">646.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-287">646.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-30" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-288">38.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-289">4,144.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-290">1,969.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-291">7,590.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-292">254.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-293">5,806.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="f-294">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-295">5,806.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-296">340.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-297">340.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-298">340.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-299">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-300">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-301">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued under stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-39" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="f-302">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-303">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-304">41.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-305">41.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-306">41.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-307">38.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-308">38.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-309">38.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-41" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-310">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-311">249.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-312">249.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-313">249.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes to noncontrolling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-5" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="f-314">84.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="f-315">84.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at March 31, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-43" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-316">647.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-317">647.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-44" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-318">41.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-319">4,393.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-320">2,049.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-321">7,930.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-322">255.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-323">5,978.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-324">84.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-325">6,062.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">consolidated condensed financial statements.</span></div><div style="height:38.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i141c83fee5da4f43b6493ac7539be527_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div><span><br/></span></div><div id="i141c83fee5da4f43b6493ac7539be527_37"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" id="f-326" continuedAt="f-326-1" escape="true">BASIS OF PRESENTATION</ix:nonNumeric></span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><ix:continuation id="f-326-1" continuedAt="f-326-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-327" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim consolidated condensed financial statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") and should be read in conjunction with the consolidated financial statements and notes included in Edwards Lifesciences' Annual Report on Form&#160;10-K for the year ended December&#160;31, 2023. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") have been condensed or omitted.</span></div></ix:nonNumeric><div style="text-indent:22.5pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationPolicyTextBlock" id="f-328" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The consolidated condensed financial statements include the accounts of all wholly-owned subsidiaries and variable interest entities for which the Company is the primary beneficiary. The Company attributes the net income or losses of its consolidated variable interest entities to controlling and noncontrolling interests using the hypothetical liquidation at book value method.  All intercompany accounts and transactions have been eliminated in consolidation.</span></div></ix:nonNumeric><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-329" escape="true">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements.  Actual results could differ from those&#160;estimates.</ix:nonNumeric>  </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the unaudited interim consolidated condensed financial statements reflect all adjustments necessary for a fair statement of the results for the interim periods presented. All such adjustments, unless otherwise noted herein, are of a normal, recurring nature. The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for the full year.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to the Company's significant accounting policies from those described in the Company's Annual Report on Form 10-K for the year ended December 31, 2023.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-330" continuedAt="f-330-1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, the Financial Accounting Standards Board ("FASB") issued an amendment to the accounting guidance on investments in tax credit structures to allow entities to elect to account for their tax equity investments, regardless of the tax credit program from which the income tax credits are received, using the proportional amortization method if certain conditions are met.   The guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years.  The Company adopted this guidance on January 1, 2024.  The adoption of this guidance did not have a material impact on the Company's consolidated financial statements.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Standards Not Yet Adopted</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2024, the SEC issued final climate-related disclosure rules that will require disclosure of material climate-related risks and material direct greenhouse gas emissions from operations owned or controlled (Scope 1) and/or material indirect greenhouse gas emissions from purchased energy consumed in owned or controlled operations (Scope 2). Additionally, the rules require disclosure in the notes to the financial statements of the effects of severe weather events and other natural conditions, subject to certain materiality thresholds. The new rules will be effective for annual reporting periods beginning in fiscal year 2025, except for the greenhouse gas emissions disclosures which will be effective for annual reporting periods beginning in fiscal year 2026. Subsequent to issuance, the rules became the subject of litigation, and the SEC has issued a stay to allow the legal process to proceed.  The Company is currently evaluating the impact the guidance will have on its consolidated financial statements.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued an amendment to the accounting guidance on income taxes which requires entities to provide additional information in the rate reconciliation and additional disaggregated disclosures about income taxes paid. This guidance requires public entities to disclose in their rate reconciliation table additional categories of information about federal, state, and foreign income taxes and to provide more details about the reconciling items in some categories if the items meet a quantitative threshold. The guidance is effective for annual periods beginning after December 15, 2024. The Company does not expect the adoption of this guidance to impact its financial statements, but the guidance will impact its income tax disclosures.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued an amendment to the accounting guidance on segment reporting. The amendments require disclosure of significant segment expenses and other segment items and requires entities to provide in interim periods</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">all disclosures about a reportable segment's profit or loss and assets that are currently required annually. The amendment also</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">requires disclosure of the title and position of the chief operating decision maker ("CODM") and an explanation of how the</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><ix:continuation id="f-330-1"><ix:continuation id="f-326-2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">resources. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">beginning after December 15, 2024. Retrospective application is required, and early adoption is permitted. The Company is</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">currently evaluating the impact the guidance will have on its consolidated financial statements.</span></div></ix:continuation></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div id="i141c83fee5da4f43b6493ac7539be527_40"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="f-331" continuedAt="f-331-1" escape="true">OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS</ix:nonNumeric></span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><ix:continuation id="f-331-1" continuedAt="f-331-2"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Composition of Certain Financial Statement Captions</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="text-indent:22.5pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="f-332" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of selected captions in the consolidated condensed balance sheets consisted of the following:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:75.586%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.190%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.191%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="f-333">280.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="f-334">252.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="f-335">258.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="f-336">220.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="f-337">668.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="f-338">695.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="f-339">1,207.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="f-340">1,168.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2024 and December&#160;31, 2023, $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" format="ixt:num-dot-decimal" scale="6" id="f-341">161.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" format="ixt:num-dot-decimal" scale="6" id="f-342">164.6</ix:nonFraction> million, respectively, of the Company's finished products inventories were held on consignment. </span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="f-343" escape="true"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:75.586%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.190%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.191%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax receivable (Note 14)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:IncomeTaxReceivable" scale="6" id="f-344">286.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:IncomeTaxReceivable" format="ixt:fixed-zero" scale="6" id="f-345">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes and other receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherReceivableAfterAllowanceForCreditLossNoncurrent" scale="6" id="f-346">159.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherReceivableAfterAllowanceForCreditLossNoncurrent" scale="6" id="f-347">155.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="ew:AcquisitionOptionsNoncurrent" scale="6" id="f-348">172.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="ew:AcquisitionOptionsNoncurrent" scale="6" id="f-349">161.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term prepaid royalties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PrepaidExpenseCurrentAndNoncurrent" scale="6" id="f-350">107.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PrepaidExpenseCurrentAndNoncurrent" scale="6" id="f-351">109.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" id="f-352">27.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" id="f-353">23.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" scale="6" id="f-354">13.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" scale="6" id="f-355">14.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="f-356">767.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="f-357">463.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued and other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and withholdings</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="f-358">237.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="f-359">371.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="f-360">85.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="f-361">59.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, payroll, and other taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="ew:AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent" scale="6" id="f-362">71.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="ew:AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent" scale="6" id="f-363">63.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="ew:ResearchAndDevelopmentAccruals" scale="6" id="f-364">75.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="ew:ResearchAndDevelopmentAccruals" scale="6" id="f-365">74.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="ew:AccruedRebates" scale="6" id="f-366">120.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="ew:AccruedRebates" scale="6" id="f-367">131.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DerivativeLiabilitiesCurrent" scale="6" id="f-368">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DerivativeLiabilitiesCurrent" scale="6" id="f-369">15.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued marketing expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AccruedMarketingCostsCurrent" scale="6" id="f-370">14.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccruedMarketingCostsCurrent" scale="6" id="f-371">15.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal and insurance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="ew:AccruedLitigationAndInsuranceReserves" scale="6" id="f-372">32.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="ew:AccruedLitigationAndInsuranceReserves" scale="6" id="f-373">30.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LitigationReserveCurrent" scale="6" id="f-374">76.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LitigationReserveCurrent" scale="6" id="f-375">69.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued relocation costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="ew:AccruedRelocationCostsCurrent" scale="6" id="f-376">19.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="ew:AccruedRelocationCostsCurrent" scale="6" id="f-377">19.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AccruedProfessionalFeesCurrent" scale="6" id="f-378">15.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccruedProfessionalFeesCurrent" scale="6" id="f-379">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued realignment reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:RestructuringReserveCurrent" scale="6" id="f-380">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:RestructuringReserveCurrent" scale="6" id="f-381">12.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued warranties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:ProductWarrantyAccrualClassifiedCurrent" scale="6" id="f-382">10.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ProductWarrantyAccrualClassifiedCurrent" scale="6" id="f-383">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="f-384">100.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="f-385">89.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="ew:AccruedAndOtherLiabilitiesCurrent" scale="6" id="f-386">873.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="ew:AccruedAndOtherLiabilitiesCurrent" scale="6" id="f-387">969.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="margin-top:5pt;text-indent:22.5pt"><span><br/></span></div><ix:continuation id="f-331-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="f-388" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supplemental Cash Flow Information</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the year for:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes (Note 14)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="f-389">349.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="f-390">21.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts included in the measurement of operating lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="f-391">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="f-392">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash investing and financing transactions:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="f-393">13.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="f-394">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures accruals</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="f-395">34.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="f-396">26.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" id="f-398" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" id="f-397" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.508%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="f-399">1,224.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="f-400">1,144.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:RestrictedCashCurrent" scale="6" id="f-401">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:RestrictedCashCurrent" scale="6" id="f-402">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="f-403">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="f-404">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents, and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-405">1,229.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-406">1,148.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts included in restricted cash primarily represent funds placed in escrow related to litigation.</span></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div id="i141c83fee5da4f43b6493ac7539be527_43"></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:LegalMattersAndContingenciesTextBlock" id="f-407" continuedAt="f-407-1" escape="true">INTELLECTUAL PROPERTY AGREEMENT AND CERTAIN LITIGATION EXPENSES</ix:nonNumeric></span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:18pt"><ix:continuation id="f-407-1" continuedAt="f-407-2"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 12, 2023, Edwards entered into an Intellectual Property Agreement (the "Intellectual Property Agreement") with Medtronic, Inc. ("Medtronic") pursuant to which the parties agreed to a <ix:nonNumeric contextRef="c-50" name="ew:IntellectualPropertyAgreementTerm" format="ixt-sec:durwordsen" id="f-408">15-year</ix:nonNumeric> global covenant not to sue ("CNS") for infringement of certain patents in the structural heart space owned or controlled by each other. In consideration for the global CNS and related mutual access to certain intellectual property rights, Edwards paid to Medtronic a one-time, lump sum payment of $<ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-5" name="us-gaap:PaymentsForLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="f-409">300.0</ix:nonFraction>&#160;million and is paying annual royalties tied to net sales of certain Edwards products.  Based upon the terms of the Intellectual Property Agreement, the Company identified the relevant elements for accounting purposes and allocated the $<ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-5" name="us-gaap:PaymentsForLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="f-410">300.0</ix:nonFraction>&#160;million upfront payment based on their respective fair values.  The Company recorded a $<ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-5" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="f-411">37.0</ix:nonFraction>&#160;million pre-tax charge in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intellectual Property Agreement and Certain Litigation Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in March 2023 related primarily to prior commercial sales incurred through March 31, 2023.  The Company recorded a prepaid royalty asset of $<ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-5" name="us-gaap:PrepaidRoyalties" format="ixt:num-dot-decimal" scale="6" id="f-412">124.0</ix:nonFraction>&#160;million in April 2023 related to future commercial sales, which will be amortized to expense during the term of the Intellectual Property Agreement.  Separately, the Company recorded a $<ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-5" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="f-413">139.0</ix:nonFraction>&#160;million pre-tax charge in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intellectual Property Agreement and Certain Litigation Expenses</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-407-2"> in April 2023 related to products currently in development.</ix:continuation>  </span></div><div><span><br/></span></div><div id="i141c83fee5da4f43b6493ac7539be527_46"></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock" id="f-414" continuedAt="f-414-1" escape="true">SEPARATION COSTS</ix:nonNumeric></span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><ix:continuation id="f-414-1"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 7, 2023, the Company announced its intention to complete a spin-off of its Critical Care product group as a separate publicly-traded company to Edwards Lifesciences' shareholders.  The proposed spin-off is intended to be a tax-free transaction for U.S. federal income tax purposes and is expected to be completed near the end of 2024, subject to the satisfaction of customary conditions including final approval by the Company's board of directors, receipt of a favorable opinion and Internal Revenue Service ruling with respect to the tax-free nature of the transaction, and the effectiveness of a registration statement on Form 10.  The Company incurred separation costs of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="f-415">41.3</ix:nonFraction>&#160;million during the three months ended March 31, 2024, related primarily to consulting, legal, tax, and other professional advisory services associated with the planned spin-off.  The costs related primarily to the Company's United States segment.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="i141c83fee5da4f43b6493ac7539be527_49"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="f-416" continuedAt="f-416-1" escape="true">INVESTMENTS</ix:nonNumeric></span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><ix:continuation id="f-416-1" continuedAt="f-416-2"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Securities</span></div><div style="text-indent:20.25pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock" id="f-417" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in debt securities at the end of each period were as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:23.164%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.730%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Held-to-maturity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank time deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-5" name="us-gaap:HeldToMaturitySecurities" scale="6" id="f-418">56.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-5" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" format="ixt:fixed-zero" scale="6" id="f-419">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-5" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" format="ixt:fixed-zero" scale="6" id="f-420">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-5" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="f-421">56.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-5" name="us-gaap:HeldToMaturitySecurities" scale="6" id="f-422">64.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-5" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" format="ixt:fixed-zero" scale="6" id="f-423">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-5" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" format="ixt:fixed-zero" scale="6" id="f-424">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-5" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="f-425">64.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-426">63.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-427">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-428">2.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-429">61.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-430">72.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-431">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-432">2.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-433">70.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-434">148.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-435">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-436">3.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-437">144.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-438">192.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-439">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-440">7.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-441">184.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-442">553.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-443">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-444">11.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-445">541.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-446">658.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-447">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-448">16.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-449">641.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-450">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-451">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-452">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-453">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-454">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-455">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-456">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-457">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-458">767.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-459">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-460">18.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-461">749.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-462">926.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-463">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-464">27.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-465">898.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="f-466" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost and fair value of investments in debt securities, by contractual maturity, as of March&#160;31, 2024, were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.578%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held-to-Maturity</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in 1&#160;year or less</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost" scale="6" id="f-467">56.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" scale="6" id="f-468">56.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" scale="6" id="f-469">422.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" scale="6" id="f-470">417.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after 1&#160;year through 5&#160;years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost" format="ixt:fixed-zero" scale="6" id="f-471">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" format="ixt:fixed-zero" scale="6" id="f-472">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" scale="6" id="f-473">181.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" scale="6" id="f-474">174.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments not due at a single maturity date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount" format="ixt:fixed-zero" scale="6" id="f-475">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" format="ixt:fixed-zero" scale="6" id="f-476">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" scale="6" id="f-477">163.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" scale="6" id="f-478">158.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" scale="6" id="f-479">56.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="f-480">56.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-481">767.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-482">749.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________</span></div><div style="padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)  &#160;&#160;&#160;&#160;Consists of mortgage-backed and asset-backed securities.</span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual maturities may differ from the contractual maturities due to call or prepayment rights.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" id="f-483" continuedAt="f-483-1" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present gross unrealized losses and fair values for those investments that were in an unrealized loss position as of March&#160;31, 2024 and December&#160;31, 2023, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.996%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.996%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.996%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.274%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:fixed-zero" scale="6" id="f-484">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="f-485">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="f-486">58.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-487">2.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="f-488">58.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-489">2.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-490">12.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="f-491">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="f-492">130.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-493">3.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="f-494">142.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-495">3.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:fixed-zero" scale="6" id="f-496">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="f-497">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="f-498">430.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-499">11.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="f-500">430.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-501">11.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:fixed-zero" scale="6" id="f-502">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="f-503">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="f-504">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-505">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="f-506">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-507">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-508">12.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="f-509">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="f-510">622.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-511">17.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="f-512">634.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-513">18.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><ix:continuation id="f-416-2" continuedAt="f-416-3"><ix:continuation id="f-483-1"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.411%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:fixed-zero" scale="6" id="f-514">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="f-515">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="f-516">67.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-517">2.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="f-518">67.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-519">2.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-520">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="f-521">1.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="f-522">172.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-523">6.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="f-524">182.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-525">7.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-526">25.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="f-527">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="f-528">601.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-529">16.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="f-530">626.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-531">16.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:fixed-zero" scale="6" id="f-532">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="f-533">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="f-534">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-535">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="f-536">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-537">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-538">35.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="f-539">1.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="f-540">843.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-541">25.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="f-542">878.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-543">27.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews its investments in debt securities to determine if there has been an other-than-temporary decline in fair value.  Consideration is given to 1) the financial condition and near-term prospects of the issuer, including the credit quality of the security's issuer, 2) the Company's intent to sell the security, and 3) whether it is more likely than not the Company will have to sell the security before recovery of its amortized cost. The unrealized losses on the debt securities were largely due to changes in interest rates, not credit quality, and as of March&#160;31, 2024, the Company did not intend to sell the securities, and it was not more likely than not that it will be required to sell the securities before recovery of the unrealized losses, and, therefore, the unrealized losses are considered temporary.  </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments in Unconsolidated Entities</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a number of equity investments in unconsolidated entities.  <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock" id="f-544" continuedAt="f-544-1" escape="true">These investments are recorded in </ix:nonNumeric></span><ix:continuation id="f-544-1" continuedAt="f-544-2"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the consolidated condensed balance sheets, and are as follows:</span></ix:continuation></div><ix:continuation id="f-544-2"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity method investments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of equity method investments</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:EquityMethodInvestments" scale="6" id="f-545">34.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:EquityMethodInvestments" scale="6" id="f-546">33.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of non-marketable equity securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="f-547">88.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="f-548">87.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total investments in unconsolidated entities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="6" id="f-549">122.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="6" id="f-550">121.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company makes equity investments in limited liability companies that invest in qualified community development entities ("CDEs") through the New Markets Tax Credit ("NMTC") program.  The NMTC program provides federal tax incentives to investors to make investments in distressed communities and promotes economic improvements through the development of successful businesses in these communities.  The NMTC is equal to <ix:nonFraction unitRef="number" contextRef="c-65" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-551">39</ix:nonFraction>% of the qualified investment and is taken over <ix:nonNumeric contextRef="c-66" name="ew:EquityMethodInvestmentsInvestmentPeriod" format="ixt-sec:durwordsen" id="f-552">seven years</ix:nonNumeric>. These limited liability companies are variable interest entities ("VIEs").  The Company determined that it is not the primary beneficiary of the VIEs because it does not have the power to direct the activities that most significantly impact the economic performance of the VIEs and, therefore, the Company does not consolidate these entities.  Instead, the NMTC investments are accounted for as equity method investments.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-marketable equity securities consist of investments in privately held companies without readily determinable fair values, and are reported at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer.  The Company recorded a downward adjustment of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" format="ixt:num-dot-decimal" scale="6" id="f-553">2.4</ix:nonFraction> million during the three months ended March 31, 2024 based on observable price changes.  As of March&#160;31, 2024, the Company had recorded cumulative upward adjustments of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" format="ixt:num-dot-decimal" scale="6" id="f-554">8.8</ix:nonFraction> million based on observable price changes, and cumulative downward adjustments of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" format="ixt:num-dot-decimal" scale="6" id="f-555">5.5</ix:nonFraction> million due to impairments and observable price changes.   </span></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-416-3">During the three months ended March 31, 2024, the gross realized gains or losses from sales of available-for-sale investments were not material.</ix:continuation> </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><div id="i141c83fee5da4f43b6493ac7539be527_52"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:VariableInterestEntityDisclosureTextBlock" id="f-556" continuedAt="f-556-1" escape="true">INVESTMENTS IN VARIABLE INTEREST ENTITIES </ix:nonNumeric></span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><ix:continuation id="f-556-1"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews its investments in other entities to determine whether the Company is the primary beneficiary of a VIE. The Company would be the primary beneficiary of the VIE, and would be required to consolidate the VIE, if it has the power to direct the significant activities of the entity and the obligation to absorb losses or receive benefits from the entity that may be significant to the VIE.  The Company's maximum loss exposure to variable interest entities, prior to the exercise of options to acquire the entities, is limited to its investment in the variable interest entities, which include equity investments, options to acquire, and promissory notes.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidated VIEs</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, the Company acquired a majority equity interest in a medical technology company pursuant to a preferred stock purchase agreement, and amended and restated a previous option agreement to acquire the remaining equity interest.  Edwards concluded that it is the primary beneficiary and consolidated the VIE.  The total assets and liabilities of the Company's consolidated VIE was $<ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-557">266.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-558">28.5</ix:nonFraction> million, respectively, as of March&#160;31, 2024, and were $<ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-559">272.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-560">31.5</ix:nonFraction> million, respectively, as of December&#160;31, 2023.  The assets of the VIE can only be used to settle obligations of the VIE and general creditors have no recourse to the Company. </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.315%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.329%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unconsolidated VIEs</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Edwards has relationships with various VIEs that it does not consolidate as Edwards lacks the power to direct the activities that significantly impact the economic success of these entities.  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Company entered into a promissory note agreement, a preferred stock purchase agreement, and an option agreement with a privately-held medical device company (the "Investee").  The secured promissory note provides for borrowings up to $<ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-5" name="ew:EquitySecuritiesFVNIMaximumSecuredPromissoryNote" format="ixt:num-dot-decimal" scale="6" id="f-561">45.0</ix:nonFraction>&#160;million. At both March&#160;31, 2024 and December&#160;31, 2023, the Company had advanced $<ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-5" name="ew:EquitySecuritiesFVNIPromissoryNoteOutstanding" format="ixt:num-dot-decimal" scale="6" id="f-562"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-5" name="ew:EquitySecuritiesFVNIPromissoryNoteOutstanding" format="ixt:num-dot-decimal" scale="6" id="f-563">30.0</ix:nonFraction></ix:nonFraction>&#160;million under the promissory note (included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). As of March&#160;31, 2024 and December&#160;31, 2023, the Company had invested $<ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="f-564">42.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="f-565">39.3</ix:nonFraction>&#160;million, respectively, in the Investee's preferred equity securities (included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and had paid $<ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-5" name="ew:EquitySecuritiesFVNIOptionToAcquireInvestment" format="ixt:num-dot-decimal" scale="6" id="f-566">20.9</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-5" name="ew:EquitySecuritiesFVNIOptionToAcquireInvestment" format="ixt:num-dot-decimal" scale="6" id="f-567">13.1</ix:nonFraction>&#160;million, respectively, for an option to acquire the Investee (included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).  Pursuant to the agreements, the Company may be required to invest up to an additional $<ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-5" name="ew:EquitySecuritiesFVNIMaximumAdditionalRequired" format="ixt:num-dot-decimal" scale="6" id="f-568">3.0</ix:nonFraction>&#160;million in the Investee's preferred equity securities and up to an additional $<ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-5" name="ew:EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment" format="ixt:num-dot-decimal" scale="6" id="f-569">6.6</ix:nonFraction>&#160;million for the option to acquire the Investee.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, the Company agreed to pay a medical device company up to $<ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-5" name="ew:LoansReceivablesMaximumLendingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-570">45.0</ix:nonFraction>&#160;million as consideration for an option</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to acquire that medical device company, of which $<ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-5" name="us-gaap:OtherPaymentsToAcquireBusinesses" format="ixt:num-dot-decimal" scale="6" id="f-571">30.0</ix:nonFraction>&#160;million had been paid as of March&#160;31, 2024. Also, in March 2023, Edwards advanced $<ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-5" name="us-gaap:NotesReceivableGross" format="ixt:num-dot-decimal" scale="6" id="f-572">5.0</ix:nonFraction>&#160;million to the medical device company under a convertible promissory note. The option and the note</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the consolidated balance sheets.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, Edwards has made equity investments through the NMTC program in limited liability companies that are considered VIEs.  For more information, see Note 5.</span></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div id="i141c83fee5da4f43b6493ac7539be527_58"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-573" continuedAt="f-573-1" escape="true">FAIR VALUE MEASUREMENTS</ix:nonNumeric></span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><ix:continuation id="f-573-1" continuedAt="f-573-2"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The Company prioritizes the inputs used to determine fair values in one of the following three categories:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Quoted market prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Inputs, other than quoted prices in active markets, that are observable, either directly or indirectly.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Unobservable inputs that are not corroborated by market data.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated condensed financial statements include financial instruments for which the fair market value of such instruments may differ from amounts reflected on a historical cost basis. Financial instruments of the Company consist of cash deposits, accounts and other receivables, investments, accounts payable, certain accrued liabilities, and borrowings under a revolving credit agreement. The carrying value of these financial instruments generally approximates fair value due to their </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><ix:continuation id="f-573-2" continuedAt="f-573-3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">short-term nature. Financial instruments also include notes payable.  As of March&#160;31, 2024, the fair value of the notes payable, based on Level 2 inputs, was $<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:NotesPayableFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-574">584.6</ix:nonFraction> million.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="text-indent:20.25pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="f-575" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:47.433%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.220%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">March 31, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="f-576">430.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-577">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-578">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="f-579">430.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-580">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-581">541.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-582">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-583">541.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-584">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-585">144.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-586">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-587">144.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-588">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-589">61.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-590">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-591">61.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-592">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-593">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-594">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-595">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held for deferred compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="f-596">130.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" format="ixt:fixed-zero" scale="6" id="f-597">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" format="ixt:fixed-zero" scale="6" id="f-598">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="f-599">130.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="f-600">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-601">57.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="f-602">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-603">57.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="f-604">560.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="f-605">807.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-606">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-607">1,368.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-5" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="f-608">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="f-609">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-5" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="f-610">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="f-611">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-5" name="us-gaap:OtherLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-612">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-5" name="us-gaap:OtherLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-613">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-5" name="us-gaap:OtherLiabilitiesFairValueDisclosure" scale="6" id="f-614">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-5" name="us-gaap:OtherLiabilitiesFairValueDisclosure" scale="6" id="f-615">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-616">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-617">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-618">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-619">9.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="f-620">579.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-621">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-622">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="f-623">579.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale investments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-624">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-625">641.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-626">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-627">641.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-628">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-629">184.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-630">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-631">184.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-632">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-633">70.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-634">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-635">70.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-636">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-637">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-638">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-639">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held for deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="f-640">125.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" format="ixt:fixed-zero" scale="6" id="f-641">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" format="ixt:fixed-zero" scale="6" id="f-642">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="f-643">125.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="f-644">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-645">47.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="f-646">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-647">47.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="f-648">705.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="f-649">945.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-650">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-651">1,650.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-5" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="f-652">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="f-653">15.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-5" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="f-654">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="f-655">15.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-5" name="us-gaap:OtherLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-656">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-5" name="us-gaap:OtherLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-657">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-5" name="us-gaap:OtherLiabilitiesFairValueDisclosure" scale="6" id="f-658">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-5" name="us-gaap:OtherLiabilitiesFairValueDisclosure" scale="6" id="f-659">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-660">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-661">15.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-662">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-663">25.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Equivalents and Available-for-sale Investments</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents included money market funds for the periods presented above.  The Company estimates the fair values of its money market funds based on quoted prices in active markets for identical assets.  The Company estimates the fair values of its corporate debt securities, asset-backed securities, United States and foreign government and agency securities, and municipal securities by taking into consideration valuations obtained from third-party pricing services. The pricing services use industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. These inputs include reported trades and broker-dealer quotes on the same or similar securities, benchmark yields, credit spreads, prepayment and default projections based on historical data, and other observable inputs.  The Company independently reviews and validates the pricing received from the third-party pricing service by comparing the prices to prices reported by a secondary pricing source.  The Company&#8217;s validation procedures have not resulted in an adjustment to the pricing received from the pricing service.  </span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Compensation Plans</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds investments related to its deferred compensation plans.  The investments are in a variety of stock, bond and money market mutual funds.  The fair values of these investments are based on quoted market prices.</span></div></ix:continuation><div style="text-indent:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><ix:continuation id="f-573-3"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Instruments</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments in the form of foreign currency forward exchange contracts and cross-currency swap contracts to manage foreign currency exposures.  All derivatives contracts are recognized on the balance sheet at their fair value.  The fair value of the derivative financial instruments was measured using quoted foreign exchange rates, interest rates, yield curves, and cross-currency swap basis rates.  The estimates presented herein are not necessarily indicative of the amounts that the Company could realize in a current market exchange.  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration Liabilities</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company's acquisitions involve contingent consideration arrangements.  Payment of additional consideration is contingent upon the acquired company reaching certain performance milestones, such as attaining specified sales levels or obtaining regulatory approvals.  These contingent consideration liabilities are measured at estimated fair value using either a probability weighted discounted cash flow analysis or a Monte Carlo simulation model, both of which consider significant unobservable inputs.  As of March&#160;31, 2024, the probability of milestone achievement was determined to be <ix:nonFraction unitRef="number" contextRef="c-116" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="f-664">0</ix:nonFraction>% and, accordingly, the contingent consideration liability was <ix:nonFraction unitRef="usd" contextRef="c-117" decimals="INF" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="0" id="f-665">zero</ix:nonFraction>.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="f-666" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the changes in fair value of Level 3 financial instruments measured at fair value on a recurring basis (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.174%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.675%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="6" id="f-667">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-668">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-669">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-670">Changes in fair value</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:fixed-zero" scale="6" id="f-671">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="f-672">5.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="f-673">5.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="6" id="f-674">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-675">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-676">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-677">26.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-678">14.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-679">40.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-680">Changes in fair value</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="f-681">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:fixed-zero" scale="6" id="f-682">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="f-683">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-684">26.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-685">14.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-686">40.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div id="i141c83fee5da4f43b6493ac7539be527_61"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;  <ix:nonNumeric contextRef="c-1" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="f-687" continuedAt="f-687-1" escape="true">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</ix:nonNumeric></span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><ix:continuation id="f-687-1" continuedAt="f-687-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" id="f-688" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk as summarized below. Notional amounts are stated in United States dollar equivalents at spot exchange rates at the respective dates. The Company does not enter into these arrangements for trading or speculation purposes.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:76.319%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.043%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-689">1,772.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-690">1,786.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-691">300.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-692">300.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative financial instruments involve credit risk in the event the counterparty should default.  It is the Company's policy to execute such instruments with global financial institutions that the Company believes to be creditworthy.  The Company diversifies its derivative financial instruments among counterparties to minimize exposure to any one of these entities.  The Company also uses International Swap Dealers Association master-netting agreements.  The master-netting agreements provide for the net settlement of all contracts through a single payment in a single currency in the event of default, as defined by the agreements.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses foreign currency forward exchange contracts and cross-currency swap contracts to manage its exposure to changes in currency exchange rates from (a) future cash flows associated with intercompany transactions and certain local currency expenses expected to occur within approximately <ix:nonNumeric contextRef="c-1" name="us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge" format="ixt-sec:duryear" id="f-693">1</ix:nonNumeric> year (designated as cash flow hedges), (b) its net investment in certain foreign subsidiaries (designated as net investment hedges) and (c) foreign currency denominated assets or liabilities (designated as fair value hedges).  The Company also uses foreign currency forward exchange contracts that are not </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><ix:continuation id="f-687-2" continuedAt="f-687-3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">designated as hedging instruments to offset the transaction gains and losses associated with revaluation of certain assets and liabilities denominated in currencies other than their functional currencies (resulting principally from intercompany and local currency transactions). </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative financial instruments are recognized at fair value in the consolidated condensed balance sheets.  For each derivative instrument that is designated as a fair value hedge, the gain or loss on the derivative included in the assessment of hedge effectiveness is recognized immediately to earnings, and offsets the loss or gain on the underlying hedged item.  The Company reports in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the gain or loss on derivative financial instruments that are designated, and that qualify, as cash flow hedges.  The Company reclassifies these gains and losses into earnings in the same line item and in the same period in which the underlying hedged transactions affect earnings.  Changes in the fair value of net investment hedges are reported in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as a part of the cumulative translation adjustment and would be reclassified into earnings if the underlying net investment is sold or substantially liquidated.  The portion of the change in fair value related to components excluded from the hedge effectiveness assessment are amortized into earnings over the life of the derivative.  The gains and losses on derivative financial instruments for which the Company does not elect hedge accounting treatment are recognized in the consolidated statements of operations in each period based upon the change in the fair value of the derivative financial instrument.  Cash flows from net investment hedges are reported as investing activities in the consolidated statements of cash flows, and cash flows from all other derivative financial instruments are reported as operating activities.</span></div><div style="text-indent:18pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" id="f-694" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the location and fair value amounts of derivative instruments reported in the consolidated condensed balance sheets (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:36.436%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.463%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.897%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet<br/>Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-695"><span style="-sec-ix-hidden:f-696">Assets</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-697">29.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-698">23.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-699">27.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-700">23.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-701"><span style="-sec-ix-hidden:f-702">Liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="f-703">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="f-704">15.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="text-indent:22.5pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:OffsettingAssetsTableTextBlock" id="f-706" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:OffsettingLiabilitiesTableTextBlock" id="f-705" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of master-netting agreements and rights of offset on the consolidated condensed balance sheets (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:29.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.325%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.889%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts <br/>Not Offset in<br/>the Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts<br/>Offset in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amounts<br/>Presented in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">March 31, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Amounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash<br/>Collateral<br/>Received</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-707">29.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:DerivativeAssetFairValueGrossLiability" format="ixt:fixed-zero" scale="6" id="f-708">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-709">29.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction" scale="6" id="f-710">4.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:DerivativeCollateralObligationToReturnCash" format="ixt:fixed-zero" scale="6" id="f-711">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" scale="6" id="f-712">24.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-713">27.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-5" name="us-gaap:DerivativeAssetFairValueGrossLiability" format="ixt:fixed-zero" scale="6" id="f-714">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-715">27.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-5" name="us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction" format="ixt:fixed-zero" scale="6" id="f-716">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-5" name="us-gaap:DerivativeCollateralObligationToReturnCash" format="ixt:fixed-zero" scale="6" id="f-717">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" scale="6" id="f-718">27.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-719">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:DerivativeLiabilityFairValueGrossAsset" format="ixt:fixed-zero" scale="6" id="f-720">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="f-721">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction" scale="6" id="f-722">4.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:DerivativeCollateralRightToReclaimCash" format="ixt:fixed-zero" scale="6" id="f-723">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral" format="ixt:fixed-zero" scale="6" id="f-724">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-725">23.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="us-gaap:DerivativeAssetFairValueGrossLiability" format="ixt:fixed-zero" scale="6" id="f-726">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-727">23.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction" scale="6" id="f-728">9.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="us-gaap:DerivativeCollateralObligationToReturnCash" format="ixt:fixed-zero" scale="6" id="f-729">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" scale="6" id="f-730">14.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-731">23.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-5" name="us-gaap:DerivativeAssetFairValueGrossLiability" format="ixt:fixed-zero" scale="6" id="f-732">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-733">23.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-5" name="us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction" format="ixt:fixed-zero" scale="6" id="f-734">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-5" name="us-gaap:DerivativeCollateralObligationToReturnCash" format="ixt:fixed-zero" scale="6" id="f-735">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" scale="6" id="f-736">23.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-737">15.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="us-gaap:DerivativeLiabilityFairValueGrossAsset" format="ixt:fixed-zero" scale="6" id="f-738">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="f-739">15.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction" scale="6" id="f-740">9.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="us-gaap:DerivativeCollateralRightToReclaimCash" format="ixt:fixed-zero" scale="6" id="f-741">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral" scale="6" id="f-742">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="f-743" continuedAt="f-743-1" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the effect of derivative and non-derivative hedging instruments on the consolidated condensed statements of operations and consolidated condensed statements of comprehensive income (in millions):</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><ix:continuation id="f-687-3" continuedAt="f-687-4"><ix:continuation id="f-743-1" continuedAt="f-743-2"><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:28.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.879%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.726%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in OCI<br/>on Derivative<br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Reclassified from<br/>Accumulated OCI<br/>into Income<br/>(Effective Portion)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Location&#160;of&#160;Gain&#160;or<br/>(Loss)&#160;Reclassified&#160;from<br/>Accumulated&#160;OCI<br/>into&#160;Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-744">36.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-745">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="f-746">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="f-747">29.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:29.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.738%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.444%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.919%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.738%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.889%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:28.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.782%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.487%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.891%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.782%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.785%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in OCI<br/>on Derivative <br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in&#160;Income on Derivative (Amount Excluded from <br/>Effectiveness Testing)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Location&#160;of&#160;Gain&#160;or<br/>(Loss)&#160;Recognized in&#160;Income on Derivative (Amount Excluded from Effectiveness Testing)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-748">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-749">2.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="f-750">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="f-751">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:28.944%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.767%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.325%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.998%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.767%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.919%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The cross-currency swap contracts have an expiration date of June 15, 2028.  At the maturity of the cross-currency swap contracts, the Company will deliver the notional amount of &#8364;<ix:nonFraction unitRef="eur" contextRef="c-154" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-752">257.2</ix:nonFraction> million and will receive $<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-753">300.0</ix:nonFraction> million from the counterparties.  The Company receives semi-annual interest payments from the counterparties based on a fixed interest rate until maturity of the agreements.</span></div><ix:continuation id="f-743-2"><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:43.980%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.177%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="f-754">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="6" id="f-755">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:43.980%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.177%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:43.980%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.177%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="f-756">12.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="f-757">5.4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="margin-bottom:12pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:43.980%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.177%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><ix:continuation id="f-687-4"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="f-758" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the effect of fair value and cash flow hedge accounting on the consolidated condensed statements of operations (in millions):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:80.917%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.528%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31, 2024</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other income, net</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts of income and expense line items presented in the consolidated condensed statements of operations in which the effects of fair value or cash flow hedges are recorded</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-759">385.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-760">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The effects of fair value and cash flow hedging:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on fair value hedging relationships:</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-5" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" format="ixt:fixed-zero" scale="6" id="f-761">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-5" sign="-" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" scale="6" id="f-762">4.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-5" name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" format="ixt:fixed-zero" scale="6" id="f-763">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" scale="6" id="f-764">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized in earnings based on an amortization approach</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" format="ixt:fixed-zero" scale="6" id="f-765">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" scale="6" id="f-766">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships:</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) reclassified from accumulated OCI into income</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="f-767">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:fixed-zero" scale="6" id="f-768">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:81.037%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.538%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31, 2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other income, net</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts of income and expense line items presented in the consolidated condensed statements of operations in which the effects of fair value or cash flow hedges are recorded</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-769">329.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-770">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The effects of fair value and cash flow hedging:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on fair value hedging relationships:</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-5" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" format="ixt:fixed-zero" scale="6" id="f-771">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-5" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" scale="6" id="f-772">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" format="ixt:fixed-zero" scale="6" id="f-773">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-5" sign="-" name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" scale="6" id="f-774">1.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized in earnings based on an amortization approach</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" format="ixt:fixed-zero" scale="6" id="f-775">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" scale="6" id="f-776">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships:</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) reclassified from accumulated OCI into income</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="f-777">29.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:fixed-zero" scale="6" id="f-778">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects that during the next twelve months it will reclassify to earnings a $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="f-779">12.7</ix:nonFraction> million gain currently recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:continuation><div style="text-indent:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><div id="i141c83fee5da4f43b6493ac7539be527_64"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;  <ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-780" continuedAt="f-780-1" escape="true">STOCK-BASED COMPENSATION  </ix:nonNumeric></span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><ix:continuation id="f-780-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="f-781" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense related to awards issued under the Company's incentive compensation plans for the three months ended March 31, 2024 and 2023 was as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.315%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.329%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-782">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-783">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-784">24.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-785">22.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-786">11.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-787">9.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separation costs</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-788">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="6" id="f-789">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-790">44.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-791">38.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="f-792">6.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="f-793">4.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense, net of tax</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="f-794">38.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="f-795">34.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2024, the total remaining compensation cost related to nonvested stock options, restricted stock units, market-based restricted stock units, and employee stock purchase plan ("ESPP") subscription awards amounted to $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="f-796">242.6</ix:nonFraction> million, which will be amortized on a straight-line basis over each award's requisite service period.  The weighted-average remaining requisite service period is <ix:nonNumeric contextRef="c-1" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:durmonth" id="f-797">30</ix:nonNumeric> months.  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Disclosures</span></div><div style="text-indent:18pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="f-798" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the weighted-average grant-date fair values of stock options granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Option Awards</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-175" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-799">4.3</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-176" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-800">4.1</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-175" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-801">None</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-176" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-802">None</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-175" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-803">32.7</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-176" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-804">31.3</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-175" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-805">5.3</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-176" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-806">5.3</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, per option</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-175" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-807">32.91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-176" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-808">27.77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" id="f-809" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the weighted-average grant-date fair values for ESPP subscriptions granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">ESPP</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-177" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-810">5.1</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-178" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-811">4.6</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-177" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-812">None</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-178" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-813">None</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-177" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-814">34.8</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-178" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-815">31.5</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-177" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-816">0.6</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-178" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-817">0.6</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, per share</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-177" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-818">25.52</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-178" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-819">21.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="i141c83fee5da4f43b6493ac7539be527_67"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;  <ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-820" continuedAt="f-820-1" escape="true">ACCELERATED SHARE REPURCHASE</ix:nonNumeric></span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><ix:continuation id="f-820-1"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2023, the Company entered into an accelerated share repurchase ("ASR") agreement providing for the repurchase of the Company's common stock based on the volume-weighted average price ("VWAP") of the Company's common stock during the term of the agreement, less a discount.  <ix:nonNumeric contextRef="c-1" name="us-gaap:AcceleratedShareRepurchasesTextBlock" id="f-821" continuedAt="f-821-1" escape="true">The following table summarizes the terms of the ASR agreement (dollars and shares in millions, except per share data):</ix:nonNumeric></span></div><ix:continuation id="f-821-1"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.730%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.437%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Initial Delivery</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Final Settlement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agreement Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount<br/>Paid</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Received</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Price per<br/>Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value of<br/>Shares as %<br/>of Contract<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlement<br/>Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Shares<br/>Received</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price<br/>per Share</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="6" id="f-822">200.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-180" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-823">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-180" decimals="2" name="us-gaap:AcceleratedShareRepurchasesInitialPricePaidPerShare" scale="0" id="f-824">80.44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-180" decimals="2" name="ew:AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount" scale="-2" id="f-825">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-181" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-826">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-181" decimals="2" name="us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare" scale="0" id="f-827">79.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ASR agreement was accounted for as two separate transactions: (1)&#160;the value of the initial delivery of shares was recorded as shares of common stock acquired in a treasury stock transaction on the acquisition date, and (2)&#160;the remaining amount of the purchase price paid was recorded as a forward contract indexed to the Company's own common stock and was initially recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Additional Paid-in Capital</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and subsequently, upon settlement, was transferred to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the consolidated condensed balance sheets. The initial delivery of shares resulted in an immediate reduction of the outstanding shares used to calculate the weighted-average common shares outstanding for basic and diluted earnings per share. The Company determined that the forward contract indexed to the Company's common stock met all the applicable criteria for equity classification and, therefore, was not accounted for as a derivative instrument.</span></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div id="i141c83fee5da4f43b6493ac7539be527_70"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;  <ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-828" continuedAt="f-828-1" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><ix:continuation id="f-828-1" continuedAt="f-828-2"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, the Company initiated an internal review and investigation into whether business activities in Japan and other markets violated certain provisions of the Foreign Corrupt Practices Act (&#8220;FCPA&#8221;).  The Company voluntarily notified the SEC and the United States Department of Justice (&#8220;DOJ&#8221;) during 2021 that it has engaged outside counsel to conduct this review and investigation. The Company has provided status updates to the SEC and DOJ since that time. Any determination that the Company&#8217;s operations or activities are not in compliance with existing laws, including the FCPA, could result in the imposition of fines, penalties, and equitable remedies. The Company cannot currently predict the final outcome of the investigation or any potential impact on its financial statements.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2021, Aortic Innovations LLC, a non-practicing entity, filed a lawsuit against Edwards Lifesciences Corporation and certain of its subsidiaries (&#8220;Edwards&#8221;) in the United States District Court for the District of Delaware alleging that Edwards&#8217; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SAPIEN 3 Ultra</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> product infringes certain of its patents.  The Company is unable to predict the ultimate outcome of this matter or estimate a range of possible exposure; therefore, no amounts have been accrued.  The Company intends to vigorously defend itself in this litigation.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The European Commission (the &#8220;Commission&#8221;) is investigating certain business practices of Edwards including its unilateral pro-innovation (anti-copycat) policy and patent practices.  The Company is cooperating with the Commission and believes its business practices support healthy competition.  The Company cannot predict the outcome of the investigation or the potential impact on our financial statements.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is or may be a party to, or may otherwise be responsible for, pending or threatened lawsuits including those related to products and services currently or formerly manufactured or performed, as applicable, by the Company, workplace and employment matters, matters involving real estate, Company operations or health care regulations, contingent considerations, or governmental investigations (the &#8220;Lawsuits&#8221;). The Lawsuits raise difficult and complex factual and legal issues and are subject to many uncertainties, including, but not limited to, the facts and circumstances of each particular case or claim, the jurisdiction in which each suit is brought, and differences in applicable law. Management does not believe that any loss relating to the Lawsuits would have a material adverse effect on the Company's overall financial condition, results of operations or cash flows. However, the resolution of <ix:nonFraction unitRef="lawsuit" contextRef="c-1" decimals="INF" name="ew:LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber" format="ixt-sec:numwordsen" scale="0" id="f-829">one</ix:nonFraction> or more of the Lawsuits in any reporting period, could have a material adverse impact on the Company's financial results for that period. The Company is not able to estimate the amount or range of any loss for legal contingencies related to the Lawsuits for which there is no reserve or additional loss for matters already reserved.</span></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-828-2">The Company is subject to various environmental laws and regulations both within and outside of the United States. The Company's operations, like those of other medical device companies, involve the use of substances regulated under environmental laws, primarily in manufacturing and sterilization processes. While it is difficult to quantify the potential impact of continuing compliance with environmental protection laws, management believes that such compliance will not have a material impact on the Company's financial results. The Company's threshold for disclosing material environmental legal proceedings involving a governmental authority where potential monetary sanctions are involved is $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-6" name="ew:AccrualForEnvironmentalLossContingenciesThresholdAmountForDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-830">1</ix:nonFraction>&#160;million.</ix:continuation>  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div id="i141c83fee5da4f43b6493ac7539be527_73"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;  <ix:nonNumeric contextRef="c-1" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="f-831" continuedAt="f-831-1" escape="true">ACCUMULATED OTHER COMPREHENSIVE LOSS</ix:nonNumeric></span></div><div style="text-indent:18pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="f-832" escape="true"><ix:continuation id="f-831-1" continuedAt="f-831-2"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the activity for each component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.642%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain on Hedges</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Loss on Available-for-sale Investments</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Costs</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-833">214.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-834">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-835">24.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-836">4.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-837">242.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-838">23.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-839">43.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-840">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-841">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-842">27.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="f-843">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="f-844">7.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="f-845">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-846">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="f-847">6.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax expense </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-848">1.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-849">9.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-850">1.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-851">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-852">11.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-853">240.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-854">27.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-855">16.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-856">3.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-857">233.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.696%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain on Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Loss on Available-for-sale Investments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Pension<br/>Credits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-858">218.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-859">23.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-860">65.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-861">5.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-862">254.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-863">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-864">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-865">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-866">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-867">20.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="f-868">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="f-869">29.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="f-870">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-871">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="f-872">27.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-873">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-874">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" format="ixt:fixed-zero" scale="6" id="f-875">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" format="ixt:fixed-zero" scale="6" id="f-876">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-877">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-878">215.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-203" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-879">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-204" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-880">52.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-881">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-882">255.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr></table></div></ix:continuation></ix:nonNumeric><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" id="f-883" escape="true"><ix:continuation id="f-831-2"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about amounts reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.800%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.384%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Affected Line on Consolidated Condensed<br/>Statements of Operations</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Details about Accumulated Other</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Comprehensive Loss Components</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-884">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-885">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-886">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-887">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="f-888">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="f-889">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on hedges</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-5" sign="-" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-890">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-5" sign="-" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-891">29.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-892">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="6" id="f-893">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-894">7.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-895">29.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-896">1.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-897">7.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="f-898">5.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="f-899">22.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on available-for-sale investments</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-5" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="f-900">2.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-5" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="f-901">4.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-902">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-903">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="f-904">1.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="f-905">3.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation></ix:nonNumeric><div><span><br/></span></div><div id="i141c83fee5da4f43b6493ac7539be527_76"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;  <ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-906" continuedAt="f-906-1" escape="true">EARNINGS PER SHARE</ix:nonNumeric></span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><ix:continuation id="f-906-1" continuedAt="f-906-2"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed by dividing net income by the weighted-average common shares outstanding during the period. Diluted earnings per share is computed based on the weighted-average common shares outstanding plus the effect of dilutive potential common shares outstanding during the period calculated using the treasury stock method. Dilutive potential common shares include employee equity share options, nonvested shares, and similar equity instruments granted by the Company. Potential common share equivalents have been excluded where their inclusion would be anti-dilutive. </span></div><div style="text-indent:18pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-907" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Edwards Lifesciences Corporation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="f-908">351.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="f-909">340.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-910">601.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-911">607.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-912">0.58</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-913">0.56</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Edwards Lifesciences Corporation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="f-914">351.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="f-915">340.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-916">601.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-917">607.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock plans</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-918">2.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-919">3.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive weighted-average shares outstanding</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-920">604.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-921">610.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-922">0.58</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-923">0.56</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-906-2">Stock options, restricted stock units, and market-based restricted stock units to purchase an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-212" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="f-924">5.3</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="c-213" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="f-925">5.2</ix:nonFraction> million common shares for the three months ended March 31, 2024 and 2023, respectively, were outstanding, but were not included in the computation of diluted earnings per share for such periods because the effect would have been anti-dilutive.</ix:continuation> </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="i141c83fee5da4f43b6493ac7539be527_79"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;  <ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-926" continuedAt="f-926-1" escape="true">INCOME TAXES</ix:nonNumeric></span></div><div style="text-indent:22.5pt"><span><br/></span></div><ix:continuation id="f-926-1" continuedAt="f-926-2"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's effective income tax rates were <ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-927">14.3</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-5" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-928">14.6</ix:nonFraction>% for the three months ended March 31, 2024 and 2023, respectively.  The decrease in the effective rate between the three months ended March 31, 2024 and 2023 is primarily due </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to an increased tax benefit from employee share-based compensation.  In addition, the effective rates for the three months ended March 31, 2024 and 2023 were lower than the federal statutory rate of 21% primarily due to (1) foreign earnings taxed at lower rates, (2) Federal and California research and development credits, and (3) the tax benefit from employee share-based compensation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective rates include a tax benefit from employee share-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">based</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> compensation of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="6" id="f-929">6.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="6" id="f-930">2.9</ix:nonFraction> million for the three months ended March 31, 2024 and 2023, respectively.   </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Internal Revenue Service ("IRS") and other taxing authorities are in different stages of examining various years of the Company's tax filings.  During these audits, the Company may receive proposed audit adjustments that could be material.  An adverse outcome in these audits could have a material effect on the Company's results of operations and financial condition.  The Company strives to resolve open matters with each tax authority at the examination level and could reach agreement with a tax authority at any time.  While the Company has accrued for matters it believes are more likely than not to require settlement, the final outcome with a tax authority may result in a tax liability that is materially different from that reflected in the consolidated financial statements.  Furthermore, the Company may later decide to challenge any assessments, if made, and may exercise its right to appeal. The uncertain tax positions are reviewed quarterly and adjusted as events occur that affect potential liabilities for additional taxes, such as lapsing of applicable statutes of limitations, proposed assessments by tax authorities, negotiations between tax authorities, identification of new issues, and issuance of new legislation, regulations, or case law.  </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2024 and December&#160;31, 2023, the gross liability recorded for income taxes associated with uncertain tax positions was $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="f-931">608.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="f-932">583.9</ix:nonFraction> million, respectively. The Company estimates that these liabilities would be reduced by $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" format="ixt:num-dot-decimal" scale="6" id="f-933">265.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" format="ixt:num-dot-decimal" scale="6" id="f-934">250.7</ix:nonFraction> million, respectively, from offsetting tax benefits associated with the correlative effects of potential transfer pricing adjustments, state income taxes, and timing adjustments. The net amounts of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="f-935">342.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="f-936">333.2</ix:nonFraction> million, respectively, if not required, would favorably affect the Company's effective tax rate. Management believes that adequate amounts of tax and related penalty and interest have been provided for any adjustments that may result from these uncertain tax positions.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company executed an Advance Pricing Agreement (&#8220;APA&#8221;) in 2018 between the United States and Switzerland governments for tax years 2009 through 2020 covering various, but not all, transfer pricing matters.  The unagreed transfer pricing matters, namely Surgical Structural Heart and Transcatheter Aortic Valve Replacement (collectively "Surgical/TAVR") intercompany royalty transactions, then reverted to IRS examination for further consideration as part of the respective years' regular tax audits.  In addition, the Company executed other bilateral APAs as follows: during 2017, an APA between the United States and Japan covering tax years 2015 through 2019; and during 2018, APAs between Singapore and Japan and between Switzerland and Japan covering tax years 2015 through 2019.  The Company has filed to renew all <ix:nonFraction unitRef="agreement" contextRef="c-214" decimals="INF" name="ew:NumberOfAdvancePricingAgreementsRenewed" format="ixt-sec:numwordsen" scale="0" id="f-937">three</ix:nonFraction> of the APAs with Japan for the years 2020 and forward.  An APA between Switzerland and Japan covering tax years 2020 through 2024 was executed in 2021.  An APA between the United States and Japan covering tax years 2020 through 2024 was executed in 2023.  The execution of some or all these APA renewals depends on many variables outside of Edwards' control.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The audits of the Company&#8217;s United States federal income tax returns through 2014 have been closed.  The IRS audit field work for the 2015 through 2017 tax years was completed during the second quarter of 2021, except for transfer pricing and related matters.  The IRS is currently examining the 2018 through 2020 tax years.  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The audits of the Company's material state, local, and foreign income tax matters have been concluded for years through 2015.  While not material, the Company continues to address matters in India for years since 2010. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, the Company received a Notice of Proposed Adjustment (&#8220;NOPA&#8221;) from the IRS for the 2015 through 2017 tax years relating to transfer pricing involving Surgical/TAVR intercompany royalty transactions between the Company's United States and Switzerland subsidiaries.  The NOPA proposed a substantial increase to the Company's United States taxable income, which could result in additional tax expense for this period of approximately $<ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-6" name="ew:IncomeTaxAssessmentEstimateOfAdditionalTaxExpense" format="ixt:num-dot-decimal" scale="6" id="f-938">230</ix:nonFraction> million and reflects a departure from a transfer pricing method the Company had previously agreed upon with the IRS.  The Company disagreed with the NOPA and pursued an administrative appeal with the IRS Independent Office of Appeals ("Appeals").  The Appeals process culminated in the third quarter of 2023 when the Company and Appeals concluded that a satisfactory resolution of the matter at the administrative level was not possible.  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2023, Appeals issued a notice of deficiency ("NOD") increasing the Company's 2015 through 2017 United States federal income tax in amounts resulting from the income adjustments previously reflected in the NOPA.  </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><ix:continuation id="f-926-2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The additional tax sought in excess of the Company's filing position is $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority" format="ixt:num-dot-decimal" scale="6" id="f-939">269.3</ix:nonFraction>&#160;million before consideration of interest and a repatriation tax offset.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company plans to vigorously contest the additional tax claimed by the IRS through the judicial process.  Final resolution of this matter is not likely within the next 12 months.  The Company believes the amounts previously accrued related to this uncertain tax position are appropriate for a number of reasons, including the interpretation and application of relevant tax law and accounting standards to the Company's facts and, accordingly, has not accrued any additional amount based on the NOD and other proceedings to date.  Nonetheless, the outcome of the judicial process cannot be predicted with certainty, and it is possible that the outcome of that process could have a material impact on the Company's consolidated financial statements.  As noted below, similar material tax disputes may arise for the 2018 through 2023 tax years. While no payment of any amount related to the NOPA or NOD has yet been required, the Company made a partial deposit with the IRS of $<ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-6" name="ew:IncomeTaxExaminationAmountDepositedToMitigateInterestOnTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-940">75</ix:nonFraction>&#160;million in November 2022 to prevent the further accrual of interest on that portion of any additional tax the Company may ultimately be found to owe.  In March 2024, the Company made an additional deposit with the IRS of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="ew:IncomeTaxExaminationAmountDepositedToMitigateInterestOnTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-941">305</ix:nonFraction>&#160;million to further mitigate interest on potential tax liabilities while the Company prepares to contest through the judicial process the IRS's entitlement to any of the additional tax claimed by the IRS. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Surgical/TAVR intercompany royalty transactions covering tax years 2018 through 2023 remain subject to IRS examination, and those transactions and related tax positions remain uncertain as of March&#160;31, 2024.  The Company has considered this information, as well as information regarding the NOPA, the rebuttal and Appeals discussions described above, in its evaluation of its uncertain tax positions.  The impact of these unresolved transfer pricing matters, net of any correlative tax adjustments, may be significant to the Company&#8217;s consolidated financial statements.  Based on the information currently available and numerous possible outcomes, the Company cannot reasonably estimate what, if any, changes in its existing uncertain tax positions may occur in the next 12 months and, therefore, has continued to record the uncertain tax positions as a long-term liability.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2024, the Company received a notice of assessment from the Israel Tax Authority (&#8220;ITA&#8221;) wherein the ITA claimed that the Company owes approximately $<ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-6" name="us-gaap:IncomeTaxExaminationEstimateOfPossibleLoss" format="ixt:num-dot-decimal" scale="6" id="f-942">110</ix:nonFraction>&#160;million of tax excluding interest and penalties in connection with a claimed 2017 transfer of intellectual property. The Company maintains that it did not transfer intellectual property outside of Israel and intends to vigorously defend that position through administrative and, if necessary, judicial proceedings.  There can be no assurance that this matter will be resolved in the Company's favor and an adverse outcome could have a material effect on the Company's consolidated financial statements.</span></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div id="i141c83fee5da4f43b6493ac7539be527_82"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.&#160;&#160;&#160;  <ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-943" continuedAt="f-943-1" escape="true">SEGMENT INFORMATION</ix:nonNumeric></span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><ix:continuation id="f-943-1" continuedAt="f-943-2"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Edwards Lifesciences conducts operations worldwide and is managed in the following geographical regions: United States, Europe, Japan, and Rest of World. All regions sell products that are used to treat advanced cardiovascular disease.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's geographic segments are reported based on the financial information provided to the Chief Operating Decision Maker (the Chief Executive Officer). The Company evaluates the performance of its geographic segments based on net sales and operating income. Segment net sales and segment operating income are based on internally derived foreign exchange rates and do not include inter-segment profits. Because of the interdependence of the reportable segments, the operating profit as presented may not be representative of the geographical distribution that would occur if the segments were not interdependent. Net sales by geographic area are based on the location of the customer. There were no customers that represented 10% or more of the Company's total net sales.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain items are maintained at the corporate level and are not allocated to the segments. The non-allocated items include corporate research and development expenses, manufacturing variances, corporate headquarters costs, net interest income, global marketing expenses, special gains and charges, stock-based compensation, foreign currency hedging activities, certain litigation costs, changes in the fair value of contingent consideration liabilities, and most of the Company's amortization expense. Although most of the Company's depreciation expense is included in segment operating income, due to the Company's methodology for cost build-up, it is impractical to determine the amount of depreciation expense included in each segment and, therefore, a portion is maintained at the corporate level. The Company neither discretely allocates assets to its operating segments, nor evaluates the operating segments using discrete asset information.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="text-indent:18pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="f-944" escape="true"><ix:continuation id="f-943-2" continuedAt="f-943-3"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents information about Edwards Lifesciences' reportable segments (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:71.801%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.715%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-945">940.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-946">849.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-947">363.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-221" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-948">335.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-949">112.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-950">104.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-951">182.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-952">165.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment net sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-953">1,598.6</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-954">1,454.4</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Operating Income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-955">616.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-956">563.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-957">191.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-221" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-958">181.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-959">60.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-960">63.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-961">77.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-962">70.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-963">945.5</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-964">879.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated pre-tax income (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:71.841%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.695%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales Reconciliation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment net sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-965">1,598.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-966">1,454.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-967">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-968">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-969">1,598.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-970">1,459.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pre-tax Income Reconciliation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-971">945.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-972">879.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate items</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-5" name="us-gaap:CostsAndExpenses" scale="6" id="f-973">503.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-5" name="us-gaap:CostsAndExpenses" scale="6" id="f-974">468.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separation costs (Note&#160;4)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-5" name="us-gaap:OtherNonrecurringIncomeExpense" scale="6" id="f-975">41.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-5" name="us-gaap:OtherNonrecurringIncomeExpense" format="ixt:fixed-zero" scale="6" id="f-976">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intellectual property agreement and certain litigation expenses</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-5" name="us-gaap:LitigationSettlementExpense" scale="6" id="f-977">8.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-5" name="us-gaap:LitigationSettlementExpense" scale="6" id="f-978">43.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:fixed-zero" scale="6" id="f-979">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="f-980">0.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="f-981">3.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-5" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="f-982">22.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated operating income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-983">387.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-984">388.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-5" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-985">21.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-5" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-986">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated pre-tax income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-987">409.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-988">398.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="f-943-3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Enterprise-wide Information</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" id="f-989" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated condensed financial statements.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:71.801%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.715%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Geographic Region</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-990">940.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-991">849.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-992">367.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-993">331.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-994">110.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-995">114.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-996">178.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-997">165.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-998">1,598.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-999">1,459.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Major Product Group</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transcatheter Aortic Valve Replacement</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1000">1,007.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-241" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1001">947.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transcatheter Mitral and Tricuspid Therapies</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-242" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1002">72.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-243" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1003">41.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Structural Heart</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-244" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1004">266.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-245" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1005">248.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Critical Care</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-246" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1006">251.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-247" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1007">221.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1008">1,598.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1009">1,459.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><div id="i141c83fee5da4f43b6493ac7539be527_85"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2.&#160;&#160;&#160;&#160;Management's Discussion and Analysis of Financial Condition and Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div id="i141c83fee5da4f43b6493ac7539be527_88"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis contains forward-looking statements within the meaning of the federal securities laws, and should be read in conjunction with the disclosures we make concerning risks and other factors that may affect our business and operating results. See &#8220;Note Regarding Forward-Looking Statements&#8221; preceding Part I, Item 1 in this Quarterly Report on Form 10-Q.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are the global leader in patient-focused medical innovations for structural heart disease and critical care monitoring. Driven by a passion to help patients, we partner with the world's leading clinicians and researchers and invest in research and development to transform care for those impacted by structural heart disease or who require hemodynamic monitoring during surgery or in intensive care.  We conduct operations worldwide and are managed in the following geographical regions: United States, Europe, Japan, and Rest of World. Our products are categorized into the following groups: Transcatheter Aortic Valve Replacement ("TAVR"), Transcatheter Mitral and Tricuspid Therapies ("TMTT"), Surgical Structural Heart ("Surgical"), and Critical Care.  On December 7, 2023, we announced our intention to complete a tax-free spin-off of our Critical Care product group near the end of 2024.  The planned separation will enable us to pursue expanded opportunities for TAVR, TMTT, and Surgical patients, as well as new investments in interventional heart failure technologies.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Highlights</span></div><div><img src="ew-20240331_g1.jpg" alt="1201" style="height:333px;margin-bottom:5pt;vertical-align:text-bottom;width:342px"/><img src="ew-20240331_g2.jpg" alt="1202" style="height:333px;margin-bottom:5pt;vertical-align:text-bottom;width:341px"/></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net sales for the first three months of 2024 were $1.6 billion, representing an increase of $138.6 million over the first three months of 2023, driven primarily by sales of our TAVR products. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our gross profit increased in the three months ended March 31, 2024, driven by our sales growth.  Gross profit as a percentage of sales decreased primarily due to foreign currency rate fluctuations. The increase in our diluted earnings per share in the three months ended March 31, 2024 was driven by our increased gross profit, partially offset by an after-tax charge of $36.8 million related to costs associated with the planned spin-off of our Critical Care product group.  See Note 4 to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Condensed Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further information.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Healthcare Environment, Opportunities, and Challenges</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical technology industry is highly competitive and continues to evolve. Our success is measured both by the development of innovative products and the value we bring to our stakeholders. We are committed to developing new technologies and providing innovative patient care, and we are committed to defending our intellectual property in support of those developments.  Our vision for growth is to treat patients with both valvular and non-valvular structural heart disease, such as heart failure, which is a natural progression of the disease for many patients suffering from aortic stenosis and mitral and tricuspid regurgitation. In the first three months of 2024, we invested 17.8% of our net sales in research and development. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are dedicated to generating robust clinical, economic, and quality-of-life evidence increasingly expected by patients, clinicians, and payors in the current healthcare environment, with the goal of encouraging the adoption of innovative new medical therapies that demonstrate superior outcomes.  </span></div><div id="i141c83fee5da4f43b6493ac7539be527_91"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Standards</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information on new accounting standards is included in Note 1 to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Condensed Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div id="i141c83fee5da4f43b6493ac7539be527_94"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Sales by Region</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars in millions)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.712%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.655%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">940.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside of the United States</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">657.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,459.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales outside of the United States include the impact of foreign currency exchange rate fluctuations.  The impact of foreign currency exchange rate fluctuations on net sales is not necessarily indicative of the impact on net income due to the corresponding effect of foreign currency exchange rate fluctuations on international manufacturing and operating costs, and our hedging activities.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Sales by Product Group</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars in millions)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.712%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.655%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transcatheter Aortic Valve Replacement</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,007.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">947.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transcatheter Mitral and Tricuspid Therapies</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Structural Heart</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Critical Care</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,459.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:12pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transcatheter Aortic Valve Replacement Sales</span></div><div style="margin-bottom:8pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><img src="ew-20240331_g3.jpg" alt="566" style="height:333px;margin-bottom:5pt;vertical-align:text-bottom;width:469px"/></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales of TAVR products increased for the three months ended March 31, 2024 driven by higher sales of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Edwards SAPIEN </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">platform in 2024, primarily the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Edwards SAPIEN 3 Ultra RESILIA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> valve in the United States and Japan, and the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Edwards SAPIEN 3 Ultra</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> valve in Europe. </span></div><div style="padding-left:13.5pt;text-indent:4.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2024, we completed patient treatment in our PROGRESS pivotal trial, studying the treatment of moderate aortic stenosis patients, and we received CE Mark approval for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Edwards SAPIEN 3 Ultra RESILIA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> valve in Europe. </span></div><div style="margin-bottom:8pt;margin-top:12pt;padding-left:36pt;text-indent:-13.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:12pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transcatheter Mitral and Tricuspid Therapies Sales</span></div><div style="margin-bottom:8pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><img src="ew-20240331_g4.jpg" alt="1517" style="height:333px;margin-bottom:5pt;vertical-align:text-bottom;width:469px"/></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales of TMTT products increased for the three months ended March 31, 2024 primarily due to higher sales of our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PASCAL </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">system and our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">EVOQUE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> replacement system in the United States and Europe.  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In mitral replacement, we completed enrollment in the ENCIRCLE pivotal trial for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SAPIEN M3 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and, in January 2024, we received FDA approval for a S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">APIEN M3 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">continued access program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2024, we received FDA approval for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">EVOQUE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the treatment of tricuspid regurgitation. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Surgical Structural Heart Sales</span></div><div style="margin-bottom:8pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><img src="ew-20240331_g5.jpg" alt="2634" style="height:333px;margin-bottom:5pt;vertical-align:text-bottom;width:469px"/></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales of Surgical products increased for the three months ended March 31, 2024 primarily due to higher sales of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">INSPIRIS RESILIA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> aortic valve in the United States and Europe, the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> KONECT RESILIA </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">tissue valved conduit in the United States, and the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MITRIS RESILIA </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">valve in the United States.   </span></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are continuing to enroll patients in our MOMENTIS clinical study to demonstrate the durability of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RESILIA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> tissue in the mitral position.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:12pt;padding-left:13.5pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Critical Care Sales</span></div><div style="margin-bottom:8pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><img src="ew-20240331_g6.jpg" alt="3468" style="height:333px;margin-bottom:5pt;vertical-align:text-bottom;width:469px"/></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales of Critical Care products increased for the three months ended March 31, 2024 primarily due to:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="padding-left:49.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">increased demand for our enhanced surgical recovery products and pressure monitoring products, primarily in the United States; </span></div><div style="padding-left:13.5pt;text-indent:4.5pt"><span><br/></span></div><div style="padding-left:13.5pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">partially offset by:</span></div><div style="padding-left:13.5pt;text-indent:4.5pt"><span><br/></span></div><div style="padding-left:49.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">foreign currency exchange rate fluctuations, which decreased net sales outside of the United States by $2.3 million for the three months ended March 31, 2024, primarily due to the weakening of the Japanese yen against the United States dollar.</span></div><div style="padding-left:13.5pt;text-indent:4.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Profit</span></div><div style="text-indent:18pt"><img src="ew-20240331_g7.jpg" alt="4039" style="height:285px;margin-bottom:5pt;vertical-align:text-bottom;width:506px"/></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in gross profit as a percentage of net sales for the three months ended March 31, 2024 was driven by a 1.6 percentage point negative impact from foreign currency rate fluctuations, primarily the weakening of the United States dollar against the Euro, partially offset by the weakening of the Japanese yen against the United States dollar.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Selling, General, and Administrative ("SG&amp;A") Expenses</span></div><div style="text-indent:18pt"><img src="ew-20240331_g8.jpg" alt="4386" style="height:285px;margin-bottom:5pt;vertical-align:text-bottom;width:506px"/></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SG&amp;A expenses increased for the three months ended March 31, 2024 primarily due to higher field-based personnel-related costs in support of our growth strategy initiatives, primarily in the United States and Europe. Foreign currency exchange rate fluctuations decreased expenses by $1.7 million for the three months ended March 31, 2024 primarily due to the weakening of the Japanese yen against the United States dollar.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development ("R&amp;D") Expenses</span></div><div style="text-indent:18pt"><img src="ew-20240331_g9.jpg" alt="4939" style="height:285px;margin-bottom:5pt;vertical-align:text-bottom;width:506px"/></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D expenses increased for the three months ended March 31, 2024 primarily due to continued investments in our aortic transcatheter valve innovations, including increased clinical trial activity. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intellectual Property Agreement and Certain Litigation Expenses</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We incurred certain litigation expenses related to intellectual property litigation and tax litigation of $8.9 million and $6.5 million during the three months ended March 31, 2024 and 2023, respectively. On April 12, 2023, we entered into an Intellectual Property Agreement (the "Intellectual Property Agreement") with Medtronic, Inc. ("Medtronic") and recorded a $37.0 million charge in March 2023.  For more information, see Note 3 to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Condensed Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Separation Costs</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 7, 2023, we announced our intention to complete a tax-free spin-off of our Critical Care product group as a separate publicly-traded company to Edwards Lifesciences' shareholders.  We incurred separation costs of $41.3 million during the three months ended March 31, 2024, primarily related to consulting, legal, tax, and other professional advisory services associated with the planned spin-off. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information, see Note 4 to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Condensed Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provision for Income Taxes</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes consists of provisions for federal, state, and foreign income taxes. We operate in an international environment with significant operations in various locations outside the United States which have statutory tax rates typically lower than the United States tax rate. Accordingly, the consolidated income tax rate is a composite rate reflecting the earnings in the various locations and the applicable rates. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective income tax rate was 14.3% and 14.6% for the three months ended March 31, 2024 and 2023, respectively.  The decrease in the effective rate between the three months ended March 31, 2024 and 2023 was primarily due to </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">an increased tax benefit from employee share-based compensation.  In addition, the effective rates for the three months ended March 31, 2024 and 2023 were lower than the federal statutory rate of 21% primarily due to (1) foreign earnings taxed at lower rates, (2) Federal and California research and development credits, and (3) the tax benefit from employee share-based compensation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Internal Revenue Service ("IRS") and other taxing authorities are in different stages of examining various years of our tax filings.  During these audits, we may receive proposed audit adjustments that could be material.  An adverse outcome in these audits could have a material effect on our results of operations and financial condition.  We strive to resolve open matters with each tax authority at the examination level and could reach agreement with a tax authority at any time.  While we have accrued for matters we believe are more likely than not to require settlement, the eventual outcome with a tax authority may result in a tax liability that is materially different from that reflected in the consolidated </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">financial statements.  Furthermore, we may later decide to challenge any assessments, if made, and may exercise our right to appeal. The uncertain tax positions are reviewed quarterly and adjusted as events occur that affect potential liabilities for additional taxes, such as lapsing of applicable statutes of limitations, proposed assessments by tax authorities, negotiations between tax authorities, identification of new issues, and issuance of new legislation, regulations, or case law. We believe that adequate amounts of tax and related penalty and interest have been provided for any adjustments that may result from these uncertain tax positions.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We executed an Advance Pricing Agreement ("APA") in 2018 between the United States and Switzerland governments for tax years 2009 through 2020 covering various, but not all, transfer pricing matters.  The unagreed transfer pricing matters, namely Surgical Structural Heart and Transcatheter Aortic Valve Replacement (collectively "Surgical/TAVR") intercompany royalty transactions, then reverted to IRS Examination for further consideration as part of the respective years' regular tax audits. In addition, we executed other bilateral APAs as follows: during 2017, an APA between the United States and Japan covering tax years 2015 through 2019; and during 2018, APAs between Singapore and Japan and between Switzerland and Japan covering tax years 2015 through 2019. We have filed to renew all three of the APAs with Japan for the years 2020 and forward.  An APA between Switzerland and Japan covering tax years 2020 through 2024 was executed in 2021.  An APA between the United States and Japan covering tax years 2020 through 2024 was executed in 2023. The execution of some or all these APA renewals depends on many variables outside of our control. </span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The audits of our United States federal income tax returns through 2014 have been closed.  The IRS audit field work for the 2015 through 2017 tax years was completed during the second quarter of 2021, except for certain transfer pricing and related matters.  The IRS is currently examining the 2018 through 2020 tax years.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The audits of our material state, local, and foreign income tax matters have been concluded for years through 2015.  While not material, we continue to address matters in India for years since 2010.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, we received a Notice of Proposed Adjustment (&#8220;NOPA&#8221;) from the IRS for the 2015 through 2017 tax years relating to transfer pricing involving Surgical/TAVR intercompany royalty transactions between our United States and Switzerland subsidiaries.  The NOPA proposed a substantial increase to our United States taxable income, which could result in additional tax expense for this period of approximately $230 million and represented a departure from a transfer pricing method we had previously agreed upon with the IRS.  We have disagreed with the NOPA and pursued an administrative appeal with the IRS Independent Office of Appeals ("Appeals"). The Appeals process culminated in the third quarter of 2023 when we and Appeals concluded that a satisfactory resolution of the matter at the administrative level was not possible.  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2023, Appeals issued a notice of deficiency ("NOD") increasing our 2015 through 2017 United States federal income tax in amounts resulting from the income adjustments previously reflected in the NOPA. The additional tax sought in excess of our filing position is $269.3 million before consideration of interest and a repatriation tax</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">offset.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We plan to vigorously contest the additional tax claimed by the IRS through the judicial process.  Final resolution of this</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">matter is not likely within the next 12 months. We believe the amounts previously accrued related to this uncertain tax position</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are appropriate for a number of reasons, including the interpretation and application of relevant tax law and accounting</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">standards to our facts and, accordingly, have not accrued any additional amount based on the NOD and other proceedings to</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">date. Nonetheless, the outcome of the judicial process cannot be predicted with certainty, and it is possible that the outcome of</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">that process could have a material impact on our consolidated financial statements. As noted below, similar material tax</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">disputes may arise for the 2018 through 2023 tax years. While no payment of any amount related to the NOPA or NOD has yet</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">been required, we made a partial deposit with the IRS of $75 million in November 2022 to prevent the further accrual of interest on that portion of any additional tax we may ultimately be found to owe.  In March 2024, we made an additional deposit with the IRS of $305 million to further mitigate interest on potential tax liabilities while we prepare to contest through the judicial process the IRS's entitlement to any of the additional tax claimed by the IRS. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Surgical/TAVR intercompany royalty transactions covering tax years 2018 through 2023 remain subject to IRS examination, and those transactions and related tax positions remain uncertain as of March&#160;31, 2024.  We have considered this information, as well as information regarding the NOD and other proceedings described above, in our evaluation of our uncertain tax positions.  The impact of these unresolved transfer pricing matters, net of any correlative tax adjustments, may be significant to our consolidated financial statements.  Based on the information currently available and numerous possible outcomes, we cannot reasonably estimate what, if any, changes in our existing uncertain tax positions may occur in the next 12 months and, therefore, have continued to record the uncertain tax positions as a long-term liability.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2024, we received a notice of assessment from the Israel Tax Authority (&#8220;ITA&#8221;) wherein the ITA claimed that we owe approximately $110 million of tax excluding interest and penalties in connection with a claimed 2017 transfer of intellectual property. We maintain that we did not transfer intellectual property outside of Israel and intend to vigorously defend that position through administrative and, if necessary, judicial proceedings.  There can be no assurance that this matter will be resolved in our favor and an adverse outcome could have a material effect on our consolidated financial statements.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, many countries are implementing some or all the Organization for Economic Co-operation and Development's Base Erosion and Profit Shifting Pillar Two rules ("Pillar Two") that impose a global minimum tax of 15%.  Under Pillar Two, a company is required to determine a combined effective tax rate for all entities located in a jurisdiction.  If the jurisdictional effective tax rate is less than 15%, a top-up tax will be due to bring the jurisdictional effective tax rate up to 15%.  We are continuing to monitor the implementation of Pillar Two by individual countries and the potential effects of Pillar Two on our effective tax rate.  We do not expect Pillar Two to have a material impact on our consolidated financial statements in 2024.  The provisions effective in 2025 may have a material impact on our consolidated financial statements in 2025 and future years, depending on future legislation, regulatory guidance, and business events.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div id="i141c83fee5da4f43b6493ac7539be527_97"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our sources of cash liquidity include cash and cash equivalents, short-term investments, cash from operations, and amounts available under credit facilities. We believe that these sources are sufficient to fund the current and long-term requirements of working capital, capital expenditures, and other financial commitments. However, we periodically consider various financing alternatives and may, from time to time, seek to take advantage of favorable interest rate environments or other market conditions. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2024, cash and cash equivalents and short-term investments held in the United States and outside of the United States were $851.4 million and $846.2 million, respectively. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a Five-year Credit Agreement (the "Credit Agreement") which provides for a $750.0 million multi-currency unsecured revolving credit facility and matures on July 15, 2027.  We may increase the amount available under the Credit Agreement by up to an additional $250.0 million in the aggregate and extend the maturity date for an additional year, subject to agreement of the lenders.  As of March&#160;31, 2024, no amounts were outstanding under the Credit Agreement.  </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2018, we issued $600.0 million of 4.3% fixed-rate unsecured senior notes (the "2018 Notes") due June 15, 2028.  We may redeem the 2018 Notes, in whole or in part, at any time and from time to time at specified redemption prices.  As of March&#160;31, 2024, we have not elected to redeem any of the 2018 Notes.  As of March&#160;31, 2024, the carrying value of the 2018 Notes was $597.2 million. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">From time to time, we repurchase shares of our common stock under share repurchase programs authorized by the Board of Directors.  We consider several factors in determining when to execute share repurchases, including, among other things, expected dilution from stock plans, cash capacity, and the market price of our common stock. During the three months ended March 31, 2024, we did not purchase any of our common stock under the Board authorized repurchase program and, as of March&#160;31, 2024, we had remaining authority to purchase $1.0 billion of our common stock under the share repurchase program.  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April 12, 2023, we entered into the Intellectual Property Agreement with Medtronic pursuant to which the parties agreed to a 15-year global covenant not to sue ("CNS") for infringement of certain patents in the structural heart space owned or controlled by each other. In consideration for the global CNS, we paid Medtronic a one-time, lump sum payment of $300.0&#160;million and are paying annual royalties that are tied to net sales of certain Edwards products.   For more information, see Note 3 to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Consolidated Condensed Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> We have purchased options to acquire and have agreed to provide promissory notes to various entities. These arrangements could result in additional cash outlays in the future should we decide to exercise the options or should the entities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">draw on the promissory notes. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2024, there had been no material changes in our cash requirements from known contractual and other obligations, including commitments for capital expenditures, as disclosed in Item 7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management's Discussion and Analysis of Financial Condition and Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2023.  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidated Cash Flows - For the three months ended March 31, 2024 and 2023: </span></div><div style="margin-bottom:8pt;margin-top:12pt;padding-left:18pt;text-indent:-18pt"><img src="ew-20240331_g10.jpg" alt="3362" style="height:200px;margin-bottom:5pt;vertical-align:text-bottom;width:213px"/><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span><img src="ew-20240331_g11.jpg" alt="3366" style="height:200px;margin-bottom:5pt;vertical-align:text-bottom;width:213px"/><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span><img src="ew-20240331_g12.jpg" alt="3369" style="height:200px;margin-bottom:5pt;vertical-align:text-bottom;width:213px"/></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash flows used in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">operating activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $53.5 million for the three months ended March 31, 2024 decreased $367.6 million&#160;over the same period last year primarily due to a $305.1 million tax deposit we made in 2024 to mitigate interest on potential tax liabilities we are contesting through the judicial process (see Note 14 to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Condensed Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">investing activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $63.1 million for the three months ended March 31, 2024 consisted primarily of net proceeds from investments of $161.4 million, partially offset by capital expenditures of $65.3 million.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by investing activities of $0.5 million for the three months ended March 31, 2023 consisted primarily of net proceeds from investments of $246.2 million, partially offset by a payment of $141.2 million to acquire a majority interest in another company and capital expenditures of $61.5 million </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">financing activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $61.7 million for the three months ended March 31, 2024 consisted primarily of proceeds from stock plans of $62.1 million. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities of $206.6 million for the three months ended March 31, 2023 consisted primarily of purchases of treasury stock of $249.3 million, partially offset by proceeds from stock plans of $41.9 million.</span></div><div style="text-indent:18pt"><span><br/></span></div><div id="i141c83fee5da4f43b6493ac7539be527_100"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States which require us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated condensed financial statements and sales and expenses during the periods reported. Actual results could differ from those estimates. Information with respect to our critical accounting policies and estimates which we believe could have the most significant effect on our reported results and require subjective or complex judgments by management is contained on pages&#160;38-40 in Item&#160;7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management's Discussion and Analysis of Financial Condition and Results of Operations,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2023. There have been no significant changes from the information discussed therein.</span></div><div style="text-indent:18pt"><span><br/></span></div><div id="i141c83fee5da4f43b6493ac7539be527_103"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures About Market Risk</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk, Foreign Currency Risk, Credit Risk, and Concentrations of Risk</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a complete discussion of our exposure to interest rate risk, foreign currency risk, credit risk, and concentrations of risk, refer to Item&#160;7A </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quantitative and Qualitative Disclosures About Market Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2023. There have been no material changes from the information discussed therein.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment Risk</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to investment risks related to changes in the underlying financial condition and credit capacity of certain of our investments.  As of March&#160;31, 2024, we had $805.8 million&#160;of investments in debt securities, of which $332.8 million were long-term. In addition, we had $122.8 million of investments in equity instruments of public and private companies.  Should these companies experience a decline in financial performance, financial condition or credit capacity, or fail to meet certain development milestones, a decline in the investments' value may occur, resulting in unrealized or realized losses.  See Note 5 to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Condensed Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div><div style="text-indent:18pt"><span><br/></span></div><div id="i141c83fee5da4f43b6493ac7539be527_106"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4.&#160;&#160;&#160;&#160;Controls and Procedures</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our management, including the Chief Executive Officer and the Chief Financial Officer, performed an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules&#160;13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of March&#160;31, 2024. Based on their evaluation, the Chief Executive Officer and Chief Financial Officer have concluded as of March&#160;31, 2024 that our disclosure controls and procedures are designed at a reasonable assurance level and effective in providing reasonable assurance that the information we are required to disclose in the reports we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission's rules and forms, and that such information is accumulated and communicated to our management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  There have been no changes in our internal control over financial reporting during the quarter ended March&#160;31, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.  </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="i141c83fee5da4f43b6493ac7539be527_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part&#160;II. Other Information</span></div><div id="i141c83fee5da4f43b6493ac7539be527_112"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1.&#160;&#160;&#160;&#160;Legal Proceedings</span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  Please see Part I, Item 1, Note 11 of the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Consolidated Condensed Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; of this Quarterly Report on Form 10-Q for a description of our legal proceedings, which is incorporated by reference herein.</span></div><div><span><br/></span></div><div id="i141c83fee5da4f43b6493ac7539be527_115"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1A.&#160;&#160;&#160;&#160;Risk Factors</span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A description of the risk factors associated with our business is contained in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section of our&#160;Annual Report on Form 10-K for our fiscal year ended&#160;December 31, 2023.&#160; There have been no material changes to our risk factors as previously reported.</span></div><div><span><br/></span></div><div id="i141c83fee5da4f43b6493ac7539be527_118"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2.&#160;&#160;&#160;&#160;Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Issuer Purchases of Equity Securities</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.268%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.828%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2022, the Board of Directors approved a stock repurchase program providing for up to $1.5 billion of repurchases of our common stock, effective July 28, 2022.  In December 2023, the Board of Directors approved an additional $1.0 billion of repurchases under this program. Repurchases under the program may be made on the open market, including pursuant to a Rule 10b5-1 plan, and in privately negotiated transactions.  The repurchase program does not have an expiration date.  We did not purchase any of our common stock during the first quarter of 2024 and, as of March&#160;31, 2024, we had remaining authority to purchase $1,048.5 million of common stock.</span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div id="i141c83fee5da4f43b6493ac7539be527_121"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;5.&#160;&#160;&#160;&#160;Other Information</span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rule 10b5-1 <ix:nonNumeric contextRef="c-1" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-1010"><ix:nonNumeric contextRef="c-1" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-1011"><ix:nonNumeric contextRef="c-1" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-1012">Trading Plans</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the first quarter of 2024, the following executive officers and directors entered into a 10b5-1 trading plan (each, a "Plan") intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act:</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><ix:nonNumeric contextRef="c-248" name="ecd:MtrlTermsOfTrdArrTextBlock" id="f-1013" escape="true"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On <ix:nonNumeric contextRef="c-248" name="ecd:TrdArrAdoptionDate" id="f-1014">February 12, 2024</ix:nonNumeric>, <ix:nonNumeric contextRef="c-248" name="ecd:TrdArrIndName" id="f-1015">Michael A. Mussallem</ix:nonNumeric>, <ix:nonNumeric contextRef="c-248" name="ecd:TrdArrIndTitle" id="f-1016">Chairman and Director</ix:nonNumeric>, <ix:nonNumeric contextRef="c-248" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-true" id="f-1017">entered</ix:nonNumeric> into a Plan providing for the potential sale of <ix:nonFraction unitRef="shares" contextRef="c-249" decimals="INF" name="ecd:TrdArrSecuritiesAggAvailAmt" format="ixt:num-dot-decimal" scale="0" id="f-1018">276,900</ix:nonFraction> shares of the Company&#8217;s stock commencing June 11, 2024.  Mr. Mussallem's Plan terminates on the earlier of May 1, 2025 or the date all shares are sold.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><ix:nonNumeric contextRef="c-250" name="ecd:MtrlTermsOfTrdArrTextBlock" id="f-1019" escape="true"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On <ix:nonNumeric contextRef="c-250" name="ecd:TrdArrAdoptionDate" id="f-1020">February 15, 2024</ix:nonNumeric>, <ix:nonNumeric contextRef="c-250" name="ecd:TrdArrIndName" id="f-1021">Scott B. Ullem</ix:nonNumeric>, <ix:nonNumeric contextRef="c-250" name="ecd:TrdArrIndTitle" id="f-1022">Corporate Vice President, Chief Financial Officer</ix:nonNumeric>, <ix:nonNumeric contextRef="c-250" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-true" id="f-1023">entered</ix:nonNumeric> into a Plan providing for the potential sale of <ix:nonFraction unitRef="shares" contextRef="c-251" decimals="INF" name="ecd:TrdArrSecuritiesAggAvailAmt" format="ixt:num-dot-decimal" scale="0" id="f-1024">67,500</ix:nonFraction> shares of the Company&#8217;s stock commencing May 21, 2024.  Mr. Ullem's Plan terminates on the earlier of May 9, 2025 or the date all shares are sold.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="c-252" name="ecd:MtrlTermsOfTrdArrTextBlock" id="f-1025" escape="true"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On <ix:nonNumeric contextRef="c-252" name="ecd:TrdArrAdoptionDate" id="f-1026">February 29, 2024</ix:nonNumeric>, <ix:nonNumeric contextRef="c-252" name="ecd:TrdArrIndName" id="f-1027">Bernard J. Zovighian</ix:nonNumeric>, <ix:nonNumeric contextRef="c-252" name="ecd:TrdArrIndTitle" id="f-1028">Chief Executive Officer and Director</ix:nonNumeric>, <ix:nonNumeric contextRef="c-252" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-true" id="f-1029">entered</ix:nonNumeric> into a Plan providing for the potential sale of <ix:nonFraction unitRef="shares" contextRef="c-253" decimals="INF" name="ecd:TrdArrSecuritiesAggAvailAmt" format="ixt:num-dot-decimal" scale="0" id="f-1030">25,147</ix:nonFraction> shares of the Company&#8217;s stock commencing May 30, 2024.  Mr. Zovighian's Plan terminates on the earlier of December 18, 2024 or the date all shares are sold.</span></div></ix:nonNumeric><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="i141c83fee5da4f43b6493ac7539be527_127"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="-sec-extract:summary;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;6.&#160;&#160;&#160;&#160;Exhibits</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exhibits listed in the Exhibit Index below are filed, furnished, or incorporated by reference as part of this report on Form 10-Q.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:8.430%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.043%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:77.494%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1099800/000110465913042912/a13-12753_1ex3d1.htm">Amended and Restated Certificate of Incorporation of Edwards Lifesciences Corporation, dated May&#160;16, 2013 (incorporated by reference to Exhibit&#160;3.1 in Edwards Lifesciences' report on Form&#160;8-K filed on May&#160;17, 2013)</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1099800/000119312520137597/d923809dex31.htm">Certificate of Amendment of Amended and Restated Certificate of Incorporation of Edwards Lifesciences Corporation, dated May 7, 2020 (incorporated by reference to Exhibit 3.1 in Edwards Lifesciences&#8217; report on Form 8-K filed on May 8, 2020)</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1099800/000119312523144564/d427364dex31.htm">Certificate of Amendment of Amended and Restated Certificate of Incorporation of Edwards Lifesciences Corporation, dated May 11, 2023 (incorporated by reference to Exhibit 3.1 in Edwards Lifesciences' report on Form 8-K filed on May 15, 2023)</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1099800/000119312523043538/d452156dex31.htm">Bylaws of Edwards Lifesciences Corporation, as amended and restated as of February 16, 2023 (incorporated by reference to Exhibit 3.1 in Edwards Lifesciences' report on Form 8-K filed on February 21, 2023)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex-10110xqq12024.htm">Edwards Lifesciences Corporation Spinoff Change in Control Agreement for Catherine Szyman, dated March 15, 2024</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex-31110xqq12024.htm">Certification Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex-31110xqq12024.htm">2002</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex-31210xqq12024.htm">Certification Pursuant to Section&#160;302 of the Sarbanes-Oxley </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex-31210xqq12024.htm">Act of 2002</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex-3210xqq12024.htm">Certification Pursuant to 18 U.S.C. Section&#160;1350, as Adopted Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Inline Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">______________________________________________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*    Represents management contract or compensatory plan</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="i141c83fee5da4f43b6493ac7539be527_130"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:4.317%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.649%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:52.635%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EDWARDS LIFESCIENCES CORPORATION</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 29, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;SCOTT B. ULLEM</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scott B. Ullem</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer; Duly Authorized Officer)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 29, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;ROBERT W.A. SELLERS</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Robert W.A. Sellers</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Corporate Controller</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex-10110xqq12024.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ic1f112e4fbf54cb9bfe7a0ff88fb3799_4"></div><div style="min-height:66.96pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="margin-top:12.95pt;padding-left:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exhibit 10.1</font></div></div><div style="margin-top:3.95pt;padding-left:17.8pt;padding-right:17.8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:17pt;font-weight:700;line-height:120%">Spinoff Change in Control Agreement</font></div><div style="margin-top:15.25pt;padding-left:5pt;padding-right:4.95pt;text-align:justify;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">THIS SPINOFF CHANGE IN CONTROL AGREEMENT is made, entered into, and is effective as of March 15, 2024 (hereinafter referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), by and between EDWARDS LIFESCIENCES CORPORATION, a Delaware corporation, and Catherine Szyman (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-top:12.95pt;padding-left:5pt;padding-right:5.4pt;text-align:justify;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Executive is currently employed by the Company in a key management capacity related to the Critical Care and Vascular Product Group&#59;</font></div><div style="margin-top:13pt;padding-left:5pt;padding-right:5.4pt;text-align:justify;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Company anticipates and recognizes that circumstances may arise in which a Spinoff or a Sale will occur, thereby causing uncertainty of employment, and that the Executive&#8217;s continued services with regard to the Critical Care and Vascular Product Group are critical to the success of any such Spinoff or Sale&#59;</font></div><div style="margin-top:12.95pt;padding-left:5pt;padding-right:5.4pt;text-align:justify;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, both the Company and the Executive are desirous that any proposal for a Spinoff or a Sale will be considered by the Executive objectively and with reference only to the business interests of the Company, including the Critical Care and Vascular Product Group, and its shareholders&#59; and</font></div><div style="margin-top:13.1pt;padding-left:5pt;padding-right:5.45pt;text-align:justify;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Executive will be in a better position to consider the Company&#8217;s best interests if the Executive is afforded reasonable security, as provided in this Agreement, against altered conditions of employment which could result from any such Spinoff or Sale.</font></div><div style="margin-top:12.95pt;padding-left:5pt;padding-right:5.5pt;text-align:justify;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">NOW, THEREFORE, in consideration of the foregoing and of the mutual covenants and agreements of the parties set forth in this Agreement, and of other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, agree as follows&#58;</font></div><div style="margin-top:12.95pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 1.&#160;&#160;&#160;&#160;Definitions</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.5pt;text-align:justify;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Wherever used in this Agreement, the following terms shall have the meanings set forth below and, when the meaning is intended, the initial letter of the word is capitalized&#58;</font></div><div style="margin-top:13.1pt;padding-left:4.5pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:30pt">&#8220;Agreement&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means this Spinoff Severance Agreement.</font></div><div style="margin-top:12.95pt;padding-left:4.5pt;padding-right:5.35pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:30pt">&#8220;Base Salary&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means, at any time, the then-regular annual rate of pay which the Executive is receiving as annual salary, excluding amounts&#58; (i) received under short- or long-term incentive or other bonus plans, regardless of whether or not the amounts are deferred, or (ii) designated by the Company as payment toward reimbursement of expenses.</font></div><div style="margin-top:12.95pt;padding-left:4.5pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:30pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Board of Directors of the Company.</font></div><div style="margin-top:13.1pt;padding-left:4.5pt;padding-right:5.35pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:30pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the occurrence of any one or more of the following (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the determination of whether &#8220;Cause&#8221; exists at any time prior to the occurrence of a Spinoff or a Sale shall be determined solely by the Board (excluding the Executive, if the Executive is then a member of the Board), in the exercise of the Board&#8217;s good faith and reasonable judgment,</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:80%">1</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.921%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="margin-top:12.95pt;padding-left:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exhibit 10.1</font></div></div><div style="margin-top:12.95pt;padding-left:5pt;padding-right:5.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and any such determination shall be final and binding upon the parties)&#58;</font></div><div style="margin-top:12.95pt;padding-left:95pt;padding-right:5.2pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">A continuing material breach by the Executive of the duties and responsibilities of the Executive (other than as a result of incapacity due to a physical or mental condition or illness), which breach is demonstrably willful and deliberate on the Executive&#8217;s part, is committed in bad faith and without a reasonable belief that such a breach is in the best interests of the Company, and (x) the Board delivers to Executive a written demand for substantial performance that specifically identifies the manner in which the Board believes the Executive has breached such duties and responsibilities, (y) the Executive fails to remedy such breach within sixty (60) days after receipt of such written demand, and (z) the Board delivers the Notice of Termination pursuant to Section 2.9 herein within thirty (30) days after the expiration of such sixty (60) day cure period&#59;</font></div><div style="margin-top:13.05pt;padding-left:95pt;padding-right:5.25pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">The Executive has engaged in conduct that is willfully, demonstrably and materially injurious to the Company, monetarily or otherwise and, if cure is reasonably possible in the circumstances, (x) the Board delivers to Executive a written demand for substantial performance that specifically identifies the manner in which the Board believes the Executive has breached such duties and responsibilities, (y) the Executive fails to remedy such breach within sixty (60) days after receipt of such written demand, and (z) the Board delivers the Notice of Termination pursuant to Section 2.9 herein within thirty (30) days after the expiration of such sixty (60) day cure period&#59; or</font></div><div style="margin-top:13pt;padding-left:95pt;padding-right:5.05pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">The Executive is convicted of, or pled guilty or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">nolo contendere </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">to a felony (under the laws of the United States or any relevant state, or a similar crime or offense under the applicable laws of any relevant foreign jurisdiction) that adversely affects the reputation of the Executive or the Company&#59;</font></div><div style="margin-top:12.95pt;padding-left:5pt;padding-right:5.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that no act or failure to act on the Executive&#8217;s part shall be deemed &#8220;willful&#8221; unless done, or omitted to be done, by the Executive not in good faith and without reasonable belief that the action or omission was in the best interest of the Company.</font></div><div style="margin-top:12.95pt;padding-left:4.5pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:30pt">&#8220;Code Section 409A&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">has the meaning ascribed to such term in Section 9.9(a) herein.</font></div><div style="margin-top:13.1pt;padding-left:4.5pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:30pt">&#8220;Code&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means the Internal Revenue Code of 1986, as amended.</font></div><div style="margin-top:12.95pt;padding-left:4.5pt;padding-right:5.3pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:30pt">&#8220;Company&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means Edwards Lifesciences Corporation, a Delaware corporation (including any and all subsidiaries), or any successor thereto, including in the case of a Sale or Spinoff, the entity formed with respect to the Critical Care and Vascular Product Group, and any acquiror thereof, as provided in Article 8 herein.</font></div><div style="margin-top:12.95pt;padding-left:4.5pt;padding-right:5.25pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:30pt">&#8220;Critical Care and Vascular Product Group&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means the business unit of the Company relating to the manufacture and sale of critical care and vascular products.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:80%">2</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.921%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="margin-top:12.95pt;padding-left:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exhibit 10.1</font></div></div><div style="margin-top:13.1pt;padding-left:4.5pt;padding-right:5.2pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:30pt">&#8220;Disability&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the meaning ascribed to such term in the Executive&#8217;s governing long-term disability plan as of the Effective Date.</font></div><div style="margin-top:12.95pt;padding-left:4.5pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24pt">&#8220;Effective Date&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means the date specified in the opening sentence of this Agreement.</font></div><div style="margin-top:12.95pt;padding-left:4.5pt;padding-right:5.25pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24pt">&#8220;Effective Date of Termination&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means the date on which a Qualifying Termination occurs, as provided in Section 2.2 herein.</font></div><div style="margin-top:13.1pt;padding-left:4.5pt;padding-right:5.35pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24pt">&#8220;Enhanced Separation Benefits&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means the payments and&#47;or benefits provided in Section 2.5 herein following the Outside Date in relation to a contemplated Spinoff.</font></div><div style="margin-top:12.95pt;padding-left:4.5pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24pt">&#8220;Executive&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means the individual specified in the opening sentence of this Agreement.</font></div><div style="margin-top:12.95pt;padding-left:4.5pt;padding-right:5.2pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24pt">&#8220;Good Reason&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means, without the Executive&#8217;s express written consent, the occurrence of any one or more of the following conditions during the Protected Period&#58;</font></div><div style="margin-top:13.1pt;padding-left:95pt;padding-right:5.15pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">A material diminution in the Executive&#8217;s role, duties, responsibilities and authorities, as measured in the aggregate, other than (i) an insubstantial or inadvertent act that is remedied by the Company, as applicable, promptly after receipt of notice thereof given by the Executive&#59; or (ii) changes resulting solely from the Critical Care and Vascular Product Group ceasing to be a business unit of Edwards Lifesciences Corporation following a Spinoff or a Sale. Notwithstanding the foregoing, in the event that following either a Spinoff or a Sale the Executive is not serving as the chief executive officer of a publicly traded company or other independent entity (which shall not include a subsidiary of publicly traded company), a material diminution giving rise to Good Reason shall be deemed to occur. For the avoidance of doubt, Executive shall not be deemed to have Good Reason if, in the case of a contemplated Spinoff, in the event an Outside Date has occurred and Executive&#8217;s role as Corporate Vice President, Critical Care, remains available and the Company determines that you will remain in such role&#59;</font></div><div style="margin-top:13pt;padding-left:95pt;padding-right:5.2pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">The Company&#8217;s requiring the Executive to be based at a location in excess of fifty (50) miles from the location of the Executive&#8217;s principal job location or office immediately prior to such change, except for required travel on the Company&#8217;s business to an extent substantially consistent with the Executive&#8217;s then present business travel obligations&#59; or</font></div><div style="margin-top:12.95pt;padding-left:95pt;padding-right:5.35pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">A material reduction by the Company of the Executive&#8217;s Base Salary in effect on the Effective Date hereof, or as the same shall be increased from time to time&#59;</font></div><div style="margin-top:12.95pt;padding-left:5pt;padding-right:5.3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that any such condition shall not constitute &#8220;Good Reason&#8221; unless the following requirements are satisfied&#58; (x) the Executive provides the Company the Notice of Termination pursuant to Section 2.9 herein within sixty (60) days following the initial existence of the event giving rise to the condition claimed to constitute &#8220;Good Reason,&#8221; (y) the Company </font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:80%">3</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.921%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="margin-top:12.95pt;padding-left:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exhibit 10.1</font></div></div><div style="margin-top:12.95pt;padding-left:5pt;padding-right:5.3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">fails to remedy such condition within thirty (30) days after receiving such Notice of Termination (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Cure Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), and (z) the Executive resigns in writing from the Executive&#8217;s employment, citing failure to remedy the condition giving rise to Good Reason, within thirty (30) days following the expiration of such thirty (30) day cure period.</font></div><div style="margin-top:3.95pt;padding-left:5pt;padding-right:5.45pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Executive&#8217;s right to terminate employment for Good Reason shall not be affected by the Executive&#8217;s incapacity due to physical or mental illness. The Executive&#8217;s continued employment shall not constitute consent to, or a waiver of rights with respect to, any circumstance constituting Good Reason herein.</font></div><div style="margin-top:12.95pt;padding-left:4.5pt;padding-right:5.15pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24pt">&#8220;Outside Date&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means the earlier of (i) December 31, 2025&#59; and (ii) the date the Company formally announces the Spinoff will not be pursued.</font></div><div style="margin-top:13.1pt;padding-left:4.5pt;padding-right:5.2pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24pt">&#8220;Protected Period&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means the twelve (12)-month period following (i) a Spinoff, (ii) a Sale, or (iii) the Outside Date in relation to a contemplated Spinoff, as applicable.</font></div><div style="margin-top:12.95pt;padding-left:4.5pt;padding-right:5.25pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24pt">&#8220;Qualifying Termination&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">has the meaning ascribed to such term in Section 2.2 herein.</font></div><div style="margin-top:13pt;padding-left:4.5pt;padding-right:5.4pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24pt">&#8220;Sale&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means the sale of the Critical Care and Vascular Product Group, whether through a sale of the assets of, or a sale of shares of an entity or entities formed in relation to, the Critical Care and Vascular Product Group, or a combination thereof.</font></div><div style="margin-top:13.05pt;padding-left:4.5pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24pt">&#8220;Sale Separation Benefits&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means the payments and&#47;or benefits provided in Section</font></div><div style="padding-left:4.5pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.4 herein following a Sale.</font></div><div style="margin-top:12.95pt;padding-left:4.5pt;padding-right:5.35pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24pt">&#8220;Separation Benefits&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means the Spinoff Separation Benefits, the Sale Separation Benefits, or the Enhanced Separation Benefits, as applicable.</font></div><div style="margin-top:13pt;padding-left:4.5pt;padding-right:5.2pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24pt">&#8220;Separation from Service&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means the Executive&#8217;s separation from service as determined in accordance with Code Section 409A and the applicable standards of the Treasury Regulations issued thereunder.</font></div><div style="margin-top:12.95pt;padding-left:4.5pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24pt">&#8220;Spinoff&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means a spinoff of the Critical Care and Vascular Product Group.</font></div><div style="margin-top:13.1pt;padding-left:4.5pt;padding-right:5.1pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.23</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Spinoff Separation Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the payments and&#47;or benefits provided in Section 2.3 herein following a Spinoff.</font></div><div style="margin-top:12.95pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 2.&#160;&#160;&#160;&#160;Separation Benefits</font></div><div style="margin-top:12pt;padding-left:58.9pt;text-indent:-31.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:16.6pt">Right to Separation Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:12.95pt;padding-left:5pt;padding-right:5.1pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:35.7pt">Spinoff Separation Benefits. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Executive shall be entitled to receive from the Company the Spinoff Separation Benefits described in Section 2.3 herein if there has been a Spinoff and if the Executive incurs a Qualifying Termination (as set forth in Section 2.2)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the Executive&#8217;s entitlement to Spinoff Separation Benefits (other than under Section 2.3(a)) is conditioned upon (i) the Executive executing and delivering to the Company a general release of claims in the form attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) within </font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:80%">4</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.921%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="margin-top:12.95pt;padding-left:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exhibit 10.1</font></div></div><div style="margin-top:12.95pt;padding-left:5pt;padding-right:5.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">twenty-one (21) days (or forty-five (45) days if such longer period is required under applicable law), and (ii) the Executive not revoking such Release.</font></div><div style="margin-top:13.1pt;padding-left:5pt;padding-right:5.35pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Executive shall not be entitled to receive Spinoff Separation Benefits if the Executive&#8217;s employment with the Company terminates (i) at any time before or after the Protected Period corresponding to a Spinoff (regardless of the reason), or (ii) during the Protected Period but other than in the case of a Qualifying Termination.</font></div><div style="margin-top:12.95pt;padding-left:5pt;padding-right:5.1pt;text-align:justify;text-indent:54.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:34.97pt">Sale Separation Benefits. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Executive shall be entitled to receive from the Company the Sale Separation Benefits described in Section 2.4 herein if there has been a Sale and if the Executive incurs a Qualifying Termination (as set forth in Section 2.2)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the Executive&#8217;s entitlement to Sale Separation Benefits (other than under Section 2.4(a)) is conditioned upon (i) the Executive executing and delivering to the Company a Release within twenty-one (21) days (or forty-five (45) days if such longer period is required under applicable law), and (ii) the Executive not revoking such Release.</font></div><div style="margin-top:13.1pt;padding-left:5pt;padding-right:5.4pt;text-align:justify;text-indent:54.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Executive shall not be entitled to receive Sale Separation Benefits if the Executive&#8217;s employment with the Company terminates (i) at any time before or after the Protected Period corresponding to a Sale (regardless of the reason), or (ii) during the Protected Period but other than in a Qualifying Termination.</font></div><div style="margin-top:12.95pt;padding-left:5pt;padding-right:5.2pt;text-align:justify;text-indent:54.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:35.65pt">Enhanced Separation Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Executive shall be entitled to receive from the Company the Enhanced Separation Benefits described in Section 2.5 herein solely in the event that a Spinoff has not occurred by the Outside Date of such contemplated Spinoff and if the Executive incurs a Qualifying Termination (as set forth in Section 2.2)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the Executive&#8217;s entitlement to Enhanced Separation Benefits (other than under Section 2.5(a)) is conditioned upon (i) the Executive executing and delivering to the Company a Release within twenty-one (21) days (or forty-five (45) days if such longer period is required under applicable law), and (ii) the Executive not revoking such Release.</font></div><div style="margin-top:13pt;padding-left:5pt;padding-right:5.35pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Executive shall not be entitled to receive Enhanced Separation Benefits if the Executive&#8217;s employment with the Company terminates (i) at any time before or after the Protected Period corresponding to the Outside Date (regardless of the reason), (ii) during the Protected Period but other than in a Qualifying Termination, or (iii) after a Spinoff or a Sale.</font></div><div style="margin-top:12.95pt;padding-left:5pt;padding-right:5.1pt;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:29.7pt">Qualifying Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The occurrence of either of the following events within the Protected Period shall constitute a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Qualifying Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;&#58;</font></div><div style="margin-top:13.1pt;padding-left:90.55pt;padding-right:5.45pt;text-indent:-31.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.3pt">The Company&#8217;s involuntary termination of the Executive&#8217;s employment without Cause&#59; or</font></div><div style="margin-top:12.95pt;padding-left:90.5pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:17.52pt">The Executive&#8217;s voluntary termination of employment for Good Reason.</font></div><div style="margin-top:12.95pt;padding-left:5pt;padding-right:5.3pt;text-align:justify;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For purposes of this Agreement, a Qualifying Termination shall not include a termination of the Executive&#8217;s employment with the Company by reason of death, Disability, voluntary normal retirement (as such term is defined under the then established rules of the Company&#8217;s tax-qualified retirement plan) unless the requirement set forth in Section 2.2(b) herein is met. A </font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:80%">5</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.921%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="margin-top:12.95pt;padding-left:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exhibit 10.1</font></div></div><div style="margin-top:12.95pt;padding-left:5pt;padding-right:5.3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Qualifying Termination shall not occur in the event of an involuntary termination of the Executive&#8217;s employment by the Company for Cause.</font></div><div style="margin-top:13.1pt;padding-left:5pt;padding-right:5.25pt;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:29.7pt">Description of Spinoff Separation Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In the event that the Executive becomes entitled to receive Spinoff Separation Benefits, as provided in Sections 2.1 and 2.2 herein, the Company shall pay to the Executive, and provide the Executive with, total Spinoff Separation Benefits equal to all of the following&#58;</font></div><div style="margin-top:12.95pt;padding-left:90.55pt;padding-right:5.25pt;text-align:justify;text-indent:-31.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.3pt">A lump-sum amount equal to the Executive&#8217;s unpaid Base Salary, accrued vacation pay, unreimbursed business expenses, and all other items earned by and owed to the Executive through and including the Effective Date of Termination.</font></div><div style="margin-top:13.1pt;padding-left:90.55pt;padding-right:5.15pt;text-align:justify;text-indent:-31.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:17.62pt">A lump-sum amount equal to the product obtained by multiplying (i) the Executive&#8217;s annual incentive pay objective amount (or other target annual incentive amount, as applicable), established under the annual bonus plan in which the Executive is then participating for the bonus plan year in which the Effective Date of Termination occurs, by (ii) a fraction, the numerator of which is the number of full completed months in the bonus plan year through the Effective Date of Termination, and the denominator of which is twelve (12). This payment will be in lieu of any other payment to be made to the Executive under the annual bonus plan in which the Executive is then participating for that plan year.</font></div><div style="margin-top:12.95pt;padding-left:90.55pt;padding-right:5.4pt;text-align:justify;text-indent:-31.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.3pt">A lump-sum amount equal to two (2) multiplied by the Executive&#8217;s annual rate of Base Salary in effect upon the Effective Date of Termination.</font></div><div style="margin-top:13pt;padding-left:90.55pt;padding-right:5.3pt;text-align:justify;text-indent:-31.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:17.62pt">A lump-sum amount equal to two (2) multiplied by the Executive&#8217;s annual incentive pay objective amount (or other target annual incentive amount, as applicable) established under the annual bonus plan in which the Executive is then participating for the bonus plan year in which the Effective Date of Termination occurs.</font></div><div style="margin-top:12.95pt;padding-left:90.55pt;padding-right:4.95pt;text-align:justify;text-indent:-31.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.3pt">Except as provided below in this Section 2.3(e), all long-term incentive awards granted by the Company to the Executive prior to the Qualifying Termination, including any such awards converted in connection with the Spinoff, to the extent such awards are outstanding and otherwise unvested immediately prior to the Qualifying Termination, shall vest </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">an additional twelve (12) months </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">upon (or, as may be necessary to give effect to the acceleration, immediately prior to) the Qualifying Termination&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that any long-term incentive award which includes performance-based (in addition to time-based) vesting requirements shall vest assuming the target level of performance was achieved. Stock options or stock appreciation rights that become vested in accordance with this Section 2.3(e), may be exercised after the Qualifying Termination only within the time frame specified in the applicable long-term incentive plan or award agreement.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:80%">6</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.921%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="margin-top:12.95pt;padding-left:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exhibit 10.1</font></div></div><div style="margin-top:13.1pt;padding-left:90.55pt;padding-right:5.15pt;text-align:justify;text-indent:-31.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.63pt">Executive shall be entitled to continue to participate in the Company&#8217;s medical and dental insurance programs (subject in each case to the eligibility and other provisions of such programs), including coverage for any of Executive&#8217;s dependents enrolled in the Company&#8217;s medical and dental insurance programs as of the Effective Date of Termination, at the same or substantially similar coverage level as in effect as of the Effective Date of Termination, for a period of thirty-six (36) months following the Effective Date of Termination and at substantially the same economic cost to the Executive as of the Effective Date of Termination&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Company may elect to pay Executive a cash payment equal to such economic cost rather than Executive (and Executive&#8217;s qualifying dependents, as applicable) continuing to participate in the Company&#8217;s medical and dental insurance programs. To the extent that any payments or reimbursements pursuant to this Section 2.3(f) are taxable to the Executive, any such payment or reimbursement shall be subject to Section 9.9 of this Agreement.</font></div><div style="margin-top:12.95pt;padding-left:5pt;padding-right:5.25pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:16pt">Description of Sale Separation Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In the event that the Executive becomes entitled to receive Sale Separation Benefits, as provided in Sections 2.1 and 2.2 herein, the Company shall pay to the Executive, and provide the Executive with, total Sale Separation Benefits equal to all of the following&#58;</font></div><div style="margin-top:13.1pt;padding-left:90.55pt;padding-right:5.25pt;text-align:justify;text-indent:-31.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.3pt">A lump-sum amount equal to the Executive&#8217;s unpaid Base Salary, accrued vacation pay, unreimbursed business expenses, and all other items earned by and owed to the Executive through and including the Effective Date of Termination.</font></div><div style="margin-top:12.95pt;padding-left:90.55pt;padding-right:5.15pt;text-align:justify;text-indent:-31.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:17.62pt">A lump-sum amount equal to the product obtained by multiplying (i) the Executive&#8217;s annual incentive pay objective amount (or other target annual incentive amount, as applicable), established under the annual bonus plan in which the Executive is then participating for the bonus plan year in which the Effective Date of Termination occurs, by (ii) a fraction, the numerator of which is the number of full completed months in the bonus plan year through the Effective Date of Termination, and the denominator of which is twelve (12). This payment will be in lieu of any other payment to be made to the Executive under the annual bonus plan in which the Executive is then participating for that plan year.</font></div><div style="margin-top:13pt;padding-left:90.55pt;padding-right:5.4pt;text-align:justify;text-indent:-31.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.3pt">A lump-sum amount equal to two (2) multiplied by the Executive&#8217;s annual rate of Base Salary in effect upon the Effective Date of Termination.</font></div><div style="margin-top:12.95pt;padding-left:90.55pt;padding-right:5.3pt;text-align:justify;text-indent:-31.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:17.62pt">A lump-sum amount equal to two (2) multiplied by the Executive&#8217;s annual incentive pay objective amount (or other target annual incentive amount, as applicable) established under the annual bonus plan in which the Executive is then participating for the bonus plan year in which the Effective Date of Termination occurs.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:80%">7</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.921%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="margin-top:12.95pt;padding-left:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exhibit 10.1</font></div></div><div style="margin-top:13.1pt;padding-left:90.55pt;padding-right:5.1pt;text-align:justify;text-indent:-31.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.3pt">Except as provided below in this Section 2.4(e), all long-term incentive awards granted by the Company to the Executive prior to the Qualifying Termination, which shall be assumed, replaced, substituted for or otherwise converted in connection with the Sale, to the extent such awards are outstanding and otherwise unvested immediately prior to the Qualifying Termination, shall vest </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">in full </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">upon (or, as may be necessary to give effect to the acceleration, immediately prior to) the Qualifying Termination&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that any long-term incentive award which includes performance-based (in addition to time-based) vesting requirements shall vest assuming the target level of performance was achieved. Stock options or stock appreciation rights that become vested in accordance with this Section 2.4(e), may be exercised after the Qualifying Termination only within the time frame specified in the applicable long-term incentive plan or award agreement.</font></div><div style="margin-top:12.95pt;padding-left:90.55pt;padding-right:5.15pt;text-align:justify;text-indent:-31.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.63pt">Executive shall be entitled to continue to participate in the Company&#8217;s medical and dental insurance programs (subject in each case to the eligibility and other provisions of such programs), including coverage for any of Executive&#8217;s dependents enrolled in the Company&#8217;s medical and dental insurance programs as of the Effective Date of Termination, at the same or substantially similar coverage level as in effect as of the Effective Date of Termination, for a period of thirty-six (36) months following the Effective Date of Termination and at substantially the same economic cost to the Executive as of the Effective Date of Termination&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Company may elect to pay Executive a cash payment equal to such economic cost rather than Executive (and Executive&#8217;s qualifying dependents, as applicable) continuing to participate in the Company&#8217;s medical and dental insurance programs. To the extent that any payments or reimbursements pursuant to this Section 2.4(f) are taxable to the Executive, any such payment or reimbursement shall be subject to Section 9.9 of this Agreement.</font></div><div style="margin-top:13pt;padding-left:5pt;padding-right:5.1pt;text-align:justify;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:29.7pt">Description of Enhanced Separation Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In the event that the Executive becomes entitled to receive Enhanced Separation Benefits, as provided in Sections 2.1 and 2.2 herein, the Company shall pay to the Executive, and provide the Executive with, total Enhanced Separation Benefits equal to all of the following&#58;</font></div><div style="margin-top:13.1pt;padding-left:90.55pt;padding-right:5.25pt;text-align:justify;text-indent:-31.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.3pt">A lump-sum amount equal to the Executive&#8217;s unpaid Base Salary, accrued vacation pay, unreimbursed business expenses, and all other items earned by and owed to the Executive through and including the Effective Date of Termination.</font></div><div style="margin-top:12.95pt;padding-left:90.55pt;padding-right:5.15pt;text-align:justify;text-indent:-31.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:17.62pt">A lump-sum amount equal to the product obtained by multiplying (i) the Executive&#8217;s annual incentive pay objective amount (or other target annual incentive amount, as applicable), established under the annual bonus plan in which the Executive is then participating for the bonus plan year in which the Effective Date of Termination occurs, by (ii) a fraction, the numerator of which is the number of full completed months in the bonus plan year through the Effective Date of Termination, and the denominator of which is twelve (12). </font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:80%">8</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.921%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="margin-top:12.95pt;padding-left:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exhibit 10.1</font></div></div><div style="margin-top:12.95pt;padding-left:90.55pt;padding-right:5.15pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This payment will be in lieu of any other payment to be made to the Executive under the annual bonus plan in which the Executive is then participating for that plan year.</font></div><div style="margin-top:12.95pt;padding-left:90.55pt;padding-right:5.4pt;text-align:justify;text-indent:-31.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.3pt">A lump-sum amount equal to two (2) multiplied by the Executive&#8217;s annual rate of Base Salary in effect upon the Effective Date of Termination.</font></div><div style="margin-top:13.1pt;padding-left:90.55pt;padding-right:5.35pt;text-align:justify;text-indent:-31.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:17.62pt">A lump-sum amount equal to two (2) multiplied by the Executive&#8217;s annual incentive pay objective amount (or other target annual incentive amount, as applicable) established under the annual bonus plan in which the Executive is then participating for the bonus plan year in which the Effective Date of Termination occurs.</font></div><div style="margin-top:12.95pt;padding-left:90.55pt;padding-right:5pt;text-align:justify;text-indent:-31.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.3pt">Except as provided below in this Section 2.5(e), all long-term incentive awards granted by the Company to the Executive prior to the Qualifying Termination, to the extent such awards are outstanding and otherwise unvested immediately prior to the Qualifying Termination, shall vest </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">an additional twelve (12) months </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">upon (or, as may be necessary to give effect to the acceleration, immediately prior to) the Qualifying Termination&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that any long-term incentive award which includes performance-based (in addition to time-based) vesting requirements shall vest assuming the target level of performance was achieved. Stock options or stock appreciation rights that become vested in accordance with this Section 2.5(e), may be exercised after the Qualifying Termination only within the time frame specified in the applicable long-term incentive plan or award agreement.</font></div><div style="margin-top:13.1pt;padding-left:90.55pt;padding-right:5.15pt;text-align:justify;text-indent:-31.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.63pt">Executive shall be entitled to continue to participate in the Company&#8217;s medical and dental insurance programs (subject in each case to the eligibility and other provisions of such programs), including coverage for any of Executive&#8217;s dependents enrolled in the Company&#8217;s medical and dental insurance programs as of the Effective Date of Termination, at the same or substantially similar coverage level as in effect as of the Effective Date of Termination, for a period of thirty-six (36) months following the Effective Date of Termination and at substantially the same economic cost to the Executive as of the Effective Date of Termination&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Company may elect to pay Executive a cash payment equal to such economic cost rather than Executive (and Executive&#8217;s qualifying dependents, as applicable) continuing to participate in the Company&#8217;s medical and dental insurance programs. To the extent that any payments or reimbursements pursuant to this Section 2.5(f) are taxable to the Executive, any such payment or reimbursement shall be subject to Section 9.9 of this Agreement.</font></div><div style="margin-top:13pt;padding-left:5pt;padding-right:5.15pt;text-align:justify;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:29.7pt">Termination due to Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. If the Executive&#8217;s employment is terminated with the Company due to Disability, the Company shall pay the Executive any unpaid Base Salary, accrued vacation, and other items earned by and owed to the Executive through the Effective Date of Termination, plus all other amounts to which the Executive is entitled under any </font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:80%">9</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.921%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="margin-top:12.95pt;padding-left:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exhibit 10.1</font></div></div><div style="margin-top:13pt;padding-left:5pt;padding-right:5.15pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">compensation plans of the Company at the time such payments are due, and the Company shall have no further obligations to the Executive under this Agreement.</font></div><div style="margin-top:12.95pt;padding-left:5pt;padding-right:5.05pt;text-align:justify;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:29.7pt">Termination due to Retirement or Death</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. If the Executive&#8217;s employment with the Company is terminated by reason of the Executive&#8217;s voluntary normal retirement (as defined under the then established rules of the Company&#8217;s tax-qualified retirement plan), or death, the Company shall pay the Executive any unpaid Base Salary, accrued vacation, and other items earned by and owed to the Executive through the Effective Date of Termination, plus all other amounts to which the Executive is entitled under any compensation plans of the Company at the time such payments are due, and the Company shall have no further obligations to the Executive under this Agreement.</font></div><div style="margin-top:12.95pt;padding-left:5pt;text-align:justify;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:29.7pt">Termination for Cause or by the Executive Other Than for Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. If the Executive&#8217;s employment is terminated either&#58; (i) by the Company for Cause&#59; or (ii) voluntarily by the Executive for a reason other than that specified in Section 2.2(b) herein, the Company shall pay the Executive any unpaid Base Salary, accrued vacation, and other items earned by and owed to the Executive through the Effective Date of Termination, plus all other amounts to which the Executive is entitled under any compensation plans of the Company at the time such payments are due, and the Company shall have no further obligations to the Executive under this Agreement.</font></div><div style="margin-top:12.95pt;padding-left:5pt;padding-right:4.9pt;text-align:justify;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:29.7pt">Notice of Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Any termination of the Executive&#8217;s employment by the Company for Cause or by the Executive for Good Reason shall be communicated by Notice of Termination to the other party. For purposes of this Agreement, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notice of Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean a written notice which shall indicate the specific termination provision in this Agreement relied upon, and shall set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Executive&#8217;s employment under the provision so indicated.</font></div><div style="margin-top:13.1pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 3.&#160;&#160;&#160;&#160;Form and Timing of Separation Benefits</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.25pt;text-align:justify;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:29.7pt">Form and Timing of Separation Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Separation Benefits described in Section 2.3(a), Section 2.4(a) or Section 2.5(a) herein, as applicable, shall be paid in cash to the Executive in a single lump sum as soon as practicable following the Effective Date of Termination, but in no event beyond ten (10) calendar days from such date. Subject to Sections 2.1 and 9.9(b), the Separation Benefits described in clauses (b) through (d) of Section 2.3, Section 2.4 or Section 2.5 herein, as applicable, shall be paid in cash to the Executive in a single lump sum on the sixtieth (60th) day following the occurrence of the Executive&#8217;s Separation from Service by reason of the Qualifying Termination. To the extent the payment of any such Separation Benefits to which the Executive becomes entitled under this Agreement is deferred beyond the Executive&#8217;s Separation from Service (including by reason of Section 9.9(b)), the Executive shall be entitled to interest on those amounts, for the period the payment of such amounts is so deferred, with such interest to accrue at the prime rate published by the Wall Street Journal as in effect on the date of the Executive&#8217;s Separation from Service and to be paid in a lump sum upon payment of such Separation Benefits.</font></div><div style="margin-top:13pt;padding-left:5pt;padding-right:5.2pt;text-align:justify;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:29.7pt">Withholding of Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company shall withhold from any amounts payable under this Agreement all federal, state, city, or other taxes as legally shall be required.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:80%">10</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.921%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="margin-top:12.95pt;padding-left:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exhibit 10.1</font></div></div><div style="margin-top:12.95pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 4.&#160;&#160;&#160;&#160;Benefit Limit</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.2pt;text-align:justify;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:29.7pt">Benefit Limit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In the event that any payments or benefits to which the Executive becomes entitled in accordance with the provisions of this Agreement (or any other agreement with the Company) would otherwise constitute a parachute payment under Code Section 280G(b)(2), then such payments and&#47;or benefits will be subject to reduction to the extent necessary to assure that the Executive receives only the greater of (i) the amount of those payments which would not constitute such a parachute payment or (ii) the amount which yields the Executive the greatest after-tax amount of benefits after taking into account any excise tax imposed under Code Section 4999 on the payments and benefits provided the Executive under this Agreement (or on any other payments or benefits to which the Executive may become entitled in connection with any change in control or ownership of the Company or the subsequent termination of the Executive&#8217;s employment with the Company).</font></div><div style="margin-top:12.95pt;padding-left:5pt;padding-right:5.35pt;text-align:justify;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:29.7pt">Order of Reduction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Should a reduction in benefits be required to satisfy the benefit limit of Section 4.1, then the portion of any parachute payment otherwise payable in cash to the Executive shall be reduced to the extent necessary to comply with such benefit limit. Should such benefit limit still be exceeded following such reduction, then the number of shares which would otherwise vest on an accelerated basis under each of the Executive&#8217;s options or other equity awards (based on the amount of the parachute payment attributable to each such option or equity award under Code Section 280G) shall be reduced to the extent necessary to eliminate such excess, with such reduction to be made in the same chronological order in which those awards were made.</font></div><div style="margin-top:13.1pt;padding-left:5pt;padding-right:5.25pt;text-align:justify;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:29.7pt">Resolution Procedures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In the event there is any disagreement between the Executive and the Company as to whether one or more payments or benefits to which the Executive becomes entitled constitute a parachute payment under Code Section 280G or as to the determination of the present value thereof, such dispute will be resolved as follows&#58;</font></div><div style="margin-top:12.95pt;padding-left:90.55pt;padding-right:5.2pt;text-align:justify;text-indent:-31.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.3pt">In the event the Treasury Regulations under Code Section 280G (or applicable judicial decisions) specifically address the status of any such payment or benefit or the method of valuation therefor, the characterization afforded to such payment or benefit by the Regulations (or such decisions) will, together with the applicable valuation methodology, be controlling.</font></div><div style="margin-top:13pt;padding-left:90.55pt;padding-right:5.2pt;text-align:justify;text-indent:-31.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:17.62pt">In the event Treasury Regulations (or applicable judicial decisions) do not address the status of any payment in dispute, the matter will be submitted for resolution to independent auditors selected and paid for by the Company. The resolution reached by the independent auditors will be final and controlling&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that if in the judgment of the independent auditors, the status of the payment in dispute can be resolved through the obtainment of a private letter ruling from the Internal Revenue Service, a formal and proper request for such ruling will be prepared and submitted by the independent auditors, and the determination made by the Internal Revenue Service in the issued ruling will be controlling. All expenses incurred in connection with the preparation and submission of the ruling request shall be paid by the Company.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:80%">11</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.921%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="margin-top:12.95pt;padding-left:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exhibit 10.1</font></div></div><div style="margin-top:12.95pt;padding-left:90.55pt;padding-right:5.15pt;text-align:justify;text-indent:-31.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.3pt">In the event Treasury Regulations (or applicable judicial decisions) do not address the appropriate valuation methodology for any payment in dispute, the present value thereof will, at the independent auditor&#8217;s election, be determined through an independent third-party appraisal, and the expenses incurred in obtaining such appraisal shall be paid by the Company.</font></div><div style="margin-top:13.1pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 5.&#160;&#160;&#160;&#160;The Company&#8217;s Payment Obligation</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.25pt;text-align:justify;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:29.7pt">Payment Obligations Absolute</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company&#8217;s obligation to make the payments and the arrangements provided for herein shall be absolute and unconditional, and shall not be affected by any circumstances including, without limitation, any offset, counterclaim, recoupment, defense, or other right which the Company may have against the Executive or anyone else. All amounts payable by the Company hereunder shall be paid without notice or demand. Each and every payment made hereunder by the Company shall be final, and the Company shall not seek to recover all or any part of such payment from the Executive or from whomsoever may be entitled thereto, for any reasons whatsoever.</font></div><div style="margin-top:12.95pt;padding-left:5pt;padding-right:5.3pt;text-align:justify;text-indent:54.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Executive shall not be obligated to seek other employment in mitigation of the amounts payable or arrangements made under any provision of this Agreement, and the obtaining of any such other employment shall in no event effect any reduction of the Company&#8217;s obligations to make the payments and arrangements required to be made under this Agreement.</font></div><div style="margin-top:13.1pt;padding-left:5pt;padding-right:5.05pt;text-align:justify;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:29.7pt">Contractual Rights to Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Agreement establishes and vests in the Executive a contractual right to the benefits to which the Executive is entitled hereunder. However, nothing herein contained shall require or be deemed to require, or prohibit or be deemed to prohibit, the Company to segregate, earmark, or otherwise set aside any funds or other assets, in trust or otherwise, to provide for any payments to be made or required hereunder.</font></div><div style="margin-top:12.95pt;padding-left:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 6.   Term of Agreement</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.5pt;text-align:justify;text-indent:54.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The current term of this Agreement extends through December 31, 2025, provided that if a Sale occurs on or prior to such date, the term shall extend until the end of the Protected Period with respect to such Sale.</font></div><div style="margin-top:13pt;padding-left:5pt;padding-right:5.55pt;text-align:justify;text-indent:54.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In addition, should a Qualifying Termination occur during the term of this Agreement, this Agreement shall continue in effect until all of Executive&#8217;s rights in respect of such termination have been satisfied.</font></div><div style="margin-top:12.95pt;padding-left:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 7.   Legal Remedies</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.35pt;text-align:justify;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:29.7pt">Dispute Resolution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Executive shall have the right and option to elect to have any good faith dispute or controversy arising under or in connection with this Agreement settled by litigation or arbitration. If arbitration is selected, such proceeding shall be conducted by final and binding arbitration before a panel of three (3) arbitrators in accordance with the rules and under the administration of the American Arbitration Association.</font></div><div style="margin-top:13.1pt;padding-left:5pt;padding-right:5.3pt;text-align:justify;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:29.7pt">Payment of Legal Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In the event that it shall be necessary or desirable for the Executive to retain legal counsel and&#47;or to incur other costs and expenses in connection with the </font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:80%">12</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.921%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="margin-top:12.95pt;padding-left:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exhibit 10.1</font></div></div><div style="margin-top:13.1pt;padding-left:5pt;padding-right:5.3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">enforcement of any or all of the Executive&#8217;s rights under this Agreement, the Company shall pay (or the Executive shall be entitled to recover from the Company) the Executive&#8217;s attorneys&#8217; fees, costs, and expenses in connection with a good faith enforcement of the Executive&#8217;s rights including the enforcement of any arbitration award, and any such payment shall be made to the Executive as soon as administratively practicable following the time at which the related expense was incurred. This shall include, without limitation, court costs and attorneys&#8217; fees incurred by the Executive as a result of any good faith claim, action, or proceeding, including any such action against the Company arising out of, or challenging the validity or enforceability of this Agreement or any provision hereof. To the extent that any payments or reimbursements pursuant to this Section 7.2 are taxable to the Executive, any such payment or reimbursement shall be subject to 9.9 of this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:3.95pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 8.&#160;&#160;&#160;&#160;Successors</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.45pt;text-align:justify;text-indent:54.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company shall require any successor to the Critical Care and Vascular Product Group (whether direct or indirect, by purchase, merger, reorganization, consolidation, spinoff, acquisition of property or stock, liquidation, or otherwise) of all or substantially all of the assets of the Critical Care and Vascular Product Group (or any entity formed in relation to the Critical Care and Vascular Product Group in connection with a Sale or a Spinoff) by agreement to expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform if no such Sale, Spinoff or other succession had taken place. Regardless of whether such agreement is executed, this Agreement shall be binding upon any such successor in accordance with the operation of law and such successor shall be deemed the &#8220;Company&#8221; for purposes of this Agreement.</font></div><div style="margin-top:13pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 9.&#160;&#160;&#160;&#160;Miscellaneous</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.25pt;text-align:justify;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:29.7pt">Employment Status</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Agreement is not, and nothing herein shall be deemed to create, an employment contract between the Executive and the Company or any of its subsidiaries. Subject to the terms of any employment contract between the Executive and the Company, the Executive acknowledges that the rights of the Company remain wholly intact to change or reduce at any time and from time to time the Executive&#8217;s compensation, title, responsibilities, location, and all other aspects of the employment relationship, or to discharge the Executive prior to a Spinoff or a Sale (subject to such discharge possibly being considered a Qualifying Termination pursuant to Section 2.2).</font></div><div style="margin-top:12.95pt;padding-left:5pt;padding-right:5.3pt;text-align:justify;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:29.7pt">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Agreement contains the entire understanding of the Company and the Executive with respect to the subject matter hereof and supersedes all prior oral and written agreements between the parties hereto with respect to the subject matter hereof. In addition, the payments provided for under this Agreement in the event of the Executive&#8217;s termination of employment as provided herein shall be in lieu of any separation benefits payable under any employment contract between the Executive and the Company or any severance plan, program, or policy of the Company to which the Executive might otherwise be entitled.</font></div><div style="margin-top:13.1pt;padding-left:4.5pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding anything in this Section 9.2 to the contrary, and for purposes of clarity, (1) the Company&#8217;s rights under its standard form of employment agreement, which generally contains the Company&#8217;s rights with respect to any trade secrets, confidentiality, </font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:80%">13</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.921%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="margin-top:12.95pt;padding-left:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exhibit 10.1</font></div></div><div style="margin-top:13.1pt;padding-left:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">inventions and arbitration, and any similar agreements or policies, previously entered into between the Company and the Executive, and (2) the Company&#8217;s and the Executive&#8217;s rights under that certain Indemnification Agreement previously entered into between the Company and the Executive, dated as of January 5, 2015, are specifically not integrated into this Agreement and shall continue in effect to the extent continuing to be applicable.</font></div><div style="margin-top:12.95pt;padding-left:5pt;padding-right:5.3pt;text-align:justify;text-indent:54.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding any other provisions of this Agreement or other agreement between the Company and the Executive or other plan or program of the Company, the Executive shall not be entitled to any payments or benefits under more than one of Sections 2.3, 2.4 and 2.5 of this Agreement or under any other severance agreement, plan or program of the Company if payments or benefits are provided to the Executive under this Agreement.</font></div><div style="margin-top:3.95pt;padding-left:5pt;padding-right:5.45pt;text-align:justify;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:29.7pt">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. All notices, requests, demands, and other communications hereunder shall be sufficient if in writing and shall be deemed to have been duly given if delivered by hand or if sent by registered or certified mail to the Executive at the last address the Executive has filed in writing with the Company or, in the case of the Company, at its principal offices to the attention of the General Counsel.</font></div><div style="margin-top:12.95pt;padding-left:5pt;padding-right:5.25pt;text-align:justify;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:29.7pt">Execution in Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Agreement may be executed by the parties hereto in counterparts, each of which shall be deemed to be an original, but all such counterparts shall constitute one and the same instrument, and all signatures need not appear on any one counterpart.</font></div><div style="margin-top:13.1pt;padding-left:5pt;padding-right:5.05pt;text-align:justify;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:29.7pt">Conflicting Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Executive hereby represents and warrants to the Company that the Executive entering into this Agreement, and the obligations and duties undertaken by the Executive hereunder, will not conflict with, constitute a breach of, or otherwise violate the terms of, any other employment or other agreement to which the Executive is a party, except to the extent any such conflict, breach, or violation under any such agreement has been disclosed to the Board in writing in advance of the signing of this Agreement.</font></div><div style="margin-top:12.95pt;padding-left:5pt;padding-right:5.35pt;text-align:justify;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:29.7pt">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In the event any provision of this Agreement shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining parts of this Agreement, and this Agreement shall be construed and enforced as if the illegal or invalid provision had not been included. Further, the captions of this Agreement are not part of the provisions hereof and shall have no force and effect.</font></div><div style="margin-top:13pt;padding-left:5pt;padding-right:5.3pt;text-align:justify;text-indent:54.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding any other provisions of this Agreement to the contrary, the Company shall have no obligation to make any payment to the Executive hereunder to the extent, but only to the extent, that such payment is prohibited by the terms of any final order of a Federal or state court or regulatory agency of competent jurisdiction&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that such an order shall not affect, impair, or invalidate any provision of this Agreement not expressly subject to such order.</font></div><div style="margin-top:12.95pt;padding-left:5pt;padding-right:5.45pt;text-align:justify;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:29.7pt">Modification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. No provision of this Agreement may be modified, waived, or discharged unless such modification, waiver, or discharge is agreed to in writing and signed by the Executive and by the Company, as applicable, or by the respective parties&#8217; legal representatives or successors.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:80%">14</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.921%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="margin-top:12.95pt;padding-left:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exhibit 10.1</font></div></div><div style="margin-top:13.1pt;padding-left:5pt;padding-right:5.25pt;text-align:justify;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:29.7pt">Applicable Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. To the extent not preempted by the laws of the United States, the laws of California shall be the controlling law in all matters relating to this Agreement without giving effect to principles of conflicts of laws.</font></div><div style="margin-top:12.95pt;padding-left:58.9pt;text-indent:-31.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:16.6pt">Compliance with Code Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:12.95pt;padding-left:90.55pt;padding-right:5pt;text-align:justify;text-indent:-31.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.3pt">It is intended that any amounts payable under this Agreement shall either be exempt from or comply with Code Section 409A (including the Treasury regulations and other published guidance relating thereto) (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Code Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) so as not to subject the Executive to payment of any additional tax, penalty or interest imposed under Code Section 409A. The provisions of this Agreement shall be construed and interpreted to avoid the imputation of any such additional tax, penalty or interest under Code Section 409A yet preserve (to the nearest extent reasonably possible) the intended benefit payable to the Executive.</font></div><div style="margin-top:12.95pt;padding-left:90.55pt;padding-right:5.1pt;text-align:justify;text-indent:-31.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:17.62pt">If the Executive is a &#8220;specified employee&#8221; within the meaning of Treasury Regulation Section 1.409A-1(i) as of the date of the Executive&#8217;s Separation from Service, the Executive shall not be entitled to the Separation Benefits described in clauses (b) through (f) of Section 2.3, Section 2.4 or Section 2.5 herein, as applicable, until the earlier of (i) the date which is six (6) months after the Executive&#8217;s Separation from Service for any reason other than death, or (ii) the date of the Executive&#8217;s death. The provisions of this Section 9.9(b) shall only apply if, and to the extent, required to avoid the imputation of any tax, penalty or interest pursuant to Code Section 409A. Any amounts otherwise payable to the Executive upon or in the six (6) month period following the Executive&#8217;s Separation from Service that are not so paid by reason of this Section 9.9(b) shall be paid as soon as practicable (and in all events within thirty (30) days) after the date that is six (6) months after the Executive&#8217;s Separation from Service (or, if earlier, as soon as practicable, and in all events within thirty (30) days, after the date of the Executive&#8217;s death).</font></div><div style="margin-top:13pt;padding-left:90.55pt;padding-right:5.2pt;text-align:justify;text-indent:-31.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.3pt">To the extent that any payments or reimbursements pursuant to this Agreement are taxable to the Executive, any payment or reimbursement shall be paid to the Executive on or before the last day of the Executive&#8217;s taxable year following the taxable year in which the related expense was incurred. Any such benefits or reimbursements are not subject to liquidation or exchange for another benefit and the amount of such benefits and reimbursements that the Executive receives in one taxable year shall not affect the amount of such benefits and reimbursements that the Executive receives in any other taxable year.</font></div><div style="margin-top:13.1pt;padding-left:5pt;padding-right:5.4pt;text-align:justify;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:29.7pt">Legal Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Each party recognizes that this is a legally binding contract and acknowledges and agrees that they have had the opportunity to consult with legal counsel of their choice. Hence, in any construction to be made of this Agreement, the same shall not be construed against either party on the basis of that party being the drafter of such language.</font></div><div><font><br></font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:80%">15</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.921%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="margin-top:12.95pt;padding-left:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exhibit 10.1</font></div></div><div style="margin-top:12.1pt"><font><br></font></div><div style="padding-left:0.1pt;padding-right:0.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#91;Remainder of page intentionally left blank&#93;</font></div><div style="text-align:center"><font><br></font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:80%">16</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.921%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="margin-top:12.95pt;padding-left:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exhibit 10.1</font></div></div><div style="text-align:center"><font><br></font></div><div style="margin-top:3.95pt;padding-left:5pt;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the parties have executed this Agreement as of the Effective Date.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.930%"><tr><td style="width:1.0%"></td><td style="width:48.036%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.038%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#34;COMPANY&#34;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#34;EXECUTIVE&#34;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Edwards Lifesciences Corporation</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;  Christine Z. McCauley</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Catherine Szyman</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Corporate Vice President, Human Resources</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:44.148%"><div style="margin-top:4.5pt"><font><br></font></div></div><div style="display:inline-block;max-width:11.703%;min-width:10.703%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:44.149%"></div></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:80%">17</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.921%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="ic1f112e4fbf54cb9bfe7a0ff88fb3799_10"></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.240%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="margin-top:4.05pt;padding-left:17.67pt;padding-right:17.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">EXHIBIT A</font></div><div style="margin-top:13.05pt;padding-left:9.12pt;padding-right:9.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FORM OF GENERAL RELEASE AGREEMENT</font></div><div style="margin-top:5.2pt"><font><br></font></div><div style="padding-left:5pt;padding-right:5.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93; (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) provides this General Release Agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) to &#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93; (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) pursuant to Section 2.1 of the Spinoff Change in Control Agreement, by and between Executive and Edwards Lifesciences Corporation (or any successor thereto), dated </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, 2024 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Severance Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), in exchange for those certain separation benefits provided for in the Severance Agreement.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.35pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22pt;text-decoration:underline">Release by Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Executive, on Executive&#8217;s own behalf and on behalf of Executive&#8217;s descendants, dependents, heirs, executors, administrators, assigns and successors, and each of them, hereby acknowledges full and complete satisfaction of and releases and discharges and covenants not to sue the Company, its divisions, subsidiaries, parents, or affiliated corporations, past and present, and each of them, as well as its and their assignees, successors, directors, officers, stockholders, partners, representatives, attorneys, agents or employees, past or present, or any of them (individually and collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Releasees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), from and with respect to any and all claims, agreements, obligations, demands and causes of action, known or unknown, suspected or unsuspected, arising out of or in any way connected with Executive&#8217;s employment or any other relationship with or interest in the Company or the termination thereof, including without limiting the generality of the foregoing, any claim for severance pay, profit sharing, bonus or similar benefit, pension, retirement, life insurance, health or medical insurance or any other fringe benefit, or disability, or any other claims, agreements, obligations, demands and causes of action, known or unknown, suspected or unsuspected resulting from any act or omission by or on the part of Releasees committed or omitted prior to the date of this Agreement set forth below, including, without limiting the generality of the foregoing, any claim under Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act, the Family and Medical Leave Act, the California Fair Employment and Housing Act, California Labor Code Section 132a, the California Family Rights Act, or any other federal, state or local law, regulation, ordinance constitution or common law (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the foregoing release does not apply to any obligation of the Company to Executive pursuant to any of the following&#58; (1) Article 2 of the Severance Agreement&#59; (2) any equity-based awards previously granted by the Company to Executive, to the extent that such awards continue after the termination of Executive&#8217;s employment with the Company in accordance with the applicable terms of such awards&#59; (3) any right to indemnification that Executive may have pursuant to the Company&#8217;s bylaws, its corporate charter or under any written indemnification agreement with the Company (or any corresponding provision of any subsidiary or affiliate of the Company) with respect to any loss, damages or expenses (including but not limited to attorneys&#8217; fees to the extent otherwise provided) that Executive may in the future incur with respect to Executive&#8217;s service as an employee, officer or director of the Company or any of its subsidiaries or affiliates&#59; (4) with respect to any rights that Executive may have to insurance coverage for such losses, damages or expenses under any Company (or subsidiary or affiliate) directors and officers liability insurance policy&#59; (5) any rights to continued medical and dental coverage that Executive may have under COBRA&#59; (6) any rights to payment of vested benefits that Executive may have under any other benefit plan sponsored or maintained by the Company. In addition, this Agreement does not cover any Claim that cannot be so released as a matter of applicable law. Executive acknowledges and agrees that Executive has</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ic1f112e4fbf54cb9bfe7a0ff88fb3799_13"></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.240%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="margin-top:3.95pt;padding-left:5pt;padding-right:5.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">received any and all leave and other benefits that Executive has been and is entitled to pursuant to the Family and Medical Leave Act of 1993.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.25pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22pt;text-decoration:underline">Acknowledgment of Payment of Wages</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Except for accrued vacation (which the parties agree totals approximately </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#93; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">days of pay) and salary for the current pay period, Executive acknowledges that Executive has received all amounts owed for Executive&#8217;s regular and usual salary (including, but not limited to, any bonus, severance, or other wages), and usual benefits through the date of this Agreement.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.35pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22pt;text-decoration:underline">Waiver of Civil Code Section 1542</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Agreement is intended to be effective as a general release of and bar to each and every Claim hereinabove specified. Accordingly, Executive hereby expressly waives any rights and benefits conferred by Section 1542 of the California Civil Code and any similar provision of any other applicable state law as to the Claims. Section 1542 of the California Civil Code provides&#58;</font></div><div style="margin-top:12pt;padding-left:77pt;padding-right:41.15pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.&#8221;</font></div><div style="margin-top:12.05pt;padding-left:5pt;padding-right:5.45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Executive acknowledges that Executive may later discover claims, demands, causes of action or facts in addition to or different from those which Executive now knows or believes to exist with respect to the subject matter of this Agreement and which, if known or suspected at the time of executing this Agreement, may have materially affected its terms. Nevertheless, Executive hereby waives, as to the Claims, any claims, demands, and causes of action that might arise as a result of such different or additional claims, demands, causes of action or facts.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.25pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22pt;text-decoration:underline">ADEA Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Executive expressly acknowledges and agrees that by entering into this Agreement, Executive is waiving any and all rights or claims that Executive may have arising under the Age Discrimination in Employment Act of 1967, as amended (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ADEA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), which have arisen on or before the date of execution of this Agreement. Executive further expressly acknowledges and agrees that&#58;</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.45pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Executive is hereby advised in writing by this Agreement to consult with an attorney before signing this Agreement&#59;</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:4.95pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Executive was given a copy of this Agreement on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#93; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">and informed that Executive had &#91;twenty-one (21)&#47;forty-five (45)&#93; days within which to consider this Agreement and that if Executive wished to execute this Agreement prior to expiration of such &#91;21&#47;45&#93;-day period, Executive agrees that Executive voluntarily chose to do so.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.25pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Nothing in this Agreement prevents or precludes Executive from challenging or seeking a determination in good faith of the validity of this waiver under the ADEA, nor does it impose any condition precedent, penalties or costs from doing so, unless specifically authorized by federal law&#59; and</font></div><div><font><br></font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.666%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.240%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div style="margin-top:3.95pt;padding-left:5pt;padding-right:5.3pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Executive was informed that Executive has seven (7) days following the date of execution of this Agreement in which to revoke this Agreement, and this Agreement will become null and void if Executive elects revocation during that time. Any revocation must be in writing and must be received by the General Counsel of the Company during the seven-day revocation period. In the event that Executive exercises Executive&#8217;s right of revocation, neither the Company nor Executive will have any obligations under this Agreement.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22pt;text-decoration:underline">No Transferred Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Executive represents and warrants to the Company that Executive has not heretofore assigned or transferred to any person not a party to this Agreement any released matter or any part or portion thereof.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22pt;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The following provisions shall apply for purposes of this Agreement&#58;</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:17.7pt;text-decoration:underline">Number and Gender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Where the context requires, the singular shall include the plural, the plural shall include the singular, and any gender shall include all other genders.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.4pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:17.02pt;text-decoration:underline">Section Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The section headings of, and titles of paragraphs and subparagraphs contained in, this Agreement are for the purpose of convenience only, and they neither form a part of this Agreement nor are they to be used in the construction or interpretation thereof.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.3pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:17.7pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Agreement, and all questions relating to its validity, interpretation, performance and enforcement, as well as the legal relations hereby created between the parties hereto, shall be governed by and construed under, and interpreted and enforced in accordance with, the laws of the State of California, notwithstanding any California or other conflict of law provision to the contrary.</font></div><div style="margin-top:12.05pt;padding-left:5pt;padding-right:5.45pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:17.02pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. If any provision of this Agreement or the application thereof is held invalid, the invalidity shall not affect other provisions or applications of this Agreement which can be given effect without the invalid provisions or applications and to this end the provisions of this Agreement are declared to be severable.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.45pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:17.7pt;text-decoration:underline">Modifications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Agreement may not be amended, modified or changed (in whole or in part), except by a formal, definitive written agreement expressly referring to this Agreement, which agreement is executed by both of the parties hereto.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.45pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.03pt;text-decoration:underline">Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. No waiver of any breach of any term or provision of this Agreement shall be construed to be, nor shall be, a waiver of any other breach of this Agreement. No waiver shall be binding unless in writing and signed by the party waiving the breach.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.25pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:17.02pt;text-decoration:underline">Arbitration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Any controversy arising out of or relating to this Agreement shall be submitted to arbitration in accordance with the arbitration provisions of the Severance Agreement.</font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.666%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.240%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.35pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:17.02pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Agreement may be executed in counterparts, and each counterpart, when executed, shall have the efficacy of a signed original. Photographic copies of such signed counterparts may be used in lieu of the originals for any purpose.</font></div><div style="margin-top:12.95pt;padding-right:5.35pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-top:3.95pt;padding-left:0.1pt;padding-right:0.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#91;Remainder of page intentionally left blank&#93;</font></div><div style="text-align:center"><font><br></font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.666%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.240%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:center"><font><br></font></div><div style="margin-top:3.95pt;padding-left:5pt;padding-right:5.45pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The undersigned have read and understand the consequences of this Agreement and voluntarily sign it. The undersigned declare under penalty of perjury under the laws of the State of California that the foregoing is true and correct.</font></div><div style="margin-top:12pt;padding-left:41pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">EXECUTED this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">day of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">County, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:12pt;padding-left:12.05pt;padding-right:12.05pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;EXECUTIVE&#8221;</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:2.65pt"><img alt="image_6.jpg" src="image_6.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:312px"></div><div style="margin-top:0.65pt;padding-left:203pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;Name&#93;</font></div><div style="margin-top:12pt"><font><br></font></div><div style="padding-left:0.85pt;padding-right:0.85pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">EXECUTED this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">day of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">County, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:12pt"><font><br></font></div><div style="padding-left:16.42pt;padding-right:16.42pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;COMPANY&#8221;</font></div><div><font><br></font></div><div style="padding-left:203pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#93;</font></div><div><font><br></font></div><div style="padding-left:203pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:206.97pt;padding-right:206.97pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;Name&#93; &#91;Title&#93;</font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.666%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5</font></div></td></tr></table></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>ex-31110xqq12024.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i726b2f4b9b944e82af50c4ec29ffe39d_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EDWARDS LIFESCIENCES CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION&#160;302 OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE SARBANES-OXLEY ACT OF&#160;2002</font></div><div><font><br></font></div><div style="margin-bottom:8pt;margin-top:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="margin-bottom:8pt;margin-top:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Bernard J. Zovighian, certify that&#58;</font></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6pt">&#160;I have reviewed this quarterly report on Form&#160;10-Q of Edwards Lifesciences Corporation&#59;</font></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6pt">&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6pt">&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6pt">&#160;The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:31.5pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:31.5pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:31.5pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:31.5pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6pt">&#160;&#160;&#160;The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:31.5pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:31.5pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:5.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.832%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.679%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 29, 2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;BERNARD J. ZOVIGHIAN</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bernard J. Zovighian</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer</font></div></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>ex-31210xqq12024.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i99d60959d6ec42c8986a76f9d32c08d2_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.2</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EDWARDS LIFESCIENCES CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION&#160;302 OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE SARBANES-OXLEY ACT OF&#160;2002</font></div><div><font><br></font></div><div style="margin-bottom:8pt;margin-top:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="margin-bottom:8pt;margin-top:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Scott B. Ullem, certify that&#58;</font></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6pt">&#160;&#160;I have reviewed this quarterly report on Form&#160;10-Q of Edwards Lifesciences Corporation&#59;</font></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6pt">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:31.5pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:31.5pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:31.5pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:31.5pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6pt">&#160;The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:31.5pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:31.5pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.678%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 29, 2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;SCOTT B. ULLEM</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scott B. Ullem</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</font></div></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>5
<FILENAME>ex-3210xqq12024.htm
<DESCRIPTION>EX-32
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="iaaea8b4c81324d4a93ba2e9258fb4202_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EDWARDS LIFESCIENCES CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION&#160;1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION&#160;906 OF THE SARBANES-OXLEY ACT OF&#160;2002</font></div><div><font><br></font></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Edwards Lifesciences Corporation (the &#34;Company&#34;) on Form&#160;10-Q for the period ended March&#160;31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the &#34;Report&#34;), we, Bernard J. Zovighian, Chief Executive Officer of the Company, and Scott B. Ullem, Corporate Vice President, Chief Financial Officer, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">The Report fully complies with the requirements of section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:56.147%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.653%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 29, 2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;BERNARD J. ZOVIGHIAN</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bernard J. Zovighian</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 29, 2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;SCOTT B. ULLEM</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scott B. Ullem</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</font></div></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>ew-20240331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:1b5f1024-67d5-4c23-ba5b-277a92b54967,g:71cdffb8-b576-4b3a-8b78-825fbaff5436-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ew="http://www.edwards.com/20240331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.edwards.com/20240331">
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ew-20240331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ew-20240331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ew-20240331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ew-20240331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="COVER" roleURI="http://www.edwards.com/role/COVER">
        <link:definition>0000001 - Document - COVER</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDCONDENSEDBALANCESHEETS" roleURI="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS">
        <link:definition>0000002 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical" roleURI="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical">
        <link:definition>0000003 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS" roleURI="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS">
        <link:definition>0000004 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME" roleURI="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME">
        <link:definition>0000005 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000006 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>0000007 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFPRESENTATION" roleURI="http://www.edwards.com/role/BASISOFPRESENTATION">
        <link:definition>0000008 - Disclosure - BASIS OF PRESENTATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS" roleURI="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS">
        <link:definition>0000009 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSES" roleURI="http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSES">
        <link:definition>0000010 - Disclosure - INTELLECTUAL PROPERTY AGREEMENT AND CERTAIN LITIGATION EXPENSES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEPARATIONCOSTS" roleURI="http://www.edwards.com/role/SEPARATIONCOSTS">
        <link:definition>0000011 - Disclosure - SEPARATION COSTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTS" roleURI="http://www.edwards.com/role/INVESTMENTS">
        <link:definition>0000012 - Disclosure - INVESTMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSINVARIABLEINTERESTENTITIES" roleURI="http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIES">
        <link:definition>0000013 - Disclosure - INVESTMENTS IN VARIABLE INTEREST ENTITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTS" roleURI="http://www.edwards.com/role/FAIRVALUEMEASUREMENTS">
        <link:definition>0000014 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES" roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES">
        <link:definition>0000015 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATION" roleURI="http://www.edwards.com/role/STOCKBASEDCOMPENSATION">
        <link:definition>0000016 - Disclosure - STOCK-BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCELERATEDSHAREREPURCHASE" roleURI="http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASE">
        <link:definition>0000017 - Disclosure - ACCELERATED SHARE REPURCHASE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>0000018 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVELOSS" roleURI="http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS">
        <link:definition>0000019 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARE" roleURI="http://www.edwards.com/role/EARNINGSPERSHARE">
        <link:definition>0000020 - Disclosure - EARNINGS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.edwards.com/role/INCOMETAXES">
        <link:definition>0000021 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATION" roleURI="http://www.edwards.com/role/SEGMENTINFORMATION">
        <link:definition>0000022 - Disclosure - SEGMENT INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFPRESENTATIONPolicies" roleURI="http://www.edwards.com/role/BASISOFPRESENTATIONPolicies">
        <link:definition>9954471 - Disclosure - BASIS OF PRESENTATION (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables" roleURI="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables">
        <link:definition>9954472 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSTables" roleURI="http://www.edwards.com/role/INVESTMENTSTables">
        <link:definition>9954473 - Disclosure - INVESTMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSTables" roleURI="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSTables">
        <link:definition>9954474 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables">
        <link:definition>9954475 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONTables" roleURI="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONTables">
        <link:definition>9954476 - Disclosure - STOCK-BASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCELERATEDSHAREREPURCHASETables" roleURI="http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASETables">
        <link:definition>9954477 - Disclosure - ACCELERATED SHARE REPURCHASE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" roleURI="http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables">
        <link:definition>9954478 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARETables" roleURI="http://www.edwards.com/role/EARNINGSPERSHARETables">
        <link:definition>9954479 - Disclosure - EARNINGS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONTables" roleURI="http://www.edwards.com/role/SEGMENTINFORMATIONTables">
        <link:definition>9954480 - Disclosure - SEGMENT INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsintheConsolidatedBalanceSheetsDetails" roleURI="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsintheConsolidatedBalanceSheetsDetails">
        <link:definition>9954481 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Components of Selected Captions in the Consolidated Balance Sheets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails" roleURI="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails">
        <link:definition>9954482 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Accrued and Other Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails" roleURI="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails">
        <link:definition>9954483 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Supplemental Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails" roleURI="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails">
        <link:definition>9954484 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSESDetails" roleURI="http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSESDetails">
        <link:definition>9954485 - Disclosure - INTELLECTUAL PROPERTY AGREEMENT AND CERTAIN LITIGATION EXPENSES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEPARATIONCOSTSDetails" roleURI="http://www.edwards.com/role/SEPARATIONCOSTSDetails">
        <link:definition>9954486 - Disclosure - SEPARATION COSTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" roleURI="http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails">
        <link:definition>9954487 - Disclosure - INVESTMENTS - Schedule of Investments in Debt Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" roleURI="http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails">
        <link:definition>9954488 - Disclosure - INVESTMENTS - Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails" roleURI="http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails">
        <link:definition>9954489 - Disclosure - INVESTMENTS - Schedule of Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails" roleURI="http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails">
        <link:definition>9954490 - Disclosure - INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSNarrativeDetails" roleURI="http://www.edwards.com/role/INVESTMENTSNarrativeDetails">
        <link:definition>9954491 - Disclosure - INVESTMENTS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSINVARIABLEINTERESTENTITIESDetails" roleURI="http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails">
        <link:definition>9954492 - Disclosure - INVESTMENTS IN VARIABLE INTEREST ENTITIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSNarrativeDetails" roleURI="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails">
        <link:definition>9954493 - Disclosure - FAIR VALUE MEASUREMENTS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" roleURI="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails">
        <link:definition>9954494 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails" roleURI="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails">
        <link:definition>9954495 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Changes in Fair Value of Contingent Consideration and Other Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails" roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails">
        <link:definition>9954496 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails" roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails">
        <link:definition>9954497 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails">
        <link:definition>9954498 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails">
        <link:definition>9954499 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails">
        <link:definition>9954500 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails" roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails">
        <link:definition>9954501 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Fair Value and Cash Flow Hedge Accounting on the Consolidated Condensed Statements of Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails" roleURI="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails">
        <link:definition>9954502 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONNarrativeDetails" roleURI="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails">
        <link:definition>9954503 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails" roleURI="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails">
        <link:definition>9954504 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Weighted-Average Assumptions for Options and ESPP Subscriptions Granted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCELERATEDSHAREREPURCHASEDetails" roleURI="http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails">
        <link:definition>9954505 - Disclosure - ACCELERATED SHARE REPURCHASE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESDetails" roleURI="http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIESDetails">
        <link:definition>9954506 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" roleURI="http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails">
        <link:definition>9954507 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" roleURI="http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails">
        <link:definition>9954508 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails" roleURI="http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails">
        <link:definition>9954509 - Disclosure - EARNINGS PER SHARE - Schedule of Computation of Basic and Diluted Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARENarrativeDetails" roleURI="http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails">
        <link:definition>9954510 - Disclosure - EARNINGS PER SHARE - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDetails" roleURI="http://www.edwards.com/role/INCOMETAXESDetails">
        <link:definition>9954511 - Disclosure - INCOME TAXES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails" roleURI="http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails">
        <link:definition>9954512 - Disclosure - SEGMENT INFORMATION - Schedule of Information about Reportable Segments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" roleURI="http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails">
        <link:definition>9954513 - Disclosure - SEGMENT INFORMATION - Schedule of Reconciliation of Segment Net Sales and Pre-Tax Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" roleURI="http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails">
        <link:definition>9954514 - Disclosure - SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="ew_IncomeTaxAssessmentEstimateOfAdditionalTaxExpense" abstract="false" name="IncomeTaxAssessmentEstimateOfAdditionalTaxExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_IntellectualPropertyAgreementTerm" abstract="false" name="IntellectualPropertyAgreementTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent" abstract="false" name="AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber" abstract="false" name="LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ew_MedtronicIncMember" abstract="true" name="MedtronicIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_JapanSegmentMember" abstract="true" name="JapanSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_NewMarketsTaxCreditMember" abstract="true" name="NewMarketsTaxCreditMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_ScottB.UllemMember" abstract="true" name="ScottB.UllemMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ew_RestOfWorldSegmentMember" abstract="true" name="RestOfWorldSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_BernardJ.ZovighianMember" abstract="true" name="BernardJ.ZovighianMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ew_EquitySecuritiesFVNIPromissoryNoteOutstanding" abstract="false" name="EquitySecuritiesFVNIPromissoryNoteOutstanding" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_CriticalCareMember" abstract="true" name="CriticalCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote" abstract="false" name="EquitySecuritiesFVNIMaximumSecuredPromissoryNote" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount" abstract="false" name="AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="ew_SeparationCostsMember" abstract="true" name="SeparationCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ew_AccruedAndOtherLiabilitiesCurrent" abstract="false" name="AccruedAndOtherLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_MedicalDeviceCompanyMember" abstract="true" name="MedicalDeviceCompanyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_AccruedLitigationAndInsuranceReserves" abstract="false" name="AccruedLitigationAndInsuranceReserves" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_MeasurementInputProbabilityOfMilestoneAchievementMember" abstract="true" name="MeasurementInputProbabilityOfMilestoneAchievementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_LoansReceivablesMaximumLendingCapacity" abstract="false" name="LoansReceivablesMaximumLendingCapacity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_EquitySecuritiesFVNIMaximumAdditionalRequired" abstract="false" name="EquitySecuritiesFVNIMaximumAdditionalRequired" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract" abstract="true" name="DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ew_RestOfWorldMember" abstract="true" name="RestOfWorldMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions" abstract="false" name="PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_AccruedRelocationCostsCurrent" abstract="false" name="AccruedRelocationCostsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_EquitySecuritiesFVNIOptionToAcquireInvestment" abstract="false" name="EquitySecuritiesFVNIOptionToAcquireInvestment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment" abstract="false" name="EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_MichaelA.MussallemMember" abstract="true" name="MichaelA.MussallemMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ew_IncomeTaxExaminationAmountDepositedToMitigateInterestOnTaxLiabilities" abstract="false" name="IncomeTaxExaminationAmountDepositedToMitigateInterestOnTaxLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_ResearchAndDevelopmentAccruals" abstract="false" name="ResearchAndDevelopmentAccruals" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_EuropeSegmentMember" abstract="true" name="EuropeSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_EquityMethodInvestmentsInvestmentPeriod" abstract="false" name="EquityMethodInvestmentsInvestmentPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ew_IncreaseDecreaseInLegalSettlementAccrual" abstract="false" name="IncreaseDecreaseInLegalSettlementAccrual" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_TranscatheterAorticValveReplacementMember" abstract="true" name="TranscatheterAorticValveReplacementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_DerivativeFairValueOfDerivativeAssetGrossAmountsNotOffsetAbstract" abstract="true" name="DerivativeFairValueOfDerivativeAssetGrossAmountsNotOffsetAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ew_InitialDeliveryOfSharesSettledFebruary2023Member" abstract="true" name="InitialDeliveryOfSharesSettledFebruary2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_UnitedStatesSegmentMember" abstract="true" name="UnitedStatesSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_ConvertiblePromissoryNoteMember" abstract="true" name="ConvertiblePromissoryNoteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_AcquisitionOptionsNoncurrent" abstract="false" name="AcquisitionOptionsNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member" abstract="true" name="February2023StockRepurchaseProgramSharesSoldInMarch2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_AccrualForEnvironmentalLossContingenciesThresholdAmountForDisclosure" abstract="false" name="AccrualForEnvironmentalLossContingenciesThresholdAmountForDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_AccruedRebates" abstract="false" name="AccruedRebates" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_SurgicalHeartValveTherapyMember" abstract="true" name="SurgicalHeartValveTherapyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_EmployeeAndNonemployeeStockOptionsMember" abstract="true" name="EmployeeAndNonemployeeStockOptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_NumberOfAdvancePricingAgreementsRenewed" abstract="false" name="NumberOfAdvancePricingAgreementsRenewed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ew_ContingentConsiderationLiabilityMember" abstract="true" name="ContingentConsiderationLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_ShareInformationAbstract" abstract="true" name="ShareInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ew_TranscatheterMitralAndTricuspidTherapiesMember" abstract="true" name="TranscatheterMitralAndTricuspidTherapiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_VariableInterestEntitiesAbstract" abstract="true" name="VariableInterestEntitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>ew-20240331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:1b5f1024-67d5-4c23-ba5b-277a92b54967,g:71cdffb8-b576-4b3a-8b78-825fbaff5436-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" xlink:type="simple" xlink:href="ew-20240331.xsd#CONSOLIDATEDCONDENSEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1a8dce01-b4e0-4691-baa6-6d332189f9f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b71ded3c-00cc-44f0-9a8e-c1a0069b793c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1a8dce01-b4e0-4691-baa6-6d332189f9f5" xlink:to="loc_us-gaap_StockholdersEquity_b71ded3c-00cc-44f0-9a8e-c1a0069b793c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_dcd863b9-2ca6-4ee3-80a4-5de298ebb1e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1a8dce01-b4e0-4691-baa6-6d332189f9f5" xlink:to="loc_us-gaap_MinorityInterest_dcd863b9-2ca6-4ee3-80a4-5de298ebb1e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8430772d-49ac-4950-b0bf-bf3ac2ba8a31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_eb3ed614-a56e-4577-b59e-9f28f2755c10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8430772d-49ac-4950-b0bf-bf3ac2ba8a31" xlink:to="loc_us-gaap_PreferredStockValue_eb3ed614-a56e-4577-b59e-9f28f2755c10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_714e69c9-642b-4db9-b36b-3207bdcc695d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8430772d-49ac-4950-b0bf-bf3ac2ba8a31" xlink:to="loc_us-gaap_CommonStockValue_714e69c9-642b-4db9-b36b-3207bdcc695d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_e332ab39-c34c-422d-acd4-bf1aae3157cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8430772d-49ac-4950-b0bf-bf3ac2ba8a31" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_e332ab39-c34c-422d-acd4-bf1aae3157cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d20112a5-0d5a-4ff0-bc78-cb9d307586e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8430772d-49ac-4950-b0bf-bf3ac2ba8a31" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d20112a5-0d5a-4ff0-bc78-cb9d307586e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_599af452-8a3c-4623-a4bd-340489bb40be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8430772d-49ac-4950-b0bf-bf3ac2ba8a31" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_599af452-8a3c-4623-a4bd-340489bb40be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_f558f5e5-fe2e-41ac-932f-43bedcb25da4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8430772d-49ac-4950-b0bf-bf3ac2ba8a31" xlink:to="loc_us-gaap_TreasuryStockCommonValue_f558f5e5-fe2e-41ac-932f-43bedcb25da4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a2a2300b-0df1-498c-b05c-cdddc69de4c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_5ff33def-6d2c-4e8c-a3d9-eb8a0259f3b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a2a2300b-0df1-498c-b05c-cdddc69de4c8" xlink:to="loc_us-gaap_AccountsPayableCurrent_5ff33def-6d2c-4e8c-a3d9-eb8a0259f3b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccruedAndOtherLiabilitiesCurrent_b1a7b740-2b81-4d58-bd89-5801469c3776" xlink:href="ew-20240331.xsd#ew_AccruedAndOtherLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a2a2300b-0df1-498c-b05c-cdddc69de4c8" xlink:to="loc_ew_AccruedAndOtherLiabilitiesCurrent_b1a7b740-2b81-4d58-bd89-5801469c3776" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_77544c5d-0333-4995-bcb3-21c66bd3ed62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a2a2300b-0df1-498c-b05c-cdddc69de4c8" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_77544c5d-0333-4995-bcb3-21c66bd3ed62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e69135da-7de6-4850-9c30-b25a6fdb4f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_bea12d3a-f535-4139-ba86-a6a732fc46d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e69135da-7de6-4850-9c30-b25a6fdb4f1c" xlink:to="loc_us-gaap_AssetsCurrent_bea12d3a-f535-4139-ba86-a6a732fc46d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_3128c085-1a65-415a-99eb-e2f0000db9e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e69135da-7de6-4850-9c30-b25a6fdb4f1c" xlink:to="loc_us-gaap_LongTermInvestments_3128c085-1a65-415a-99eb-e2f0000db9e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_5b412051-93be-44a1-ac38-0de650da6c63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e69135da-7de6-4850-9c30-b25a6fdb4f1c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_5b412051-93be-44a1-ac38-0de650da6c63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1615e28d-0988-4f82-940b-63b26330d688" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e69135da-7de6-4850-9c30-b25a6fdb4f1c" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_1615e28d-0988-4f82-940b-63b26330d688" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e045c784-7797-4064-b02d-6c0fbf9cad35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e69135da-7de6-4850-9c30-b25a6fdb4f1c" xlink:to="loc_us-gaap_Goodwill_e045c784-7797-4064-b02d-6c0fbf9cad35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2d463c07-0ddf-41bb-ac57-0920315dcc35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e69135da-7de6-4850-9c30-b25a6fdb4f1c" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2d463c07-0ddf-41bb-ac57-0920315dcc35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_c12c1a5b-6cc4-46d4-bd4f-1a098bff7f53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e69135da-7de6-4850-9c30-b25a6fdb4f1c" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_c12c1a5b-6cc4-46d4-bd4f-1a098bff7f53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_fbe58b87-9cef-48e3-8185-23e9a8b4b88f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e69135da-7de6-4850-9c30-b25a6fdb4f1c" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_fbe58b87-9cef-48e3-8185-23e9a8b4b88f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_8c61575b-ab5e-48ee-b4b8-5e1c7d8e88f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_c5e6485d-48df-475b-a08c-30e9c07a9e6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_8c61575b-ab5e-48ee-b4b8-5e1c7d8e88f3" xlink:to="loc_us-gaap_LiabilitiesCurrent_c5e6485d-48df-475b-a08c-30e9c07a9e6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_3ac7d07e-3ee9-470d-86a3-689a0b56fad6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_8c61575b-ab5e-48ee-b4b8-5e1c7d8e88f3" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_3ac7d07e-3ee9-470d-86a3-689a0b56fad6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrentAndNoncurrent_b7af681d-3aa0-4150-a31c-e3f3f7eb00de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_8c61575b-ab5e-48ee-b4b8-5e1c7d8e88f3" xlink:to="loc_us-gaap_TaxesPayableCurrentAndNoncurrent_b7af681d-3aa0-4150-a31c-e3f3f7eb00de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_79e1dd3e-2011-41e6-9fd1-2c4449f164df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_8c61575b-ab5e-48ee-b4b8-5e1c7d8e88f3" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_79e1dd3e-2011-41e6-9fd1-2c4449f164df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_8b5efb61-e9f5-4b8b-acdf-9cd956b2d718" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_8c61575b-ab5e-48ee-b4b8-5e1c7d8e88f3" xlink:to="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_8b5efb61-e9f5-4b8b-acdf-9cd956b2d718" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent_8de0f9d2-8aa8-4e0a-b02b-f16c99a0fe6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_8c61575b-ab5e-48ee-b4b8-5e1c7d8e88f3" xlink:to="loc_us-gaap_LitigationReserveNoncurrent_8de0f9d2-8aa8-4e0a-b02b-f16c99a0fe6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_0010ab76-ae22-4bcc-90aa-211007cdfe03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_8c61575b-ab5e-48ee-b4b8-5e1c7d8e88f3" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_0010ab76-ae22-4bcc-90aa-211007cdfe03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_086b6b77-abbd-4bf3-9db0-6403571d39a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_6227c0ad-3973-4808-8712-98f6eb474344" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_086b6b77-abbd-4bf3-9db0-6403571d39a4" xlink:to="loc_us-gaap_InventoryNet_6227c0ad-3973-4808-8712-98f6eb474344" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_66b5f883-1342-4a6c-b5b9-d490e4ee2808" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_086b6b77-abbd-4bf3-9db0-6403571d39a4" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_66b5f883-1342-4a6c-b5b9-d490e4ee2808" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_e7c45f8d-ace6-415a-9cb0-dcb768d9c349" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_086b6b77-abbd-4bf3-9db0-6403571d39a4" xlink:to="loc_us-gaap_OtherAssetsCurrent_e7c45f8d-ace6-415a-9cb0-dcb768d9c349" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_a919299c-9f43-44eb-8315-69013444716d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_086b6b77-abbd-4bf3-9db0-6403571d39a4" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_a919299c-9f43-44eb-8315-69013444716d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_3f2f885e-2807-4f3d-99ba-98a0e31db1d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_086b6b77-abbd-4bf3-9db0-6403571d39a4" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_3f2f885e-2807-4f3d-99ba-98a0e31db1d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_99214417-bc6d-451b-87ec-5bf79928e2f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_086b6b77-abbd-4bf3-9db0-6403571d39a4" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_99214417-bc6d-451b-87ec-5bf79928e2f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_f8d70af8-f940-4c08-b15b-8fd3cfb28e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_086b6b77-abbd-4bf3-9db0-6403571d39a4" xlink:to="loc_us-gaap_ShortTermInvestments_f8d70af8-f940-4c08-b15b-8fd3cfb28e9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_fd3a7d9a-9410-4d13-a031-08d8329a337c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_4ca17063-e614-4187-9e42-ae9f452ccf20" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_fd3a7d9a-9410-4d13-a031-08d8329a337c" xlink:to="loc_us-gaap_Liabilities_4ca17063-e614-4187-9e42-ae9f452ccf20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_6979dc3a-ad43-46e0-b690-bb8c04131a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_fd3a7d9a-9410-4d13-a031-08d8329a337c" xlink:to="loc_us-gaap_CommitmentsAndContingencies_6979dc3a-ad43-46e0-b690-bb8c04131a7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_11dd6541-386b-4bf7-a90f-f635b166e895" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_fd3a7d9a-9410-4d13-a031-08d8329a337c" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_11dd6541-386b-4bf7-a90f-f635b166e895" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="ew-20240331.xsd#CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_92c4dad4-bda0-408f-84ac-7ccd02af4372" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_11b0454a-6625-4cd0-8d20-e26b954349ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_92c4dad4-bda0-408f-84ac-7ccd02af4372" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_11b0454a-6625-4cd0-8d20-e26b954349ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_dffe380c-0e22-4114-877e-784cf9cef513" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_92c4dad4-bda0-408f-84ac-7ccd02af4372" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_dffe380c-0e22-4114-877e-784cf9cef513" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_724841d4-f339-4b1f-b2c5-9437d751ad9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_47d45b6e-9948-4c5f-a1b5-818e28f9bc25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_724841d4-f339-4b1f-b2c5-9437d751ad9b" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_47d45b6e-9948-4c5f-a1b5-818e28f9bc25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c20e3a7f-252d-4314-99f3-8a90d20ea561" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_724841d4-f339-4b1f-b2c5-9437d751ad9b" xlink:to="loc_us-gaap_ProfitLoss_c20e3a7f-252d-4314-99f3-8a90d20ea561" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_dc4f81d4-a5cd-4284-ba28-552b5287c030" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_284f8f16-bc84-4a29-a3b8-e88b083ce9d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_dc4f81d4-a5cd-4284-ba28-552b5287c030" xlink:to="loc_us-gaap_GrossProfit_284f8f16-bc84-4a29-a3b8-e88b083ce9d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_1bb3b896-1ba9-4dbf-925a-9a4b94e9adca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_dc4f81d4-a5cd-4284-ba28-552b5287c030" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_1bb3b896-1ba9-4dbf-925a-9a4b94e9adca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_c32c81b3-d90c-4633-8592-42ad102c4890" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_dc4f81d4-a5cd-4284-ba28-552b5287c030" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_c32c81b3-d90c-4633-8592-42ad102c4890" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_5944ac65-b98f-4b92-b622-51735ce214cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_dc4f81d4-a5cd-4284-ba28-552b5287c030" xlink:to="loc_us-gaap_LitigationSettlementExpense_5944ac65-b98f-4b92-b622-51735ce214cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a4143811-c509-442f-8228-cbca66822ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_dc4f81d4-a5cd-4284-ba28-552b5287c030" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a4143811-c509-442f-8228-cbca66822ee1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonrecurringIncomeExpense_c79b66dd-fc12-4792-a650-78cf7da5363d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonrecurringIncomeExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_dc4f81d4-a5cd-4284-ba28-552b5287c030" xlink:to="loc_us-gaap_OtherNonrecurringIncomeExpense_c79b66dd-fc12-4792-a650-78cf7da5363d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_eaa14af8-626a-4646-bbb4-582de3c37f37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_33c46d13-6582-4449-805b-bbf5cc6134a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_eaa14af8-626a-4646-bbb4-582de3c37f37" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_33c46d13-6582-4449-805b-bbf5cc6134a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_29bea097-a7f0-4cf7-9292-7494f36f6999" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_eaa14af8-626a-4646-bbb4-582de3c37f37" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_29bea097-a7f0-4cf7-9292-7494f36f6999" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f650aad8-b805-4a13-8d4d-d181d19839e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ee9cfead-ac8b-48ae-b211-5e408eb049fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f650aad8-b805-4a13-8d4d-d181d19839e6" xlink:to="loc_us-gaap_OperatingIncomeLoss_ee9cfead-ac8b-48ae-b211-5e408eb049fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_fdcca46b-e108-4bbc-ab5f-bfdca32d4d46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f650aad8-b805-4a13-8d4d-d181d19839e6" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_fdcca46b-e108-4bbc-ab5f-bfdca32d4d46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_d5530ebf-9f9a-4fa6-9b2e-591cdec8cc86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f650aad8-b805-4a13-8d4d-d181d19839e6" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_d5530ebf-9f9a-4fa6-9b2e-591cdec8cc86" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="ew-20240331.xsd#CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_53b1d7c7-fd81-46cb-b464-178b863a417d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3845d033-b715-4841-aa08-4eff817f0783" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_53b1d7c7-fd81-46cb-b464-178b863a417d" xlink:to="loc_us-gaap_ProfitLoss_3845d033-b715-4841-aa08-4eff817f0783" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9bf7998b-0025-464e-8d9a-edd0b6efd545" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_53b1d7c7-fd81-46cb-b464-178b863a417d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9bf7998b-0025-464e-8d9a-edd0b6efd545" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_745989d4-30ac-4526-be52-ba8302fa9515" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_da1bef87-49fa-4a55-9c92-86aacc2f0fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_745989d4-30ac-4526-be52-ba8302fa9515" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_da1bef87-49fa-4a55-9c92-86aacc2f0fc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_fd861095-3ac6-4117-a33f-f27b990193f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_745989d4-30ac-4526-be52-ba8302fa9515" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_fd861095-3ac6-4117-a33f-f27b990193f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3b02edf0-b9b5-4ea8-81ec-40d16c60db7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7262b676-3d3b-4d0b-8045-7e9aaefff727" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3b02edf0-b9b5-4ea8-81ec-40d16c60db7a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7262b676-3d3b-4d0b-8045-7e9aaefff727" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_156ae800-fed0-4baa-bb45-5c690232066e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3b02edf0-b9b5-4ea8-81ec-40d16c60db7a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_156ae800-fed0-4baa-bb45-5c690232066e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_f1f87676-4570-4c42-b3f4-5e61dbf5d815" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3b02edf0-b9b5-4ea8-81ec-40d16c60db7a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_f1f87676-4570-4c42-b3f4-5e61dbf5d815" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_f5dd8265-42c5-41f6-8912-acbf4c04b59d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3b02edf0-b9b5-4ea8-81ec-40d16c60db7a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_f5dd8265-42c5-41f6-8912-acbf4c04b59d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="ew-20240331.xsd#CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b720c289-0200-497a-b601-85a14cd8ed25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_b613e63a-5916-4418-8f35-d7760ba01fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b720c289-0200-497a-b601-85a14cd8ed25" xlink:to="loc_us-gaap_ProceedsFromStockPlans_b613e63a-5916-4418-8f35-d7760ba01fdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_fe49098f-6be9-4b52-a58a-73f5fa0d202c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b720c289-0200-497a-b601-85a14cd8ed25" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_fe49098f-6be9-4b52-a58a-73f5fa0d202c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_73140028-29a0-4966-be00-b3b3b54d4bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b720c289-0200-497a-b601-85a14cd8ed25" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_73140028-29a0-4966-be00-b3b3b54d4bd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_81e5559c-b479-45a4-bf48-9fe2927ea658" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bc650dd-cc52-4630-9395-7221ff5344b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_81e5559c-b479-45a4-bf48-9fe2927ea658" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bc650dd-cc52-4630-9395-7221ff5344b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_fed36f31-7372-4e12-b70b-ac435eb34870" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_81e5559c-b479-45a4-bf48-9fe2927ea658" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_fed36f31-7372-4e12-b70b-ac435eb34870" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7c0cea1d-e161-4a27-a52c-e64e45ebf79d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_81e5559c-b479-45a4-bf48-9fe2927ea658" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7c0cea1d-e161-4a27-a52c-e64e45ebf79d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ae06f580-f8d9-4dd0-948e-76af8764bd51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_81e5559c-b479-45a4-bf48-9fe2927ea658" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ae06f580-f8d9-4dd0-948e-76af8764bd51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_86842e1c-2d9a-427b-be9f-f9c89df71b52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPaymentsToAcquireBusinesses_34f97544-07aa-4406-bba3-3f22ad41a456" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPaymentsToAcquireBusinesses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_86842e1c-2d9a-427b-be9f-f9c89df71b52" xlink:to="loc_us-gaap_OtherPaymentsToAcquireBusinesses_34f97544-07aa-4406-bba3-3f22ad41a456" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_6347eda6-bd20-4615-9b55-909b0e5b443c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_86842e1c-2d9a-427b-be9f-f9c89df71b52" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_6347eda6-bd20-4615-9b55-909b0e5b443c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireReceivables_6ea551f6-21ec-4585-b8d3-54452919aa0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireReceivables"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_86842e1c-2d9a-427b-be9f-f9c89df71b52" xlink:to="loc_us-gaap_PaymentsToAcquireReceivables_6ea551f6-21ec-4585-b8d3-54452919aa0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_49e59e8e-9cc7-4fec-9a4a-28b0b3d92675" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_86842e1c-2d9a-427b-be9f-f9c89df71b52" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_49e59e8e-9cc7-4fec-9a4a-28b0b3d92675" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_1aeecd15-be23-4c79-82e5-66733a508c00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_86842e1c-2d9a-427b-be9f-f9c89df71b52" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_1aeecd15-be23-4c79-82e5-66733a508c00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_0386a1e4-4d27-4213-b02a-45a87aaa7997" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_86842e1c-2d9a-427b-be9f-f9c89df71b52" xlink:to="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_0386a1e4-4d27-4213-b02a-45a87aaa7997" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_b800ff3b-a463-4b5d-a8e2-e2e3b0544800" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_86842e1c-2d9a-427b-be9f-f9c89df71b52" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_b800ff3b-a463-4b5d-a8e2-e2e3b0544800" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_2dfb7e5d-731f-40fe-8b9e-75a32ca93948" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_86842e1c-2d9a-427b-be9f-f9c89df71b52" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_2dfb7e5d-731f-40fe-8b9e-75a32ca93948" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions_5c559ab7-edf4-43ad-9f88-6da7061fd791" xlink:href="ew-20240331.xsd#ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_86842e1c-2d9a-427b-be9f-f9c89df71b52" xlink:to="loc_ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions_5c559ab7-edf4-43ad-9f88-6da7061fd791" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_7ceba2de-f48f-48a9-9ecf-f6c3824444fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_86842e1c-2d9a-427b-be9f-f9c89df71b52" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_7ceba2de-f48f-48a9-9ecf-f6c3824444fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_084be44e-aa01-4fb2-90d7-211e5c8ba585" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_4216fdd3-5a43-4095-bec5-3e4cb8463a29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_084be44e-aa01-4fb2-90d7-211e5c8ba585" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_4216fdd3-5a43-4095-bec5-3e4cb8463a29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_46a832a1-1b94-4cf1-9c50-c84a40e2cd0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_084be44e-aa01-4fb2-90d7-211e5c8ba585" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_46a832a1-1b94-4cf1-9c50-c84a40e2cd0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_IncreaseDecreaseInLegalSettlementAccrual_0a8ea155-de44-4913-9a94-d66f9f0a7f06" xlink:href="ew-20240331.xsd#ew_IncreaseDecreaseInLegalSettlementAccrual"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_084be44e-aa01-4fb2-90d7-211e5c8ba585" xlink:to="loc_ew_IncreaseDecreaseInLegalSettlementAccrual_0a8ea155-de44-4913-9a94-d66f9f0a7f06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_7cca2125-f884-4516-9304-de971de32bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_084be44e-aa01-4fb2-90d7-211e5c8ba585" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_7cca2125-f884-4516-9304-de971de32bf6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_17962d83-97b2-492f-b331-1e02fd51b538" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_084be44e-aa01-4fb2-90d7-211e5c8ba585" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_17962d83-97b2-492f-b331-1e02fd51b538" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_bf97a197-7a37-443a-8fc1-f6064e69b175" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_084be44e-aa01-4fb2-90d7-211e5c8ba585" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_bf97a197-7a37-443a-8fc1-f6064e69b175" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_18ab36b6-16b4-4b1e-bc04-500d77097e51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_084be44e-aa01-4fb2-90d7-211e5c8ba585" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_18ab36b6-16b4-4b1e-bc04-500d77097e51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_ea0d6a68-c370-4605-bf84-54f50e28dff9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_084be44e-aa01-4fb2-90d7-211e5c8ba585" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_ea0d6a68-c370-4605-bf84-54f50e28dff9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_9691ec0a-ac0f-463e-9370-1fce0d4485d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_084be44e-aa01-4fb2-90d7-211e5c8ba585" xlink:to="loc_us-gaap_ShareBasedCompensation_9691ec0a-ac0f-463e-9370-1fce0d4485d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d282fcab-400c-4bcd-be7a-3b118164e96c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_084be44e-aa01-4fb2-90d7-211e5c8ba585" xlink:to="loc_us-gaap_ProfitLoss_d282fcab-400c-4bcd-be7a-3b118164e96c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_72e22eec-82e6-48d6-a6c5-ff1ec6e70056" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_084be44e-aa01-4fb2-90d7-211e5c8ba585" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_72e22eec-82e6-48d6-a6c5-ff1ec6e70056" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_66b62876-6b92-4de3-821f-f2a17b52baa4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_084be44e-aa01-4fb2-90d7-211e5c8ba585" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_66b62876-6b92-4de3-821f-f2a17b52baa4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_47ae10b5-b55f-4cdb-9a0c-a020077560ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_084be44e-aa01-4fb2-90d7-211e5c8ba585" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_47ae10b5-b55f-4cdb-9a0c-a020077560ae" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsintheConsolidatedBalanceSheetsDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsintheConsolidatedBalanceSheetsDetails"/>
  <link:calculationLink xlink:role="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsintheConsolidatedBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_717629a8-e764-418a-8c3c-c8e6dedc932c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_218a8dbd-dd16-410c-93e7-945dd290e485" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_717629a8-e764-418a-8c3c-c8e6dedc932c" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_218a8dbd-dd16-410c-93e7-945dd290e485" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_e0da647e-7dd4-4af4-b6e6-8a5971038437" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_717629a8-e764-418a-8c3c-c8e6dedc932c" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_e0da647e-7dd4-4af4-b6e6-8a5971038437" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_1084fb47-7359-4fa4-b14f-611f83c9f9f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_717629a8-e764-418a-8c3c-c8e6dedc932c" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_1084fb47-7359-4fa4-b14f-611f83c9f9f3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_768b19c6-80d9-4883-93ba-cfd43bca302f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent_73ad4280-5c2a-4d3e-a891-1dec8773f186" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_768b19c6-80d9-4883-93ba-cfd43bca302f" xlink:to="loc_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent_73ad4280-5c2a-4d3e-a891-1dec8773f186" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent_c339e49e-b036-43d3-8438-ef6c52c3420d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_768b19c6-80d9-4883-93ba-cfd43bca302f" xlink:to="loc_us-gaap_DerivativeAssetsNoncurrent_c339e49e-b036-43d3-8438-ef6c52c3420d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReceivable_80b707c0-9fad-4bd5-bacc-3ee078ebacb3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReceivable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_768b19c6-80d9-4883-93ba-cfd43bca302f" xlink:to="loc_us-gaap_IncomeTaxReceivable_80b707c0-9fad-4bd5-bacc-3ee078ebacb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AcquisitionOptionsNoncurrent_762796e4-aef3-4feb-8523-028c97f0156f" xlink:href="ew-20240331.xsd#ew_AcquisitionOptionsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_768b19c6-80d9-4883-93ba-cfd43bca302f" xlink:to="loc_ew_AcquisitionOptionsNoncurrent_762796e4-aef3-4feb-8523-028c97f0156f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrentAndNoncurrent_62b5c6f0-d19b-45c6-89c3-a07a35b0f410" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrentAndNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_768b19c6-80d9-4883-93ba-cfd43bca302f" xlink:to="loc_us-gaap_PrepaidExpenseCurrentAndNoncurrent_62b5c6f0-d19b-45c6-89c3-a07a35b0f410" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_249d8ca4-771e-49fb-b47f-0123a7227dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_768b19c6-80d9-4883-93ba-cfd43bca302f" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_249d8ca4-771e-49fb-b47f-0123a7227dd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccruedAndOtherLiabilitiesCurrent_bf7870c6-fe58-477b-962b-611e8003cda4" xlink:href="ew-20240331.xsd#ew_AccruedAndOtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_1e87465c-f7a1-4e4c-be21-04bbe1c1af93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ew_AccruedAndOtherLiabilitiesCurrent_bf7870c6-fe58-477b-962b-611e8003cda4" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_1e87465c-f7a1-4e4c-be21-04bbe1c1af93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_7f55cfa1-2aea-4289-b3b1-4099ec497510" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ew_AccruedAndOtherLiabilitiesCurrent_bf7870c6-fe58-477b-962b-611e8003cda4" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_7f55cfa1-2aea-4289-b3b1-4099ec497510" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_8e295070-e432-4dac-ace9-afa0eeb0f6a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ew_AccruedAndOtherLiabilitiesCurrent_bf7870c6-fe58-477b-962b-611e8003cda4" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_8e295070-e432-4dac-ace9-afa0eeb0f6a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_0de22ebf-d9d0-4ccb-9113-042290ea42a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ew_AccruedAndOtherLiabilitiesCurrent_bf7870c6-fe58-477b-962b-611e8003cda4" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_0de22ebf-d9d0-4ccb-9113-042290ea42a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_ResearchAndDevelopmentAccruals_4b93646d-f983-4452-8c9c-cd41b653e1b6" xlink:href="ew-20240331.xsd#ew_ResearchAndDevelopmentAccruals"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ew_AccruedAndOtherLiabilitiesCurrent_bf7870c6-fe58-477b-962b-611e8003cda4" xlink:to="loc_ew_ResearchAndDevelopmentAccruals_4b93646d-f983-4452-8c9c-cd41b653e1b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccruedLitigationAndInsuranceReserves_3dd023f5-5776-4868-9af0-05c8c582f3df" xlink:href="ew-20240331.xsd#ew_AccruedLitigationAndInsuranceReserves"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ew_AccruedAndOtherLiabilitiesCurrent_bf7870c6-fe58-477b-962b-611e8003cda4" xlink:to="loc_ew_AccruedLitigationAndInsuranceReserves_3dd023f5-5776-4868-9af0-05c8c582f3df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccruedRebates_4e5ce862-e61c-4ce6-9fc9-d5859d5a96c0" xlink:href="ew-20240331.xsd#ew_AccruedRebates"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ew_AccruedAndOtherLiabilitiesCurrent_bf7870c6-fe58-477b-962b-611e8003cda4" xlink:to="loc_ew_AccruedRebates_4e5ce862-e61c-4ce6-9fc9-d5859d5a96c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_f75e42a3-e681-47ae-aaf8-8f0e16a569c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ew_AccruedAndOtherLiabilitiesCurrent_bf7870c6-fe58-477b-962b-611e8003cda4" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_f75e42a3-e681-47ae-aaf8-8f0e16a569c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccruedRelocationCostsCurrent_dd78f454-44a9-482e-83ea-622f8126c830" xlink:href="ew-20240331.xsd#ew_AccruedRelocationCostsCurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ew_AccruedAndOtherLiabilitiesCurrent_bf7870c6-fe58-477b-962b-611e8003cda4" xlink:to="loc_ew_AccruedRelocationCostsCurrent_dd78f454-44a9-482e-83ea-622f8126c830" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent_b91534d6-03c7-4a49-80c0-9ff9d362d7f9" xlink:href="ew-20240331.xsd#ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ew_AccruedAndOtherLiabilitiesCurrent_bf7870c6-fe58-477b-962b-611e8003cda4" xlink:to="loc_ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent_b91534d6-03c7-4a49-80c0-9ff9d362d7f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_27f4f1bc-c346-4c37-a7fe-580df420eb01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ew_AccruedAndOtherLiabilitiesCurrent_bf7870c6-fe58-477b-962b-611e8003cda4" xlink:to="loc_us-gaap_RestructuringReserveCurrent_27f4f1bc-c346-4c37-a7fe-580df420eb01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_ac60ef67-5c0b-45ad-be6c-8049ac440b39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ew_AccruedAndOtherLiabilitiesCurrent_bf7870c6-fe58-477b-962b-611e8003cda4" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_ac60ef67-5c0b-45ad-be6c-8049ac440b39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_89a38a42-67a8-492f-850e-b2722c5f0c94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ew_AccruedAndOtherLiabilitiesCurrent_bf7870c6-fe58-477b-962b-611e8003cda4" xlink:to="loc_us-gaap_LitigationReserveCurrent_89a38a42-67a8-492f-850e-b2722c5f0c94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent_1acf0bf2-3594-48b4-af58-9f656cad330c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ew_AccruedAndOtherLiabilitiesCurrent_bf7870c6-fe58-477b-962b-611e8003cda4" xlink:to="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent_1acf0bf2-3594-48b4-af58-9f656cad330c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:calculationLink xlink:role="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8b8c854d-6595-4d93-be33-1d151166e931" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_fd5c84f0-c215-4eda-ae67-edc872f2e6b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8b8c854d-6595-4d93-be33-1d151166e931" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_fd5c84f0-c215-4eda-ae67-edc872f2e6b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_78106f00-6774-4226-8815-d5d7fdfe382b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8b8c854d-6595-4d93-be33-1d151166e931" xlink:to="loc_us-gaap_RestrictedCashCurrent_78106f00-6774-4226-8815-d5d7fdfe382b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_a1074362-5244-43c2-88da-6479342f138a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8b8c854d-6595-4d93-be33-1d151166e931" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_a1074362-5244-43c2-88da-6479342f138a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8d147c4e-8018-4406-9583-b18107717178" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a044f163-e3df-4395-aba4-e7c89b902f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8d147c4e-8018-4406-9583-b18107717178" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a044f163-e3df-4395-aba4-e7c89b902f1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_e130f398-4b10-4518-b2d6-e844e81a3da1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8d147c4e-8018-4406-9583-b18107717178" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_e130f398-4b10-4518-b2d6-e844e81a3da1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_36328801-3c8d-44bf-b8e2-599aff4f7d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8d147c4e-8018-4406-9583-b18107717178" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_36328801-3c8d-44bf-b8e2-599aff4f7d6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_6bb1e69f-8e05-404a-af35-a108e51dd975" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_3549c4a4-d857-452a-9fef-5f0f7b85f132" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecurities_6bb1e69f-8e05-404a-af35-a108e51dd975" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_3549c4a4-d857-452a-9fef-5f0f7b85f132" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_83cdd4a5-c488-41e2-a3c5-7ae3ce631468" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecurities_6bb1e69f-8e05-404a-af35-a108e51dd975" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_83cdd4a5-c488-41e2-a3c5-7ae3ce631468" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_77b03bb9-c575-4f1d-a4f5-660596b581d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecurities_6bb1e69f-8e05-404a-af35-a108e51dd975" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_77b03bb9-c575-4f1d-a4f5-660596b581d7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_2ccd833b-da8e-46d4-90c3-9f45ecc62c80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_53ed98bd-ca76-420c-8c95-eb25604c8c47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesFairValue_2ccd833b-da8e-46d4-90c3-9f45ecc62c80" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_53ed98bd-ca76-420c-8c95-eb25604c8c47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_d4a603da-74c1-414c-ab2a-97172a91a44d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesFairValue_2ccd833b-da8e-46d4-90c3-9f45ecc62c80" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_d4a603da-74c1-414c-ab2a-97172a91a44d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_bc0e67cd-c5c1-465e-916a-748ff144101d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesFairValue_2ccd833b-da8e-46d4-90c3-9f45ecc62c80" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_bc0e67cd-c5c1-465e-916a-748ff144101d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_06ce2b07-9192-4674-9205-a7828fa73321" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_8519e4c7-589e-428a-bd8e-32fcaf4b8a28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_06ce2b07-9192-4674-9205-a7828fa73321" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_8519e4c7-589e-428a-bd8e-32fcaf4b8a28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_6371cc35-9d75-475d-93cc-2e4993ff1b61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_06ce2b07-9192-4674-9205-a7828fa73321" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_6371cc35-9d75-475d-93cc-2e4993ff1b61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_5bf557b6-0c39-459f-bf7f-e52c03342ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_06ce2b07-9192-4674-9205-a7828fa73321" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_5bf557b6-0c39-459f-bf7f-e52c03342ae6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_0d979b96-5656-431c-9abc-d7b87e5ea17f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_60fb49da-b99f-4382-9217-4ac0ddb5ee43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_0d979b96-5656-431c-9abc-d7b87e5ea17f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_60fb49da-b99f-4382-9217-4ac0ddb5ee43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_82e947b8-187c-4186-9190-b6ccc49b991b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_0d979b96-5656-431c-9abc-d7b87e5ea17f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_82e947b8-187c-4186-9190-b6ccc49b991b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_d3bafd70-fd57-449c-9992-53b1c070c10b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_0d979b96-5656-431c-9abc-d7b87e5ea17f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_d3bafd70-fd57-449c-9992-53b1c070c10b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_ea68cefb-a5e9-4840-a38b-e25bb64cf0d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost_a63bbffd-eafb-4d49-947d-a5bb5adc4a68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_ea68cefb-a5e9-4840-a38b-e25bb64cf0d9" xlink:to="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost_a63bbffd-eafb-4d49-947d-a5bb5adc4a68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost_39e87e72-2184-4fc6-b0e0-324f6320f866" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_ea68cefb-a5e9-4840-a38b-e25bb64cf0d9" xlink:to="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost_39e87e72-2184-4fc6-b0e0-324f6320f866" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount_e704829b-c80a-45c4-a2b2-ed51fa87f5d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_ea68cefb-a5e9-4840-a38b-e25bb64cf0d9" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount_e704829b-c80a-45c4-a2b2-ed51fa87f5d7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails"/>
  <link:calculationLink xlink:role="http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_e3b8fc24-f2b0-455f-95cf-5cb427116722" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_d22ad85a-5a36-4786-8802-e70b437b3cad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_e3b8fc24-f2b0-455f-95cf-5cb427116722" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_d22ad85a-5a36-4786-8802-e70b437b3cad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_a91cf660-8444-475f-867b-5665af356185" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_e3b8fc24-f2b0-455f-95cf-5cb427116722" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_a91cf660-8444-475f-867b-5665af356185" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_8072e62a-2358-4980-b8b9-af87b040e274" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_f4d99f60-39cb-470c-a028-6cf51ad709cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_8072e62a-2358-4980-b8b9-af87b040e274" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_f4d99f60-39cb-470c-a028-6cf51ad709cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_c44b352c-2a34-48b9-a309-41639190867c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_8072e62a-2358-4980-b8b9-af87b040e274" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_c44b352c-2a34-48b9-a309-41639190867c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails"/>
  <link:calculationLink xlink:role="http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_6c6847f5-9a66-4f8a-88f3-4c6cf7f7dd31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_e4952400-7625-401b-9920-bb6794c7480e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_6c6847f5-9a66-4f8a-88f3-4c6cf7f7dd31" xlink:to="loc_us-gaap_EquityMethodInvestments_e4952400-7625-401b-9920-bb6794c7480e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_0b9b57b5-47fd-4f36-b6e4-791e6000cc0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_6c6847f5-9a66-4f8a-88f3-4c6cf7f7dd31" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_0b9b57b5-47fd-4f36-b6e4-791e6000cc0f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_967ebd70-a91d-4dee-9b6d-7b310f99f0b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_78807e7c-bc09-4bd6-ae64-f63947536e01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_967ebd70-a91d-4dee-9b6d-7b310f99f0b0" xlink:to="loc_us-gaap_DerivativeLiabilities_78807e7c-bc09-4bd6-ae64-f63947536e01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_1a9751c7-622d-4076-8d35-654c317ba226" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_967ebd70-a91d-4dee-9b6d-7b310f99f0b0" xlink:to="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_1a9751c7-622d-4076-8d35-654c317ba226" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_6e4305ac-a13b-4d2c-9dd0-0baa4a10d297" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_4532045d-9e83-4075-bd99-e38b35c8a245" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_6e4305ac-a13b-4d2c-9dd0-0baa4a10d297" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_4532045d-9e83-4075-bd99-e38b35c8a245" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0848c345-96af-49b0-88cb-668db8a97069" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_6e4305ac-a13b-4d2c-9dd0-0baa4a10d297" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0848c345-96af-49b0-88cb-668db8a97069" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_0ff7e499-8152-4ce5-ae8a-74e4ac02d4a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_6e4305ac-a13b-4d2c-9dd0-0baa4a10d297" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_0ff7e499-8152-4ce5-ae8a-74e4ac02d4a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_c2711b73-a736-4bb9-826b-7cd07b7de12d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_6e4305ac-a13b-4d2c-9dd0-0baa4a10d297" xlink:to="loc_us-gaap_DerivativeAssets_c2711b73-a736-4bb9-826b-7cd07b7de12d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_1eb9108a-750f-4a90-95e0-7c9e5293a059" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_7215e3e4-0a71-44aa-9483-05bf925e20af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_1eb9108a-750f-4a90-95e0-7c9e5293a059" xlink:to="loc_us-gaap_DerivativeLiabilities_7215e3e4-0a71-44aa-9483-05bf925e20af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_9f77bde1-5772-4cd8-a2c5-2d6be6539de9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_1eb9108a-750f-4a90-95e0-7c9e5293a059" xlink:to="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_9f77bde1-5772-4cd8-a2c5-2d6be6539de9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralRightToReclaimCash_a91db516-5035-4b34-a58d-bf21ab3043ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeCollateralRightToReclaimCash"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_1eb9108a-750f-4a90-95e0-7c9e5293a059" xlink:to="loc_us-gaap_DerivativeCollateralRightToReclaimCash_a91db516-5035-4b34-a58d-bf21ab3043ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_be3abb22-7156-49db-9bec-606ee94838d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_3f720983-b685-4639-a48f-56671dfc670a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeAssets_be3abb22-7156-49db-9bec-606ee94838d7" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_3f720983-b685-4639-a48f-56671dfc670a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueGrossLiability_3cac64a5-6bbc-407d-ab4b-d5042795580a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetFairValueGrossLiability"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeAssets_be3abb22-7156-49db-9bec-606ee94838d7" xlink:to="loc_us-gaap_DerivativeAssetFairValueGrossLiability_3cac64a5-6bbc-407d-ab4b-d5042795580a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_33cab916-d1f4-4699-8086-640d4586f7b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_e1e687d0-7503-4a6e-b12a-966c4f08cb0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeLiabilities_33cab916-d1f4-4699-8086-640d4586f7b4" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_e1e687d0-7503-4a6e-b12a-966c4f08cb0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_2c7b454d-ba4f-4448-8726-23f98d81189c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityFairValueGrossAsset"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeLiabilities_33cab916-d1f4-4699-8086-640d4586f7b4" xlink:to="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_2c7b454d-ba4f-4448-8726-23f98d81189c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_9e1fe94f-7e53-4175-b98e-7cb1996ab238" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_210391ce-c22d-42ef-99dc-2a396004b6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_9e1fe94f-7e53-4175-b98e-7cb1996ab238" xlink:to="loc_us-gaap_DerivativeAssets_210391ce-c22d-42ef-99dc-2a396004b6d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_e0d96e96-71b5-42f8-b0cb-c03337399b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_9e1fe94f-7e53-4175-b98e-7cb1996ab238" xlink:to="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_e0d96e96-71b5-42f8-b0cb-c03337399b5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralObligationToReturnCash_c0db0008-a2f4-41e7-8a7b-15d47970acc2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeCollateralObligationToReturnCash"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_9e1fe94f-7e53-4175-b98e-7cb1996ab238" xlink:to="loc_us-gaap_DerivativeCollateralObligationToReturnCash_c0db0008-a2f4-41e7-8a7b-15d47970acc2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_88ae5003-4ff8-48c6-89ab-7dac934a1c91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_756be080-6381-4c98-b012-c4d5aac3af41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_88ae5003-4ff8-48c6-89ab-7dac934a1c91" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_756be080-6381-4c98-b012-c4d5aac3af41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_928eb0f2-577b-4492-a996-74b04c06f7f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_88ae5003-4ff8-48c6-89ab-7dac934a1c91" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_928eb0f2-577b-4492-a996-74b04c06f7f0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cbd57f32-3ee6-437c-b21c-6bc44d2673c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8a6b4dab-4951-4046-93c5-06cd2ace9efa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cbd57f32-3ee6-437c-b21c-6bc44d2673c6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8a6b4dab-4951-4046-93c5-06cd2ace9efa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_05fb67d1-978a-4945-a833-a8adfcc0350e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cbd57f32-3ee6-437c-b21c-6bc44d2673c6" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_05fb67d1-978a-4945-a833-a8adfcc0350e" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>ew-20240331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:1b5f1024-67d5-4c23-ba5b-277a92b54967,g:71cdffb8-b576-4b3a-8b78-825fbaff5436-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="ew-20240331.xsd#CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7fa7b61f-fef9-4780-80a3-eebe88b97c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8ad9aeaa-84b1-4f62-a8e8-b5147b5d388d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_7fa7b61f-fef9-4780-80a3-eebe88b97c0c" xlink:to="loc_us-gaap_StatementTable_8ad9aeaa-84b1-4f62-a8e8-b5147b5d388d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a470d422-30ae-4965-990f-0aa6b936b2ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_8ad9aeaa-84b1-4f62-a8e8-b5147b5d388d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a470d422-30ae-4965-990f-0aa6b936b2ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a470d422-30ae-4965-990f-0aa6b936b2ad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a470d422-30ae-4965-990f-0aa6b936b2ad" xlink:to="loc_us-gaap_EquityComponentDomain_a470d422-30ae-4965-990f-0aa6b936b2ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ec28378b-ca71-45fb-ba76-804dd24b8e77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a470d422-30ae-4965-990f-0aa6b936b2ad" xlink:to="loc_us-gaap_EquityComponentDomain_ec28378b-ca71-45fb-ba76-804dd24b8e77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_c66816a8-8acf-4992-8534-ebb39a9870dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ec28378b-ca71-45fb-ba76-804dd24b8e77" xlink:to="loc_us-gaap_ParentMember_c66816a8-8acf-4992-8534-ebb39a9870dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_cd6bf8fd-6962-47b2-8522-380b08c66ee2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_c66816a8-8acf-4992-8534-ebb39a9870dd" xlink:to="loc_us-gaap_CommonStockMember_cd6bf8fd-6962-47b2-8522-380b08c66ee2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_3ee9fa0b-17cd-4de0-9726-315849b05b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_c66816a8-8acf-4992-8534-ebb39a9870dd" xlink:to="loc_us-gaap_TreasuryStockCommonMember_3ee9fa0b-17cd-4de0-9726-315849b05b5f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_6974eb95-8f6f-4642-8939-b2728d758a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_c66816a8-8acf-4992-8534-ebb39a9870dd" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_6974eb95-8f6f-4642-8939-b2728d758a9c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_3f1ab2f0-7d75-4166-bb32-75520a27b1f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_c66816a8-8acf-4992-8534-ebb39a9870dd" xlink:to="loc_us-gaap_RetainedEarningsMember_3f1ab2f0-7d75-4166-bb32-75520a27b1f6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7a2aa122-69aa-49a9-ac82-f8861cb435e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_c66816a8-8acf-4992-8534-ebb39a9870dd" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7a2aa122-69aa-49a9-ac82-f8861cb435e2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_b8b118b6-44f4-4d72-9252-b801783f0b74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ec28378b-ca71-45fb-ba76-804dd24b8e77" xlink:to="loc_us-gaap_NoncontrollingInterestMember_b8b118b6-44f4-4d72-9252-b801783f0b74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c61bed1-ca03-49f4-be2c-9e0f6fe6a318" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7fa7b61f-fef9-4780-80a3-eebe88b97c0c" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c61bed1-ca03-49f4-be2c-9e0f6fe6a318" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_5dda2770-dc48-43f0-96d5-6d50b0168a63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c61bed1-ca03-49f4-be2c-9e0f6fe6a318" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_5dda2770-dc48-43f0-96d5-6d50b0168a63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7d58fde6-920e-4b3a-afcf-e3d5a8f70269" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c61bed1-ca03-49f4-be2c-9e0f6fe6a318" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7d58fde6-920e-4b3a-afcf-e3d5a8f70269" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_723f9d4d-9d85-4e6e-a475-3c8aa31ab04f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c61bed1-ca03-49f4-be2c-9e0f6fe6a318" xlink:to="loc_us-gaap_TreasuryStockCommonShares_723f9d4d-9d85-4e6e-a475-3c8aa31ab04f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_2326354d-cdf9-4911-877f-5402a49e31f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c61bed1-ca03-49f4-be2c-9e0f6fe6a318" xlink:to="loc_us-gaap_ProfitLoss_2326354d-cdf9-4911-877f-5402a49e31f5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a53fe431-702f-48fb-8c04-99703d36b37c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c61bed1-ca03-49f4-be2c-9e0f6fe6a318" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a53fe431-702f-48fb-8c04-99703d36b37c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_a4b5f201-2ce8-4879-8153-b4c2442746c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c61bed1-ca03-49f4-be2c-9e0f6fe6a318" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_a4b5f201-2ce8-4879-8153-b4c2442746c9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3e1c9cc7-485f-454f-8661-da94bf7bcf4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c61bed1-ca03-49f4-be2c-9e0f6fe6a318" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3e1c9cc7-485f-454f-8661-da94bf7bcf4d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_cf8462a4-87e4-44d0-b93d-30ae0f604896" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c61bed1-ca03-49f4-be2c-9e0f6fe6a318" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_cf8462a4-87e4-44d0-b93d-30ae0f604896" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_1c77ebaf-2b81-4b79-9be8-61bbe2ca557b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c61bed1-ca03-49f4-be2c-9e0f6fe6a318" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_1c77ebaf-2b81-4b79-9be8-61bbe2ca557b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_f4a96654-72b6-4dbc-8158-f9262b10cf1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c61bed1-ca03-49f4-be2c-9e0f6fe6a318" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_f4a96654-72b6-4dbc-8158-f9262b10cf1a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_1c457a90-daa6-4b7c-a06b-1702852575e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c61bed1-ca03-49f4-be2c-9e0f6fe6a318" xlink:to="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_1c457a90-daa6-4b7c-a06b-1702852575e0" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_b3b938e5-61c7-479d-8148-9184d0c51591" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ec5fa3cc-d185-41ae-adea-daabff304b43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_1718beb4-c417-4d28-a8a8-ca96caf884a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSESDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSESDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_d44d1248-8bc1-406e-9f82-30075be804b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_8fcdb4a2-2c03-4046-9c00-ddaf2c9f9153" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_d44d1248-8bc1-406e-9f82-30075be804b9" xlink:to="loc_us-gaap_LossContingenciesTable_8fcdb4a2-2c03-4046-9c00-ddaf2c9f9153" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_5e17033f-91a4-467d-94f9-50f3aa388745" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_8fcdb4a2-2c03-4046-9c00-ddaf2c9f9153" xlink:to="loc_srt_LitigationCaseAxis_5e17033f-91a4-467d-94f9-50f3aa388745" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_5e17033f-91a4-467d-94f9-50f3aa388745_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_5e17033f-91a4-467d-94f9-50f3aa388745" xlink:to="loc_srt_LitigationCaseTypeDomain_5e17033f-91a4-467d-94f9-50f3aa388745_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_6572c860-5e8b-4443-8d75-8697c9cf873e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_5e17033f-91a4-467d-94f9-50f3aa388745" xlink:to="loc_srt_LitigationCaseTypeDomain_6572c860-5e8b-4443-8d75-8697c9cf873e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MedtronicIncMember_49dacc47-a999-46cf-b570-d77c3f07797a" xlink:href="ew-20240331.xsd#ew_MedtronicIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_6572c860-5e8b-4443-8d75-8697c9cf873e" xlink:to="loc_ew_MedtronicIncMember_49dacc47-a999-46cf-b570-d77c3f07797a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_IntellectualPropertyAgreementTerm_3681031e-1cf1-4169-aafb-3e8def50b1ca" xlink:href="ew-20240331.xsd#ew_IntellectualPropertyAgreementTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d44d1248-8bc1-406e-9f82-30075be804b9" xlink:to="loc_ew_IntellectualPropertyAgreementTerm_3681031e-1cf1-4169-aafb-3e8def50b1ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_8dd2dc1e-0003-493b-a686-7d18e8d71e80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d44d1248-8bc1-406e-9f82-30075be804b9" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_8dd2dc1e-0003-493b-a686-7d18e8d71e80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_942991f4-838b-4c6b-bf50-7bdce00820db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d44d1248-8bc1-406e-9f82-30075be804b9" xlink:to="loc_us-gaap_LitigationSettlementExpense_942991f4-838b-4c6b-bf50-7bdce00820db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidRoyalties_dd7e2226-f49e-4821-9dfd-1f1a4f7ddb11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidRoyalties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d44d1248-8bc1-406e-9f82-30075be804b9" xlink:to="loc_us-gaap_PrepaidRoyalties_dd7e2226-f49e-4821-9dfd-1f1a4f7ddb11" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_83275da6-9c64-4bf8-ac82-8d098e4e4982" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_8457ba8c-aaa7-4c6f-b9c0-07b9ba1dd356" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_83275da6-9c64-4bf8-ac82-8d098e4e4982" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_8457ba8c-aaa7-4c6f-b9c0-07b9ba1dd356" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_d8c82515-a790-4b5b-b571-695305f56ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_8457ba8c-aaa7-4c6f-b9c0-07b9ba1dd356" xlink:to="loc_us-gaap_FinancialInstrumentAxis_d8c82515-a790-4b5b-b571-695305f56ab2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d8c82515-a790-4b5b-b571-695305f56ab2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d8c82515-a790-4b5b-b571-695305f56ab2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d8c82515-a790-4b5b-b571-695305f56ab2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bfad895f-4e8c-4ec4-9db6-fdd9e6efd305" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d8c82515-a790-4b5b-b571-695305f56ab2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bfad895f-4e8c-4ec4-9db6-fdd9e6efd305" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember_2d89e9ff-00d2-42c9-9c7e-e534c9a34569" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bfad895f-4e8c-4ec4-9db6-fdd9e6efd305" xlink:to="loc_us-gaap_BankTimeDepositsMember_2d89e9ff-00d2-42c9-9c7e-e534c9a34569" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_a5adc00b-4c3c-4df3-a938-e9e335016984" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bfad895f-4e8c-4ec4-9db6-fdd9e6efd305" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_a5adc00b-4c3c-4df3-a938-e9e335016984" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_cdc5ab5d-415a-4de7-b17c-d86812b7843b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bfad895f-4e8c-4ec4-9db6-fdd9e6efd305" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_cdc5ab5d-415a-4de7-b17c-d86812b7843b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_32c09afe-a490-4dd2-b6e4-a6493e8feb79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bfad895f-4e8c-4ec4-9db6-fdd9e6efd305" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_32c09afe-a490-4dd2-b6e4-a6493e8feb79" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_b964f85d-cbf6-4110-bea6-12afee4bfaa7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MunicipalBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bfad895f-4e8c-4ec4-9db6-fdd9e6efd305" xlink:to="loc_us-gaap_MunicipalBondsMember_b964f85d-cbf6-4110-bea6-12afee4bfaa7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAbstract_68baa51b-02d6-41c7-bfda-0baf9f56b700" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_83275da6-9c64-4bf8-ac82-8d098e4e4982" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAbstract_68baa51b-02d6-41c7-bfda-0baf9f56b700" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_16ac70c6-8d62-43c5-a6f4-42ff4b91e242" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesAbstract_68baa51b-02d6-41c7-bfda-0baf9f56b700" xlink:to="loc_us-gaap_HeldToMaturitySecurities_16ac70c6-8d62-43c5-a6f4-42ff4b91e242" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_1017c342-c244-42ab-b7b6-04409caed050" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesAbstract_68baa51b-02d6-41c7-bfda-0baf9f56b700" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_1017c342-c244-42ab-b7b6-04409caed050" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_923c2280-2f6d-44b9-8d7f-a354effa8c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesAbstract_68baa51b-02d6-41c7-bfda-0baf9f56b700" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_923c2280-2f6d-44b9-8d7f-a354effa8c7f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_68d7c872-c561-4722-995b-c7c0ec1f947b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesAbstract_68baa51b-02d6-41c7-bfda-0baf9f56b700" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_68d7c872-c561-4722-995b-c7c0ec1f947b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_09855d8f-3bf5-494e-b3cc-65fb06849691" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_83275da6-9c64-4bf8-ac82-8d098e4e4982" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAbstract_09855d8f-3bf5-494e-b3cc-65fb06849691" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_770e904a-c1aa-4f4c-9121-7b338a74ba46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_09855d8f-3bf5-494e-b3cc-65fb06849691" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_770e904a-c1aa-4f4c-9121-7b338a74ba46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_240cfd40-7ddf-40e5-b761-dbe33937689e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_09855d8f-3bf5-494e-b3cc-65fb06849691" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_240cfd40-7ddf-40e5-b761-dbe33937689e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_603b4135-bdb9-44f2-baf2-733fa320aa9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_09855d8f-3bf5-494e-b3cc-65fb06849691" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_603b4135-bdb9-44f2-baf2-733fa320aa9a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0de15853-c08a-4941-9a66-d73f62591bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_09855d8f-3bf5-494e-b3cc-65fb06849691" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0de15853-c08a-4941-9a66-d73f62591bd0" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c82d297d-130a-4af9-ad09-1cfd68c6c685" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_cd8e07e4-7446-458a-992d-71ca667d98a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c82d297d-130a-4af9-ad09-1cfd68c6c685" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_cd8e07e4-7446-458a-992d-71ca667d98a6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_fea7fc24-6848-44f8-ba56-2c7ccaa11b99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_cd8e07e4-7446-458a-992d-71ca667d98a6" xlink:to="loc_us-gaap_FinancialInstrumentAxis_fea7fc24-6848-44f8-ba56-2c7ccaa11b99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fea7fc24-6848-44f8-ba56-2c7ccaa11b99_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_fea7fc24-6848-44f8-ba56-2c7ccaa11b99" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fea7fc24-6848-44f8-ba56-2c7ccaa11b99_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9c426a49-a726-477f-a465-c2282b5b64c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_fea7fc24-6848-44f8-ba56-2c7ccaa11b99" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9c426a49-a726-477f-a465-c2282b5b64c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_f7968157-cda6-470b-b127-3cc9b0dfdfdb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9c426a49-a726-477f-a465-c2282b5b64c1" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_f7968157-cda6-470b-b127-3cc9b0dfdfdb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_e0781c52-8b33-4194-9599-aa2c497430b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9c426a49-a726-477f-a465-c2282b5b64c1" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_e0781c52-8b33-4194-9599-aa2c497430b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_58f7aa61-f481-41e0-b12a-926dd1da1269" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9c426a49-a726-477f-a465-c2282b5b64c1" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_58f7aa61-f481-41e0-b12a-926dd1da1269" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_456539ca-4839-433e-ae2b-eaaca831d558" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MunicipalBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9c426a49-a726-477f-a465-c2282b5b64c1" xlink:to="loc_us-gaap_MunicipalBondsMember_456539ca-4839-433e-ae2b-eaaca831d558" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_9518e0f7-921a-4959-a307-2a1d93377c45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c82d297d-130a-4af9-ad09-1cfd68c6c685" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_9518e0f7-921a-4959-a307-2a1d93377c45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_f907c520-5754-47c1-87be-e2b6759b8c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c82d297d-130a-4af9-ad09-1cfd68c6c685" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_f907c520-5754-47c1-87be-e2b6759b8c1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_10d1dbb8-c2bb-43bb-8328-060f17ada162" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c82d297d-130a-4af9-ad09-1cfd68c6c685" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_10d1dbb8-c2bb-43bb-8328-060f17ada162" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_16d00b59-b28d-4dc0-a4aa-351a523e3f06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c82d297d-130a-4af9-ad09-1cfd68c6c685" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_16d00b59-b28d-4dc0-a4aa-351a523e3f06" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_345719a5-9de2-4aaa-9244-8caf02ba59f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c82d297d-130a-4af9-ad09-1cfd68c6c685" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_345719a5-9de2-4aaa-9244-8caf02ba59f3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_cede0d34-8327-40ba-a433-2b232787e692" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c82d297d-130a-4af9-ad09-1cfd68c6c685" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_cede0d34-8327-40ba-a433-2b232787e692" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INVESTMENTSNarrativeDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#INVESTMENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/INVESTMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_a6ad7cb1-cfcf-42f0-9d40-fa57842f7808" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_bf84f740-690b-4982-ab70-6e941406d53b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_a6ad7cb1-cfcf-42f0-9d40-fa57842f7808" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_bf84f740-690b-4982-ab70-6e941406d53b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b0109516-fb80-43d6-ab65-2b0ad431f3ca" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_bf84f740-690b-4982-ab70-6e941406d53b" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b0109516-fb80-43d6-ab65-2b0ad431f3ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_b0109516-fb80-43d6-ab65-2b0ad431f3ca_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b0109516-fb80-43d6-ab65-2b0ad431f3ca" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_b0109516-fb80-43d6-ab65-2b0ad431f3ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_6486ba1a-f9b2-4a49-8b55-7148dd3e57fc" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b0109516-fb80-43d6-ab65-2b0ad431f3ca" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_6486ba1a-f9b2-4a49-8b55-7148dd3e57fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_NewMarketsTaxCreditMember_248b62c2-887f-479b-9a82-d8b636f2d3d4" xlink:href="ew-20240331.xsd#ew_NewMarketsTaxCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_6486ba1a-f9b2-4a49-8b55-7148dd3e57fc" xlink:to="loc_ew_NewMarketsTaxCreditMember_248b62c2-887f-479b-9a82-d8b636f2d3d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_691aaa70-ed1f-410f-b29a-ef9b6ad3ce9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_bf84f740-690b-4982-ab70-6e941406d53b" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_691aaa70-ed1f-410f-b29a-ef9b6ad3ce9d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_691aaa70-ed1f-410f-b29a-ef9b6ad3ce9d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_691aaa70-ed1f-410f-b29a-ef9b6ad3ce9d" xlink:to="loc_us-gaap_RelatedPartyDomain_691aaa70-ed1f-410f-b29a-ef9b6ad3ce9d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_845a8a2f-17a7-461f-a85e-3af9b0922e34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_691aaa70-ed1f-410f-b29a-ef9b6ad3ce9d" xlink:to="loc_us-gaap_RelatedPartyDomain_845a8a2f-17a7-461f-a85e-3af9b0922e34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyMember_cdf1c48c-c9b6-4034-8198-93dfd9f4025b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LimitedLiabilityCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_845a8a2f-17a7-461f-a85e-3af9b0922e34" xlink:to="loc_us-gaap_LimitedLiabilityCompanyMember_cdf1c48c-c9b6-4034-8198-93dfd9f4025b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_87877d68-2eec-44ee-b3a2-811c48d96046" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_a6ad7cb1-cfcf-42f0-9d40-fa57842f7808" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_87877d68-2eec-44ee-b3a2-811c48d96046" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquityMethodInvestmentsInvestmentPeriod_6bd520d0-ddae-479f-9736-08f56f0ea11d" xlink:href="ew-20240331.xsd#ew_EquityMethodInvestmentsInvestmentPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_a6ad7cb1-cfcf-42f0-9d40-fa57842f7808" xlink:to="loc_ew_EquityMethodInvestmentsInvestmentPeriod_6bd520d0-ddae-479f-9736-08f56f0ea11d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount_154765df-6a3b-402d-a088-8147906f30d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_a6ad7cb1-cfcf-42f0-9d40-fa57842f7808" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount_154765df-6a3b-402d-a088-8147906f30d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_37242643-8a04-4737-8c20-309b95ff5c49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_a6ad7cb1-cfcf-42f0-9d40-fa57842f7808" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_37242643-8a04-4737-8c20-309b95ff5c49" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_b6f60efc-5fcf-4a0b-9be1-7f1ad180f61e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_a6ad7cb1-cfcf-42f0-9d40-fa57842f7808" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_b6f60efc-5fcf-4a0b-9be1-7f1ad180f61e" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#INVESTMENTSINVARIABLEINTERESTENTITIESDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_566015de-e904-4170-873e-5db38c89273a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_3c1d6cd8-7989-4af3-980c-27214ae732fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_566015de-e904-4170-873e-5db38c89273a" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_3c1d6cd8-7989-4af3-980c-27214ae732fc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_484e3499-ed60-4853-80ba-66d3677241e4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_3c1d6cd8-7989-4af3-980c-27214ae732fc" xlink:to="loc_srt_CounterpartyNameAxis_484e3499-ed60-4853-80ba-66d3677241e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_484e3499-ed60-4853-80ba-66d3677241e4_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_484e3499-ed60-4853-80ba-66d3677241e4" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_484e3499-ed60-4853-80ba-66d3677241e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_bd298c88-57de-4ec4-aed1-9996fd4d46fd" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_484e3499-ed60-4853-80ba-66d3677241e4" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_bd298c88-57de-4ec4-aed1-9996fd4d46fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MedicalDeviceCompanyMember_3c076cba-0c71-4d64-8cc4-26a91c5049e8" xlink:href="ew-20240331.xsd#ew_MedicalDeviceCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_bd298c88-57de-4ec4-aed1-9996fd4d46fd" xlink:to="loc_ew_MedicalDeviceCompanyMember_3c076cba-0c71-4d64-8cc4-26a91c5049e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_36150e02-3aef-4598-b80b-2247cd594ca9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_3c1d6cd8-7989-4af3-980c-27214ae732fc" xlink:to="loc_srt_ConsolidatedEntitiesAxis_36150e02-3aef-4598-b80b-2247cd594ca9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_36150e02-3aef-4598-b80b-2247cd594ca9_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_36150e02-3aef-4598-b80b-2247cd594ca9" xlink:to="loc_srt_ConsolidatedEntitiesDomain_36150e02-3aef-4598-b80b-2247cd594ca9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_41d03f71-d1b6-41c5-86ba-58c5c669007d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_36150e02-3aef-4598-b80b-2247cd594ca9" xlink:to="loc_srt_ConsolidatedEntitiesDomain_41d03f71-d1b6-41c5-86ba-58c5c669007d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_3bec6ec5-a0bd-4b12-b43a-c833884e354f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_41d03f71-d1b6-41c5-86ba-58c5c669007d" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_3bec6ec5-a0bd-4b12-b43a-c833884e354f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_7b3ae029-7d06-4694-8010-fbf5c21e4b80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_41d03f71-d1b6-41c5-86ba-58c5c669007d" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_7b3ae029-7d06-4694-8010-fbf5c21e4b80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_289b1a55-d745-4b88-9b4f-0a43c1b16347" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_3c1d6cd8-7989-4af3-980c-27214ae732fc" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_289b1a55-d745-4b88-9b4f-0a43c1b16347" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_289b1a55-d745-4b88-9b4f-0a43c1b16347_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_289b1a55-d745-4b88-9b4f-0a43c1b16347" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_289b1a55-d745-4b88-9b4f-0a43c1b16347_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_c106492f-9fdc-4b52-ad17-08d974923855" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_289b1a55-d745-4b88-9b4f-0a43c1b16347" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_c106492f-9fdc-4b52-ad17-08d974923855" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MedicalDeviceCompanyMember_482776f3-17de-4dce-a4c4-938c86aea2ef" xlink:href="ew-20240331.xsd#ew_MedicalDeviceCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_c106492f-9fdc-4b52-ad17-08d974923855" xlink:to="loc_ew_MedicalDeviceCompanyMember_482776f3-17de-4dce-a4c4-938c86aea2ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_55461e1a-af92-406a-8eca-5e42a229610d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_3c1d6cd8-7989-4af3-980c-27214ae732fc" xlink:to="loc_us-gaap_DebtInstrumentAxis_55461e1a-af92-406a-8eca-5e42a229610d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_55461e1a-af92-406a-8eca-5e42a229610d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_55461e1a-af92-406a-8eca-5e42a229610d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_55461e1a-af92-406a-8eca-5e42a229610d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ab520112-ba18-4211-a78c-9067f194638b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_55461e1a-af92-406a-8eca-5e42a229610d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ab520112-ba18-4211-a78c-9067f194638b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_ConvertiblePromissoryNoteMember_b58b4ba4-22ad-4287-b6a7-29ea185f843b" xlink:href="ew-20240331.xsd#ew_ConvertiblePromissoryNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ab520112-ba18-4211-a78c-9067f194638b" xlink:to="loc_ew_ConvertiblePromissoryNoteMember_b58b4ba4-22ad-4287-b6a7-29ea185f843b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_92beb5d0-cd41-46f4-8a6f-4e8fc6df247d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_566015de-e904-4170-873e-5db38c89273a" xlink:to="loc_us-gaap_Assets_92beb5d0-cd41-46f4-8a6f-4e8fc6df247d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_905a0195-9f5b-4021-a4a9-911c271547dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_566015de-e904-4170-873e-5db38c89273a" xlink:to="loc_us-gaap_Liabilities_905a0195-9f5b-4021-a4a9-911c271547dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote_7042769f-929f-43a6-a8e4-42f4033bcd09" xlink:href="ew-20240331.xsd#ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_566015de-e904-4170-873e-5db38c89273a" xlink:to="loc_ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote_7042769f-929f-43a6-a8e4-42f4033bcd09" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquitySecuritiesFVNIPromissoryNoteOutstanding_5944330c-e349-41a4-8e7a-fe2c651a8398" xlink:href="ew-20240331.xsd#ew_EquitySecuritiesFVNIPromissoryNoteOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_566015de-e904-4170-873e-5db38c89273a" xlink:to="loc_ew_EquitySecuritiesFVNIPromissoryNoteOutstanding_5944330c-e349-41a4-8e7a-fe2c651a8398" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_298cf0e6-7eb3-4f31-afdc-3c7f7311c3ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_566015de-e904-4170-873e-5db38c89273a" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_298cf0e6-7eb3-4f31-afdc-3c7f7311c3ea" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquitySecuritiesFVNIOptionToAcquireInvestment_2e4263d9-91a3-4ea9-9666-0e5d5ab87862" xlink:href="ew-20240331.xsd#ew_EquitySecuritiesFVNIOptionToAcquireInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_566015de-e904-4170-873e-5db38c89273a" xlink:to="loc_ew_EquitySecuritiesFVNIOptionToAcquireInvestment_2e4263d9-91a3-4ea9-9666-0e5d5ab87862" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquitySecuritiesFVNIMaximumAdditionalRequired_f33d67f3-b67c-4dfc-ad52-f91eb97401a5" xlink:href="ew-20240331.xsd#ew_EquitySecuritiesFVNIMaximumAdditionalRequired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_566015de-e904-4170-873e-5db38c89273a" xlink:to="loc_ew_EquitySecuritiesFVNIMaximumAdditionalRequired_f33d67f3-b67c-4dfc-ad52-f91eb97401a5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment_6005ec6b-dae6-4774-b2ff-ac4e7c11ef69" xlink:href="ew-20240331.xsd#ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_566015de-e904-4170-873e-5db38c89273a" xlink:to="loc_ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment_6005ec6b-dae6-4774-b2ff-ac4e7c11ef69" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_LoansReceivablesMaximumLendingCapacity_ef3c0b1c-a54c-4f82-82c7-53da36ba7b8a" xlink:href="ew-20240331.xsd#ew_LoansReceivablesMaximumLendingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_566015de-e904-4170-873e-5db38c89273a" xlink:to="loc_ew_LoansReceivablesMaximumLendingCapacity_ef3c0b1c-a54c-4f82-82c7-53da36ba7b8a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPaymentsToAcquireBusinesses_aa0e2d42-7e3d-4d00-84f1-a6ac2afc8214" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPaymentsToAcquireBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_566015de-e904-4170-873e-5db38c89273a" xlink:to="loc_us-gaap_OtherPaymentsToAcquireBusinesses_aa0e2d42-7e3d-4d00-84f1-a6ac2afc8214" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableGross_3e8e4887-7f64-4644-b7f5-2556f71b0cde" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReceivableGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_566015de-e904-4170-873e-5db38c89273a" xlink:to="loc_us-gaap_NotesReceivableGross_3e8e4887-7f64-4644-b7f5-2556f71b0cde" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#FAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ebd92558-d913-47c4-80fb-40c5a91aa32b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_cccf2858-239b-4682-8bf6-530a32354a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ebd92558-d913-47c4-80fb-40c5a91aa32b" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_cccf2858-239b-4682-8bf6-530a32354a2a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4790492a-b431-4b41-b016-d93229a0296c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_cccf2858-239b-4682-8bf6-530a32354a2a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4790492a-b431-4b41-b016-d93229a0296c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4790492a-b431-4b41-b016-d93229a0296c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4790492a-b431-4b41-b016-d93229a0296c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4790492a-b431-4b41-b016-d93229a0296c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_91fb1183-54ec-41d6-9b8f-e817e464b193" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4790492a-b431-4b41-b016-d93229a0296c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_91fb1183-54ec-41d6-9b8f-e817e464b193" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_fdaf2e83-2dd6-48a4-a527-e01697aa7b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_91fb1183-54ec-41d6-9b8f-e817e464b193" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_fdaf2e83-2dd6-48a4-a527-e01697aa7b7f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_dc65767b-b6ae-4023-9137-7b77df729078" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_cccf2858-239b-4682-8bf6-530a32354a2a" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_dc65767b-b6ae-4023-9137-7b77df729078" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_dc65767b-b6ae-4023-9137-7b77df729078_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_dc65767b-b6ae-4023-9137-7b77df729078" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_dc65767b-b6ae-4023-9137-7b77df729078_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_62c79e7a-0f2d-47bc-87b3-f2b0925d33b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_dc65767b-b6ae-4023-9137-7b77df729078" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_62c79e7a-0f2d-47bc-87b3-f2b0925d33b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MeasurementInputProbabilityOfMilestoneAchievementMember_fc34cf87-add5-47b6-b0ac-8e81737fbe00" xlink:href="ew-20240331.xsd#ew_MeasurementInputProbabilityOfMilestoneAchievementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_62c79e7a-0f2d-47bc-87b3-f2b0925d33b8" xlink:to="loc_ew_MeasurementInputProbabilityOfMilestoneAchievementMember_fc34cf87-add5-47b6-b0ac-8e81737fbe00" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_286d8a26-1dd3-4aa8-981b-8ceac6bd3090" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_cccf2858-239b-4682-8bf6-530a32354a2a" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_286d8a26-1dd3-4aa8-981b-8ceac6bd3090" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_286d8a26-1dd3-4aa8-981b-8ceac6bd3090_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_286d8a26-1dd3-4aa8-981b-8ceac6bd3090" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_286d8a26-1dd3-4aa8-981b-8ceac6bd3090_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_7c06fda2-6ebf-40e5-bb6f-6b362f343379" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_286d8a26-1dd3-4aa8-981b-8ceac6bd3090" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_7c06fda2-6ebf-40e5-bb6f-6b362f343379" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_ContingentConsiderationLiabilityMember_cb0ffd53-8660-4e9f-959a-f1dc085e1985" xlink:href="ew-20240331.xsd#ew_ContingentConsiderationLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_7c06fda2-6ebf-40e5-bb6f-6b362f343379" xlink:to="loc_ew_ContingentConsiderationLiabilityMember_cb0ffd53-8660-4e9f-959a-f1dc085e1985" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableFairValueDisclosure_e139b04e-0596-4380-888b-70ce77a93d06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ebd92558-d913-47c4-80fb-40c5a91aa32b" xlink:to="loc_us-gaap_NotesPayableFairValueDisclosure_e139b04e-0596-4380-888b-70ce77a93d06" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_9f1bcdf7-c534-4e50-8c13-2ce27d340c22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ebd92558-d913-47c4-80fb-40c5a91aa32b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_9f1bcdf7-c534-4e50-8c13-2ce27d340c22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_0515df65-3efe-4153-b954-28f3d64686ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ebd92558-d913-47c4-80fb-40c5a91aa32b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_0515df65-3efe-4153-b954-28f3d64686ac" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2088ff0d-baf4-40c2-962a-4aa945b13d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d9cdb647-8ce9-40ab-9b38-fe48e19b2aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2088ff0d-baf4-40c2-962a-4aa945b13d0e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d9cdb647-8ce9-40ab-9b38-fe48e19b2aaf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_e3e543a3-099b-46b9-abff-597a961a74db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d9cdb647-8ce9-40ab-9b38-fe48e19b2aaf" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_e3e543a3-099b-46b9-abff-597a961a74db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_e3e543a3-099b-46b9-abff-597a961a74db_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_e3e543a3-099b-46b9-abff-597a961a74db" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_e3e543a3-099b-46b9-abff-597a961a74db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_1d74bb95-a425-4f81-ab1c-d6cc089c7681" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_e3e543a3-099b-46b9-abff-597a961a74db" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_1d74bb95-a425-4f81-ab1c-d6cc089c7681" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_bbd61cc6-d880-4d27-955f-aa7fbe875196" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_1d74bb95-a425-4f81-ab1c-d6cc089c7681" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_bbd61cc6-d880-4d27-955f-aa7fbe875196" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_5dc8deda-1c21-42a2-97cc-14af544e1b70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_bbd61cc6-d880-4d27-955f-aa7fbe875196" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_5dc8deda-1c21-42a2-97cc-14af544e1b70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_22f915a4-39f3-48ad-b025-dcde3d115a10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d9cdb647-8ce9-40ab-9b38-fe48e19b2aaf" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_22f915a4-39f3-48ad-b025-dcde3d115a10" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_22f915a4-39f3-48ad-b025-dcde3d115a10_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_22f915a4-39f3-48ad-b025-dcde3d115a10" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_22f915a4-39f3-48ad-b025-dcde3d115a10_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_fa6efcf3-6a65-45a4-a4a7-601d9e6f2a52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_22f915a4-39f3-48ad-b025-dcde3d115a10" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_fa6efcf3-6a65-45a4-a4a7-601d9e6f2a52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_6aab031c-ea35-4e50-9687-66e6c57c6c21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_fa6efcf3-6a65-45a4-a4a7-601d9e6f2a52" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_6aab031c-ea35-4e50-9687-66e6c57c6c21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ff0c3a17-6f60-48d6-b90f-d5c9e105471a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d9cdb647-8ce9-40ab-9b38-fe48e19b2aaf" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ff0c3a17-6f60-48d6-b90f-d5c9e105471a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ff0c3a17-6f60-48d6-b90f-d5c9e105471a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ff0c3a17-6f60-48d6-b90f-d5c9e105471a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ff0c3a17-6f60-48d6-b90f-d5c9e105471a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fc93f61d-d233-43ad-8265-7cb0cc09649a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ff0c3a17-6f60-48d6-b90f-d5c9e105471a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fc93f61d-d233-43ad-8265-7cb0cc09649a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_9add72c7-35a4-4a8c-8291-e668fd39ede1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fc93f61d-d233-43ad-8265-7cb0cc09649a" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_9add72c7-35a4-4a8c-8291-e668fd39ede1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_f6d536cd-9f7f-4f49-9a14-24e27c522af1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fc93f61d-d233-43ad-8265-7cb0cc09649a" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_f6d536cd-9f7f-4f49-9a14-24e27c522af1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_7370d1f0-15b2-466f-a3f0-ad5b14f38a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fc93f61d-d233-43ad-8265-7cb0cc09649a" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_7370d1f0-15b2-466f-a3f0-ad5b14f38a1f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_37b48719-0aa9-497f-ba14-522396480a89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d9cdb647-8ce9-40ab-9b38-fe48e19b2aaf" xlink:to="loc_us-gaap_FinancialInstrumentAxis_37b48719-0aa9-497f-ba14-522396480a89" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_37b48719-0aa9-497f-ba14-522396480a89_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_37b48719-0aa9-497f-ba14-522396480a89" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_37b48719-0aa9-497f-ba14-522396480a89_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b5715a43-42d6-4aa7-bcfb-5965f80185d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_37b48719-0aa9-497f-ba14-522396480a89" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b5715a43-42d6-4aa7-bcfb-5965f80185d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_06a9064f-f028-4549-b98d-d48cdeab071e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b5715a43-42d6-4aa7-bcfb-5965f80185d0" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_06a9064f-f028-4549-b98d-d48cdeab071e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_9af4d0b8-9a28-465d-bfba-60c08e050339" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b5715a43-42d6-4aa7-bcfb-5965f80185d0" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_9af4d0b8-9a28-465d-bfba-60c08e050339" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_a8822173-a5e3-498d-b939-17dc5c0abd42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b5715a43-42d6-4aa7-bcfb-5965f80185d0" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_a8822173-a5e3-498d-b939-17dc5c0abd42" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_1c42d259-3ec9-459b-969b-d56c1811637c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MunicipalBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b5715a43-42d6-4aa7-bcfb-5965f80185d0" xlink:to="loc_us-gaap_MunicipalBondsMember_1c42d259-3ec9-459b-969b-d56c1811637c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_eec0feee-b667-4e5d-b960-06e2efd79c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2088ff0d-baf4-40c2-962a-4aa945b13d0e" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_eec0feee-b667-4e5d-b960-06e2efd79c3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_4b0f3b26-ff2d-4539-bdd6-2baeba09be41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_eec0feee-b667-4e5d-b960-06e2efd79c3c" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_4b0f3b26-ff2d-4539-bdd6-2baeba09be41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_183103da-374e-4f28-a22a-5c8503234012" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_eec0feee-b667-4e5d-b960-06e2efd79c3c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_183103da-374e-4f28-a22a-5c8503234012" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_42ece04a-3bbe-428c-a15a-b5fbfa656feb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_eec0feee-b667-4e5d-b960-06e2efd79c3c" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_42ece04a-3bbe-428c-a15a-b5fbfa656feb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_366d4265-c3a9-46ba-afeb-adf8dfa366c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_eec0feee-b667-4e5d-b960-06e2efd79c3c" xlink:to="loc_us-gaap_DerivativeAssets_366d4265-c3a9-46ba-afeb-adf8dfa366c4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_ba5d85bc-8e0f-4289-bc4d-b57d1b0749bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_eec0feee-b667-4e5d-b960-06e2efd79c3c" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_ba5d85bc-8e0f-4289-bc4d-b57d1b0749bd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_4546ce52-0360-41e0-bcde-ebfbe521aa28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2088ff0d-baf4-40c2-962a-4aa945b13d0e" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_4546ce52-0360-41e0-bcde-ebfbe521aa28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_5d778c6f-9d4c-41f8-ac26-99c73c071a84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_4546ce52-0360-41e0-bcde-ebfbe521aa28" xlink:to="loc_us-gaap_DerivativeLiabilities_5d778c6f-9d4c-41f8-ac26-99c73c071a84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_c2567040-03da-48fa-b16b-c5d70a82e280" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_4546ce52-0360-41e0-bcde-ebfbe521aa28" xlink:to="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_c2567040-03da-48fa-b16b-c5d70a82e280" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_b8dc3c53-3b2f-4c47-ae10-cbc710dc38b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_4546ce52-0360-41e0-bcde-ebfbe521aa28" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_b8dc3c53-3b2f-4c47-ae10-cbc710dc38b8" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_10adde18-6af1-4d69-9964-e99a8620bf42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_795a27d0-6e87-4bc1-bc6a-a8fe3a545212" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_10adde18-6af1-4d69-9964-e99a8620bf42" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_795a27d0-6e87-4bc1-bc6a-a8fe3a545212" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_2b25167a-aa56-4e06-91aa-10d7d9dd4f46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_795a27d0-6e87-4bc1-bc6a-a8fe3a545212" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_2b25167a-aa56-4e06-91aa-10d7d9dd4f46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2b25167a-aa56-4e06-91aa-10d7d9dd4f46_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_2b25167a-aa56-4e06-91aa-10d7d9dd4f46" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2b25167a-aa56-4e06-91aa-10d7d9dd4f46_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6c3e8efb-2c20-46a7-9514-1b9cf4ff2382" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_2b25167a-aa56-4e06-91aa-10d7d9dd4f46" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6c3e8efb-2c20-46a7-9514-1b9cf4ff2382" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_ContingentConsiderationLiabilityMember_dad2ce50-4af4-4cd4-8098-52a4cc64d575" xlink:href="ew-20240331.xsd#ew_ContingentConsiderationLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6c3e8efb-2c20-46a7-9514-1b9cf4ff2382" xlink:to="loc_ew_ContingentConsiderationLiabilityMember_dad2ce50-4af4-4cd4-8098-52a4cc64d575" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_e37d35f2-fee9-4723-96a9-6e008366a12e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6c3e8efb-2c20-46a7-9514-1b9cf4ff2382" xlink:to="loc_us-gaap_OtherLiabilitiesMember_e37d35f2-fee9-4723-96a9-6e008366a12e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_8c043a8e-cce2-4ba8-b74b-fdf03a84ea60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_795a27d0-6e87-4bc1-bc6a-a8fe3a545212" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_8c043a8e-cce2-4ba8-b74b-fdf03a84ea60" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_8c043a8e-cce2-4ba8-b74b-fdf03a84ea60_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_8c043a8e-cce2-4ba8-b74b-fdf03a84ea60" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_8c043a8e-cce2-4ba8-b74b-fdf03a84ea60_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_9f60c5a3-5166-4322-8436-9eebb200c4c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_8c043a8e-cce2-4ba8-b74b-fdf03a84ea60" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_9f60c5a3-5166-4322-8436-9eebb200c4c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_297e67cf-d4a8-44f7-9945-f66e2c8be4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_9f60c5a3-5166-4322-8436-9eebb200c4c5" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_297e67cf-d4a8-44f7-9945-f66e2c8be4eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_82e8366d-5b54-46c8-8eb9-517186825255" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_795a27d0-6e87-4bc1-bc6a-a8fe3a545212" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_82e8366d-5b54-46c8-8eb9-517186825255" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_82e8366d-5b54-46c8-8eb9-517186825255_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_82e8366d-5b54-46c8-8eb9-517186825255" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_82e8366d-5b54-46c8-8eb9-517186825255_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_52d8a2ea-222b-4c6d-9d54-f1601dab8073" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_82e8366d-5b54-46c8-8eb9-517186825255" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_52d8a2ea-222b-4c6d-9d54-f1601dab8073" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_0123100d-9406-49c9-8772-4d181b81bc9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_52d8a2ea-222b-4c6d-9d54-f1601dab8073" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_0123100d-9406-49c9-8772-4d181b81bc9a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_7994c18d-f628-4adb-b386-bea665eff5f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_10adde18-6af1-4d69-9964-e99a8620bf42" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_7994c18d-f628-4adb-b386-bea665eff5f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_cf401b1e-1a47-47f0-9f59-299cc1bb1ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_7994c18d-f628-4adb-b386-bea665eff5f8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_cf401b1e-1a47-47f0-9f59-299cc1bb1ce5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_50ee1c81-a6c9-4ae4-9902-66e9ca589474" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_7994c18d-f628-4adb-b386-bea665eff5f8" xlink:to="loc_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_50ee1c81-a6c9-4ae4-9902-66e9ca589474" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_9d63838d-c388-4e8e-bb97-90dd5d9c6c15" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_7994c18d-f628-4adb-b386-bea665eff5f8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_9d63838d-c388-4e8e-bb97-90dd5d9c6c15" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_ebfca8be-d56c-4291-975c-49a7910400ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_6a4d4848-eac9-4e4e-84a6-c05a0d4fb7dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_7ebf4729-36b3-4f0f-b165-b93655c3c87a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_6a4d4848-eac9-4e4e-84a6-c05a0d4fb7dd" xlink:to="loc_us-gaap_DerivativeTable_7ebf4729-36b3-4f0f-b165-b93655c3c87a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_dd8ff429-f362-4640-93dc-bd77984c8dda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_7ebf4729-36b3-4f0f-b165-b93655c3c87a" xlink:to="loc_us-gaap_HedgingDesignationAxis_dd8ff429-f362-4640-93dc-bd77984c8dda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_dd8ff429-f362-4640-93dc-bd77984c8dda_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_dd8ff429-f362-4640-93dc-bd77984c8dda" xlink:to="loc_us-gaap_HedgingDesignationDomain_dd8ff429-f362-4640-93dc-bd77984c8dda_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_78a4cae4-e8d9-427d-92f8-a1af1293f91f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_dd8ff429-f362-4640-93dc-bd77984c8dda" xlink:to="loc_us-gaap_HedgingDesignationDomain_78a4cae4-e8d9-427d-92f8-a1af1293f91f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_832b06c2-c903-49a7-b7f0-57cdb443b4d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_78a4cae4-e8d9-427d-92f8-a1af1293f91f" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_832b06c2-c903-49a7-b7f0-57cdb443b4d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_310a5f88-6998-487b-a882-bcfa35c409d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_7ebf4729-36b3-4f0f-b165-b93655c3c87a" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_310a5f88-6998-487b-a882-bcfa35c409d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_310a5f88-6998-487b-a882-bcfa35c409d9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_310a5f88-6998-487b-a882-bcfa35c409d9" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_310a5f88-6998-487b-a882-bcfa35c409d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_af97d754-1a9f-4512-a5fd-d9ed501d2e84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_310a5f88-6998-487b-a882-bcfa35c409d9" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_af97d754-1a9f-4512-a5fd-d9ed501d2e84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_6be8cba1-ae23-4713-a0a3-d92cc57bc171" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_af97d754-1a9f-4512-a5fd-d9ed501d2e84" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_6be8cba1-ae23-4713-a0a3-d92cc57bc171" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_5e39aff9-75e3-4758-a6ee-c1317d48ef3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_af97d754-1a9f-4512-a5fd-d9ed501d2e84" xlink:to="loc_us-gaap_CurrencySwapMember_5e39aff9-75e3-4758-a6ee-c1317d48ef3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_1996ab73-4478-4b2b-b7ae-ce27028c29e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_6a4d4848-eac9-4e4e-84a6-c05a0d4fb7dd" xlink:to="loc_us-gaap_DerivativeNotionalAmount_1996ab73-4478-4b2b-b7ae-ce27028c29e3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_d9960968-9789-4dbf-b4ef-e569d19aa176" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_33d0fadf-007d-42ca-8f60-f0d1ad8e1d96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_d9960968-9789-4dbf-b4ef-e569d19aa176" xlink:to="loc_us-gaap_DerivativeTable_33d0fadf-007d-42ca-8f60-f0d1ad8e1d96" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a4d030c4-ae57-49c1-b395-4b07e9033824" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_33d0fadf-007d-42ca-8f60-f0d1ad8e1d96" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a4d030c4-ae57-49c1-b395-4b07e9033824" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_a4d030c4-ae57-49c1-b395-4b07e9033824_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a4d030c4-ae57-49c1-b395-4b07e9033824" xlink:to="loc_us-gaap_HedgingRelationshipDomain_a4d030c4-ae57-49c1-b395-4b07e9033824_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_b9f432b8-e369-4894-a70d-bc07c75b8d34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a4d030c4-ae57-49c1-b395-4b07e9033824" xlink:to="loc_us-gaap_HedgingRelationshipDomain_b9f432b8-e369-4894-a70d-bc07c75b8d34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_72eba471-c9cd-4651-9d5b-4709bd6c4651" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_b9f432b8-e369-4894-a70d-bc07c75b8d34" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_72eba471-c9cd-4651-9d5b-4709bd6c4651" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_e5dc76c2-51d2-46cc-a77c-a5a0c5b7e85a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_33d0fadf-007d-42ca-8f60-f0d1ad8e1d96" xlink:to="loc_us-gaap_HedgingDesignationAxis_e5dc76c2-51d2-46cc-a77c-a5a0c5b7e85a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_e5dc76c2-51d2-46cc-a77c-a5a0c5b7e85a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_e5dc76c2-51d2-46cc-a77c-a5a0c5b7e85a" xlink:to="loc_us-gaap_HedgingDesignationDomain_e5dc76c2-51d2-46cc-a77c-a5a0c5b7e85a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_a391d03e-0dc1-4b77-84e7-b37909cff429" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_e5dc76c2-51d2-46cc-a77c-a5a0c5b7e85a" xlink:to="loc_us-gaap_HedgingDesignationDomain_a391d03e-0dc1-4b77-84e7-b37909cff429" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_bcd33254-21e6-46f6-86c7-bc7ac318a121" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_a391d03e-0dc1-4b77-84e7-b37909cff429" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_bcd33254-21e6-46f6-86c7-bc7ac318a121" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4641fe49-d89c-46a8-af77-4e34c538d558" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_33d0fadf-007d-42ca-8f60-f0d1ad8e1d96" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4641fe49-d89c-46a8-af77-4e34c538d558" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4641fe49-d89c-46a8-af77-4e34c538d558_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4641fe49-d89c-46a8-af77-4e34c538d558" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4641fe49-d89c-46a8-af77-4e34c538d558_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1d793ad2-6c65-40bf-8d71-d98c5b5f7b16" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4641fe49-d89c-46a8-af77-4e34c538d558" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1d793ad2-6c65-40bf-8d71-d98c5b5f7b16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_4f8c249d-aef4-4fab-ad93-88b22446711c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1d793ad2-6c65-40bf-8d71-d98c5b5f7b16" xlink:to="loc_us-gaap_CurrencySwapMember_4f8c249d-aef4-4fab-ad93-88b22446711c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_2996e0e8-93f2-464b-b0d0-d6a301dd6773" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_d9960968-9789-4dbf-b4ef-e569d19aa176" xlink:to="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_2996e0e8-93f2-464b-b0d0-d6a301dd6773" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_71baa96f-7ca6-499c-9002-7733e84d6d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_d9960968-9789-4dbf-b4ef-e569d19aa176" xlink:to="loc_us-gaap_DerivativeNotionalAmount_71baa96f-7ca6-499c-9002-7733e84d6d2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_68f9a110-3a73-4f12-a053-c68da54a2a72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_d9960968-9789-4dbf-b4ef-e569d19aa176" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_68f9a110-3a73-4f12-a053-c68da54a2a72" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_547122bc-e627-47c8-8bda-e6125e5ac10a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a763620e-f166-4679-a831-89226e9aa8e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_547122bc-e627-47c8-8bda-e6125e5ac10a" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a763620e-f166-4679-a831-89226e9aa8e9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_6036bc19-c897-41fe-ad5a-7ade75958311" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a763620e-f166-4679-a831-89226e9aa8e9" xlink:to="loc_us-gaap_HedgingDesignationAxis_6036bc19-c897-41fe-ad5a-7ade75958311" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_6036bc19-c897-41fe-ad5a-7ade75958311_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_6036bc19-c897-41fe-ad5a-7ade75958311" xlink:to="loc_us-gaap_HedgingDesignationDomain_6036bc19-c897-41fe-ad5a-7ade75958311_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_d4bd00fe-f5dc-4227-983c-3bff00ecfae6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_6036bc19-c897-41fe-ad5a-7ade75958311" xlink:to="loc_us-gaap_HedgingDesignationDomain_d4bd00fe-f5dc-4227-983c-3bff00ecfae6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_76a0cace-7d4c-4b21-9be5-1e9588d1a403" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_d4bd00fe-f5dc-4227-983c-3bff00ecfae6" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_76a0cace-7d4c-4b21-9be5-1e9588d1a403" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_47644481-9c74-42e4-8a53-e2128522ecd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a763620e-f166-4679-a831-89226e9aa8e9" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_47644481-9c74-42e4-8a53-e2128522ecd8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_47644481-9c74-42e4-8a53-e2128522ecd8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_47644481-9c74-42e4-8a53-e2128522ecd8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_47644481-9c74-42e4-8a53-e2128522ecd8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3f1af2f6-ead3-4ae0-99ce-52c9858dd07e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_47644481-9c74-42e4-8a53-e2128522ecd8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3f1af2f6-ead3-4ae0-99ce-52c9858dd07e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_7aa9d018-7c2c-46e2-a7d7-c517a340fb36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3f1af2f6-ead3-4ae0-99ce-52c9858dd07e" xlink:to="loc_us-gaap_ForeignExchangeContractMember_7aa9d018-7c2c-46e2-a7d7-c517a340fb36" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_21eb25b8-e138-4dcf-b895-3e603301a159" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignExchangeContractMember_7aa9d018-7c2c-46e2-a7d7-c517a340fb36" xlink:to="loc_us-gaap_CurrencySwapMember_21eb25b8-e138-4dcf-b895-3e603301a159" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsAbstract_9550d967-a39f-457c-b65c-870b5a83c4ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_547122bc-e627-47c8-8bda-e6125e5ac10a" xlink:to="loc_us-gaap_DerivativeAssetsAbstract_9550d967-a39f-457c-b65c-870b5a83c4ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_2f68c66a-bfec-4f9a-b937-c1559420c8e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_9550d967-a39f-457c-b65c-870b5a83c4ec" xlink:to="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_2f68c66a-bfec-4f9a-b937-c1559420c8e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_d21e3ea4-fc25-469d-b1e9-3c25f804fe48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_9550d967-a39f-457c-b65c-870b5a83c4ec" xlink:to="loc_us-gaap_DerivativeAssets_d21e3ea4-fc25-469d-b1e9-3c25f804fe48" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesAbstract_a40cd9aa-7796-4ae2-bde0-6dc578514f14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_547122bc-e627-47c8-8bda-e6125e5ac10a" xlink:to="loc_us-gaap_DerivativeLiabilitiesAbstract_a40cd9aa-7796-4ae2-bde0-6dc578514f14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_b6e872d6-32c4-4ca2-a5a9-4a9de191387f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_a40cd9aa-7796-4ae2-bde0-6dc578514f14" xlink:to="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_b6e872d6-32c4-4ca2-a5a9-4a9de191387f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_2ca36a80-2a43-4fde-a067-53fec43f2075" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_a40cd9aa-7796-4ae2-bde0-6dc578514f14" xlink:to="loc_us-gaap_DerivativeLiabilities_2ca36a80-2a43-4fde-a067-53fec43f2075" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsLineItems_63a86a80-40f7-4f15-a12b-e20d0d6fdc85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTable_3418f483-2ddb-4326-8b3f-2da69a3a6e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_63a86a80-40f7-4f15-a12b-e20d0d6fdc85" xlink:to="loc_us-gaap_OffsettingAssetsTable_3418f483-2ddb-4326-8b3f-2da69a3a6e5f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7770d970-3320-4640-bf78-0493726a5ede" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OffsettingAssetsTable_3418f483-2ddb-4326-8b3f-2da69a3a6e5f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7770d970-3320-4640-bf78-0493726a5ede" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7770d970-3320-4640-bf78-0493726a5ede_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7770d970-3320-4640-bf78-0493726a5ede" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7770d970-3320-4640-bf78-0493726a5ede_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_844ceafa-e045-4867-bdc9-7469c5883514" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7770d970-3320-4640-bf78-0493726a5ede" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_844ceafa-e045-4867-bdc9-7469c5883514" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_6906c702-1ea7-47df-bd2e-c5385917dbeb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_844ceafa-e045-4867-bdc9-7469c5883514" xlink:to="loc_us-gaap_ForeignExchangeContractMember_6906c702-1ea7-47df-bd2e-c5385917dbeb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_2e903be1-f38e-4e9a-a56a-94fd4b041569" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_844ceafa-e045-4867-bdc9-7469c5883514" xlink:to="loc_us-gaap_CurrencySwapMember_2e903be1-f38e-4e9a-a56a-94fd4b041569" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingDerivativeAssetsAbstract_464d52c8-f466-4493-ad37-44da20cf6d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingDerivativeAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_63a86a80-40f7-4f15-a12b-e20d0d6fdc85" xlink:to="loc_us-gaap_OffsettingDerivativeAssetsAbstract_464d52c8-f466-4493-ad37-44da20cf6d5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_1d2616da-7b06-4d0f-b4ed-710be3c38ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingDerivativeAssetsAbstract_464d52c8-f466-4493-ad37-44da20cf6d5d" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_1d2616da-7b06-4d0f-b4ed-710be3c38ec2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueGrossLiability_27fe624d-ff6d-49db-bd7a-79a1a6e437aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetFairValueGrossLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingDerivativeAssetsAbstract_464d52c8-f466-4493-ad37-44da20cf6d5d" xlink:to="loc_us-gaap_DerivativeAssetFairValueGrossLiability_27fe624d-ff6d-49db-bd7a-79a1a6e437aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_f3df458f-e836-404f-978d-9a3002f77834" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingDerivativeAssetsAbstract_464d52c8-f466-4493-ad37-44da20cf6d5d" xlink:to="loc_us-gaap_DerivativeAssets_f3df458f-e836-404f-978d-9a3002f77834" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_DerivativeFairValueOfDerivativeAssetGrossAmountsNotOffsetAbstract_edb3c0f1-3497-4dee-8a91-abe5a52c8cfc" xlink:href="ew-20240331.xsd#ew_DerivativeFairValueOfDerivativeAssetGrossAmountsNotOffsetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingDerivativeAssetsAbstract_464d52c8-f466-4493-ad37-44da20cf6d5d" xlink:to="loc_ew_DerivativeFairValueOfDerivativeAssetGrossAmountsNotOffsetAbstract_edb3c0f1-3497-4dee-8a91-abe5a52c8cfc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_f6842f8d-b47a-4955-88be-4feb58707bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ew_DerivativeFairValueOfDerivativeAssetGrossAmountsNotOffsetAbstract_edb3c0f1-3497-4dee-8a91-abe5a52c8cfc" xlink:to="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_f6842f8d-b47a-4955-88be-4feb58707bf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralObligationToReturnCash_b9600fdc-39a9-42dd-bd17-1811d1eb8538" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeCollateralObligationToReturnCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ew_DerivativeFairValueOfDerivativeAssetGrossAmountsNotOffsetAbstract_edb3c0f1-3497-4dee-8a91-abe5a52c8cfc" xlink:to="loc_us-gaap_DerivativeCollateralObligationToReturnCash_b9600fdc-39a9-42dd-bd17-1811d1eb8538" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_9e484d90-8535-4f52-9ed4-382f49046684" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingDerivativeAssetsAbstract_464d52c8-f466-4493-ad37-44da20cf6d5d" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_9e484d90-8535-4f52-9ed4-382f49046684" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingDerivativeLiabilitiesAbstract_704c2863-90ed-4fc7-b491-5e32973a6854" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingDerivativeLiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_63a86a80-40f7-4f15-a12b-e20d0d6fdc85" xlink:to="loc_us-gaap_OffsettingDerivativeLiabilitiesAbstract_704c2863-90ed-4fc7-b491-5e32973a6854" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_9d3ed8d1-d4fc-43bc-8c61-58b266965da6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingDerivativeLiabilitiesAbstract_704c2863-90ed-4fc7-b491-5e32973a6854" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_9d3ed8d1-d4fc-43bc-8c61-58b266965da6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_cb70fb1a-9b55-4317-8012-3f39a16fcb93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityFairValueGrossAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingDerivativeLiabilitiesAbstract_704c2863-90ed-4fc7-b491-5e32973a6854" xlink:to="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_cb70fb1a-9b55-4317-8012-3f39a16fcb93" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_5e83c2e9-d8f5-4b5e-b7d1-69840fb809df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingDerivativeLiabilitiesAbstract_704c2863-90ed-4fc7-b491-5e32973a6854" xlink:to="loc_us-gaap_DerivativeLiabilities_5e83c2e9-d8f5-4b5e-b7d1-69840fb809df" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract_60a5fc67-0d73-4265-93fd-df80ac84efa5" xlink:href="ew-20240331.xsd#ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingDerivativeLiabilitiesAbstract_704c2863-90ed-4fc7-b491-5e32973a6854" xlink:to="loc_ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract_60a5fc67-0d73-4265-93fd-df80ac84efa5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_e1c9ed06-3e5c-4a6a-bd38-128c36f010af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract_60a5fc67-0d73-4265-93fd-df80ac84efa5" xlink:to="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_e1c9ed06-3e5c-4a6a-bd38-128c36f010af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralRightToReclaimCash_dd57a1ff-6bb4-47df-95ff-b81cf0ae928a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeCollateralRightToReclaimCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract_60a5fc67-0d73-4265-93fd-df80ac84efa5" xlink:to="loc_us-gaap_DerivativeCollateralRightToReclaimCash_dd57a1ff-6bb4-47df-95ff-b81cf0ae928a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_bbee1c1b-8a85-4757-b303-247ad9b95462" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingDerivativeLiabilitiesAbstract_704c2863-90ed-4fc7-b491-5e32973a6854" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_bbee1c1b-8a85-4757-b303-247ad9b95462" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_87cb18cb-93e1-4a87-9c22-53685e89c084" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_309ff3c7-f2e9-44aa-bb02-86a185c087aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_87cb18cb-93e1-4a87-9c22-53685e89c084" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_309ff3c7-f2e9-44aa-bb02-86a185c087aa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d824ac1b-4660-4007-9510-9f76508fc61d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_309ff3c7-f2e9-44aa-bb02-86a185c087aa" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d824ac1b-4660-4007-9510-9f76508fc61d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d824ac1b-4660-4007-9510-9f76508fc61d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d824ac1b-4660-4007-9510-9f76508fc61d" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d824ac1b-4660-4007-9510-9f76508fc61d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_6b0ae500-7c61-479e-bab2-68c1946b7a43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d824ac1b-4660-4007-9510-9f76508fc61d" xlink:to="loc_us-gaap_HedgingRelationshipDomain_6b0ae500-7c61-479e-bab2-68c1946b7a43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_31603c09-0858-437d-b983-b975806834ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_6b0ae500-7c61-479e-bab2-68c1946b7a43" xlink:to="loc_us-gaap_CashFlowHedgingMember_31603c09-0858-437d-b983-b975806834ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_4d8eecd7-e3d7-4d15-adda-2e7fe6672d75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_6b0ae500-7c61-479e-bab2-68c1946b7a43" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_4d8eecd7-e3d7-4d15-adda-2e7fe6672d75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_cc3a2e76-a8c4-4aa2-a05c-473b685a5986" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_6b0ae500-7c61-479e-bab2-68c1946b7a43" xlink:to="loc_us-gaap_FairValueHedgingMember_cc3a2e76-a8c4-4aa2-a05c-473b685a5986" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_08b8273c-bef6-4fea-b042-8d041f5140f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_309ff3c7-f2e9-44aa-bb02-86a185c087aa" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_08b8273c-bef6-4fea-b042-8d041f5140f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_08b8273c-bef6-4fea-b042-8d041f5140f6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_08b8273c-bef6-4fea-b042-8d041f5140f6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_08b8273c-bef6-4fea-b042-8d041f5140f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e9f1f474-9e79-48af-9501-20acd7e2e86c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_08b8273c-bef6-4fea-b042-8d041f5140f6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e9f1f474-9e79-48af-9501-20acd7e2e86c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_ca954c8a-f39d-40b0-8d11-189b30399e08" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e9f1f474-9e79-48af-9501-20acd7e2e86c" xlink:to="loc_us-gaap_ForeignExchangeContractMember_ca954c8a-f39d-40b0-8d11-189b30399e08" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_862baf8a-eb85-4a6b-8971-2bd4d6cc7c97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignExchangeContractMember_ca954c8a-f39d-40b0-8d11-189b30399e08" xlink:to="loc_us-gaap_CurrencySwapMember_862baf8a-eb85-4a6b-8971-2bd4d6cc7c97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_5b1c8912-4b1f-45d6-b4e1-798adf2046b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_309ff3c7-f2e9-44aa-bb02-86a185c087aa" xlink:to="loc_us-gaap_HedgingDesignationAxis_5b1c8912-4b1f-45d6-b4e1-798adf2046b0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5b1c8912-4b1f-45d6-b4e1-798adf2046b0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_5b1c8912-4b1f-45d6-b4e1-798adf2046b0" xlink:to="loc_us-gaap_HedgingDesignationDomain_5b1c8912-4b1f-45d6-b4e1-798adf2046b0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_849ec670-b97a-4c8d-aa28-7d58e9740ad6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_5b1c8912-4b1f-45d6-b4e1-798adf2046b0" xlink:to="loc_us-gaap_HedgingDesignationDomain_849ec670-b97a-4c8d-aa28-7d58e9740ad6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b2eb4834-be6d-43cc-9e87-251febbe47e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_849ec670-b97a-4c8d-aa28-7d58e9740ad6" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b2eb4834-be6d-43cc-9e87-251febbe47e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_f74d1ad9-4a1f-414b-a331-c9b59b670740" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_849ec670-b97a-4c8d-aa28-7d58e9740ad6" xlink:to="loc_us-gaap_NondesignatedMember_f74d1ad9-4a1f-414b-a331-c9b59b670740" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_96008005-fc45-48fd-9f94-8822efe39663" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_309ff3c7-f2e9-44aa-bb02-86a185c087aa" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_96008005-fc45-48fd-9f94-8822efe39663" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_96008005-fc45-48fd-9f94-8822efe39663_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_96008005-fc45-48fd-9f94-8822efe39663" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_96008005-fc45-48fd-9f94-8822efe39663_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e322e7f8-597d-467a-ad7d-46e0ecf68557" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_96008005-fc45-48fd-9f94-8822efe39663" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e322e7f8-597d-467a-ad7d-46e0ecf68557" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_974a42c8-6d01-4c09-9bba-2a626a0e41ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e322e7f8-597d-467a-ad7d-46e0ecf68557" xlink:to="loc_us-gaap_CostOfSalesMember_974a42c8-6d01-4c09-9bba-2a626a0e41ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeMember_2202fdb5-e5bc-42f0-991a-8b3fa3c09687" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e322e7f8-597d-467a-ad7d-46e0ecf68557" xlink:to="loc_us-gaap_InterestIncomeMember_2202fdb5-e5bc-42f0-991a-8b3fa3c09687" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_b2fdde8b-be78-4b22-a69d-c8bfefe83136" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_87cb18cb-93e1-4a87-9c22-53685e89c084" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_b2fdde8b-be78-4b22-a69d-c8bfefe83136" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_294810f1-3fd2-4ae1-bcf2-5acd39632dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_87cb18cb-93e1-4a87-9c22-53685e89c084" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_294810f1-3fd2-4ae1-bcf2-5acd39632dc6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_25eea7a5-1e55-46fb-bbb1-a299a92565e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_87cb18cb-93e1-4a87-9c22-53685e89c084" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_25eea7a5-1e55-46fb-bbb1-a299a92565e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_831284c0-76d2-461b-8e42-ba2cdc58535e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_87cb18cb-93e1-4a87-9c22-53685e89c084" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_831284c0-76d2-461b-8e42-ba2cdc58535e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_c61f6c6b-7c08-415f-8089-a5df378261b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_87cb18cb-93e1-4a87-9c22-53685e89c084" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_c61f6c6b-7c08-415f-8089-a5df378261b3" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_59f31a71-464f-459d-b61e-525c47c9bc8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_727e3974-cab3-48ac-8121-d01e56af51dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_59f31a71-464f-459d-b61e-525c47c9bc8c" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_727e3974-cab3-48ac-8121-d01e56af51dc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e60624c0-2f3e-4827-8307-e9f66db5f2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_727e3974-cab3-48ac-8121-d01e56af51dc" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e60624c0-2f3e-4827-8307-e9f66db5f2b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e60624c0-2f3e-4827-8307-e9f66db5f2b1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e60624c0-2f3e-4827-8307-e9f66db5f2b1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e60624c0-2f3e-4827-8307-e9f66db5f2b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e60ec1e4-f780-409d-b429-26152e7c2758" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e60624c0-2f3e-4827-8307-e9f66db5f2b1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e60ec1e4-f780-409d-b429-26152e7c2758" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_e096b6ec-c011-405e-9878-dd7cdf87ddd9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e60ec1e4-f780-409d-b429-26152e7c2758" xlink:to="loc_us-gaap_ForeignExchangeContractMember_e096b6ec-c011-405e-9878-dd7cdf87ddd9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_896a95e0-6e0a-43d1-a15d-eac7697e65af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_727e3974-cab3-48ac-8121-d01e56af51dc" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_896a95e0-6e0a-43d1-a15d-eac7697e65af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_896a95e0-6e0a-43d1-a15d-eac7697e65af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_896a95e0-6e0a-43d1-a15d-eac7697e65af" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_896a95e0-6e0a-43d1-a15d-eac7697e65af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_70807617-4629-48d4-8a6b-18df37ae946a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_896a95e0-6e0a-43d1-a15d-eac7697e65af" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_70807617-4629-48d4-8a6b-18df37ae946a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_0b32cdda-75ee-4d81-963e-aafc7bd595c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_70807617-4629-48d4-8a6b-18df37ae946a" xlink:to="loc_us-gaap_CostOfSalesMember_0b32cdda-75ee-4d81-963e-aafc7bd595c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_c0baa9ec-8afa-4f2a-b9ec-c5cc818e6868" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_70807617-4629-48d4-8a6b-18df37ae946a" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_c0baa9ec-8afa-4f2a-b9ec-c5cc818e6868" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_eca913cb-7c15-40c0-9433-68313de3a527" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_727e3974-cab3-48ac-8121-d01e56af51dc" xlink:to="loc_us-gaap_HedgingDesignationAxis_eca913cb-7c15-40c0-9433-68313de3a527" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_eca913cb-7c15-40c0-9433-68313de3a527_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_eca913cb-7c15-40c0-9433-68313de3a527" xlink:to="loc_us-gaap_HedgingDesignationDomain_eca913cb-7c15-40c0-9433-68313de3a527_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_19369e13-32a0-4524-bc5b-651693d21a76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_eca913cb-7c15-40c0-9433-68313de3a527" xlink:to="loc_us-gaap_HedgingDesignationDomain_19369e13-32a0-4524-bc5b-651693d21a76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6758dd46-71ab-483b-9293-7bb521f6ea03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_19369e13-32a0-4524-bc5b-651693d21a76" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6758dd46-71ab-483b-9293-7bb521f6ea03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_ac903ab5-78fe-43f7-8adf-42e3438dd690" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_59f31a71-464f-459d-b61e-525c47c9bc8c" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_ac903ab5-78fe-43f7-8adf-42e3438dd690" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_540909d1-b8a4-4245-a006-aae6e1a85fee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_59f31a71-464f-459d-b61e-525c47c9bc8c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_540909d1-b8a4-4245-a006-aae6e1a85fee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract_1c74abf3-1ceb-46b8-91ee-f0c316919991" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_59f31a71-464f-459d-b61e-525c47c9bc8c" xlink:to="loc_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract_1c74abf3-1ceb-46b8-91ee-f0c316919991" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_496ef399-85b6-493e-b5c2-608dd711ce12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract_1c74abf3-1ceb-46b8-91ee-f0c316919991" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_496ef399-85b6-493e-b5c2-608dd711ce12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_bfeebb80-39fc-4543-8719-f097f4bc6f80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract_1c74abf3-1ceb-46b8-91ee-f0c316919991" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_bfeebb80-39fc-4543-8719-f097f4bc6f80" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax_c72f56e3-b1cc-4ba0-9e2c-d483ee04e1be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract_1c74abf3-1ceb-46b8-91ee-f0c316919991" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax_c72f56e3-b1cc-4ba0-9e2c-d483ee04e1be" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_43346375-88c2-4da0-9611-c6672da36956" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_59f31a71-464f-459d-b61e-525c47c9bc8c" xlink:to="loc_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_43346375-88c2-4da0-9611-c6672da36956" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_3ba5ae90-314b-447b-bd1f-9e27855efdd2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_43346375-88c2-4da0-9611-c6672da36956" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_3ba5ae90-314b-447b-bd1f-9e27855efdd2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_5bd911bb-1a04-47bc-a23f-9a9680324617" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8764abe4-961e-4a51-91d2-7cd1fde768be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_5bd911bb-1a04-47bc-a23f-9a9680324617" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8764abe4-961e-4a51-91d2-7cd1fde768be" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_4a103480-d21c-448c-9010-6ceec3a345ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8764abe4-961e-4a51-91d2-7cd1fde768be" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_4a103480-d21c-448c-9010-6ceec3a345ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4a103480-d21c-448c-9010-6ceec3a345ee_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4a103480-d21c-448c-9010-6ceec3a345ee" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4a103480-d21c-448c-9010-6ceec3a345ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4ea87aaf-aee3-4d70-8630-285d919adb53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4a103480-d21c-448c-9010-6ceec3a345ee" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4ea87aaf-aee3-4d70-8630-285d919adb53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_f87fd9f5-44a8-401b-8e79-a90a626a3420" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4ea87aaf-aee3-4d70-8630-285d919adb53" xlink:to="loc_us-gaap_CostOfSalesMember_f87fd9f5-44a8-401b-8e79-a90a626a3420" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_2510471b-3084-4c32-a68d-9079c6bf83c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4ea87aaf-aee3-4d70-8630-285d919adb53" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_2510471b-3084-4c32-a68d-9079c6bf83c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_98dde119-2c2e-480b-abc8-1c18b29104a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4ea87aaf-aee3-4d70-8630-285d919adb53" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_98dde119-2c2e-480b-abc8-1c18b29104a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_SeparationCostsMember_e7ac1fe4-bf7d-40cc-a026-a73b63392d83" xlink:href="ew-20240331.xsd#ew_SeparationCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4ea87aaf-aee3-4d70-8630-285d919adb53" xlink:to="loc_ew_SeparationCostsMember_e7ac1fe4-bf7d-40cc-a026-a73b63392d83" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_409bde82-cbec-4a2d-9276-c292a145b975" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_5bd911bb-1a04-47bc-a23f-9a9680324617" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_409bde82-cbec-4a2d-9276-c292a145b975" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_1aed137e-0eb4-4d9b-88fa-5632e2f131e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_5bd911bb-1a04-47bc-a23f-9a9680324617" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_1aed137e-0eb4-4d9b-88fa-5632e2f131e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_ea379f7b-a5a5-4730-9875-4c4b5641ee5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_5bd911bb-1a04-47bc-a23f-9a9680324617" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_ea379f7b-a5a5-4730-9875-4c4b5641ee5e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b379ed59-2860-4cbb-a23e-1b2aefaa892c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5a050926-39a9-4d31-a182-cbeea9568329" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b379ed59-2860-4cbb-a23e-1b2aefaa892c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5a050926-39a9-4d31-a182-cbeea9568329" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_95c4abb0-796c-4b63-a277-e7d2ed67e2cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5a050926-39a9-4d31-a182-cbeea9568329" xlink:to="loc_us-gaap_AwardTypeAxis_95c4abb0-796c-4b63-a277-e7d2ed67e2cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_95c4abb0-796c-4b63-a277-e7d2ed67e2cd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_95c4abb0-796c-4b63-a277-e7d2ed67e2cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_95c4abb0-796c-4b63-a277-e7d2ed67e2cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f1545a5-6088-4ff2-9fe7-f3b00a46a5dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_95c4abb0-796c-4b63-a277-e7d2ed67e2cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f1545a5-6088-4ff2-9fe7-f3b00a46a5dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EmployeeAndNonemployeeStockOptionsMember_83b02a0f-a336-4b47-8081-c7e60784dd6c" xlink:href="ew-20240331.xsd#ew_EmployeeAndNonemployeeStockOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f1545a5-6088-4ff2-9fe7-f3b00a46a5dd" xlink:to="loc_ew_EmployeeAndNonemployeeStockOptionsMember_83b02a0f-a336-4b47-8081-c7e60784dd6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_a501312b-ce6b-45bc-94ac-7449e65fcafe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f1545a5-6088-4ff2-9fe7-f3b00a46a5dd" xlink:to="loc_us-gaap_EmployeeStockMember_a501312b-ce6b-45bc-94ac-7449e65fcafe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_8e0f915f-dc78-4b20-a74c-68ab648f7c2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b379ed59-2860-4cbb-a23e-1b2aefaa892c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_8e0f915f-dc78-4b20-a74c-68ab648f7c2c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_4aa2fc8f-2add-4236-9fd2-2ec71e5cafe6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b379ed59-2860-4cbb-a23e-1b2aefaa892c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_4aa2fc8f-2add-4236-9fd2-2ec71e5cafe6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c77400bd-006b-4c1b-9a5c-4ce035c7faec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b379ed59-2860-4cbb-a23e-1b2aefaa892c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c77400bd-006b-4c1b-9a5c-4ce035c7faec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_c45230ce-3019-4a93-8f97-69d0bd64174d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b379ed59-2860-4cbb-a23e-1b2aefaa892c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_c45230ce-3019-4a93-8f97-69d0bd64174d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_bbaccd4c-eaba-43ba-88e4-9f5c5bd80035" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b379ed59-2860-4cbb-a23e-1b2aefaa892c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_bbaccd4c-eaba-43ba-88e4-9f5c5bd80035" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#ACCELERATEDSHAREREPURCHASEDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_ca66e118-d4c8-4159-a79a-0cb3b1fbf216" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_537d13f4-22f0-43c2-862e-982f7a924cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_ca66e118-d4c8-4159-a79a-0cb3b1fbf216" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_537d13f4-22f0-43c2-862e-982f7a924cb6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_9b73811e-26f7-43e8-a6ef-b0b1b6aed8d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_537d13f4-22f0-43c2-862e-982f7a924cb6" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_9b73811e-26f7-43e8-a6ef-b0b1b6aed8d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_9b73811e-26f7-43e8-a6ef-b0b1b6aed8d6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_9b73811e-26f7-43e8-a6ef-b0b1b6aed8d6" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_9b73811e-26f7-43e8-a6ef-b0b1b6aed8d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_c59519e8-b066-4f75-ba5e-72755eb3a73d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_9b73811e-26f7-43e8-a6ef-b0b1b6aed8d6" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_c59519e8-b066-4f75-ba5e-72755eb3a73d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_InitialDeliveryOfSharesSettledFebruary2023Member_ec9b86a4-de98-41f9-94b3-a25b3718b5d8" xlink:href="ew-20240331.xsd#ew_InitialDeliveryOfSharesSettledFebruary2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_c59519e8-b066-4f75-ba5e-72755eb3a73d" xlink:to="loc_ew_InitialDeliveryOfSharesSettledFebruary2023Member_ec9b86a4-de98-41f9-94b3-a25b3718b5d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member_2f3b7e94-087b-4aa8-a65a-741252c1e355" xlink:href="ew-20240331.xsd#ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_c59519e8-b066-4f75-ba5e-72755eb3a73d" xlink:to="loc_ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member_2f3b7e94-087b-4aa8-a65a-741252c1e355" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_2a0c2fa0-a1b7-413f-8988-9eb8a4c2f2be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_ca66e118-d4c8-4159-a79a-0cb3b1fbf216" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_2a0c2fa0-a1b7-413f-8988-9eb8a4c2f2be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_516f2c5f-07a9-4863-8695-817548427a51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_ca66e118-d4c8-4159-a79a-0cb3b1fbf216" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_516f2c5f-07a9-4863-8695-817548427a51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare_b2f8d60e-7896-451c-b59a-0ed31792b7ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_ca66e118-d4c8-4159-a79a-0cb3b1fbf216" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare_b2f8d60e-7896-451c-b59a-0ed31792b7ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount_408d827f-22e7-4a9f-a35b-8cb04f40ea8f" xlink:href="ew-20240331.xsd#ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_ca66e118-d4c8-4159-a79a-0cb3b1fbf216" xlink:to="loc_ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount_408d827f-22e7-4a9f-a35b-8cb04f40ea8f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_32b866a1-75ac-4cb6-b3a3-85398b242c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_ca66e118-d4c8-4159-a79a-0cb3b1fbf216" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_32b866a1-75ac-4cb6-b3a3-85398b242c8a" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a5b5e45a-ab30-4fe1-b596-55d3d986e8df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_5b59c374-6a34-4773-800a-a80abc958a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a5b5e45a-ab30-4fe1-b596-55d3d986e8df" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_5b59c374-6a34-4773-800a-a80abc958a3e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f0329734-eec8-4dc3-963d-dfacdbf3501d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_5b59c374-6a34-4773-800a-a80abc958a3e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f0329734-eec8-4dc3-963d-dfacdbf3501d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f0329734-eec8-4dc3-963d-dfacdbf3501d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f0329734-eec8-4dc3-963d-dfacdbf3501d" xlink:to="loc_us-gaap_EquityComponentDomain_f0329734-eec8-4dc3-963d-dfacdbf3501d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7b26cdb4-4454-412b-8658-c53db10ba8a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f0329734-eec8-4dc3-963d-dfacdbf3501d" xlink:to="loc_us-gaap_EquityComponentDomain_7b26cdb4-4454-412b-8658-c53db10ba8a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a61401e9-9c2d-4334-8428-83660bca773c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7b26cdb4-4454-412b-8658-c53db10ba8a1" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a61401e9-9c2d-4334-8428-83660bca773c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_c101a3e6-ad7a-487d-ba91-0ccad88d530e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a61401e9-9c2d-4334-8428-83660bca773c" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_c101a3e6-ad7a-487d-ba91-0ccad88d530e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_ebc99a10-5c6c-4960-9c02-67f3f905b185" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a61401e9-9c2d-4334-8428-83660bca773c" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_ebc99a10-5c6c-4960-9c02-67f3f905b185" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_907b17d6-a3d1-4365-b4f7-23abd5694a35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a61401e9-9c2d-4334-8428-83660bca773c" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_907b17d6-a3d1-4365-b4f7-23abd5694a35" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_e8132b3d-5c94-48f8-9d91-81f4fb3d9ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a61401e9-9c2d-4334-8428-83660bca773c" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_e8132b3d-5c94-48f8-9d91-81f4fb3d9ee7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_e7062a2b-d88f-4a5a-81da-85433e81a400" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a5b5e45a-ab30-4fe1-b596-55d3d986e8df" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_e7062a2b-d88f-4a5a-81da-85433e81a400" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_31907fc7-b10a-457d-a95e-a83146a664b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_e7062a2b-d88f-4a5a-81da-85433e81a400" xlink:to="loc_us-gaap_StockholdersEquity_31907fc7-b10a-457d-a95e-a83146a664b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_d8f464f5-398c-4a3e-8685-025eb39b35de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_e7062a2b-d88f-4a5a-81da-85433e81a400" xlink:to="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_d8f464f5-398c-4a3e-8685-025eb39b35de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_7e613842-86c5-412b-a998-2d4edbd13371" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_e7062a2b-d88f-4a5a-81da-85433e81a400" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_7e613842-86c5-412b-a998-2d4edbd13371" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_aced1cf9-9629-4f12-8e6a-9baeff7dd78c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_e7062a2b-d88f-4a5a-81da-85433e81a400" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_aced1cf9-9629-4f12-8e6a-9baeff7dd78c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d8ec99aa-2e20-4ebd-955d-d85b206847e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_1d8dda72-d3a5-4453-a3de-1f1f2e99ba4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_f475a5b7-8fb1-49bb-a582-eaa976dc4437" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_1d8dda72-d3a5-4453-a3de-1f1f2e99ba4d" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_f475a5b7-8fb1-49bb-a582-eaa976dc4437" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_2b8f3574-e4d0-4da4-b247-3c62d5e27bca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_f475a5b7-8fb1-49bb-a582-eaa976dc4437" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_2b8f3574-e4d0-4da4-b247-3c62d5e27bca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_2b8f3574-e4d0-4da4-b247-3c62d5e27bca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_2b8f3574-e4d0-4da4-b247-3c62d5e27bca" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_2b8f3574-e4d0-4da4-b247-3c62d5e27bca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_b2adef76-8949-4f01-94f0-cc6c8b2efc2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_2b8f3574-e4d0-4da4-b247-3c62d5e27bca" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_b2adef76-8949-4f01-94f0-cc6c8b2efc2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_dcc75833-e59e-48aa-935b-f0bcaa7f3698" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_b2adef76-8949-4f01-94f0-cc6c8b2efc2c" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_dcc75833-e59e-48aa-935b-f0bcaa7f3698" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_375dc615-e2b6-4525-a600-675f4dc3efd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_f475a5b7-8fb1-49bb-a582-eaa976dc4437" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_375dc615-e2b6-4525-a600-675f4dc3efd8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_375dc615-e2b6-4525-a600-675f4dc3efd8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_375dc615-e2b6-4525-a600-675f4dc3efd8" xlink:to="loc_us-gaap_EquityComponentDomain_375dc615-e2b6-4525-a600-675f4dc3efd8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_bc1a3d09-84cf-4ea8-b983-7b574bfc9cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_375dc615-e2b6-4525-a600-675f4dc3efd8" xlink:to="loc_us-gaap_EquityComponentDomain_bc1a3d09-84cf-4ea8-b983-7b574bfc9cbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_caa9d43b-a8c8-441b-b3cd-d14dc1b7a9f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_bc1a3d09-84cf-4ea8-b983-7b574bfc9cbc" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_caa9d43b-a8c8-441b-b3cd-d14dc1b7a9f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_ce20ee7b-2c01-4bc2-afd5-7c9bfebb18c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_bc1a3d09-84cf-4ea8-b983-7b574bfc9cbc" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_ce20ee7b-2c01-4bc2-afd5-7c9bfebb18c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_86466a77-a1d4-498f-8e31-29fd2c4e02ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_bc1a3d09-84cf-4ea8-b983-7b574bfc9cbc" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_86466a77-a1d4-498f-8e31-29fd2c4e02ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_326bb7ec-496f-41f2-8fe0-48f765be6d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_1d8dda72-d3a5-4453-a3de-1f1f2e99ba4d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_326bb7ec-496f-41f2-8fe0-48f765be6d7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_2eeebe61-dd6f-4818-8651-2401cb03cb28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_1d8dda72-d3a5-4453-a3de-1f1f2e99ba4d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_2eeebe61-dd6f-4818-8651-2401cb03cb28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_210daec0-b4b4-4e21-b4db-8880fd350666" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_1d8dda72-d3a5-4453-a3de-1f1f2e99ba4d" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_210daec0-b4b4-4e21-b4db-8880fd350666" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_d0385e1e-c659-4e72-b6c2-81df45379339" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_1d8dda72-d3a5-4453-a3de-1f1f2e99ba4d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_d0385e1e-c659-4e72-b6c2-81df45379339" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_7f6d0902-d763-4995-8f3f-ae45072128c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_1d8dda72-d3a5-4453-a3de-1f1f2e99ba4d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_7f6d0902-d763-4995-8f3f-ae45072128c9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_caf2c754-f038-49e5-b911-97642019783c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_1d8dda72-d3a5-4453-a3de-1f1f2e99ba4d" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_caf2c754-f038-49e5-b911-97642019783c" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#EARNINGSPERSHARENarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_960e59d1-da27-47fb-9d22-ed15f4a4f18e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_d891788a-f19a-4626-a8b6-310e70410ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_960e59d1-da27-47fb-9d22-ed15f4a4f18e" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_d891788a-f19a-4626-a8b6-310e70410ae9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_903f14c7-c1b8-4d4a-a1ec-1996a9386175" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_d891788a-f19a-4626-a8b6-310e70410ae9" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_903f14c7-c1b8-4d4a-a1ec-1996a9386175" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_903f14c7-c1b8-4d4a-a1ec-1996a9386175_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_903f14c7-c1b8-4d4a-a1ec-1996a9386175" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_903f14c7-c1b8-4d4a-a1ec-1996a9386175_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_343ea767-e273-4f9b-a002-167fd054ef63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_903f14c7-c1b8-4d4a-a1ec-1996a9386175" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_343ea767-e273-4f9b-a002-167fd054ef63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_acf3e88f-8c44-4327-abfd-d128c01f1608" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_343ea767-e273-4f9b-a002-167fd054ef63" xlink:to="loc_us-gaap_StockCompensationPlanMember_acf3e88f-8c44-4327-abfd-d128c01f1608" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_015766a6-2669-4a72-b23a-6f51010c7d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_960e59d1-da27-47fb-9d22-ed15f4a4f18e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_015766a6-2669-4a72-b23a-6f51010c7d3c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INCOMETAXESDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#INCOMETAXESDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/INCOMETAXESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_6073b326-cfb2-4b33-aded-2c9ee04b1ade" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_c2cfccf1-ae9e-4ec0-8181-6efaa98f81e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6073b326-cfb2-4b33-aded-2c9ee04b1ade" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_c2cfccf1-ae9e-4ec0-8181-6efaa98f81e7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_e1315b40-3cb6-4ef4-929c-8e9caa210528" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_c2cfccf1-ae9e-4ec0-8181-6efaa98f81e7" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_e1315b40-3cb6-4ef4-929c-8e9caa210528" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_e1315b40-3cb6-4ef4-929c-8e9caa210528_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_e1315b40-3cb6-4ef4-929c-8e9caa210528" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_e1315b40-3cb6-4ef4-929c-8e9caa210528_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_78aa9e6a-9f58-42fa-983e-f815938003c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_e1315b40-3cb6-4ef4-929c-8e9caa210528" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_78aa9e6a-9f58-42fa-983e-f815938003c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IsraelTaxAuthorityMember_f688f5bc-7ad9-46f3-9287-bcc306829793" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IsraelTaxAuthorityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_78aa9e6a-9f58-42fa-983e-f815938003c0" xlink:to="loc_us-gaap_IsraelTaxAuthorityMember_f688f5bc-7ad9-46f3-9287-bcc306829793" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_a939ddc2-170d-464b-83a8-4e7715ae7b45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6073b326-cfb2-4b33-aded-2c9ee04b1ade" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_a939ddc2-170d-464b-83a8-4e7715ae7b45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_9b2c8c39-7486-4c9c-8ef4-eb2f531d1b01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6073b326-cfb2-4b33-aded-2c9ee04b1ade" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_9b2c8c39-7486-4c9c-8ef4-eb2f531d1b01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_37dd1af2-d8aa-40a9-bbf6-71e081ada6e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6073b326-cfb2-4b33-aded-2c9ee04b1ade" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_37dd1af2-d8aa-40a9-bbf6-71e081ada6e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_61789518-782e-41e3-912c-c917cebe1111" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6073b326-cfb2-4b33-aded-2c9ee04b1ade" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_61789518-782e-41e3-912c-c917cebe1111" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_71f5dd9d-67ff-4160-9625-46694eca5395" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6073b326-cfb2-4b33-aded-2c9ee04b1ade" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_71f5dd9d-67ff-4160-9625-46694eca5395" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_NumberOfAdvancePricingAgreementsRenewed_550d84ae-58bb-4d9e-9e82-e2a693460c54" xlink:href="ew-20240331.xsd#ew_NumberOfAdvancePricingAgreementsRenewed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6073b326-cfb2-4b33-aded-2c9ee04b1ade" xlink:to="loc_ew_NumberOfAdvancePricingAgreementsRenewed_550d84ae-58bb-4d9e-9e82-e2a693460c54" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_IncomeTaxAssessmentEstimateOfAdditionalTaxExpense_8bf98201-d1bf-4fc0-9e78-6c6d3f20b867" xlink:href="ew-20240331.xsd#ew_IncomeTaxAssessmentEstimateOfAdditionalTaxExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6073b326-cfb2-4b33-aded-2c9ee04b1ade" xlink:to="loc_ew_IncomeTaxAssessmentEstimateOfAdditionalTaxExpense_8bf98201-d1bf-4fc0-9e78-6c6d3f20b867" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority_8d529d83-3e84-4d9a-882b-87dd2b659086" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6073b326-cfb2-4b33-aded-2c9ee04b1ade" xlink:to="loc_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority_8d529d83-3e84-4d9a-882b-87dd2b659086" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_IncomeTaxExaminationAmountDepositedToMitigateInterestOnTaxLiabilities_ad0be3b9-f707-41be-a18e-d7e322fc39fd" xlink:href="ew-20240331.xsd#ew_IncomeTaxExaminationAmountDepositedToMitigateInterestOnTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6073b326-cfb2-4b33-aded-2c9ee04b1ade" xlink:to="loc_ew_IncomeTaxExaminationAmountDepositedToMitigateInterestOnTaxLiabilities_ad0be3b9-f707-41be-a18e-d7e322fc39fd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss_aea9dd3d-9894-4206-a303-f280bd3146f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6073b326-cfb2-4b33-aded-2c9ee04b1ade" xlink:to="loc_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss_aea9dd3d-9894-4206-a303-f280bd3146f1" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_d062d652-1bcc-4d1d-b677-e282ebd2f9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_741679a7-cd7f-4b77-a88b-7aa26c04beec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d062d652-1bcc-4d1d-b677-e282ebd2f9e5" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_741679a7-cd7f-4b77-a88b-7aa26c04beec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_5b85f3c6-f0e9-410e-aa97-ee34848a1dfa" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_741679a7-cd7f-4b77-a88b-7aa26c04beec" xlink:to="loc_srt_ConsolidationItemsAxis_5b85f3c6-f0e9-410e-aa97-ee34848a1dfa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_5b85f3c6-f0e9-410e-aa97-ee34848a1dfa_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_5b85f3c6-f0e9-410e-aa97-ee34848a1dfa" xlink:to="loc_srt_ConsolidationItemsDomain_5b85f3c6-f0e9-410e-aa97-ee34848a1dfa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a77bf27b-0670-4a21-ad7f-e0b26e34a108" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_5b85f3c6-f0e9-410e-aa97-ee34848a1dfa" xlink:to="loc_srt_ConsolidationItemsDomain_a77bf27b-0670-4a21-ad7f-e0b26e34a108" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_5409baf9-fdba-4be6-911b-ed929351736e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_a77bf27b-0670-4a21-ad7f-e0b26e34a108" xlink:to="loc_us-gaap_OperatingSegmentsMember_5409baf9-fdba-4be6-911b-ed929351736e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_8caac057-bcf2-4498-bd58-279a931b7783" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_741679a7-cd7f-4b77-a88b-7aa26c04beec" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_8caac057-bcf2-4498-bd58-279a931b7783" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8caac057-bcf2-4498-bd58-279a931b7783_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8caac057-bcf2-4498-bd58-279a931b7783" xlink:to="loc_us-gaap_SegmentDomain_8caac057-bcf2-4498-bd58-279a931b7783_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f5c37aba-909e-4a75-9f5a-4171ee4887ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8caac057-bcf2-4498-bd58-279a931b7783" xlink:to="loc_us-gaap_SegmentDomain_f5c37aba-909e-4a75-9f5a-4171ee4887ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_UnitedStatesSegmentMember_a2faa2f2-11a0-4cca-b71a-25f7cf85ea89" xlink:href="ew-20240331.xsd#ew_UnitedStatesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f5c37aba-909e-4a75-9f5a-4171ee4887ec" xlink:to="loc_ew_UnitedStatesSegmentMember_a2faa2f2-11a0-4cca-b71a-25f7cf85ea89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EuropeSegmentMember_f8817e5e-89a2-4cf3-b90d-f4ab5cb4c37a" xlink:href="ew-20240331.xsd#ew_EuropeSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f5c37aba-909e-4a75-9f5a-4171ee4887ec" xlink:to="loc_ew_EuropeSegmentMember_f8817e5e-89a2-4cf3-b90d-f4ab5cb4c37a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_JapanSegmentMember_ae38587b-a624-4fdf-a524-1c94b87f2025" xlink:href="ew-20240331.xsd#ew_JapanSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f5c37aba-909e-4a75-9f5a-4171ee4887ec" xlink:to="loc_ew_JapanSegmentMember_ae38587b-a624-4fdf-a524-1c94b87f2025" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_RestOfWorldSegmentMember_6e4c628b-8701-4e32-a854-a2cf2a51f4d2" xlink:href="ew-20240331.xsd#ew_RestOfWorldSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f5c37aba-909e-4a75-9f5a-4171ee4887ec" xlink:to="loc_ew_RestOfWorldSegmentMember_6e4c628b-8701-4e32-a854-a2cf2a51f4d2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_5bd4ffdc-dcf0-4f77-b0df-f287636d7d86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d062d652-1bcc-4d1d-b677-e282ebd2f9e5" xlink:to="loc_us-gaap_RevenuesAbstract_5bd4ffdc-dcf0-4f77-b0df-f287636d7d86" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6fb174d5-706a-416d-a544-25581f77349f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_5bd4ffdc-dcf0-4f77-b0df-f287636d7d86" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6fb174d5-706a-416d-a544-25581f77349f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_34eece32-7603-4253-a308-90a55cdb0f56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d062d652-1bcc-4d1d-b677-e282ebd2f9e5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_34eece32-7603-4253-a308-90a55cdb0f56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_b7370deb-e5ba-434a-8bbd-04f1b6b167d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_34eece32-7603-4253-a308-90a55cdb0f56" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_b7370deb-e5ba-434a-8bbd-04f1b6b167d0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_be003ef2-7b64-4de1-9834-04e83c9dd381" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0f7d1cd3-4b1e-4d31-90f0-a86c8606b2cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_be003ef2-7b64-4de1-9834-04e83c9dd381" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0f7d1cd3-4b1e-4d31-90f0-a86c8606b2cb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_c3f5f6c4-aa6d-4174-8f26-3946774890ed" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0f7d1cd3-4b1e-4d31-90f0-a86c8606b2cb" xlink:to="loc_srt_ConsolidationItemsAxis_c3f5f6c4-aa6d-4174-8f26-3946774890ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_c3f5f6c4-aa6d-4174-8f26-3946774890ed_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_c3f5f6c4-aa6d-4174-8f26-3946774890ed" xlink:to="loc_srt_ConsolidationItemsDomain_c3f5f6c4-aa6d-4174-8f26-3946774890ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a39b03dc-d481-4692-8726-e1b9e0a337df" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_c3f5f6c4-aa6d-4174-8f26-3946774890ed" xlink:to="loc_srt_ConsolidationItemsDomain_a39b03dc-d481-4692-8726-e1b9e0a337df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_d6d0d6c3-ec87-46ec-a34a-cee86299761e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_a39b03dc-d481-4692-8726-e1b9e0a337df" xlink:to="loc_us-gaap_OperatingSegmentsMember_d6d0d6c3-ec87-46ec-a34a-cee86299761e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_0f94b382-f52b-4b40-8664-4922cb72f6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_a39b03dc-d481-4692-8726-e1b9e0a337df" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_0f94b382-f52b-4b40-8664-4922cb72f6bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_475c03a5-11de-438c-8b1a-c68af912b052" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_a39b03dc-d481-4692-8726-e1b9e0a337df" xlink:to="loc_us-gaap_CorporateNonSegmentMember_475c03a5-11de-438c-8b1a-c68af912b052" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_4d9437ff-f5f4-44dd-930a-4e4bbdbbfe02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_be003ef2-7b64-4de1-9834-04e83c9dd381" xlink:to="loc_us-gaap_RevenuesAbstract_4d9437ff-f5f4-44dd-930a-4e4bbdbbfe02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_77e0b2fc-880a-4197-9cf2-485858bbaa67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_4d9437ff-f5f4-44dd-930a-4e4bbdbbfe02" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_77e0b2fc-880a-4197-9cf2-485858bbaa67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_72af9a0a-bf52-43fe-9730-0534ffc7dda3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_be003ef2-7b64-4de1-9834-04e83c9dd381" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_72af9a0a-bf52-43fe-9730-0534ffc7dda3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_7fbdfc4e-c959-470e-89f1-78b1ab7fdca1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_72af9a0a-bf52-43fe-9730-0534ffc7dda3" xlink:to="loc_us-gaap_OperatingIncomeLoss_7fbdfc4e-c959-470e-89f1-78b1ab7fdca1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_16f1aeed-cf22-447f-bfeb-9c82165f105f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_72af9a0a-bf52-43fe-9730-0534ffc7dda3" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_16f1aeed-cf22-447f-bfeb-9c82165f105f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_8e5df85c-a500-493c-96d9-f7083465e819" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_16f1aeed-cf22-447f-bfeb-9c82165f105f" xlink:to="loc_us-gaap_CostsAndExpenses_8e5df85c-a500-493c-96d9-f7083465e819" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonrecurringIncomeExpense_87d8a5c3-0434-4623-a6e2-31f8d6e96539" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonrecurringIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_16f1aeed-cf22-447f-bfeb-9c82165f105f" xlink:to="loc_us-gaap_OtherNonrecurringIncomeExpense_87d8a5c3-0434-4623-a6e2-31f8d6e96539" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_6eef149f-fa4a-4494-a46b-5946f315328e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_16f1aeed-cf22-447f-bfeb-9c82165f105f" xlink:to="loc_us-gaap_LitigationSettlementExpense_6eef149f-fa4a-4494-a46b-5946f315328e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_c006659d-6b1f-4e1f-8cfd-764fda4ae820" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_16f1aeed-cf22-447f-bfeb-9c82165f105f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_c006659d-6b1f-4e1f-8cfd-764fda4ae820" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_258f7833-4706-43de-adea-2dd45524d3f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_16f1aeed-cf22-447f-bfeb-9c82165f105f" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_258f7833-4706-43de-adea-2dd45524d3f6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_b104c86f-f3e0-4a69-b01f-6417cbebe639" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_16f1aeed-cf22-447f-bfeb-9c82165f105f" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_b104c86f-f3e0-4a69-b01f-6417cbebe639" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3923cf95-dbbd-4e56-94c1-1baac665e385" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_72af9a0a-bf52-43fe-9730-0534ffc7dda3" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3923cf95-dbbd-4e56-94c1-1baac665e385" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_92dfefa5-4bc0-4173-b572-b7ff74707619" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_27c7bc65-94f4-4224-a1be-2ee9d3fe961c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_92dfefa5-4bc0-4173-b572-b7ff74707619" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_27c7bc65-94f4-4224-a1be-2ee9d3fe961c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_0625ac2b-09a1-4e4d-ab51-f4ecbf75edcb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_27c7bc65-94f4-4224-a1be-2ee9d3fe961c" xlink:to="loc_srt_StatementGeographicalAxis_0625ac2b-09a1-4e4d-ab51-f4ecbf75edcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0625ac2b-09a1-4e4d-ab51-f4ecbf75edcb_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_0625ac2b-09a1-4e4d-ab51-f4ecbf75edcb" xlink:to="loc_srt_SegmentGeographicalDomain_0625ac2b-09a1-4e4d-ab51-f4ecbf75edcb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_5a9eb310-1616-4f52-a02a-3d967912249c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_0625ac2b-09a1-4e4d-ab51-f4ecbf75edcb" xlink:to="loc_srt_SegmentGeographicalDomain_5a9eb310-1616-4f52-a02a-3d967912249c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_4d134e62-9ecf-4ce2-982e-dae6bd8ebc38" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_5a9eb310-1616-4f52-a02a-3d967912249c" xlink:to="loc_country_US_4d134e62-9ecf-4ce2-982e-dae6bd8ebc38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_0c66b4d7-c136-4d2c-9371-d2e6f5ffc249" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_5a9eb310-1616-4f52-a02a-3d967912249c" xlink:to="loc_srt_EuropeMember_0c66b4d7-c136-4d2c-9371-d2e6f5ffc249" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP_27df9228-10d6-4ac3-9972-60ed8a2ac075" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_JP"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_5a9eb310-1616-4f52-a02a-3d967912249c" xlink:to="loc_country_JP_27df9228-10d6-4ac3-9972-60ed8a2ac075" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_RestOfWorldMember_9ba0244d-4480-4b78-934a-07c7a9984eb2" xlink:href="ew-20240331.xsd#ew_RestOfWorldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_5a9eb310-1616-4f52-a02a-3d967912249c" xlink:to="loc_ew_RestOfWorldMember_9ba0244d-4480-4b78-934a-07c7a9984eb2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_3e22c50b-92e7-4401-a1c0-3d669351bf86" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_27c7bc65-94f4-4224-a1be-2ee9d3fe961c" xlink:to="loc_srt_ProductOrServiceAxis_3e22c50b-92e7-4401-a1c0-3d669351bf86" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3e22c50b-92e7-4401-a1c0-3d669351bf86_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_3e22c50b-92e7-4401-a1c0-3d669351bf86" xlink:to="loc_srt_ProductsAndServicesDomain_3e22c50b-92e7-4401-a1c0-3d669351bf86_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1b706cc0-ced9-48db-9e5e-f7f0afc606aa" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_3e22c50b-92e7-4401-a1c0-3d669351bf86" xlink:to="loc_srt_ProductsAndServicesDomain_1b706cc0-ced9-48db-9e5e-f7f0afc606aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_TranscatheterAorticValveReplacementMember_13fb3b38-00ac-4f8d-8137-ad92c009eb78" xlink:href="ew-20240331.xsd#ew_TranscatheterAorticValveReplacementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1b706cc0-ced9-48db-9e5e-f7f0afc606aa" xlink:to="loc_ew_TranscatheterAorticValveReplacementMember_13fb3b38-00ac-4f8d-8137-ad92c009eb78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_TranscatheterMitralAndTricuspidTherapiesMember_13c57ee7-43e9-4c60-b8d1-1244220b17d0" xlink:href="ew-20240331.xsd#ew_TranscatheterMitralAndTricuspidTherapiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1b706cc0-ced9-48db-9e5e-f7f0afc606aa" xlink:to="loc_ew_TranscatheterMitralAndTricuspidTherapiesMember_13c57ee7-43e9-4c60-b8d1-1244220b17d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_SurgicalHeartValveTherapyMember_ba6b4dcb-d25a-4a2e-8fa5-c6021a153d13" xlink:href="ew-20240331.xsd#ew_SurgicalHeartValveTherapyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1b706cc0-ced9-48db-9e5e-f7f0afc606aa" xlink:to="loc_ew_SurgicalHeartValveTherapyMember_ba6b4dcb-d25a-4a2e-8fa5-c6021a153d13" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_CriticalCareMember_f4901eeb-c2ba-4e44-9557-5252e1e35c22" xlink:href="ew-20240331.xsd#ew_CriticalCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1b706cc0-ced9-48db-9e5e-f7f0afc606aa" xlink:to="loc_ew_CriticalCareMember_f4901eeb-c2ba-4e44-9557-5252e1e35c22" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_314c192a-b26c-460c-8c51-f64b0931cb31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_92dfefa5-4bc0-4173-b572-b7ff74707619" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_314c192a-b26c-460c-8c51-f64b0931cb31" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccruedAndOtherLiabilitiesCurrent_0fee1c34-3bf0-4bd2-a362-523e0a8fdefa" xlink:href="ew-20240331.xsd#ew_AccruedAndOtherLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="loc_ew_AccruedAndOtherLiabilitiesCurrent_0fee1c34-3bf0-4bd2-a362-523e0a8fdefa" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTypeOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EmployeeAndNonemployeeStockOptionsMember_d017d8e6-5155-4aae-8c25-c6ee0c70cf0e" xlink:href="ew-20240331.xsd#ew_EmployeeAndNonemployeeStockOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ew_EmployeeAndNonemployeeStockOptionsMember_d017d8e6-5155-4aae-8c25-c6ee0c70cf0e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockMember" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#IndividualsOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MichaelA.MussallemMember_bff04dd2-6f98-4aa3-b978-ece3dbc9b095" xlink:href="ew-20240331.xsd#ew_MichaelA.MussallemMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ew_MichaelA.MussallemMember_bff04dd2-6f98-4aa3-b978-ece3dbc9b095" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_ScottB.UllemMember_2256f6a4-a941-4cb4-baa8-637438f024f7" xlink:href="ew-20240331.xsd#ew_ScottB.UllemMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ew_ScottB.UllemMember_2256f6a4-a941-4cb4-baa8-637438f024f7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_BernardJ.ZovighianMember_3557af9d-b2a4-46ed-91e3-8030294a5ea1" xlink:href="ew-20240331.xsd#ew_BernardJ.ZovighianMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ew_BernardJ.ZovighianMember_3557af9d-b2a4-46ed-91e3-8030294a5ea1" xlink:type="arc" order="4"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>ew-20240331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:1b5f1024-67d5-4c23-ba5b-277a92b54967,g:71cdffb8-b576-4b3a-8b78-825fbaff5436-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions_ee3947d7-9c42-4f11-ae27-8d86862d8ead_negatedTerseLabel_en-US" xlink:label="lab_ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Business combination, net of cash</link:label>
    <link:label id="lab_ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions_label_en-US" xlink:label="lab_ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments To Acquire Businesses, Net Of Cash Acquired, Excluding Options</link:label>
    <link:label id="lab_ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions_documentation_en-US" xlink:label="lab_ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payments To Acquire Businesses, Net Of Cash Acquired, Excluding Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions" xlink:href="ew-20240331.xsd#ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions" xlink:to="lab_ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_e7479be5-59f1-41d9-9d4c-f9407a966a3d_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_cd08f7ff-6df6-41d2-86d5-7cd0072d9c5d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in fair value</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1d2d9e50-8894-4fc3-bd6b-e922702b4ae6_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss attributable to noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax_8f95b236-d5c9-426d-9af5-3cce0867776d_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Amount excluded from effectiveness testing recognized in earnings based on an amortization approach</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_81fbba2e-fbd1-4a5c-8473-7ebe8798db6f_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss_453273fd-42b4-4b65-a6bb-c6ec46c467cd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimate of additional tax owed</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Examination, Estimate of Possible Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss" xlink:to="lab_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_81a39ce6-fed2-4368-aa7c-bf4c648fec67_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_42bf216e-1cb1-458d-bd36-567ee99e1a6f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_170e2df0-8712-4b7c-a35d-5370fbad8438_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_AccruedRelocationCostsCurrent_7b1b5670-ec6e-4024-8b9b-3482e91fa655_terseLabel_en-US" xlink:label="lab_ew_AccruedRelocationCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued relocation costs</link:label>
    <link:label id="lab_ew_AccruedRelocationCostsCurrent_label_en-US" xlink:label="lab_ew_AccruedRelocationCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Relocation Costs, Current</link:label>
    <link:label id="lab_ew_AccruedRelocationCostsCurrent_documentation_en-US" xlink:label="lab_ew_AccruedRelocationCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Relocation Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccruedRelocationCostsCurrent" xlink:href="ew-20240331.xsd#ew_AccruedRelocationCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_AccruedRelocationCostsCurrent" xlink:to="lab_ew_AccruedRelocationCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_d0fa632c-f2af-450e-8846-423f427b32ad_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt and Equity Securities, FV-NI [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt and Equity Securities, FV-NI [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:to="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserveNoncurrent_157c983c-7070-488c-b94c-03a9a4134f20_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation settlement accrual</link:label>
    <link:label id="lab_us-gaap_LitigationReserveNoncurrent_label_en-US" xlink:label="lab_us-gaap_LitigationReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Estimated Litigation Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserveNoncurrent" xlink:to="lab_us-gaap_LitigationReserveNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_d1f2ab6f-b3fd-49ec-ad5f-9afd3800b78c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffsettingAssetsTable_d1e1cfec-6066-47d1-a3b9-9d2ff3e993ef_terseLabel_en-US" xlink:label="lab_us-gaap_OffsettingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Offsetting Assets [Table]</link:label>
    <link:label id="lab_us-gaap_OffsettingAssetsTable_label_en-US" xlink:label="lab_us-gaap_OffsettingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Offsetting Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffsettingAssetsTable" xlink:to="lab_us-gaap_OffsettingAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e3108d59-2d65-4c89-91a4-ebb45ec8404e_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_3f5dc57a-0fb8-4ecd-9084-f0f60f2aca9c_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7538e373-0efa-47b1-864a-ccbe7508169a_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract_b33c6b30-0f74-477d-bd44-3ce7400010ea_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Held-to-Maturity</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Held-to-Maturity, Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_7ac1ae59-a260-4926-b9a5-ad2e7fd924b3_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_59f5d3c8-bf3f-4d51-aa4c-4e5a3855c6d2_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_f26147ef-2005-449a-9d98-ed81a206edc2_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Instruments not due at a single maturity date</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3028a88e-3a4f-4cbd-b37b-a56c26fa7bb3_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_19a4d93c-2552-466a-a441-dab530de14ab_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_d12f319f-1f4f-4c18-950a-0ab007644d77_verboseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_8f92c439-901e-4d23-8ad6-6a4b1cc802e5_netLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_b08f3104-3405-4859-9530-0eb100888745_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-operating income</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_EmployeeAndNonemployeeStockOptionsMember_b9f31383-5868-408c-9b06-e367fd538ece_verboseLabel_en-US" xlink:label="lab_ew_EmployeeAndNonemployeeStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">&#160;Option Awards</link:label>
    <link:label id="lab_ew_EmployeeAndNonemployeeStockOptionsMember_label_en-US" xlink:label="lab_ew_EmployeeAndNonemployeeStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee and Nonemployee Stock Options [Member]</link:label>
    <link:label id="lab_ew_EmployeeAndNonemployeeStockOptionsMember_documentation_en-US" xlink:label="lab_ew_EmployeeAndNonemployeeStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">An arrangement whereby an employee or nonemployee (including a member of the entity's Board of Directors) is entitled to receive in the future, subject to vesting and other restrictions, a number of shares in the entity at a specified price, as defined in the agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EmployeeAndNonemployeeStockOptionsMember" xlink:href="ew-20240331.xsd#ew_EmployeeAndNonemployeeStockOptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_EmployeeAndNonemployeeStockOptionsMember" xlink:to="lab_ew_EmployeeAndNonemployeeStockOptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_f1d5be6c-9d9f-4ef6-85bc-39686db73461_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies (Note&#160;11)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_NumberOfAdvancePricingAgreementsRenewed_be1a2102-131f-4aea-b2e6-07f5ae5724c2_terseLabel_en-US" xlink:label="lab_ew_NumberOfAdvancePricingAgreementsRenewed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of APAs renewed</link:label>
    <link:label id="lab_ew_NumberOfAdvancePricingAgreementsRenewed_label_en-US" xlink:label="lab_ew_NumberOfAdvancePricingAgreementsRenewed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Advance Pricing Agreements Renewed</link:label>
    <link:label id="lab_ew_NumberOfAdvancePricingAgreementsRenewed_documentation_en-US" xlink:label="lab_ew_NumberOfAdvancePricingAgreementsRenewed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Advance Pricing Agreements Renewed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_NumberOfAdvancePricingAgreementsRenewed" xlink:href="ew-20240331.xsd#ew_NumberOfAdvancePricingAgreementsRenewed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_NumberOfAdvancePricingAgreementsRenewed" xlink:to="lab_ew_NumberOfAdvancePricingAgreementsRenewed" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_dc3d7dce-3a55-4b15-9889-444bc3062af5_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ACCELERATED SHARE REPURCHASE</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_e86c3c70-51d4-40b5-851a-19d95e9638eb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Enterprise-Wide Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_a7a53fb3-96f8-45db-9c43-d36bf936c332_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_01106af7-04fd-4aee-a894-11c9c43a3f84_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from stock plans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Stock Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockPlans" xlink:to="lab_us-gaap_ProceedsFromStockPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_d319e758-18b5-48fa-bdd4-137f528bc485_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_1df3cd4d-21f6-4676-893d-12e0f6eff491_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_f3360a5b-ce7f-4efc-9ade-7012abd96759_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock_58b96084-e09f-4547-b905-aea1f30f6c51_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEPARATION COSTS</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unusual or Infrequent Items, or Both, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock" xlink:to="lab_us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_7a0f8e1a-cc60-464f-9787-e5ff90b2912e_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract_44860dfa-1c1a-430e-98e1-0d7a74fca8b1_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain (loss) on fair value hedging relationships:</link:label>
    <link:label id="lab_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Fair Value Hedges on Results of Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract" xlink:to="lab_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_65d3b6b0-442d-4827-9b0f-ef1371d8dfd4_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_22250fc9-3daf-430e-b92f-e1c0273858ef_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6964d0e9-8488-4ba9-895b-91284bca8ed0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNetAbstract_400532c9-4ed2-4b4e-8ba8-e87dadff8f37_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNetAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNetAbstract" xlink:to="lab_us-gaap_InventoryNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_8f4368e6-b0c8-40d8-9d10-2bbf53d1af59_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireReceivables_218506f3-98a5-4b47-8450-38ba895c39a8_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Issuances of notes receivable</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireReceivables_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireReceivables" xlink:to="lab_us-gaap_PaymentsToAcquireReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_089da166-e064-482b-874a-1db81987335e_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_31ff5e52-ebb4-4817-91cf-ad3ed43a850a_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Diluted earnings per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_7455c20f-6744-4a7d-a0b8-8fecd37cf38b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross Amounts</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Liability, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_80dc2970-8f61-4827-beef-f9aec137e1d1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_540a731f-caf2-4eba-b702-800b60f7c475_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, net of allowances of $13.5 and $8.3, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_9627ae4d-1ee8-480e-9389-37c0cb4d9c36_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount of gain (loss) reclassified from accumulated OCI into income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_49051d01-c926-4937-94e8-9a4d72fdc6d1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_a215cfe4-61d2-4166-9084-7d1d24d36f04_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_b182e060-f257-462d-bc06-532b423232a8_periodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_7768f02d-2d50-4734-b40e-f98b8511f567_periodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_8bf08e67-2214-4051-a1d6-722d547c62f9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:to="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_01a353ce-ba89-4603-ad2f-1a9b1f32b101_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_084bc129-ceb1-4deb-8a54-7ad4f2515712_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a6f6d481-36cb-41aa-bc38-a38ec99ff393_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value, per option/share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_80f41616-d316-4f81-9cf8-ab174987c697_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net income attributable to Edwards Lifesciences Corporation</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Income (Loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_ea2922b7-be86-4381-bce8-0892ba2380bf_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Due in 1&#160;year or less</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Held-to-Maturity, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_91a87905-b15c-4cf7-a949-3028bfc3b5d1_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_af3049d6-6730-40a9-a39c-33cb092e90ce_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_2cc6370e-f03a-45e4-b1e1-5bb56b129978_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_e38a3aa4-895f-4176-9e2c-47f5df2fe149_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_ef3876cd-176f-4341-aaad-454ee121bd3b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fe37450e-44c0-4923-ada1-3bf7ea880dbb_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_f32c8857-5672-417a-8427-5f57cd60b288_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">&#160;ESPP</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_37b979cd-7a01-46ce-99b0-801c1cfd818a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_20ce71c8-8838-47d2-9cbe-cb4ee784288a_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">INVESTMENTS</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_feba9976-5ae3-4d5d-970e-c8bd02aba59e_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent_bd6c6389-5407-4c7e-af0d-a5a9f9151e95_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Miscellaneous, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:to="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_1ba98294-7a5d-450f-b863-18e0836e1dc2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_MeasurementInputProbabilityOfMilestoneAchievementMember_69e722d6-5b3e-4d0f-9d13-993fcbe29d76_terseLabel_en-US" xlink:label="lab_ew_MeasurementInputProbabilityOfMilestoneAchievementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Probability of Milestone Achievement</link:label>
    <link:label id="lab_ew_MeasurementInputProbabilityOfMilestoneAchievementMember_label_en-US" xlink:label="lab_ew_MeasurementInputProbabilityOfMilestoneAchievementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Probability Of Milestone Achievement [Member]</link:label>
    <link:label id="lab_ew_MeasurementInputProbabilityOfMilestoneAchievementMember_documentation_en-US" xlink:label="lab_ew_MeasurementInputProbabilityOfMilestoneAchievementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Measurement Input, Probability Of Milestone Achievement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MeasurementInputProbabilityOfMilestoneAchievementMember" xlink:href="ew-20240331.xsd#ew_MeasurementInputProbabilityOfMilestoneAchievementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_MeasurementInputProbabilityOfMilestoneAchievementMember" xlink:to="lab_ew_MeasurementInputProbabilityOfMilestoneAchievementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsAbstract_cc0b30b6-0cc4-44b6-ad3d-d0a59fa529fb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_OtherAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsAbstract" xlink:to="lab_us-gaap_OtherAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_20595779-b8d1-4f2e-a256-a546d918086a_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Affected Line on Consolidated Condensed Statements of Operations</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_a9dec48e-e7dc-4d29-bb5c-c500be1dffd6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Computation of Basic and Diluted Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_e2959b9d-6a5c-49bd-babb-da651c80eb2d_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_db7f9e91-40a4-4159-a1b1-701c3271e516_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_0eb40a53-9276-4ac6-ae3e-366d78dbc636_negatedLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_859b17de-4c48-4e3d-bbf7-b1a123febc9b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_1fdc5247-2fd6-449c-a0af-9272350ca616_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Liability, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Liability, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:to="lab_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_beefe4bc-39b0-4de0-80d1-3a5b168faaa3_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_55d22625-2ef7-4e1b-b8af-ffc1f8e2b40d_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_ceb9ce46-44a0-485c-b449-f0b356a3f298_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_IncreaseDecreaseInLegalSettlementAccrual_cf943a73-59d5-4c4e-acf2-3edc97b4c2ab_terseLabel_en-US" xlink:label="lab_ew_IncreaseDecreaseInLegalSettlementAccrual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intellectual property agreement accrual</link:label>
    <link:label id="lab_ew_IncreaseDecreaseInLegalSettlementAccrual_label_en-US" xlink:label="lab_ew_IncreaseDecreaseInLegalSettlementAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Legal Settlement Accrual</link:label>
    <link:label id="lab_ew_IncreaseDecreaseInLegalSettlementAccrual_documentation_en-US" xlink:label="lab_ew_IncreaseDecreaseInLegalSettlementAccrual" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Legal Settlement Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_IncreaseDecreaseInLegalSettlementAccrual" xlink:href="ew-20240331.xsd#ew_IncreaseDecreaseInLegalSettlementAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_IncreaseDecreaseInLegalSettlementAccrual" xlink:to="lab_ew_IncreaseDecreaseInLegalSettlementAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_d3d63e38-c496-4030-acbf-b16647e05c71_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_02f03aed-7cf0-4c92-9323-84770f48f61d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4cab186f-8b5a-425b-b2c8-6dc2188c5591_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_c199260c-669d-4c41-90a7-4bb921af7137_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_EquitySecuritiesFVNIMaximumAdditionalRequired_a01ac9d1-4a5c-49d8-8f0c-4951e45e7e25_terseLabel_en-US" xlink:label="lab_ew_EquitySecuritiesFVNIMaximumAdditionalRequired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum additional required investment</link:label>
    <link:label id="lab_ew_EquitySecuritiesFVNIMaximumAdditionalRequired_label_en-US" xlink:label="lab_ew_EquitySecuritiesFVNIMaximumAdditionalRequired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Securities, FV-NI, Maximum Additional Required</link:label>
    <link:label id="lab_ew_EquitySecuritiesFVNIMaximumAdditionalRequired_documentation_en-US" xlink:label="lab_ew_EquitySecuritiesFVNIMaximumAdditionalRequired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Equity Securities, FV-NI, Maximum Additional Required</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquitySecuritiesFVNIMaximumAdditionalRequired" xlink:href="ew-20240331.xsd#ew_EquitySecuritiesFVNIMaximumAdditionalRequired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_EquitySecuritiesFVNIMaximumAdditionalRequired" xlink:to="lab_ew_EquitySecuritiesFVNIMaximumAdditionalRequired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_b461245b-18cc-42e8-8b70-82e697c6db89_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_a1f6327a-c3a7-4b70-b0ee-bcc456a85064_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_2e726da3-6a69-410e-80aa-537f1313a97b_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ACCUMULATED OTHER COMPREHENSIVE LOSS</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_1a9ddd6d-d1cb-43d7-ba28-0e9cd3d103a9_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_cf95a274-4b4b-4beb-ba20-84c981334cce_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_f23a1cf0-837d-4c42-808a-cfc78f017e33_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling, general, and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_4f8f405b-708a-47da-b33f-e4f2d4f583ac_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_f72b8604-2b9a-4788-8db9-0fe5c06a42d0_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Derivative liability, fair value</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_0d2e9988-590f-42ed-8d21-618f65d574d1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized gain on available-for-sale investments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_ed2387ad-cfb7-492f-89cb-346ee9ad6cd5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_0f7088b5-353e-4737-bcc5-220ba9a88b0c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_c0497175-8a86-41a2-b396-367f889d0c00_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_8c2ec95f-e1a9-49b2-bede-6da4b5d39418_negatedLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification from AOCI, Current Period, before Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_bb414e7d-96e7-47e8-8d4e-daefdb709746_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_c0b400fb-bf5c-4d78-8f75-1a5ffb00f57f_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Tax benefit from employee share-based compensation</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract_77ed7a2c-3b2c-4ca3-b803-061569e9b65b_terseLabel_en-US" xlink:label="lab_ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross Amounts Not Offset in the Consolidated Balance Sheet</link:label>
    <link:label id="lab_ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract_label_en-US" xlink:label="lab_ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Fair Value of Derivative Liability Gross Amounts Not Offset [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract" xlink:href="ew-20240331.xsd#ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract" xlink:to="lab_ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_641774ca-79b1-4082-b576-fe53a8040b77_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Foreign Exchange Contracts, Statement of Financial Position [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_RestOfWorldSegmentMember_f3d7cc34-dd0c-4727-b008-34ca6141e600_terseLabel_en-US" xlink:label="lab_ew_RestOfWorldSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rest of World</link:label>
    <link:label id="lab_ew_RestOfWorldSegmentMember_label_en-US" xlink:label="lab_ew_RestOfWorldSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rest of World Segment [Member]</link:label>
    <link:label id="lab_ew_RestOfWorldSegmentMember_documentation_en-US" xlink:label="lab_ew_RestOfWorldSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the reportable segment of the entity comprised of regions other than the United States, Europe and Japan (Rest of World).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_RestOfWorldSegmentMember" xlink:href="ew-20240331.xsd#ew_RestOfWorldSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_RestOfWorldSegmentMember" xlink:to="lab_ew_RestOfWorldSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8d572b10-00c6-4f3e-b470-1ec8a53553e7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_9747331b-f984-442b-8bfa-db3f3cf822ac_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_b94bc886-2070-4236-89cf-942c36ae8721_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_7b5840ea-90ee-42c1-8384-95538140b0e7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_00265b93-4836-4984-87fc-37b27b8e4231_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes to noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:to="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_ed6d2cb7-29ea-4dea-b852-f35ad9610ef9_totalLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stock-based compensation expense, net of tax</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_fa2b0ae7-8225-430e-ae6a-8ca3f7a3b362_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency forward exchange contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_TranscatheterMitralAndTricuspidTherapiesMember_051e566e-7f51-4635-b78c-9b0bf489019c_terseLabel_en-US" xlink:label="lab_ew_TranscatheterMitralAndTricuspidTherapiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transcatheter Mitral and Tricuspid Therapies</link:label>
    <link:label id="lab_ew_TranscatheterMitralAndTricuspidTherapiesMember_label_en-US" xlink:label="lab_ew_TranscatheterMitralAndTricuspidTherapiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Transcatheter Mitral And Tricuspid Therapies [Member]</link:label>
    <link:label id="lab_ew_TranscatheterMitralAndTricuspidTherapiesMember_documentation_en-US" xlink:label="lab_ew_TranscatheterMitralAndTricuspidTherapiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Transcatheter Mitral And Tricuspid Therapies [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_TranscatheterMitralAndTricuspidTherapiesMember" xlink:href="ew-20240331.xsd#ew_TranscatheterMitralAndTricuspidTherapiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_TranscatheterMitralAndTricuspidTherapiesMember" xlink:to="lab_ew_TranscatheterMitralAndTricuspidTherapiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_f280af1c-2f86-4a6b-84f1-b1d019f8eb24_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_08fccd44-d65e-4acb-b9f1-2c04ea8e7e7a_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_db4c3009-9964-484b-9b6b-277b061e39af_terseLabel_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued and other liabilities</link:label>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_5efb4f92-c137-445d-b997-56b7539ab0c2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_00432cbb-84d7-449c-8a74-fdeb0f2c1303_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_27305753-197c-4541-8b1c-411b7d1bcd57_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accrued and Other Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeCollateralRightToReclaimCash_fbd5c0d1-9d8f-4d18-b357-cdac45c3fc6e_negatedLabel_en-US" xlink:label="lab_us-gaap_DerivativeCollateralRightToReclaimCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Cash Collateral Received</link:label>
    <link:label id="lab_us-gaap_DerivativeCollateralRightToReclaimCash_label_en-US" xlink:label="lab_us-gaap_DerivativeCollateralRightToReclaimCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Liability, Subject to Master Netting Arrangement, Collateral, Right to Reclaim Cash Not Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralRightToReclaimCash" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeCollateralRightToReclaimCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeCollateralRightToReclaimCash" xlink:to="lab_us-gaap_DerivativeCollateralRightToReclaimCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_0078412a-b411-4915-9a2f-72973b5dc0d5_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_9eac3e7a-3254-4093-b59e-b8c94acfa5a2_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableFairValueDisclosure_3d719bac-65fd-4563-8b35-41859f31144c_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes payable fair value disclosure</link:label>
    <link:label id="lab_us-gaap_NotesPayableFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_NotesPayableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Payable, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableFairValueDisclosure" xlink:to="lab_us-gaap_NotesPayableFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_9dd34e30-ed09-48ff-91ed-900a563b326e_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Anti-dilutive securities excluded from the computation of earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_d03059aa-0361-4616-a01c-d751c629095d_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f0a335ac-0fa5-4fd8-9e81-e9e8748e9bc2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_6fa33898-510f-49a5-b65c-2ae469a6b303_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_8df55df1-ddbf-48c4-9f99-3fa381a705d9_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capital expenditures accruals</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_84b2ab21-72af-466f-987c-e8399d090206_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_21e5dea1-fe6e-4194-9546-df27df425559_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_8df23aae-c9bb-4c96-bb5a-75c40d2be2a4_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right-of-use assets obtained in exchange for new lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_09fa03b4-e1b8-4be5-893c-6954c27731b2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_4d5a5e81-ab13-44ff-952b-31798a701e69_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration liability measurement input</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_d39030ed-24a3-4bba-ab08-f7ec57a6a949_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_40257c28-c0d1-4958-af4e-e9339da2d394_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivatives designated as hedging instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAbstract_76251e8d-85a7-46fb-9865-7e3171abe926_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Available-for-sale</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_31adf8e7-a20b-4042-95fd-f3005edcd228_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_114a95b8-d407-4761-91a5-3263214d0627_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_aef76618-8e76-4f69-81e8-a09b307526b4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffsettingDerivativeLiabilitiesAbstract_06e43f39-5692-443e-8cc5-2801a16acb1b_terseLabel_en-US" xlink:label="lab_us-gaap_OffsettingDerivativeLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative liabilities</link:label>
    <link:label id="lab_us-gaap_OffsettingDerivativeLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_OffsettingDerivativeLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Offsetting Derivative Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingDerivativeLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingDerivativeLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffsettingDerivativeLiabilitiesAbstract" xlink:to="lab_us-gaap_OffsettingDerivativeLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_05891b79-9ab4-48c9-9691-620f2321258c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_4747ed22-44ad-4124-a098-619184021947_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_b55b791d-a6cb-4ed3-811c-effdd4818cb1_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized Loss on Available-for-sale Investments</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_6446cb4b-0194-441e-8a2a-304ccfa55615_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Loss on available-for-sale investments</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_eb78e9d8-0ceb-42f0-8a97-e497137321db_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:to="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent_be13c0eb-6d6f-445a-9694-529f39eb04a4_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued warranties</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product Warranty Accrual, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:to="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_20f533f9-b6e8-4901-b507-1552980f0bfa_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_45573a6c-3d7f-4171-b939-ddd651caba93_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from available-for-sale investments (Note 5)</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_21671f54-4524-4aca-b0ee-930606b39539_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermInvestments_4310dd64-9cab-4a31-9afa-09ad813762ee_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term investments (Note&#160;5)</link:label>
    <link:label id="lab_us-gaap_LongTermInvestments_label_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermInvestments" xlink:to="lab_us-gaap_LongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_bb857e1e-3232-4a21-b9ec-597f1d4203cb_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recently Adopted Accounting Standards and New Accounting Standards Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffsettingLiabilitiesTableTextBlock_fdee0a4e-e77c-4874-851a-792266f7b670_terseLabel_en-US" xlink:label="lab_us-gaap_OffsettingLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Liabilities</link:label>
    <link:label id="lab_us-gaap_OffsettingLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OffsettingLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Offsetting Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffsettingLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OffsettingLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_0e068aa8-e9de-4671-8afe-410a7fd2b5ea_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_b30ecc9b-befb-40d3-a97a-73bf09180f60_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9a638a06-da6d-40a3-a722-dffe7d1c13a6_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents, and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7bdefc0d-69ba-40cd-bb11-1d17bd30a06a_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents, and restricted cash at end of period (Note 2)</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f843ed2c-beae-4c21-9061-9a727e307b31_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_571a9e75-232d-4472-abe0-bd0074f99bee_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value, 12 months or greater</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_3bbec8ec-e5e4-4c64-a560-d1063177a2d4_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_542d84a0-bb92-4751-a289-8111c8ba1931_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_6c70e79b-e2ea-42d5-80f2-a9739b450246_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Investments in Debt Securities</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrealized Gain (Loss) on Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_ede967ae-a459-48c8-955b-a8c54866acb1_negatedLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Held-to-Maturity, Accumulated Unrecognized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_069b1249-1bfc-44e8-96c3-b740123cf8f3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Weighted-Average Assumptions for Options Granted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_bc183851-67bd-4010-9c9b-2bd1209a7d09_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, at cost, 49.4 and 49.4 shares, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue" xlink:to="lab_us-gaap_TreasuryStockCommonValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_d4fb0d84-14e5-4461-b48c-072e91901aa0_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_1e31f4be-d2c2-44a3-ab29-3fe963c484c7_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_40385c68-b1ab-4ee3-85e9-f1d100dafa1e_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Gross unrealized losses, total</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_e4172131-17e7-4f0a-9b1a-48886e9ff306_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling, general, and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_85f6a74e-c558-4d4d-a97f-9116febba3d9_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive loss (Note 12)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_cd63078e-6e35-4415-a251-d504567d7ee5_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Currency Translation Adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_292dd78d-fd7e-4e62-aad2-18669327b638_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_1c8473be-c307-4ae1-bc08-d3ddfd649a8f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount_7c05601e-3fcc-45a1-aa9c-705c0bf13b8d_terseLabel_en-US" xlink:label="lab_ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Value of Shares as % of Contract Value</link:label>
    <link:label id="lab_ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount_label_en-US" xlink:label="lab_ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accelerated Share Repurchases, Value Of Shares Repurchased As Percentage Of Contract Amount</link:label>
    <link:label id="lab_ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount_documentation_en-US" xlink:label="lab_ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the value of the initial shares repurchased as a percentage of the contract amount under accelerated share repurchase agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount" xlink:href="ew-20240331.xsd#ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount" xlink:to="lab_ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_4e80a55b-e56a-4a4f-9e01-d06ee22190ee_negatedLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Liability, Subject to Master Netting Arrangement, Deduction of Financial Instrument Not Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction" xlink:to="lab_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_6860f732-24bc-4efa-99e3-395653086504_negatedLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Corporate items</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_517c53e4-ad08-451e-892b-4f6d50989105_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized compensation cost, recognition period</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_f721fe4c-100f-4486-9b2f-736abec58709_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_d90d4b75-4eb6-4cec-bc05-58f10a35bee7_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive income attributable to Edwards Lifesciences Corporation</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_78e54d9e-cf4f-44a9-b008-eb98ca07e5d3_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total remaining unrecognized compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_5ab68a70-e7b6-486e-a0a3-493350da5545_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_cc792375-0009-433b-85b0-5f964f9a6f62_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber_c65efc57-7ebe-4cab-8c6b-608ddf378b44_terseLabel_en-US" xlink:label="lab_ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of lawsuits that if settled could have a material adverse impact on net income or cash flows</link:label>
    <link:label id="lab_ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber_label_en-US" xlink:label="lab_ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Claims That If Settled Could Have A Material Adverse Impact, Number</link:label>
    <link:label id="lab_ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber_documentation_en-US" xlink:label="lab_ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingency, Claims That If Settled Could Have A Material Adverse Impact, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber" xlink:href="ew-20240331.xsd#ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber" xlink:to="lab_ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrencySwapMember_adfe56c0-ce6d-4793-97c5-083909115627_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cross-currency swap contracts</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_f327f78f-e5e3-4a83-8f60-e730d98e3cdb_terseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cross-currency swap contracts</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_label_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrencySwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrencySwapMember" xlink:to="lab_us-gaap_CurrencySwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_70bd9c7c-f430-44e5-bed2-c8f7cb612b0a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_8231147e-0509-4094-b474-e71bbdf46686_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchases of treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_ea46abcc-ec59-4531-8701-31a0359fe964_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_b121624a-88d3-4ce8-bd6b-f878f9bd3477_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Held-to-Maturity, Accumulated Unrecognized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesCurrent_50871d02-bf3e-48ff-a390-3f43bb33380e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesCurrent" xlink:to="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_55ba4f03-6acb-4e6a-9ea8-eddf0fdc154f_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">STOCK-BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ba0e792b-6e9d-4807-befa-1b052061ab3b_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_1c320dca-e1fe-4344-a6b7-0ecbdb912ade_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_333869e1-ce5d-4526-927a-859dc07caa25_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchases of available-for-sale investments (Note 5)</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bc3ad8d1-e39e-4a34-9c58-74a68f8722e8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4a9da3cf-3cb1-46a6-9f1c-9df6913517f2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial instruments</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_NewMarketsTaxCreditMember_4c5007d4-8a68-4c7e-a12c-e378263a0f31_terseLabel_en-US" xlink:label="lab_ew_NewMarketsTaxCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Markets Tax Credit</link:label>
    <link:label id="lab_ew_NewMarketsTaxCreditMember_label_en-US" xlink:label="lab_ew_NewMarketsTaxCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Markets Tax Credit [Member]</link:label>
    <link:label id="lab_ew_NewMarketsTaxCreditMember_documentation_en-US" xlink:label="lab_ew_NewMarketsTaxCreditMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">New Markets Tax Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_NewMarketsTaxCreditMember" xlink:href="ew-20240331.xsd#ew_NewMarketsTaxCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_NewMarketsTaxCreditMember" xlink:to="lab_ew_NewMarketsTaxCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_587cda81-18eb-454d-965e-763b39579fac_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_5bf70369-1022-434c-a734-dfba601274bf_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_85152290-a457-40e6-ab53-ce8eeb8a8e81_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash included in other assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_9e2915a8-a289-4590-9fe7-d1f210a0be0b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from held-to-maturity investments (Note 5)</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale and Maturity of Held-to-Maturity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9da9106f-6e02-4029-910b-8f49115e02f4_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_fc5916a3-96a0-42b6-9755-a2eac821d5e1_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Final settlement per share price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accelerated Share Repurchases, Final Price Paid Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonrecurringIncomeExpense_46862682-0850-40bb-bf53-50e91775f58c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonrecurringIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Separation costs (Note&#160;4)</link:label>
    <link:label id="lab_us-gaap_OtherNonrecurringIncomeExpense_dcfb6aa9-6368-42ce-b914-f029125531f3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonrecurringIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Separation costs (Note&#160;4)</link:label>
    <link:label id="lab_us-gaap_OtherNonrecurringIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonrecurringIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonrecurring (Income) Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonrecurringIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonrecurringIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonrecurringIncomeExpense" xlink:to="lab_us-gaap_OtherNonrecurringIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_c466c662-3ac5-47f3-8738-de9ac8dd67a1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_20c6c8b0-92fd-4ed5-aba1-62ef5f1dc513_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_1b3924a6-f1bb-4fac-b946-f5394f270ba1_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6e9411ea-8aba-44d7-a913-71c9355b363e_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_be9d6a4a-00e6-4de2-8170-8cdc1f3fee12_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_d0d7215d-bd96-46aa-bca7-6faf8800a736_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_001caaf0-df12-46f0-8438-3df58d638a82_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair value of derivative liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_697d4a64-c43b-4c0b-994f-41c85a024cce_totalLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net Amounts Presented in the Consolidated Balance Sheet</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReceivable_dec3d377-cb1a-4c5a-af4d-86e1adf73888_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReceivable" xlink:to="lab_us-gaap_IncomeTaxReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_561a3f6b-441b-4e3a-bd23-8c84577e755f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_label_en-US" xlink:label="lab_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:to="lab_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_d5193357-e697-4efd-b1bc-468fdf2e7307_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Instruments not due at a single maturity date</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Held-to-Maturity, Maturity, without Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_78af91a1-3e2f-470f-9993-ff2f52ccf3c9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_8fc0ac80-c8a1-4885-abb2-7cd92b8e9b6e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock issued under stock plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_3aeaf513-4e71-4c6e-88aa-0d1bd45d8a67_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_56da2d76-54bd-454e-9dbd-71de335e4769_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_4eaf8f50-7d46-463d-8b7f-8d338fb712a1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_8da1be47-438d-4ecb-802a-d9f961ae7bd7_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c787c2bb-afc8-4c7e-a819-99119d19ccf5_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_afc669cb-5c55-4077-bcef-51c7cc412ced_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_721d52e7-7b57-48db-8ca8-e7f4a4263310_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Carrying value of equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_bc6810b7-ace5-471e-8f91-10620eaf3009_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventories (Note&#160;2)</link:label>
    <link:label id="lab_us-gaap_InventoryNet_02a03407-35ac-4639-bbe7-9f202992e27b_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_EuropeSegmentMember_5acee177-c0d4-40c0-a5a8-127a4eab501c_terseLabel_en-US" xlink:label="lab_ew_EuropeSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_ew_EuropeSegmentMember_label_en-US" xlink:label="lab_ew_EuropeSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Europe Segment [Member]</link:label>
    <link:label id="lab_ew_EuropeSegmentMember_documentation_en-US" xlink:label="lab_ew_EuropeSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the Europe reportable segment of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EuropeSegmentMember" xlink:href="ew-20240331.xsd#ew_EuropeSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_EuropeSegmentMember" xlink:to="lab_ew_EuropeSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount_20fdff2e-3de6-4a66-8d6f-8d1d17d42328_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Instruments not due at a single maturity date</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, without Single Maturity Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_9d6685c0-d8d6-47cb-aea4-7de4019f3149_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_4a973f51-9705-45ef-9644-4523874caad1_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_b6b7711f-43f4-426a-b005-4061d69ecd84_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_EquityMethodInvestmentsInvestmentPeriod_232e5006-b170-48e8-8aa3-24638f441c8b_terseLabel_en-US" xlink:label="lab_ew_EquityMethodInvestmentsInvestmentPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments taken period</link:label>
    <link:label id="lab_ew_EquityMethodInvestmentsInvestmentPeriod_label_en-US" xlink:label="lab_ew_EquityMethodInvestmentsInvestmentPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investments, Investment Period</link:label>
    <link:label id="lab_ew_EquityMethodInvestmentsInvestmentPeriod_documentation_en-US" xlink:label="lab_ew_EquityMethodInvestmentsInvestmentPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Equity Method Investments, Investment Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquityMethodInvestmentsInvestmentPeriod" xlink:href="ew-20240331.xsd#ew_EquityMethodInvestmentsInvestmentPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_EquityMethodInvestmentsInvestmentPeriod" xlink:to="lab_ew_EquityMethodInvestmentsInvestmentPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_53a7c1c7-45f0-4181-a022-6fc26ad2a9f1_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net income to net cash (used in) provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_UnitedStatesSegmentMember_4ad57b79-8436-4361-a0de-80650264e19d_terseLabel_en-US" xlink:label="lab_ew_UnitedStatesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United States</link:label>
    <link:label id="lab_ew_UnitedStatesSegmentMember_label_en-US" xlink:label="lab_ew_UnitedStatesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">United States Segment [Member]</link:label>
    <link:label id="lab_ew_UnitedStatesSegmentMember_documentation_en-US" xlink:label="lab_ew_UnitedStatesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the United States reportable segment of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_UnitedStatesSegmentMember" xlink:href="ew-20240331.xsd#ew_UnitedStatesSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_UnitedStatesSegmentMember" xlink:to="lab_ew_UnitedStatesSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_6754e69c-e626-431d-9f71-e8d458b7ee5a_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchases of treasury stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_4841dfcd-8c62-4bae-9012-dcf4ff2afec8_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_13f7b2ea-d1d6-4455-a44b-3ab63e401a0b_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Due after 1&#160;year through 5&#160;years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges_0a0373ab-26fd-4a43-8f7b-3b224a3dbf5c_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Special charge</link:label>
    <link:label id="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Costs and Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:to="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_SurgicalHeartValveTherapyMember_7f413924-5025-4748-9a0b-6989260bdd7e_terseLabel_en-US" xlink:label="lab_ew_SurgicalHeartValveTherapyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Surgical Structural Heart</link:label>
    <link:label id="lab_ew_SurgicalHeartValveTherapyMember_label_en-US" xlink:label="lab_ew_SurgicalHeartValveTherapyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Surgical Heart Valve Therapy [Member]</link:label>
    <link:label id="lab_ew_SurgicalHeartValveTherapyMember_documentation_en-US" xlink:label="lab_ew_SurgicalHeartValveTherapyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">This element represents the surgical heart valve therapy product line.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_SurgicalHeartValveTherapyMember" xlink:href="ew-20240331.xsd#ew_SurgicalHeartValveTherapyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_SurgicalHeartValveTherapyMember" xlink:to="lab_ew_SurgicalHeartValveTherapyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_f6364428-92c4-4723-868e-79c2b6990c68_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Due in 1&#160;year or less</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_0ddd98c6-8b34-4bf4-b263-a8f96456cdc3_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash investing and financing transactions:</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_1b12a429-8ef4-45de-aef1-b237a4d5deba_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Edwards Lifesciences Corporation Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_594365f9-b027-4c42-a551-c5ea901d6f8b_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationPlanAssets_8e27a76b-bab7-4541-8306-00193a928549_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments held for deferred compensation plans</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationPlanAssets_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Compensation Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationPlanAssets" xlink:to="lab_us-gaap_DeferredCompensationPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_7f33f056-4977-4f6e-9004-3bbbe9f605a7_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8323ad79-c611-4d0a-a75f-461a127e1f90_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_97669180-b91f-47f7-8391-a587d5a94f24_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_06f3a6ed-e973-4a04-9bc9-7f1ac01941bb_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_8366e514-7ebd-4b8a-a2a0-96c84ba18c4d_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4ad2ddf6-c083-4781-a2f0-4cbf500f0b15_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_14f98a24-435f-4df9-8b12-632481430859_negatedLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, Deduction of Financial Instrument Not Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction" xlink:to="lab_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IsraelTaxAuthorityMember_22cb4080-da0b-4559-8b89-2b3f4e657709_terseLabel_en-US" xlink:label="lab_us-gaap_IsraelTaxAuthorityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Israel Tax Authority</link:label>
    <link:label id="lab_us-gaap_IsraelTaxAuthorityMember_label_en-US" xlink:label="lab_us-gaap_IsraelTaxAuthorityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Israel Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IsraelTaxAuthorityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IsraelTaxAuthorityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IsraelTaxAuthorityMember" xlink:to="lab_us-gaap_IsraelTaxAuthorityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_01107904-829f-4ac4-8d90-577eee9b1bbf_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_38c4df1b-93d8-42a4-b852-91463e8ca8fc_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_JapanSegmentMember_04581cad-9d09-480f-ae38-1728d25a60b0_terseLabel_en-US" xlink:label="lab_ew_JapanSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Japan</link:label>
    <link:label id="lab_ew_JapanSegmentMember_label_en-US" xlink:label="lab_ew_JapanSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Japan Segment [Member]</link:label>
    <link:label id="lab_ew_JapanSegmentMember_documentation_en-US" xlink:label="lab_ew_JapanSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the Japan reportable segment of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_JapanSegmentMember" xlink:href="ew-20240331.xsd#ew_JapanSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_JapanSegmentMember" xlink:to="lab_ew_JapanSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_4ba9f00c-005b-4118-9ef5-fc73d279a4ea_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_2f3463bc-56f9-4281-8fb3-3e66e0fe38de_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_70951296-dec1-4c59-97d0-b330f641a3e2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c8cf1c44-e31c-4dcc-b624-672f48c42df7_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Anti-dilutive securities</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_f2047674-3b1c-4552-ba70-9803f0937de2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amounts included in the measurement of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_7dc767aa-b0a5-40f4-830b-f2c5d7b5b44e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_0318dc26-19f8-4ac1-aaeb-0e6b76d49462_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Common stock, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_309a1471-ad7a-4b47-bfb7-b6edbe35e00c_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Common stock, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_b17a3af6-ca12-4acd-a8e3-cc7e0a4064f4_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment_ad2f8171-d739-4ba5-bad8-2780f2b8733b_terseLabel_en-US" xlink:label="lab_ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum additional option to acquire investment</link:label>
    <link:label id="lab_ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment_label_en-US" xlink:label="lab_ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Securities, FV-NI, Maximum Additional Option To Acquire Investment</link:label>
    <link:label id="lab_ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment_documentation_en-US" xlink:label="lab_ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Equity Securities, FV-NI, Maximum Additional Option To Acquire Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment" xlink:href="ew-20240331.xsd#ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment" xlink:to="lab_ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_2d73f5f5-6f9f-4425-8162-0c3ddc00eb20_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Accounts and other receivables, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts and Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesAbstract_e8d3cb83-07a8-44d3-9e5d-00258cdfe39b_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Held-to-maturity</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Held-to-Maturity, Fair Value to Amortized Cost, after Allowance for Credit Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesAbstract" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTextBlock_9586e680-4564-4271-80e0-ddc23a279703_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accelerated Share Repurchases</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTextBlock_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accelerated Share Repurchases [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcceleratedShareRepurchasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTextBlock" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_TranscatheterAorticValveReplacementMember_de514036-b782-4334-84c7-d30d1fd4cf96_terseLabel_en-US" xlink:label="lab_ew_TranscatheterAorticValveReplacementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transcatheter Aortic Valve Replacement</link:label>
    <link:label id="lab_ew_TranscatheterAorticValveReplacementMember_label_en-US" xlink:label="lab_ew_TranscatheterAorticValveReplacementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Transcatheter Aortic Valve Replacement [Member]</link:label>
    <link:label id="lab_ew_TranscatheterAorticValveReplacementMember_documentation_en-US" xlink:label="lab_ew_TranscatheterAorticValveReplacementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Transcatheter Aortic Valve Replacement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_TranscatheterAorticValveReplacementMember" xlink:href="ew-20240331.xsd#ew_TranscatheterAorticValveReplacementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_TranscatheterAorticValveReplacementMember" xlink:to="lab_ew_TranscatheterAorticValveReplacementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_95b932bc-7f3c-4628-a879-bc7d25b21642_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount of Gain or (Loss) Recognized in&#160;Income on Derivative (Amount Excluded from Effectiveness Testing)</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_58bdd5f0-b682-44f8-b3f4-77416467cadb_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_fe2e66ec-489d-47bd-bfa2-842c6d1fb786_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority_78f81f11-e8c0-4163-8758-2a65432026b4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional tax sought in excess of filing position</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority" xlink:to="lab_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_09d44391-20a3-4246-ab65-17369135903d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross Amounts</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_a2098218-cce3-4c41-8592-ce6b4ad9ffd9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_4fc7686c-1c4f-480b-8b69-df856894a708_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation settlement</link:label>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_label_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Estimated Litigation Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserveCurrent" xlink:to="lab_us-gaap_LitigationReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_e9e9e835-cd66-4d37-8e51-05fc9104ae6f_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_41d02188-8b5c-4d67-899d-a70ecdf41747_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Carrying value of non-marketable equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrentAndNoncurrent_12d286b7-8c80-419d-8178-4b7b906bf81a_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Taxes payable</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_08ec88dd-28dc-4941-b05f-0f3cb33de7fc_netLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Net of tax</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_6984c378-f920-40e0-be0f-47b8344c7a2e_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income attributable to Edwards Lifesciences Corporation</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_e04c80cd-f2e2-4b84-a8e4-d652d0516302_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_3255b81c-6420-4835-887b-a06f0e7b17bc_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Due after 1&#160;year through 5&#160;years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_32ca6e73-f12d-417a-a6ab-af156aea3296_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_36708270-ad9d-490b-8871-a8f587094df5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Components of Selected Captions in the Consolidated Balance Sheets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_67b298ca-3f0f-4b73-a03c-fd44c79ce1f1_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Enterprise-Wide Information</link:label>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_1af67e0f-4e90-4dd5-9a68-59fb728a04ca_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_4e380da3-5d8e-4191-94ba-7aaf131793e8_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intellectual property agreement and certain litigation expenses (Note 3)</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_2037aa17-2131-446d-9bc7-3cf03aec2dc3_verboseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Intellectual property litigation expense</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_c6a553c5-2fc1-43c0-babb-05048d6d7881_negatedLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Intellectual property agreement and certain litigation expenses</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementExpense" xlink:to="lab_us-gaap_LitigationSettlementExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7fd0a732-aa63-459f-9460-20a2f79ffb39_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective income tax rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_564964e4-6a61-44c9-a73f-6a950af8bf28_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_1436d573-2e30-48ec-a0ca-cc1211a1d671_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Uncertain tax positions</link:label>
    <link:label id="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability for Uncertainty in Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:to="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidRoyalties_a1771c78-5d57-4f4a-a3cb-d74ce13938f8_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidRoyalties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid royalty asset</link:label>
    <link:label id="lab_us-gaap_PrepaidRoyalties_label_en-US" xlink:label="lab_us-gaap_PrepaidRoyalties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Royalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidRoyalties" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidRoyalties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidRoyalties" xlink:to="lab_us-gaap_PrepaidRoyalties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_6830cf5d-6e5a-4344-98e0-f46b053e8cce_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_e65c074e-74cd-4a8d-a6d4-6cf9bb802d85_terseLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_317c4a7c-0d9f-4010-9f0b-220f320f6fda_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_b500df94-2289-4c79-a172-af240410e0b5_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Allocation of stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_64f2202c-d366-4db1-9853-59c69f3b1535_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_6519add8-3607-4f73-ab60-34623ed37c11_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0d9954ec-639f-49e9-95c4-6914ad6adcc4_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Fair value, total</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_572ea7ee-13e5-4712-97c8-4e94461d8487_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Gain (loss) on cash flow hedging relationships:</link:label>
    <link:label id="lab_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Cash Flow Hedges on Results of Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract" xlink:to="lab_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_5fea640b-7132-4bc4-bf8c-c7298f7e4818_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_109400c8-bae7-4799-9c33-507303568e1e_totalLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Liability, Including Not Subject to Master Netting Arrangement, after Offset and Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_61f102df-827e-4e70-b3c6-adf7e24e5ddd_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_9ced07a7-f379-4370-b992-e9e2c257fdf6_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized Pension Credits (Costs)</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_IntellectualPropertyAgreementTerm_2d712b2c-f443-4d62-8330-255af8680d31_terseLabel_en-US" xlink:label="lab_ew_IntellectualPropertyAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intellectual property agreement term</link:label>
    <link:label id="lab_ew_IntellectualPropertyAgreementTerm_label_en-US" xlink:label="lab_ew_IntellectualPropertyAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intellectual Property Agreement Term</link:label>
    <link:label id="lab_ew_IntellectualPropertyAgreementTerm_documentation_en-US" xlink:label="lab_ew_IntellectualPropertyAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Intellectual Property Agreement Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_IntellectualPropertyAgreementTerm" xlink:href="ew-20240331.xsd#ew_IntellectualPropertyAgreementTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_IntellectualPropertyAgreementTerm" xlink:to="lab_ew_IntellectualPropertyAgreementTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_c51d3664-ddbf-43a3-a5e2-15ce626dec00_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_7f3df173-1798-48e6-b38b-a0f39e3bb0e1_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_2f09e871-19a0-4cb5-aaf3-7865c3840c18_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_AccrualForEnvironmentalLossContingenciesThresholdAmountForDisclosure_2df821a5-8cfc-4940-b148-34e1e4d7e3b8_terseLabel_en-US" xlink:label="lab_ew_AccrualForEnvironmentalLossContingenciesThresholdAmountForDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Threshold of disclosing material environmental legal proceedings</link:label>
    <link:label id="lab_ew_AccrualForEnvironmentalLossContingenciesThresholdAmountForDisclosure_label_en-US" xlink:label="lab_ew_AccrualForEnvironmentalLossContingenciesThresholdAmountForDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrual For Environmental Loss Contingencies Threshold Amount For Disclosure</link:label>
    <link:label id="lab_ew_AccrualForEnvironmentalLossContingenciesThresholdAmountForDisclosure_documentation_en-US" xlink:label="lab_ew_AccrualForEnvironmentalLossContingenciesThresholdAmountForDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrual For Environmental Loss Contingencies Threshold Amount For Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccrualForEnvironmentalLossContingenciesThresholdAmountForDisclosure" xlink:href="ew-20240331.xsd#ew_AccrualForEnvironmentalLossContingenciesThresholdAmountForDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_AccrualForEnvironmentalLossContingenciesThresholdAmountForDisclosure" xlink:to="lab_ew_AccrualForEnvironmentalLossContingenciesThresholdAmountForDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_fb38c6c5-fefc-4970-998f-8e7f3ba31f80_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedged items</link:label>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_label_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:to="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_486a886e-fbac-4117-af73-1fff416855ad_terseLabel_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Decrease in unrecognized tax benefits is reasonably possible</link:label>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_label_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:to="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_04497b41-4c8b-4f03-87db-794506afe80c_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common stock, $1.00 par value, 1,050.0 shares authorized, 651.8 and 650.5 shares issued, and 602.4 and 601.1 shares outstanding, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_06f2e7b4-27f0-4191-9c25-fd5e5bb0762a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value, less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_2ee2a924-15ce-45da-aeca-2f7e3b379e80_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deferred income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e68d33a6-4607-4d7a-ae7b-503140f2da50_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_1483202d-2acb-41c1-81d5-a09688ff7eac_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued professional services</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_1a3f8358-a146-4273-b747-d145191b262c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Periodic Reduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_82c85795-3950-4e01-bbed-939b7bfa4304_terseLabel_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">INTELLECTUAL PROPERTY AGREEMENT AND CERTAIN LITIGATION EXPENSES</link:label>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Matters and Contingencies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:to="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_bd20c151-515a-411e-ade8-a88fe9062b6c_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LimitedLiabilityCompanyMember_fda25d74-7ae6-423b-8ed8-c5ea38a3e5a9_terseLabel_en-US" xlink:label="lab_us-gaap_LimitedLiabilityCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Limited Liability Company</link:label>
    <link:label id="lab_us-gaap_LimitedLiabilityCompanyMember_label_en-US" xlink:label="lab_us-gaap_LimitedLiabilityCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Limited Liability Company [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LimitedLiabilityCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LimitedLiabilityCompanyMember" xlink:to="lab_us-gaap_LimitedLiabilityCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_0c2e7e81-5842-4dd9-bdf1-a7ce30e6d456_totalLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total investments in unconsolidated entities</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_5a04207f-ccca-4fbd-bdd2-197c6ceea071_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_089dcc65-c3c6-4052-9873-347c9d255e55_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid during the year for:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_05bacae6-f657-4533-9630-8f19589bb624_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_81045001-d032-48cf-8513-e04da36b083a_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_20ffa531-ddbd-46cb-90ab-543b8415dc4d_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_01462e21-92fe-423b-b9e2-faae3d2b6deb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_185271b1-120b-406c-990f-7cfbfde7a129_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_a7bf11d3-7bcf-4000-95c4-ccb8dabfe28d_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchases of held-to-maturity investments (Note 5)</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Held-to-Maturity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:to="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_MichaelA.MussallemMember_label_en-US" xlink:label="lab_ew_MichaelA.MussallemMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Michael A. Mussallem [Member]</link:label>
    <link:label id="lab_ew_MichaelA.MussallemMember_documentation_en-US" xlink:label="lab_ew_MichaelA.MussallemMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Michael A. Mussallem</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MichaelA.MussallemMember" xlink:href="ew-20240331.xsd#ew_MichaelA.MussallemMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_MichaelA.MussallemMember" xlink:to="lab_ew_MichaelA.MussallemMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_9faa05f4-e36f-4961-a70f-51e4bef67ca4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_country_JP_eb5a61c3-9ff3-4624-81d5-0cb5af040bcb_terseLabel_en-US" xlink:label="lab_country_JP" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Japan</link:label>
    <link:label id="lab_country_JP_label_en-US" xlink:label="lab_country_JP" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">JAPAN</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_JP"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_JP" xlink:to="lab_country_JP" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_c7100edc-2f46-440f-8478-42e10887983a_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_c9bede49-4416-473d-80f7-2c325f5b94a4_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount Paid</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_e1a8ed88-4e6f-44c2-92ab-881e538a528f_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivatives designated as hedging instruments</link:label>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_label_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:to="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesFairValue_222cf714-1509-440a-a13b-3d32dcea2125_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesFairValue_9b77e871-240b-4061-81aa-72cf6909aa92_totalLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesFairValue_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Held-to-Maturity, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_e0b2ee32-d5be-4df4-a848-4c1393b876c4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Effect of Fair Value and Cash Flow Hedge Accounting on the Consolidated Condensed Statements of Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_5bcd1d37-f47e-4678-9ffe-eddf592fba01_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability for income taxes associated with uncertain tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_f826443d-11d5-492d-b84c-c83c91ec0310_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Fair value beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_d953178b-315a-4582-bcb2-f01ec0d629f1_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Fair value ending balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_ce63651a-e302-44f0-b793-1e4b0d241a4a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_c91556f9-d606-41b9-be3a-ce29f2aba75f_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Due after 1&#160;year through 5&#160;years</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Held-to-Maturity, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_7b91c04f-3d5d-421d-acf7-0ba09cdda06a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_c9c3340a-a68f-4a97-89ee-9e667154e6eb_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_4ac088d2-5a6d-48ec-bcd8-28db804ed370_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">U.S. government and agency securities</link:label>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_4c007dea-5f9a-47e3-b067-7c86a04b04f7_verboseLabel_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">U.S. government and agency securities</link:label>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_a7605c2b-3571-4910-87d2-760d04a2ef75_netLabel_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">United States government and agency securities</link:label>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_label_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">US Treasury and Government [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:to="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_59dd8344-7dd4-46ab-ae92-738971ab083a_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash included in other current assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_MedicalDeviceCompanyMember_2eee6d46-ca30-4a06-a20e-a735cd04150e_terseLabel_en-US" xlink:label="lab_ew_MedicalDeviceCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Medical Device Company</link:label>
    <link:label id="lab_ew_MedicalDeviceCompanyMember_1652921c-83c7-434c-8a71-100eaff8e356_verboseLabel_en-US" xlink:label="lab_ew_MedicalDeviceCompanyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Investee</link:label>
    <link:label id="lab_ew_MedicalDeviceCompanyMember_label_en-US" xlink:label="lab_ew_MedicalDeviceCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Medical Device Company [Member]</link:label>
    <link:label id="lab_ew_MedicalDeviceCompanyMember_documentation_en-US" xlink:label="lab_ew_MedicalDeviceCompanyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Medical Device Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MedicalDeviceCompanyMember" xlink:href="ew-20240331.xsd#ew_MedicalDeviceCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_MedicalDeviceCompanyMember" xlink:to="lab_ew_MedicalDeviceCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_c59d140d-0523-4dcc-bd4c-7bf081b0e42f_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_4ac67cf0-65ad-4930-a78e-b3a00b3ab0a1_terseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset-backed securities</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_fa7af6b3-1b62-460f-b2fb-0235b251ab71_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash (used in) provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_MedtronicIncMember_bf6192dd-35a3-4129-8314-82b25abbcfa4_terseLabel_en-US" xlink:label="lab_ew_MedtronicIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Medtronic Inc</link:label>
    <link:label id="lab_ew_MedtronicIncMember_label_en-US" xlink:label="lab_ew_MedtronicIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Medtronic Inc [Member]</link:label>
    <link:label id="lab_ew_MedtronicIncMember_documentation_en-US" xlink:label="lab_ew_MedtronicIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Medtronic Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MedtronicIncMember" xlink:href="ew-20240331.xsd#ew_MedtronicIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_MedtronicIncMember" xlink:to="lab_ew_MedtronicIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesFairValueDisclosure_59bf5b49-963a-492a-a2a5-3e52a13d1817_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_a0b92229-da45-43a7-b95f-8d6f57257923_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_437fb259-7017-41df-981d-a22668c923f1_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Corporate items</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateAxis_76fb6aae-acb0-4dc6-aba4-ecc779996b1c_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accelerated Share Repurchases, Date [Axis]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateAxis_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accelerated Share Repurchases, Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_EquitySecuritiesFVNIPromissoryNoteOutstanding_04523ef7-1506-4730-9f1f-5a0a11759511_terseLabel_en-US" xlink:label="lab_ew_EquitySecuritiesFVNIPromissoryNoteOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investee drew additional amount</link:label>
    <link:label id="lab_ew_EquitySecuritiesFVNIPromissoryNoteOutstanding_label_en-US" xlink:label="lab_ew_EquitySecuritiesFVNIPromissoryNoteOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Securities, FV-NI Promissory Note Outstanding</link:label>
    <link:label id="lab_ew_EquitySecuritiesFVNIPromissoryNoteOutstanding_documentation_en-US" xlink:label="lab_ew_EquitySecuritiesFVNIPromissoryNoteOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Equity Securities, FV-NI Promissory Note Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquitySecuritiesFVNIPromissoryNoteOutstanding" xlink:href="ew-20240331.xsd#ew_EquitySecuritiesFVNIPromissoryNoteOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_EquitySecuritiesFVNIPromissoryNoteOutstanding" xlink:to="lab_ew_EquitySecuritiesFVNIPromissoryNoteOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_b79d72ea-2892-40ff-8d77-722fa64bd286_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_63065ea6-65d9-4f54-8ef1-a3a665d52b43_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_4e12829a-004b-407c-a152-31ab470d423e_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Due in 1&#160;year or less</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecurities_53f8c237-ed51-48d1-8176-bcce20c327fe_totalLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecurities_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecurities" xlink:to="lab_us-gaap_HeldToMaturitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_fc05321a-8728-4238-87f2-faa9b9f3fee5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_427afe6c-5bf8-4f9e-8db1-9dbe55b39a91_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Edwards Lifesciences Corporation stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_4a0b77a4-420e-4be8-9ed2-a61d0c2dfb65_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_2d56fd56-a645-44ec-9833-3168dfcdd627_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_f482fc34-6e38-465b-9d3d-e284d44cc12b_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_09abbe86-f3b1-41e0-b168-f3f467901108_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net amounts that would favorably affect effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_AcquisitionOptionsNoncurrent_1a563ec9-a082-4ba5-a2ec-015ed6c62fc4_terseLabel_en-US" xlink:label="lab_ew_AcquisitionOptionsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisition options</link:label>
    <link:label id="lab_ew_AcquisitionOptionsNoncurrent_label_en-US" xlink:label="lab_ew_AcquisitionOptionsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquisition Options, Noncurrent</link:label>
    <link:label id="lab_ew_AcquisitionOptionsNoncurrent_documentation_en-US" xlink:label="lab_ew_AcquisitionOptionsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Acquisition Options, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AcquisitionOptionsNoncurrent" xlink:href="ew-20240331.xsd#ew_AcquisitionOptionsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_AcquisitionOptionsNoncurrent" xlink:to="lab_ew_AcquisitionOptionsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9314d183-0395-4cf7-b77b-3d56a2b9a9ce_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_SeparationCostsMember_d14bfce3-83b2-4aae-9e46-c9f9ad93159a_terseLabel_en-US" xlink:label="lab_ew_SeparationCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Separation costs</link:label>
    <link:label id="lab_ew_SeparationCostsMember_label_en-US" xlink:label="lab_ew_SeparationCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Separation Costs [Member]</link:label>
    <link:label id="lab_ew_SeparationCostsMember_documentation_en-US" xlink:label="lab_ew_SeparationCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Separation Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_SeparationCostsMember" xlink:href="ew-20240331.xsd#ew_SeparationCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_SeparationCostsMember" xlink:to="lab_ew_SeparationCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_BernardJ.ZovighianMember_label_en-US" xlink:label="lab_ew_BernardJ.ZovighianMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Bernard J. Zovighian [Member]</link:label>
    <link:label id="lab_ew_BernardJ.ZovighianMember_documentation_en-US" xlink:label="lab_ew_BernardJ.ZovighianMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Bernard J. Zovighian</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_BernardJ.ZovighianMember" xlink:href="ew-20240331.xsd#ew_BernardJ.ZovighianMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_BernardJ.ZovighianMember" xlink:to="lab_ew_BernardJ.ZovighianMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_77ba3ca1-167f-47b4-a75f-284b5b3b24df_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_7273cfdd-3566-4462-afb6-219b2cf057ee_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_d9b245fd-1edc-43da-ba38-ea59c3ca4e8b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized Gain on Hedges</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_a2c6b31f-0302-46af-a177-25a77049a922_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Gain on hedges</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_77b7fb67-23d1-436d-8465-2f88a54b634f_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Expected term (years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f2731fe5-3ae1-4b05-b7dc-9b725250d337_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Income before provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_6e989344-e10e-4246-a79f-7af7c0e88424_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">INVESTMENTS IN VARIABLE INTEREST ENTITIES</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Interest Entity Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:to="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract_e43e0506-6fe0-497b-ab92-40107c65ebef_terseLabel_en-US" xlink:label="lab_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Rolling Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract" xlink:to="lab_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_511a2665-2736-447c-b833-eef93ffa43ea_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Investments in intangible assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_4f67c073-3050-46b9-8619-0028d0e54c9c_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Decrease in non-marketable equity securities due to observable price changes</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_f1c28d43-84d0-4b9b-86e9-2cec55498064_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivatives not designated as hedging instruments</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_64aa63f6-00cd-4eed-ae3c-e9bd1c3e976b_terseLabel_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive (loss) income before reclassifications</link:label>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">OCI, before Reclassifications, before Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:to="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_e161544b-3999-4527-8f2d-0694341c32a3_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_983e3456-0ca8-4790-a01a-8e329853f1ca_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_287a9828-4f0f-45d1-8441-9cd03e267ecd_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net investment hedges</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_5f376f6e-28c1-4806-b2da-fa9f86501878_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_10ced1e6-355a-4729-8ec2-2de39b2e3b2a_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_d0556bd3-cada-4761-a65a-06333ee4f632_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9a367265-05ef-4fb8-ae9d-b59fa231192e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_IncomeTaxExaminationAmountDepositedToMitigateInterestOnTaxLiabilities_e8b64965-e582-4fb5-ae30-1e7e8248ca92_terseLabel_en-US" xlink:label="lab_ew_IncomeTaxExaminationAmountDepositedToMitigateInterestOnTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional deposit</link:label>
    <link:label id="lab_ew_IncomeTaxExaminationAmountDepositedToMitigateInterestOnTaxLiabilities_label_en-US" xlink:label="lab_ew_IncomeTaxExaminationAmountDepositedToMitigateInterestOnTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Examination, Amount Deposited To Mitigate Interest On Tax Liabilities</link:label>
    <link:label id="lab_ew_IncomeTaxExaminationAmountDepositedToMitigateInterestOnTaxLiabilities_documentation_en-US" xlink:label="lab_ew_IncomeTaxExaminationAmountDepositedToMitigateInterestOnTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income Tax Examination, Amount Deposited To Mitigate Interest On Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_IncomeTaxExaminationAmountDepositedToMitigateInterestOnTaxLiabilities" xlink:href="ew-20240331.xsd#ew_IncomeTaxExaminationAmountDepositedToMitigateInterestOnTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_IncomeTaxExaminationAmountDepositedToMitigateInterestOnTaxLiabilities" xlink:to="lab_ew_IncomeTaxExaminationAmountDepositedToMitigateInterestOnTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_5fddde11-87fb-4e50-9325-00e0e79bb427_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b4085177-e015-4aea-9c2e-f458f267864f_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_b5e332a1-83d7-48ff-9c22-a44177b19292_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Compensation Plan</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_ca16ca1c-29bd-4694-a89a-9bda71fef71c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation (Note&#160;9)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_bd5e5f6e-fddd-48fd-b677-f88a9ad8a350_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_4bb4aed8-3c13-4b02-b909-012971cdf678_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Unrealized pension credits (costs)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_9cc7ea69-ee43-4ded-b3af-e75e1ff3ef37_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_26fb90b3-9347-4796-8484-77bc252ab9ea_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_0db48792-dee9-4c00-8032-76e30db6c8f6_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_dc766fc6-2700-4548-a77a-2e3c6ed31f3c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EARNINGS PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_62539a7a-0125-466e-8210-cb16d1e90580_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract_56ca80ce-0121-46e2-a8af-9cc46633aaa1_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments, All Other Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsNoncurrent_5c914202-22b1-44f1-bcdf-0754f213bf18_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Asset, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsNoncurrent" xlink:to="lab_us-gaap_DerivativeAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_4fd34cb3-8fa1-4a44-9f39-248515f23eea_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment percentage (in percent)</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_d459f903-f72c-489c-a447-fa7131899ecd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Changes in Fair Value of Contingent Consideration and Other Liability</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_f8c842b0-2157-49cb-bd6e-215944b9f079_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_88bcb6be-7dd8-4d7b-85e3-6cd104d78599_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_53a3ef17-0e05-4c8b-bc06-225c8ccfb6f2_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7cccf80d-6ca5-439c-a762-dd03d8f37e39_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ceeacae1-7ad0-4295-923e-c9663bdb1408_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedMarketingCostsCurrent_8f73c98b-5ed9-45f0-894f-1ce8bfcc04a3_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued marketing expenses</link:label>
    <link:label id="lab_us-gaap_AccruedMarketingCostsCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Marketing Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedMarketingCostsCurrent" xlink:to="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_b32e4b62-10f8-4f28-b712-d3a1f9685b72_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average number of common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_03ec778b-454b-4c55-8faf-dfd40c798105_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant, and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_a3840fd8-24d2-4a12-b32e-477165cca420_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BASIS OF PRESENTATION</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3cd97732-a417-4126-a45a-36db34d1cbbd_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_f4d917f0-a45e-4c27-be11-51343dd0569f_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Held-to-Maturity, Fair Value, Rolling Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_6f7b7a94-b8b3-4610-a8ed-7220a0f50496_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flow gain to be reclassified in the next twelve months</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_dbad6a9c-fe81-4b00-8dd0-cbab47a911af_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_cda36ad9-0972-433d-ac55-aa75f3176af6_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_19837bf5-c8e8-49fa-a620-8c3b2623550e_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_a4bab14f-f09a-43ee-95ff-c32ce75b6dc9_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss), Foreign Currency Transaction, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_582bea0d-a181-4669-b9d7-e2e0f060d8f8_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Available-for-Sale</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Available-for-Sale Securities, Debt Maturities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesAbstract_f8e6ffc2-4456-45b9-9934-ae68d8504576_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract" xlink:to="lab_us-gaap_DerivativeLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_9e8cc73c-02bf-4ec9-a0f0-f33be9e5a983_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_c5a513ec-0202-4166-97fa-30e41c82eab1_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_7331bc27-5018-4aa6-a142-010361642ebb_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_ebb8334e-e8f6-4276-bf2d-aa50dabb6893_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_23fe4ab0-9598-4780-ad8a-1f38ac997bb2_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_8339fa22-5458-4dbf-b38a-e3f7f12b262e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent_6ab602ad-f1d6-4ebc-8f7a-ebd80979d1c9_terseLabel_en-US" xlink:label="lab_ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, payroll, and other taxes</link:label>
    <link:label id="lab_ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent_label_en-US" xlink:label="lab_ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrual for Property Payroll and Other Taxes Other than Income Taxes Current</link:label>
    <link:label id="lab_ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent_documentation_en-US" xlink:label="lab_ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes, payroll taxes and other taxes, excluding income taxes payable. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent" xlink:href="ew-20240331.xsd#ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent" xlink:to="lab_ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_f1e7a5f4-9691-4985-8acd-2a719f681ace_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_69a67e47-6f8e-4093-acca-68c1f3bd2d83_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_IncomeTaxAssessmentEstimateOfAdditionalTaxExpense_a343808b-36c4-40e7-b4e7-1e62d208c5e3_terseLabel_en-US" xlink:label="lab_ew_IncomeTaxAssessmentEstimateOfAdditionalTaxExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional tax expense</link:label>
    <link:label id="lab_ew_IncomeTaxAssessmentEstimateOfAdditionalTaxExpense_label_en-US" xlink:label="lab_ew_IncomeTaxAssessmentEstimateOfAdditionalTaxExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Assessment, Estimate Of Additional Tax Expense</link:label>
    <link:label id="lab_ew_IncomeTaxAssessmentEstimateOfAdditionalTaxExpense_documentation_en-US" xlink:label="lab_ew_IncomeTaxAssessmentEstimateOfAdditionalTaxExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income Tax Assessment, Estimate Of Additional Tax Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_IncomeTaxAssessmentEstimateOfAdditionalTaxExpense" xlink:href="ew-20240331.xsd#ew_IncomeTaxAssessmentEstimateOfAdditionalTaxExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_IncomeTaxAssessmentEstimateOfAdditionalTaxExpense" xlink:to="lab_ew_IncomeTaxAssessmentEstimateOfAdditionalTaxExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_ba50956e-4b7d-4351-b572-e1c7dda51e87_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_f1826505-71d7-4cb8-af62-90ce3793faba_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_0ef93a7b-79f7-4e08-8213-1574091fc4ed_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_69e5d6a5-ef24-476e-982d-967a2b37227e_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_f3504a81-8880-4470-af29-364dd5d7ac1e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other assets (Note 2)</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_e5dd203f-b241-4c16-a15d-0ec02e40e0c5_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Other assets, noncurrent</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_48b1add1-ccc8-48d1-a6a5-51b3dd39413e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_a66fe22f-2643-495f-acf9-30489dc95281_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized gain (loss) on hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_0425d2c0-5305-471a-a629-1ea08c0295f9_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_3a3ef67e-19de-4a42-9fa7-91240d30472d_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basic earnings per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_911e75ce-7765-4b0d-a03d-8277e1afef45_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_0435ef4c-4c65-414c-818b-c0398759e023_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_d61522cf-f8ae-4f84-bf96-d6f9cbc9880e_verboseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Unallocated amounts:</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_782082f2-b336-4f0d-958e-6b039a216ed2_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net income attributable to Edwards Lifesciences Corporation</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_6bd5d7eb-6b16-456f-9101-727d0ce441bf_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_1fbe2b7c-18f3-48dd-89af-d67606b54a91_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_b5974191-1457-498f-a39b-e3d5b2ad25e4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Restricted Cash</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restrictions on Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_ad47e44c-ed3a-4cf1-a069-2b7dbb69eb3c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Information about Reportable Segments and Reconciliation of Segment Net Sales and Pre-Tax Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_b9537fd3-0f32-41cb-af63-01f921160912_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Instruments not due at a single maturity date</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_ShareInformationAbstract_3b661324-6e5b-437c-b614-c713a7cd6879_terseLabel_en-US" xlink:label="lab_ew_ShareInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share information (Note 13)</link:label>
    <link:label id="lab_ew_ShareInformationAbstract_label_en-US" xlink:label="lab_ew_ShareInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_ShareInformationAbstract" xlink:href="ew-20240331.xsd#ew_ShareInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_ShareInformationAbstract" xlink:to="lab_ew_ShareInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost_7ef9f50c-d1b6-4f4d-9eba-7c07f82a5173_terseLabel_en-US" xlink:label="lab_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Due in 1&#160;year or less</link:label>
    <link:label id="lab_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Rolling within One Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost" xlink:to="lab_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_a00bdad4-d3b6-45e3-b9f0-8f9900facccb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_13ad0899-b964-4fad-b8ef-af49737e1eaf_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_0dbf6210-2298-4da8-a2c8-8d03f73b01e2_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f779768a-3515-4d9f-b6c5-940499e708dc_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_cffb8dd7-0a28-4037-ad2c-5088987a7fab_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_e0c239a1-8b88-44bc-b075-9cd1e9db5efa_terseLabel_en-US" xlink:label="lab_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finished products inventories held on consignment</link:label>
    <link:label id="lab_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_label_en-US" xlink:label="lab_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Inventory, Materials, Supplies and Merchandise under Consignment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:to="lab_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount_75737257-bbd8-4e4c-aa7d-d52ad80adc2a_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Downward price adjustment, annual amount</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_AccruedRebates_233609d2-2968-45c5-8701-3c751875003d_terseLabel_en-US" xlink:label="lab_ew_AccruedRebates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued rebates</link:label>
    <link:label id="lab_ew_AccruedRebates_label_en-US" xlink:label="lab_ew_AccruedRebates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Rebates</link:label>
    <link:label id="lab_ew_AccruedRebates_documentation_en-US" xlink:label="lab_ew_AccruedRebates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Aggregate carrying amount, as of the balance sheet date, of current obligations associated with sales rebates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccruedRebates" xlink:href="ew-20240331.xsd#ew_AccruedRebates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_AccruedRebates" xlink:to="lab_ew_AccruedRebates" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_6c4e3e40-ecea-4b96-a4aa-8020b04b2921_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost_bf2a387a-dcc4-4578-90cd-ca3a8dffe298_terseLabel_en-US" xlink:label="lab_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Due after 1&#160;year through 5&#160;years</link:label>
    <link:label id="lab_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost_label_en-US" xlink:label="lab_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Rolling after One through Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost" xlink:to="lab_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_ScottB.UllemMember_label_en-US" xlink:label="lab_ew_ScottB.UllemMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scott B. Ullem [Member]</link:label>
    <link:label id="lab_ew_ScottB.UllemMember_documentation_en-US" xlink:label="lab_ew_ScottB.UllemMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Scott B. Ullem</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_ScottB.UllemMember" xlink:href="ew-20240331.xsd#ew_ScottB.UllemMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_ScottB.UllemMember" xlink:to="lab_ew_ScottB.UllemMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c6f47d4d-7e6c-4829-9e13-5f48414e3efa_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4b157a08-882b-4afa-be64-d092e8e8daa6_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6a9d7b26-261a-4385-8a14-b6990513266f_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Available-for-sale investments:</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_333b5a80-a7f0-4b66-818b-4b1c0227d7d1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of financial instruments measured on a recurring basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_45a8860a-3ff5-457f-9a47-7cabc797d88f_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_AccruedLitigationAndInsuranceReserves_a3b66156-7503-4b94-b627-3fd67e23aca2_terseLabel_en-US" xlink:label="lab_ew_AccruedLitigationAndInsuranceReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Legal and insurance</link:label>
    <link:label id="lab_ew_AccruedLitigationAndInsuranceReserves_label_en-US" xlink:label="lab_ew_AccruedLitigationAndInsuranceReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Litigation And Insurance Reserves</link:label>
    <link:label id="lab_ew_AccruedLitigationAndInsuranceReserves_documentation_en-US" xlink:label="lab_ew_AccruedLitigationAndInsuranceReserves" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Litigation And Insurance Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccruedLitigationAndInsuranceReserves" xlink:href="ew-20240331.xsd#ew_AccruedLitigationAndInsuranceReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_AccruedLitigationAndInsuranceReserves" xlink:to="lab_ew_AccruedLitigationAndInsuranceReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_6b158d3f-a602-426a-9639-9299df1c1b86_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_f5258360-cafa-438e-92f9-2a680746da71_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_6b31fad2-9b54-4096-9be3-4714c1dc8a7b_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_31f3f28d-8ae1-4064-9053-4f91ee4abad6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote_b90c870e-ba1c-4865-91e2-d6aa8da01395_terseLabel_en-US" xlink:label="lab_ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum secured promissory note</link:label>
    <link:label id="lab_ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote_label_en-US" xlink:label="lab_ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Securities, FV-NI, Maximum Secured Promissory Note</link:label>
    <link:label id="lab_ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote_documentation_en-US" xlink:label="lab_ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Equity Securities, FV-NI, Maximum Secured Promissory Note</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote" xlink:href="ew-20240331.xsd#ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote" xlink:to="lab_ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_d4e13abb-a4b8-4622-a83f-3f224d0c67d5_terseLabel_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes due to currency rate movements and expenses expected to occur, maximum term</link:label>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_label_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum Length of Time, Foreign Currency Cash Flow Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:to="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_7283f975-0fa5-4f56-a421-d3ea182ee8d5_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Comprehensive loss attributable to noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeCollateralObligationToReturnCash_18c2338e-41c0-4cc3-8eb1-6e248f1da7d6_negatedLabel_en-US" xlink:label="lab_us-gaap_DerivativeCollateralObligationToReturnCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Cash Collateral Received</link:label>
    <link:label id="lab_us-gaap_DerivativeCollateralObligationToReturnCash_label_en-US" xlink:label="lab_us-gaap_DerivativeCollateralObligationToReturnCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, Collateral, Obligation to Return Cash Not Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralObligationToReturnCash" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeCollateralObligationToReturnCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeCollateralObligationToReturnCash" xlink:to="lab_us-gaap_DerivativeCollateralObligationToReturnCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_915a783e-06b9-4cbd-b72d-84119cd522c7_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss), net of tax (Note&#160;12):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_244adc5e-9349-42fc-ac6f-c1fd74e5db30_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_115016fb-e459-4754-ac65-708da265ad67_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair value of derivative assets</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_29480c19-ef2a-42de-bc0c-cd54345acf30_totalLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net Amounts Presented in the Consolidated Balance Sheet</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7e641267-a89d-4445-8f5c-08afc4b4b63b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent_3b72587d-59d0-471b-9133-cae15d555c60_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes and other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Receivable, after Allowance for Credit Loss, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent" xlink:to="lab_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock_3c22295e-391e-407f-aaa8-ebf7d123865c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Investments in Unconsolidated Affiliates</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Investments in and Advances to Affiliates, Schedule of Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_DerivativeFairValueOfDerivativeAssetGrossAmountsNotOffsetAbstract_60e9d57f-a456-4763-903a-118a17ebfb17_terseLabel_en-US" xlink:label="lab_ew_DerivativeFairValueOfDerivativeAssetGrossAmountsNotOffsetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross Amounts Not Offset in the Consolidated Balance Sheet</link:label>
    <link:label id="lab_ew_DerivativeFairValueOfDerivativeAssetGrossAmountsNotOffsetAbstract_label_en-US" xlink:label="lab_ew_DerivativeFairValueOfDerivativeAssetGrossAmountsNotOffsetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Fair Value of Derivative Asset Gross Amounts Not Offset [Abstract]</link:label>
    <link:label id="lab_ew_DerivativeFairValueOfDerivativeAssetGrossAmountsNotOffsetAbstract_documentation_en-US" xlink:label="lab_ew_DerivativeFairValueOfDerivativeAssetGrossAmountsNotOffsetAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Derivative Fair Value of Derivative Asset Gross Amounts Not Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_DerivativeFairValueOfDerivativeAssetGrossAmountsNotOffsetAbstract" xlink:href="ew-20240331.xsd#ew_DerivativeFairValueOfDerivativeAssetGrossAmountsNotOffsetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_DerivativeFairValueOfDerivativeAssetGrossAmountsNotOffsetAbstract" xlink:to="lab_ew_DerivativeFairValueOfDerivativeAssetGrossAmountsNotOffsetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_973e3eab-1ee6-4309-b17f-956f620a407b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableGross_47386771-ffea-40b1-aff8-ce9105bd0b6e_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing receivable</link:label>
    <link:label id="lab_us-gaap_NotesReceivableGross_label_en-US" xlink:label="lab_us-gaap_NotesReceivableGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Receivable, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReceivableGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableGross" xlink:to="lab_us-gaap_NotesReceivableGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MunicipalBondsMember_abede711-281b-4952-90fc-b4e376c04d35_terseLabel_en-US" xlink:label="lab_us-gaap_MunicipalBondsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Municipal securities</link:label>
    <link:label id="lab_us-gaap_MunicipalBondsMember_516f9c44-21c9-4da8-a5af-5e15ecb887f0_verboseLabel_en-US" xlink:label="lab_us-gaap_MunicipalBondsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Municipal securities</link:label>
    <link:label id="lab_us-gaap_MunicipalBondsMember_a7da065c-91cc-45ed-8e39-6bb285e37d04_netLabel_en-US" xlink:label="lab_us-gaap_MunicipalBondsMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Municipal securities</link:label>
    <link:label id="lab_us-gaap_MunicipalBondsMember_label_en-US" xlink:label="lab_us-gaap_MunicipalBondsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Municipal Bonds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MunicipalBondsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MunicipalBondsMember" xlink:to="lab_us-gaap_MunicipalBondsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_fe483933-c9ea-4d36-96d7-719de79c86fd_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_ResearchAndDevelopmentAccruals_327e0235-a4d5-42b1-8efa-559b7cf67769_terseLabel_en-US" xlink:label="lab_ew_ResearchAndDevelopmentAccruals" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development accruals</link:label>
    <link:label id="lab_ew_ResearchAndDevelopmentAccruals_label_en-US" xlink:label="lab_ew_ResearchAndDevelopmentAccruals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research And Development Accruals</link:label>
    <link:label id="lab_ew_ResearchAndDevelopmentAccruals_documentation_en-US" xlink:label="lab_ew_ResearchAndDevelopmentAccruals" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Aggregate carrying amount, as of the balance sheet date, of current obligations associated with research and development and clinical trials.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_ResearchAndDevelopmentAccruals" xlink:href="ew-20240331.xsd#ew_ResearchAndDevelopmentAccruals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_ResearchAndDevelopmentAccruals" xlink:to="lab_ew_ResearchAndDevelopmentAccruals" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_6b919687-bc6d-4ef2-9ffd-6e4e625d4319_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued realignment reserves</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Reserve, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveCurrent" xlink:to="lab_us-gaap_RestructuringReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4931fade-0914-4033-8910-0ec19c0eed9b_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f9d6c886-b869-4464-9206-c2c9757a8e9a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_4a0fbb25-0e2c-4462-924f-867723b109f4_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock issued under stock plans (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_be865693-d30a-4191-aa21-8d0749372c70_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_5f89656e-4e38-4f09-8ffb-f5a640cee742_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dilutive effect of stock plans (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_cc316e55-c1d3-4a1d-805b-e565ecf9c413_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_25ac4b01-6473-470c-a47d-2d838c374237_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value of contingent consideration liabilities (Note 7)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_9e9077e3-62b6-4034-a0aa-63309224d38f_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Change in fair value of contingent consideration liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_87efd606-abb1-4954-b00c-a02d1e1b8b99_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_f015c523-f4bf-45ec-bb3e-29783d1e6e6d_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_f2a9db81-086e-4a83-a24e-5edfd7e0f2f8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member_45099a60-8f1f-483a-8925-46866d29b799_terseLabel_en-US" xlink:label="lab_ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">February 2023 Stock Repurchase Program Shares Sold in March 2023</link:label>
    <link:label id="lab_ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member_label_en-US" xlink:label="lab_ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">February 2023 Stock Repurchase Program Shares Sold In March 2023 [Member]</link:label>
    <link:label id="lab_ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member_documentation_en-US" xlink:label="lab_ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">February 2023 Stock Repurchase Program Shares Sold In March 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member" xlink:href="ew-20240331.xsd#ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member" xlink:to="lab_ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_182e539e-41d0-4967-b0b6-60c44a3b1a1f_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_32319d2f-833c-4af7-9d79-6747987b259a_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_3a3ebe09-b416-4c53-b526-a7c5b76266d7_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount Reclassified from Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrentAndNoncurrent_9c8e9f15-585a-478d-bb56-f6dbec08e4aa_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term prepaid royalties</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrentAndNoncurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_e2ccb61c-1a73-4619-a4d3-5a629973e84c_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_66f3f331-b28b-41a1-bcaf-5f0e1786b0a3_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_729c8238-0698-41eb-a8df-4c334d8b9530_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount of Gain or (Loss) Recognized in Income on Derivative</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_bea93dd7-eddb-413b-9648-6af14a877e78_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_d63b3dfa-1a30-4107-b2bb-cca61a03b5f4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_7fb9776b-a43c-4048-9acb-5fa1cc2e6cbb_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_LoansReceivablesMaximumLendingCapacity_468f2990-90f2-49d7-b193-d2cb467aa58a_terseLabel_en-US" xlink:label="lab_ew_LoansReceivablesMaximumLendingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loans receivables, maximum lending amount</link:label>
    <link:label id="lab_ew_LoansReceivablesMaximumLendingCapacity_label_en-US" xlink:label="lab_ew_LoansReceivablesMaximumLendingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loans Receivables, Maximum Lending Capacity</link:label>
    <link:label id="lab_ew_LoansReceivablesMaximumLendingCapacity_documentation_en-US" xlink:label="lab_ew_LoansReceivablesMaximumLendingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loans Receivables, Maximum Lending Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_LoansReceivablesMaximumLendingCapacity" xlink:href="ew-20240331.xsd#ew_LoansReceivablesMaximumLendingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_LoansReceivablesMaximumLendingCapacity" xlink:to="lab_ew_LoansReceivablesMaximumLendingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_34c83588-99bb-465d-a122-64dcab897aed_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Finished products</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_3f86f1d8-4625-4af4-807a-e0d14b844238_verboseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Derivatives designated as hedging instruments</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_fe4da253-6d0e-4ba5-8c61-da98b037b106_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivatives designated as hedging instruments</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_b0aec268-a3ef-49e6-bd75-35b2136cad8e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee compensation and withholdings</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_eff554f7-ae12-46fd-bf21-8e6ef25aab8e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_61655b9e-fdb3-4c31-a816-5e5d1c8bcd77_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_93483dd7-76b7-4872-aae3-07fd9e158ab9_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments for legal settlements</link:label>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_label_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLegalSettlements" xlink:to="lab_us-gaap_PaymentsForLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_7c46d975-3c81-47c4-bf1d-19b65bc819e4_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Gross unrealized losses, 12 months or greater</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_cb1d6ab2-bb06-41cd-a387-64f34e6599d5_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e748fe23-5b4c-4239-9961-e4531ed21766_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b302c70f-6c72-4dfc-939e-b8c0787ee825_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_faaf11b2-e155-4895-966f-99fca1e24e1c_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total segment net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_e62fb3bc-310f-4f0a-b1b7-4f82c78f94b6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_CriticalCareMember_d5fe7df8-2fdc-43df-9d0d-1c2e41359cfe_terseLabel_en-US" xlink:label="lab_ew_CriticalCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Critical Care</link:label>
    <link:label id="lab_ew_CriticalCareMember_label_en-US" xlink:label="lab_ew_CriticalCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Critical Care [Member]</link:label>
    <link:label id="lab_ew_CriticalCareMember_documentation_en-US" xlink:label="lab_ew_CriticalCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">This element represents the critical care product line.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_CriticalCareMember" xlink:href="ew-20240331.xsd#ew_CriticalCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_CriticalCareMember" xlink:to="lab_ew_CriticalCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_fdf88837-03a0-454b-8ed7-a67dcbf9d8b2_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgingMember_38db28f8-5f56-47b5-af7b-cc300c21c657_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value hedges</link:label>
    <link:label id="lab_us-gaap_FairValueHedgingMember_label_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgingMember" xlink:to="lab_us-gaap_FairValueHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityFairValueGrossAsset_8b863633-1144-487b-8f2a-5eed6dd2baf0_negatedLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityFairValueGrossAsset" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Gross Amounts Offset in the Consolidated Balance Sheet</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityFairValueGrossAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityFairValueGrossAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Liability, Subject to Master Netting Arrangement, Asset Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityFairValueGrossAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset" xlink:to="lab_us-gaap_DerivativeLiabilityFairValueGrossAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_e6e62c3a-785d-4517-81bc-6f42661fde25_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Weighted-Average Assumptions for ESPP Subscriptions Granted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_964a4803-cae1-40cf-b8f0-c119f5fe0215_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_ce925e6f-41b4-481b-b7ea-362b9316f13a_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Gross unrealized losses, less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_57411723-ab13-41f0-a0c3-332f4464c2df_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_49047bd0-4c30-4b3d-b6ea-fd1aa9ce82f3_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1a721fff-994e-4f1f-bbad-6b4a07cb5a1a_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_e9774f7b-dcf9-40ed-a3a8-90f7cf3eb31f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest income, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_32ad7d7e-042d-48c2-b20b-fadd4169b0d1_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Interest income, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract_0224a18e-166a-4caf-8e81-1fee8525313d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investment, Financial Statement, Reported Amounts [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract" xlink:to="lab_us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_05c6f2c0-79a0-4b1c-b34d-9aaf6c4d8cd1_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BankTimeDepositsMember_298452cb-fb7d-4b7e-94de-fe6cfc5a1a86_terseLabel_en-US" xlink:label="lab_us-gaap_BankTimeDepositsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Bank time deposits</link:label>
    <link:label id="lab_us-gaap_BankTimeDepositsMember_label_en-US" xlink:label="lab_us-gaap_BankTimeDepositsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Bank Time Deposits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BankTimeDepositsMember" xlink:to="lab_us-gaap_BankTimeDepositsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_2f45ca7b-8458-4f66-bdfe-b876e6daaf26_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchases of treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_9fbc8388-c812-4549-97b6-aff14bb9f24c_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Shares Received (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_efd62ae6-24c2-4137-86fb-29ac7f608e26_totalLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Asset, Including Not Subject to Master Netting Arrangement, after Offset and Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_a94b64d9-bd5e-44c7-ab1c-3066365c9fe9_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_ContingentConsiderationLiabilityMember_d4387276-5afa-4bd2-8024-422c17d2e6cc_terseLabel_en-US" xlink:label="lab_ew_ContingentConsiderationLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent Consideration</link:label>
    <link:label id="lab_ew_ContingentConsiderationLiabilityMember_label_en-US" xlink:label="lab_ew_ContingentConsiderationLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Consideration Liability [Member]</link:label>
    <link:label id="lab_ew_ContingentConsiderationLiabilityMember_documentation_en-US" xlink:label="lab_ew_ContingentConsiderationLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contingent Consideration Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_ContingentConsiderationLiabilityMember" xlink:href="ew-20240331.xsd#ew_ContingentConsiderationLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_ContingentConsiderationLiabilityMember" xlink:to="lab_ew_ContingentConsiderationLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a25ae15f-a1c5-43c3-8ba0-b2205660d525_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6d2f1e0f-462d-4068-8aae-7c39c9011743_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Dilutive weighted-average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsAbstract_f36c983f-7a6a-4c94-a14a-0aba097df0b7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Asset [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsAbstract" xlink:to="lab_us-gaap_DerivativeAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_e9a2b52a-9576-4490-9bed-8d1f80130f14_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_VariableInterestEntitiesAbstract_label_en-US" xlink:label="lab_ew_VariableInterestEntitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Interest Entities [Abstract]</link:label>
    <link:label id="lab_ew_VariableInterestEntitiesAbstract_documentation_en-US" xlink:label="lab_ew_VariableInterestEntitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Investments in Variable Interest Entities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_VariableInterestEntitiesAbstract" xlink:href="ew-20240331.xsd#ew_VariableInterestEntitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_VariableInterestEntitiesAbstract" xlink:to="lab_ew_VariableInterestEntitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateDomain_e02fd19b-1d1d-49a7-ad8f-8966f4787534_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accelerated Share Repurchases, Date [Domain]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateDomain_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accelerated Share Repurchases, Date [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffsettingDerivativeAssetsAbstract_792e634a-8145-47b9-8250-2d31ccead00f_terseLabel_en-US" xlink:label="lab_us-gaap_OffsettingDerivativeAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative assets</link:label>
    <link:label id="lab_us-gaap_OffsettingDerivativeAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_OffsettingDerivativeAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Offsetting Derivative Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingDerivativeAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingDerivativeAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffsettingDerivativeAssetsAbstract" xlink:to="lab_us-gaap_OffsettingDerivativeAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_140aaddf-9f96-42c3-83d2-1d179988fb12_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_74dbf813-e5c7-4b7b-b003-6d55a08390fb_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeMember_c8f1d2c9-433f-4fd4-9b08-4d4ce97af16a_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeMember_label_en-US" xlink:label="lab_us-gaap_InterestIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeMember" xlink:to="lab_us-gaap_InterestIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_9ceea3ae-f02d-4f4b-afb5-dc707754e32c_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_21a46a83-1a0b-4f8d-a020-09be228e376a_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_8160318b-ef1a-4138-b65d-2cac697edcee_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_AccruedAndOtherLiabilitiesCurrent_79fba460-0fb2-4643-a4f5-fcdabe004e6a_terseLabel_en-US" xlink:label="lab_ew_AccruedAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued and other liabilities (Note 2)</link:label>
    <link:label id="lab_ew_AccruedAndOtherLiabilitiesCurrent_3d2de05e-28df-4fb3-a0df-09cfebaf3854_totalLabel_en-US" xlink:label="lab_ew_AccruedAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total accrued and other liabilities</link:label>
    <link:label id="lab_ew_AccruedAndOtherLiabilitiesCurrent_label_en-US" xlink:label="lab_ew_AccruedAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued And Other Liabilities, Current</link:label>
    <link:label id="lab_ew_AccruedAndOtherLiabilitiesCurrent_documentation_en-US" xlink:label="lab_ew_AccruedAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued And Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccruedAndOtherLiabilitiesCurrent" xlink:href="ew-20240331.xsd#ew_AccruedAndOtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_AccruedAndOtherLiabilitiesCurrent" xlink:to="lab_ew_AccruedAndOtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_5cd94c1f-7971-45db-bc67-ec4c97ef3cde_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesMember" xlink:to="lab_us-gaap_OtherLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_d96aee25-875c-4e9b-a5e5-7830e9b421af_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_c710a666-9112-4edb-846a-a1c0d1d45a55_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3c7c5a79-7ecc-44f9-801f-5211f9992dc0_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_2d712cdd-fcfe-4d2a-87cc-65cc98cbf828_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_4097062b-e89c-4c12-b7a8-00055f2c4fe2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_776ecb36-2ddc-4bf7-8e71-0f70f225f737_terseLabel_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciling items</link:label>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_label_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reconciling Items [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaterialReconcilingItemsMember" xlink:to="lab_us-gaap_MaterialReconcilingItemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_9eefd348-9225-46b5-a46c-10df2d27e3b0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_afcd94b9-04d7-4ffa-8ab3-849eeb9b67a1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Supplemental Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_916fc141-3d89-4fd0-a448-67659f75fa4a_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-term investments (Note&#160;5)</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_7d09bdfa-f75c-4457-a2a7-4bf43491dd72_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_91cfa5f7-01a2-4b5f-ab13-51ac85e0f21b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_6aa4696f-9bf3-4cab-a12d-f071cd8147ec_verboseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash flow hedges</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_fa651195-71ef-41dd-b8eb-a3a819e12c5a_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEGMENT INFORMATION</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d02b37f6-04ae-4c4d-8df2-2d8c1305c4c8_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net increase in cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_RestOfWorldMember_61b5cbba-f1c4-4f60-92a4-37ab2af447a4_terseLabel_en-US" xlink:label="lab_ew_RestOfWorldMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rest of World</link:label>
    <link:label id="lab_ew_RestOfWorldMember_label_en-US" xlink:label="lab_ew_RestOfWorldMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rest of World [Member]</link:label>
    <link:label id="lab_ew_RestOfWorldMember_documentation_en-US" xlink:label="lab_ew_RestOfWorldMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the geographic areas of the world other than the United States, Europe and Japan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_RestOfWorldMember" xlink:href="ew-20240331.xsd#ew_RestOfWorldMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_RestOfWorldMember" xlink:to="lab_ew_RestOfWorldMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_a1aac090-3225-4895-9bc5-5d1870e372d1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_4a15d18a-664e-4f5c-b476-d6f1448ae245_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total before tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_aa69a755-f77d-40f5-8ace-0250268cbb21_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total segment operating income</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_054b89e2-32e1-41c7-9f11-3aa87e011ee3_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffsettingAssetsTableTextBlock_e4db0c20-756b-4303-a57b-0e3ae56d5f36_verboseLabel_en-US" xlink:label="lab_us-gaap_OffsettingAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets</link:label>
    <link:label id="lab_us-gaap_OffsettingAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OffsettingAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Offsetting Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffsettingAssetsTableTextBlock" xlink:to="lab_us-gaap_OffsettingAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_c8adfdd6-b348-409a-b486-b091f693d25e_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract_ef7ac433-0bfd-4371-bd84-530929973c5a_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Rolling Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetFairValueGrossLiability_9508e8b1-2d33-4607-9db4-eb80c8c3f169_negatedLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetFairValueGrossLiability" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Gross Amounts Offset in the Consolidated Balance Sheet</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetFairValueGrossLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetFairValueGrossLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, Liability Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueGrossLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetFairValueGrossLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetFairValueGrossLiability" xlink:to="lab_us-gaap_DerivativeAssetFairValueGrossLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0d1e1887-23b0-44dc-ac46-bac6e327b5e7_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1ec0a858-e70d-41cc-9981-3371de5b5cd7_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_b2627a3a-e52c-40bc-92f0-b8cd4521678b_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffsettingAssetsLineItems_3b559222-274d-4834-b1fb-d77fcaa5bf41_terseLabel_en-US" xlink:label="lab_us-gaap_OffsettingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Offsetting Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_OffsettingAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_OffsettingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Offsetting Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffsettingAssetsLineItems" xlink:to="lab_us-gaap_OffsettingAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare_1fc11fd4-8db5-46a4-bb20-45e5f5ac56a8_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Initial delivery, price per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accelerated Share Repurchases, Initial Price Paid Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_898d660d-63ff-4dc1-87e5-95e1d66aaa57_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Operating income, net</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_2ccac0f4-c38c-4b3b-81aa-d87a94c74e78_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidated operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_d8181f94-8c52-46ec-aa9f-af1018a784f2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Net Sales</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_caa99397-072a-4bce-a3fd-59c9cfe6ebc4_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net Sales Reconciliation</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_6f2ad94b-15e1-4ddb-9ded-c66759e3ef4d_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_7a94b4df-331a-4ad6-9ecd-25488c48e2b0_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_bb7efd36-b9f4-4306-90b5-3ca6c947279c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_e3b3a558-9a24-46fb-842b-6284864cab16_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase in non-marketable equity securities due to observable price changes</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_71bd1a64-ec8f-4323-a794-973b03423afd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_17413d18-da91-412e-b475-2d15dc273994_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_4e3c5b37-fa6a-49ce-89d9-2dfb23bec299_verboseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Estimate of Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPaymentsToAcquireBusinesses_090befe9-551b-4b72-b0b4-f69d59909680_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherPaymentsToAcquireBusinesses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payment for acquisition options (Note 6)</link:label>
    <link:label id="lab_us-gaap_OtherPaymentsToAcquireBusinesses_bf85b9ab-772a-436d-9ae7-34fbbe68f794_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPaymentsToAcquireBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payment for acquisition options</link:label>
    <link:label id="lab_us-gaap_OtherPaymentsToAcquireBusinesses_label_en-US" xlink:label="lab_us-gaap_OtherPaymentsToAcquireBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Payments to Acquire Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPaymentsToAcquireBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPaymentsToAcquireBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPaymentsToAcquireBusinesses" xlink:to="lab_us-gaap_OtherPaymentsToAcquireBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_InitialDeliveryOfSharesSettledFebruary2023Member_485684fc-619c-4a38-a112-3528d8973fc6_terseLabel_en-US" xlink:label="lab_ew_InitialDeliveryOfSharesSettledFebruary2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Initial Delivery of Shares Settled February2023</link:label>
    <link:label id="lab_ew_InitialDeliveryOfSharesSettledFebruary2023Member_label_en-US" xlink:label="lab_ew_InitialDeliveryOfSharesSettledFebruary2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Initial Delivery Of Shares Settled February 2023 [Member]</link:label>
    <link:label id="lab_ew_InitialDeliveryOfSharesSettledFebruary2023Member_documentation_en-US" xlink:label="lab_ew_InitialDeliveryOfSharesSettledFebruary2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Initial Delivery Of Shares Settled February 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_InitialDeliveryOfSharesSettledFebruary2023Member" xlink:href="ew-20240331.xsd#ew_InitialDeliveryOfSharesSettledFebruary2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_InitialDeliveryOfSharesSettledFebruary2023Member" xlink:to="lab_ew_InitialDeliveryOfSharesSettledFebruary2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_EquitySecuritiesFVNIOptionToAcquireInvestment_79675f1d-205d-4858-8cd3-5aa4654b53d1_terseLabel_en-US" xlink:label="lab_ew_EquitySecuritiesFVNIOptionToAcquireInvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment option to acquire</link:label>
    <link:label id="lab_ew_EquitySecuritiesFVNIOptionToAcquireInvestment_label_en-US" xlink:label="lab_ew_EquitySecuritiesFVNIOptionToAcquireInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Securities, FV-NI, Option To Acquire Investment</link:label>
    <link:label id="lab_ew_EquitySecuritiesFVNIOptionToAcquireInvestment_documentation_en-US" xlink:label="lab_ew_EquitySecuritiesFVNIOptionToAcquireInvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Equity Securities, FV-NI, Option To Acquire Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquitySecuritiesFVNIOptionToAcquireInvestment" xlink:href="ew-20240331.xsd#ew_EquitySecuritiesFVNIOptionToAcquireInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_EquitySecuritiesFVNIOptionToAcquireInvestment" xlink:to="lab_ew_EquitySecuritiesFVNIOptionToAcquireInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_09675370-b212-4a61-bda0-f333415108d4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Operating Income</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_9ccde49a-48b6-4ff2-93c2-ca8a8912678f_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Pre-tax Income Reconciliation</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_ConvertiblePromissoryNoteMember_3cf19c21-ca93-4e4c-b944-80b818e838d1_terseLabel_en-US" xlink:label="lab_ew_ConvertiblePromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Promissory Note</link:label>
    <link:label id="lab_ew_ConvertiblePromissoryNoteMember_label_en-US" xlink:label="lab_ew_ConvertiblePromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Promissory Note [Member]</link:label>
    <link:label id="lab_ew_ConvertiblePromissoryNoteMember_documentation_en-US" xlink:label="lab_ew_ConvertiblePromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Convertible Promissory Note</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_ConvertiblePromissoryNoteMember" xlink:href="ew-20240331.xsd#ew_ConvertiblePromissoryNoteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_ConvertiblePromissoryNoteMember" xlink:to="lab_ew_ConvertiblePromissoryNoteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_fad09728-1e1c-474b-b023-dfaeaffd264e_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_0130b4e2-346d-49c2-b59d-e235ed1ffd55_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_d04fb7c0-fc80-43f7-8e1b-6c89a1bf2f0d_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>ew-20240331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:1b5f1024-67d5-4c23-ba5b-277a92b54967,g:71cdffb8-b576-4b3a-8b78-825fbaff5436-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.edwards.com/role/COVER" xlink:type="simple" xlink:href="ew-20240331.xsd#COVER"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/COVER" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_06fb25ea-eaff-423b-90c3-c3fc0300bee6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_f89ccc6f-8f72-450a-95a2-2e2f0ce6f761" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_06fb25ea-eaff-423b-90c3-c3fc0300bee6" xlink:to="loc_dei_DocumentType_f89ccc6f-8f72-450a-95a2-2e2f0ce6f761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_4800984a-ae9c-4e47-b838-5b2502b39e7e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_06fb25ea-eaff-423b-90c3-c3fc0300bee6" xlink:to="loc_dei_DocumentQuarterlyReport_4800984a-ae9c-4e47-b838-5b2502b39e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_27135b1e-2437-4943-a04a-3e2d2f76adee" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_06fb25ea-eaff-423b-90c3-c3fc0300bee6" xlink:to="loc_dei_DocumentPeriodEndDate_27135b1e-2437-4943-a04a-3e2d2f76adee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_ad93d1e7-32ef-4a34-842b-6d9df81f171e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_06fb25ea-eaff-423b-90c3-c3fc0300bee6" xlink:to="loc_dei_DocumentTransitionReport_ad93d1e7-32ef-4a34-842b-6d9df81f171e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_f60d6a21-2282-4196-910e-41eab60495e3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_06fb25ea-eaff-423b-90c3-c3fc0300bee6" xlink:to="loc_dei_EntityFileNumber_f60d6a21-2282-4196-910e-41eab60495e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_35979cff-a67e-4ab6-beb8-cdf6422a5dbb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_06fb25ea-eaff-423b-90c3-c3fc0300bee6" xlink:to="loc_dei_EntityRegistrantName_35979cff-a67e-4ab6-beb8-cdf6422a5dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_622d3265-3c36-45a8-bb24-8adfe1d35451" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_06fb25ea-eaff-423b-90c3-c3fc0300bee6" xlink:to="loc_dei_EntityIncorporationStateCountryCode_622d3265-3c36-45a8-bb24-8adfe1d35451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_9896d6c6-c277-44ac-a738-aad4c200ed5a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_06fb25ea-eaff-423b-90c3-c3fc0300bee6" xlink:to="loc_dei_EntityTaxIdentificationNumber_9896d6c6-c277-44ac-a738-aad4c200ed5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_d55b0fe3-ecf6-47c5-9814-c77157caa1fc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_06fb25ea-eaff-423b-90c3-c3fc0300bee6" xlink:to="loc_dei_EntityAddressAddressLine1_d55b0fe3-ecf6-47c5-9814-c77157caa1fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_3e3e63a1-a018-48c8-824a-b56b5f5ef7f5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_06fb25ea-eaff-423b-90c3-c3fc0300bee6" xlink:to="loc_dei_EntityAddressCityOrTown_3e3e63a1-a018-48c8-824a-b56b5f5ef7f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_f26aaa23-ba72-46b7-87e0-44ca3d9464f4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_06fb25ea-eaff-423b-90c3-c3fc0300bee6" xlink:to="loc_dei_EntityAddressStateOrProvince_f26aaa23-ba72-46b7-87e0-44ca3d9464f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_4d93609f-ce9b-4fe8-9ed3-2e1ddca2403a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_06fb25ea-eaff-423b-90c3-c3fc0300bee6" xlink:to="loc_dei_EntityAddressPostalZipCode_4d93609f-ce9b-4fe8-9ed3-2e1ddca2403a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_62f5f4aa-bc78-483a-bae2-12fe54996bd6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_06fb25ea-eaff-423b-90c3-c3fc0300bee6" xlink:to="loc_dei_CityAreaCode_62f5f4aa-bc78-483a-bae2-12fe54996bd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_de85bedc-c858-407a-8dca-241ab09c2cb8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_06fb25ea-eaff-423b-90c3-c3fc0300bee6" xlink:to="loc_dei_LocalPhoneNumber_de85bedc-c858-407a-8dca-241ab09c2cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_2e682a1d-7004-42b9-89e9-77f1098da326" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_06fb25ea-eaff-423b-90c3-c3fc0300bee6" xlink:to="loc_dei_Security12bTitle_2e682a1d-7004-42b9-89e9-77f1098da326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_41cd00bb-3839-4278-986f-5620c40dfe7b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_06fb25ea-eaff-423b-90c3-c3fc0300bee6" xlink:to="loc_dei_TradingSymbol_41cd00bb-3839-4278-986f-5620c40dfe7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_502e16e5-c7b9-4648-8275-1e9a54e8238f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_06fb25ea-eaff-423b-90c3-c3fc0300bee6" xlink:to="loc_dei_SecurityExchangeName_502e16e5-c7b9-4648-8275-1e9a54e8238f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_0084c97a-e10c-4d7c-93d9-9ba3d6740ad8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_06fb25ea-eaff-423b-90c3-c3fc0300bee6" xlink:to="loc_dei_EntityCurrentReportingStatus_0084c97a-e10c-4d7c-93d9-9ba3d6740ad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_f146a937-052e-4d65-af73-c789b2c4a86e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_06fb25ea-eaff-423b-90c3-c3fc0300bee6" xlink:to="loc_dei_EntityInteractiveDataCurrent_f146a937-052e-4d65-af73-c789b2c4a86e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_82b50de6-a82c-4359-97b8-d650e9a9bcf4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_06fb25ea-eaff-423b-90c3-c3fc0300bee6" xlink:to="loc_dei_EntityFilerCategory_82b50de6-a82c-4359-97b8-d650e9a9bcf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_3ae91061-4e36-4dc5-aaf3-a44eaf2d0a07" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_06fb25ea-eaff-423b-90c3-c3fc0300bee6" xlink:to="loc_dei_EntitySmallBusiness_3ae91061-4e36-4dc5-aaf3-a44eaf2d0a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_d2ce6628-9649-4a1f-a6b1-d2ff8f98a727" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_06fb25ea-eaff-423b-90c3-c3fc0300bee6" xlink:to="loc_dei_EntityEmergingGrowthCompany_d2ce6628-9649-4a1f-a6b1-d2ff8f98a727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_0e0465d7-f2bd-480e-9e16-10bc71c5f46f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_06fb25ea-eaff-423b-90c3-c3fc0300bee6" xlink:to="loc_dei_EntityShellCompany_0e0465d7-f2bd-480e-9e16-10bc71c5f46f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_5dd40361-07f2-4ea4-bdd7-330d9c227218" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_06fb25ea-eaff-423b-90c3-c3fc0300bee6" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_5dd40361-07f2-4ea4-bdd7-330d9c227218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_7761ed29-58e5-4c01-84b3-821f7e3012ce" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_06fb25ea-eaff-423b-90c3-c3fc0300bee6" xlink:to="loc_dei_EntityCentralIndexKey_7761ed29-58e5-4c01-84b3-821f7e3012ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_c1d48521-168b-4592-ba6a-f950385e6356" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_06fb25ea-eaff-423b-90c3-c3fc0300bee6" xlink:to="loc_dei_CurrentFiscalYearEndDate_c1d48521-168b-4592-ba6a-f950385e6356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_cbd7489b-5fb3-4016-83b7-73ab7e1ca23d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_06fb25ea-eaff-423b-90c3-c3fc0300bee6" xlink:to="loc_dei_DocumentFiscalYearFocus_cbd7489b-5fb3-4016-83b7-73ab7e1ca23d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_7d5004ce-b29d-4180-8415-766074914e8c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_06fb25ea-eaff-423b-90c3-c3fc0300bee6" xlink:to="loc_dei_DocumentFiscalPeriodFocus_7d5004ce-b29d-4180-8415-766074914e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_ebad7091-3460-4d36-a398-0895ed786a6f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_06fb25ea-eaff-423b-90c3-c3fc0300bee6" xlink:to="loc_dei_AmendmentFlag_ebad7091-3460-4d36-a398-0895ed786a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" xlink:type="simple" xlink:href="ew-20240331.xsd#CONSOLIDATEDCONDENSEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_fe14d378-72c5-4443-85c0-24577559cd48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_acd72343-b4a3-4852-a713-d2e508e8caf0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fe14d378-72c5-4443-85c0-24577559cd48" xlink:to="loc_us-gaap_AssetsAbstract_acd72343-b4a3-4852-a713-d2e508e8caf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_87b226e1-fb72-4518-aff4-43f5538066c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_acd72343-b4a3-4852-a713-d2e508e8caf0" xlink:to="loc_us-gaap_AssetsCurrentAbstract_87b226e1-fb72-4518-aff4-43f5538066c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e2b51fed-fc82-49a8-a5f0-727a0a30c040" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_87b226e1-fb72-4518-aff4-43f5538066c5" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e2b51fed-fc82-49a8-a5f0-727a0a30c040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_6c1693b9-093f-42d9-b9f1-0486ddb28154" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_87b226e1-fb72-4518-aff4-43f5538066c5" xlink:to="loc_us-gaap_ShortTermInvestments_6c1693b9-093f-42d9-b9f1-0486ddb28154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_7b6b1f52-9b4c-438f-ab89-974ee7da97fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_87b226e1-fb72-4518-aff4-43f5538066c5" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_7b6b1f52-9b4c-438f-ab89-974ee7da97fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_3210b5dd-16ed-4e90-b7ce-b77cfb809ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_87b226e1-fb72-4518-aff4-43f5538066c5" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_3210b5dd-16ed-4e90-b7ce-b77cfb809ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_c06fff11-15af-49f2-8c9d-8ccc7676ef48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_87b226e1-fb72-4518-aff4-43f5538066c5" xlink:to="loc_us-gaap_InventoryNet_c06fff11-15af-49f2-8c9d-8ccc7676ef48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_660a737f-52e7-4141-8961-46384d182fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_87b226e1-fb72-4518-aff4-43f5538066c5" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_660a737f-52e7-4141-8961-46384d182fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_daf9ea50-9e4b-4766-bcdf-73593e946571" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_87b226e1-fb72-4518-aff4-43f5538066c5" xlink:to="loc_us-gaap_OtherAssetsCurrent_daf9ea50-9e4b-4766-bcdf-73593e946571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_4ee66fc7-f655-4546-955d-33c77b601d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_87b226e1-fb72-4518-aff4-43f5538066c5" xlink:to="loc_us-gaap_AssetsCurrent_4ee66fc7-f655-4546-955d-33c77b601d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_8214f526-bcbc-4304-a15a-61e26d3c5f6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_acd72343-b4a3-4852-a713-d2e508e8caf0" xlink:to="loc_us-gaap_LongTermInvestments_8214f526-bcbc-4304-a15a-61e26d3c5f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_87e95acf-3ded-4695-9f03-b446e5b6d350" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_acd72343-b4a3-4852-a713-d2e508e8caf0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_87e95acf-3ded-4695-9f03-b446e5b6d350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_beb1ef21-4c37-4cd7-ba3b-546246356604" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_acd72343-b4a3-4852-a713-d2e508e8caf0" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_beb1ef21-4c37-4cd7-ba3b-546246356604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8b98dca2-4f1f-4adb-b41b-1d6517a70b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_acd72343-b4a3-4852-a713-d2e508e8caf0" xlink:to="loc_us-gaap_Goodwill_8b98dca2-4f1f-4adb-b41b-1d6517a70b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7e5c1cfc-3a85-42a7-b580-080b3bddca3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_acd72343-b4a3-4852-a713-d2e508e8caf0" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7e5c1cfc-3a85-42a7-b580-080b3bddca3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_511cd25a-6470-47b9-8266-0e5f06f37b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_acd72343-b4a3-4852-a713-d2e508e8caf0" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_511cd25a-6470-47b9-8266-0e5f06f37b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_44f8cd91-29de-455b-a9db-9df3b87323b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_acd72343-b4a3-4852-a713-d2e508e8caf0" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_44f8cd91-29de-455b-a9db-9df3b87323b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_c8015d28-d825-4beb-a299-b82409a58291" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_acd72343-b4a3-4852-a713-d2e508e8caf0" xlink:to="loc_us-gaap_Assets_c8015d28-d825-4beb-a299-b82409a58291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd77f027-e695-44d6-9561-37a69a881f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fe14d378-72c5-4443-85c0-24577559cd48" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd77f027-e695-44d6-9561-37a69a881f0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_a23f5f50-c462-4261-a292-05696c6dfb49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd77f027-e695-44d6-9561-37a69a881f0f" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_a23f5f50-c462-4261-a292-05696c6dfb49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_ed018f35-7a52-41d5-8518-89cbca6d3412" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a23f5f50-c462-4261-a292-05696c6dfb49" xlink:to="loc_us-gaap_AccountsPayableCurrent_ed018f35-7a52-41d5-8518-89cbca6d3412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccruedAndOtherLiabilitiesCurrent_c19e2308-16dd-4111-af11-938c9dc193b8" xlink:href="ew-20240331.xsd#ew_AccruedAndOtherLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a23f5f50-c462-4261-a292-05696c6dfb49" xlink:to="loc_ew_AccruedAndOtherLiabilitiesCurrent_c19e2308-16dd-4111-af11-938c9dc193b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_998a3064-57a2-4a44-bbf1-549689a70bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a23f5f50-c462-4261-a292-05696c6dfb49" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_998a3064-57a2-4a44-bbf1-549689a70bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_845b597d-5a4d-4fb2-b6c7-dc85bf29dc5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a23f5f50-c462-4261-a292-05696c6dfb49" xlink:to="loc_us-gaap_LiabilitiesCurrent_845b597d-5a4d-4fb2-b6c7-dc85bf29dc5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_28864a30-7289-427a-9f86-ecdf10506387" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd77f027-e695-44d6-9561-37a69a881f0f" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_28864a30-7289-427a-9f86-ecdf10506387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrentAndNoncurrent_56b42370-c09d-4d3a-8a16-027b00a47d73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd77f027-e695-44d6-9561-37a69a881f0f" xlink:to="loc_us-gaap_TaxesPayableCurrentAndNoncurrent_56b42370-c09d-4d3a-8a16-027b00a47d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_5e08ce4f-3e20-46a6-af90-bc3150766b60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd77f027-e695-44d6-9561-37a69a881f0f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_5e08ce4f-3e20-46a6-af90-bc3150766b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_4e66ffcc-921a-4822-b1f3-ce7795ff4391" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd77f027-e695-44d6-9561-37a69a881f0f" xlink:to="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_4e66ffcc-921a-4822-b1f3-ce7795ff4391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent_3f7c6ede-a136-41fd-9613-af8a64f3fd8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd77f027-e695-44d6-9561-37a69a881f0f" xlink:to="loc_us-gaap_LitigationReserveNoncurrent_3f7c6ede-a136-41fd-9613-af8a64f3fd8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_5762688b-7653-4eab-ae43-a687cabc3037" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd77f027-e695-44d6-9561-37a69a881f0f" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_5762688b-7653-4eab-ae43-a687cabc3037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_618fc7f8-6ef7-4b54-9994-4c1d4933bed2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd77f027-e695-44d6-9561-37a69a881f0f" xlink:to="loc_us-gaap_Liabilities_618fc7f8-6ef7-4b54-9994-4c1d4933bed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_e4de12c6-f530-4154-bed3-83dae8dc0c17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd77f027-e695-44d6-9561-37a69a881f0f" xlink:to="loc_us-gaap_CommitmentsAndContingencies_e4de12c6-f530-4154-bed3-83dae8dc0c17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_71d8a5f9-bfa6-4a96-9433-b3972e4976e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd77f027-e695-44d6-9561-37a69a881f0f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_71d8a5f9-bfa6-4a96-9433-b3972e4976e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_8c5b72f3-b43a-4fe4-bff4-e3d6be7a6f84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_71d8a5f9-bfa6-4a96-9433-b3972e4976e4" xlink:to="loc_us-gaap_PreferredStockValue_8c5b72f3-b43a-4fe4-bff4-e3d6be7a6f84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_fb5bb69b-3caf-4b80-94eb-20222dddb09c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_71d8a5f9-bfa6-4a96-9433-b3972e4976e4" xlink:to="loc_us-gaap_CommonStockValue_fb5bb69b-3caf-4b80-94eb-20222dddb09c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_80972057-d88c-4279-9d73-72051ef20160" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_71d8a5f9-bfa6-4a96-9433-b3972e4976e4" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_80972057-d88c-4279-9d73-72051ef20160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_fafcc8f8-5c29-45c2-9d5a-e839dc4d84fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_71d8a5f9-bfa6-4a96-9433-b3972e4976e4" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_fafcc8f8-5c29-45c2-9d5a-e839dc4d84fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b2225583-7fa4-4553-9990-5db7e35b5f65" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_71d8a5f9-bfa6-4a96-9433-b3972e4976e4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b2225583-7fa4-4553-9990-5db7e35b5f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_57e35933-acde-44bd-884d-f5535ec339d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_71d8a5f9-bfa6-4a96-9433-b3972e4976e4" xlink:to="loc_us-gaap_TreasuryStockCommonValue_57e35933-acde-44bd-884d-f5535ec339d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_fd670b5d-90c7-4754-beba-0e65bbbdbc97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_71d8a5f9-bfa6-4a96-9433-b3972e4976e4" xlink:to="loc_us-gaap_StockholdersEquity_fd670b5d-90c7-4754-beba-0e65bbbdbc97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_716a8c96-7382-4c0e-a886-aef0f4a394ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_71d8a5f9-bfa6-4a96-9433-b3972e4976e4" xlink:to="loc_us-gaap_MinorityInterest_716a8c96-7382-4c0e-a886-aef0f4a394ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e442c4be-3baa-4246-81fa-ba02b3fab462" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_71d8a5f9-bfa6-4a96-9433-b3972e4976e4" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e442c4be-3baa-4246-81fa-ba02b3fab462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_4bffef8e-0bb3-48e2-8317-9145fcdb2399" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd77f027-e695-44d6-9561-37a69a881f0f" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_4bffef8e-0bb3-48e2-8317-9145fcdb2399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="ew-20240331.xsd#CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_b189b23e-37b6-484c-bbf6-a8bfb242899f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_72832ab6-ad74-4b70-8bfe-a5bd78087900" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b189b23e-37b6-484c-bbf6-a8bfb242899f" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_72832ab6-ad74-4b70-8bfe-a5bd78087900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_7e92cff0-2dd8-4e02-8ccd-ea08d36ee1df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b189b23e-37b6-484c-bbf6-a8bfb242899f" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_7e92cff0-2dd8-4e02-8ccd-ea08d36ee1df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_24367bc6-2eea-4ff3-b3f4-69575d175c28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b189b23e-37b6-484c-bbf6-a8bfb242899f" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_24367bc6-2eea-4ff3-b3f4-69575d175c28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_9fc1431f-c8a3-47f2-aecb-350f0ea415df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b189b23e-37b6-484c-bbf6-a8bfb242899f" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_9fc1431f-c8a3-47f2-aecb-350f0ea415df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_dc879130-a480-4b89-ad41-84809b68dbae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b189b23e-37b6-484c-bbf6-a8bfb242899f" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_dc879130-a480-4b89-ad41-84809b68dbae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_3f9c21dc-95fa-42fb-a167-3f34e0c889c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b189b23e-37b6-484c-bbf6-a8bfb242899f" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_3f9c21dc-95fa-42fb-a167-3f34e0c889c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_4fb0c5eb-f154-414c-8236-1522462e1007" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b189b23e-37b6-484c-bbf6-a8bfb242899f" xlink:to="loc_us-gaap_CommonStockSharesIssued_4fb0c5eb-f154-414c-8236-1522462e1007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_f4917dc0-6d80-4b4f-acb7-ef829023a76c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b189b23e-37b6-484c-bbf6-a8bfb242899f" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_f4917dc0-6d80-4b4f-acb7-ef829023a76c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_b4c17d2b-a24e-4a64-8739-d56ac26502cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b189b23e-37b6-484c-bbf6-a8bfb242899f" xlink:to="loc_us-gaap_TreasuryStockCommonShares_b4c17d2b-a24e-4a64-8739-d56ac26502cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="ew-20240331.xsd#CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_c3a3a59a-64ec-4e2c-8706-19e36a042847" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_06faf65d-8965-452b-9a89-1e2083b8b6f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c3a3a59a-64ec-4e2c-8706-19e36a042847" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_06faf65d-8965-452b-9a89-1e2083b8b6f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_d921894f-0e1c-4f4b-8bd2-a05b04059dac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c3a3a59a-64ec-4e2c-8706-19e36a042847" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_d921894f-0e1c-4f4b-8bd2-a05b04059dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_aa2a51eb-b188-4564-b8da-4e92a0008504" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c3a3a59a-64ec-4e2c-8706-19e36a042847" xlink:to="loc_us-gaap_GrossProfit_aa2a51eb-b188-4564-b8da-4e92a0008504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_782e80f3-6b97-4383-9053-0ceb51a2e24a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c3a3a59a-64ec-4e2c-8706-19e36a042847" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_782e80f3-6b97-4383-9053-0ceb51a2e24a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_86575007-4b51-4050-8847-f69100399ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c3a3a59a-64ec-4e2c-8706-19e36a042847" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_86575007-4b51-4050-8847-f69100399ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_bea2a6ba-4c0b-486e-84f7-89ce751ab07b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c3a3a59a-64ec-4e2c-8706-19e36a042847" xlink:to="loc_us-gaap_LitigationSettlementExpense_bea2a6ba-4c0b-486e-84f7-89ce751ab07b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_ec9bcd38-d50c-469f-91d7-8a1c216bc3bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c3a3a59a-64ec-4e2c-8706-19e36a042847" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_ec9bcd38-d50c-469f-91d7-8a1c216bc3bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonrecurringIncomeExpense_6d3e9c8a-d1f5-409c-80c4-2f9d8b047c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonrecurringIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c3a3a59a-64ec-4e2c-8706-19e36a042847" xlink:to="loc_us-gaap_OtherNonrecurringIncomeExpense_6d3e9c8a-d1f5-409c-80c4-2f9d8b047c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_bdc21555-deaf-4125-bd28-456e3299425a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c3a3a59a-64ec-4e2c-8706-19e36a042847" xlink:to="loc_us-gaap_OperatingIncomeLoss_bdc21555-deaf-4125-bd28-456e3299425a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_db21de85-5f24-4393-8942-92c174e0601b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c3a3a59a-64ec-4e2c-8706-19e36a042847" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_db21de85-5f24-4393-8942-92c174e0601b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_04abfcfa-b92f-4b45-aaa5-34cfad4a8450" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c3a3a59a-64ec-4e2c-8706-19e36a042847" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_04abfcfa-b92f-4b45-aaa5-34cfad4a8450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_64a6076f-ca51-4a9f-a3a6-6597be044673" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c3a3a59a-64ec-4e2c-8706-19e36a042847" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_64a6076f-ca51-4a9f-a3a6-6597be044673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c80f8611-ec03-4605-a47d-090795e8c559" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c3a3a59a-64ec-4e2c-8706-19e36a042847" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c80f8611-ec03-4605-a47d-090795e8c559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_585a1e8c-a2cc-418f-a6af-f453110eeb55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c3a3a59a-64ec-4e2c-8706-19e36a042847" xlink:to="loc_us-gaap_ProfitLoss_585a1e8c-a2cc-418f-a6af-f453110eeb55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_15a6785e-ad0a-4be2-9b33-db995278ba7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c3a3a59a-64ec-4e2c-8706-19e36a042847" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_15a6785e-ad0a-4be2-9b33-db995278ba7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4cf6bfdc-b75e-450e-bfaa-006381f8e423" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c3a3a59a-64ec-4e2c-8706-19e36a042847" xlink:to="loc_us-gaap_NetIncomeLoss_4cf6bfdc-b75e-450e-bfaa-006381f8e423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_ShareInformationAbstract_77cb059a-495f-435c-9be4-c02428a51913" xlink:href="ew-20240331.xsd#ew_ShareInformationAbstract"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c3a3a59a-64ec-4e2c-8706-19e36a042847" xlink:to="loc_ew_ShareInformationAbstract_77cb059a-495f-435c-9be4-c02428a51913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_128ad68a-d280-4cbb-a7f3-1a98da436d44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ew_ShareInformationAbstract_77cb059a-495f-435c-9be4-c02428a51913" xlink:to="loc_us-gaap_EarningsPerShareAbstract_128ad68a-d280-4cbb-a7f3-1a98da436d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_488dcafd-df49-48d4-a339-6e741ed4ad4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_128ad68a-d280-4cbb-a7f3-1a98da436d44" xlink:to="loc_us-gaap_EarningsPerShareBasic_488dcafd-df49-48d4-a339-6e741ed4ad4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_caa4105f-54cf-4d25-a7e0-a577f8ec0181" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_128ad68a-d280-4cbb-a7f3-1a98da436d44" xlink:to="loc_us-gaap_EarningsPerShareDiluted_caa4105f-54cf-4d25-a7e0-a577f8ec0181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_4a37374d-b3ea-4891-8c91-9f2246179295" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ew_ShareInformationAbstract_77cb059a-495f-435c-9be4-c02428a51913" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_4a37374d-b3ea-4891-8c91-9f2246179295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3ab67829-43dc-4fd8-b199-87fe0990e4e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_4a37374d-b3ea-4891-8c91-9f2246179295" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3ab67829-43dc-4fd8-b199-87fe0990e4e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_80c2af35-531c-4370-b657-3c885c7dd64e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_4a37374d-b3ea-4891-8c91-9f2246179295" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_80c2af35-531c-4370-b657-3c885c7dd64e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="ew-20240331.xsd#CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_cb5c24ba-6fb8-48d4-87f0-e57ef500fa67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_610ebe12-2d5d-44b0-9556-36f5092c757f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_cb5c24ba-6fb8-48d4-87f0-e57ef500fa67" xlink:to="loc_us-gaap_ProfitLoss_610ebe12-2d5d-44b0-9556-36f5092c757f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_8434412e-7fe2-468f-af58-9594ef54485e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_cb5c24ba-6fb8-48d4-87f0-e57ef500fa67" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_8434412e-7fe2-468f-af58-9594ef54485e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_701068ea-c82b-4577-8456-d21229b2726d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_8434412e-7fe2-468f-af58-9594ef54485e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_701068ea-c82b-4577-8456-d21229b2726d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_bfa40251-501b-49f5-99fe-e72bbfe94caf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_8434412e-7fe2-468f-af58-9594ef54485e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_bfa40251-501b-49f5-99fe-e72bbfe94caf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_f66aaa82-6e4b-49f8-b95f-4000a7eb1442" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_8434412e-7fe2-468f-af58-9594ef54485e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_f66aaa82-6e4b-49f8-b95f-4000a7eb1442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_bd87e2b6-7fc4-45ae-8894-753b55f86b15" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_8434412e-7fe2-468f-af58-9594ef54485e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_bd87e2b6-7fc4-45ae-8894-753b55f86b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cbcd2d69-954c-4c32-a4af-c7c51fea33f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_8434412e-7fe2-468f-af58-9594ef54485e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cbcd2d69-954c-4c32-a4af-c7c51fea33f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_114042d8-1f41-48b4-b251-59e0ead3c574" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_cb5c24ba-6fb8-48d4-87f0-e57ef500fa67" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_114042d8-1f41-48b4-b251-59e0ead3c574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_91bb675a-629d-4378-87f0-cbd092a82b11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_cb5c24ba-6fb8-48d4-87f0-e57ef500fa67" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_91bb675a-629d-4378-87f0-cbd092a82b11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_099d3eac-47ba-4792-b260-08ad35015ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_cb5c24ba-6fb8-48d4-87f0-e57ef500fa67" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_099d3eac-47ba-4792-b260-08ad35015ce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="ew-20240331.xsd#CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_070c2290-d8ca-433c-a1f6-d375dfaf0638" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_0b7788c9-9092-483d-8fcc-de18128322e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_070c2290-d8ca-433c-a1f6-d375dfaf0638" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_0b7788c9-9092-483d-8fcc-de18128322e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9afa3eda-9db3-4cc2-a5e0-d82a6784b74b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_0b7788c9-9092-483d-8fcc-de18128322e8" xlink:to="loc_us-gaap_ProfitLoss_9afa3eda-9db3-4cc2-a5e0-d82a6784b74b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6f899087-3542-4951-b701-480185a93f34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_0b7788c9-9092-483d-8fcc-de18128322e8" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6f899087-3542-4951-b701-480185a93f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_b60c0e12-fe76-4182-83ac-443eec76b9f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6f899087-3542-4951-b701-480185a93f34" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_b60c0e12-fe76-4182-83ac-443eec76b9f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_3e25c62f-4b0f-48f7-a472-772871a635a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6f899087-3542-4951-b701-480185a93f34" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_3e25c62f-4b0f-48f7-a472-772871a635a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_f4ff9539-339f-4bab-b9af-edc029360d25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6f899087-3542-4951-b701-480185a93f34" xlink:to="loc_us-gaap_ShareBasedCompensation_f4ff9539-339f-4bab-b9af-edc029360d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_a5bd8938-6237-408a-86c6-02a0c8ecdbfe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6f899087-3542-4951-b701-480185a93f34" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_a5bd8938-6237-408a-86c6-02a0c8ecdbfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_cf912f89-add1-4ec1-adbd-77933209c933" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6f899087-3542-4951-b701-480185a93f34" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_cf912f89-add1-4ec1-adbd-77933209c933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3794f803-7eb3-4600-bb9a-83c3916bfc64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6f899087-3542-4951-b701-480185a93f34" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3794f803-7eb3-4600-bb9a-83c3916bfc64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_d2152b71-276d-482f-adb3-eb86574dc8ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3794f803-7eb3-4600-bb9a-83c3916bfc64" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_d2152b71-276d-482f-adb3-eb86574dc8ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_0851d6ea-e941-493b-b5b7-f7e0139dbca5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3794f803-7eb3-4600-bb9a-83c3916bfc64" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_0851d6ea-e941-493b-b5b7-f7e0139dbca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_aa09c725-808c-4912-9ac3-53b7871f2679" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3794f803-7eb3-4600-bb9a-83c3916bfc64" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_aa09c725-808c-4912-9ac3-53b7871f2679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_e55fdfbd-5e4f-4c82-acfc-ab2e9ef52893" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3794f803-7eb3-4600-bb9a-83c3916bfc64" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_e55fdfbd-5e4f-4c82-acfc-ab2e9ef52893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_a51e4e2a-703c-4fae-8a1d-8b3fddb6ad55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3794f803-7eb3-4600-bb9a-83c3916bfc64" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_a51e4e2a-703c-4fae-8a1d-8b3fddb6ad55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_IncreaseDecreaseInLegalSettlementAccrual_60895ccf-11de-406a-a532-d98f5e31bd8a" xlink:href="ew-20240331.xsd#ew_IncreaseDecreaseInLegalSettlementAccrual"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3794f803-7eb3-4600-bb9a-83c3916bfc64" xlink:to="loc_ew_IncreaseDecreaseInLegalSettlementAccrual_60895ccf-11de-406a-a532-d98f5e31bd8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_0c801d8c-c8e9-4b90-ad68-3023f9012015" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3794f803-7eb3-4600-bb9a-83c3916bfc64" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_0c801d8c-c8e9-4b90-ad68-3023f9012015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_09a49d5d-1f4c-4f9b-b0a8-d8dbc34ae2da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6f899087-3542-4951-b701-480185a93f34" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_09a49d5d-1f4c-4f9b-b0a8-d8dbc34ae2da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_2757951d-52c1-4f8e-acfc-00426a02e2d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_070c2290-d8ca-433c-a1f6-d375dfaf0638" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_2757951d-52c1-4f8e-acfc-00426a02e2d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f9599f95-5443-490e-88e0-b4eaf0feafd3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_2757951d-52c1-4f8e-acfc-00426a02e2d2" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f9599f95-5443-490e-88e0-b4eaf0feafd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_a05a1042-0302-44d4-ab90-e3cec4e7181f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_2757951d-52c1-4f8e-acfc-00426a02e2d2" xlink:to="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_a05a1042-0302-44d4-ab90-e3cec4e7181f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_d74ed491-0f6a-4550-a33c-852886407487" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_2757951d-52c1-4f8e-acfc-00426a02e2d2" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_d74ed491-0f6a-4550-a33c-852886407487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_276b04a6-37e2-474b-a311-9506aba9e268" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_2757951d-52c1-4f8e-acfc-00426a02e2d2" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_276b04a6-37e2-474b-a311-9506aba9e268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_b044c3db-73d9-4b9e-830e-c8d12885f1a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_2757951d-52c1-4f8e-acfc-00426a02e2d2" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_b044c3db-73d9-4b9e-830e-c8d12885f1a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_510a1087-6294-4fc7-a528-fe6cfae0b437" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_2757951d-52c1-4f8e-acfc-00426a02e2d2" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_510a1087-6294-4fc7-a528-fe6cfae0b437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions_431e076e-9a30-4fa0-9562-98292ebab118" xlink:href="ew-20240331.xsd#ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_2757951d-52c1-4f8e-acfc-00426a02e2d2" xlink:to="loc_ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions_431e076e-9a30-4fa0-9562-98292ebab118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPaymentsToAcquireBusinesses_28e91473-8a0b-49e9-a0d4-5b93a00958ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPaymentsToAcquireBusinesses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_2757951d-52c1-4f8e-acfc-00426a02e2d2" xlink:to="loc_us-gaap_OtherPaymentsToAcquireBusinesses_28e91473-8a0b-49e9-a0d4-5b93a00958ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireReceivables_6166589a-6288-4b45-aeb3-5a8654599868" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireReceivables"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_2757951d-52c1-4f8e-acfc-00426a02e2d2" xlink:to="loc_us-gaap_PaymentsToAcquireReceivables_6166589a-6288-4b45-aeb3-5a8654599868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_0fd6a758-d968-45a6-9501-48d742c57328" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_2757951d-52c1-4f8e-acfc-00426a02e2d2" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_0fd6a758-d968-45a6-9501-48d742c57328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_363a4c75-ee07-455b-a99e-d6eda7c671a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_2757951d-52c1-4f8e-acfc-00426a02e2d2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_363a4c75-ee07-455b-a99e-d6eda7c671a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_773d9174-f6e0-4659-8d66-bb5f3df555d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_070c2290-d8ca-433c-a1f6-d375dfaf0638" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_773d9174-f6e0-4659-8d66-bb5f3df555d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_4c06e5a0-1c74-4327-aec5-a44ba89de58e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_773d9174-f6e0-4659-8d66-bb5f3df555d2" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_4c06e5a0-1c74-4327-aec5-a44ba89de58e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_b06f4a98-8b8c-4468-8f2f-bdbcbc5e1f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_773d9174-f6e0-4659-8d66-bb5f3df555d2" xlink:to="loc_us-gaap_ProceedsFromStockPlans_b06f4a98-8b8c-4468-8f2f-bdbcbc5e1f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_febccaaf-1e1f-42fc-88f4-e13b56a503e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_773d9174-f6e0-4659-8d66-bb5f3df555d2" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_febccaaf-1e1f-42fc-88f4-e13b56a503e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_590b26d5-30c5-4c64-8703-768d39b3bb78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_773d9174-f6e0-4659-8d66-bb5f3df555d2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_590b26d5-30c5-4c64-8703-768d39b3bb78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a3b73a32-46e3-4145-bfae-e3078a29e258" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_070c2290-d8ca-433c-a1f6-d375dfaf0638" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a3b73a32-46e3-4145-bfae-e3078a29e258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_72583817-38b5-4dfa-a526-ae5c16ec12b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_070c2290-d8ca-433c-a1f6-d375dfaf0638" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_72583817-38b5-4dfa-a526-ae5c16ec12b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e075b646-c47f-442a-b84e-84cb95439ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_070c2290-d8ca-433c-a1f6-d375dfaf0638" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e075b646-c47f-442a-b84e-84cb95439ef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4f899db8-36ae-4108-8057-678d76552eea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_070c2290-d8ca-433c-a1f6-d375dfaf0638" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4f899db8-36ae-4108-8057-678d76552eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="ew-20240331.xsd#CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_3b8a194e-2467-4996-b10a-33a3459216c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8ad9aeaa-84b1-4f62-a8e8-b5147b5d388d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_3b8a194e-2467-4996-b10a-33a3459216c5" xlink:to="loc_us-gaap_StatementTable_8ad9aeaa-84b1-4f62-a8e8-b5147b5d388d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a470d422-30ae-4965-990f-0aa6b936b2ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8ad9aeaa-84b1-4f62-a8e8-b5147b5d388d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a470d422-30ae-4965-990f-0aa6b936b2ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ec28378b-ca71-45fb-ba76-804dd24b8e77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a470d422-30ae-4965-990f-0aa6b936b2ad" xlink:to="loc_us-gaap_EquityComponentDomain_ec28378b-ca71-45fb-ba76-804dd24b8e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_c66816a8-8acf-4992-8534-ebb39a9870dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ec28378b-ca71-45fb-ba76-804dd24b8e77" xlink:to="loc_us-gaap_ParentMember_c66816a8-8acf-4992-8534-ebb39a9870dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_cd6bf8fd-6962-47b2-8522-380b08c66ee2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_c66816a8-8acf-4992-8534-ebb39a9870dd" xlink:to="loc_us-gaap_CommonStockMember_cd6bf8fd-6962-47b2-8522-380b08c66ee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_3ee9fa0b-17cd-4de0-9726-315849b05b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_c66816a8-8acf-4992-8534-ebb39a9870dd" xlink:to="loc_us-gaap_TreasuryStockCommonMember_3ee9fa0b-17cd-4de0-9726-315849b05b5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_6974eb95-8f6f-4642-8939-b2728d758a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_c66816a8-8acf-4992-8534-ebb39a9870dd" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_6974eb95-8f6f-4642-8939-b2728d758a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_3f1ab2f0-7d75-4166-bb32-75520a27b1f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_c66816a8-8acf-4992-8534-ebb39a9870dd" xlink:to="loc_us-gaap_RetainedEarningsMember_3f1ab2f0-7d75-4166-bb32-75520a27b1f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7a2aa122-69aa-49a9-ac82-f8861cb435e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_c66816a8-8acf-4992-8534-ebb39a9870dd" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7a2aa122-69aa-49a9-ac82-f8861cb435e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_b8b118b6-44f4-4d72-9252-b801783f0b74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ec28378b-ca71-45fb-ba76-804dd24b8e77" xlink:to="loc_us-gaap_NoncontrollingInterestMember_b8b118b6-44f4-4d72-9252-b801783f0b74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7fa7b61f-fef9-4780-80a3-eebe88b97c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8ad9aeaa-84b1-4f62-a8e8-b5147b5d388d" xlink:to="loc_us-gaap_StatementLineItems_7fa7b61f-fef9-4780-80a3-eebe88b97c0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c61bed1-ca03-49f4-be2c-9e0f6fe6a318" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7fa7b61f-fef9-4780-80a3-eebe88b97c0c" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c61bed1-ca03-49f4-be2c-9e0f6fe6a318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_5dda2770-dc48-43f0-96d5-6d50b0168a63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c61bed1-ca03-49f4-be2c-9e0f6fe6a318" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_5dda2770-dc48-43f0-96d5-6d50b0168a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7d58fde6-920e-4b3a-afcf-e3d5a8f70269" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c61bed1-ca03-49f4-be2c-9e0f6fe6a318" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7d58fde6-920e-4b3a-afcf-e3d5a8f70269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_723f9d4d-9d85-4e6e-a475-3c8aa31ab04f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c61bed1-ca03-49f4-be2c-9e0f6fe6a318" xlink:to="loc_us-gaap_TreasuryStockCommonShares_723f9d4d-9d85-4e6e-a475-3c8aa31ab04f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_2326354d-cdf9-4911-877f-5402a49e31f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c61bed1-ca03-49f4-be2c-9e0f6fe6a318" xlink:to="loc_us-gaap_ProfitLoss_2326354d-cdf9-4911-877f-5402a49e31f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a53fe431-702f-48fb-8c04-99703d36b37c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c61bed1-ca03-49f4-be2c-9e0f6fe6a318" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a53fe431-702f-48fb-8c04-99703d36b37c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_a4b5f201-2ce8-4879-8153-b4c2442746c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c61bed1-ca03-49f4-be2c-9e0f6fe6a318" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_a4b5f201-2ce8-4879-8153-b4c2442746c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3e1c9cc7-485f-454f-8661-da94bf7bcf4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c61bed1-ca03-49f4-be2c-9e0f6fe6a318" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3e1c9cc7-485f-454f-8661-da94bf7bcf4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_cf8462a4-87e4-44d0-b93d-30ae0f604896" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c61bed1-ca03-49f4-be2c-9e0f6fe6a318" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_cf8462a4-87e4-44d0-b93d-30ae0f604896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_1c77ebaf-2b81-4b79-9be8-61bbe2ca557b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c61bed1-ca03-49f4-be2c-9e0f6fe6a318" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_1c77ebaf-2b81-4b79-9be8-61bbe2ca557b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_f4a96654-72b6-4dbc-8158-f9262b10cf1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c61bed1-ca03-49f4-be2c-9e0f6fe6a318" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_f4a96654-72b6-4dbc-8158-f9262b10cf1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_1c457a90-daa6-4b7c-a06b-1702852575e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c61bed1-ca03-49f4-be2c-9e0f6fe6a318" xlink:to="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_1c457a90-daa6-4b7c-a06b-1702852575e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_b3b938e5-61c7-479d-8148-9184d0c51591" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c61bed1-ca03-49f4-be2c-9e0f6fe6a318" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_b3b938e5-61c7-479d-8148-9184d0c51591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ec5fa3cc-d185-41ae-adea-daabff304b43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c61bed1-ca03-49f4-be2c-9e0f6fe6a318" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ec5fa3cc-d185-41ae-adea-daabff304b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_1718beb4-c417-4d28-a8a8-ca96caf884a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c61bed1-ca03-49f4-be2c-9e0f6fe6a318" xlink:to="loc_us-gaap_TreasuryStockCommonShares_1718beb4-c417-4d28-a8a8-ca96caf884a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/BASISOFPRESENTATION" xlink:type="simple" xlink:href="ew-20240331.xsd#BASISOFPRESENTATION"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/BASISOFPRESENTATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_3055c75d-b0ce-4171-895f-6713ebed8dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_3969c9d1-4a84-4fe7-81b0-5c8bd8adb03f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3055c75d-b0ce-4171-895f-6713ebed8dbd" xlink:to="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_3969c9d1-4a84-4fe7-81b0-5c8bd8adb03f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS" xlink:type="simple" xlink:href="ew-20240331.xsd#OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e49cfd1e-6c07-42ca-aae7-469911babe95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_97b1b3bd-eb67-4dbc-933b-ca15f846e7e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e49cfd1e-6c07-42ca-aae7-469911babe95" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_97b1b3bd-eb67-4dbc-933b-ca15f846e7e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSES" xlink:type="simple" xlink:href="ew-20240331.xsd#INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSES"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_80e4065f-a896-45b3-8d7b-40c55c28a535" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock_2a00a1aa-e7b2-4390-a16c-eb4e14596f42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_80e4065f-a896-45b3-8d7b-40c55c28a535" xlink:to="loc_us-gaap_LegalMattersAndContingenciesTextBlock_2a00a1aa-e7b2-4390-a16c-eb4e14596f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/SEPARATIONCOSTS" xlink:type="simple" xlink:href="ew-20240331.xsd#SEPARATIONCOSTS"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/SEPARATIONCOSTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_fdc7d8ed-7d5c-48df-a7f4-1235c59afe0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock_3bd74453-5ee1-48c5-81c3-3ceacbc0b97d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_fdc7d8ed-7d5c-48df-a7f4-1235c59afe0a" xlink:to="loc_us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock_3bd74453-5ee1-48c5-81c3-3ceacbc0b97d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INVESTMENTS" xlink:type="simple" xlink:href="ew-20240331.xsd#INVESTMENTS"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/INVESTMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_2f8ca81e-8c14-4b86-8fa3-7eb6f071352b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_0ebbeb09-eb7e-403f-b8a0-73256260cc73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_2f8ca81e-8c14-4b86-8fa3-7eb6f071352b" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_0ebbeb09-eb7e-403f-b8a0-73256260cc73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIES" xlink:type="simple" xlink:href="ew-20240331.xsd#INVESTMENTSINVARIABLEINTERESTENTITIES"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ew_VariableInterestEntitiesAbstract_bf87198c-639c-431e-8a60-485774db54e8" xlink:href="ew-20240331.xsd#ew_VariableInterestEntitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_ecc9d431-19f2-4aa9-a06a-a65b1d36d29e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ew_VariableInterestEntitiesAbstract_bf87198c-639c-431e-8a60-485774db54e8" xlink:to="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_ecc9d431-19f2-4aa9-a06a-a65b1d36d29e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/FAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="ew-20240331.xsd#FAIRVALUEMEASUREMENTS"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/FAIRVALUEMEASUREMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_12fea194-f246-443e-8224-6fa1fabf163f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_dd195cdd-b872-44e3-8e1e-aea5d080842a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_12fea194-f246-443e-8224-6fa1fabf163f" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_dd195cdd-b872-44e3-8e1e-aea5d080842a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES" xlink:type="simple" xlink:href="ew-20240331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a2f102eb-6569-4383-af32-cd362030ccd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_78e91e88-40c4-42a6-9aff-89a38f2a4905" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a2f102eb-6569-4383-af32-cd362030ccd4" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_78e91e88-40c4-42a6-9aff-89a38f2a4905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/STOCKBASEDCOMPENSATION" xlink:type="simple" xlink:href="ew-20240331.xsd#STOCKBASEDCOMPENSATION"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/STOCKBASEDCOMPENSATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e9dbf20e-0311-4716-a589-c9d5529d1ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_2bedec74-bdf7-4110-a28e-7a63dc1d7751" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e9dbf20e-0311-4716-a589-c9d5529d1ffb" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_2bedec74-bdf7-4110-a28e-7a63dc1d7751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASE" xlink:type="simple" xlink:href="ew-20240331.xsd#ACCELERATEDSHAREREPURCHASE"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e212b85f-1914-411d-bb12-e0b4b6863a6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_2e4053e1-a7c9-4300-a114-24b1bc3eca9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e212b85f-1914-411d-bb12-e0b4b6863a6a" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_2e4053e1-a7c9-4300-a114-24b1bc3eca9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="ew-20240331.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0b2b65cf-7038-43a0-98ec-e600d3ce35a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_d0441bc7-d43c-4e92-b263-09eba593fce7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0b2b65cf-7038-43a0-98ec-e600d3ce35a9" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_d0441bc7-d43c-4e92-b263-09eba593fce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="ew-20240331.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSS"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_ea94c8c4-9c35-4fff-bc82-1e8cfbf2f398" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_da4a30f8-e7d9-493c-9654-5c11205e380c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ea94c8c4-9c35-4fff-bc82-1e8cfbf2f398" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_da4a30f8-e7d9-493c-9654-5c11205e380c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/EARNINGSPERSHARE" xlink:type="simple" xlink:href="ew-20240331.xsd#EARNINGSPERSHARE"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/EARNINGSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e8c903fc-0c8d-496e-9467-92408cc5606c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_809617c3-ed67-4359-92ee-29fdc7b725f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e8c903fc-0c8d-496e-9467-92408cc5606c" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_809617c3-ed67-4359-92ee-29fdc7b725f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INCOMETAXES" xlink:type="simple" xlink:href="ew-20240331.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_30b29783-7a68-4c0c-a6fe-71bc39b5f6b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_23e971bd-e324-47f7-ab00-1b78826b37a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_30b29783-7a68-4c0c-a6fe-71bc39b5f6b6" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_23e971bd-e324-47f7-ab00-1b78826b37a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/SEGMENTINFORMATION" xlink:type="simple" xlink:href="ew-20240331.xsd#SEGMENTINFORMATION"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/SEGMENTINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ee7d2015-a6e8-4907-a8ce-5ff70d977faf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_2ec89ad3-1c1c-466b-902f-4d4316098c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ee7d2015-a6e8-4907-a8ce-5ff70d977faf" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_2ec89ad3-1c1c-466b-902f-4d4316098c9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/BASISOFPRESENTATIONPolicies" xlink:type="simple" xlink:href="ew-20240331.xsd#BASISOFPRESENTATIONPolicies"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/BASISOFPRESENTATIONPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_72268881-3282-416a-9353-0ce9b3a2f149" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_abc5ae83-c8a4-4410-9a11-033ec72e3f94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_72268881-3282-416a-9353-0ce9b3a2f149" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_abc5ae83-c8a4-4410-9a11-033ec72e3f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_b35e544e-a298-47b9-8ea2-5df896b890f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_72268881-3282-416a-9353-0ce9b3a2f149" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_b35e544e-a298-47b9-8ea2-5df896b890f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_4c817f8e-af07-480d-b63c-23d686bd57fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_72268881-3282-416a-9353-0ce9b3a2f149" xlink:to="loc_us-gaap_UseOfEstimates_4c817f8e-af07-480d-b63c-23d686bd57fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_043d022c-04a7-4533-9ba0-02a7c0cf71a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_72268881-3282-416a-9353-0ce9b3a2f149" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_043d022c-04a7-4533-9ba0-02a7c0cf71a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables" xlink:type="simple" xlink:href="ew-20240331.xsd#OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_90406531-ad44-4a6a-84d6-7333614ec6a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_2cf17787-ec30-4e3a-9ebe-29f91dc6e185" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_90406531-ad44-4a6a-84d6-7333614ec6a8" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_2cf17787-ec30-4e3a-9ebe-29f91dc6e185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_5a08b912-c477-473f-a143-23d1e92dcce2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_90406531-ad44-4a6a-84d6-7333614ec6a8" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_5a08b912-c477-473f-a143-23d1e92dcce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_c75c2ecd-4a1c-4a50-8a5f-2f573170d687" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_90406531-ad44-4a6a-84d6-7333614ec6a8" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_c75c2ecd-4a1c-4a50-8a5f-2f573170d687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_9578ed88-c7e5-45fe-9d41-c372265baf03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_90406531-ad44-4a6a-84d6-7333614ec6a8" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_9578ed88-c7e5-45fe-9d41-c372265baf03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_a96c89a1-742a-47f7-96b7-f8fcafb744ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_90406531-ad44-4a6a-84d6-7333614ec6a8" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_a96c89a1-742a-47f7-96b7-f8fcafb744ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INVESTMENTSTables" xlink:type="simple" xlink:href="ew-20240331.xsd#INVESTMENTSTables"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/INVESTMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0a8a4ec6-af2e-4891-b1f0-9c26bd0fedd6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_0ef7d7be-9a86-4a0b-b774-f41f8320e15e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0a8a4ec6-af2e-4891-b1f0-9c26bd0fedd6" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_0ef7d7be-9a86-4a0b-b774-f41f8320e15e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_6e0c065b-af75-42ba-8503-2e41a42ee068" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0a8a4ec6-af2e-4891-b1f0-9c26bd0fedd6" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_6e0c065b-af75-42ba-8503-2e41a42ee068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_0059f39d-62e9-4f67-8fff-8777719bc03d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0a8a4ec6-af2e-4891-b1f0-9c26bd0fedd6" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_0059f39d-62e9-4f67-8fff-8777719bc03d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock_2a0afcbd-39f1-4ae3-992d-713f516b4e75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0a8a4ec6-af2e-4891-b1f0-9c26bd0fedd6" xlink:to="loc_us-gaap_ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock_2a0afcbd-39f1-4ae3-992d-713f516b4e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="ew-20240331.xsd#FAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_47046847-526c-4068-bc98-35159b98131a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_d1136c29-8bf7-40b4-b68d-e8691256b6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_47046847-526c-4068-bc98-35159b98131a" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_d1136c29-8bf7-40b4-b68d-e8691256b6b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_f35da5b9-42cd-4309-ac60-9922c0b1fd90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_47046847-526c-4068-bc98-35159b98131a" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_f35da5b9-42cd-4309-ac60-9922c0b1fd90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" xlink:type="simple" xlink:href="ew-20240331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_02f79973-493e-4fb2-a35c-ab3d79a7c7cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_b8dcc59a-a25f-4027-8b3f-20e4ac8563c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_02f79973-493e-4fb2-a35c-ab3d79a7c7cc" xlink:to="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_b8dcc59a-a25f-4027-8b3f-20e4ac8563c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_83842c87-caa5-4783-899a-fd5428858ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_02f79973-493e-4fb2-a35c-ab3d79a7c7cc" xlink:to="loc_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_83842c87-caa5-4783-899a-fd5428858ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTableTextBlock_a2d57589-8098-4969-b261-ca0f25e8469a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_02f79973-493e-4fb2-a35c-ab3d79a7c7cc" xlink:to="loc_us-gaap_OffsettingAssetsTableTextBlock_a2d57589-8098-4969-b261-ca0f25e8469a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingLiabilitiesTableTextBlock_4321ebf6-6645-43ae-882b-aa6ecde71ad6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_02f79973-493e-4fb2-a35c-ab3d79a7c7cc" xlink:to="loc_us-gaap_OffsettingLiabilitiesTableTextBlock_4321ebf6-6645-43ae-882b-aa6ecde71ad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_2e8668c3-849c-4e78-a03b-cd9c1497afe8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_02f79973-493e-4fb2-a35c-ab3d79a7c7cc" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_2e8668c3-849c-4e78-a03b-cd9c1497afe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_0f371826-962e-4756-b8c2-6aa04c424448" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_02f79973-493e-4fb2-a35c-ab3d79a7c7cc" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_0f371826-962e-4756-b8c2-6aa04c424448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="ew-20240331.xsd#STOCKBASEDCOMPENSATIONTables"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_95f1ee9d-14db-4b6a-a70f-37029f2622e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_a9de5ecc-f9cb-4d40-9224-12eea7247472" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_95f1ee9d-14db-4b6a-a70f-37029f2622e9" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_a9de5ecc-f9cb-4d40-9224-12eea7247472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1e0922e5-abfe-4b59-9e35-02a86e8da129" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_95f1ee9d-14db-4b6a-a70f-37029f2622e9" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1e0922e5-abfe-4b59-9e35-02a86e8da129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_9ede2482-addc-41d5-9903-e01c1c0a4a03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_95f1ee9d-14db-4b6a-a70f-37029f2622e9" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_9ede2482-addc-41d5-9903-e01c1c0a4a03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASETables" xlink:type="simple" xlink:href="ew-20240331.xsd#ACCELERATEDSHAREREPURCHASETables"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_4a4ec4b7-89f1-48ef-9722-6ddfffa9d754" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTextBlock_93db9223-f2ac-40e1-bef6-af85e7d0b17d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcceleratedShareRepurchasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4a4ec4b7-89f1-48ef-9722-6ddfffa9d754" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesTextBlock_93db9223-f2ac-40e1-bef6-af85e7d0b17d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" xlink:type="simple" xlink:href="ew-20240331.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSSTables"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_c001d68c-f915-44a3-b848-9c95eb8265ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_ba725d3b-4e59-48ce-9e99-b6ebdd315a72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c001d68c-f915-44a3-b848-9c95eb8265ef" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_ba725d3b-4e59-48ce-9e99-b6ebdd315a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_01219a61-a843-4b34-adf2-57090b48c681" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c001d68c-f915-44a3-b848-9c95eb8265ef" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_01219a61-a843-4b34-adf2-57090b48c681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/EARNINGSPERSHARETables" xlink:type="simple" xlink:href="ew-20240331.xsd#EARNINGSPERSHARETables"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/EARNINGSPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_37fb8c57-27f2-4d13-baca-c6be0cd55fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_0355ac01-546d-4eca-acbe-1d8b0da33432" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_37fb8c57-27f2-4d13-baca-c6be0cd55fe2" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_0355ac01-546d-4eca-acbe-1d8b0da33432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/SEGMENTINFORMATIONTables" xlink:type="simple" xlink:href="ew-20240331.xsd#SEGMENTINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/SEGMENTINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_8e98218f-034b-485a-9e8b-058f4d7301c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_0eacfb36-0efe-48b1-872f-e2556b1f9dcb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8e98218f-034b-485a-9e8b-058f4d7301c8" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_0eacfb36-0efe-48b1-872f-e2556b1f9dcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_07a61348-d427-4a79-b3bf-cf9c837645e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8e98218f-034b-485a-9e8b-058f4d7301c8" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_07a61348-d427-4a79-b3bf-cf9c837645e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsintheConsolidatedBalanceSheetsDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsintheConsolidatedBalanceSheetsDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsintheConsolidatedBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_20323a12-3a94-475b-88cc-ea36ee6560e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_4a08dd1c-61ba-42d6-9194-04294047dad6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_20323a12-3a94-475b-88cc-ea36ee6560e9" xlink:to="loc_us-gaap_InventoryNetAbstract_4a08dd1c-61ba-42d6-9194-04294047dad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_b3fbb87e-0905-43e8-b455-c1cade6559ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_4a08dd1c-61ba-42d6-9194-04294047dad6" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_b3fbb87e-0905-43e8-b455-c1cade6559ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_65e5817c-3c05-4a47-a80b-afc120a60cb1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_4a08dd1c-61ba-42d6-9194-04294047dad6" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_65e5817c-3c05-4a47-a80b-afc120a60cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_d6c86225-2feb-46b2-83d4-df789e8986e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_4a08dd1c-61ba-42d6-9194-04294047dad6" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_d6c86225-2feb-46b2-83d4-df789e8986e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_1ed75773-3f09-45ad-8544-25a3efc4f431" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_4a08dd1c-61ba-42d6-9194-04294047dad6" xlink:to="loc_us-gaap_InventoryNet_1ed75773-3f09-45ad-8544-25a3efc4f431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_d481a3c6-b221-4605-8ea4-0a75954b4d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_20323a12-3a94-475b-88cc-ea36ee6560e9" xlink:to="loc_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_d481a3c6-b221-4605-8ea4-0a75954b4d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_40dd34c9-b09e-4310-ab43-2c1c2c98c7f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsAbstract_b247762d-8b0b-4b1d-8b4d-81c2042e28bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_40dd34c9-b09e-4310-ab43-2c1c2c98c7f3" xlink:to="loc_us-gaap_OtherAssetsAbstract_b247762d-8b0b-4b1d-8b4d-81c2042e28bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReceivable_773b9c49-7e4e-49ea-84d6-62958fd554e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_b247762d-8b0b-4b1d-8b4d-81c2042e28bd" xlink:to="loc_us-gaap_IncomeTaxReceivable_773b9c49-7e4e-49ea-84d6-62958fd554e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent_f182628f-a328-430c-8750-cad4e29a7a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_b247762d-8b0b-4b1d-8b4d-81c2042e28bd" xlink:to="loc_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent_f182628f-a328-430c-8750-cad4e29a7a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AcquisitionOptionsNoncurrent_49da5c20-2156-4ab5-acce-d1b6c9c66257" xlink:href="ew-20240331.xsd#ew_AcquisitionOptionsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_b247762d-8b0b-4b1d-8b4d-81c2042e28bd" xlink:to="loc_ew_AcquisitionOptionsNoncurrent_49da5c20-2156-4ab5-acce-d1b6c9c66257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrentAndNoncurrent_d8008aa8-6574-4440-a877-58e06b082eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrentAndNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_b247762d-8b0b-4b1d-8b4d-81c2042e28bd" xlink:to="loc_us-gaap_PrepaidExpenseCurrentAndNoncurrent_d8008aa8-6574-4440-a877-58e06b082eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent_35ff9350-b5c0-4239-9b42-6509c377291b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_b247762d-8b0b-4b1d-8b4d-81c2042e28bd" xlink:to="loc_us-gaap_DerivativeAssetsNoncurrent_35ff9350-b5c0-4239-9b42-6509c377291b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_f611fa87-722e-4cd5-b034-29e605f7f450" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_b247762d-8b0b-4b1d-8b4d-81c2042e28bd" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_f611fa87-722e-4cd5-b034-29e605f7f450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_e103b2b4-04bd-4a3c-b2c4-8d3a8e3c184a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_b247762d-8b0b-4b1d-8b4d-81c2042e28bd" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_e103b2b4-04bd-4a3c-b2c4-8d3a8e3c184a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_0332dcea-ffa2-49c9-9888-49af59f971d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_40dd34c9-b09e-4310-ab43-2c1c2c98c7f3" xlink:to="loc_us-gaap_PayablesAndAccrualsAbstract_0332dcea-ffa2-49c9-9888-49af59f971d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_715ded57-0fbc-436c-aa51-1a5fec9b9f8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_0332dcea-ffa2-49c9-9888-49af59f971d6" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_715ded57-0fbc-436c-aa51-1a5fec9b9f8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_821506a6-bc3f-498d-89d0-c1be514cca25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_0332dcea-ffa2-49c9-9888-49af59f971d6" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_821506a6-bc3f-498d-89d0-c1be514cca25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent_f7d53981-077b-48e1-bc09-ec2ad458ebbf" xlink:href="ew-20240331.xsd#ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_0332dcea-ffa2-49c9-9888-49af59f971d6" xlink:to="loc_ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent_f7d53981-077b-48e1-bc09-ec2ad458ebbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_ResearchAndDevelopmentAccruals_226ed7d4-b8ff-4b6f-bfac-4fe9d006398a" xlink:href="ew-20240331.xsd#ew_ResearchAndDevelopmentAccruals"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_0332dcea-ffa2-49c9-9888-49af59f971d6" xlink:to="loc_ew_ResearchAndDevelopmentAccruals_226ed7d4-b8ff-4b6f-bfac-4fe9d006398a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccruedRebates_8a447c34-6f5d-4637-bbb7-b4e7c9528278" xlink:href="ew-20240331.xsd#ew_AccruedRebates"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_0332dcea-ffa2-49c9-9888-49af59f971d6" xlink:to="loc_ew_AccruedRebates_8a447c34-6f5d-4637-bbb7-b4e7c9528278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_20f2adca-cbcb-41c6-9027-dcafdfbe1076" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_0332dcea-ffa2-49c9-9888-49af59f971d6" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_20f2adca-cbcb-41c6-9027-dcafdfbe1076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_b6d1c95e-7b0b-4980-a06d-f3ac5c85ead1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_0332dcea-ffa2-49c9-9888-49af59f971d6" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_b6d1c95e-7b0b-4980-a06d-f3ac5c85ead1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccruedLitigationAndInsuranceReserves_c9660f2e-859a-420a-a6aa-cb1d6bdfc87c" xlink:href="ew-20240331.xsd#ew_AccruedLitigationAndInsuranceReserves"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_0332dcea-ffa2-49c9-9888-49af59f971d6" xlink:to="loc_ew_AccruedLitigationAndInsuranceReserves_c9660f2e-859a-420a-a6aa-cb1d6bdfc87c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_fa86862f-6b91-45be-9132-af8ebc8333e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_0332dcea-ffa2-49c9-9888-49af59f971d6" xlink:to="loc_us-gaap_LitigationReserveCurrent_fa86862f-6b91-45be-9132-af8ebc8333e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccruedRelocationCostsCurrent_47c0901f-bab8-425f-8fe5-c6b661a0d457" xlink:href="ew-20240331.xsd#ew_AccruedRelocationCostsCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_0332dcea-ffa2-49c9-9888-49af59f971d6" xlink:to="loc_ew_AccruedRelocationCostsCurrent_47c0901f-bab8-425f-8fe5-c6b661a0d457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_ea09d47c-e097-49c4-acaf-77f1b58e934c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_0332dcea-ffa2-49c9-9888-49af59f971d6" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_ea09d47c-e097-49c4-acaf-77f1b58e934c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_74330067-86cf-4f41-b65b-944b707e4e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_0332dcea-ffa2-49c9-9888-49af59f971d6" xlink:to="loc_us-gaap_RestructuringReserveCurrent_74330067-86cf-4f41-b65b-944b707e4e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent_7cd2cb0c-313a-4454-bec9-56c93a19a9dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_0332dcea-ffa2-49c9-9888-49af59f971d6" xlink:to="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent_7cd2cb0c-313a-4454-bec9-56c93a19a9dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_e46d7804-db86-491e-86c6-f9add17355d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_0332dcea-ffa2-49c9-9888-49af59f971d6" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_e46d7804-db86-491e-86c6-f9add17355d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccruedAndOtherLiabilitiesCurrent_fbd186ba-d9ac-470d-aa09-596a450beb1d" xlink:href="ew-20240331.xsd#ew_AccruedAndOtherLiabilitiesCurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_0332dcea-ffa2-49c9-9888-49af59f971d6" xlink:to="loc_ew_AccruedAndOtherLiabilitiesCurrent_fbd186ba-d9ac-470d-aa09-596a450beb1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_10ec849a-2cbf-4a2e-82bb-88c19be377f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_d033123e-24a4-4126-829c-99816b3daa7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_10ec849a-2cbf-4a2e-82bb-88c19be377f9" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_d033123e-24a4-4126-829c-99816b3daa7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_4e89523d-3b29-4eb6-a947-b40699875f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_d033123e-24a4-4126-829c-99816b3daa7f" xlink:to="loc_us-gaap_IncomeTaxesPaid_4e89523d-3b29-4eb6-a947-b40699875f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_4c115ac7-c9f1-47f1-a8b2-08cecf8009a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_d033123e-24a4-4126-829c-99816b3daa7f" xlink:to="loc_us-gaap_OperatingLeasePayments_4c115ac7-c9f1-47f1-a8b2-08cecf8009a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_8480310e-df0f-4921-8be8-1e4d87dc742d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_10ec849a-2cbf-4a2e-82bb-88c19be377f9" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_8480310e-df0f-4921-8be8-1e4d87dc742d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_16299119-fb72-4ab9-a0fc-1a893b26075a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_8480310e-df0f-4921-8be8-1e4d87dc742d" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_16299119-fb72-4ab9-a0fc-1a893b26075a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_8cf966ec-66f0-4abb-be6c-63e06a8ee984" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_8480310e-df0f-4921-8be8-1e4d87dc742d" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_8cf966ec-66f0-4abb-be6c-63e06a8ee984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_87a0557e-b21f-4c05-89ab-d597bf784d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_92a89bcd-2dc2-40e8-a2b2-6f9f7378ec33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_87a0557e-b21f-4c05-89ab-d597bf784d9d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_92a89bcd-2dc2-40e8-a2b2-6f9f7378ec33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_45889b32-c2a3-4492-9c6b-13e39f608027" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_87a0557e-b21f-4c05-89ab-d597bf784d9d" xlink:to="loc_us-gaap_RestrictedCashCurrent_45889b32-c2a3-4492-9c6b-13e39f608027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_fa0c5588-a82a-4934-812f-995724c7d7dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_87a0557e-b21f-4c05-89ab-d597bf784d9d" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_fa0c5588-a82a-4934-812f-995724c7d7dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b55701d3-5b18-4716-9275-354f3b32aadb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_87a0557e-b21f-4c05-89ab-d597bf784d9d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b55701d3-5b18-4716-9275-354f3b32aadb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSESDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSESDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_91df953d-2c4b-44ad-91fb-92105d5fd782" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_8fcdb4a2-2c03-4046-9c00-ddaf2c9f9153" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_91df953d-2c4b-44ad-91fb-92105d5fd782" xlink:to="loc_us-gaap_LossContingenciesTable_8fcdb4a2-2c03-4046-9c00-ddaf2c9f9153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_5e17033f-91a4-467d-94f9-50f3aa388745" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8fcdb4a2-2c03-4046-9c00-ddaf2c9f9153" xlink:to="loc_srt_LitigationCaseAxis_5e17033f-91a4-467d-94f9-50f3aa388745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_6572c860-5e8b-4443-8d75-8697c9cf873e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_5e17033f-91a4-467d-94f9-50f3aa388745" xlink:to="loc_srt_LitigationCaseTypeDomain_6572c860-5e8b-4443-8d75-8697c9cf873e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MedtronicIncMember_49dacc47-a999-46cf-b570-d77c3f07797a" xlink:href="ew-20240331.xsd#ew_MedtronicIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_6572c860-5e8b-4443-8d75-8697c9cf873e" xlink:to="loc_ew_MedtronicIncMember_49dacc47-a999-46cf-b570-d77c3f07797a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_d44d1248-8bc1-406e-9f82-30075be804b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8fcdb4a2-2c03-4046-9c00-ddaf2c9f9153" xlink:to="loc_us-gaap_LossContingenciesLineItems_d44d1248-8bc1-406e-9f82-30075be804b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_IntellectualPropertyAgreementTerm_3681031e-1cf1-4169-aafb-3e8def50b1ca" xlink:href="ew-20240331.xsd#ew_IntellectualPropertyAgreementTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d44d1248-8bc1-406e-9f82-30075be804b9" xlink:to="loc_ew_IntellectualPropertyAgreementTerm_3681031e-1cf1-4169-aafb-3e8def50b1ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_8dd2dc1e-0003-493b-a686-7d18e8d71e80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d44d1248-8bc1-406e-9f82-30075be804b9" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_8dd2dc1e-0003-493b-a686-7d18e8d71e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_942991f4-838b-4c6b-bf50-7bdce00820db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d44d1248-8bc1-406e-9f82-30075be804b9" xlink:to="loc_us-gaap_LitigationSettlementExpense_942991f4-838b-4c6b-bf50-7bdce00820db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidRoyalties_dd7e2226-f49e-4821-9dfd-1f1a4f7ddb11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidRoyalties"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d44d1248-8bc1-406e-9f82-30075be804b9" xlink:to="loc_us-gaap_PrepaidRoyalties_dd7e2226-f49e-4821-9dfd-1f1a4f7ddb11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/SEPARATIONCOSTSDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#SEPARATIONCOSTSDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/SEPARATIONCOSTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_e6964428-4f6f-4be4-bb2e-80d3afde47bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_522b1759-8fe2-4f05-8a91-616542712d82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_e6964428-4f6f-4be4-bb2e-80d3afde47bd" xlink:to="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_522b1759-8fe2-4f05-8a91-616542712d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_91a31959-9dec-4aee-a3f6-ef3c8b827f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_8457ba8c-aaa7-4c6f-b9c0-07b9ba1dd356" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_91a31959-9dec-4aee-a3f6-ef3c8b827f3e" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_8457ba8c-aaa7-4c6f-b9c0-07b9ba1dd356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_d8c82515-a790-4b5b-b571-695305f56ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_8457ba8c-aaa7-4c6f-b9c0-07b9ba1dd356" xlink:to="loc_us-gaap_FinancialInstrumentAxis_d8c82515-a790-4b5b-b571-695305f56ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bfad895f-4e8c-4ec4-9db6-fdd9e6efd305" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d8c82515-a790-4b5b-b571-695305f56ab2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bfad895f-4e8c-4ec4-9db6-fdd9e6efd305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember_2d89e9ff-00d2-42c9-9c7e-e534c9a34569" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bfad895f-4e8c-4ec4-9db6-fdd9e6efd305" xlink:to="loc_us-gaap_BankTimeDepositsMember_2d89e9ff-00d2-42c9-9c7e-e534c9a34569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_a5adc00b-4c3c-4df3-a938-e9e335016984" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bfad895f-4e8c-4ec4-9db6-fdd9e6efd305" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_a5adc00b-4c3c-4df3-a938-e9e335016984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_cdc5ab5d-415a-4de7-b17c-d86812b7843b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bfad895f-4e8c-4ec4-9db6-fdd9e6efd305" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_cdc5ab5d-415a-4de7-b17c-d86812b7843b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_32c09afe-a490-4dd2-b6e4-a6493e8feb79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bfad895f-4e8c-4ec4-9db6-fdd9e6efd305" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_32c09afe-a490-4dd2-b6e4-a6493e8feb79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_b964f85d-cbf6-4110-bea6-12afee4bfaa7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MunicipalBondsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bfad895f-4e8c-4ec4-9db6-fdd9e6efd305" xlink:to="loc_us-gaap_MunicipalBondsMember_b964f85d-cbf6-4110-bea6-12afee4bfaa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_83275da6-9c64-4bf8-ac82-8d098e4e4982" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_8457ba8c-aaa7-4c6f-b9c0-07b9ba1dd356" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_83275da6-9c64-4bf8-ac82-8d098e4e4982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAbstract_68baa51b-02d6-41c7-bfda-0baf9f56b700" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_83275da6-9c64-4bf8-ac82-8d098e4e4982" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAbstract_68baa51b-02d6-41c7-bfda-0baf9f56b700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_16ac70c6-8d62-43c5-a6f4-42ff4b91e242" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesAbstract_68baa51b-02d6-41c7-bfda-0baf9f56b700" xlink:to="loc_us-gaap_HeldToMaturitySecurities_16ac70c6-8d62-43c5-a6f4-42ff4b91e242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_1017c342-c244-42ab-b7b6-04409caed050" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesAbstract_68baa51b-02d6-41c7-bfda-0baf9f56b700" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_1017c342-c244-42ab-b7b6-04409caed050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_923c2280-2f6d-44b9-8d7f-a354effa8c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesAbstract_68baa51b-02d6-41c7-bfda-0baf9f56b700" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_923c2280-2f6d-44b9-8d7f-a354effa8c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_68d7c872-c561-4722-995b-c7c0ec1f947b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesAbstract_68baa51b-02d6-41c7-bfda-0baf9f56b700" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_68d7c872-c561-4722-995b-c7c0ec1f947b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_09855d8f-3bf5-494e-b3cc-65fb06849691" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_83275da6-9c64-4bf8-ac82-8d098e4e4982" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAbstract_09855d8f-3bf5-494e-b3cc-65fb06849691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_770e904a-c1aa-4f4c-9121-7b338a74ba46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_09855d8f-3bf5-494e-b3cc-65fb06849691" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_770e904a-c1aa-4f4c-9121-7b338a74ba46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_240cfd40-7ddf-40e5-b761-dbe33937689e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_09855d8f-3bf5-494e-b3cc-65fb06849691" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_240cfd40-7ddf-40e5-b761-dbe33937689e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_603b4135-bdb9-44f2-baf2-733fa320aa9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_09855d8f-3bf5-494e-b3cc-65fb06849691" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_603b4135-bdb9-44f2-baf2-733fa320aa9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0de15853-c08a-4941-9a66-d73f62591bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_09855d8f-3bf5-494e-b3cc-65fb06849691" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0de15853-c08a-4941-9a66-d73f62591bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_af9a18ad-4475-41e7-a78e-5cc0721d1378" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract_f810b507-f7b2-4a18-94db-0513646d2df3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_af9a18ad-4475-41e7-a78e-5cc0721d1378" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract_f810b507-f7b2-4a18-94db-0513646d2df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract_48f11afa-a009-4c90-b073-467cab73f6c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract_f810b507-f7b2-4a18-94db-0513646d2df3" xlink:to="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract_48f11afa-a009-4c90-b073-467cab73f6c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost_9f99bf7e-56d3-46ef-9d1c-1876c203c21f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract_48f11afa-a009-4c90-b073-467cab73f6c9" xlink:to="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost_9f99bf7e-56d3-46ef-9d1c-1876c203c21f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost_958b248b-db76-4d8d-aef4-3eb0a2e05f00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract_48f11afa-a009-4c90-b073-467cab73f6c9" xlink:to="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost_958b248b-db76-4d8d-aef4-3eb0a2e05f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount_65ee650b-6691-4a7e-a134-23d6f3cf8f91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract_48f11afa-a009-4c90-b073-467cab73f6c9" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount_65ee650b-6691-4a7e-a134-23d6f3cf8f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_6ef69c52-12be-4c15-8eda-12c9ab246b04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract_48f11afa-a009-4c90-b073-467cab73f6c9" xlink:to="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_6ef69c52-12be-4c15-8eda-12c9ab246b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_8bced6cb-75ed-471e-8990-5fa10874c35f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract_f810b507-f7b2-4a18-94db-0513646d2df3" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_8bced6cb-75ed-471e-8990-5fa10874c35f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_ac9de38b-ae71-4d39-9e87-c2edb21ee5d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_8bced6cb-75ed-471e-8990-5fa10874c35f" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_ac9de38b-ae71-4d39-9e87-c2edb21ee5d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_4ec83410-4501-4b19-80c2-bdc01ec6e7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_8bced6cb-75ed-471e-8990-5fa10874c35f" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_4ec83410-4501-4b19-80c2-bdc01ec6e7a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_0dd18cbb-25ad-4262-b262-936d5694ca03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_8bced6cb-75ed-471e-8990-5fa10874c35f" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_0dd18cbb-25ad-4262-b262-936d5694ca03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_da20e7a5-88ee-430a-8923-ab90666de920" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_8bced6cb-75ed-471e-8990-5fa10874c35f" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_da20e7a5-88ee-430a-8923-ab90666de920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_ba8561eb-2150-4e26-bd33-6a914cac41de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_af9a18ad-4475-41e7-a78e-5cc0721d1378" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_ba8561eb-2150-4e26-bd33-6a914cac41de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract_28b34411-0fa7-4fe2-9836-b51b13051f47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_ba8561eb-2150-4e26-bd33-6a914cac41de" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract_28b34411-0fa7-4fe2-9836-b51b13051f47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_d81990c1-7126-4b24-a8aa-2cd98b4d0a20" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract_28b34411-0fa7-4fe2-9836-b51b13051f47" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_d81990c1-7126-4b24-a8aa-2cd98b4d0a20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_8cf94fe3-27f7-4c1e-a5a0-0cffbd8e3365" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract_28b34411-0fa7-4fe2-9836-b51b13051f47" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_8cf94fe3-27f7-4c1e-a5a0-0cffbd8e3365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_27b53945-d8a1-40c4-9b26-07ae6958dfc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract_28b34411-0fa7-4fe2-9836-b51b13051f47" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_27b53945-d8a1-40c4-9b26-07ae6958dfc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_bb643247-575f-4415-99a9-b05c53995d40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract_28b34411-0fa7-4fe2-9836-b51b13051f47" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_bb643247-575f-4415-99a9-b05c53995d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_8475edda-8efb-4344-933b-34371086ed1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_ba8561eb-2150-4e26-bd33-6a914cac41de" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_8475edda-8efb-4344-933b-34371086ed1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_65086778-46b7-4ffe-adba-e6867c429ded" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_8475edda-8efb-4344-933b-34371086ed1f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_65086778-46b7-4ffe-adba-e6867c429ded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_f1919353-d49b-42aa-a116-11d9910c54b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_8475edda-8efb-4344-933b-34371086ed1f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_f1919353-d49b-42aa-a116-11d9910c54b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_d67fcdc4-0df6-475c-81df-0f147ba679db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_8475edda-8efb-4344-933b-34371086ed1f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_d67fcdc4-0df6-475c-81df-0f147ba679db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f3462a4b-ee3a-4c7d-863c-73f0b0a3be26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_8475edda-8efb-4344-933b-34371086ed1f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f3462a4b-ee3a-4c7d-863c-73f0b0a3be26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_da92e677-0eda-4661-a355-040acfa4942e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_cd8e07e4-7446-458a-992d-71ca667d98a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_da92e677-0eda-4661-a355-040acfa4942e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_cd8e07e4-7446-458a-992d-71ca667d98a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_fea7fc24-6848-44f8-ba56-2c7ccaa11b99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_cd8e07e4-7446-458a-992d-71ca667d98a6" xlink:to="loc_us-gaap_FinancialInstrumentAxis_fea7fc24-6848-44f8-ba56-2c7ccaa11b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9c426a49-a726-477f-a465-c2282b5b64c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_fea7fc24-6848-44f8-ba56-2c7ccaa11b99" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9c426a49-a726-477f-a465-c2282b5b64c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_f7968157-cda6-470b-b127-3cc9b0dfdfdb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9c426a49-a726-477f-a465-c2282b5b64c1" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_f7968157-cda6-470b-b127-3cc9b0dfdfdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_e0781c52-8b33-4194-9599-aa2c497430b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9c426a49-a726-477f-a465-c2282b5b64c1" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_e0781c52-8b33-4194-9599-aa2c497430b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_58f7aa61-f481-41e0-b12a-926dd1da1269" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9c426a49-a726-477f-a465-c2282b5b64c1" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_58f7aa61-f481-41e0-b12a-926dd1da1269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_456539ca-4839-433e-ae2b-eaaca831d558" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MunicipalBondsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9c426a49-a726-477f-a465-c2282b5b64c1" xlink:to="loc_us-gaap_MunicipalBondsMember_456539ca-4839-433e-ae2b-eaaca831d558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c82d297d-130a-4af9-ad09-1cfd68c6c685" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_cd8e07e4-7446-458a-992d-71ca667d98a6" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c82d297d-130a-4af9-ad09-1cfd68c6c685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_9518e0f7-921a-4959-a307-2a1d93377c45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c82d297d-130a-4af9-ad09-1cfd68c6c685" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_9518e0f7-921a-4959-a307-2a1d93377c45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_f907c520-5754-47c1-87be-e2b6759b8c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c82d297d-130a-4af9-ad09-1cfd68c6c685" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_f907c520-5754-47c1-87be-e2b6759b8c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_10d1dbb8-c2bb-43bb-8328-060f17ada162" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c82d297d-130a-4af9-ad09-1cfd68c6c685" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_10d1dbb8-c2bb-43bb-8328-060f17ada162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_16d00b59-b28d-4dc0-a4aa-351a523e3f06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c82d297d-130a-4af9-ad09-1cfd68c6c685" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_16d00b59-b28d-4dc0-a4aa-351a523e3f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_345719a5-9de2-4aaa-9244-8caf02ba59f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c82d297d-130a-4af9-ad09-1cfd68c6c685" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_345719a5-9de2-4aaa-9244-8caf02ba59f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_cede0d34-8327-40ba-a433-2b232787e692" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c82d297d-130a-4af9-ad09-1cfd68c6c685" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_cede0d34-8327-40ba-a433-2b232787e692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_5d2fb05e-8892-4871-8e9f-d8c4a134eaa9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract_02fcac62-5556-469c-9b5c-f11ff02d0027" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_5d2fb05e-8892-4871-8e9f-d8c4a134eaa9" xlink:to="loc_us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract_02fcac62-5556-469c-9b5c-f11ff02d0027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_178b8881-70b0-4035-9abd-5631da383fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract_02fcac62-5556-469c-9b5c-f11ff02d0027" xlink:to="loc_us-gaap_EquityMethodInvestments_178b8881-70b0-4035-9abd-5631da383fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_cdc0e493-80fe-488b-aa64-ad91152abb5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_5d2fb05e-8892-4871-8e9f-d8c4a134eaa9" xlink:to="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_cdc0e493-80fe-488b-aa64-ad91152abb5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_d2d2bdbc-50a6-422f-95f3-e33650665522" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_cdc0e493-80fe-488b-aa64-ad91152abb5b" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_d2d2bdbc-50a6-422f-95f3-e33650665522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_ce90fd22-b1fe-4dc9-860b-63657849439a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_5d2fb05e-8892-4871-8e9f-d8c4a134eaa9" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_ce90fd22-b1fe-4dc9-860b-63657849439a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INVESTMENTSNarrativeDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#INVESTMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/INVESTMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_12f740b1-a307-4bad-8edc-b0fda5aa52d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_bf84f740-690b-4982-ab70-6e941406d53b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_12f740b1-a307-4bad-8edc-b0fda5aa52d1" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_bf84f740-690b-4982-ab70-6e941406d53b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b0109516-fb80-43d6-ab65-2b0ad431f3ca" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_bf84f740-690b-4982-ab70-6e941406d53b" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b0109516-fb80-43d6-ab65-2b0ad431f3ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_6486ba1a-f9b2-4a49-8b55-7148dd3e57fc" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b0109516-fb80-43d6-ab65-2b0ad431f3ca" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_6486ba1a-f9b2-4a49-8b55-7148dd3e57fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_NewMarketsTaxCreditMember_248b62c2-887f-479b-9a82-d8b636f2d3d4" xlink:href="ew-20240331.xsd#ew_NewMarketsTaxCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_6486ba1a-f9b2-4a49-8b55-7148dd3e57fc" xlink:to="loc_ew_NewMarketsTaxCreditMember_248b62c2-887f-479b-9a82-d8b636f2d3d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_691aaa70-ed1f-410f-b29a-ef9b6ad3ce9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_bf84f740-690b-4982-ab70-6e941406d53b" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_691aaa70-ed1f-410f-b29a-ef9b6ad3ce9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_845a8a2f-17a7-461f-a85e-3af9b0922e34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_691aaa70-ed1f-410f-b29a-ef9b6ad3ce9d" xlink:to="loc_us-gaap_RelatedPartyDomain_845a8a2f-17a7-461f-a85e-3af9b0922e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyMember_cdf1c48c-c9b6-4034-8198-93dfd9f4025b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LimitedLiabilityCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_845a8a2f-17a7-461f-a85e-3af9b0922e34" xlink:to="loc_us-gaap_LimitedLiabilityCompanyMember_cdf1c48c-c9b6-4034-8198-93dfd9f4025b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_a6ad7cb1-cfcf-42f0-9d40-fa57842f7808" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_bf84f740-690b-4982-ab70-6e941406d53b" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_a6ad7cb1-cfcf-42f0-9d40-fa57842f7808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_87877d68-2eec-44ee-b3a2-811c48d96046" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_a6ad7cb1-cfcf-42f0-9d40-fa57842f7808" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_87877d68-2eec-44ee-b3a2-811c48d96046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquityMethodInvestmentsInvestmentPeriod_6bd520d0-ddae-479f-9736-08f56f0ea11d" xlink:href="ew-20240331.xsd#ew_EquityMethodInvestmentsInvestmentPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_a6ad7cb1-cfcf-42f0-9d40-fa57842f7808" xlink:to="loc_ew_EquityMethodInvestmentsInvestmentPeriod_6bd520d0-ddae-479f-9736-08f56f0ea11d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount_154765df-6a3b-402d-a088-8147906f30d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_a6ad7cb1-cfcf-42f0-9d40-fa57842f7808" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount_154765df-6a3b-402d-a088-8147906f30d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_37242643-8a04-4737-8c20-309b95ff5c49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_a6ad7cb1-cfcf-42f0-9d40-fa57842f7808" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_37242643-8a04-4737-8c20-309b95ff5c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_b6f60efc-5fcf-4a0b-9be1-7f1ad180f61e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_a6ad7cb1-cfcf-42f0-9d40-fa57842f7808" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_b6f60efc-5fcf-4a0b-9be1-7f1ad180f61e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#INVESTMENTSINVARIABLEINTERESTENTITIESDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ew_VariableInterestEntitiesAbstract_9977df2a-0362-4721-90ae-a171643f99e2" xlink:href="ew-20240331.xsd#ew_VariableInterestEntitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_3c1d6cd8-7989-4af3-980c-27214ae732fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ew_VariableInterestEntitiesAbstract_9977df2a-0362-4721-90ae-a171643f99e2" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_3c1d6cd8-7989-4af3-980c-27214ae732fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_484e3499-ed60-4853-80ba-66d3677241e4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_3c1d6cd8-7989-4af3-980c-27214ae732fc" xlink:to="loc_srt_CounterpartyNameAxis_484e3499-ed60-4853-80ba-66d3677241e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_bd298c88-57de-4ec4-aed1-9996fd4d46fd" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_484e3499-ed60-4853-80ba-66d3677241e4" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_bd298c88-57de-4ec4-aed1-9996fd4d46fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MedicalDeviceCompanyMember_3c076cba-0c71-4d64-8cc4-26a91c5049e8" xlink:href="ew-20240331.xsd#ew_MedicalDeviceCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_bd298c88-57de-4ec4-aed1-9996fd4d46fd" xlink:to="loc_ew_MedicalDeviceCompanyMember_3c076cba-0c71-4d64-8cc4-26a91c5049e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_36150e02-3aef-4598-b80b-2247cd594ca9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_3c1d6cd8-7989-4af3-980c-27214ae732fc" xlink:to="loc_srt_ConsolidatedEntitiesAxis_36150e02-3aef-4598-b80b-2247cd594ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_41d03f71-d1b6-41c5-86ba-58c5c669007d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_36150e02-3aef-4598-b80b-2247cd594ca9" xlink:to="loc_srt_ConsolidatedEntitiesDomain_41d03f71-d1b6-41c5-86ba-58c5c669007d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_3bec6ec5-a0bd-4b12-b43a-c833884e354f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_41d03f71-d1b6-41c5-86ba-58c5c669007d" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_3bec6ec5-a0bd-4b12-b43a-c833884e354f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_7b3ae029-7d06-4694-8010-fbf5c21e4b80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_41d03f71-d1b6-41c5-86ba-58c5c669007d" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_7b3ae029-7d06-4694-8010-fbf5c21e4b80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_289b1a55-d745-4b88-9b4f-0a43c1b16347" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_3c1d6cd8-7989-4af3-980c-27214ae732fc" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_289b1a55-d745-4b88-9b4f-0a43c1b16347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_c106492f-9fdc-4b52-ad17-08d974923855" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_289b1a55-d745-4b88-9b4f-0a43c1b16347" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_c106492f-9fdc-4b52-ad17-08d974923855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MedicalDeviceCompanyMember_482776f3-17de-4dce-a4c4-938c86aea2ef" xlink:href="ew-20240331.xsd#ew_MedicalDeviceCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_c106492f-9fdc-4b52-ad17-08d974923855" xlink:to="loc_ew_MedicalDeviceCompanyMember_482776f3-17de-4dce-a4c4-938c86aea2ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_55461e1a-af92-406a-8eca-5e42a229610d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_3c1d6cd8-7989-4af3-980c-27214ae732fc" xlink:to="loc_us-gaap_DebtInstrumentAxis_55461e1a-af92-406a-8eca-5e42a229610d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ab520112-ba18-4211-a78c-9067f194638b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_55461e1a-af92-406a-8eca-5e42a229610d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ab520112-ba18-4211-a78c-9067f194638b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_ConvertiblePromissoryNoteMember_b58b4ba4-22ad-4287-b6a7-29ea185f843b" xlink:href="ew-20240331.xsd#ew_ConvertiblePromissoryNoteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ab520112-ba18-4211-a78c-9067f194638b" xlink:to="loc_ew_ConvertiblePromissoryNoteMember_b58b4ba4-22ad-4287-b6a7-29ea185f843b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_566015de-e904-4170-873e-5db38c89273a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_3c1d6cd8-7989-4af3-980c-27214ae732fc" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_566015de-e904-4170-873e-5db38c89273a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_92beb5d0-cd41-46f4-8a6f-4e8fc6df247d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_566015de-e904-4170-873e-5db38c89273a" xlink:to="loc_us-gaap_Assets_92beb5d0-cd41-46f4-8a6f-4e8fc6df247d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_905a0195-9f5b-4021-a4a9-911c271547dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_566015de-e904-4170-873e-5db38c89273a" xlink:to="loc_us-gaap_Liabilities_905a0195-9f5b-4021-a4a9-911c271547dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote_7042769f-929f-43a6-a8e4-42f4033bcd09" xlink:href="ew-20240331.xsd#ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_566015de-e904-4170-873e-5db38c89273a" xlink:to="loc_ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote_7042769f-929f-43a6-a8e4-42f4033bcd09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquitySecuritiesFVNIPromissoryNoteOutstanding_5944330c-e349-41a4-8e7a-fe2c651a8398" xlink:href="ew-20240331.xsd#ew_EquitySecuritiesFVNIPromissoryNoteOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_566015de-e904-4170-873e-5db38c89273a" xlink:to="loc_ew_EquitySecuritiesFVNIPromissoryNoteOutstanding_5944330c-e349-41a4-8e7a-fe2c651a8398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_298cf0e6-7eb3-4f31-afdc-3c7f7311c3ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_566015de-e904-4170-873e-5db38c89273a" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_298cf0e6-7eb3-4f31-afdc-3c7f7311c3ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquitySecuritiesFVNIOptionToAcquireInvestment_2e4263d9-91a3-4ea9-9666-0e5d5ab87862" xlink:href="ew-20240331.xsd#ew_EquitySecuritiesFVNIOptionToAcquireInvestment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_566015de-e904-4170-873e-5db38c89273a" xlink:to="loc_ew_EquitySecuritiesFVNIOptionToAcquireInvestment_2e4263d9-91a3-4ea9-9666-0e5d5ab87862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquitySecuritiesFVNIMaximumAdditionalRequired_f33d67f3-b67c-4dfc-ad52-f91eb97401a5" xlink:href="ew-20240331.xsd#ew_EquitySecuritiesFVNIMaximumAdditionalRequired"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_566015de-e904-4170-873e-5db38c89273a" xlink:to="loc_ew_EquitySecuritiesFVNIMaximumAdditionalRequired_f33d67f3-b67c-4dfc-ad52-f91eb97401a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment_6005ec6b-dae6-4774-b2ff-ac4e7c11ef69" xlink:href="ew-20240331.xsd#ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_566015de-e904-4170-873e-5db38c89273a" xlink:to="loc_ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment_6005ec6b-dae6-4774-b2ff-ac4e7c11ef69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_LoansReceivablesMaximumLendingCapacity_ef3c0b1c-a54c-4f82-82c7-53da36ba7b8a" xlink:href="ew-20240331.xsd#ew_LoansReceivablesMaximumLendingCapacity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_566015de-e904-4170-873e-5db38c89273a" xlink:to="loc_ew_LoansReceivablesMaximumLendingCapacity_ef3c0b1c-a54c-4f82-82c7-53da36ba7b8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPaymentsToAcquireBusinesses_aa0e2d42-7e3d-4d00-84f1-a6ac2afc8214" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPaymentsToAcquireBusinesses"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_566015de-e904-4170-873e-5db38c89273a" xlink:to="loc_us-gaap_OtherPaymentsToAcquireBusinesses_aa0e2d42-7e3d-4d00-84f1-a6ac2afc8214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableGross_3e8e4887-7f64-4644-b7f5-2556f71b0cde" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReceivableGross"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_566015de-e904-4170-873e-5db38c89273a" xlink:to="loc_us-gaap_NotesReceivableGross_3e8e4887-7f64-4644-b7f5-2556f71b0cde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#FAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_da2e23c3-0efe-488b-9f65-ea486b14e43e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_cccf2858-239b-4682-8bf6-530a32354a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_da2e23c3-0efe-488b-9f65-ea486b14e43e" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_cccf2858-239b-4682-8bf6-530a32354a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4790492a-b431-4b41-b016-d93229a0296c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_cccf2858-239b-4682-8bf6-530a32354a2a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4790492a-b431-4b41-b016-d93229a0296c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_91fb1183-54ec-41d6-9b8f-e817e464b193" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4790492a-b431-4b41-b016-d93229a0296c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_91fb1183-54ec-41d6-9b8f-e817e464b193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_fdaf2e83-2dd6-48a4-a527-e01697aa7b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_91fb1183-54ec-41d6-9b8f-e817e464b193" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_fdaf2e83-2dd6-48a4-a527-e01697aa7b7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_dc65767b-b6ae-4023-9137-7b77df729078" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_cccf2858-239b-4682-8bf6-530a32354a2a" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_dc65767b-b6ae-4023-9137-7b77df729078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_62c79e7a-0f2d-47bc-87b3-f2b0925d33b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_dc65767b-b6ae-4023-9137-7b77df729078" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_62c79e7a-0f2d-47bc-87b3-f2b0925d33b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MeasurementInputProbabilityOfMilestoneAchievementMember_fc34cf87-add5-47b6-b0ac-8e81737fbe00" xlink:href="ew-20240331.xsd#ew_MeasurementInputProbabilityOfMilestoneAchievementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_62c79e7a-0f2d-47bc-87b3-f2b0925d33b8" xlink:to="loc_ew_MeasurementInputProbabilityOfMilestoneAchievementMember_fc34cf87-add5-47b6-b0ac-8e81737fbe00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_286d8a26-1dd3-4aa8-981b-8ceac6bd3090" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_cccf2858-239b-4682-8bf6-530a32354a2a" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_286d8a26-1dd3-4aa8-981b-8ceac6bd3090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_7c06fda2-6ebf-40e5-bb6f-6b362f343379" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_286d8a26-1dd3-4aa8-981b-8ceac6bd3090" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_7c06fda2-6ebf-40e5-bb6f-6b362f343379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_ContingentConsiderationLiabilityMember_cb0ffd53-8660-4e9f-959a-f1dc085e1985" xlink:href="ew-20240331.xsd#ew_ContingentConsiderationLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_7c06fda2-6ebf-40e5-bb6f-6b362f343379" xlink:to="loc_ew_ContingentConsiderationLiabilityMember_cb0ffd53-8660-4e9f-959a-f1dc085e1985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ebd92558-d913-47c4-80fb-40c5a91aa32b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_cccf2858-239b-4682-8bf6-530a32354a2a" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ebd92558-d913-47c4-80fb-40c5a91aa32b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableFairValueDisclosure_e139b04e-0596-4380-888b-70ce77a93d06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ebd92558-d913-47c4-80fb-40c5a91aa32b" xlink:to="loc_us-gaap_NotesPayableFairValueDisclosure_e139b04e-0596-4380-888b-70ce77a93d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_9f1bcdf7-c534-4e50-8c13-2ce27d340c22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ebd92558-d913-47c4-80fb-40c5a91aa32b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_9f1bcdf7-c534-4e50-8c13-2ce27d340c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_0515df65-3efe-4153-b954-28f3d64686ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ebd92558-d913-47c4-80fb-40c5a91aa32b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_0515df65-3efe-4153-b954-28f3d64686ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_348aa816-1431-4d1a-a0bc-784e3587577c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d9cdb647-8ce9-40ab-9b38-fe48e19b2aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_348aa816-1431-4d1a-a0bc-784e3587577c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d9cdb647-8ce9-40ab-9b38-fe48e19b2aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_e3e543a3-099b-46b9-abff-597a961a74db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d9cdb647-8ce9-40ab-9b38-fe48e19b2aaf" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_e3e543a3-099b-46b9-abff-597a961a74db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_1d74bb95-a425-4f81-ab1c-d6cc089c7681" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_e3e543a3-099b-46b9-abff-597a961a74db" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_1d74bb95-a425-4f81-ab1c-d6cc089c7681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_bbd61cc6-d880-4d27-955f-aa7fbe875196" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_1d74bb95-a425-4f81-ab1c-d6cc089c7681" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_bbd61cc6-d880-4d27-955f-aa7fbe875196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_5dc8deda-1c21-42a2-97cc-14af544e1b70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_bbd61cc6-d880-4d27-955f-aa7fbe875196" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_5dc8deda-1c21-42a2-97cc-14af544e1b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_22f915a4-39f3-48ad-b025-dcde3d115a10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d9cdb647-8ce9-40ab-9b38-fe48e19b2aaf" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_22f915a4-39f3-48ad-b025-dcde3d115a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_fa6efcf3-6a65-45a4-a4a7-601d9e6f2a52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_22f915a4-39f3-48ad-b025-dcde3d115a10" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_fa6efcf3-6a65-45a4-a4a7-601d9e6f2a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_6aab031c-ea35-4e50-9687-66e6c57c6c21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_fa6efcf3-6a65-45a4-a4a7-601d9e6f2a52" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_6aab031c-ea35-4e50-9687-66e6c57c6c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ff0c3a17-6f60-48d6-b90f-d5c9e105471a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d9cdb647-8ce9-40ab-9b38-fe48e19b2aaf" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ff0c3a17-6f60-48d6-b90f-d5c9e105471a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fc93f61d-d233-43ad-8265-7cb0cc09649a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ff0c3a17-6f60-48d6-b90f-d5c9e105471a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fc93f61d-d233-43ad-8265-7cb0cc09649a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_9add72c7-35a4-4a8c-8291-e668fd39ede1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fc93f61d-d233-43ad-8265-7cb0cc09649a" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_9add72c7-35a4-4a8c-8291-e668fd39ede1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_f6d536cd-9f7f-4f49-9a14-24e27c522af1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fc93f61d-d233-43ad-8265-7cb0cc09649a" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_f6d536cd-9f7f-4f49-9a14-24e27c522af1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_7370d1f0-15b2-466f-a3f0-ad5b14f38a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fc93f61d-d233-43ad-8265-7cb0cc09649a" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_7370d1f0-15b2-466f-a3f0-ad5b14f38a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_37b48719-0aa9-497f-ba14-522396480a89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d9cdb647-8ce9-40ab-9b38-fe48e19b2aaf" xlink:to="loc_us-gaap_FinancialInstrumentAxis_37b48719-0aa9-497f-ba14-522396480a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b5715a43-42d6-4aa7-bcfb-5965f80185d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_37b48719-0aa9-497f-ba14-522396480a89" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b5715a43-42d6-4aa7-bcfb-5965f80185d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_06a9064f-f028-4549-b98d-d48cdeab071e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b5715a43-42d6-4aa7-bcfb-5965f80185d0" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_06a9064f-f028-4549-b98d-d48cdeab071e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_9af4d0b8-9a28-465d-bfba-60c08e050339" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b5715a43-42d6-4aa7-bcfb-5965f80185d0" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_9af4d0b8-9a28-465d-bfba-60c08e050339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_a8822173-a5e3-498d-b939-17dc5c0abd42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b5715a43-42d6-4aa7-bcfb-5965f80185d0" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_a8822173-a5e3-498d-b939-17dc5c0abd42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_1c42d259-3ec9-459b-969b-d56c1811637c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MunicipalBondsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b5715a43-42d6-4aa7-bcfb-5965f80185d0" xlink:to="loc_us-gaap_MunicipalBondsMember_1c42d259-3ec9-459b-969b-d56c1811637c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2088ff0d-baf4-40c2-962a-4aa945b13d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d9cdb647-8ce9-40ab-9b38-fe48e19b2aaf" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2088ff0d-baf4-40c2-962a-4aa945b13d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_eec0feee-b667-4e5d-b960-06e2efd79c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2088ff0d-baf4-40c2-962a-4aa945b13d0e" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_eec0feee-b667-4e5d-b960-06e2efd79c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_4b0f3b26-ff2d-4539-bdd6-2baeba09be41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_eec0feee-b667-4e5d-b960-06e2efd79c3c" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_4b0f3b26-ff2d-4539-bdd6-2baeba09be41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_183103da-374e-4f28-a22a-5c8503234012" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_eec0feee-b667-4e5d-b960-06e2efd79c3c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_183103da-374e-4f28-a22a-5c8503234012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_42ece04a-3bbe-428c-a15a-b5fbfa656feb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_eec0feee-b667-4e5d-b960-06e2efd79c3c" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_42ece04a-3bbe-428c-a15a-b5fbfa656feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_366d4265-c3a9-46ba-afeb-adf8dfa366c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_eec0feee-b667-4e5d-b960-06e2efd79c3c" xlink:to="loc_us-gaap_DerivativeAssets_366d4265-c3a9-46ba-afeb-adf8dfa366c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_ba5d85bc-8e0f-4289-bc4d-b57d1b0749bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_eec0feee-b667-4e5d-b960-06e2efd79c3c" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_ba5d85bc-8e0f-4289-bc4d-b57d1b0749bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_4546ce52-0360-41e0-bcde-ebfbe521aa28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2088ff0d-baf4-40c2-962a-4aa945b13d0e" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_4546ce52-0360-41e0-bcde-ebfbe521aa28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_5d778c6f-9d4c-41f8-ac26-99c73c071a84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_4546ce52-0360-41e0-bcde-ebfbe521aa28" xlink:to="loc_us-gaap_DerivativeLiabilities_5d778c6f-9d4c-41f8-ac26-99c73c071a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_c2567040-03da-48fa-b16b-c5d70a82e280" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_4546ce52-0360-41e0-bcde-ebfbe521aa28" xlink:to="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_c2567040-03da-48fa-b16b-c5d70a82e280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_b8dc3c53-3b2f-4c47-ae10-cbc710dc38b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_4546ce52-0360-41e0-bcde-ebfbe521aa28" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_b8dc3c53-3b2f-4c47-ae10-cbc710dc38b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_39201409-4d57-4975-ad7b-c3e9f2ab74f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_795a27d0-6e87-4bc1-bc6a-a8fe3a545212" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_39201409-4d57-4975-ad7b-c3e9f2ab74f3" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_795a27d0-6e87-4bc1-bc6a-a8fe3a545212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_2b25167a-aa56-4e06-91aa-10d7d9dd4f46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_795a27d0-6e87-4bc1-bc6a-a8fe3a545212" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_2b25167a-aa56-4e06-91aa-10d7d9dd4f46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6c3e8efb-2c20-46a7-9514-1b9cf4ff2382" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_2b25167a-aa56-4e06-91aa-10d7d9dd4f46" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6c3e8efb-2c20-46a7-9514-1b9cf4ff2382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_ContingentConsiderationLiabilityMember_dad2ce50-4af4-4cd4-8098-52a4cc64d575" xlink:href="ew-20240331.xsd#ew_ContingentConsiderationLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6c3e8efb-2c20-46a7-9514-1b9cf4ff2382" xlink:to="loc_ew_ContingentConsiderationLiabilityMember_dad2ce50-4af4-4cd4-8098-52a4cc64d575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_e37d35f2-fee9-4723-96a9-6e008366a12e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6c3e8efb-2c20-46a7-9514-1b9cf4ff2382" xlink:to="loc_us-gaap_OtherLiabilitiesMember_e37d35f2-fee9-4723-96a9-6e008366a12e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_8c043a8e-cce2-4ba8-b74b-fdf03a84ea60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_795a27d0-6e87-4bc1-bc6a-a8fe3a545212" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_8c043a8e-cce2-4ba8-b74b-fdf03a84ea60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_9f60c5a3-5166-4322-8436-9eebb200c4c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_8c043a8e-cce2-4ba8-b74b-fdf03a84ea60" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_9f60c5a3-5166-4322-8436-9eebb200c4c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_297e67cf-d4a8-44f7-9945-f66e2c8be4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_9f60c5a3-5166-4322-8436-9eebb200c4c5" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_297e67cf-d4a8-44f7-9945-f66e2c8be4eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_82e8366d-5b54-46c8-8eb9-517186825255" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_795a27d0-6e87-4bc1-bc6a-a8fe3a545212" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_82e8366d-5b54-46c8-8eb9-517186825255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_52d8a2ea-222b-4c6d-9d54-f1601dab8073" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_82e8366d-5b54-46c8-8eb9-517186825255" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_52d8a2ea-222b-4c6d-9d54-f1601dab8073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_0123100d-9406-49c9-8772-4d181b81bc9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_52d8a2ea-222b-4c6d-9d54-f1601dab8073" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_0123100d-9406-49c9-8772-4d181b81bc9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_10adde18-6af1-4d69-9964-e99a8620bf42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_795a27d0-6e87-4bc1-bc6a-a8fe3a545212" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_10adde18-6af1-4d69-9964-e99a8620bf42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_7994c18d-f628-4adb-b386-bea665eff5f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_10adde18-6af1-4d69-9964-e99a8620bf42" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_7994c18d-f628-4adb-b386-bea665eff5f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_cf401b1e-1a47-47f0-9f59-299cc1bb1ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_7994c18d-f628-4adb-b386-bea665eff5f8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_cf401b1e-1a47-47f0-9f59-299cc1bb1ce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_50ee1c81-a6c9-4ae4-9902-66e9ca589474" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_7994c18d-f628-4adb-b386-bea665eff5f8" xlink:to="loc_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_50ee1c81-a6c9-4ae4-9902-66e9ca589474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_9d63838d-c388-4e8e-bb97-90dd5d9c6c15" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_7994c18d-f628-4adb-b386-bea665eff5f8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_9d63838d-c388-4e8e-bb97-90dd5d9c6c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_ebfca8be-d56c-4291-975c-49a7910400ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_7994c18d-f628-4adb-b386-bea665eff5f8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_ebfca8be-d56c-4291-975c-49a7910400ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_12595ee7-0ebf-417f-b64e-acc599b6641a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_7ebf4729-36b3-4f0f-b165-b93655c3c87a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_12595ee7-0ebf-417f-b64e-acc599b6641a" xlink:to="loc_us-gaap_DerivativeTable_7ebf4729-36b3-4f0f-b165-b93655c3c87a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_dd8ff429-f362-4640-93dc-bd77984c8dda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_7ebf4729-36b3-4f0f-b165-b93655c3c87a" xlink:to="loc_us-gaap_HedgingDesignationAxis_dd8ff429-f362-4640-93dc-bd77984c8dda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_78a4cae4-e8d9-427d-92f8-a1af1293f91f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_dd8ff429-f362-4640-93dc-bd77984c8dda" xlink:to="loc_us-gaap_HedgingDesignationDomain_78a4cae4-e8d9-427d-92f8-a1af1293f91f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_832b06c2-c903-49a7-b7f0-57cdb443b4d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_78a4cae4-e8d9-427d-92f8-a1af1293f91f" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_832b06c2-c903-49a7-b7f0-57cdb443b4d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_310a5f88-6998-487b-a882-bcfa35c409d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_7ebf4729-36b3-4f0f-b165-b93655c3c87a" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_310a5f88-6998-487b-a882-bcfa35c409d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_af97d754-1a9f-4512-a5fd-d9ed501d2e84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_310a5f88-6998-487b-a882-bcfa35c409d9" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_af97d754-1a9f-4512-a5fd-d9ed501d2e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_6be8cba1-ae23-4713-a0a3-d92cc57bc171" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_af97d754-1a9f-4512-a5fd-d9ed501d2e84" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_6be8cba1-ae23-4713-a0a3-d92cc57bc171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_5e39aff9-75e3-4758-a6ee-c1317d48ef3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_af97d754-1a9f-4512-a5fd-d9ed501d2e84" xlink:to="loc_us-gaap_CurrencySwapMember_5e39aff9-75e3-4758-a6ee-c1317d48ef3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_6a4d4848-eac9-4e4e-84a6-c05a0d4fb7dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_7ebf4729-36b3-4f0f-b165-b93655c3c87a" xlink:to="loc_us-gaap_DerivativeLineItems_6a4d4848-eac9-4e4e-84a6-c05a0d4fb7dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_1996ab73-4478-4b2b-b7ae-ce27028c29e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_6a4d4848-eac9-4e4e-84a6-c05a0d4fb7dd" xlink:to="loc_us-gaap_DerivativeNotionalAmount_1996ab73-4478-4b2b-b7ae-ce27028c29e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_47916ae1-34fb-464c-aabb-d82877b6ab75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_33d0fadf-007d-42ca-8f60-f0d1ad8e1d96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_47916ae1-34fb-464c-aabb-d82877b6ab75" xlink:to="loc_us-gaap_DerivativeTable_33d0fadf-007d-42ca-8f60-f0d1ad8e1d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a4d030c4-ae57-49c1-b395-4b07e9033824" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_33d0fadf-007d-42ca-8f60-f0d1ad8e1d96" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a4d030c4-ae57-49c1-b395-4b07e9033824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_b9f432b8-e369-4894-a70d-bc07c75b8d34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a4d030c4-ae57-49c1-b395-4b07e9033824" xlink:to="loc_us-gaap_HedgingRelationshipDomain_b9f432b8-e369-4894-a70d-bc07c75b8d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_72eba471-c9cd-4651-9d5b-4709bd6c4651" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_b9f432b8-e369-4894-a70d-bc07c75b8d34" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_72eba471-c9cd-4651-9d5b-4709bd6c4651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_e5dc76c2-51d2-46cc-a77c-a5a0c5b7e85a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_33d0fadf-007d-42ca-8f60-f0d1ad8e1d96" xlink:to="loc_us-gaap_HedgingDesignationAxis_e5dc76c2-51d2-46cc-a77c-a5a0c5b7e85a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_a391d03e-0dc1-4b77-84e7-b37909cff429" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_e5dc76c2-51d2-46cc-a77c-a5a0c5b7e85a" xlink:to="loc_us-gaap_HedgingDesignationDomain_a391d03e-0dc1-4b77-84e7-b37909cff429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_bcd33254-21e6-46f6-86c7-bc7ac318a121" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_a391d03e-0dc1-4b77-84e7-b37909cff429" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_bcd33254-21e6-46f6-86c7-bc7ac318a121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4641fe49-d89c-46a8-af77-4e34c538d558" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_33d0fadf-007d-42ca-8f60-f0d1ad8e1d96" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4641fe49-d89c-46a8-af77-4e34c538d558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1d793ad2-6c65-40bf-8d71-d98c5b5f7b16" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4641fe49-d89c-46a8-af77-4e34c538d558" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1d793ad2-6c65-40bf-8d71-d98c5b5f7b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_4f8c249d-aef4-4fab-ad93-88b22446711c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1d793ad2-6c65-40bf-8d71-d98c5b5f7b16" xlink:to="loc_us-gaap_CurrencySwapMember_4f8c249d-aef4-4fab-ad93-88b22446711c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_d9960968-9789-4dbf-b4ef-e569d19aa176" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_33d0fadf-007d-42ca-8f60-f0d1ad8e1d96" xlink:to="loc_us-gaap_DerivativeLineItems_d9960968-9789-4dbf-b4ef-e569d19aa176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_2996e0e8-93f2-464b-b0d0-d6a301dd6773" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_d9960968-9789-4dbf-b4ef-e569d19aa176" xlink:to="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_2996e0e8-93f2-464b-b0d0-d6a301dd6773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_71baa96f-7ca6-499c-9002-7733e84d6d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_d9960968-9789-4dbf-b4ef-e569d19aa176" xlink:to="loc_us-gaap_DerivativeNotionalAmount_71baa96f-7ca6-499c-9002-7733e84d6d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_68f9a110-3a73-4f12-a053-c68da54a2a72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_d9960968-9789-4dbf-b4ef-e569d19aa176" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_68f9a110-3a73-4f12-a053-c68da54a2a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_15b306c8-8375-4a1c-8be4-d52705d60a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a763620e-f166-4679-a831-89226e9aa8e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_15b306c8-8375-4a1c-8be4-d52705d60a8f" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a763620e-f166-4679-a831-89226e9aa8e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_6036bc19-c897-41fe-ad5a-7ade75958311" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a763620e-f166-4679-a831-89226e9aa8e9" xlink:to="loc_us-gaap_HedgingDesignationAxis_6036bc19-c897-41fe-ad5a-7ade75958311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_d4bd00fe-f5dc-4227-983c-3bff00ecfae6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_6036bc19-c897-41fe-ad5a-7ade75958311" xlink:to="loc_us-gaap_HedgingDesignationDomain_d4bd00fe-f5dc-4227-983c-3bff00ecfae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_76a0cace-7d4c-4b21-9be5-1e9588d1a403" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_d4bd00fe-f5dc-4227-983c-3bff00ecfae6" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_76a0cace-7d4c-4b21-9be5-1e9588d1a403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_47644481-9c74-42e4-8a53-e2128522ecd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a763620e-f166-4679-a831-89226e9aa8e9" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_47644481-9c74-42e4-8a53-e2128522ecd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3f1af2f6-ead3-4ae0-99ce-52c9858dd07e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_47644481-9c74-42e4-8a53-e2128522ecd8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3f1af2f6-ead3-4ae0-99ce-52c9858dd07e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_7aa9d018-7c2c-46e2-a7d7-c517a340fb36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3f1af2f6-ead3-4ae0-99ce-52c9858dd07e" xlink:to="loc_us-gaap_ForeignExchangeContractMember_7aa9d018-7c2c-46e2-a7d7-c517a340fb36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_21eb25b8-e138-4dcf-b895-3e603301a159" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignExchangeContractMember_7aa9d018-7c2c-46e2-a7d7-c517a340fb36" xlink:to="loc_us-gaap_CurrencySwapMember_21eb25b8-e138-4dcf-b895-3e603301a159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_547122bc-e627-47c8-8bda-e6125e5ac10a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a763620e-f166-4679-a831-89226e9aa8e9" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_547122bc-e627-47c8-8bda-e6125e5ac10a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsAbstract_9550d967-a39f-457c-b65c-870b5a83c4ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_547122bc-e627-47c8-8bda-e6125e5ac10a" xlink:to="loc_us-gaap_DerivativeAssetsAbstract_9550d967-a39f-457c-b65c-870b5a83c4ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_2f68c66a-bfec-4f9a-b937-c1559420c8e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_9550d967-a39f-457c-b65c-870b5a83c4ec" xlink:to="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_2f68c66a-bfec-4f9a-b937-c1559420c8e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_d21e3ea4-fc25-469d-b1e9-3c25f804fe48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_9550d967-a39f-457c-b65c-870b5a83c4ec" xlink:to="loc_us-gaap_DerivativeAssets_d21e3ea4-fc25-469d-b1e9-3c25f804fe48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesAbstract_a40cd9aa-7796-4ae2-bde0-6dc578514f14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_547122bc-e627-47c8-8bda-e6125e5ac10a" xlink:to="loc_us-gaap_DerivativeLiabilitiesAbstract_a40cd9aa-7796-4ae2-bde0-6dc578514f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_b6e872d6-32c4-4ca2-a5a9-4a9de191387f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_a40cd9aa-7796-4ae2-bde0-6dc578514f14" xlink:to="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_b6e872d6-32c4-4ca2-a5a9-4a9de191387f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_2ca36a80-2a43-4fde-a067-53fec43f2075" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_a40cd9aa-7796-4ae2-bde0-6dc578514f14" xlink:to="loc_us-gaap_DerivativeLiabilities_2ca36a80-2a43-4fde-a067-53fec43f2075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e8c109f3-a522-4a35-a78e-e8709244459d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTable_3418f483-2ddb-4326-8b3f-2da69a3a6e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e8c109f3-a522-4a35-a78e-e8709244459d" xlink:to="loc_us-gaap_OffsettingAssetsTable_3418f483-2ddb-4326-8b3f-2da69a3a6e5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7770d970-3320-4640-bf78-0493726a5ede" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_3418f483-2ddb-4326-8b3f-2da69a3a6e5f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7770d970-3320-4640-bf78-0493726a5ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_844ceafa-e045-4867-bdc9-7469c5883514" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7770d970-3320-4640-bf78-0493726a5ede" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_844ceafa-e045-4867-bdc9-7469c5883514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_6906c702-1ea7-47df-bd2e-c5385917dbeb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_844ceafa-e045-4867-bdc9-7469c5883514" xlink:to="loc_us-gaap_ForeignExchangeContractMember_6906c702-1ea7-47df-bd2e-c5385917dbeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_2e903be1-f38e-4e9a-a56a-94fd4b041569" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_844ceafa-e045-4867-bdc9-7469c5883514" xlink:to="loc_us-gaap_CurrencySwapMember_2e903be1-f38e-4e9a-a56a-94fd4b041569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsLineItems_63a86a80-40f7-4f15-a12b-e20d0d6fdc85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_3418f483-2ddb-4326-8b3f-2da69a3a6e5f" xlink:to="loc_us-gaap_OffsettingAssetsLineItems_63a86a80-40f7-4f15-a12b-e20d0d6fdc85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingDerivativeAssetsAbstract_464d52c8-f466-4493-ad37-44da20cf6d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingDerivativeAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_63a86a80-40f7-4f15-a12b-e20d0d6fdc85" xlink:to="loc_us-gaap_OffsettingDerivativeAssetsAbstract_464d52c8-f466-4493-ad37-44da20cf6d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_1d2616da-7b06-4d0f-b4ed-710be3c38ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingDerivativeAssetsAbstract_464d52c8-f466-4493-ad37-44da20cf6d5d" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_1d2616da-7b06-4d0f-b4ed-710be3c38ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueGrossLiability_27fe624d-ff6d-49db-bd7a-79a1a6e437aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetFairValueGrossLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingDerivativeAssetsAbstract_464d52c8-f466-4493-ad37-44da20cf6d5d" xlink:to="loc_us-gaap_DerivativeAssetFairValueGrossLiability_27fe624d-ff6d-49db-bd7a-79a1a6e437aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_f3df458f-e836-404f-978d-9a3002f77834" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingDerivativeAssetsAbstract_464d52c8-f466-4493-ad37-44da20cf6d5d" xlink:to="loc_us-gaap_DerivativeAssets_f3df458f-e836-404f-978d-9a3002f77834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_DerivativeFairValueOfDerivativeAssetGrossAmountsNotOffsetAbstract_edb3c0f1-3497-4dee-8a91-abe5a52c8cfc" xlink:href="ew-20240331.xsd#ew_DerivativeFairValueOfDerivativeAssetGrossAmountsNotOffsetAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingDerivativeAssetsAbstract_464d52c8-f466-4493-ad37-44da20cf6d5d" xlink:to="loc_ew_DerivativeFairValueOfDerivativeAssetGrossAmountsNotOffsetAbstract_edb3c0f1-3497-4dee-8a91-abe5a52c8cfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_f6842f8d-b47a-4955-88be-4feb58707bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ew_DerivativeFairValueOfDerivativeAssetGrossAmountsNotOffsetAbstract_edb3c0f1-3497-4dee-8a91-abe5a52c8cfc" xlink:to="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_f6842f8d-b47a-4955-88be-4feb58707bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralObligationToReturnCash_b9600fdc-39a9-42dd-bd17-1811d1eb8538" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeCollateralObligationToReturnCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ew_DerivativeFairValueOfDerivativeAssetGrossAmountsNotOffsetAbstract_edb3c0f1-3497-4dee-8a91-abe5a52c8cfc" xlink:to="loc_us-gaap_DerivativeCollateralObligationToReturnCash_b9600fdc-39a9-42dd-bd17-1811d1eb8538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_9e484d90-8535-4f52-9ed4-382f49046684" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingDerivativeAssetsAbstract_464d52c8-f466-4493-ad37-44da20cf6d5d" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_9e484d90-8535-4f52-9ed4-382f49046684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingDerivativeLiabilitiesAbstract_704c2863-90ed-4fc7-b491-5e32973a6854" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingDerivativeLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_63a86a80-40f7-4f15-a12b-e20d0d6fdc85" xlink:to="loc_us-gaap_OffsettingDerivativeLiabilitiesAbstract_704c2863-90ed-4fc7-b491-5e32973a6854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_9d3ed8d1-d4fc-43bc-8c61-58b266965da6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingDerivativeLiabilitiesAbstract_704c2863-90ed-4fc7-b491-5e32973a6854" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_9d3ed8d1-d4fc-43bc-8c61-58b266965da6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_cb70fb1a-9b55-4317-8012-3f39a16fcb93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityFairValueGrossAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingDerivativeLiabilitiesAbstract_704c2863-90ed-4fc7-b491-5e32973a6854" xlink:to="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_cb70fb1a-9b55-4317-8012-3f39a16fcb93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_5e83c2e9-d8f5-4b5e-b7d1-69840fb809df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingDerivativeLiabilitiesAbstract_704c2863-90ed-4fc7-b491-5e32973a6854" xlink:to="loc_us-gaap_DerivativeLiabilities_5e83c2e9-d8f5-4b5e-b7d1-69840fb809df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract_60a5fc67-0d73-4265-93fd-df80ac84efa5" xlink:href="ew-20240331.xsd#ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingDerivativeLiabilitiesAbstract_704c2863-90ed-4fc7-b491-5e32973a6854" xlink:to="loc_ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract_60a5fc67-0d73-4265-93fd-df80ac84efa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_e1c9ed06-3e5c-4a6a-bd38-128c36f010af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract_60a5fc67-0d73-4265-93fd-df80ac84efa5" xlink:to="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_e1c9ed06-3e5c-4a6a-bd38-128c36f010af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralRightToReclaimCash_dd57a1ff-6bb4-47df-95ff-b81cf0ae928a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeCollateralRightToReclaimCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract_60a5fc67-0d73-4265-93fd-df80ac84efa5" xlink:to="loc_us-gaap_DerivativeCollateralRightToReclaimCash_dd57a1ff-6bb4-47df-95ff-b81cf0ae928a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_bbee1c1b-8a85-4757-b303-247ad9b95462" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingDerivativeLiabilitiesAbstract_704c2863-90ed-4fc7-b491-5e32973a6854" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_bbee1c1b-8a85-4757-b303-247ad9b95462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_adaa036b-a6c9-4ca0-8f1d-2009101fe4fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_309ff3c7-f2e9-44aa-bb02-86a185c087aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_adaa036b-a6c9-4ca0-8f1d-2009101fe4fc" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_309ff3c7-f2e9-44aa-bb02-86a185c087aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d824ac1b-4660-4007-9510-9f76508fc61d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_309ff3c7-f2e9-44aa-bb02-86a185c087aa" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d824ac1b-4660-4007-9510-9f76508fc61d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_6b0ae500-7c61-479e-bab2-68c1946b7a43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d824ac1b-4660-4007-9510-9f76508fc61d" xlink:to="loc_us-gaap_HedgingRelationshipDomain_6b0ae500-7c61-479e-bab2-68c1946b7a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_31603c09-0858-437d-b983-b975806834ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_6b0ae500-7c61-479e-bab2-68c1946b7a43" xlink:to="loc_us-gaap_CashFlowHedgingMember_31603c09-0858-437d-b983-b975806834ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_4d8eecd7-e3d7-4d15-adda-2e7fe6672d75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_6b0ae500-7c61-479e-bab2-68c1946b7a43" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_4d8eecd7-e3d7-4d15-adda-2e7fe6672d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_cc3a2e76-a8c4-4aa2-a05c-473b685a5986" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_6b0ae500-7c61-479e-bab2-68c1946b7a43" xlink:to="loc_us-gaap_FairValueHedgingMember_cc3a2e76-a8c4-4aa2-a05c-473b685a5986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_08b8273c-bef6-4fea-b042-8d041f5140f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_309ff3c7-f2e9-44aa-bb02-86a185c087aa" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_08b8273c-bef6-4fea-b042-8d041f5140f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e9f1f474-9e79-48af-9501-20acd7e2e86c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_08b8273c-bef6-4fea-b042-8d041f5140f6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e9f1f474-9e79-48af-9501-20acd7e2e86c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_ca954c8a-f39d-40b0-8d11-189b30399e08" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e9f1f474-9e79-48af-9501-20acd7e2e86c" xlink:to="loc_us-gaap_ForeignExchangeContractMember_ca954c8a-f39d-40b0-8d11-189b30399e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_862baf8a-eb85-4a6b-8971-2bd4d6cc7c97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignExchangeContractMember_ca954c8a-f39d-40b0-8d11-189b30399e08" xlink:to="loc_us-gaap_CurrencySwapMember_862baf8a-eb85-4a6b-8971-2bd4d6cc7c97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_5b1c8912-4b1f-45d6-b4e1-798adf2046b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_309ff3c7-f2e9-44aa-bb02-86a185c087aa" xlink:to="loc_us-gaap_HedgingDesignationAxis_5b1c8912-4b1f-45d6-b4e1-798adf2046b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_849ec670-b97a-4c8d-aa28-7d58e9740ad6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_5b1c8912-4b1f-45d6-b4e1-798adf2046b0" xlink:to="loc_us-gaap_HedgingDesignationDomain_849ec670-b97a-4c8d-aa28-7d58e9740ad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b2eb4834-be6d-43cc-9e87-251febbe47e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_849ec670-b97a-4c8d-aa28-7d58e9740ad6" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b2eb4834-be6d-43cc-9e87-251febbe47e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_f74d1ad9-4a1f-414b-a331-c9b59b670740" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_849ec670-b97a-4c8d-aa28-7d58e9740ad6" xlink:to="loc_us-gaap_NondesignatedMember_f74d1ad9-4a1f-414b-a331-c9b59b670740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_96008005-fc45-48fd-9f94-8822efe39663" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_309ff3c7-f2e9-44aa-bb02-86a185c087aa" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_96008005-fc45-48fd-9f94-8822efe39663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e322e7f8-597d-467a-ad7d-46e0ecf68557" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_96008005-fc45-48fd-9f94-8822efe39663" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e322e7f8-597d-467a-ad7d-46e0ecf68557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_974a42c8-6d01-4c09-9bba-2a626a0e41ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e322e7f8-597d-467a-ad7d-46e0ecf68557" xlink:to="loc_us-gaap_CostOfSalesMember_974a42c8-6d01-4c09-9bba-2a626a0e41ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeMember_2202fdb5-e5bc-42f0-991a-8b3fa3c09687" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e322e7f8-597d-467a-ad7d-46e0ecf68557" xlink:to="loc_us-gaap_InterestIncomeMember_2202fdb5-e5bc-42f0-991a-8b3fa3c09687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_87cb18cb-93e1-4a87-9c22-53685e89c084" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_309ff3c7-f2e9-44aa-bb02-86a185c087aa" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_87cb18cb-93e1-4a87-9c22-53685e89c084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_b2fdde8b-be78-4b22-a69d-c8bfefe83136" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_87cb18cb-93e1-4a87-9c22-53685e89c084" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_b2fdde8b-be78-4b22-a69d-c8bfefe83136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_294810f1-3fd2-4ae1-bcf2-5acd39632dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_87cb18cb-93e1-4a87-9c22-53685e89c084" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_294810f1-3fd2-4ae1-bcf2-5acd39632dc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_25eea7a5-1e55-46fb-bbb1-a299a92565e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_87cb18cb-93e1-4a87-9c22-53685e89c084" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_25eea7a5-1e55-46fb-bbb1-a299a92565e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_831284c0-76d2-461b-8e42-ba2cdc58535e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_87cb18cb-93e1-4a87-9c22-53685e89c084" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_831284c0-76d2-461b-8e42-ba2cdc58535e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_c61f6c6b-7c08-415f-8089-a5df378261b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_87cb18cb-93e1-4a87-9c22-53685e89c084" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_c61f6c6b-7c08-415f-8089-a5df378261b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e2d44485-20d2-4451-b419-adf6a354db95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_727e3974-cab3-48ac-8121-d01e56af51dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e2d44485-20d2-4451-b419-adf6a354db95" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_727e3974-cab3-48ac-8121-d01e56af51dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e60624c0-2f3e-4827-8307-e9f66db5f2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_727e3974-cab3-48ac-8121-d01e56af51dc" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e60624c0-2f3e-4827-8307-e9f66db5f2b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e60ec1e4-f780-409d-b429-26152e7c2758" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e60624c0-2f3e-4827-8307-e9f66db5f2b1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e60ec1e4-f780-409d-b429-26152e7c2758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_e096b6ec-c011-405e-9878-dd7cdf87ddd9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e60ec1e4-f780-409d-b429-26152e7c2758" xlink:to="loc_us-gaap_ForeignExchangeContractMember_e096b6ec-c011-405e-9878-dd7cdf87ddd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_896a95e0-6e0a-43d1-a15d-eac7697e65af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_727e3974-cab3-48ac-8121-d01e56af51dc" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_896a95e0-6e0a-43d1-a15d-eac7697e65af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_70807617-4629-48d4-8a6b-18df37ae946a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_896a95e0-6e0a-43d1-a15d-eac7697e65af" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_70807617-4629-48d4-8a6b-18df37ae946a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_0b32cdda-75ee-4d81-963e-aafc7bd595c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_70807617-4629-48d4-8a6b-18df37ae946a" xlink:to="loc_us-gaap_CostOfSalesMember_0b32cdda-75ee-4d81-963e-aafc7bd595c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_c0baa9ec-8afa-4f2a-b9ec-c5cc818e6868" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_70807617-4629-48d4-8a6b-18df37ae946a" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_c0baa9ec-8afa-4f2a-b9ec-c5cc818e6868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_eca913cb-7c15-40c0-9433-68313de3a527" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_727e3974-cab3-48ac-8121-d01e56af51dc" xlink:to="loc_us-gaap_HedgingDesignationAxis_eca913cb-7c15-40c0-9433-68313de3a527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_19369e13-32a0-4524-bc5b-651693d21a76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_eca913cb-7c15-40c0-9433-68313de3a527" xlink:to="loc_us-gaap_HedgingDesignationDomain_19369e13-32a0-4524-bc5b-651693d21a76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6758dd46-71ab-483b-9293-7bb521f6ea03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_19369e13-32a0-4524-bc5b-651693d21a76" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6758dd46-71ab-483b-9293-7bb521f6ea03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_59f31a71-464f-459d-b61e-525c47c9bc8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_727e3974-cab3-48ac-8121-d01e56af51dc" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_59f31a71-464f-459d-b61e-525c47c9bc8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_ac903ab5-78fe-43f7-8adf-42e3438dd690" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_59f31a71-464f-459d-b61e-525c47c9bc8c" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_ac903ab5-78fe-43f7-8adf-42e3438dd690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_540909d1-b8a4-4245-a006-aae6e1a85fee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_59f31a71-464f-459d-b61e-525c47c9bc8c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_540909d1-b8a4-4245-a006-aae6e1a85fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract_1c74abf3-1ceb-46b8-91ee-f0c316919991" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_59f31a71-464f-459d-b61e-525c47c9bc8c" xlink:to="loc_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract_1c74abf3-1ceb-46b8-91ee-f0c316919991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_496ef399-85b6-493e-b5c2-608dd711ce12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract_1c74abf3-1ceb-46b8-91ee-f0c316919991" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_496ef399-85b6-493e-b5c2-608dd711ce12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_bfeebb80-39fc-4543-8719-f097f4bc6f80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract_1c74abf3-1ceb-46b8-91ee-f0c316919991" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_bfeebb80-39fc-4543-8719-f097f4bc6f80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax_c72f56e3-b1cc-4ba0-9e2c-d483ee04e1be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract_1c74abf3-1ceb-46b8-91ee-f0c316919991" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax_c72f56e3-b1cc-4ba0-9e2c-d483ee04e1be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_43346375-88c2-4da0-9611-c6672da36956" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_59f31a71-464f-459d-b61e-525c47c9bc8c" xlink:to="loc_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_43346375-88c2-4da0-9611-c6672da36956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_3ba5ae90-314b-447b-bd1f-9e27855efdd2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_43346375-88c2-4da0-9611-c6672da36956" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_3ba5ae90-314b-447b-bd1f-9e27855efdd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d2243abd-310e-4b8c-a946-dab8179dfdcd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8764abe4-961e-4a51-91d2-7cd1fde768be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d2243abd-310e-4b8c-a946-dab8179dfdcd" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8764abe4-961e-4a51-91d2-7cd1fde768be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_4a103480-d21c-448c-9010-6ceec3a345ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8764abe4-961e-4a51-91d2-7cd1fde768be" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_4a103480-d21c-448c-9010-6ceec3a345ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4ea87aaf-aee3-4d70-8630-285d919adb53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4a103480-d21c-448c-9010-6ceec3a345ee" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4ea87aaf-aee3-4d70-8630-285d919adb53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_f87fd9f5-44a8-401b-8e79-a90a626a3420" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4ea87aaf-aee3-4d70-8630-285d919adb53" xlink:to="loc_us-gaap_CostOfSalesMember_f87fd9f5-44a8-401b-8e79-a90a626a3420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_2510471b-3084-4c32-a68d-9079c6bf83c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4ea87aaf-aee3-4d70-8630-285d919adb53" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_2510471b-3084-4c32-a68d-9079c6bf83c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_98dde119-2c2e-480b-abc8-1c18b29104a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4ea87aaf-aee3-4d70-8630-285d919adb53" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_98dde119-2c2e-480b-abc8-1c18b29104a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_SeparationCostsMember_e7ac1fe4-bf7d-40cc-a026-a73b63392d83" xlink:href="ew-20240331.xsd#ew_SeparationCostsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4ea87aaf-aee3-4d70-8630-285d919adb53" xlink:to="loc_ew_SeparationCostsMember_e7ac1fe4-bf7d-40cc-a026-a73b63392d83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_5bd911bb-1a04-47bc-a23f-9a9680324617" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8764abe4-961e-4a51-91d2-7cd1fde768be" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_5bd911bb-1a04-47bc-a23f-9a9680324617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_409bde82-cbec-4a2d-9276-c292a145b975" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_5bd911bb-1a04-47bc-a23f-9a9680324617" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_409bde82-cbec-4a2d-9276-c292a145b975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_1aed137e-0eb4-4d9b-88fa-5632e2f131e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_5bd911bb-1a04-47bc-a23f-9a9680324617" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_1aed137e-0eb4-4d9b-88fa-5632e2f131e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_ea379f7b-a5a5-4730-9875-4c4b5641ee5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_5bd911bb-1a04-47bc-a23f-9a9680324617" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_ea379f7b-a5a5-4730-9875-4c4b5641ee5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#STOCKBASEDCOMPENSATIONNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_729c8be8-4e44-4467-aabb-ef78380fe80a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_7f8bb04d-09ca-4875-a3e3-7bcf81fe10eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_729c8be8-4e44-4467-aabb-ef78380fe80a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_7f8bb04d-09ca-4875-a3e3-7bcf81fe10eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_99aa6247-f38e-470f-b510-841c899e81da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_729c8be8-4e44-4467-aabb-ef78380fe80a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_99aa6247-f38e-470f-b510-841c899e81da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_07ffb389-6ee9-4f48-aca8-02cc99d26109" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5a050926-39a9-4d31-a182-cbeea9568329" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_07ffb389-6ee9-4f48-aca8-02cc99d26109" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5a050926-39a9-4d31-a182-cbeea9568329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_95c4abb0-796c-4b63-a277-e7d2ed67e2cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5a050926-39a9-4d31-a182-cbeea9568329" xlink:to="loc_us-gaap_AwardTypeAxis_95c4abb0-796c-4b63-a277-e7d2ed67e2cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f1545a5-6088-4ff2-9fe7-f3b00a46a5dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_95c4abb0-796c-4b63-a277-e7d2ed67e2cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f1545a5-6088-4ff2-9fe7-f3b00a46a5dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EmployeeAndNonemployeeStockOptionsMember_83b02a0f-a336-4b47-8081-c7e60784dd6c" xlink:href="ew-20240331.xsd#ew_EmployeeAndNonemployeeStockOptionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f1545a5-6088-4ff2-9fe7-f3b00a46a5dd" xlink:to="loc_ew_EmployeeAndNonemployeeStockOptionsMember_83b02a0f-a336-4b47-8081-c7e60784dd6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_a501312b-ce6b-45bc-94ac-7449e65fcafe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f1545a5-6088-4ff2-9fe7-f3b00a46a5dd" xlink:to="loc_us-gaap_EmployeeStockMember_a501312b-ce6b-45bc-94ac-7449e65fcafe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b379ed59-2860-4cbb-a23e-1b2aefaa892c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5a050926-39a9-4d31-a182-cbeea9568329" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b379ed59-2860-4cbb-a23e-1b2aefaa892c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_8e0f915f-dc78-4b20-a74c-68ab648f7c2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b379ed59-2860-4cbb-a23e-1b2aefaa892c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_8e0f915f-dc78-4b20-a74c-68ab648f7c2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_4aa2fc8f-2add-4236-9fd2-2ec71e5cafe6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b379ed59-2860-4cbb-a23e-1b2aefaa892c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_4aa2fc8f-2add-4236-9fd2-2ec71e5cafe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c77400bd-006b-4c1b-9a5c-4ce035c7faec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b379ed59-2860-4cbb-a23e-1b2aefaa892c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c77400bd-006b-4c1b-9a5c-4ce035c7faec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_c45230ce-3019-4a93-8f97-69d0bd64174d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b379ed59-2860-4cbb-a23e-1b2aefaa892c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_c45230ce-3019-4a93-8f97-69d0bd64174d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_bbaccd4c-eaba-43ba-88e4-9f5c5bd80035" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b379ed59-2860-4cbb-a23e-1b2aefaa892c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_bbaccd4c-eaba-43ba-88e4-9f5c5bd80035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#ACCELERATEDSHAREREPURCHASEDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e206fee1-53d7-476b-8d91-9bef488ff0a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_537d13f4-22f0-43c2-862e-982f7a924cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e206fee1-53d7-476b-8d91-9bef488ff0a4" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_537d13f4-22f0-43c2-862e-982f7a924cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_9b73811e-26f7-43e8-a6ef-b0b1b6aed8d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_537d13f4-22f0-43c2-862e-982f7a924cb6" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_9b73811e-26f7-43e8-a6ef-b0b1b6aed8d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_c59519e8-b066-4f75-ba5e-72755eb3a73d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_9b73811e-26f7-43e8-a6ef-b0b1b6aed8d6" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_c59519e8-b066-4f75-ba5e-72755eb3a73d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_InitialDeliveryOfSharesSettledFebruary2023Member_ec9b86a4-de98-41f9-94b3-a25b3718b5d8" xlink:href="ew-20240331.xsd#ew_InitialDeliveryOfSharesSettledFebruary2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_c59519e8-b066-4f75-ba5e-72755eb3a73d" xlink:to="loc_ew_InitialDeliveryOfSharesSettledFebruary2023Member_ec9b86a4-de98-41f9-94b3-a25b3718b5d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member_2f3b7e94-087b-4aa8-a65a-741252c1e355" xlink:href="ew-20240331.xsd#ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_c59519e8-b066-4f75-ba5e-72755eb3a73d" xlink:to="loc_ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member_2f3b7e94-087b-4aa8-a65a-741252c1e355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_ca66e118-d4c8-4159-a79a-0cb3b1fbf216" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_537d13f4-22f0-43c2-862e-982f7a924cb6" xlink:to="loc_us-gaap_ClassOfStockLineItems_ca66e118-d4c8-4159-a79a-0cb3b1fbf216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_2a0c2fa0-a1b7-413f-8988-9eb8a4c2f2be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_ca66e118-d4c8-4159-a79a-0cb3b1fbf216" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_2a0c2fa0-a1b7-413f-8988-9eb8a4c2f2be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_516f2c5f-07a9-4863-8695-817548427a51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_ca66e118-d4c8-4159-a79a-0cb3b1fbf216" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_516f2c5f-07a9-4863-8695-817548427a51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare_b2f8d60e-7896-451c-b59a-0ed31792b7ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_ca66e118-d4c8-4159-a79a-0cb3b1fbf216" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare_b2f8d60e-7896-451c-b59a-0ed31792b7ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount_408d827f-22e7-4a9f-a35b-8cb04f40ea8f" xlink:href="ew-20240331.xsd#ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_ca66e118-d4c8-4159-a79a-0cb3b1fbf216" xlink:to="loc_ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount_408d827f-22e7-4a9f-a35b-8cb04f40ea8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_32b866a1-75ac-4cb6-b3a3-85398b242c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_ca66e118-d4c8-4159-a79a-0cb3b1fbf216" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_32b866a1-75ac-4cb6-b3a3-85398b242c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_091a23b1-8069-44f0-a606-f3516e005b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber_0077679a-e492-4543-8a5a-8337f559573d" xlink:href="ew-20240331.xsd#ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_091a23b1-8069-44f0-a606-f3516e005b8d" xlink:to="loc_ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber_0077679a-e492-4543-8a5a-8337f559573d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccrualForEnvironmentalLossContingenciesThresholdAmountForDisclosure_a0990149-afbd-46a4-a58b-c6b85574382c" xlink:href="ew-20240331.xsd#ew_AccrualForEnvironmentalLossContingenciesThresholdAmountForDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_091a23b1-8069-44f0-a606-f3516e005b8d" xlink:to="loc_ew_AccrualForEnvironmentalLossContingenciesThresholdAmountForDisclosure_a0990149-afbd-46a4-a58b-c6b85574382c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_62f22943-068e-44cb-925a-1118cc0ad67e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_5b59c374-6a34-4773-800a-a80abc958a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_62f22943-068e-44cb-925a-1118cc0ad67e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_5b59c374-6a34-4773-800a-a80abc958a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f0329734-eec8-4dc3-963d-dfacdbf3501d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_5b59c374-6a34-4773-800a-a80abc958a3e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f0329734-eec8-4dc3-963d-dfacdbf3501d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7b26cdb4-4454-412b-8658-c53db10ba8a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f0329734-eec8-4dc3-963d-dfacdbf3501d" xlink:to="loc_us-gaap_EquityComponentDomain_7b26cdb4-4454-412b-8658-c53db10ba8a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a61401e9-9c2d-4334-8428-83660bca773c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7b26cdb4-4454-412b-8658-c53db10ba8a1" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a61401e9-9c2d-4334-8428-83660bca773c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_c101a3e6-ad7a-487d-ba91-0ccad88d530e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a61401e9-9c2d-4334-8428-83660bca773c" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_c101a3e6-ad7a-487d-ba91-0ccad88d530e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_ebc99a10-5c6c-4960-9c02-67f3f905b185" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a61401e9-9c2d-4334-8428-83660bca773c" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_ebc99a10-5c6c-4960-9c02-67f3f905b185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_907b17d6-a3d1-4365-b4f7-23abd5694a35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a61401e9-9c2d-4334-8428-83660bca773c" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_907b17d6-a3d1-4365-b4f7-23abd5694a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_e8132b3d-5c94-48f8-9d91-81f4fb3d9ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a61401e9-9c2d-4334-8428-83660bca773c" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_e8132b3d-5c94-48f8-9d91-81f4fb3d9ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a5b5e45a-ab30-4fe1-b596-55d3d986e8df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_5b59c374-6a34-4773-800a-a80abc958a3e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a5b5e45a-ab30-4fe1-b596-55d3d986e8df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_e7062a2b-d88f-4a5a-81da-85433e81a400" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a5b5e45a-ab30-4fe1-b596-55d3d986e8df" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_e7062a2b-d88f-4a5a-81da-85433e81a400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_31907fc7-b10a-457d-a95e-a83146a664b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_e7062a2b-d88f-4a5a-81da-85433e81a400" xlink:to="loc_us-gaap_StockholdersEquity_31907fc7-b10a-457d-a95e-a83146a664b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_d8f464f5-398c-4a3e-8685-025eb39b35de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_e7062a2b-d88f-4a5a-81da-85433e81a400" xlink:to="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_d8f464f5-398c-4a3e-8685-025eb39b35de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_7e613842-86c5-412b-a998-2d4edbd13371" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_e7062a2b-d88f-4a5a-81da-85433e81a400" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_7e613842-86c5-412b-a998-2d4edbd13371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_aced1cf9-9629-4f12-8e6a-9baeff7dd78c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_e7062a2b-d88f-4a5a-81da-85433e81a400" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_aced1cf9-9629-4f12-8e6a-9baeff7dd78c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d8ec99aa-2e20-4ebd-955d-d85b206847e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_e7062a2b-d88f-4a5a-81da-85433e81a400" xlink:to="loc_us-gaap_StockholdersEquity_d8ec99aa-2e20-4ebd-955d-d85b206847e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_d88d90ce-61c1-43eb-ab9b-50874c4b2660" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_f475a5b7-8fb1-49bb-a582-eaa976dc4437" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_d88d90ce-61c1-43eb-ab9b-50874c4b2660" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_f475a5b7-8fb1-49bb-a582-eaa976dc4437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_2b8f3574-e4d0-4da4-b247-3c62d5e27bca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_f475a5b7-8fb1-49bb-a582-eaa976dc4437" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_2b8f3574-e4d0-4da4-b247-3c62d5e27bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_b2adef76-8949-4f01-94f0-cc6c8b2efc2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_2b8f3574-e4d0-4da4-b247-3c62d5e27bca" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_b2adef76-8949-4f01-94f0-cc6c8b2efc2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_dcc75833-e59e-48aa-935b-f0bcaa7f3698" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_b2adef76-8949-4f01-94f0-cc6c8b2efc2c" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_dcc75833-e59e-48aa-935b-f0bcaa7f3698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_375dc615-e2b6-4525-a600-675f4dc3efd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_f475a5b7-8fb1-49bb-a582-eaa976dc4437" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_375dc615-e2b6-4525-a600-675f4dc3efd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_bc1a3d09-84cf-4ea8-b983-7b574bfc9cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_375dc615-e2b6-4525-a600-675f4dc3efd8" xlink:to="loc_us-gaap_EquityComponentDomain_bc1a3d09-84cf-4ea8-b983-7b574bfc9cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_caa9d43b-a8c8-441b-b3cd-d14dc1b7a9f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_bc1a3d09-84cf-4ea8-b983-7b574bfc9cbc" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_caa9d43b-a8c8-441b-b3cd-d14dc1b7a9f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_ce20ee7b-2c01-4bc2-afd5-7c9bfebb18c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_bc1a3d09-84cf-4ea8-b983-7b574bfc9cbc" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_ce20ee7b-2c01-4bc2-afd5-7c9bfebb18c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_86466a77-a1d4-498f-8e31-29fd2c4e02ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_bc1a3d09-84cf-4ea8-b983-7b574bfc9cbc" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_86466a77-a1d4-498f-8e31-29fd2c4e02ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_1d8dda72-d3a5-4453-a3de-1f1f2e99ba4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_f475a5b7-8fb1-49bb-a582-eaa976dc4437" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_1d8dda72-d3a5-4453-a3de-1f1f2e99ba4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_326bb7ec-496f-41f2-8fe0-48f765be6d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_1d8dda72-d3a5-4453-a3de-1f1f2e99ba4d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_326bb7ec-496f-41f2-8fe0-48f765be6d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_2eeebe61-dd6f-4818-8651-2401cb03cb28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_1d8dda72-d3a5-4453-a3de-1f1f2e99ba4d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_2eeebe61-dd6f-4818-8651-2401cb03cb28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_210daec0-b4b4-4e21-b4db-8880fd350666" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_1d8dda72-d3a5-4453-a3de-1f1f2e99ba4d" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_210daec0-b4b4-4e21-b4db-8880fd350666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_d0385e1e-c659-4e72-b6c2-81df45379339" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_1d8dda72-d3a5-4453-a3de-1f1f2e99ba4d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_d0385e1e-c659-4e72-b6c2-81df45379339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_7f6d0902-d763-4995-8f3f-ae45072128c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_1d8dda72-d3a5-4453-a3de-1f1f2e99ba4d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_7f6d0902-d763-4995-8f3f-ae45072128c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_caf2c754-f038-49e5-b911-97642019783c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_1d8dda72-d3a5-4453-a3de-1f1f2e99ba4d" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_caf2c754-f038-49e5-b911-97642019783c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_88e43ae2-a06f-4270-9576-c257bb32f385" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_8ad02820-88c5-4eba-89f2-eb42a9009555" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_88e43ae2-a06f-4270-9576-c257bb32f385" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_8ad02820-88c5-4eba-89f2-eb42a9009555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_b54047e6-e5f4-41bf-a4d9-47b80bdd2a38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_8ad02820-88c5-4eba-89f2-eb42a9009555" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_b54047e6-e5f4-41bf-a4d9-47b80bdd2a38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_98d7ee9f-7129-4009-8768-f4b667405070" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_8ad02820-88c5-4eba-89f2-eb42a9009555" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_98d7ee9f-7129-4009-8768-f4b667405070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_209dd87e-afac-44d2-a97a-d0aadc969b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_8ad02820-88c5-4eba-89f2-eb42a9009555" xlink:to="loc_us-gaap_EarningsPerShareBasic_209dd87e-afac-44d2-a97a-d0aadc969b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_3388365a-e5af-4073-bdc0-b4746145fd92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_88e43ae2-a06f-4270-9576-c257bb32f385" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_3388365a-e5af-4073-bdc0-b4746145fd92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_3d4dcc57-1cfb-4976-8e94-ac09f20f02a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_3388365a-e5af-4073-bdc0-b4746145fd92" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_3d4dcc57-1cfb-4976-8e94-ac09f20f02a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f36d2a88-b54b-48cc-89a5-48a6e53b67c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_3388365a-e5af-4073-bdc0-b4746145fd92" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f36d2a88-b54b-48cc-89a5-48a6e53b67c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_d78caeed-ae37-41cd-98bb-9d2baa893652" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_3388365a-e5af-4073-bdc0-b4746145fd92" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_d78caeed-ae37-41cd-98bb-9d2baa893652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a2b462d3-aa8e-4652-9724-d3781a086528" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_3388365a-e5af-4073-bdc0-b4746145fd92" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a2b462d3-aa8e-4652-9724-d3781a086528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_52782113-222b-447e-b3e8-0b0fe542dd70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_3388365a-e5af-4073-bdc0-b4746145fd92" xlink:to="loc_us-gaap_EarningsPerShareDiluted_52782113-222b-447e-b3e8-0b0fe542dd70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#EARNINGSPERSHARENarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e64f402a-5eb0-4a1b-9e8c-8bc451d3d908" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_d891788a-f19a-4626-a8b6-310e70410ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e64f402a-5eb0-4a1b-9e8c-8bc451d3d908" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_d891788a-f19a-4626-a8b6-310e70410ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_903f14c7-c1b8-4d4a-a1ec-1996a9386175" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_d891788a-f19a-4626-a8b6-310e70410ae9" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_903f14c7-c1b8-4d4a-a1ec-1996a9386175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_343ea767-e273-4f9b-a002-167fd054ef63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_903f14c7-c1b8-4d4a-a1ec-1996a9386175" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_343ea767-e273-4f9b-a002-167fd054ef63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_acf3e88f-8c44-4327-abfd-d128c01f1608" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_343ea767-e273-4f9b-a002-167fd054ef63" xlink:to="loc_us-gaap_StockCompensationPlanMember_acf3e88f-8c44-4327-abfd-d128c01f1608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_960e59d1-da27-47fb-9d22-ed15f4a4f18e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_d891788a-f19a-4626-a8b6-310e70410ae9" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_960e59d1-da27-47fb-9d22-ed15f4a4f18e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_015766a6-2669-4a72-b23a-6f51010c7d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_960e59d1-da27-47fb-9d22-ed15f4a4f18e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_015766a6-2669-4a72-b23a-6f51010c7d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INCOMETAXESDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#INCOMETAXESDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/INCOMETAXESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_eac4ed37-5409-44f6-b9b5-0f34383667ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_c2cfccf1-ae9e-4ec0-8181-6efaa98f81e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_eac4ed37-5409-44f6-b9b5-0f34383667ba" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_c2cfccf1-ae9e-4ec0-8181-6efaa98f81e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_e1315b40-3cb6-4ef4-929c-8e9caa210528" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_c2cfccf1-ae9e-4ec0-8181-6efaa98f81e7" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_e1315b40-3cb6-4ef4-929c-8e9caa210528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_78aa9e6a-9f58-42fa-983e-f815938003c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_e1315b40-3cb6-4ef4-929c-8e9caa210528" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_78aa9e6a-9f58-42fa-983e-f815938003c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IsraelTaxAuthorityMember_f688f5bc-7ad9-46f3-9287-bcc306829793" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IsraelTaxAuthorityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_78aa9e6a-9f58-42fa-983e-f815938003c0" xlink:to="loc_us-gaap_IsraelTaxAuthorityMember_f688f5bc-7ad9-46f3-9287-bcc306829793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_6073b326-cfb2-4b33-aded-2c9ee04b1ade" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_c2cfccf1-ae9e-4ec0-8181-6efaa98f81e7" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_6073b326-cfb2-4b33-aded-2c9ee04b1ade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_a939ddc2-170d-464b-83a8-4e7715ae7b45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6073b326-cfb2-4b33-aded-2c9ee04b1ade" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_a939ddc2-170d-464b-83a8-4e7715ae7b45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_9b2c8c39-7486-4c9c-8ef4-eb2f531d1b01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6073b326-cfb2-4b33-aded-2c9ee04b1ade" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_9b2c8c39-7486-4c9c-8ef4-eb2f531d1b01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_37dd1af2-d8aa-40a9-bbf6-71e081ada6e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6073b326-cfb2-4b33-aded-2c9ee04b1ade" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_37dd1af2-d8aa-40a9-bbf6-71e081ada6e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_61789518-782e-41e3-912c-c917cebe1111" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6073b326-cfb2-4b33-aded-2c9ee04b1ade" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_61789518-782e-41e3-912c-c917cebe1111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_71f5dd9d-67ff-4160-9625-46694eca5395" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6073b326-cfb2-4b33-aded-2c9ee04b1ade" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_71f5dd9d-67ff-4160-9625-46694eca5395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_NumberOfAdvancePricingAgreementsRenewed_550d84ae-58bb-4d9e-9e82-e2a693460c54" xlink:href="ew-20240331.xsd#ew_NumberOfAdvancePricingAgreementsRenewed"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6073b326-cfb2-4b33-aded-2c9ee04b1ade" xlink:to="loc_ew_NumberOfAdvancePricingAgreementsRenewed_550d84ae-58bb-4d9e-9e82-e2a693460c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_IncomeTaxAssessmentEstimateOfAdditionalTaxExpense_8bf98201-d1bf-4fc0-9e78-6c6d3f20b867" xlink:href="ew-20240331.xsd#ew_IncomeTaxAssessmentEstimateOfAdditionalTaxExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6073b326-cfb2-4b33-aded-2c9ee04b1ade" xlink:to="loc_ew_IncomeTaxAssessmentEstimateOfAdditionalTaxExpense_8bf98201-d1bf-4fc0-9e78-6c6d3f20b867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority_8d529d83-3e84-4d9a-882b-87dd2b659086" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6073b326-cfb2-4b33-aded-2c9ee04b1ade" xlink:to="loc_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority_8d529d83-3e84-4d9a-882b-87dd2b659086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_IncomeTaxExaminationAmountDepositedToMitigateInterestOnTaxLiabilities_ad0be3b9-f707-41be-a18e-d7e322fc39fd" xlink:href="ew-20240331.xsd#ew_IncomeTaxExaminationAmountDepositedToMitigateInterestOnTaxLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6073b326-cfb2-4b33-aded-2c9ee04b1ade" xlink:to="loc_ew_IncomeTaxExaminationAmountDepositedToMitigateInterestOnTaxLiabilities_ad0be3b9-f707-41be-a18e-d7e322fc39fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss_aea9dd3d-9894-4206-a303-f280bd3146f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6073b326-cfb2-4b33-aded-2c9ee04b1ade" xlink:to="loc_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss_aea9dd3d-9894-4206-a303-f280bd3146f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_5cc6f0c1-7818-4936-950a-f653e4219bb4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_741679a7-cd7f-4b77-a88b-7aa26c04beec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5cc6f0c1-7818-4936-950a-f653e4219bb4" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_741679a7-cd7f-4b77-a88b-7aa26c04beec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_5b85f3c6-f0e9-410e-aa97-ee34848a1dfa" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_741679a7-cd7f-4b77-a88b-7aa26c04beec" xlink:to="loc_srt_ConsolidationItemsAxis_5b85f3c6-f0e9-410e-aa97-ee34848a1dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a77bf27b-0670-4a21-ad7f-e0b26e34a108" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_5b85f3c6-f0e9-410e-aa97-ee34848a1dfa" xlink:to="loc_srt_ConsolidationItemsDomain_a77bf27b-0670-4a21-ad7f-e0b26e34a108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_5409baf9-fdba-4be6-911b-ed929351736e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_a77bf27b-0670-4a21-ad7f-e0b26e34a108" xlink:to="loc_us-gaap_OperatingSegmentsMember_5409baf9-fdba-4be6-911b-ed929351736e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_8caac057-bcf2-4498-bd58-279a931b7783" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_741679a7-cd7f-4b77-a88b-7aa26c04beec" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_8caac057-bcf2-4498-bd58-279a931b7783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f5c37aba-909e-4a75-9f5a-4171ee4887ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8caac057-bcf2-4498-bd58-279a931b7783" xlink:to="loc_us-gaap_SegmentDomain_f5c37aba-909e-4a75-9f5a-4171ee4887ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_UnitedStatesSegmentMember_a2faa2f2-11a0-4cca-b71a-25f7cf85ea89" xlink:href="ew-20240331.xsd#ew_UnitedStatesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f5c37aba-909e-4a75-9f5a-4171ee4887ec" xlink:to="loc_ew_UnitedStatesSegmentMember_a2faa2f2-11a0-4cca-b71a-25f7cf85ea89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EuropeSegmentMember_f8817e5e-89a2-4cf3-b90d-f4ab5cb4c37a" xlink:href="ew-20240331.xsd#ew_EuropeSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f5c37aba-909e-4a75-9f5a-4171ee4887ec" xlink:to="loc_ew_EuropeSegmentMember_f8817e5e-89a2-4cf3-b90d-f4ab5cb4c37a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_JapanSegmentMember_ae38587b-a624-4fdf-a524-1c94b87f2025" xlink:href="ew-20240331.xsd#ew_JapanSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f5c37aba-909e-4a75-9f5a-4171ee4887ec" xlink:to="loc_ew_JapanSegmentMember_ae38587b-a624-4fdf-a524-1c94b87f2025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_RestOfWorldSegmentMember_6e4c628b-8701-4e32-a854-a2cf2a51f4d2" xlink:href="ew-20240331.xsd#ew_RestOfWorldSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f5c37aba-909e-4a75-9f5a-4171ee4887ec" xlink:to="loc_ew_RestOfWorldSegmentMember_6e4c628b-8701-4e32-a854-a2cf2a51f4d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_d062d652-1bcc-4d1d-b677-e282ebd2f9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_741679a7-cd7f-4b77-a88b-7aa26c04beec" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_d062d652-1bcc-4d1d-b677-e282ebd2f9e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_5bd4ffdc-dcf0-4f77-b0df-f287636d7d86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d062d652-1bcc-4d1d-b677-e282ebd2f9e5" xlink:to="loc_us-gaap_RevenuesAbstract_5bd4ffdc-dcf0-4f77-b0df-f287636d7d86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6fb174d5-706a-416d-a544-25581f77349f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_5bd4ffdc-dcf0-4f77-b0df-f287636d7d86" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6fb174d5-706a-416d-a544-25581f77349f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_34eece32-7603-4253-a308-90a55cdb0f56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d062d652-1bcc-4d1d-b677-e282ebd2f9e5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_34eece32-7603-4253-a308-90a55cdb0f56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_b7370deb-e5ba-434a-8bbd-04f1b6b167d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_34eece32-7603-4253-a308-90a55cdb0f56" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_b7370deb-e5ba-434a-8bbd-04f1b6b167d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_c7f77eaa-f256-4429-83fb-5b476f1c2d46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0f7d1cd3-4b1e-4d31-90f0-a86c8606b2cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c7f77eaa-f256-4429-83fb-5b476f1c2d46" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0f7d1cd3-4b1e-4d31-90f0-a86c8606b2cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_c3f5f6c4-aa6d-4174-8f26-3946774890ed" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0f7d1cd3-4b1e-4d31-90f0-a86c8606b2cb" xlink:to="loc_srt_ConsolidationItemsAxis_c3f5f6c4-aa6d-4174-8f26-3946774890ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a39b03dc-d481-4692-8726-e1b9e0a337df" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_c3f5f6c4-aa6d-4174-8f26-3946774890ed" xlink:to="loc_srt_ConsolidationItemsDomain_a39b03dc-d481-4692-8726-e1b9e0a337df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_d6d0d6c3-ec87-46ec-a34a-cee86299761e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_a39b03dc-d481-4692-8726-e1b9e0a337df" xlink:to="loc_us-gaap_OperatingSegmentsMember_d6d0d6c3-ec87-46ec-a34a-cee86299761e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_0f94b382-f52b-4b40-8664-4922cb72f6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_a39b03dc-d481-4692-8726-e1b9e0a337df" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_0f94b382-f52b-4b40-8664-4922cb72f6bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_475c03a5-11de-438c-8b1a-c68af912b052" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_a39b03dc-d481-4692-8726-e1b9e0a337df" xlink:to="loc_us-gaap_CorporateNonSegmentMember_475c03a5-11de-438c-8b1a-c68af912b052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_be003ef2-7b64-4de1-9834-04e83c9dd381" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0f7d1cd3-4b1e-4d31-90f0-a86c8606b2cb" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_be003ef2-7b64-4de1-9834-04e83c9dd381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_4d9437ff-f5f4-44dd-930a-4e4bbdbbfe02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_be003ef2-7b64-4de1-9834-04e83c9dd381" xlink:to="loc_us-gaap_RevenuesAbstract_4d9437ff-f5f4-44dd-930a-4e4bbdbbfe02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_77e0b2fc-880a-4197-9cf2-485858bbaa67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_4d9437ff-f5f4-44dd-930a-4e4bbdbbfe02" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_77e0b2fc-880a-4197-9cf2-485858bbaa67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_72af9a0a-bf52-43fe-9730-0534ffc7dda3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_be003ef2-7b64-4de1-9834-04e83c9dd381" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_72af9a0a-bf52-43fe-9730-0534ffc7dda3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_7fbdfc4e-c959-470e-89f1-78b1ab7fdca1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_72af9a0a-bf52-43fe-9730-0534ffc7dda3" xlink:to="loc_us-gaap_OperatingIncomeLoss_7fbdfc4e-c959-470e-89f1-78b1ab7fdca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_16f1aeed-cf22-447f-bfeb-9c82165f105f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_72af9a0a-bf52-43fe-9730-0534ffc7dda3" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_16f1aeed-cf22-447f-bfeb-9c82165f105f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_8e5df85c-a500-493c-96d9-f7083465e819" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_16f1aeed-cf22-447f-bfeb-9c82165f105f" xlink:to="loc_us-gaap_CostsAndExpenses_8e5df85c-a500-493c-96d9-f7083465e819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonrecurringIncomeExpense_87d8a5c3-0434-4623-a6e2-31f8d6e96539" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonrecurringIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_16f1aeed-cf22-447f-bfeb-9c82165f105f" xlink:to="loc_us-gaap_OtherNonrecurringIncomeExpense_87d8a5c3-0434-4623-a6e2-31f8d6e96539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_6eef149f-fa4a-4494-a46b-5946f315328e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_16f1aeed-cf22-447f-bfeb-9c82165f105f" xlink:to="loc_us-gaap_LitigationSettlementExpense_6eef149f-fa4a-4494-a46b-5946f315328e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_c006659d-6b1f-4e1f-8cfd-764fda4ae820" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_16f1aeed-cf22-447f-bfeb-9c82165f105f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_c006659d-6b1f-4e1f-8cfd-764fda4ae820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_258f7833-4706-43de-adea-2dd45524d3f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_16f1aeed-cf22-447f-bfeb-9c82165f105f" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_258f7833-4706-43de-adea-2dd45524d3f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_b104c86f-f3e0-4a69-b01f-6417cbebe639" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_16f1aeed-cf22-447f-bfeb-9c82165f105f" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_b104c86f-f3e0-4a69-b01f-6417cbebe639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3923cf95-dbbd-4e56-94c1-1baac665e385" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_72af9a0a-bf52-43fe-9730-0534ffc7dda3" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3923cf95-dbbd-4e56-94c1-1baac665e385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" xlink:type="simple" xlink:href="ew-20240331.xsd#SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_e9e757b3-3aee-48d6-8784-61d57164c25f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_27c7bc65-94f4-4224-a1be-2ee9d3fe961c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_e9e757b3-3aee-48d6-8784-61d57164c25f" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_27c7bc65-94f4-4224-a1be-2ee9d3fe961c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_0625ac2b-09a1-4e4d-ab51-f4ecbf75edcb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_27c7bc65-94f4-4224-a1be-2ee9d3fe961c" xlink:to="loc_srt_StatementGeographicalAxis_0625ac2b-09a1-4e4d-ab51-f4ecbf75edcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_5a9eb310-1616-4f52-a02a-3d967912249c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_0625ac2b-09a1-4e4d-ab51-f4ecbf75edcb" xlink:to="loc_srt_SegmentGeographicalDomain_5a9eb310-1616-4f52-a02a-3d967912249c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_4d134e62-9ecf-4ce2-982e-dae6bd8ebc38" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_5a9eb310-1616-4f52-a02a-3d967912249c" xlink:to="loc_country_US_4d134e62-9ecf-4ce2-982e-dae6bd8ebc38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_0c66b4d7-c136-4d2c-9371-d2e6f5ffc249" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_5a9eb310-1616-4f52-a02a-3d967912249c" xlink:to="loc_srt_EuropeMember_0c66b4d7-c136-4d2c-9371-d2e6f5ffc249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP_27df9228-10d6-4ac3-9972-60ed8a2ac075" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_JP"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_5a9eb310-1616-4f52-a02a-3d967912249c" xlink:to="loc_country_JP_27df9228-10d6-4ac3-9972-60ed8a2ac075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_RestOfWorldMember_9ba0244d-4480-4b78-934a-07c7a9984eb2" xlink:href="ew-20240331.xsd#ew_RestOfWorldMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_5a9eb310-1616-4f52-a02a-3d967912249c" xlink:to="loc_ew_RestOfWorldMember_9ba0244d-4480-4b78-934a-07c7a9984eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_3e22c50b-92e7-4401-a1c0-3d669351bf86" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_27c7bc65-94f4-4224-a1be-2ee9d3fe961c" xlink:to="loc_srt_ProductOrServiceAxis_3e22c50b-92e7-4401-a1c0-3d669351bf86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1b706cc0-ced9-48db-9e5e-f7f0afc606aa" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_3e22c50b-92e7-4401-a1c0-3d669351bf86" xlink:to="loc_srt_ProductsAndServicesDomain_1b706cc0-ced9-48db-9e5e-f7f0afc606aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_TranscatheterAorticValveReplacementMember_13fb3b38-00ac-4f8d-8137-ad92c009eb78" xlink:href="ew-20240331.xsd#ew_TranscatheterAorticValveReplacementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1b706cc0-ced9-48db-9e5e-f7f0afc606aa" xlink:to="loc_ew_TranscatheterAorticValveReplacementMember_13fb3b38-00ac-4f8d-8137-ad92c009eb78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_TranscatheterMitralAndTricuspidTherapiesMember_13c57ee7-43e9-4c60-b8d1-1244220b17d0" xlink:href="ew-20240331.xsd#ew_TranscatheterMitralAndTricuspidTherapiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1b706cc0-ced9-48db-9e5e-f7f0afc606aa" xlink:to="loc_ew_TranscatheterMitralAndTricuspidTherapiesMember_13c57ee7-43e9-4c60-b8d1-1244220b17d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_SurgicalHeartValveTherapyMember_ba6b4dcb-d25a-4a2e-8fa5-c6021a153d13" xlink:href="ew-20240331.xsd#ew_SurgicalHeartValveTherapyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1b706cc0-ced9-48db-9e5e-f7f0afc606aa" xlink:to="loc_ew_SurgicalHeartValveTherapyMember_ba6b4dcb-d25a-4a2e-8fa5-c6021a153d13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_CriticalCareMember_f4901eeb-c2ba-4e44-9557-5252e1e35c22" xlink:href="ew-20240331.xsd#ew_CriticalCareMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1b706cc0-ced9-48db-9e5e-f7f0afc606aa" xlink:to="loc_ew_CriticalCareMember_f4901eeb-c2ba-4e44-9557-5252e1e35c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_92dfefa5-4bc0-4173-b572-b7ff74707619" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_27c7bc65-94f4-4224-a1be-2ee9d3fe961c" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_92dfefa5-4bc0-4173-b572-b7ff74707619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_314c192a-b26c-460c-8c51-f64b0931cb31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_92dfefa5-4bc0-4173-b572-b7ff74707619" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_314c192a-b26c-460c-8c51-f64b0931cb31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EmployeeAndNonemployeeStockOptionsMember" xlink:href="ew-20240331.xsd#ew_EmployeeAndNonemployeeStockOptionsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ew_EmployeeAndNonemployeeStockOptionsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MichaelA.MussallemMember" xlink:href="ew-20240331.xsd#ew_MichaelA.MussallemMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ew_MichaelA.MussallemMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_ScottB.UllemMember" xlink:href="ew-20240331.xsd#ew_ScottB.UllemMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ew_ScottB.UllemMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_BernardJ.ZovighianMember" xlink:href="ew-20240331.xsd#ew_BernardJ.ZovighianMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ew_BernardJ.ZovighianMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_us-gaap_NetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>ew-20240331_g1.jpg
<TEXT>
begin 644 ew-20240331_g1.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M $&H/^^J/^$Q\,?]!J#_ +ZH TJ*S?\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^J
M-*BLW_A,?#'_ $&H/^^J/^$Q\,?]!J#_ +ZH TJ*S?\ A,?#'_0:@_[ZH_X3
M'PQ_T&H/^^J -*BLW_A,?#'_ $&H/^^J/^$Q\,?]!J#_ +ZH TJ*S?\ A,?#
M'_0:@_[ZH_X3'PQ_T&H/^^J -*BLW_A,?#'_ $&H/^^J/^$Q\,?]!J#_ +ZH
M TJ*S?\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^J -*BLW_A,?#'_ $&H/^^J/^$Q
M\,?]!J#_ +ZH TJ*S?\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^J -*BLW_A,?#'_
M $&H/^^J/^$Q\,?]!J#_ +ZH TJ*S?\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^J
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M:?\ \^,/_?H4?V=I_P#SXP_]^A4U% $/]G:?_P ^,/\ WZ%']G:?_P ^,/\
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M3_Z":V*Q_$O_ "%]'_Z_3_Z":V* "BBB@ HHHH **** "BBB@ HHHH ****
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MBB@ HHHH **** "BBB@#'LO^1WO?^O*+^9K8K'LO^1WO?^O*+^9K8H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O"_VL/^
M2V? _P#['N7_ -)FKW2O"_VL/^2V? __ +'N7_TF:@#W2BBB@ HHHH ****
M"BBB@ HHHH **** ,?Q+_P A?1_^OT_^@FMBL?Q+_P A?1_^OT_^@FMB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@#'LO^1WO?\ KRB_F:V*Q[+_ )'>]_Z\HOYFMB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *\+_:P_Y+9\#_\ L>Y?_29J
M]TKPO]K#_DMGP/\ ^Q[E_P#29J /=**** "BBB@ HKCOB/\ '[X2?"35(-%^
M(7BS^S[FYM_/@B^P7$NZ/<5SF*-@.0>"<USO_#:O[,W_ $4O_P HU[_\9H ]
M3HKRS_AM7]F;_HI?_E&O?_C-'_#:O[,W_12__*->_P#QF@#U.BO+/^&U?V9O
M^BE_^4:]_P#C-'_#:O[,W_12_P#RC7O_ ,9H ]3HKRS_ (;5_9F_Z*7_ .4:
M]_\ C-'_  VK^S-_T4O_ ,HU[_\ &: .[\2_\A?1_P#K]/\ Z":V*\:US]L7
M]G&\U'39[;XB[DM[DO,?[(O!M&W&>8>?PK2_X;5_9F_Z*7_Y1KW_ .,T >IT
M5Y9_PVK^S-_T4O\ \HU[_P#&:/\ AM7]F;_HI?\ Y1KW_P",T >IT5Y9_P -
MJ_LS?]%+_P#*->__ !FC_AM7]F;_ **7_P"4:]_^,T >IT5Y9_PVK^S-_P!%
M+_\ *->__&:/^&U?V9O^BE_^4:]_^,T >IT5Y9_PVK^S-_T4O_RC7O\ \9KT
M;PYXAT?Q;H-IXF\/WGVBQO[=9[2?RV3?&PR#M8 CCL0#0!=HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** ,>R_P"1WO?^O*+^9K8K'LO^1WO?^O*+
M^9K8H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@"GX@\0Z!X3T2[\3>*=<L],TV
MPMVGOM0U"Y2&"WB49:221R%10.220!6-\(/C)\*OV@/AY8?%OX)?$#2O%/AC
M57G73-?T.\6XM+OR9Y()#%*N5D42Q2+N4D';D$CFL+]JKX9?#KXM?L]>+_"/
MQ0\"Z1XATQ_#M])]@UK38KJ$2"VE D"2*0' 8X8<C)P:^5?^#9W_ )0>? ?_
M +!FM?\ I]U&@#[LKR3X[?M[_L0_LO>+X/A_^TA^US\./ FNW-@E];Z/XM\9
M66GW4ELSNBS"*:16*%HY%#8P2C#L:];/ SC-?B/\2_V@G_9?_:0\6?&'_@O'
M_P $,_#6J>"_B'\0I9-/^/.HZ5HWC)?#6GOY=KINGW$8BN/LMO#;Q0@JDB%Y
M?/E2&1Y6! /V8\-?%GX7^,?AE;?&GPK\1-%U#P?>:3_:EKXHM=3B?3Y;'87^
MU+<!O+,.P%O,SMV\YQ7*_!/]L/\ 9?\ VC=:N/#?P0^./A_Q)J%OIZ:@;+3[
MT&6:Q=MJ7D2L 9[9F^5;B/=$QX#$U\(?\%XOB3X=U#X4_LE_L'?!F73;3X?_
M +0/QP\+>'M2@\.A(K&Y\)0S6Q:S@$.$6V=9K4A4^4QQ[ -K8K9_X.$/'ES^
MR1:?LM_MP_#O;I^N?#[]H?2]!E:V4)]H\/:I:7,>HV!QC]W*EK"-O0% PP5!
MH ^[OC/^T+\$OV>-(L=;^-7Q+TOP]%JE[]CTB*^G_?ZC<[2WDVT*@RW$FT,Q
M2-68*I8C )K2^%WQ8^&?QN\$6?Q)^$/CS2O$F@W^\6FK:->I/"[(Q1TW*3AT
M=61D.&5E*L 017Y^?LH?$/5/VIO^#C3]HW7/%DAN]*_9Z^&>B^$/ EI,<QV$
MNJ".[O[E$/"3220O$9!\QB14)P,5-^QI\1=2^#/_  </?M0_L9^'[@Q>$O'7
MP\T?XHV^D*<06.KJMC87TT:]%>Z:=)93_$T2GM0!^CM%%% !7A?[6'_);/@?
M_P!CW+_Z3-7NE>%_M8?\EL^!_P#V/<O_ *3-0![I1110 4444 ?'?_!1S_DJ
M&A?]@#_VO)7SO7T1_P %'/\ DJ&A?]@#_P!KR5\[T %%%% !1110 4444 %%
M%% !1110 4444 %%%% !7Z,?LY_\D'\(_P#8 MO_ $6*_.>OT8_9S_Y(/X1_
M[ %M_P"BQ0!VE%%% !1110 4444 %%%% !1110 4444 %%%% !1110!CV7_(
M[WO_ %Y1?S-;%8]E_P CO>_]>47\S6Q0 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% ')?'W5=,T+X%^,]9UK4(+2TM?"FH2W-S<RA(XD%M(2S,>  .YKXX_X-C]
M5TS4_P#@A_\  ^+3M1@G:TL]:ANEAE#&&0:YJ!*,!]UL$'!YP0>]?<'C#P/X
M*^(6C'P[X^\'Z7KFGF19#8ZQI\=S"77[K;)%*Y&3@XXJGX&^$OPJ^&#73?#3
MX9^'_#IO0@O3H6C06GVC9NV;_*1=^W<V,YQN..IH \K^#W_!2S]AWX]^,?BG
MX ^$W[0&FZMK'P5GN(OB58K9743:1Y!E69QYL2BXC1H95,D'F*&3&<E<^4_M
M%?M\_P#!.G]M#]@[QGX=^&'QN\(_%6W^(WA#4-$\.^!?#^H1W.L:[?SV[QPV
M<6GMBXCG\PHV9(T\@+YSF-$+KZ_\&OV0O"W@#]ICQI^U9?>#_"NC:_XITX:3
M%8>$]+2&/[*+J2XEN[N<1QO>7MS(T;R2.H$:PQ1KN*R32]U\.OV=_P!G_P"$
M&L7OB'X2_ SP=X7U#4L_VC?>'?#-I8S763D^8\,:L^3S\Q/- 'YF_P#!1+]A
MKXK?LU?\$Y_V+?BW/#<>)-9_8Q\7>#-9^(,6F(\[2:+9QVT>JR0*H+2)"8(F
MX'$$;L<;:[S_ (+6^'M"_P""BWC/]E?]AGX%^)+#Q(_B+XQZ9\1/%-YH=XEU
M%IWA#3;:?SK^5XR5CBF-VD<#,0)I<*A)SC])G1)%*.H96&"",@BN:^'/P7^#
MOP>6_7X2?"?PSX6&JW'GZF/#F@V]C]LEY_>2^2B^8W)^9LGDT ?!OP-^'LO[
M%G_!PC\9]9\=2)IWA7]J3X>:3K/@?6;IPEO<:WHZ);WNE!VP#<^6\EV$[Q,2
M,[2 O[ 7PTNOV@_^"WG[3G_!2CPVRW/@#3_"^E_"[P-X@A.ZWUV>W2TFU:2W
M<<2107=JL'F*2C/O )*,!]]_$/X8_#;XN^&I/!GQ7^'NA^)]'ED6272?$.DP
MWML[K]UC%,K(2.QQQ6EH>A:)X8T:U\.^&M&M-.T^Q@6&RL+&W6&&WB485$1
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M_DMGP/\ ^Q[E_P#29J /=**** "BBB@#X[_X*.?\E0T+_L ?^UY*^=Z^B/\
M@HY_R5#0O^P!_P"UY*^=Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-U?Q11$,%V0RF*/S?E Q/VH_V0_VL?VW_P#@I1XP^%OQ _X*%_&;X(_#70?
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M_DX[5O\ KTM/_1"5Y#7KW[<W_)QVK?\ 7I:?^B$KR&@ HHHH **** "BBB@
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MY=6E2JQVE%M-=UINGU3T:T:/G3_AWQI'VS?_ ,+0N?L^?]5_92[\?[WF8_\
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MQS^Q=_P5O\4?\%"O!OP[U_Q/\.?C;\/K30_B9;>$M(EU'4="U[33&MCJ'V.
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MPTG5/'7Q%T,0:9I4,D@W%C'NR\@4PIN90'E0Y8X1@#] J*** "BBB@ HHHH
M**** "BBB@ HHHH *\+_ &L/^2V? _\ ['N7_P!)FKW2O"_VL/\ DMGP/_['
MN7_TF:@#W2BBB@ HHHH ^._^"CG_ "5#0O\ L ?^UY*^=Z^B/^"CG_)4-"_[
M '_M>2OG>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_1C]G/_ )(/
MX1_[ %M_Z+%?G/7Z,?LY_P#)!_"/_8 MO_18H [2BBB@ HHHH **** "BBB@
M#X1_;F_Y..U;_KTM/_1"5Y#7KW[<W_)QVK?]>EI_Z(2O(: "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ K]0M"_Y =G_ ->D?_H(K\O:_4+0O^0'9_\
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M_P"B$KR&@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_4+0O^0'9_\
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M10 5X7^UA_R6SX'_ /8]R_\ I,U>Z5X7^UA_R6SX'_\ 8]R_^DS4 >Z4444
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MKR5\[U] ?\%#-4T_5?B7HDVG7:3*NA;69#T/G25\_P! !1110 4444 %%%%
M!1110 4444 %%%% !1110 5^C'[.?_)!_"/_ & +;_T6*_.>OT(_9[\4^'K7
MX'>%+:XU:%)$T*W5U)Y!V#B@#T2BLW_A,?#'_0:@_P"^J/\ A,?#'_0:@_[Z
MH TJ*S?^$Q\,?]!J#_OJC_A,?#'_ $&H/^^J -*BLW_A,?#'_0:@_P"^J/\
MA,?#'_0:@_[ZH TJ*S?^$Q\,?]!J#_OJC_A,?#'_ $&H/^^J /B/]N;_ )..
MU;_KTM/_ $0E>0UZS^VS?6FH_M#:K=6-PLL;6MJ Z]#B!*\FH **** "BBB@
M HHHH **** "BBB@ HHHH **** "OU"T+_D!V?\ UZ1_^@BOR]K],-#\7^&5
MT6S5M9A!%K&",_[(H W**S?^$Q\,?]!J#_OJC_A,?#'_ $&H/^^J -*BLW_A
M,?#'_0:@_P"^JL:?K>DZJ[1Z=?QS,@RP0]!0!:HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#/\6:GK6B^%=3UGPWX<
M?6=1M-/FFL-(CN4@:^G5"R0"23Y8R[ +N;Y1NR>!7QSH/[:?[4W[;7[/>O\
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M*\PRWD^M4G#G2E&ZM=/K_6IY^ S7+LT]I]4JQGR2<96=[-='_5GT"BBBN ]
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MJOUMW"BBBLS0**** "OT8_9S_P"2#^$?^P!;?^BQ7YSU^C'[.?\ R0?PC_V
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M\@.S_P"O2/\ ]!% %JBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/^"CG_)4-"_[ '_M>2OG>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*_1C]G/_ )(/X1_[ %M_Z+%?G/7Z,?LY_P#)!_"/_8 MO_18H [2BBB@ HHH
MH **** "BBB@#X1_;F_Y..U;_KTM/_1"5Y#7KW[<W_)QVK?]>EI_Z(2O(: "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ K]0M"_Y =G_ ->D?_H(K\O:
M_4+0O^0'9_\ 7I'_ .@B@"U1110 4444 %%%% !1110 4444 %%%% !1110
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M .Q[E_\ 29J]TJ"[TO3+^>"YOM.@FDM9-]M)-"K-$V,;E)'RG'<5/0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!X
M7X!_Y2">/_\ L1-*_P#1C5[I4$>EZ9%J$FK1:= MW+&$ENEA42.HZ*6QD@>E
M3T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MGQE^&W[/GBCXB?L_^&/#6M>(]'T.[O[&T\5:K/:V3"*WDERS6\,CR$E5 0;
M0Q/F+CGS#_@D%^U=\4?VXO\ @G%\,?VK?C3%I<?B?QGIU[=ZK%HMHT%K&R:A
M=0HD2,SLJB.)!RS$XR22<UI_#C2O'&A?\$L=!T3XFQSIXDL_V?[6#Q"MSGS!
M?)H:K.'SSN\P/G/.:\@_X-O?^4)7P#_[%_4/_3M>T ?37[8'C_XB_"C]DOXH
M_%+X/V5K<^+?#7P[UO5?"]O?0F2&74;>PFFMED0$%D,J("H(R"1D5\P?"+]J
M;_@I1^T9_P $_?@#K7P3\)>!X?C#\6_A[#XD\2^,_%EC<IX>\.6'E0/]J-M
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M  4=_:)^(GPK_8(\1>'?"7PN^$NNGP]XM^,6NZ$VKW&O:ZHW36&CVHFBA2*
M;?,NYS(&\Q!'"582UG_M&_MV_M(_\$I_B7X&U#]NGQEX?^('P-^('B.+PZWQ
M1TGPV='U7P9JLJLT']I6Z326]U92+&Y\^)86BV/N1_D#^)?\&=USI7_#I_5]
M'AB,6JZ?\8M;A\00R*5E2[^SV+8D!Y#>4T0Y]/:NV_X.Q)/#:?\ !$[XA)KG
ME_:G\1^'5T8/U-S_ &K;EMOOY G_  S0!]O?M4^//C+\-OV?/%'Q$_9_\,>&
MM:\1Z/H=W?V-IXJU6>ULF$5O)+EFMX9'D)*J @V AB?,7'/F'_!(+]J[XH_M
MQ?\ !.+X8_M6_&F+2X_$_C/3KV[U6+1;1H+6-DU"ZA1(D9G95$<2#EF)QDDD
MYK3^'&E>.-"_X)8Z#HGQ-CG3Q)9_L_VL'B%;G/F"^30U6</GG=Y@?.><UY!_
MP;>_\H2O@'_V+^H?^G:]H ^FOVP/'_Q%^%'[)?Q1^*7P?LK6Y\6^&OAWK>J^
M%[>^A,D,NHV]A--;+(@(+(940%01D$C(KY@^$7[4W_!2C]HS_@G[\ =:^"?A
M+P/#\8?BW\/8?$GB7QGXLL;E/#WARP\J!_M1MH"9)KJ<75N(;8,J$^<Y(2$J
M?MW5=+T_6],N=%U:T2XM;R!X+F"0962-U*LI]B"1^-9G@KP=X*^$'P[TGX?^
M#]/ATCPYX7T6WT_2[0SL8[*RMH5CB3?(Q.U(T4;F).%R2>M 'P-^R%^WE_P4
M4^"G_!2NR_X)>_\ !3O2? WB2]\<>$;OQ'\*_BA\.K":S@U!+8.]Q:75O(2$
M=4CE.0%*%%!\P2JZ^P?MAV7_  6$^(6I^(+_ /86\7?"OP#I/AN-DT"R\>Z%
M/J=_XQND0,Y:2.58M-M2Y,4>5DE<H9&,:LHJO^S_ /":/]K?]O.X_P""G>OZ
M>T?A'PQX+D\&_ F*>,J^IVL\_G:CXCP>5BN6"6]K_?MHFGQMN(R/3_V^_@_^
MU[\=?V=->^&7[&7[1V@_##Q1JNF7%L/$.L>%I-1DPZ;0D$J7"?8F(W S^5.R
M;@R(&4$@'-?\$COVW_%W_!1;_@GYX _:X\?_  \B\,:YXDM[R#6-+M-_V4W-
MI>36DDUOO);R9&@+JK%BNXH6?;N/TC7Q!_P0(_:7^)7QS_8GU+X/_&KX1:%X
M*\9_ /Q[J'PN\2Z1X7LUM]->?2XX-LMO$ORQ@I,BL%.TNC.H5751]OT %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MT_Q+J?A*757N-9TJVDA@N/M>IW5XNU)/F&U;@*<]U)KZ4HHH **** "BBB@
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MOQX^'O@KPJMR+GQM9^,/#]UJ#^(0C9CL)4B94^Q' ,L1SY_^K?,1DCE^KZ*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^S[>+;*)X%#9CC4GAV&,XY^E?)]>^_\ !.G_ )+;JG_8JS_^E-M0!]GT444
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MBNX7E2ZLYA%$SP?NV3,D<;[TD4HNWGUR@ HHHH **** "BBB@ HHHH ****
M"N<^)_Q>^%OP5\--XP^+?Q!TCPYIBMM%YJ]\D"N^,[$W$%V/95R3V%'Q>^)_
MAKX*_"WQ!\6_&$C+IGAS2)]0O!'C>ZQH6V+GJS$!5'<L!7\^O[4O[4OQ7_:Y
M^*][\5/BIK<DLDLC+IFF)*3;:7;9RMO"IX50,9/5CEF)))KYSB#B"GDE.*4>
M:I+9=$N[_K4_9/"/PCQGB9C*M2I5]CA:-E.:5Y2D]5"">E[:MNZBFM'<_:?0
MO^"KO_!/;Q%KB^'M/_::TB.X9]@DOK"\M8,^\\T*1 >Y;%>^Z-K6C^(M*M]=
M\/ZM;7]C=Q++:WEG.LL4R$9#HZDAE(Z$'%?S*5]A?\$COV]/&7[-WQST?X-^
M*M?FN/ /B[4X[&YL+B4M'IEW,P2*[BR<1C>563'!0EB"46OG\JXVJ5\5&EBX
M)*3M>-]/5-O3SOH?KG'?T9,)E615<?P_B:E2I2BY.G5Y6YI*[Y)1C&TK;1:?
M-M=,_;*BBBOT,_C\**** (KV]L]-LYM1U&[BM[>WB:2>>>0(D:*,LS,>   2
M2> !7A,7_!47_@GW<F:YLOVJ_"USIEM*\=UXEM+B2;18&1MK^9J:(;- IX):
M4 $')X-?&G_!9+XN>(/VJ/\ @J!^S3_P1'MM>O-.\$_$99_&?QAALKEHFUW1
M;-;R>+2G="&6"4Z9=B50?F+0]-O/Z2:C<_"SX(?#/&H#1?"_A'P_I\=NL?E1
MVMAI]JH$:1A0 D<8&U0  H&!TH /AI\6_A?\9M#G\4?"3X@:1XETRWO7M)-3
MT._2ZM_.559D66,E'(#KG:2.<=0:Z*OB?]FCX]?L _LH_L[?&3QM^P!XST+X
MN>%M+\1:IX[OO ?P;US2;J30HY;6"2\AB#WD<*Q^;#-<*FY"HG$<<;;%#1?L
M=?\ !87QK^V=<?"+Q?\ #[_@GY\1;;X;?$W2K^?5/BG-?VK:3X;N;5)G:";I
M(\>8EC-P5CC\US'&96CD"@'V[17Q[>_\%3_&?BS]G;6_VV?V=/V/M9^('P9T
M%KZ8^(;3Q/!9ZSKFGV4LD=UJ6EZ9)$1=6RF*8H)KBWEF6,E(B&0MU^M_\%/_
M -G_ %C]G;X2_M ? B[C\:0_'7Q)9Z!\+;+[<M@E]J,\<\C1W4TBM]D6%;6Y
M$WR/(KQ&-8WD94(!])T5X'X)_;/\6Z5XL^+7A7]J'X&'X?0_"+P1IOBO5/$5
MAXB_M?2]5TVZ&J-)-:2"W@E/DC2Y@ZR0QR9883;M9^:\"_M^?&/Q9I/PB^)M
M[^R,8OA_\:-1T^+PWXDTOQU#>W6CVU[;/<VL^J6HME2#S$55 MY[E1)(J,ZY
M!(!].W=W;6%I+?7DPCAAC:261NBJ!DD_A7@>N?\ !5S_ ()D^&->O?"WB7]O
M_P"#VG:GILKQ:CIU_P#$/3X9[1U.&66-Y0T9!X(8#'>OH"ORE_8'\7_#?P1_
MP<4_M[Q^._%&B:1;W6A^$2JZO?0VZ3(-+A:8_O" P .6^N30!^GOPV^*7PR^
M,O@^U^(7P@^(NA>*] O@39:YX;U>&^L[@ X.R:!F1\'T)K=K\8/^",7BB]^'
MW_!1C]N;X[_L6_#C7?%/[,UOJ22^&]"\#BU2QUCQ"CH;@Z1]JG@M&"C[824D
M5/*:V )!A!^KOV-?^"UWC#]N7P[\(?B5\$/^"=?Q-OO WQ)\0:CI/B+QK%>V
MCV?A"2WNKB&-KA<AYE:.&.:2156&/SQ$DLTRO& #[QHKY/C_ ."E'C[XJ_#G
MQA\>OV./V2]0^*7P]\%:K?Z?/KL'BR#3[OQ))8.T=Z^AVK0R"_CCD22)6EEM
MA-)$RQ>8-K-0^*W_  41L/VB_P#@E)X@_;@_8&T6X\7Z?K'@76;B"=]7BTN[
M\.F&PNC--,LF[]_;3Q!6A0DL<,C,N&(!V/Q,_P""MO\ P3S^#?B^R\(?%/\
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M)/->RT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQ;A+.T,1'XH?^W1[Q_%/1]&]VBBBOB#[H*;--%;0O<3R!4C4L['H !DFG44
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M#K]O7]M?]G_QO\0-,TWQSXB_:FU*^T'PC<7 _M+4+26W,BW,5N,R/"$C=VE
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M;XLZUJ6MVFOWB6TFJ:1>%)X=9B,I'G6\C"4F1<J%,3,1YBY\/\%_"ZX\$?\
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MJS2WM[:,=$CCC 5%'H !0!H4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
;%%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>ew-20240331_g10.jpg
<TEXT>
begin 644 ew-20240331_g10.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:?\ \&P?[;=SX$;45T=_&&B169MMW^K:;3EUG;C^$V+0B3MY><T ?OI\./\
M@L1^PK\4/%O@O0- \?ZS:Z3\2]:NM'^&GC76/"MY9Z%XKU&VD,4MK97LT:H[
M[PR(6V+,RE8FD/%7?C+_ ,%<OV#/V>?VLM)_8E^-OQ=O?#/Q#UV&&?2=.U;P
MKJ,5I<6\OF!+D7I@^S"',,P,ID"*8G#$%3C\T/V+_P!B#P'_ ,%6?^"'/P)U
M3XB_\% #X/\ !_P;N%U$Q^'_  K9PW7AG5M-^T0,D]P\I8G;*)QE59Q+$XSN
M&>9_X+C?#[PM\5/^#IW]D/P#XXTN&_TG4/"'A5=1L+A T5U$OB+6Y&AD4\/&
M^W:R'(96(.030!^HO[,/_!9W_@G)^U[X6^*7C[X,?M#6DOASX."&3QUXBUFP
MGT^RM;>83F*Y26X1!)$YMIP&')*=/F3=G?\ #[']@_3OBI\._A=XX\2>+O"2
M_%R!)?A?XF\9> ]1TO2/$RN8Q']FN;B)0N[SH2#*(QB:(Y_>)NQO^"N'PO\
M^":?P._X)R_''Q?^U1\&K/1? ?B^*RN?B"WP\TF#3M9\2:DEY"; ^="J&>Y^
MTB':\Q90-V_]WOK\,O\ @K%XK\1>+/V1OV O%NGQ^'_#?@6XDU3_ (59\/=,
MU:35-1T+18[C2HXIM2U&1P;JZF*$LL<,,4)B\M5)5B #];/^"^O_  6SN?\
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M_!W[!NGPZ'\8Y_A7J+_'GXJ^.->EFT32;"WAL1<6VEZ9YD8NKX[;-7EEE6"
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M'_X._P#]F)?A LYU./P)I*ZU]C!S]@,^MF^\S'\/V(R9SVQ[5S__  6:\/\
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MBD=Y10!P/Q"_9C^"?Q3^-_P__:+\<^"H;[QA\+SJG_"$ZN[L&T_^T+=;:[P
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M#:3WD:1Q+YC1R.GE(N\-%M3K_P!DG]OC]C#]L_\ X*<>#_%?@3]B7]H3PO\
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M2RA_@G^1]/?V=I__ #XP_P#?H5)'%%"NR&-47T5<"G45_+9_5@4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !7BWC;]G/]G*+]M30OVV/&/Q!O\
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M 5<KSW]JKX9?#KXM?L]>+_"/Q0\"Z1XATQ_#M])]@UK38KJ$2"VE D"2*0'
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M* /"_P#@GO\ \D3U;_L>]9_]*37NE>%_\$]_^2)ZM_V/>L_^E)KW2@ HHHH
M*Q[+_D=[W_KRB_F:V*Q[+_D=[W_KRB_F: -BBBB@ HHHH **** /FC_@JM_R
M;?IW_8W6W_I/<U^>5?H;_P %5O\ DV_3O^QNMO\ TGN:_/*OZA\)O^217^.?
MZ'\K>+O_ "6#_P"O</U"BBBOTL_, HHHH *_0#_@DY_R0?7_ /L;I?\ TEMJ
M_/\ K] /^"3G_)!]?_[&Z7_TEMJ_-_%;_DCY_P".'YGZ9X2?\EE#_!/\CZDH
MHHK^6S^K HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "ODO]JW]F
MK_@E+^U=^WAX+^'/[6OA3P3XP^+UE\-]0G\-^!_$UJMP]UHLEY&QNS$ZE6\J
M6WG6/)R!+<D*0"5^M*^9?VO/V[/^"?O[#_[27@_4/VOM?\(^"_$/B3P=J2^&
M/'^NZ</M)MK:YM?/TY+E86>-&:YCEV%U5BI.TD9 !\M?%2V_X-0?@A\1]:^$
M7Q:^'_[-F@>)?#NH26.MZ-J'@^%)K.XC.'C<>1U!]./2NE_8K\5_\&]^O?MF
M^"8/^";=A\.%^* M-4,;_"_2?LNW319R?:/MF(U1HMQAVC_6>9L*_() 4E_X
M*!?\&T5_\2O%GQ@\1_&_X#:WXE\;:K%J'B#6=>T&"]N)I8[.VLT59)K9F6,1
M6L1V [=Y=\;G8GKOV<OVN/\ @BG\;OVOO '@_P#86/PNUSXCA-4N$U#X?>'X
MK&?3],2PF%P9I8K91)$[M @@+C+,L@SY1! /NVBBB@ KDOC[JNF:%\"_&>LZ
MUJ$%I:6OA34);FYN90D<2"VD)9F/  '<UUM9?C#P/X*^(6C'P[X^\'Z7KFGF
M19#8ZQI\=S"77[K;)%*Y&3@XXH ^'_\ @V/U73-3_P""'_P/BT[48)VM+/6H
M;I890QAD&N:@2C ?=;!!P><$'O7&_P#!%C0]!_X)U>.?VJ_V&/CIXCT_PU_P
MC?Q@U'XC^%]0UR]2UAU#PAJEO"(+Z.20A7CA-F\<[@D12DJQ'&?T&\#?"7X5
M?#!KIOAI\,_#_ATWH07IT+1H+3[1LW;-_E(N_;N;&<XW''4U#\0_@K\&_B[+
MI\_Q8^$OAGQ.^D7'GZ2_B+0;>]-E+Q^\B,R-Y;<#E<'@>E 'XQ>$O^"8_P 8
MOVV/^"/W[:/QET/PA?0>*?VE_C'J?Q)^%NB75NT5S>:19:E]LTU/+<!E>ZC%
MTL08 %)X7SALU]#?\%'/VG]&_;!_X(*:)X"^ ]U#KOQ&^/\ H'A_PEX2\&6L
MRF^DUF2XM1J5K)%]Z(V:17AN&8!8?(;>5'-?IZ  , 8 Z 5S&A?!3X->%_'V
MH?%;PU\)/#&G>*-739JOB2QT&WAO[U<@XEN$022#('#,>E &=^S'\&;/]G']
MFWX>_L]:?>BYM_ ?@?2?#L%RJX$J65G%;!\'ID19_&NXHHH R?'7@[2_B#X1
MO_!>MW%W#::C 89Y+&Y:&95)!RCKRIXZBO(?^'>_P3_Z&WQW_P"%E<_XU[I1
M0!\X?\$\? 6C0? W4K=+J^*Q>--5B4F\8DA)M@R>YPHR>YR:]W_X0?2/^?F]
M_P# MJ\C_P"">_\ R1/5O^Q[UG_TI->Z4 8__"#Z1_S\WO\ X%M1_P (/I'_
M #\WO_@6U;%% &/_ ,(/I'_/S>_^!;5F6OA73I/%-U8-/<[([:-E(N&W9)/4
MUU=8]E_R.][_ ->47\S0 ?\ "#Z1_P _-[_X%M1_P@^D?\_-[_X%M6Q10!C_
M /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;5L44 8__  @^D?\ /S>_^!;4?\(/
MI'_/S>_^!;5L44 ?+'_!4+PY8:1^SO875M-<,Q\5VRD2SEACR+GL?I7P%7Z&
M_P#!5;_DV_3O^QNMO_2>YK\\J_J'PF_Y)%?XY_H?RMXN_P#)8/\ Z]P_4***
M*_2S\P"BBB@ K[Q_X)8>';'5_@=KMQ=37"LOBN10(IRHQ]FMST'UKX.K] /^
M"3G_ "0?7_\ L;I?_26VK\W\5O\ DCY_XX?F?IGA)_R64/\ !/\ (^C/^$'T
MC_GYO?\ P+:M#3=.@TJU%I;O(RAB<RN6//N:L45_+9_5@4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !7@G[=O\ P3,_8S_X*0>&-*\/_M6_"*UU
MRZ\//+)X9UV)O+O=(DD*%S$^"CHQCC+0RI)"^P;XVQ7O=?%__!7[_@M3\%_^
M"1^A>$]+\8?"[7O&GC+X@?:U\&>'M,N8+.UE:W:%9&N[V8[;:,&XC&X)(>2=
MH +  \N'_!*[PM^RAQK/_!,']G']I7P3;];S3/@QX8T#QQ9Q#N\#6T>F:LP
MY,;:>YR (Y#U]"_89T'_ ((P?&?XV:;\4_V"OAQ\,/ ?Q+\ 37]IXF\*^&_
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M&Z7_ -);:OS?Q6_Y(^?^.'YGZ9X2?\EE#_!/\CZDHHHK^6S^K HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "OG[]IOQ?^S5\'?CWX7^,O[5GA;1
M].T5M GT#0/B-XABB?3='N[JYBDEL[R65-M@+CR+;RKAV$4CQO$[(Y@6;Z!J
MAXI\*^&/'/AN^\&^-?#EAK&D:I:O:ZGI6J6:7%M=P.I5XI8I 5D1@2"K @@X
M- &+HW@'X)>(]*@UWP]X*\*W]C=1B2UO++3;:6*9#T9752&!]0:X[XT:;^QY
M\!I]&_:-^,VK>"O *^#)+J>S\3ZI/9Z8D:36TD$T+3.%+(RNK&,'YGCB/)4
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MG\"Z'XH\6O9:/KUU9VKW/C/46D,<<K(I8B8 G &2 /I7,_\ "&V?_0R>)_\
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M*=<L],TVPMVGOM0U"Y2&"WB49:221R%10.220!5RO/?VJOAE\.OBU^SUXO\
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M->]UCV7_ ".][_UY1?S-7_K3Q/\ ]!U;_P &S_\ DB?]5.%O^@"C_P""H?\
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M _\ Z&[QW_X5\]>U>$M&E\.>%-,\/3S+(]AI\-N\B# <I&JDCV.*T* /!?\
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MAM/#\4L*B*ZF!:XE>'<6B@650,RD#]4* "BBB@ HHHH **** "BBB@ HHHH
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7 HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>ew-20240331_g11.jpg
<TEXT>
begin 644 ew-20240331_g11.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%FP 2/AW_@]7_P"46_P__P"R^Z7_ .F36Z^;_P#@L4GCV;]J#_@EC%XE,X\
MMIGA 6Q?/V;[>;W2/MF[MN\C[+U[9]Z /V<^ /\ P46_9F_:$^,^M_LTZ+JV
MM^&OB;X>TV/4M3^'?CCP]<:3J_V&159+N**90MQ"0RY:)GV$@.%) KD/@3_P
M61_8-_:4_:)\1_LF?!WQUXIU+XC>$;+4+KQ+X3N/AQK5I=:?'9.L=P)!<6J
M.LCI&$!+,\BJH)85^<'_  4;F\>/_P '?_[,2_"!9SJ<?@325UK[&#G[ 9];
M-]YF/X?L1DSGMCVKG_\ @LUX?^+?_!+O_@X,^"G_  4?_9L^'LNN'XTVPT'4
M/#EJVQ-8UCRTTR6V;' ,D-QI\J9QNFB9NH) !^HW[)/_  6!_82_;F\:>+?A
MU^S!\0/$7B37/ MA)=^*=+;P!J]G-8*C,AC9;FVC)F+HZ"(9<LI &:N>(?\
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MY'VJ2$0$(@9MJC<V?5Z** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZC>0/(8Y&(4[4)*@XZGK0!Z]16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\
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MO_1C4 >Z4444 %%%% !6/9?\CO>_]>47\S6Q6/9?\CO>_P#7E%_,T ;%%%%
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M-_Z%0!L4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_$?QMHVHZPO@O3S<WFGZ:T,3QF4^6 A/! W9/?(H ^IJ^9_^"J__ ";AIO\
MV-]M_P"DUU7T!]B\;_\ 0;LO_ 8_XU\W_P#!4.W\1Q?L\:<VK:C;S1?\)9;
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M\#_\@B7_ *_9O_0JV*Q_ _\ R")?^OV;_P!"H V**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KY+_:M_9J_X)2_M7?MX>"_
MAS^UKX4\$^,/B]9?#?4)_#?@?Q-:K</=:+)>1L;LQ.I5O*EMYUCR<@2W)"D
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M3PUXALXY87M[BRU#3UBAFV+*8V\PHR;X0$<AB3\--\1?VF?^"K)_M'_@H_\
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M_P"A0O?^^EKYO_X*AZQ?W_[/&G0W.@W%JH\66Q$DI&"?L]SQQ_GBOJBOF?\
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M17Q+\2ZMXY>^7S1>6ID.G)8DMS]FBA@:*.+[J(Q"@9-:_P#P;+_'#QK\4/\
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M HHHH **** "BBB@ JIK^B:?XFT*]\.:O$9+34+22VNHP<;HY%*L,_0FK=%
M'YG?\$,O&OA'_@G!^P9\4/V0/VL/&5CX8U?]FGQUKW_"0-JMPD#7.A7$IO['
M5H58@O;W*S2"(CEG1DQN&*[[_@W(_98^)W[,W_!.6/Q#\:?#%SH7BKXM^.]6
M^(.KZ%>QE)]/&H&)+>*53@JYMK:"0J0&4R%6 8$5]F>+_@I\&OB%XITKQSX^
M^$GAC7-;T)]^AZQK&@V]S=:<V=V8)9$+PG/.4(YKIZ "BBB@#Q+5/V"/@UJ^
MIW.K7/BKQNLEU.\TBQ>+[E5#,Q8@ '@9/ [5R7Q$_P""47[-OQ,MH;?7/%_Q
M!@,,N\36GC"4.W! !+JW'/2OIJB@#XY_X<A?LF_]%&^*?_A;'_XU1_PY"_9-
M_P"BC?%/_P +8_\ QJOL:B@#XY_X<A?LF_\ 11OBG_X6Q_\ C5'_  Y"_9-_
MZ*-\4_\ PMC_ /&J^QJ* /CG_AR%^R;_ -%&^*?_ (6Q_P#C5>8^%O\ @DS^
MSEJ_[5WBKX.W7CWXC#2M'\,6-_:RIXO83M+*[!@S^7@KQP,#%?HI7GWASX,Z
MGHG[27B3XXRZU ]IKGAZSTZ*Q6-A)$T+$ER>A!S0!\]?\.0OV3?^BC?%/_PM
MC_\ &J/^'(7[)O\ T4;XI_\ A;'_ .-5]C44 ?'/_#D+]DW_ **-\4__  MC
M_P#&J/\ AR%^R;_T4;XI_P#A;'_XU7V-10!\<_\ #D+]DW_HHWQ3_P#"V/\
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MOB#2+77M&O$N+.]MDN+2XC/RRQ.H96'L00?QJS7(_L__ /)!_!/_ &*.F_\
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MTW7D:<2_9[F*V16MPX)#B+_5!@<$1@CBO<*** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
ABB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>ew-20240331_g12.jpg
<TEXT>
begin 644 ew-20240331_g12.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)"^!/CS/^T%X8_94AM]0N+S[4_A__A(+YM$\W>'YT\S>0\>\9$#*T(P,1@
M>E_M#?\ !(W]@3]JK]HW0OVM_CO\']9UKXB>%VLV\->)(?B/X@LGTDVLQGMS
M:Q6M]'%!LF)D&Q%RY+'))-?25% 'S7\4?^"17[ 7QH_:HT?]MGXE_"'6]2^*
M7A^2T?0_%W_"RO$,,MA]F),*Q1Q7ZPHBEF)0)M8NY8'>V7^ /^"2'[ OPO\
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M>!;"2[\4Z6W@#5[.:P5&9#&RW-M&3,71T$0RY92 ,U<\0_\ !5W]C?P[\"_
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M26VGB>[E19[^6)3(L"X15V^;+$64'QG_ (-G?^4'GP'_ .P9K7_I]U&O-/\
M@UZUO5?B3^S_ /M&?'GQA,T_B/QG^U=XHNM8N)3E\BWL&6(^@5I9,#H V!@4
M ?<7P,_;3_9T_:"_9<B_;%\$^/(K7P*NE7=]J^H:TGV2311:;Q>PWJ/S;RV[
M12K*K?=,9()&"?']#_X*T>!V\">"_P!HKXA_ 3Q=X1^"WQ%UFTTWPC\4M=GM
M%B/VQ]EA>WUFLIGL+*[;8(9Y <>=$9D@#Y'X[?M'?&7QS\+?^"='_!4KX,^!
M;Z>UT&W_ &N1;6:P,0MI%J6ME;V%.RHR6<<17IMD/K7ZA?\ !:#X=>%=(_X-
MYOB5\//LD7]FZ'\(M(CL(MHVH;.2R:WQV&'BC(^@H ^_**\;_P""=/C[Q/\
M%;_@GU\"OBAXVNI9]9\1_!SPSJFKSSDEY;JXTJVEE=B>22[L>>>:]DH **R?
M'7B'5/"GA&_\1Z)X5N]<N[2 R0:38LHFNFR/D0MQGZ^E>0_\-8?&S_HQ_P =
M_P#@5;?_ !5 'NE%><?!+]H&;XU^"CXRT[X=:A8A+^>TFM9;N*5HY(FVL"R$
MC.>W:NO_ .$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI
M: -BBL?_ (275_\ H4+W_OI:C7Q??/<M9KX6NC*BAFC$BY /0XS0!N45C_\
M"2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM &Q16/\ \)+J_P#T*%[_ -]+1_PD
MNK_]"A>_]]+0!L45C_\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM &Q16/\
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M!V?NRC9O_$E^ 4445XI[@4444 %9OC'_ )%B]_ZX&M*LWQC_ ,BQ>_\ 7 T
M7-._Y!\'_7%?Y"IJAT[_ )!\'_7%?Y"IJ "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH _)_]N+]KO\ X(;>%?\ @H)J/BSQ
ME^PA\1?C3\9/AMK=M)XAUCX7_#^[U:STC5XXT$374?VF&TGO(TCB7S&CD=/*
M1=X:+:G7_LD_M\?L8?MG_P#!3CP?XK\"?L2_M">%_B7=Z#K21^,_C-;:I8:?
M8Z8ML'GM-/M9-1FMD>600,4CA50J,WWMIK$\.?MF?MH?LB?MI?M(_"[]EO\
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M_P /3_\ @GM_T=7X8_[^2_\ Q%?SYXS_ /(QPG^"7YH_HKP2_P"1;B_\<?\
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MRXM=.M$@C#'J=J #)]:O45_+9_5@4444 %%%% !1110 4444 %%%% !1110
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MO_)8/_KW#]0HHHK]+/S **** "OT _X).?\ )!]?_P"QNE_]);:OS_K] /\
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M +&ZV_\ 2>YK\\J_J'PF_P"217^.?Z'\K>+O_)8/_KW#]0HHHK]+/S ****
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M4[XA_!7X-_%V73Y_BQ\)?#/B=](N//TE_$6@V]Z;*7C]Y$9D;RVX'*X/ ]*
M/QB\)?\ !,?XQ?ML?\$?OVT?C+H?A"^@\4_M+_&/4_B3\+=$NK=HKF\TBRU+
M[9IJ>6X#*]U&+I8@P *3POG#9KZ&_P""CG[3^C?M@_\ !!31/ 7P'NH==^(W
MQ_T#P_X2\)>#+693?2:S)<6HU*UDB^]$;-(KPW#, L/D-O*CFOT]  & , =
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M$;X_Z!X?\)>$O!EK,IOI-9DN+4:E:R1?>B-FD5X;AF 6'R&WE1S7Z>@ # &
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
BHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>ew-20240331_g2.jpg
<TEXT>
begin 644 ew-20240331_g2.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P#SXP_]^A4U% $/]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ%344 0_P!G:?\
M\^,/_?H4?V=I_P#SXP_]^A4U% $/]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ%3
M44 0_P!G:?\ \^,/_?H5G>++.TA\-WDL-K&C+"2K*@!%:]9OC'_D6+W_ *X&
M@">PL+%K&%FLHB3$I),8YXJ7^SM/_P"?&'_OT*-._P"0?!_UQ7^0J:@"'^SM
M/_Y\8?\ OT*/[.T__GQA_P"_0J:B@"'^SM/_ .?&'_OT*/[.T_\ Y\8?^_0J
M:B@"'^SM/_Y\8?\ OT*/[.T__GQA_P"_0J:B@"'^SM/_ .?&'_OT*/[.T_\
MY\8?^_0J:B@"'^SM/_Y\8?\ OT*/[.T__GQA_P"_0J:B@"'^SM/_ .?&'_OT
M*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\8?\ OT*/[.T__GQA_P"_0J:B@"'^SM/_
M .?&'_OT*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\8?\ OT*/[.T__GQA_P"_0J:B
M@"'^SM/_ .?&'_OT*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\8?\ OT*/[.T__GQA
M_P"_0J:B@"'^SM/_ .?&'_OT*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\8?\ OT*R
M;.UM6\97D#6T91;2,JA08!R><5N5CV7_ ".][_UY1?S- &E_9VG_ //C#_WZ
M%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\
M9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_
M -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A
M1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%21Q10KLAC5%]%7 IU% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% 'A?_  3W_P"2)ZM_V/>L_P#I2:]TKPO_ ()[_P#)$]6_
M['O6?_2DU[I0 4444 %%%% !1110 4444 %%%% !6;XQ_P"18O?^N!K2K-\8
M_P#(L7O_ %P- %S3O^0?!_UQ7^0J:H=._P"0?!_UQ7^0J:@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K'LO^1WO
M?^O*+^9K8K'LO^1WO?\ KRB_F: -BBBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% 'A?_!/?_DB>K?\ 8]ZS_P"E
M)KW2O"_^">__ "1/5O\ L>]9_P#2DU[I0 4444 %%%% !1110 4444 %%%%
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MO6?_ $I->Z5X7_P3W_Y(GJW_ &/>L_\ I2:]TH **** "BBB@ HHHH ****
M"BBB@ K-\8_\BQ>_]<#6E6;XQ_Y%B]_ZX&@"YIW_ "#X/^N*_P A4U0Z=_R#
MX/\ KBO\A4U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !6/9?\CO>_\ 7E%_,UL5CV7_ ".][_UY1?S- &Q1110
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M@ HHHH **** "BBB@ K'LO\ D=[W_KRB_F:V*Q[+_D=[W_KRB_F: -BBBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#PO\ X)[_
M /)$]6_['O6?_2DU[I7A?_!/?_DB>K?]CWK/_I2:]TH **** "BBB@ HHHH
M**** "BBB@ K-\8_\BQ>_P#7 UI5F^,?^18O?^N!H N:=_R#X/\ KBO\A4U0
MZ=_R#X/^N*_R%34 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %8]E_P CO>_]>47\S6Q6/9?\CO>_]>47\S0!L444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >%_P#!
M/?\ Y(GJW_8]ZS_Z4FO=*\+_ .">_P#R1/5O^Q[UG_TI->Z4 %%%% !1110
M4444 %%%% !17D/[3'[=W[*G[(USI^E?'/XOZ7IFK:G=V$5IH$,ZS:BT5W?0
MV271MD)D%LLLR[YMNT!6QEL*>T^#WQR^#'[0G@Y/B#\"?BMX=\8Z&\S0_P!J
M^&M8AO8%E7&Z)GB9@LBY&Y#AES@@4 =56;XQ_P"18O?^N!KSY_VW?V1D^+1^
M!C?M#>%O^$I&LC1VTO\ M1/EU0KN&G&7_5B\*\BU+><1SLKT'QC_ ,BQ>_\
M7 T 7-._Y!\'_7%?Y"IJYKQ_\5/AG\$?AE=_%/XQ_$#1O"WAK1[2.75=?\0:
ME%9V=FC,J*TDTK*B NRJ,D9+ =37(_ /]N+]C7]JG7K[PO\ LT?M3_#_ ,?Z
MEIEH+K4;'P?XLM-1EM8"P022+!(Q12Q R<#)Q0!ZG17E7Q'_ &X?V3/A)XJU
M3P5\0?CMH=AJ6@PQR^)(1*\RZ'&Z[T>_DB5DL%*?.&N&C!3YL[>:],T;6='\
M1Z/:^(?#VJVU_87]LEQ8WUE.LL-Q"ZADD1U)5T92"&!((((H LT444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6/9?\CO>_\
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MGKW[-_[+WPXU;XF^)/"$ZV_CG5M*NH;30/#%T1D6E[J,K8:ZQR;:UCN)H_\
MEHD8YH ][HJ*Q>]DLH9-2MXHKAHE-Q%!,9$1\?,JN54L <@$JI(YP.E2T %%
M%% 'A?\ P3W_ .2)ZM_V/>L_^E)KW2O"_P#@GO\ \D3U;_L>]9_]*37NE !1
M110 4444 %%%% !1110!^*'[6_Q_\>?\$R/^"D?Q9LOVTO 6HK\-?VB?C7\,
M_$_@/XWQQ&6PTNWT/7-+N+C2KZ3DPI!;6UP40?,/+WA&68O']P_MQ>.? G[!
MG_!//]IO]O;]ES6M,>]\<:(_BW2]6T0Q26;ZM<:;9Z7;:A$\1*3!FCMYRXX=
MMQ).XDYG[7G[17[*W[<W[//CK]FOQ<WA[4KCPE^T3X.\(_$3P+JU[%+(+5?&
M^C1>=+$VUOL]Q:R!P^-HWN@8F-C7R5^Q;^PCXB^,G['O[??_  3U_9K\<ZAK
MOP NM<?2OV;-1U74VN;./51:R7%_:6MRY/F64.HK:0>:I9"R3/EG,A(![-HO
M[+_A$?\ !J^?A]<VN+RY_9B?QU)?ER9_^$A?3CKXO6E^\9A?D2>9G=D9S7TI
M_P $POVD_%G[7O\ P2M^$G[1/CZ\-SK_ (B^']J=>O& !NKZ#-M<3D#H9)87
M?';?7RHG[6NA2_\ !L\?!#+(OQ)/P5;X-CP%M_XG1\8BR_L#^S19_P"M-SYW
M[[RMN?*/F8V?-7NGP'\1_ +_ ((Z_P#!-KX _LM?M7_%>P\-:S?:;IGA&P#6
M\]Q'?>([E3-/;HT$;A8_/>4>=)MC VEF7<* .5_X+3V'[;WB6Q^%NF? '_@G
M;I?[1/PQ\/ZA-X@^*7@?6/$EA;0ZV\4#16-FUK<EFNTC>1[HQB&0&6&U(5MC
M+71_\$6?VC?^"<W[3'PY\6^*?V+OV/?#/P,\;:)J,.D?%[X=67@*QT+5M)O8
MC+Y45VMK#$9XPWVCRG8#D2@K&X=![GXQ_P""@?[%/PC^.=K^RO\ %G]ICPGX
M6\>R^&H=:@T#Q+J8L#/9.SHLD<T^V&1BT4G[M7,@"%BN.:\3_8V^$O@GXC_\
M%0_C;_P4.^!H@/@#Q9X!\/\ A6+7]/4?8_&&M6<US)=ZE;./EN8(8#8VJW*;
MDD>.<*Q\LD@'R=^S9_P4+OO^"/\ \:_C)_P3M_;M^$NI7OBSQY\2]<\8_!/Q
M;&T*6/Q,&L7@$%I<7<[+%:W'F,D;RSL(HT!1ROE1^=^@'_!*G]DSQ_\ L-?\
M$_/AI^RU\4_%EMK/B'POI,XU:ZL7=K:&:XNY[LVL!<!C!;^>+>,D#,<*\+T'
MQK^R+^S#^SK_ ,%,?V5/VD/!'_!3W1M.N?BC-\7M=A^),VLW$<&I^"(+1W71
MFL99?FM+*"R82V[C]Q*)KAF\P2S;OHC_ ((*R_M #_@F#X"TS]H;Q1?:_>:;
M=:I8>%O$>J(ZW.L>'H+^:+3+QP_S;9+58VC)Y:'RFR=VX@'V-1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !117QM_P7J_:4^.G[)W_  37
M\5_&/X#76L6%W;ZUI-IXDU_P]$'U#1=$GO8XKZ[ML@A)A$Q19"/W9E\P$% P
M /L&RU?2=2N;NST[4[>XFT^X%O?Q03J[6TIC241R '*,8Y(WVG!VR*W1@38K
M\U?V2?V<?@A^T9'\1/VE?^"=OQ\\40_V=\??"]_X<\5Z)\2]4N;?Q!HJ>'_"
M<VI6.I)=7$BWQDC>^1_M*M/%-QN5D*5U_P"TM\=?$?[6/_!9?P;_ ,$K],\3
MZKIWP^\&_"RZ^(_Q:MM$U.:RE\02M<1VEAI<T\#)*MLCSQ7$D:L%G\Q$?*JR
MD ^^ZQ[+_D=[W_KRB_F:^(?V?/C=KW[(W_!9CQ+_ ,$O+GQ#J5]\.O'OPFM_
MB)\*[/5M3FO'\.W<=S+9W^EP2SLTGV:3[/)=)$6*PE66,*CA1]IZEKNC^%]:
MUKQ-XAU".TL-.T?[5?74QPD,,:L[NQ] H)/TH Z.BOQ&_9T^+_[#'_!;3]I'
M7]8\1_\ !8_]IWX3_%+Q#K]Y'HGP7\$_$63PKIUGIEO*T-C#:13V3QW-V]K%
M'/.$E+F:28A J@U^B/\ P4P_;MTS_@F'^RAH=SX#\*W'C'Q_XFU?3_!'P@\(
M7^H233:YK=P!#;"XE=C(\:A?,ED+;G("[@\JM0!]445\P?L1? WX>21)XS^,
MW[45C\<_C-I[I<^+];'B=+RQT&^;.;?3M,BD-OI<$;!D0K$LSA=TCN^2/I^@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH _,C_@G)K>J_$S_ (.)?VYO&GBJ5GN/"?AW
MPAX;T**0Y^S6#6OF,B9Z*\D E(Z%I":?^SGXBU#PM_P=4?M!_#[0I&CTOQ9^
MS;HFNZ_#&<++?V4^FVEO(XZ%E@N)%!/.&/O7J'B?]G?QS^Q=_P %;_%'_!0K
MP;\.]?\ $_PY^-OP^M-#^)EMX2TB74=1T+7M-,:V.H?8X T]Q:RVJ&!A!'(\
M<H#L-C$C2_8$_9*^)%S^W5\>O^"I/QQ\#WOAG5?BJFF^'_A[X0U0Q_;]*\-:
M?;Q1B:Z5&989[R:))S 6+0JJ!\.61 #IO^"W?[7WC']A;_@EM\7?VCOAO>-;
M>)M.T*'3O#EY']^TO;^[AL(KE>VZ$W/G#/&8AD'H?D+X6_%#]M/_ ((7_P#!
M*CX:_%VZ_9:^'_B?X8Z!I^G:C\8+;1?%E[+XK>?4Y(VN]:,LMND$\AN+A=T)
MW&-=B><R(94^B?BE\.OB_P#\%N?^"3/Q)^"'[0O[+^O? #Q1XNEN]/T;P]XO
MU 7<MM<V%W%<:??N\<2-Y$D\$>X!,[ ^PR*4=^,^,$_[5'[8W_!*6;_@GEK_
M .R]XO\ #_QK\3>$;+P3XOEU[0Y$\/:2R>5!>:X-5 -I=6OEQR3Q16\DMPS/
M'&8E.YE /OCX:_$/PE\7?ASX?^*_@'5!?:%XGT2TU;1;U5*BXM+F%9H9,'D;
MD=3@^M;=<G\!/A!X>_9\^!?@OX!^$KB6;2O _A/3O#^F2SXWO;V=K';1LV/X
MBD:D^]=90!G^*_%?ASP-X<N_%OBW5X;#3;"$RWEY.<)$G3<<=N:\X_X;G_9'
M_P"B]:#_ -_G_P#B:]2OK"QU2TDT_4[**XMY5VRP3QAT<>A4\$5C_P#"KOAG
M_P!$[T+_ ,%$/_Q- 'B?_!//QKX4F^!VISQ:Y R2>-M6DC8$_,CS[U/T*L#^
M->[_ /"8^&/^@U!_WU7BW_!/;3=.7X):JJZ?  /'.L  1#@"X( Z=@ /PKW7
M^SM/_P"?&'_OT* *?_"8^&/^@U!_WU1_PF/AC_H-0?\ ?57/[.T__GQA_P"_
M0H_L[3_^?&'_ +]"@"G_ ,)CX8_Z#4'_ 'U1_P )CX8_Z#4'_?57/[.T_P#Y
M\8?^_0H_L[3_ /GQA_[]"@"G_P )CX8_Z#4'_?5'_"8^&/\ H-0?]]5<_L[3
M_P#GQA_[]"C^SM/_ .?&'_OT* *?_"8^&/\ H-0?]]4?\)CX8_Z#4'_?57/[
M.T__ )\8?^_0H_L[3_\ GQA_[]"@#R']H7]EK]B[]JA+1_CS\(?!WB.ZL=5T
MZ_MM2U30+6>Z5K.\ANXXO-DB9O*9X522/.V2)W0_*Y%>D:)JOP^\-:1;>'_#
MCZ?I]A9PK#9V-E"L4,$:C"HB* JJ!P   *UO[.T__GQA_P"_0H_L[3_^?&'_
M +]"@#C$\"_LYQ_$IOC-'\/O"2^,&@\AO%8T*W&I&+;MV&ZV>;MV\8W8QQ1\
M5=%^$/Q+T"WM_&7AS0M>DTF^CU'15U73HKDV5]'GR[F'S%/E3+N;;(N&7)P1
MFNS_ +.T_P#Y\8?^_0K.\76-E'X:O'CLXE80G!6, B@#D/'/PJ_9?^+MSI6M
M?%_X4^"O%&H:3"%TV\\2>&[6^FL^A(B>:-C'SS\I'-=C#XJ\)6T*6]OJMM''
M&H6.-.%50,   <"K.GZ?8-80$V4))A7),8]!4W]G:?\ \^,/_?H4 <#X[^$W
M[*WQ2\2VGC/XF_"7P/XCUBP14L=6U[PU:WES;JK;E$<LL;.@# , ",$9KL1X
MO\+* JZS  !P :N_V=I__/C#_P!^A1_9VG_\^,/_ 'Z% %/_ (3'PQ_T&H/^
M^J/^$Q\,?]!J#_OJKG]G:?\ \^,/_?H4?V=I_P#SXP_]^A0!3_X3'PQ_T&H/
M^^J/^$Q\,?\ 0:@_[ZJY_9VG_P#/C#_WZ%']G:?_ ,^,/_?H4 4_^$Q\,?\
M0:@_[ZH_X3'PQ_T&H/\ OJKG]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ% %/\
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M^4:R_P#C-'_#:O[3/_12_P#RC67_ ,9KRRB@#U/_ (;5_:9_Z*7_ .4:R_\
MC-'_  VK^TS_ -%+_P#*-9?_ !FO+** /7_#O[97[25_X@L+&[^(^^*:\BCE
M7^Q[,94N 1D0YZ5]VU^8GA'_ )&O3/\ L(P?^C%K].Z "BBB@ HHHH ****
M"BBB@ HKC?CO\6O^%)_#N?Q[_P (_P#VGY%Q%%]D^U^3NWMMSNV-C'TKPO\
MX>6_]45_\N/_ .YJ /J:BOEG_AY;_P!45_\ +C_^YJ/^'EO_ %17_P N/_[F
MH ^IJ*^6?^'EO_5%?_+C_P#N:C_AY;_U17_RX_\ [FH ^IJ*^6?^'EO_ %17
M_P N/_[FH_X>6_\ 5%?_ "X__N:@#ZFK'LO^1WO?^O*+^9KYQ_X>6_\ 5%?_
M "X__N:J<'_!1?R=;GUG_A3N?.A6/R_^$AZ8[Y^ST ?65%?+/_#RW_JBO_EQ
M_P#W-1_P\M_ZHK_Y<?\ ]S4 ?4U%?+/_  \M_P"J*_\ EQ__ '-1_P /+?\
MJBO_ )<?_P!S4 ?4U%?+/_#RW_JBO_EQ_P#W-1_P\M_ZHK_Y<?\ ]S4 ?4U%
M?+/_  \M_P"J*_\ EQ__ '-1_P /+?\ JBO_ )<?_P!S4 ?4U%>:?LV_M$?\
M-":3JFJ?\(?_ &1_9MQ'%L_M#[1YFY2<Y\M,8Q[UZ70 4444 %%%% !1110
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M* "BBB@#PO\ X)[_ /)$]6_['O6?_2DU[I7A?_!/?_DB>K?]CWK/_I2:]TH
M**** "OSV_:N_P"3B/%7_81'_HM*_0FOSV_:N_Y.(\5?]A$?^BTH \\HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** -'PC_R->F?]A&#_ -&+7Z=U
M^8GA'_D:],_[",'_ *,6OT[H **** "BBB@ HHHH **** /'/V[_ /DW>_\
M^PC:_P#HP5\+5]T_MW_\F[W_ /V$;7_T8*^%J "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH ^M_^";?_(J>*/\ L(V__HMJ^E:^:O\ @FW_ ,BI
MXH_["-O_ .BVKZ5H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?IW0 4444 %%%% !1110 4444 >.?MW_ /)N]_\ ]A&U_P#1@KX6K[I_;O\
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M_%6GZ_?:7:?$"YWZI<6%PMW9QO*SGRXDNHK><A%#,;=5WA6=6_4:LCPI\0?
M7CM[R/P/XWTC66TZX\C4%TK4HK@VLO/[N3RV.QN#P<'B@#Y9_P""?WQ-_P""
MJ'CK]HCQUIG_  49^"O@KP1IMIX/TB7P59> -:EO[*YE>ZOA=O+))(Q$P"6X
MV[5PA7[V3CZ]HHH **** "BBB@ HHHH **** /"_^">__)$]6_['O6?_ $I-
M>Z5X7_P3W_Y(GJW_ &/>L_\ I2:]TH **** "OSV_:N_Y.(\5?\ 81'_ *+2
MOT)K\]OVKO\ DXCQ5_V$1_Z+2@#SRBBB@ HHHH **** "BBB@ HHHH ****
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M^,/['_\ P3MUSX=>*K/QOHGA6^U!/C':W3^-[/4;A+2YL=0A:9H[AF61KM9
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M1110 4444 %%%% !1110 4444 %%%% &CX1_Y&O3/^PC!_Z,6OT[K\Q/"/\
MR->F?]A&#_T8M?IW0 4444 %%%% !1110 4444 >.?MW_P#)N]__ -A&U_\
M1@KX6K[I_;O_ .3=[_\ ["-K_P"C!7PM0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% 'UO_ ,$V_P#D5/%'_81M_P#T6U?2M?-7_!-O_D5/%'_8
M1M__ $6U?2M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?!/[4*7:?'[Q.E]*DDPOQO=%P"?+3H* .!HHHH **** "BBB@ HHHH ****
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M* /"_P#@GO\ \D3U;_L>]9_]*37NE>%_\$]_^2)ZM_V/>L_^E)KW2@ HHHH
M*_/;]J[_ ).(\5?]A$?^BTK]":_/;]J[_DXCQ5_V$1_Z+2@#SRBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH T?"/_(UZ9_V$8/\ T8M?IW7YB>$?
M^1KTS_L(P?\ HQ:_3N@ HHHH **** "BBB@ HHHH \<_;O\ ^3=[_P#["-K_
M .C!7PM7W3^W?_R;O?\ _81M?_1@KX6H **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#ZW_X)M_\BIXH_P"PC;_^BVKZ5KYJ_P"";?\ R*GBC_L(
MV_\ Z+:OI6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /"_P#@GO\ \D3U;_L>
M]9_]*37NE>%_\$]_^2)ZM_V/>L_^E)KW2@ HHHH *_/;]J[_ ).(\5?]A$?^
MBTK]":_/;]J[_DXCQ5_V$1_Z+2@#SRBBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH T?"/_(UZ9_V$8/\ T8M?IW7YB>$?^1KTS_L(P?\ HQ:_3N@
MHHHH **** "BBB@ HHHH \<_;O\ ^3=[_P#["-K_ .C!7PM7W3^W?_R;O?\
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M* /"_P#@GO\ \D3U;_L>]9_]*37NE>%_\$]_^2)ZM_V/>L_^E)KW2@ HHHH
M*_/;]J[_ ).(\5?]A$?^BTK]":_/;]J[_DXCQ5_V$1_Z+2@#SRBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH T?"/_(UZ9_V$8/\ T8M?IW7YB>$?
M^1KTS_L(P?\ HQ:_3N@ HHHH **** "BBB@ HHHH \<_;O\ ^3=[_P#["-K_
M .C!7PM7W3^W?_R;O?\ _81M?_1@KX6H **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#ZW_X)M_\BIXH_P"PC;_^BVKZ5KYJ_P"";?\ R*GBC_L(
MV_\ Z+:OI6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /"_P#@GO\ \D3U;_L>
M]9_]*37NE>%_\$]_^2)ZM_V/>L_^E)KW2@ HHHH *_/;]J[_ ).(\5?]A$?^
MBTK]":_/;]J[_DXCQ5_V$1_Z+2@#SRBBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH T?"/_(UZ9_V$8/\ T8M?IW7YB>$?^1KTS_L(P?\ HQ:_3N@
MHHHH **** "BBB@ HHHH \<_;O\ ^3=[_P#["-K_ .C!7PM7W3^W?_R;O?\
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M* /"_P#@GO\ \D3U;_L>]9_]*37NE>%_\$]_^2)ZM_V/>L_^E)KW2@ HHHH
M*_/;]J[_ ).(\5?]A$?^BTK]":_/;]J[_DXCQ5_V$1_Z+2@#SRBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH T?"/_(UZ9_V$8/\ T8M?IW7YB>$?
M^1KTS_L(P?\ HQ:_3N@ HHHH **** "BBB@ HHHH \<_;O\ ^3=[_P#["-K_
M .C!7PM7W3^W?_R;O?\ _81M?_1@KX6H **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#ZW_X)M_\BIXH_P"PC;_^BVKZ5KYJ_P"";?\ R*GBC_L(
MV_\ Z+:OI6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX*>!/"_B#P1K&G 1W&E:MIDUG*+R)P/EF?\ ?AGZMY\A.2QH _2:BO.OV/\
MXTW7[2/[)?PN_:'OK6."?QY\.]$\13P1#"Q/>V$-RR =@#(1CVKT6@ HHHH
M\+_X)[_\D3U;_L>]9_\ 2DU[I7A?_!/?_DB>K?\ 8]ZS_P"E)KW2@ HHHH *
M_/;]J[_DXCQ5_P!A$?\ HM*_0FOSV_:N_P"3B/%7_81'_HM* //**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@#1\(_\ (UZ9_P!A&#_T8M?IW7YB
M>$?^1KTS_L(P?^C%K].Z "BBB@ HHHH **** "BBB@#QS]N__DW>_P#^PC:_
M^C!7PM7W3^W?_P F[W__ &$;7_T8*^%J "BBB@ HHHH **** "BBB@ HHHH
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M% 'QS_PY"_9-_P"BC?%/_P +8_\ QJC_ (<A?LF_]%&^*?\ X6Q_^-5]C44
M?'/_  Y"_9-_Z*-\4_\ PMC_ /&J/^'(7[)O_11OBG_X6Q_^-5]C44 ?'/\
MPY"_9-_Z*-\4_P#PMC_\:H_X<A?LF_\ 11OBG_X6Q_\ C5?8U% 'QS_PY"_9
M-_Z*-\4__"V/_P :H_X<A?LF_P#11OBG_P"%L?\ XU7V-10!\<_\.0OV3?\
MHHWQ3_\ "V/_ ,:H_P"'(7[)O_11OBG_ .%L?_C5?8U% 'QS_P .0OV3?^BC
M?%/_ ,+8_P#QJN%_::_X)"?LT_"CX">*?B+X:\?_ !)EO](TMI[6.]\8L\3,
M& ^91&"1SZBOT KCOV@OAG??&7X+^(OA?IFIQ65QK>G-;174Z%DC)(.2!R1Q
M0!\K^"?^"+'[*VO>#-(UR]^(GQ06:]TRWGE6+QH0H9XU8X'E<#)K3_X<A?LF
M_P#11OBG_P"%L?\ XU7UMX2T:7PYX4TSP]/,LCV&GPV[R(,!RD:J2/8XK0H
M^.?^'(7[)O\ T4;XI_\ A;'_ .-4?\.0OV3?^BC?%/\ \+8__&J^QJ* /CG_
M (<A?LF_]%&^*?\ X6Q_^-4?\.0OV3?^BC?%/_PMC_\ &J^QJ* /CG_AR%^R
M;_T4;XI_^%L?_C5'_#D+]DW_ **-\4__  MC_P#&J^QJ* /CG_AR%^R;_P!%
M&^*?_A;'_P"-4?\ #D+]DW_HHWQ3_P#"V/\ \:K[&HH ^.?^'(7[)O\ T4;X
MI_\ A;'_ .-4?\.0OV3?^BC?%/\ \+8__&J^QJ* /CG_ (<A?LF_]%&^*?\
MX6Q_^-4?\.0OV3?^BC?%/_PMC_\ &J^QJ* /CG_AR%^R;_T4;XI_^%L?_C5'
M_#D+]DW_ **-\4__  MC_P#&J^QJ* /CG_AR%^R;_P!%&^*?_A;'_P"-4?\
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MXI_^%L?_ (U7V-10!\<_\.0OV3?^BC?%/_PMC_\ &J/^'(7[)O\ T4;XI_\
MA;'_ .-5]C44 ?'/_#D+]DW_ **-\4__  MC_P#&J/\ AR%^R;_T4;XI_P#A
M;'_XU7V-10!\<_\ #D+]DW_HHWQ3_P#"V/\ \:KZ%_9H_9M\"?LJ_#0?"OX=
MZOKE]IPU"6\\_P 0:F;NX\R0*&&\@87Y1@8XY]:]!HH **** "BBB@ HHHH
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M^&]K9GPGK-O!>Z9%X@DM+9+G4&B.^*6>)TNDAD^8(MW,5)+!A\_VO[(/P_\
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M0DJ #['HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MFC5@"8I(W(RYKZPU7]E_]FC7?B'_ ,+=UO\ 9W\"WGBPRK*?%%UX2LI-1WJ
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M[N_8Z(;]D7X6,IR#\.-#P1_UX04 ?G__ ,%P;?Q+X;_X**?L1^&_!GQ8\?\
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M^.3.? \&I>&=2L8O$B0VTES+-I\]S;QQ7T*P1/)YT#O'MP0WS+GX_P#V+?\
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M4:HVF>%]0N[2ZATK6KU6VFUL]3>(65U-O&SRXIF8M\H&[BOF[]NC]COX4?\
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M[>>C_'^R_:S_ ."=^O\ Q<T7PGX3L(_C/#9>&_ /ASS[VXT"V-A&OD7.JRR
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
6444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>ew-20240331_g3.jpg
<TEXT>
begin 644 ew-20240331_g3.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[@ .061O8F4 90     !_]L 0P " 0$!
M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D*
M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\  $0@"
MF@.J P$B  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*
M"__$ +40  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A
M""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U15
M5E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H
MJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V
M]_CY^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (!
M @0$ P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P
M%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E
M9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V
MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#
M 0 "$0,1 #\ _?RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MXR?"?P3\,6^-/BSXCZ+8>$EL8;P>([C48Q9R02[?)=)<[7$A= FTDN74+DL
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MC#P=X*U'5M+TS6O%=[%<WGF1ZE<BYMS+#!!&Z0W/G0KM3 $84$[<T ;OC_\
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M>&+2\FM+_5;"5D%G/$H:2*=)51X&",KXD53M96Z$$XGA3_@H;^Q_XU\8^&?
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MWAG3?%6E76D#PE81Z)#8VQ9&2:WT)9+=K=!)$R@ADV.C#((K%_93^*,OC?\
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M^"?/_99-<_\ 3=#0!^B5%([I&I>1PJCJ6.!2T ?+O[7O_!/?7_V^/B1<:?\
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MH V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EH V**Q_P#A)=7_ .A0O?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^']GJ]P\&E77C'Q);:<EY*BAG2(SNH<J""0,X!&>M<E\)_\ @I5_P3U^//Q
MT_X3_!/]MWX5>+?$^K-(-+\/>'/'=A>7MV8XGED$<,4K.^V.-W. <*C$\ T
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M^(,GA(MJ\FO;OMS6WVF;["USO^?SC9?92Y?Y]Y;?\V:\"_X-\O%/AK7OB/\
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MU^)VB3VGD[K(XU"XT^T>43ZA:VGS>=,@4'RI?($Y3! /K.BO*?C;^VO^S=\
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M$,'10#UJBBB@ KPO]K#_ )+9\#_^Q[E_])FKW2O"_P!K#_DMGP/_ .Q[E_\
M29J /=**** "BBB@ HHHH **** "BBB@ HHHH **** "O([K]@[]CR[^/&E?
MM*G]F_P7'XQT>PO;:UU>'PO9K([7,UK*UP["+<\Z-:((Y2=T8EF /[QL^N44
M 5=:T31?$ND7/A_Q%I%K?V%Y"T-Y97MNLL,\;##(Z,"K*1P01@USW@_X$? _
MX>:P/$7@#X->%-#U 1-&+[1_#MM;3!&^\N^- V#@9&<'%=710!XKXF_9#\,>
M/OVR/#G[57B;PAX5L;KP-%._A_4-+TM#K&JW<]A+9&6]NS&KK#!;W5Y%':@R
M*QG\TNI58U]$^(?P5^#?Q=ET^?XL?"7PSXG?2+CS])?Q%H-O>FREX_>1&9&\
MMN!RN#P/2NFHH QO$@ U;1P!@"\. /\ =-4="^"GP:\+^/M0^*WAKX2>&-.\
M4:NFS5?$ECH-O#?WJY!Q+<(@DD&0.&8]*O\ B7_D+Z/_ -?I_P#036Q0!0\4
M>%O#/CCPUJ'@SQKX<L-8T?5K*6SU72=4LTN+:\MY%*20RQ2 I)&RDJR,"""0
M00:LZ?I]AI-A!I>EV4-M:VT*Q6UM;QA(XHU "HJCA5    X %344 8.F?"WX
M8Z)J.OZOHWPYT&TN_%;J_BBZM=(ACDUAA'Y8:Z95!N"(_D!DW87CIQ1\/?A7
M\,/A)I$GA_X4_#C0?#%A-.9I;'P]H\%E"\IZN4A55+'N<9K>HH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *AU"_L=*L)]4U2]BMK:VA:6XN)Y B11J"6=F/"@ $DG@ 5-65
MXY\':)\1/!.L?#_Q-$\FFZ[I5QI^H1Q/M9H)HVCD /8[6//:@#Y T#_@K?XO
M^+/BWPSXH_9K_8K\;^/?AGXD\'>)=>T;7["]TVUU3Q#:Z3?Z7:/>:;8W-W&S
MVY-^^U)S#//^[,<>W[_L'C'_ (*&_L]^#/V1/"'[95XVMW&@_$*#1U\!^'[;
M31_;.O7^J!/L&FV]L[J#=RLX78S*J;79V5$9A^5?PG^,'[1/_!NC^U=\-_@%
M_P %!OM'C;]G31/"/BO1/A+\7/"^FF:[T;2]0U70IYO[6MT)=8[::"TCX4D?
M;L1-,%2)/HC_ (+<V=WX=^"7[)G[<_[+'AB3QG\(O@C\8]$\8^(-.\#H;Y&\
M.&-=NHVZQD^;'%%N 89VBX#'"!V !]9:+_P4*A\*?M*^$?V5_P!J?X%:S\+_
M !!\1[2YE^&^IW^L6>HZ7KL]NH>?3OM-LY^SWR(ROY+KLD'$<LC?+7OWBWQ9
MX8\!>%=3\<^-=>M-*T;1M/FOM6U._G$4%I;1(9)9I';A45%9BQX !-?D)_P7
M)_;I_9G_ &PO#W[(&G_L1_%^Q\;>+;W]J_PMJ7AC5_#,$\T5LB).DD;7 01Q
M3"6>T+6[LLH RR *<?>WQ.3_ (;C_: E_9ZLAYWPG^&>K6]U\4;E>8?$NO1[
M+BT\/ ]'M[?,-W>#HS&UMCN5KJ, %7_@G1_P4?\ A!_P44^&GC#]ICX<Z!J?
MA[PMH'B;4=#%QXE*PR316)4M>.I_U",CAMC_ #)@AN17A%K_ ,'#MKKM@/$G
M@;_@CQ^VSXBT"X4S:7XDT;X'O+9:C;<E+F&3[0-T3KAU;C@C.*Q?^#;_ $31
MO$W[+OQR\.>(])MK_3]0_:'\;6U_8WD"RPW$,EQ&KQNC AT9205((()!KZ5_
MX*\_%3Q?\//V%_$G@3X57OD>.?BK?6/PY\!%<AEU36YUL%F7'0P0RSW)/9;8
MGM0!Z'^P[^UOX5_;M_97\(_M9^!? 7B+PUHGC2SFN])TKQ7!!'?+;I/)"DKK
M!+*@601^8F'.4="<$X$?[2G[7W@[]GKQ;X+^$=CX5U/Q=\0OB-?7-MX)\#Z'
M)"EQ>I;1>;=W<LL[I%;6EO&5:69VS\Z(BR2.J-V_P8^%'A#X#_"#PK\$/A]8
M_9M"\'^';+1=&M\#]W:VL"01 X[[$&?>OSH_X*6^/=:_8A_X+>?L_?\ !0[X
MU65_#\"[KX9:G\/_ !+XMBM))[3PKJ4]Q//%<W6P'R(YFDM8_,; VQ2'/R8H
M ^P?V?\ ]O/PQ\5OVB_$O[&WQ3^&VJ_#OXL^&-$AUUO"FLWD%U#K.BRR&--3
MTZZ@8K=6XE'E/E8Y(Y 59!U/O=?DM\<OVDOA7^TS_P ')?['NK?LI>-(O$<.
MF_#7Q9-XK\0:1;RM87>CS65Z("EP4$=U#]HCD >)G02D#(8$#]:: "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@#F?C2 WP<\6JPR#X9O\@_]>\E?
M'/\ P;._\H//@/\ ]@S6O_3[J-?6G[2?B.7PS\"_%-W:>%];UJZN-"N[:QTK
MP]I$U[=74\D#K'&J1*<9; WMM1<_,P'-?+O_  ;W?#_XJ? G_@EC\-OV:?CO
M\(_$_@SQIX'M]1@UW2/$6C20+^_U6]N(7AFP8IP8I$)V,2A.&"Y&0#WG_@H9
M\0O$_P )/V _CC\5O!-U)!K7AGX/^)M5TB>%L/'=6^E7,T3*1T(=%/X5\R?\
M$./AWX6A_P"#?3X7^"+RTB?3=8^&6LR:E&P&V07ES?2S[O7)F?.:]#^!7[9G
MBW]M/X__ !R_X)_?M,_L/>*_AOIFDZ;J%KH6KZ[J FM_&WAYYY-/FO(@(D\E
M7W*R!6E5EE.'RC"O#OV9/!G[8'["'_!-;Q/_ ,$NK#]G_P 7^,/B)X;M]?\
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M]^A1_9VG_P#/C#_WZ% %/_A,?#'_ $&H/^^J/^$Q\,?]!J#_ +ZJY_9VG_\
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M_?5'_"8^&/\ H-0?]]5<_L[3_P#GQA_[]"C^SM/_ .?&'_OT* *?_"8^&/\
MH-0?]]4?\)CX8_Z#4'_?57/[.T__ )\8?^_0H_L[3_\ GQA_[]"@"G_PF/AC
M_H-0?]]4?\)CX8_Z#4'_ 'U5S^SM/_Y\8?\ OT*/[.T__GQA_P"_0H I_P#"
M8^&/^@U!_P!]4?\ "8^&/^@U!_WU5S^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0H
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M_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\
MA,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[Z
MH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[
MZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!
MJ#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A
M,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4
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M )1K+_XS1_PVK^TS_P!%+_\ *-9?_&: /OFBO@;_ (;5_:9_Z*7_ .4:R_\
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M".E 'U]1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>%_M8?
M\EL^!_\ V/<O_I,U>Z5X7^UA_P EL^!__8]R_P#I,U 'NE%%% !1110 4444
M %?!?[;O_)RFO?\ 7*S_ /26*OO2O@O]MW_DY37O^N5G_P"DL5 'D]%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% 'ZCV/_ !Y0_P#7)?Y5+45C_P >4/\ UR7^52T %%%% !1110 4444 %%%%
M !1110 4444 %?EQ??\ '[-_UU;^=?J/7Y<7W_'[-_UU;^= $5%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>G?L;?
M\G*>&/\ KK<_^DLU>8UZ=^QM_P G*>&/^NMS_P"DLU 'W]1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?_'+X/1>)_V<_$OA=;/QH7@?59H6%T6A*E4V'J =QSV% 'U[16/_ ,)+J_\
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MQ16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\
MWTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T
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MKN)EN+L274Q(RQ+NQ.2>Y-<IXE_9D_X(:?M2_$_6?V8+WX2?LX^)/'NB1O\
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MBB@ HHHH **** "BBB@#]1['_CRA_P"N2_RJ6HK'_CRA_P"N2_RJ6@ HHHH
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MOF",J-Q(1@#]$Z*** "BBB@ HHHH **** "BBB@ HHHH *\+_:P_Y+9\#_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _-?_ (*E?L<V]O\
MM57O[;?QM_X+-^-?V;? *^$++1] M=&\7Q6!;46DE^W0P><W^KDCM].E\B)7
M+RI*Y VJ:YG]B_\ 8ZT/X^_$;P9\>_V;/^"_7Q'_ &AM&\">-=.U7Q%X%U_Q
MS!?V-Q"DF,7,$+"2&1 3-'YJ$,\*X X=?3?C+^SE_P $]?CW_P %/O&6L?\
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MBB@ HHHH **** /U'L?^/*'_ *Y+_*I:BL?^/*'_ *Y+_*I: "BBB@ HHHH
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MQ'_P2*_:&\!6?BKQ_I5G-XQ^+'@)K/1M*VW"S+(TJLV)BT06+)4>8RGYL;&
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M44 %%%% !1110 4444 %>G?L;?\ )RGAC_KK<_\ I+-7F->G?L;?\G*>&/\
MKK<_^DLU 'W]1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !7RY_P4F_;,_:%_9%U#X8P_L_?\$^=1^/>I>+_$-]8VMM
MI?BJ#2YM&O8K&2:-PTUM*O[VV6_!?='M6)ERWF8'U'7E'QT\8_M:>'_C?\*?
M#_P(^"7ASQ+X&U?6;Y/BMXBUC7Q:77ART2!3;36D)YN'DD:16 #$;5! #F1
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MW'/85]>UX7^UA_R6SX'_ /8]R_\ I,U 'KG_  DNK_\ 0H7O_?2T?\)+J_\
MT*%[_P!]+6Q10!C_ /"2ZO\ ]"A>_P#?2T?\)+J__0H7O_?2UL44 8__  DN
MK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+6Q10!C_ /"2ZO\ ]"A>_P#?2U\._MF7
M4UY^T3KEQ<63V[M%:9BD(R/]&B':OOJO@O\ ;=_Y.4U[_KE9_P#I+%0!Y/11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110!^E]EXEU86<(_X1"\_U2_Q+Z5+_P )+J__ $*%[_WTM:=C_P >4/\
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M4 %%%% !1110 5^7%]_Q^S?]=6_G7ZCU^7%]_P ?LW_75OYT 14444 %%%%
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M[6'_ "6SX'_]CW+_ .DS4 >Z4444 %%%% !1110 5\%_MN_\G*:]_P!<K/\
M])8J^]*^"_VW?^3E->_ZY6?_ *2Q4 >3T444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 ?J/8_\ 'E#_ -<E_E4M
M16/_ !Y0_P#7)?Y5+0 4444 %%%% !1110 4444 %%%% !1110 5^7%]_P ?
MLW_75OYU^H]?EQ??\?LW_75OYT 14444 %%%% !1110 4444 %%%% !1110
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MVL/^2V? _P#['N7_ -)FH ]THHHH **** "BBB@ KX+_ &W?^3E->_ZY6?\
MZ2Q5]Z5\%_MN_P#)RFO?]<K/_P!)8J /)Z*** "BBB@ HHHH **** "BBB@
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MA4Z._ACQ5-%YEE&B^?*)K"Y*31 2'SH617:6168+\A_\%5?VJ?@A^VS\0_\
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M/_CE\'HO$_[.?B7PNMGXT+P/JLT+"Z+0E2J;#U .XY["@#Z]HK'_ .$EU?\
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M@#8K\N+[_C]F_P"NK?SK]+_^$EU?_H4+W_OI:_-"].;R8X_Y:M_.@"*BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O
M3OV-O^3E/#'_ %UN?_26:O,:](_9%N9;3]HGPW<06CSNLMQB*,\M_HTH[T ?
MH)16/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[_P!]
M+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM &Q
M16/_ ,)+J_\ T*%[_P!]+6AIMY/?6HGN+"2V8L1Y4I&?KQ0!8HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KYH_P""
MOG["GBS_ (*3_P#!/_QM^QQX(\=Z=X:U/Q5<:7);ZSJMM)-! +34K:\8,D?S
M'<L!48[L*^EZ* /#?V_?V'/!?[>_[-4WP*\3^);C0-6T[5;+7?!/B^QMUEN/
M#VNV3^9:7\:,0'VMN5D)&^.21=RE@PX+7/V)/CK^U3^T'\*/C3^W-K/@E=+^
M">H/K?A7PAX$:[GM]9\2&(11ZQ=RW:1M MN-[P6D:R%))-SW$@4*?J^B@#YF
M^,O[$WCK1_VWM._X*)?LIZEX?M_'%QX*D\(>/?"_BF>>VTWQ3I0F6>VD-S;Q
MRO:7=O*@VS>3,'B8Q%5 5AJ?L5_L/S_L[_$CXI?M/?%GQ58^)/BU\:==M=0\
M;:UIMFT%E96EI +;3]*LTD9G^SVT(V^8YWS.6=@N51/H6B@ HHHH *\+_:P_
MY+9\#_\ L>Y?_29J]TKPO]K#_DMGP/\ ^Q[E_P#29J /=**** "BBB@ HHHH
M *^"_P!MW_DY37O^N5G_ .DL5?>E?!?[;O\ R<IKW_7*S_\ 26*@#R>BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#]1['_CRA_P"N2_RJ6HK'_CRA_P"N2_RJ6@ HHHH **** "BBB@ HHHH
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M*** "BBB@ HHHH *^"_VW?\ DY37O^N5G_Z2Q5]Z5\%_MN_\G*:]_P!<K/\
M])8J /)Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%UYXOU#QPZZ7JLEHAN+FR72T406]JZ+(D-LGR(/+1_-7<& /UCHK\V_VZ_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+_P&/^-;%% &/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^-;%% &/]B\;_\
M0;LO_ 8_XT?8O&__ $&[+_P&/^-;%% &/]B\;_\ 0;LO_ 8_XU\._MF)?1_M
M$ZXFI3I),(K3>\:;0?\ 1HL<?2OOJO@O]MW_ ).4U[_KE9_^DL5 'D]%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% 'Z7V5EXV^QPXUNS_U2_\ +L?3ZU+]B\;_ /0;LO\ P&/^-:=C_P >4/\
MUR7^52T 8_V+QO\ ]!NR_P# 8_XT?8O&_P#T&[+_ ,!C_C6Q10!C_8O&_P#T
M&[+_ ,!C_C1]B\;_ /0;LO\ P&/^-;%% &/]B\;_ /0;LO\ P&/^-'V+QO\
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M->;UZ=^QM_R<IX8_ZZW/_I+-0!]S?8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\
MP&/^-;%% &/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XUL44 8_V+QO\
M]!NR_P# 8_XT?8O&_P#T&[+_ ,!C_C6Q10!C_8O&_P#T&[+_ ,!C_C6AIL>H
MQ6H35+B.67<<O$FT8[<58HH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O"_P!K#_DM
MGP/_ .Q[E_\ 29J]TKPO]K#_ )+9\#_^Q[E_])FH ]THHHH **** "BBB@ K
MX+_;=_Y.4U[_ *Y6?_I+%7WI7P7^V[_R<IKW_7*S_P#26*@#R>BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#]
M1['_ (\H?^N2_P JEJ*Q_P"/*'_KDO\ *I: "BBB@ HHHH **** "BBB@ HH
MHH **** "ORXOO\ C]F_ZZM_.OU'K\N+[_C]F_ZZM_.@"*BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O3OV-O^3E/
M#'_76Y_])9J\QKT[]C;_ ).4\,?]=;G_ -)9J /OZBBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\N+[_C]F_P"NK?SH BHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;_T>1\+/_"1_^YJ/^%+_ /!:W_H\CX6?^$C_ /<U 'V-17QS_P *7_X+6_\
M1Y'PL_\ "1_^YJ/^%+_\%K?^CR/A9_X2/_W-0!]C5\%_MN_\G*:]_P!<K/\
M])8JZ[_A2_\ P6M_Z/(^%G_A(_\ W-7!>-_^"?7_  4]^(_B6X\7^,_VD?A9
M>:C=!!/<?V'=1[@B!%^6.)5&%4#@=J /-J*[/_AV%_P44_Z+[\+/_!5>_P#Q
M%'_#L+_@HI_T7WX6?^"J]_\ B* .,HKL_P#AV%_P44_Z+[\+/_!5>_\ Q%'_
M  ["_P""BG_1??A9_P""J]_^(H XRBNS_P"'87_!13_HOOPL_P#!5>__ !%'
M_#L+_@HI_P!%]^%G_@JO?_B* .,HKL_^'87_  44_P"B^_"S_P %5[_\11_P
M["_X**?]%]^%G_@JO?\ XB@#C**[/_AV%_P44_Z+[\+/_!5>_P#Q%'_#L+_@
MHI_T7WX6?^"J]_\ B* .,HKL_P#AV%_P44_Z+[\+/_!5>_\ Q%'_  ["_P""
MBG_1??A9_P""J]_^(H XRBG?$K]B+]OGX;>+?"'A+5?C=\.9IO%VLMI]D]KI
M-T4B<1E\R;E!VX'\.3FNQ_X=A?\ !13_ *+[\+/_  57O_Q% '&45V?_  ["
M_P""BG_1??A9_P""J]_^(H_X=A?\%%/^B^_"S_P57O\ \10!QE%=G_P["_X*
M*?\ 1??A9_X*KW_XBC_AV%_P44_Z+[\+/_!5>_\ Q% '&45V?_#L+_@HI_T7
MWX6?^"J]_P#B*/\ AV%_P44_Z+[\+/\ P57O_P 10!QE%=G_ ,.PO^"BG_1?
M?A9_X*KW_P"(H_X=A?\ !13_ *+[\+/_  57O_Q% '&45V?_  ["_P""BG_1
M??A9_P""J]_^(H_X=A?\%%/^B^_"S_P57O\ \10!QE%=G_P["_X**?\ 1??A
M9_X*KW_XBC_AV%_P44_Z+[\+/_!5>_\ Q% 'Z*6/_'E#_P!<E_E4M?'"?!/_
M (+5QH(T_;'^%@51@#_A$3T_\!J7_A2__!:W_H\CX6?^$C_]S4 ?8U%?'/\
MPI?_ (+6_P#1Y'PL_P#"1_\ N:C_ (4O_P %K?\ H\CX6?\ A(__ '-0!]C4
M5\<_\*7_ ."UO_1Y'PL_\)'_ .YJ/^%+_P#!:W_H\CX6?^$C_P#<U 'V-17Q
MS_PI?_@M;_T>1\+/_"1_^YJ/^%+_ /!:W_H\CX6?^$C_ /<U 'V-17QS_P *
M7_X+6_\ 1Y'PL_\ "1_^YJ/^%+_\%K?^CR/A9_X2/_W-0!]C45\<_P#"E_\
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M ,10!QE%=G_P["_X**?]%]^%G_@JO?\ XBC_ (=A?\%%/^B^_"S_ ,%5[_\
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MS4 ?8U%?'/\ PI?_ (+6_P#1Y'PL_P#"1_\ N:C_ (4O_P %K?\ H\CX6?\
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M3?$NP_LCXB?![XSZI8>+?#\YQ-;I/%"89\=XY)(KE4?HPA)'!%=C_P '4OB
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M$6A_#O1(=7E\'?$Q?&UM=-XEGEUV_:Y@.FI&)K+R9&=-\CL)-FX !@*_4^@
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M,:K'9VNIV]S>^5*MP\<8N'!#KE!,(R$&4.3G]&Z_.W_@Z%_Y19S?]E3\)_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
/ "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>ew-20240331_g4.jpg
<TEXT>
begin 644 ew-20240331_g4.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MXR?"?P3\,6^-/BSXCZ+8>$EL8;P>([C48Q9R02[?)=)<[7$A= FTDN74+DL
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MC#P=X*U'5M+TS6O%=[%<WGF1ZE<BYMS+#!!&Z0W/G0KM3 $84$[<T ;OC_\
M;L_8V^%GQOT[]FOXA?M+^#=*\>:G9W=Y#X5NM;B%Y!;6UE+?3W%P@)^RPK:P
M2R^;-L0JAP2>*Y'X7?\ !6'_ ()P_&72_&NM?#W]L+P9=VOPZM1=>,Y;N_:S
M&F6[,$6=OM"QEXF=E59$W(S.B@DNH/S%_P %)/!OA+Q5_P %_O\ @G[9^)_#
M5CJ$,]A\2GGAO;5)4D:WT$30%@P()24!US]U@".:A^(OP^\#:E_P=6>"]6U'
MPAIMQ<G]CV;43--9HS?;(O$$T<5QR/\ 6HF%5_O * #P, 'VC^RA^W-^R7^W
M'X?UCQ-^RE\<-(\96WA[418ZZE@)8I]/G()5)H)T26/<%;:S* VQMI.TXROB
MI_P4;_8K^"NKZOI/Q(^.UC8Q^'=02Q\4:M!IMY=:9H%TVW$&HW]O"]KI\GSH
M2EQ+&P#J2 "#7Q+\/=3\8_#K_@M_^WSKGP6T=6\0C]G[PWJ^E6%M "+W5XM+
M;[,S(!AW+[5Y!)W'UKT+_@W>M/A;^T'_ ,$,?A_X;\26EMXAMO%%GXDLOB);
MZ@?.DU*]N=5OA??:RV6D>59-Q+DDI(IZ8H ^K_VA_P!N;]CS]D_X9V/QB_:*
M_:2\(>%/#>K6XGT34M2UF/&JQE5<&S1"SW?RNK8A5SM8'H<UAV/_  4M_8+U
M/]J-/V+=-_:F\*7'Q.DFE@C\*0WI:1[B)2TML)0ODFX0 [H _FKM(*@@U^(W
MB1?B!<_\&;_C72_B!?SZII?A[XJ+I_P\U*].]GT:'Q1:PQLCGJ@E-W&N. HV
MC"@"OT"_X+P^ _!7PY3]AA/ /A33]&30/VV? ^G:+'IEHD*V5I*;DR01A0 B
M.88]RCAM@SG% 'J_QJ_X+0?LZ_"7_@I)H7[!VI:_);PVO@[4]:\<^()M%NY(
M;6XCD@BM+*!HXV,SDM.TKJ"D9C1-V\NJ> >"OB'\&OV2O^#B+X_?$CXL?%V?
M0_!UK^S/I.IWFI>,/%-U=PVDMQJMJAC@-U+(R"1U14MXN"S!43) KT#XE$#_
M (.C/AOD]?V/=2Q_X/I:S/AAX3\,>(/^#I'XI:SKOA^SO;O1OV8-&N=(N+JV
M61[*=M02(RQ%@?+<QNZ;A@[79<X8@@'VM^S%^V;^RY^V9\+)_C7^S%\;-%\7
M>&+2\FM+_5;"5D%G/$H:2*=)51X&",KXD53M96Z$$XGA3_@H;^Q_XU\8^&?
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MWAG3?%6E76D#PE81Z)#8VQ9&2:WT)9+=K=!)$R@ADV.C#((K%_93^*,OC?\
MX.3_ (]_#_XI:Q<W5[X(^ GAJP^%"ZRNR9M)GBL[O4YXT95Q(]W<()6"JW[L
M*0 F  <]_P $P?'OPH^(O_!?/]JCQ%\$/B/JWB+PW+\,/#1A;6=9U"[FL+K?
MBZM674&:>U9)UD#6[A/+8E=BC K]+_B9\./#OQ9\%7W@/Q3<ZI#9W\+1R3Z+
MK5SIUU%D$!H[BUDCEC89R"K#!Q7P%^R'H^D:1_P<F_M:R:7I\-N]]\(O!MS=
MF% OG2^3$AD;'5MJJ"?85^C= 'XU_P#!M!^V;^TKX2^(FH?L!?MP_&'Q#XPU
M?QY\-M#^+7P@\3^+=:N+ZXU#3+^QA-Y9)-<N[L(9.%0'&ZWO& Q7V-_P7(_:
M'^*WPI_8PUSX0_LW^*+G1_B3\0-!UD:1K%A.\<^B:/ING3:AJ^IHZ%6C:.UA
M^SQR*RLMS?6V#DBO@W]J#X/>/?A7_P $<OV'O^"P/[/&D&;Q]^S%X!\+:CJ\
M%OE6U;PO=65O#?VDA4;B@W#/]R&>Z;C.:^H)_'VA_MW_ +*W[4'_  5 T>*Z
M?PAJ_P !O$7@SX)_;[9HI!H5OIMQ-J=_L;E&N]3#1'UBTFV8?>H ['_@@=XS
MLM)_X(W?#?\ :=^/7QCUF_U#5O#FHZOXV\;?$'QK=7NV.&_O 999[Z9U@BCB
M0#@JH5,GN:^A?AC_ ,%#_P!COXO?$K0OA!X,^, 3Q'XKTJ34_"&F:YH&H:4W
MB*SC7>]QISWUO$FH1A/G+V[2#8-WW>:_//\ 93\;_LB^ ?\ @TK\):W^W1I.
ML:E\,I/ TUOKND>';EXK_49)-?F6VMK=T="LCW'DC)8(!DN=@:M/]N_1_P!H
M6P_;V_X)XZ]\:]*\)>&(E^*E]9Z#X%\,+/>2^'X#IL*M;W&J2N!?/L6-6\NW
MA0%2,RC#T ?<_P 1?^"I?_!.SX3^+/%O@;Q]^V+X%L=6\!:')J_C.Q36DG?1
MK9+F&U(N/*W".8SW$,:VY/G,TBA4-=&?VZ?V3)/@[X2^/.G_ !JTW4/#/CV$
M2>"+C2;>>\NM?^0N4L[."-[FYD559GCCB9T"-N5=IQ\5Z=\-O 'C+_@Z@\5M
MXL\':=J0M?V,X+F".]M%D032:XEH[E6!#,;>62(D@_)(R]":L_"?QIX&^'W_
M  <F:]^SIXGTC3/#UAI7[+EA:? W0;>TCM+*"T-^)]1CL84"HDCM$V[RP"8[
M$C[L>  ?1'QN^.W[-?[=/[!GQCO/@?\ &:XU:UT/POKEGJ[^&M<O]'U/1M3M
M[.9C;W*1M!=6LJL 3#,%W#[RLIKY?_X(_P#_  4R_87_ &2?^"4?[-7PW_:B
M_:H\,^%/$GB'PF6M;'6;US+^^U"Z5);AE5A;([*^)9RB-L?#':V/H_XH?LZ?
ML@_ ?3_VI?&/P4\)0:9\2/B=\-;CQ#\4&MK^ZF^U*ECJ$%G<21.[0VQ=A>8$
M:H92DK$,5)'P-X1^''@&#_@S-U%K?P=IL;:A\);C5M0D2R0-<WT>J$QW,AQE
MY5\J(!SD@1H 0%  !^TJ.DBAT8,K#((.017@7[7/[!FC_MNZW'H_QK^-OCS3
M? UCIRI8>#_ 7BFYT(7-\S.9+R]N+5UEN=J^2L,!811E9'99&=?+Z[]B'4+S
M5OV+OA#JNHW+S7%S\+] EGFD;+.[:= 68GN22372_&WX+>!?V@_AKJ?PE^)7
M]LG1-7@:'4(]"\37^D3RQLI5D^T6,T,P4@D%0^UNX- 'Q[_P0<\)_M,_#KX3
M?%[X6_&#XM^(_'GP^\)?&K6=$^"/B_QA>M=:CJ6@6KB$L;AO^/B!9EDCCD^Z
M6279B,1J.1_X*GZA\7_ '_!5#]B2X\.?M%>.(O#7C/XHZE9ZYX$BU6.#1Y5M
M[&)XF,,$<;3D,\IS.\N"_P NT "J'_!%;X!?$3]A']NG]I__ ()W^#OB1KWB
M?X(^ X_#.M?#V+Q#?&YE\.SZI;SSS:<LA  &%#%!QM2.0@-,Y;8_X+"_\I+?
M^"?/_99-<_\ 3=#0!^B5%([I&I>1PJCJ6.!2T ?+O[7O_!/?7_V^/B1<:?\
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M%"]_[Z6@#8HK'_X275_^A0O?^^EH_P"$EU?_ *%"]_[Z6@#8HK'_ .$EU?\
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MZO\ ]"A>_P#?2T ;%%8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2T ;%%8_\
MPDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2T ;%%8__"2ZO_T*%[_WTM'_  DN
MK_\ 0H7O_?2T ;%%8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2T ;%%8_
M_"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2T ;%%8_\ PDNK_P#0H7O_ 'TM'_"2
MZO\ ]"A>_P#?2T ;%%8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2T ;%%8_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7
MA?\ P3W_ .2)ZM_V/>L_^E)KW2O"_P#@GO\ \D3U;_L>]9_]*30![I1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!C^)?^0OH__7Z?
M_036Q6/XE_Y"^C_]?I_]!-;% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %8_B7_D+Z/\ ]?I_]!-;%8_B7_D+Z/\ ]?I_]!- &Q1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %>%_\$]_^2)ZM_V/>L_^E)KW2O"_^">__)$]6_['O6?_ $I-
M 'NE%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &/XE
M_P"0OH__ %^G_P!!-;%8_B7_ )"^C_\ 7Z?_ $$UL4 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 5C^)?^0OH__7Z?_036Q6/XE_Y"^C_]
M?I_]!- &Q1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O"_P#@GO\
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MY"^C_P#7Z?\ T$T ;%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!\"_$C_@B7XS_ &A?B-XF^//QX_X*J_M1>%]:\2ZS
M<7[>&?A'\6/[%\/:':$XM[*V@DM9"1%"L:/,2GFNK2&-"Y49_P#P1BU)/V:_
M^";'C[]L#XP_M"_$[QUX,U7Q5XD\5>%=9^)?BJXUS5X_"-C));Z> 7PIDGAM
M&N@D2*':[4 =*]Q_X*Z_%/Q?\/OV&O$O@7X67WD>.?BK?6/PZ\!LI.]=4UN=
M;!9EQT,$,L]T3V6V8]J]T^#7PI\(? GX1>%O@E\/['[-H7@_P[9:+HUOQ^[M
M;6!((@<=]B+F@#\=_P!@2Y_8F_X+)?%!_B9??\%G/VGM!^,6MWSZ[XH^!?AC
MXK3^'-)TP>89#IFGVDEF&N+:WA"P.\$S.PC>5C&7X_:Q55%"*. ,"OSI_P"#
M@C]B;X?^,O@/HO[:WP4\+VFA_M$?#WX@>&9/AEXKT6W6#4=6OKC6+2TCTR9D
M :Z1_/+*C;BA3(PC2AOT7H ***R?'5GXQO\ PC?V?P_UBTT_6I("-.O;ZW,L
M,,F1AG0?>&,\4 :U>%_\$]_^2)ZM_P!CWK/_ *4FC_A ?^"@G_1?_ G_ (2D
MG_Q58G_!/&Q\>+\#=26?7;%I!XTU42L+4X:038<CG@%MQ [ B@#Z/HK'^Q>-
M_P#H-V7_ (#'_&C[%XW_ .@W9?\ @,?\: -BBL?[%XW_ .@W9?\ @,?\:/L7
MC?\ Z#=E_P" Q_QH V**Q_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&@#
M8HK'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\ @,?\: -BBL?[%XW_ .@W9?\
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MXT?8O&__ $&[+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^-
M&Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\ 0;LO_ 8_
MXT?8O&__ $&[+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^-
M&Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\ 0;LO_ 8_
MXT?8O&__ $&[+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^-
M&Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\ 0;LO_ 8_
MXT?8O&__ $&[+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^-
M&Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\ 0;LO_ 8_
MXT?8O&__ $&[+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^-
M&Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\ 0;LO_ 8_
MXT?8O&__ $&[+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^-
M&Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\ 0;LO_ 8_
MXT?8O&__ $&[+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^-
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M:,=N* +%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M% 'U-_P\M_ZHK_Y<?_W-1_P\M_ZHK_Y<?_W-7RS10!]3?\/+?^J*_P#EQ_\
MW-1_P\M_ZHK_ .7'_P#<U?+-% 'U-_P\M_ZHK_Y<?_W-1_P\M_ZHK_Y<?_W-
M7RS10!]3?\/+?^J*_P#EQ_\ W-1_P\M_ZHK_ .7'_P#<U?+-% 'U-_P\M_ZH
MK_Y<?_W-1_P\M_ZHK_Y<?_W-7RS10!]-:G_P47_M&[L[K_A3NS[),9-O_"0Y
MW\8Q_P >_%7/^'EO_5%?_+C_ /N:OEFB@#ZF_P"'EO\ U17_ ,N/_P"YJ/\
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5X7_P $]_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_(7T?_K]/_H)K8K'\2_\A?1_^OT_^@F@#8HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M)_US/\J_+:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5O\ L>]9_P#2DT >Z4444 %%%% !1110 RZ_X]I/^N9_E7Y;5^I-U_Q[2?\
M7,_RK\MJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@#U?]B7_DY;P]_USO/_ $DFK[UKX*_8E_Y.6\/?]<[S
M_P!))J^]: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ K'\2_P#(7T?_ *_3_P"@FMBL?Q+_ ,A?1_\ K]/_
M *": -BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KY<_X*3?MF?M
M"_LBZA\,8?V?O^"?.H_'O4O%_B&^L;6VTOQ5!I<VC7L5C)-&X::VE7][;+?@
MONCVK$RY;S,#ZCKRCXZ>,?VM/#_QO^%/A_X$?!+PYXE\#:OK-\GQ6\1:QKXM
M+KPY:) IMIK2$\W#R2-(K !B-J@@!S(@!\C_ /#U'_@L7_TKN>,/_#]:+_\
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MO_::_P"#6/XC2?M+_P"E?$/X=?$J+P5\2=5LU CU632/$MO:-=X4 ',@@WL
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M/"-_XCT3PK=ZY=VD!D@TFQ91-=-D?(A;C/U]*UJ* /"_^&L/C9_T8_X[_P#
MJV_^*K$_X)X^*=9E^!NI2OX+OD9_&FJNR%ERA:;<5/NI)4^ZFOH^O"_^">__
M "1/5O\ L>]9_P#2DT >N?\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM;%%
M&/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+6Q10!C_\ "2ZO_P!"A>_]]+1_
MPDNK_P#0H7O_ 'TM;%% &'<^)=7-M(/^$0O/N'^)?2OS/K]2;K_CVD_ZYG^5
M?EM0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 >H?L:W4UG^T7H-Q;V;W#JEWB*,C+?Z+*._YU]R?\)+J_\
MT*%[_P!]+7Q%^Q+_ ,G+>'O^N=Y_Z235]ZT 8_\ PDNK_P#0H7O_ 'TM'_"2
MZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\
MPDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DN
MK_\ 0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8_
M_"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2
MZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\
MPDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DN
MK_\ 0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8_
M_"2ZO_T*%[_WTM0ZAXTN=*L)]4U3PY/;6UM"TMQ<3S(B11J"6=F)PH !))X
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MGQQJNE:&3-+;>%] >[8Y9(E\V;Y8+92\L8W2R+G)VAMI ^3O"'P&\(_LV?\
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MZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\
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M<1?#O]E/49/"/[?'_!/W]H+X4:W;';/<IX4M]:T*Y;.,V>J6UP([I<_Q!%[
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MV)?^3EO#W_7.\_\ 22:OO6O@K]B7_DY;P]_USO/_ $DFK[UH **** "BBB@
MHHHH **** "BBB@ HHHH ***9.S) [J<$(2#^% #Z*^!O^&U?VF?^BE_^4:R
M_P#C-'_#:O[3/_12_P#RC67_ ,9H ^^:*^!O^&U?VF?^BE_^4:R_^,T?\-J_
MM,_]%+_\HUE_\9H ^^:*^!O^&U?VF?\ HI?_ )1K+_XS1_PVK^TS_P!%+_\
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MSO/_ $DFK[UKX*_8E_Y.6\/?]<[S_P!))J^]: "BBB@ HHHH **** "BBB@
MHHHH **** "F77_'M)_US/\ *GTRZ_X]I/\ KF?Y4 ?EM1110 4444 %%%%
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MP_\  7B:'Q!!\.-*\,I&=7U"""1;:2]OGF9Y$AN'%PD<<<:[HX]P<H''MU%
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M_P J?3+K_CVD_P"N9_E0!^6U%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !7J_[$O_ "<MX>_ZYWG_ *235Y17
MJ_[$O_)RWA[_ *YWG_I)-0!]ZT444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %>%_\ !/?_ )(GJW_8]ZS_ .E)KW2O"_\ @GO_ ,D3U;_L>]9_]*30
M![I1110 4444 %%%% #+K_CVD_ZYG^5?EM7ZDW7_ ![2?]<S_*ORVH ****
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M],NO^/:3_KF?Y4 ?EM1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5ZO\ L2_\G+>'O^N=Y_Z235Y17J_[$O\
MR<MX>_ZYWG_I)-0!]ZT444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "O"_\ @GO_ ,D3U;_L>]9_]*37NE>%_P#!/?\
MY(GJW_8]ZS_Z4F@#W2BBB@ HHHH **** &77_'M)_P!<S_*ORVK]2;K_ (]I
M/^N9_E7Y;4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% 'J_[$O\ R<MX>_ZYWG_I)-7WK7P5^Q+_ ,G+>'O^
MN=Y_Z235]ZT %%%% !1110 4444 %%%% !1110 4444 %,NO^/:3_KF?Y4^F
M77_'M)_US/\ *@#\MJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "O5_V)?^3EO#W_ %SO/_22:O**]7_8E_Y.
M6\/?]<[S_P!))J /O6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
MPO\ X)[_ /)$]6_['O6?_2DU[I7A?_!/?_DB>K?]CWK/_I2: /=**** "BBB
M@ HHHH 9=?\ 'M)_US/\J_+:OU)NO^/:3_KF?Y5^6U !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!ZO^Q+_R
M<MX>_P"N=Y_Z235]ZU\%?L2_\G+>'O\ KG>?^DDU?>M !1110 4444 %%%%
M!1110 4444 %%%% !3+K_CVD_P"N9_E3Z9=?\>TG_7,_RH _+:BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
MU?\ 8E_Y.6\/?]<[S_TDFKRBO5_V)?\ DY;P]_USO/\ TDFH ^]:*** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "O"_^">__)$]6_['O6?_ $I->Z5X
M7_P3W_Y(GJW_ &/>L_\ I2: /=**** "BBB@ HHHH 9=?\>TG_7,_P J_+:O
MU)NO^/:3_KF?Y5^6U !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!ZO\ L2_\G+>'O^N=Y_Z235]ZU\%?L2_\
MG+>'O^N=Y_Z235]ZT %%%% !1110 4444 %%%% !1110 4444 %,NO\ CVD_
MZYG^5/IEU_Q[2?\ 7,_RH _+:BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ KU?]B7_DY;P]_USO/_ $DFKRBO
M5_V)?^3EO#W_ %SO/_22:@#[UHHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH *\+_X)[_\ )$]6_P"Q[UG_ -*37NE>%_\ !/?_ )(GJW_8]ZS_ .E)
MH ]THHHH **** "BBB@!EU_Q[2?]<S_*ORVK]2;K_CVD_P"N9_E7Y;4 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% 'J_[$O_ "<MX>_ZYWG_ *235]ZU\%?L2_\ )RWA[_KG>?\ I)-7WK0
M4444 %%%% !1110 4444 %%%% !1110 4RZ_X]I/^N9_E3Z9=?\ 'M)_US/\
MJ /RVHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *]7_8E_P"3EO#W_7.\_P#22:O**]7_ &)?^3EO#W_7.\_]
M))J /O6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^,;_ ,(W]G\/]8M-/UJ2 C3KV^MS+##)D89T'WAC/% &M7A?_!/?_DB>K?\
M8]ZS_P"E)H_X0'_@H)_T7_P)_P"$I)_\57D]I^RK_P %0_AKYVA? 7]I_P"'
M&D:)<74MY+:WWAN25S=2N7E?+Q2$ DC W8'8"@#[,HKXY_X4O_P6M_Z/(^%G
M_A(__<U'_"E_^"UO_1Y'PL_\)'_[FH ^QJ*^.?\ A2__  6M_P"CR/A9_P"$
MC_\ <U'_  I?_@M;_P!'D?"S_P )'_[FH ^QJ*^.?^%+_P#!:W_H\CX6?^$C
M_P#<U'_"E_\ @M;_ -'D?"S_ ,)'_P"YJ /L.Z_X]I/^N9_E7Y;5]"O\%/\
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MO_Q% '&45V?_  ["_P""BG_1??A9_P""J]_^(H_X=A?\%%/^B^_"S_P57O\
M\10!QE%=G_P["_X**?\ 1??A9_X*KW_XBC_AV%_P44_Z+[\+/_!5>_\ Q% '
M&45V?_#L+_@HI_T7WX6?^"J]_P#B*/\ AV%_P44_Z+[\+/\ P57O_P 10!TG
M[$O_ "<MX>_ZYWG_ *235]ZU^?G@C_@GS_P4\^'/B6W\8>#?VD/A99ZC:AQ;
MW']B74FW>A1OE>)E.58CD=Z[W_A2_P#P6M_Z/(^%G_A(_P#W-0!]C45\<_\
M"E_^"UO_ $>1\+/_  D?_N:C_A2__!:W_H\CX6?^$C_]S4 ?8U%?'/\ PI?_
M (+6_P#1Y'PL_P#"1_\ N:C_ (4O_P %K?\ H\CX6?\ A(__ '-0!]C45\<_
M\*7_ ."UO_1Y'PL_\)'_ .YJ/^%+_P#!:W_H\CX6?^$C_P#<U 'V-17QS_PI
M?_@M;_T>1\+/_"1_^YJ/^%+_ /!:W_H\CX6?^$C_ /<U 'V-17QS_P *7_X+
M6_\ 1Y'PL_\ "1_^YJ/^%+_\%K?^CR/A9_X2/_W-0!]C45\<_P#"E_\ @M;_
M -'D?"S_ ,)'_P"YJ/\ A2__  6M_P"CR/A9_P"$C_\ <U 'V-3+K_CVD_ZY
MG^5?'G_"E_\ @M;_ -'D?"S_ ,)'_P"YJ1_@I_P6L=2C?MC_  L((P1_PB)_
M^1J /GJBNS_X=A?\%%/^B^_"S_P57O\ \11_P["_X**?]%]^%G_@JO?_ (B@
M#C**[/\ X=A?\%%/^B^_"S_P57O_ ,11_P .PO\ @HI_T7WX6?\ @JO?_B*
M.,HKL_\ AV%_P44_Z+[\+/\ P57O_P 11_P["_X**?\ 1??A9_X*KW_XB@#C
M**[/_AV%_P %%/\ HOOPL_\ !5>__$4?\.PO^"BG_1??A9_X*KW_ .(H XRB
MNS_X=A?\%%/^B^_"S_P57O\ \11_P["_X**?]%]^%G_@JO?_ (B@#C**[/\
MX=A?\%%/^B^_"S_P57O_ ,11_P .PO\ @HI_T7WX6?\ @JO?_B* .,HKL_\
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M3ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
(@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>ew-20240331_g5.jpg
<TEXT>
begin 644 ew-20240331_g5.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@#\Z/^#H75?&'PQ_X)3^+OC_\ "CXF^,/!_C#PSK.BII.N>$/&
M%_I4J1SZE#!*CBUFC656CF<8<-@X(P0*]6\7?\$_?V;O&W[.NB:+J_QP^,7@
M_7_&&C6MAHGB?2?CYXL6[AU6XM=T<D2-J31R.&#/LD1D(0Y&*\E_X.N?^4(W
MQ-_[#GAS_P!/-I7L7PW_ ."67[-#W'P7^/WA%O%EEXD\ WEEKFGS:I\0];U2
MUEWZ?+;S1&UO;R6!=R7#$.J!E*@ A2RD ]LU+XO^ _V5?@WX.T_]H_XIVD6K
M/866CQR@S75WKVJ);CS$M+=%:YO)7*22;(T>0J&8C@D'P2_;)_9B_:(L/$E[
M\)?C#IE_)X-F,7C'3KU9;"^T!PI?%]:7:13V@*JS RH@(5B"0#CXL\1?$O5K
MK_@Z:\-?#3XMN4T:P_90OY?A/;7/^J;5+C5(WOKB 'CSVM;:XB<CGRX #Q5;
M]HKPAKO@;_@YV_9Z\:_!Z!K9O'OP0\26GQ=BLAM6\TJRCF:RGN5'#$7CVD:N
MV3^ZC7.%& #Z-\2?\%G/^"5_A/PY/XPUG]NGX?C28/%?_"-'4[75_M%O)J?E
MQRM#')$K+*J)+&SRH6BC#KO=<U]&>*O%/A_P1X9U#QEXJU2.RTS2[.2[O[N0
M$K##&I9V( ). #P 2>P-?FE_P13^!'P5\?\ [0'[>K>/?A/X=UU;K]KG6[>X
MAUK1X;N)XH95N(E\N564!9G:08'WL'JJX_3V@#XD_8)_X*B?L[_\%8-/^*/P
MS@U36=*M!\0M3T#PII=K_:FCZG=:-9V=D7NWN;<QR6TDEP;IPGF1R+&4C9<A
ML_,7_!!?_@H[^QQ^Q9_P1[^&Q_;'_:BT?PSJ?B#Q?XF>V;7KN6XO+L'6[E#<
MRK&KR+&9#M,\@";C@MFO9_\ @V__ .2 _M$#T_;"\=9_[[LZ^=_^"27PX\ W
M/_!JY\7KZ;P=IK7&O>!?B5)K-P;)/,O'@&I+ TC8RQC"+L)^X5!&#0!^NGBG
MXR?"?P3\,6^-/BSXCZ+8>$EL8;P>([C48Q9R02[?)=)<[7$A= FTDN74+DL
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MC#P=X*U'5M+TS6O%=[%<WGF1ZE<BYMS+#!!&Z0W/G0KM3 $84$[<T ;OC_\
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M>&+2\FM+_5;"5D%G/$H:2*=)51X&",KXD53M96Z$$XGA3_@H;^Q_XU\8^&?
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MWAG3?%6E76D#PE81Z)#8VQ9&2:WT)9+=K=!)$R@ADV.C#((K%_93^*,OC?\
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M^"?/_99-<_\ 3=#0!^B5%([I&I>1PJCJ6.!2T ?+O[7O_!/?7_V^/B1<:?\
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M_:!F^-?@H^,M.^'6H6(2_GM)K66[BE:.2)MK LA(SGMVH ]'HK'_ .$EU?\
MZ%"]_P"^EH_X275_^A0O?^^EH V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^
M^EH V**Q_P#A)=7_ .A0O?\ OI:/^$EU?_H4+W_OI: -BBL?_A)=7_Z%"]_[
MZ6C_ (275_\ H4+W_OI: -BBL?\ X275_P#H4+W_ +Z6C_A)=7_Z%"]_[Z6@
M#8HK'_X275_^A0O?^^EH_P"$EU?_ *%"]_[Z6@#8HK'_ .$EU?\ Z%"]_P"^
MEH_X275_^A0O?^^EH V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EH V**Q
M_P#A)=7_ .A0O?\ OI:/^$EU?_H4+W_OI: -BBL?_A)=7_Z%"]_[Z6C_ (27
M5_\ H4+W_OI: -BBL.;Q??6\D<4_A:Z1I6VQJTB@L?0<U)_PDNK_ /0H7O\
MWTM &Q16/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[
M_P!]+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]"A>_]]+1_P )+J__ $*%[_WT
MM &Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]"A>_
M]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\
MWTM &Q16/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[
M_P!]+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]"A>_]]+1_P )+J__ $*%[_WT
MM &Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]"A>_
M]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\
MWTM &Q16/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[
M_P!]+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]"A>_]]+1_P )+J__ $*%[_WT
MM &Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]"A>_
M]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\
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M;T:UTK2+;=GR;6WB6&),]\(BC\*V:* "BBB@ KPO_@GO_P D3U;_ +'O6?\
MTI->Z5X7_P $]_\ DB>K?]CWK/\ Z4F@#W2BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@#'\2_\A?1_P#K]/\ Z":V*Q_$O_(7T?\
MZ_3_ .@FMB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L
M?Q+_ ,A?1_\ K]/_ *":V*Q_$O\ R%]'_P"OT_\ H)H V**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "L?Q+_R%]'_ .OT_P#H)K8K'\2_\A?1_P#K]/\ Z":
M-BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *\+_ .">_P#R1/5O^Q[UG_TI->Z5X7_P3W_Y(GJW
M_8]ZS_Z4F@#W2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#'\2_\ (7T?_K]/_H)K8K'\2_\ (7T?_K]/_H)K8H **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ K'\2_\A?1_^OT_^@FMBL?Q+_R%
M]'_Z_3_Z": -BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "1/5O\ L>]9_P#2DU[I7A?_  3W_P"2)ZM_V/>L_P#I2: /=**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,?Q+_R%]'_ .OT_P#H
M)K8K'\2_\A?1_P#K]/\ Z":V* "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *Q_$O\ R%]'_P"OT_\ H)K8K'\2_P#(7T?_ *_3_P"@F@#8
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "O"_\ @GO_ ,D3U;_L>]9_]*37NE>%_P#!/?\ Y(GJ
MW_8]ZS_Z4F@#W2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@#'\2_\A?1_^OT_^@FMBL?Q+_R%]'_Z_3_Z":V* "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;LO_  &/^-'V+QO_ -!NR_\  8_XT ;%%8_V+QO_ -!NR_\  8_XT?8O&_\
MT&[+_P !C_C0!L45C_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_  &/^- &Q16/
M]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\  8_XT ;%%8_V+QO_ -!NR_\  8_X
MT?8O&_\ T&[+_P !C_C0!L45^;?Q?_;P_:K_ &D?C=\7?@K^SG\:=!^'VD_
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M^ Q_QH^Q>-_^@W9?^ Q_QH V**Q_L7C?_H-V7_@,?\:/L7C?_H-V7_@,?\:
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MC_C1]B\;_P#0;LO_  &/^- &Q16/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\
M 8_XT ;%%8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !C_C0!L45C_8O&_\
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MOCWQI\//%?BW1;?2/&^K?#W6X[%_$=E &%NET)(I0)8E=TCNH1%<QHY59@H
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MOH__ %^G_P!!-:T$\%U ES;3))'(@:.1&!5E(R"".H(KY8^'G_!3CX%_'_\
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M% !1110 4444 %%%% !1110 4444 8_B7_D+Z/\ ]?I_]!-;%8_B7_D+Z/\
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M^"9GCY/C%XJ2>WLO@U(Z7<V@SB>:-+J_E86Y^SB.-)PFV.5_-2/$>6D3P?\
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M\2_\A?1_^OT_^@F@#8HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_:9_Z*7_ .4:R_\ C->644 >I_\ #:O[3/\ T4O_ ,HUE_\ &:/^&U?VF?\
MHI?_ )1K+_XS7EE% 'J?_#:O[3/_ $4O_P HUE_\9H_X;5_:9_Z*7_Y1K+_X
MS7EE% 'J?_#:O[3/_12__*-9?_&:/^&U?VF?^BE_^4:R_P#C->644 >I_P##
M:O[3/_12_P#RC67_ ,9H_P"&U?VF?^BE_P#E&LO_ (S7EE% 'J?_  VK^TS_
M -%+_P#*-9?_ !FC_AM7]IG_ **7_P"4:R_^,UY910!ZG_PVK^TS_P!%+_\
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M-HW@3QKIVJ^(O NO^.8+^QN(4DQBY@A820R("9H_-0AGA7 '#KZ;\9?V<O\
M@GK\>_\ @I]XRUC_ (*57?A/7_$6@>'](B^"W@;XEZG$ND+H$EN&N[ZUL[AE
M@O+B34A=Q3%ED:-+:V!"AT+<W\4=1_X)*?!W]LGX)^"/^">/A/X5:=\?-5^(
M5A9C3O@?86,#KX:)SK1U=-, B-JNGK,Z+<?,)DMWC'[LLH!^DM%%% !1110
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MYWG_ *234 ?>M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %>5?'+]KWX=_ 'XV_"OX#>+?"/BZ_P!6^+NKWVG>'K[0
M/#LEW8V,MK LTC7TRG%LA5P%)#9PYP%1V7U6OFK_ (*(_P#!1>[_ & 7\!V]
ME^Q[\5OB[<^/]4O-.TZP^%6AQZA<V]S;P"X\N2$R*YWPK/("H8!;64L5 &0#
MYU_X*Z_MO?\ !)G4OBK/^PQ_P4)_8R\>_$_5-%TJVUJR71/AM-J0MK:[!"W%
MI=VTJ3P!FC>)FC*9:%E).VO)O^"<_P"V5_P1E_9D^-GA3X&?\$[O^"<_Q(\
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M* &77_'M)_US/\J_+:OU)NO^/:3_ *YG^5?EM0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >K_L2_\ )RWA
M[_KG>?\ I)-7WK7P5^Q+_P G+>'O^N=Y_P"DDU?>M !1110 4444 %%%% !1
M110 4444 %%%% !3+K_CVD_ZYG^5/IEU_P >TG_7,_RH _+:BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KU?
M]B7_ ).6\/?]<[S_ -))J\HKU?\ 8E_Y.6\/?]<[S_TDFH ^]:*** "BBB@
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M1_PDNK_]"A>_]]+6Q10!C_\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM;%%
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MM?@O\07M#_97COP!KCZ9XNOT7@(L-HK2:K$",>3<PW%N,_,@ZUY-_P $B_\
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MO/\ TDFK[UKX*_8E_P"3EO#W_7.\_P#22:OO6@ HHHH **** "BBB@ HHHH
M**** "BBB@ IEU_Q[2?]<S_*GTRZ_P"/:3_KF?Y4 ?EM1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5ZO^Q+_
M ,G+>'O^N=Y_Z235Y17J_P"Q+_R<MX>_ZYWG_I)-0!]ZT444 %%%% !1110
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MUXBTV;QGXC,3W>@^&[B5]'\/6T>[R;"T:0*UPR[W:6[=5>>1B=L<20PQ>E4
M%%%% !1110 4444 %%%% !7A?_!/?_DB>K?]CWK/_I2:]TKPO_@GO_R1/5O^
MQ[UG_P!*30![I1110 4444 %%%% #+K_ (]I/^N9_E7Y;5^I-U_Q[2?]<S_*
MORVH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** /5_P!B7_DY;P]_USO/_22:OO6O@K]B7_DY;P]_USO/_22:
MOO6@ HHHH **** "BBB@ HHHH **** "BBB@ IEU_P >TG_7,_RI],NO^/:3
M_KF?Y4 ?EM1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 5ZO\ L2_\G+>'O^N=Y_Z235Y17J_[$O\ R<MX>_ZY
MWG_I)-0!]ZT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 445\I_\%(/C_X[\(>./A-^SS\-OBCX^\"7'C/Q3->>)_%W
M@/X87?B*]BT6SLKF:6TM%33KR 7,TXMT):-VBA\R0IC:2 ?5E%?F/_P5$_X+
M)^(_@!\,/#/[%G[!MM\0_%G[1_Q(*V'AAO%WPIUBUO\ 2K [_/UV6SETV%KK
MRUCEVB&W= 8I'9&6%HWY[X!ZA\<?^"=?B'P/\5/%O_!0']I_XUZ?K_B33="^
M*WA?XK?!#Q4UB[ZC.EI%>Z+)/I@DL9(;N:#%KOD^T1LZ*OF>6* /U9HJ'3KZ
M#5-/@U.V298[F%98UN;9X9 K $!HY '1L'E6 8'@@$8J:@ HHHH **** "BB
MB@ HHHH *\+_ .">_P#R1/5O^Q[UG_TI->Z5X7_P3W_Y(GJW_8]ZS_Z4F@#W
M2BBB@ HHHH **** &77_ ![2?]<S_*ORVK]2;K_CVD_ZYG^5?EM0 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 >K_L2_\G+>'O\ KG>?^DDU?>M?!7[$O_)RWA[_ *YWG_I)-7WK0 4444 %
M%%% !1110 4444 %%%% !1110 4RZ_X]I/\ KF?Y4^F77_'M)_US/\J /RVH
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *]7_ &)?^3EO#W_7.\_]))J\HKU?]B7_ ).6\/?]<[S_ -))J /O
M6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "O*?VOOV4="_:W^&UIX1F^)'BCP1X@T+5DU?P=X[\%:@+;5- U%8I8?/
MA9E9'5X9YX9(G5DDBF=2!D,/5J* /CS_ ()^?\$=?AE^Q5\;/%/[6OQ,^.GC
M'XU?&?Q=;"RO_B5\0ID>YL[$;?\ 1;2)<B!"%0-R3M1578F5/JOQP_94^)'Q
M[^/W@/Q[XL_:#>S^'_@+Q-#X@@^'&E>&4C.KZA!!(MM)>WSS,\B0W#BX2...
M-=T<>X.4#CVZB@ HHHH **** "BBB@ HHHH **** "O"_P#@GO\ \D3U;_L>
M]9_]*37NE>%_\$]_^2)ZM_V/>L_^E)H ]THHHH **** "BBB@!EU_P >TG_7
M,_RK\MJ_4FZ_X]I/^N9_E7Y;4 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% 'J_[$O_)RWA[_ *YWG_I)-7WK
M7P5^Q+_R<MX>_P"N=Y_Z235]ZT %%%% !1110 4444 %%%% !1110 4444 %
M,NO^/:3_ *YG^5/IEU_Q[2?]<S_*@#\MJ*** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O5_P!B7_DY;P]_USO/
M_22:O**]7_8E_P"3EO#W_7.\_P#22:@#[UHHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *\+_X)[_\D3U;_L>]9_\ 2DU[I7A?_!/?_DB>K?\ 8]ZS
M_P"E)H ]THHHH **** "BBB@!EU_Q[2?]<S_ "K\MJ_4FZ_X]I/^N9_E7Y;4
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% 'J_P"Q+_R<MX>_ZYWG_I)-7WK7P5^Q+_R<MX>_ZYWG_I)-7WK0
M 4444 %%%% !1110 4444 %%%% !1110 4RZ_P"/:3_KF?Y4^F77_'M)_P!<
MS_*@#\MJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M &/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U;%% &/_P@^D?\_-[_ .!;4?\
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M@#'_ .$'TC_GYO?_  +:C_A!](_Y^;W_ ,"VK8HH Q_^$'TC_GYO?_ MJ/\
MA!](_P"?F]_\"VK8HH Q_P#A!](_Y^;W_P "VK0TW3H-*M1:6[R,H8G,KECS
M[FK%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2_\ )RWA[_KG>?\ I)-0!]ZT444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %>%_\$]_^2)ZM_V/>L_^E)KW2O"_^">__)$]6_['O6?_ $I- 'NE%%%
M!1110 4444 ,NO\ CVD_ZYG^5?EM7ZDW7_'M)_US/\J_+:@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ]7_
M &)?^3EO#W_7.\_]))J^]:^"OV)?^3EO#W_7.\_]))J^]: "BBB@ HHHH **
M** "BBB@ HHHH **** "F77_ ![2?]<S_*GTRZ_X]I/^N9_E0!^6U%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !7J_P"Q+_R<MX>_ZYWG_I)-7E%>K_L2_P#)RWA[_KG>?^DDU 'WK1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 5X7_P3W_Y(GJW_ &/>L_\ I2:]
MTKPO_@GO_P D3U;_ +'O6?\ TI- 'NE%%% !1110 4444 ,NO^/:3_KF?Y5^
M6U?J3=?\>TG_ %S/\J_+:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ]7_8E_Y.6\/?]<[S_P!))J^]:^"O
MV)?^3EO#W_7.\_\ 22:OO6@ HHHH **** "BBB@ HHHH **** "BBB@ IEU_
MQ[2?]<S_ "I],NO^/:3_ *YG^5 'Y;4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %>K_L2_\ )RWA[_KG>?\
MI)-7E%>K_L2_\G+>'O\ KG>?^DDU 'WK1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 5X7_P $]_\ DB>K?]CWK/\ Z4FO=*\+_P"">_\ R1/5O^Q[
MUG_TI- 'NE%%% !1110 4444 ,NO^/:3_KF?Y5^6U?J3=?\ 'M)_US/\J_+:
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MGAX:9X@GM85)9[2SOX);I^.T=N)93[1&@#SK]JKX;_&#]A+_ ()-:)_P4@\
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M ,10!QE%=G_P["_X**?]%]^%G_@JO?\ XBC_ (=A?\%%/^B^_"S_ ,%5[_\
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MT7WX6?\ @JO?_B* .,HKL_\ AV%_P44_Z+[\+/\ P57O_P 11_P["_X**?\
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MJ /L:BOCG_A2_P#P6M_Z/(^%G_A(_P#W-1_PI?\ X+6_]'D?"S_PD?\ [FH
M^QJ*^.?^%+_\%K?^CR/A9_X2/_W-1_PI?_@M;_T>1\+/_"1_^YJ /L:BOCG_
M (4O_P %K?\ H\CX6?\ A(__ '-1_P *7_X+6_\ 1Y'PL_\ "1_^YJ /L:BO
MCG_A2_\ P6M_Z/(^%G_A(_\ W-1_PI?_ (+6_P#1Y'PL_P#"1_\ N:@#[&IE
MU_Q[2?\ 7,_RKX\_X4O_ ,%K?^CR/A9_X2/_ -S4C_!3_@M8ZE&_;'^%A!&"
M/^$1/_R-0!\]45V?_#L+_@HI_P!%]^%G_@JO?_B*/^'87_!13_HOOPL_\%5[
M_P#$4 <9179_\.PO^"BG_1??A9_X*KW_ .(H_P"'87_!13_HOOPL_P#!5>__
M !% '&45V?\ P["_X**?]%]^%G_@JO?_ (BC_AV%_P %%/\ HOOPL_\ !5>_
M_$4 <9179_\ #L+_ (**?]%]^%G_ (*KW_XBC_AV%_P44_Z+[\+/_!5>_P#Q
M% '&45V?_#L+_@HI_P!%]^%G_@JO?_B*/^'87_!13_HOOPL_\%5[_P#$4 <9
M179_\.PO^"BG_1??A9_X*KW_ .(H_P"'87_!13_HOOPL_P#!5>__ !% '&45
MV?\ P["_X**?]%]^%G_@JO?_ (BN.^)7[$7[?/PV\6^$/"6J_&[X<S3>+M9;
M3[)[72;HI$XC+YDW*#MP/X<G- #:*[/_ (=A?\%%/^B^_"S_ ,%5[_\ $4?\
M.PO^"BG_ $7WX6?^"J]_^(H XRBNS_X=A?\ !13_ *+[\+/_  57O_Q%'_#L
M+_@HI_T7WX6?^"J]_P#B* .,HKL_^'87_!13_HOOPL_\%5[_ /$4?\.PO^"B
MG_1??A9_X*KW_P"(H XRBNS_ .'87_!13_HOOPL_\%5[_P#$4?\ #L+_ (**
M?]%]^%G_ (*KW_XB@#C**[/_ (=A?\%%/^B^_"S_ ,%5[_\ $4?\.PO^"BG_
M $7WX6?^"J]_^(H XRBNS_X=A?\ !13_ *+[\+/_  57O_Q%'_#L+_@HI_T7
MWX6?^"J]_P#B* .,KU?]B7_DY;P]_P!<[S_TDFKF_P#AV%_P44_Z+[\+/_!5
M>_\ Q%:W@C_@GS_P4\^'/B6W\8>#?VD/A99ZC:AQ;W']B74FW>A1OE>)E.58
MCD=Z /T#HKXY_P"%+_\ !:W_ */(^%G_ (2/_P!S4?\ "E_^"UO_ $>1\+/_
M  D?_N:@#[&HKXY_X4O_ ,%K?^CR/A9_X2/_ -S4?\*7_P""UO\ T>1\+/\
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M!1_%JV7XPZ?=?\*\AAT2=;.562 #6/M*?/M@\LP_=;)YK]DJ "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 >6_M2?L:_L__ +8>@Z1IGQJ\(S2ZCX9U(:EX/\4Z-J$MAK'AV_&-MU8W
ML#+-;R9520K;'V@.KJ,5^='Q,_93_P""BGPR_;%TS1/^"F'BCQC^UI^R0TPD
MTA-!T:%;OP[>QRI):7&O:+I,$4FN0Q%2'.RYC)VSF-"OE5^M-% &!X/\8>"/
MB;X,_M3X7>,[.ZT^2)K>WO\ 198I/LCA0-H4JRI(F1^[=?E( 9>U>-_LS?\
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M_P $X/A#^RC\>?'?[1GPT^)?CVY\0_$_4H[_ .(*ZYK<%U;:W<QI*L4CQ&W
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M!(/?44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
..%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>ew-20240331_g6.jpg
<TEXT>
begin 644 ew-20240331_g6.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[@ .061O8F4 90     !_]L 0P " 0$!
M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D*
M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\  $0@"
MF@.J P$B  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*
M"__$ +40  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A
M""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U15
M5E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H
MJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V
M]_CY^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (!
M @0$ P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P
M%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E
M9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V
MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#
M 0 "$0,1 #\ _?RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@#\Z/^#H75?&'PQ_X)3^+OC_\ "CXF^,/!_C#PSK.BII.N>$/&
M%_I4J1SZE#!*CBUFC656CF<8<-@X(P0*]6\7?\$_?V;O&W[.NB:+J_QP^,7@
M_7_&&C6MAHGB?2?CYXL6[AU6XM=T<D2-J31R.&#/LD1D(0Y&*\E_X.N?^4(W
MQ-_[#GAS_P!/-I7L7PW_ ."67[-#W'P7^/WA%O%EEXD\ WEEKFGS:I\0];U2
MUEWZ?+;S1&UO;R6!=R7#$.J!E*@ A2RD ]LU+XO^ _V5?@WX.T_]H_XIVD6K
M/866CQR@S75WKVJ);CS$M+=%:YO)7*22;(T>0J&8C@D'P2_;)_9B_:(L/$E[
M\)?C#IE_)X-F,7C'3KU9;"^T!PI?%]:7:13V@*JS RH@(5B"0#CXL\1?$O5K
MK_@Z:\-?#3XMN4T:P_90OY?A/;7/^J;5+C5(WOKB 'CSVM;:XB<CGRX #Q5;
M]HKPAKO@;_@YV_9Z\:_!Z!K9O'OP0\26GQ=BLAM6\TJRCF:RGN5'#$7CVD:N
MV3^ZC7.%& #Z-\2?\%G/^"5_A/PY/XPUG]NGX?C28/%?_"-'4[75_M%O)J?E
MQRM#')$K+*J)+&SRH6BC#KO=<U]&>*O%/A_P1X9U#QEXJU2.RTS2[.2[O[N0
M$K##&I9V( ). #P 2>P-?FE_P13^!'P5\?\ [0'[>K>/?A/X=UU;K]KG6[>X
MAUK1X;N)XH95N(E\N564!9G:08'WL'JJX_3V@#XD_8)_X*B?L[_\%8-/^*/P
MS@U36=*M!\0M3T#PII=K_:FCZG=:-9V=D7NWN;<QR6TDEP;IPGF1R+&4C9<A
ML_,7_!!?_@H[^QQ^Q9_P1[^&Q_;'_:BT?PSJ?B#Q?XF>V;7KN6XO+L'6[E#<
MRK&KR+&9#M,\@";C@MFO9_\ @V__ .2 _M$#T_;"\=9_[[LZ^=_^"27PX\ W
M/_!JY\7KZ;P=IK7&O>!?B5)K-P;)/,O'@&I+ TC8RQC"+L)^X5!&#0!^NGBG
MXR?"?P3\,6^-/BSXCZ+8>$EL8;P>([C48Q9R02[?)=)<[7$A= FTDN74+DL
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MC#P=X*U'5M+TS6O%=[%<WGF1ZE<BYMS+#!!&Z0W/G0KM3 $84$[<T ;OC_\
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M>&+2\FM+_5;"5D%G/$H:2*=)51X&",KXD53M96Z$$XGA3_@H;^Q_XU\8^&?
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MWAG3?%6E76D#PE81Z)#8VQ9&2:WT)9+=K=!)$R@ADV.C#((K%_93^*,OC?\
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M^"?/_99-<_\ 3=#0!^B5%([I&I>1PJCJ6.!2T ?+O[7O_!/?7_V^/B1<:?\
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M_:!F^-?@H^,M.^'6H6(2_GM)K66[BE:.2)MK LA(SGMVH ]'HK'_ .$EU?\
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M5_\ H4+W_OI: -BBL.;Q??6\D<4_A:Z1I6VQJTB@L?0<U)_PDNK_ /0H7O\
MWTM &Q16/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[
M_P!]+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]"A>_]]+1_P )+J__ $*%[_WT
MM &Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]"A>_
M]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\
MWTM &Q16/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[
M_P!]+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]"A>_]]+1_P )+J__ $*%[_WT
MM &Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]"A>_
M]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\
MWTM &Q16/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[
M_P!]+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]"A>_]]+1_P )+J__ $*%[_WT
MM &Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]"A>_
M]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\
MWTM &Q16/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[
M_P!]+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]"A>_]]+4<WB^^MY(XI_"UTC2
MMMC5I%!8^@YH W**Q_\ A)=7_P"A0O?^^EH_X275_P#H4+W_ +Z6@#8HK'_X
M275_^A0O?^^EH_X275_^A0O?^^EH V**Q_\ A)=7_P"A0O?^^EH_X275_P#H
M4+W_ +Z6@#8HK'_X275_^A0O?^^EH_X275_^A0O?^^EH V**Q_\ A)=7_P"A
M0O?^^EH_X275_P#H4+W_ +Z6@#8HK'_X275_^A0O?^^EH_X275_^A0O?^^EH
M V**Q_\ A)=7_P"A0O?^^EH_X275_P#H4+W_ +Z6@#8HK'_X275_^A0O?^^E
MH_X275_^A0O?^^EH V**Q_\ A)=7_P"A0O?^^EH_X275_P#H4+W_ +Z6@#8H
MK'_X275_^A0O?^^EH_X275_^A0O?^^EH V**Q_\ A)=7_P"A0O?^^EK0TV\G
MOK43W%A);,6(\J4C/UXH L4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% 'RQ^U;_P12_X)A_MO_&&Y^/O[4G[+-IXK\77EE!:
M7.L3>)M5M6>&%-D2>7;74<8VKQD+D]\U\D?\$U?^"%_[/7[.'_!7']H+XQW'
M['-SX>\%>"=1\(W7[-VMW&M7[6]O(^EW"ZN]N6N6-Q^_90PN-X4D!<"OU>HH
M ^ _V2OA'X^_X)+_ !W_ &@O B?!#QKXP^%OQ4^($_Q&^&=YX \//JDEOJE[
M$D>H:)<Q1'-F5DA@,$\VVV:(_/,C(PKD?@]_P1,\2_$3_@EA\??V>/VEKJPT
MCXI?M/>,M8\>^+9;><74'A[6KF[2\T^U\U.)X[:6&$R%.&9YPC,I5C^E5% '
MYJ?M(>#?VP_V]?\ @F5X<_X)?:I^S_XN\'_$GQ%9:#X<^+_B[6-**:%H%A87
M%L]_J=M?$^1J0N5M2+>"W:23_21YPAV.1^B7PY\ ^&?A5\/=!^%_@JQ^RZ-X
M;T:UTK2+;=GR;6WB6&),]\(BC\*V:* "BBB@ KPO_@GO_P D3U;_ +'O6?\
MTI->Z5X7_P $]_\ DB>K?]CWK/\ Z4F@#W2BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@#'\2_\A?1_P#K]/\ Z":V*Q_$O_(7T?\
MZ_3_ .@FMB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L
M?Q+_ ,A?1_\ K]/_ *":V*Q_$O\ R%]'_P"OT_\ H)H V**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "L?Q+_R%]'_ .OT_P#H)K8K'\2_\A?1_P#K]/\ Z":
M-BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *\+_ .">_P#R1/5O^Q[UG_TI->Z5X7_P3W_Y(GJW
M_8]ZS_Z4F@#W2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#'\2_\ (7T?_K]/_H)K8K'\2_\ (7T?_K]/_H)K8H **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ K'\2_\A?1_^OT_^@FMBL?Q+_R%
M]'_Z_3_Z": -BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "1/5O\ L>]9_P#2DU[I7A?_  3W_P"2)ZM_V/>L_P#I2: /=**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,?Q+_R%]'_ .OT_P#H
M)K8K'\2_\A?1_P#K]/\ Z":V* "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *Q_$O\ R%]'_P"OT_\ H)K8K'\2_P#(7T?_ *_3_P"@F@#8
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "O"_\ @GO_ ,D3U;_L>]9_]*37NE>%_P#!/?\ Y(GJ
MW_8]ZS_Z4F@#W2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@#'\2_\A?1_^OT_^@FMBL?Q+_R%]'_Z_3_Z":V* "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;LO_  &/^-'V+QO_ -!NR_\  8_XT ;%%8_V+QO_ -!NR_\  8_XT?8O&_\
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M+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\
M0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[
M+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\
M0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[
M+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !6/XE_Y"^C_P#7Z?\ T$UL5C^)?^0OH_\
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M^G_T$UL5C^)?^0OH_P#U^G_T$T ;%%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@#'\2_\ (7T?_K]/_H)K8K'\2_\
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M4 ?IA14=I=V]_:17UG*)(9HUDBD7HRD9!_*I* "BBB@ HHHH **** "BBB@
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M(8MR^8(RHW$A& /T3HHHH **** "BBB@ HHHH **** "O"_^">__ "1/5O\
ML>]9_P#2DU[I7A?_  3W_P"2)ZM_V/>L_P#I2: /=**** "BBB@ HHHH 9=?
M\>TG_7,_RK\MJ_4FZ_X]I/\ KF?Y5^6U !1110 4444 %%%% !1110 4444
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M9ZGHUSI=_J]_>I%J$T$Z/&Q\ZVCBVR!'VK(JA_E#$ELL0#SG_@HG^P/\'/\
M@I3^ROKG[+'QJN;^RL=2FAO-*US275;O2-0@;=!=P[@064EE*GAD=UR-V1^:
MO_!4_P#9P_;0_:3O/@7_ ,$6O'W[;D?Q=\0^+O$MEKGC^ZT/X<0:*VE^#=.)
M$VK:NYNKIFN'E*+ T;6T<LL3J49F0C],/V;_ -ASP+^R)^R'X:_8T_9S^*?C
M7PYH'A2*:/2M=:]L[_5 DMQ+<2*TE[:S0D%YGP!$ JA57:!71? #]D[X*_LV
M7.O:_P##W0;JX\1^++M+KQ?XRU_4)+_6-=F1=J-<W<Q+LB+\L<*E885.V*-%
MXH ]&M[>"TMTM;:)4CB0)&BC 50, #\*?110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% 'YK_\%2OV.;>W_:JO?VV_C;_P6;\:_LV^ 5\(66CZ!:Z-XOBL"VHM
M)+]NA@\YO]7)';Z=+Y$2N7E25R!M4US/[%_['6A_'WXC>#/CW^S9_P %^OB/
M^T-HW@3QKIVJ^(O NO\ CF"_L;B%),8N8(6$D,B F:/S4(9X5P!PZ^F_&7]G
M+_@GK\>_^"GWC+6/^"E5WX3U_P 1:!X?TB+X+>!OB7J<2Z0N@26X:[OK6SN&
M6"\N)-2%W%,661HTMK8$*'0MS?Q1U'_@DI\'?VR?@GX(_P"">/A/X5:=\?-5
M^(5A9C3O@?86,#KX:)SK1U=-, B-JNGK,Z+<?,)DMWC'[LLH!^DM%%% !111
M0 4444 %%%% !1110 5X7_P3W_Y(GJW_ &/>L_\ I2:]TKPO_@GO_P D3U;_
M +'O6?\ TI- 'NE%%% !1110 4444 ,NO^/:3_KF?Y5^6U?J3=?\>TG_ %S/
M\J_+:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH ]7_8E_Y.6\/?]<[S_P!))J^]:^"OV)?^3EO#W_7.\_\
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M@=\1O$MOX/\ !OC?[9J-T'-O;_V;<Q[MB%V^9XU4852>3VH [VBBB@ HHHH
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M]<[S_P!))J^]: "BBB@ HHHH **** "BBB@ HHHH **** "F77_'M)_US/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M]0_8UNIK/]HO0;BWLWN'5+O$49&6_P!%E'?\Z^Y/^$EU?_H4+W_OI:^(OV)?
M^3EO#W_7.\_]))J^]: ,?_A)=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6MBB@#'_P"$
MEU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI:V** ,?_A)=7_Z%"]_[Z6C_A)=7_Z%
M"]_[Z6MBB@#'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI:V** ,?_A)=7_Z
M%"]_[Z6C_A)=7_Z%"]_[Z6MBB@#'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\
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M#W2BBB@ HHHH **** &77_'M)_US/\J_+:OU)NO^/:3_ *YG^5?EM0 4444
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M^DDU>45ZO^Q+_P G+>'O^N=Y_P"DDU 'WK1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !7E/[7W[*.A?M;_  VM/",W
MQ(\4>"/$&A:LFK^#O'?@K4!;:IH&HK%+#Y\+,K(ZO#//#)$ZLDD4SJ0,AAZM
M10!\>?\ !/S_ ((Z_#+]BKXV>*?VM?B9\=/&/QJ^,_BZV%E?_$KXA3(]S9V(
MV_Z+:1+D0(0J!N2=J*J[$RI]5^.'[*GQ(^/?Q^\!^/?%G[0;V?P_\!>)H?$$
M'PXTKPRD9U?4(()%MI+V^>9GD2&X<7"1QQQKNCCW!R@<>W44 %%%% !1110
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MYWG_ *234 ?>M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7A?_!/
M?_DB>K?]CWK/_I2:]TKPO_@GO_R1/5O^Q[UG_P!*30![I1110 4444 %%%%
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M_P G+>'O^N=Y_P"DDU?>M?!7[$O_ "<MX>_ZYWG_ *235]ZT %%%% !1110
M4444 %%%% !1110 4444 %,NO^/:3_KF?Y4^F77_ ![2?]<S_*@#\MJ*** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "O5_V)?\ DY;P]_USO/\ TDFKRBO5_P!B7_DY;P]_USO/_22:@#[UHHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH 9=?\>TG_ %S/\J_+:OU)NO\ CVD_ZYG^5?EM0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >
MK_L2_P#)RWA[_KG>?^DDU?>M?!7[$O\ R<MX>_ZYWG_I)-7WK0 4444 %%%%
M !1110 4444 %%%% !1110 4RZ_X]I/^N9_E3Z9=?\>TG_7,_P J /RVHHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *]7_8E_Y.6\/?\ 7.\_]))J\HKU?]B7_DY;P]_USO/_ $DFH ^]:***
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/:3_ *YG^5/IEU_Q[2?]<S_*@#\MJ*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "O5_P!B7_DY;P]_USO/_22:
MO**]7_8E_P"3EO#W_7.\_P#22:@#[UHHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>?\ I)-7WK7P5^Q+_P G+>'O^N=Y_P"DDU?>M !1110 4444 %%%% !1110
M4444 %%%% !3+K_CVD_ZYG^5/IEU_P >TG_7,_RH _+:BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KU?]B7_
M ).6\/?]<[S_ -))J\HKU?\ 8E_Y.6\/?]<[S_TDFH ^]:*** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ/\ A2__  6M_P"CR/A9_P"$C_\ <U 'V-17QS_PI?\ X+6_]'D?"S_PD?\
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M_P#Q%'_#L+_@HI_T7WX6?^"J]_\ B* .,HKL_P#AV%_P44_Z+[\+/_!5>_\
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MN>+OVH[^U\':WK=VUY_PC6BW$5A<R7=C%.6C$D5G?.L$>/+,EK"&78#7@/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
EHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>ew-20240331_g7.jpg
<TEXT>
begin 644 ew-20240331_g7.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH CO+2"_LY;&Z5C%/&T<@5RI*D8.""".#U!S7Y._L(?"U?C)_P6M_
M;/\ V=/B9\7_ (KZIX*^'S>&KCP7X>/QH\2P0:2U[:&:X$7DWZ':SGA22%
M4 #%?K-7Y"?L;_LV?"?]H[_@X*_;QTWXJ6NO2Q:9%X/>S_L+QGJFC,#)IJAM
MS:?<P-)PHP'+!><8R<@'WC^S)^RAX,^#_P"T=XF^+OP/^/7CC6?"=_HLGA_7
MO!OBOXC:QK]MINM6ETK&XM3J5Q.T+%'EBE57"@QQ[1]^M7Q?_P %,/V%_ 6L
M-IGB_P#:(TJQM(]=.BW'B66SNCH-OJ0?RVLI=7$1L(IUD!1HGG5U8%2 1BO'
M?VBOV?M6_P"";7_!'W]H/PE^Q_?ZO]JTSPOXP\1>%9)=0N+N^TUKQ9[J1A<3
M.\TTD)DED21V9R47<6.2>:_9"\!_ /X^_P#!MGX.^'DVGZ;<>$=7_9@6TUH;
M5,4=_'I;"]G)Z++'?QSRE_O+*F[AAF@#ZN^/'[:'[*/[,6J^'O#_ ,>_V@/"
M_AC5/%NHV]CX8T?4=43[;JLT\JPQ"WMUS+*ID95+JI5<_,0.:K_LV?MQ_LD?
MMA:YXP\.?LP_'SP_XWO/ 6IQV'BV/0;DRK83R>9Y8+X"R(YAE"R1ED8Q. Q*
MG'XS?$JW\=?%?_@W/_8%B_:1LI=2U"^_:.\(V)_M/<9)M'^W:O;V*EC\VUM.
M%N 0>4(/>OW2\)_##X:> M5U+7? WP\T+1;[6O(_MB\TG28;:6^\F/RX?.>-
M09?+3Y$W$[5X&!Q0!\Q?\%+O^"L7PB_X)_>.?A1\'=8N9)O$_P 2_B)HNER?
M\2R>>WTG1I+U!?7DS1J1O\A9DBB!,C.P<(RQO7S?_P %%/&'POU?_@KC_P $
M_P#]H_P?\1]2'ASQ/K'C>YU2ZU+7[V+2_L]CHT7EW'V2ZD$-IY8DN"TBQQE@
MS,Y; ([G_@NQQ\?OV$B?^CPO#W_H$E9G_!7[PGX8\;_\%>/^"=_AKQCX?L]4
MTZ?QCXZ>>QU"W66&1H]*L9$+(P(;#HK#(ZJ* /KO]E[_ (**?L2?MI^*O$/@
M?]ES]H_P]XRUCPJ$?7-.TR619H(G.%F59$4S0DD 31[HSN7YOF&9/CU_P4$_
M8_\ V9=0U+3?C3\9H-+?0TA?Q'-:Z3>WT.A+, 8FU"6TAECT\.&#*;AHPRD,
M,CFODWQK:6FA_P#!TYX+OM(MDMI=:_8XO4U5X5"F[$>OR%/,Q]\C8@!.3A%'
M0"N!_P""+GAB_P#VZ?V.?B[X&\=?MB^/M%\577Q:\::9\:O ^E:?X:?RKJ^O
M[G=Y@OM(N+K9):ND2L\K*/(:--JQ;$ /U$\(^+O"OC_PMIWCCP-XDL-9T75[
M**\TK5M+NTGMKRWD4/'-%(A*R(RD$,I((((KY)_;-_X+!? K]D[]NGX._L3Z
MSJLBZAXSU'4KKQQJ<FD7,MOHVEV^C7=S"JO&AWW,MU]B^1 Y2(NSA \9;TW_
M ()J?LS_  *_8W_9'T7]F#]FWXI^)O&'@_P7K&K:;I^K^++Z&YNDG34)_M5M
MYL-O!&Z0W)GB&U,*4*9)4X^9_P#@HCQ_P7X_X)Z$_P#/K\4?_4=2@#A?C3XX
M^$GPM_X.*_A9\?-8^*UUIO@K5/V6-;\2ZIJ?BCQ1='3;.-KE_P#242\E*62-
M$(P418U^4?+NSG[E_9S_ ."B'[$G[6?@;Q/\2?V?_P!I/PSKVB>"YS%XNOFN
MFM!HQ"LVZY6Y6-H8RJ.1(X"-Y;X8[6Q\A?M)>$_"_BW_ (.<_@)%XI\/6>HI
MI_[.&M7UDE[;+*L%S'J,QCF4," Z$Y5NJG!&" :N?LCV5IHG_!R-^UE8:1;1
MV\.J_"'P9?ZA%"@5;BY2)(UE8#JX4D9//- 'T''_ ,%BO^"8$\7A^XM/VVO
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M+;3-(^._QEM=+L85VQ6L*Z/&%CC4<*H & .!73>(B#_P: 1D'_FUVU_]$1T
M?1G[''_!2S]@WX6_!?\ 9Z_9%^('[4GA72_B-K7PM\*V6G^&;B\8R&ZETJT,
M5M)(JF*&=P\>R*1U=_,3:IWKGZ4^+W[3'P9^!NL:9X9^('B6\_MG6;>>XTO0
M-!T"^U?4KFWA*":X6SL(9I_(C,D8>;9Y:&1 S L ?RU_X*P>"/!O@K_@VQ^"
M%YX1\+:?ILFC-\-=6TQ[*T2,V]]*;4RW*E0,2N9IBTGWF,CDDEC7T;_P49^
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M%KWCM$_9]\4(CNVG>#-:\RXU.^$F-J-8V2W-PI_BO)'3/% &UX?_ &COCO\
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M_P"5<)87'Q(CB'D!44QR.RE4Z( PW #H>E?0'Q$\$:;\%?\ @V:TSXU?L_\
MPZTK3?'FC_L?:?\ V;XGT[2XQJ=A;WNE6T^I2Q7(7S8RPDGN&*L/G&\\@&@#
M[%U+_@I=^PQH_C/3/!.J_M#Z5;2:UKYT+1]:GL[I=%OM5#.AL(M5,7V&2Y#H
MZ>2LYDWHR[=P(KXW_:SOO ?P-_X.._@?\4_&7Q&N]&\/R? CQ9JOB.Z\2>++
MAM+T\0),K7"I<S&&S01_>\L(IVY(SDGV7X6?!?\ X)U_MP?\$5OA7H7QI\.:
M-JOP1T_X8Z%K$D8U6:RATO\ LVS0R,TUK)')$\#Q3)* P.5D5LY(KRS]JSP]
MX1\?_P#!Q[^RF_B+PU!?VL?P1\2ZA96NJV.?)GC9Y(9#'(,K)&VUER-R.H(P
MR@@ ^S?V4/V]/V/_ -N2RUZ^_91^/.B^,QX7O4M/$,&G^;'/I\K[MGFPS(DB
MJ^Q]K[=K;'VD[3CT?QWI_B_5O!6K:5X \0VVD:Y<Z?-%I.K7=E]IBLKAD(CG
M:'<OFA&(;82 VW!(!S7Y_?LYV=KHG_!S3^T/:Z1;I;QZO^SOX:OM22%0HN;E
M+F*%97Q]YA'\N3SCBOT7H _*K]N?_@GA\4OV0OCG\!/C_P#L&?M3?&?5_B[X
MF^-.F:/XLTKQ?\0[O5[/Q9HTB2S:G<7MK(?*BA@AA+N8DCAB0X1%?R2OZ>?$
M'PGJ/CGP??>%-*\>:SX9FO8O+&M>'C;B\MP3R8C<0S1J2,C<4)&<J58 C\U/
M^#AS]@W2M ^!VJ?\%6OV=OBSXZ\(?'3X036>H>&-4M/&=_<VMY%+?00R:<MG
M/+)%"LGF_+%;HBROB-U=7P/TS\'7FOZCX1TK4/%>G)9ZI/IL$FI6D9RL%PT:
MF1!R> Q(_"@#X/\ ^#:KQY\3OB-_P3?N?$?Q@^)VO^,=?'Q7\3V]YXA\3:I)
M>7EUY5Z44O+(2QX' Z#H !Q7Z U^=O\ P;"?\HTK_P#[+)XN_P#3BU?HB'1F
M**X++]X \B@#E_C9:?%;4?A1KNE? [5;'3O%M[8-:Z#JNIP"6#39Y2(Q>/$>
M)A &,WE9'F>7LR-V1^3W_!6;_@GE\2O^"8?[+NI_\%0_V0OV_OCG<?%+X<ZO
MIE[XB/C[Q]+JMAXQAN;^WM)+>YM"J1 %YT98D41[5,80$HR?L57RUXV\):7_
M ,%)_BIH%M*JW7P*^&OBR+5Y[@C=#X^\1V4A-O%%VETNQG7S7DY6YNXHU7,=
MO(90#RS_ (*D?M=_%O\ X6'^RY^P#\.==U7P3XF_:2\7J/&VJ:)>/#J.B^';
M&&&YU2WMITP]M<2B3R4N%PR*DI7#;67.^//CV/\ X)9_\%*OV<? _P +-3U2
MW^$O[0]WJ/@OQ3X0U#6[F]MM.U^)8'TS5+07,CM#-,\QMYPK*LBA796D4-7'
M_P#!4+3;;1_^"T7_  3_ /VM;?4;>^\'7'B;Q)X-EU:UG62VBU*^L6CLH_,4
ME2TKO,J@'.;=AVJU_P %M?">K_&7_@I5_P $]_@EX0B>XU2W^-MYXRO(X1DP
M:=HWV&[GE?'W5*JR@G@D8&3Q0!ZQ^TM_P2,U/]O/Q;XG^(O[4'[7GQ>\/W<F
MHW-O\._#WPT\<OI6E^%K")FCM;E88UQ=7DP47,TLV[!E$*A5B!.3_P &]_QO
M_:C^+7[&_C'P'^UEX^N/&6O_  E^-'B'X?Z=XZO2S3^(['33 J7<CL29F\R2
M:+S"2S"$;F9PS'Z(_:?^-'CF*\C_ &:/V:KNVD^*?B?3FDMKZ>'SK7PAISLT
M;ZY?+T*H0XM[<D-=SIY8VQI<30^6?&SX+?%?]CG_ ()QW?[)?_!+3P*/$GCS
M0=(L[:PTN;QC9Z=JS07MXXOM8>ZNOW:7LV+^9)Y$9#<AF$<@C,1 /E'_ (+@
M_M3_ !V^(6J_"N]^ GC^^T#X5>%OVJO"7A#7]3TNX>)_&.N-=RM=VT<B$$V-
MB;?R).JS7<DJ'!LCO_6:OP?_ ."L_P 8_P#@HCX9_93_ &?O@IXS_P""-.G?
M"'PCX-_:!\''P6;3]H72M;&HW]O]I%KIC+#;*\1G)<M=R%@K*6<,7S7[7?L^
M>-/C!\1/@WH7C3X^_!-/ASXPO[9WUSP3'XFAUE=*D$CJL8O8$2.?*!'W*H W
MXZ@T 97QE_:V_9_^ GBG3/ 7Q'\<RKXCUBQFOM,\+Z%HE[J^JW%I"0);I;*P
MAFN/(0D!IO+\M20"P-9>@_MY_L8>(_V=O^&M=._:=\%Q_#99)(I?&-]KL5K9
M0S(Q5X)&F*&.<,"IA<"3/&W)Q7SUXQ\5_#;Q)_P6*\1^%OV2O .GS_'W2_@K
M9:?\2/B%XOU&[DT7PSX=EOOM-I:QZ=%(C:A>2RE92BO;(L84M<!CY;?+W_!,
MK1[J#_@EC_P4B\*^)KRWU)[3X]_&"VN9([(0PS,-%ME=DAW,(D8[B$R0N<9/
M6@#[J\0_\%C_ /@F#X2;P4OB;]M+P98GXA6EO=>%/M-U(OVBWN&*P32Y3_1(
MY"#M>X\M6"D@D X]P^+WQG^%7P"\#W'Q)^,OCS3?#FB6TT4+W^ISA%>:5PD4
M,:_>EED<JB1(&=V8*JDD"OR$^(?PV^']C_P9H!;'P9ID)O/A#H^KW;162*T]
M^-2M6%RY RTN54;SSA0,X %>C_&3XPZEJ?\ P5G_ ."<OP@^+^IG_A"[GX6Z
MEXATE=0?_1K_ ,5'1'A@DDW?+)/$NWRB?F62Z^7YG% #/BG\9?@I\7?^#DC]
MEO4OA#X_\37-\/!WC,>+O"_B.36+*33)TT:;[-)_96IB-K$21R2%72&-90&.
M6()K]5=8N-1M-(NKK1].6[NXK9WM;1IA&)I I*H7.0N3@9[9S7YV_MIZ/H]M
M_P '(/[%WB&+3X4O[OX<^/;:XNP@$DL46FRO'&6ZE5,LI [&1O4U^C= 'Y<_
MMX?\$?/B=;_LO^.?VV;O_@HW\:[+]H7PEX5OO%J>*M,\=SVF@07EI;O=/IUM
MIJ!8[;3L(\2*"752'D:4[U>;]I3_ (*L_M/_  ]_X(,?!C]I2W^SZ5\<OCU:
M>&_"OAS4C8KY=OJNJ(Q.J+!C;S;0RW$:XV"22(8*_*?J7]JK3I?V]K_6/V%?
M >IS1^!4GCM?COXKL92JBR(61_#-K(O6[NXRJW+*?]&M)&!Q+<0X^6/^#DSP
M?X?TO]E'X&?%_P #0V \*_ G]I;PG?>+;32]GV?1=,CW6^'5.(1&TUHFP@86
M9>@QD V_^"D!MO\ @B_\-?A)^VO\$O&_BRYTW0_B+I7ASXW0>)/%=[J0\8:%
M?J\5Q?W8N97#:A%.L<T5PH5E+R1D^4VRO?OVN/\ @G3K/[?GQ+OU_: _:+^(
MOAOX<Z-:06WA'P5\,O%\FCI?W#1B2XU34)H5\R>0.XAA@)\N);=I,,TYV?/W
M_!U%H.K_ !/_ .";/A[]GCP7!]J\1_%+XU^&/#/ABRC&YKF\FEEE15 Y(Q"2
M3V%?;WQ\^.<'P%\+:3X2\'Z"WBCQWXBW:?X#\'QW/ERZK<QH-TLTF#]GLX5*
MR7%R05B3  >1XHI #XN_X(C:I^T]\$OVI?VI_P#@FQ\7/CAX@^*'@[X%^(/#
M[?#OQKXNNVN=1CM=6L9;P:=/<'F8Q1>0/]AO,P%1D1>._P""N/\ P3?^(7@#
M]ES7OVV/AG^V7\:IOVEM)U33KCPIJ>A^-;N*QU35+B^A@CT6RT9'-O%:N9FC
MB@12_0S//^]+_<W['/[-OA?]DOP?=^%?$/C>SUSXB_$'7;[Q9X_\12!8)_$6
ML2F/[5/# 6+):P*8+>*(%A#"D*DEB6;Q#_@M+_P3*^$7[<'[-?B+XGZU\1O&
M/A/QW\.M O/$'@'Q1I'CG4+:TT?4+2WDFCE:T\[[*H)0*\RQK,%R5D4B@#Z,
M\6?'SPW^S#^RQ#\>_P!M#QWI'A>W\.>&K*X\?:V=QL[6\98HY=@0,S*UP^Q%
M4$L64 $D5V_@?QMX3^)?@K1_B/X"U^VU;0O$&EV^I:+JEF^Z&\M)XUEAF1NZ
M.C*P/<$5\]_\$[;KQ/\ MB?\$J_A'J'[;?@C3O%6H^-_ACIDWC+2_%6D174&
ML"2%&6:YMYE,;F5!',RE<;GR . /H_1=%T;PWHUIX=\.Z3;6&GV%M';6%A90
M+%#;0HH5(XT4!415 4*    !0!9HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"'4+::]L)[
M.VU":TDEA9([NW5#)"Q! =1(K(6'4;E9<CD$<5\U_ ?_ ()6? W]G/\ :G\7
M?ME_#GXJ_$?_ (3OX@S1/X[OM3\0P7-OKJQL"D<UNUOY<:J%VKY*QM&I*H4!
MKZ:HH CNK6UOK62RO;:.:&:,I-#*@974C!4@\$$<$&OE#PA_P1M_9A^'7A+Q
M'\&/AM\0OB5X=^$OBR^N+G7_ (+Z1XN$7AR87!W7,$0,)O+2VF);S+>WN8H7
M#NI3:Q6OK.B@#YY_;#_X)F_L[?MM>!/!GPI^*.J>*-&\*?#_ %2RU/PGX<\%
M:K'I5K87MFCQVDZ>5%O!AC<HB!A&HQA 1FO>?#NDW6A:%::->^(+W59;:!8W
MU'41%Y]P1_')Y2(FX]]JJ/:KM% 'B_[;O[!GP$_;^^'^@^ ?CHFO6K>%/%=I
MXE\*:_X4UV73-3T;5+;<(KFWN(OF1P'<=\9###*K+Q7Q#_X)0?L\_$7XH?"[
MXOWWQ!^(MEK7P8:YD^'%Q:^*A*=-N+H+]LNI6N8I7OI[EEWS2W33-(S-DX)%
M?3M% 'S[K/\ P3E^$FO?MMZ5_P %!-3^)GCM_B/HNA'0M.NEU>V6RCTAI7E?
M3S:BV$;1,TCDL09<D,) RJP\H_:*_P"" W[ _P"T1^TUJ'[6JS?$'P#XO\0-
MGQA+\,/',^B0^(R<;S=K$"<O@;S$T1<Y9B6)8_;-% &#\+_AA\/_ (*_#K1?
MA+\*O"EIH7AOP[IT5AHND6*;8K6WC4*J#.2>!RQ)9B222237D_[9'_!.W]GK
M]N'Q1\/_ !_\6KKQ9I'B7X8:K<WW@WQ1X'\6W6BZE8_:42.ZA6XMF5UCF2.-
M7VD-A/E9<G/NU% 'S?<?\$OO@*?VK_"O[9FD^./'&F^,O _A=?#7A1;'6X18
MZ=HH# Z>+9X&22,AVR\F^4D@^9N52)?"G_!-7X6>"/VL?%_[;?A?XQ_$2V^(
MWCK0TT?Q)K!U:SDAGLHE18(EM7M#!'Y7EQE&1 V5.2V]]WT710!X)^PY_P $
M[/@M_P $^;#Q-H?P$\9>-)M*\7Z_<Z]KFE>)==6_AEU6?R_.O59XA(DCB-0P
M5PC=2I(!'D?[27_! O\ 8+_:0_:9OOVMFG^(/@'QEK@ \6W?PO\ '$^B1^(N
M@;[6L0)RX WM$8V<C<Q+$L?M>B@#POXZ?\$V/V+?VBOV0+;]A3XE?!#3I?AI
MIMG;P:'HEE(\#Z2\"D0W%M,I\R.==S?O=Q9][A]XD<-R'[!W_!(G]E;_ ()]
M:Y+XP^&6N^//%NOKIC:7I>O?$GQ?+K%QH^G,RLUE9*P2*TA8I'N$:!F\M0S$
M*!7U'10!B?$CP5_PL?P)JG@-O%.JZ*FK6C6TVIZ'+''=PQMP_E/)&ZHS+E=V
MW<H8E2K ,/GKX5_\$G?V?O@M^Q)J_P#P3R^''Q'^(6G_  KUFSO;*?1/[>MY
M)H;.],[7MK%<O;&:.*=KB1G ;<#]QD#.'^H** /E[Q'_ ,$F_P!GWQ9^PQ;?
M\$Y->^(_Q"G^$]K:0V,>B?V];K.UC"\<D-FUT+83&&.2)6 W[C]TL4 0;?Q@
M_P""9'[-?Q]_9W\&_L[?%R?Q-J\7PYNK2[^'WC,:U]E\0^'+JU"K;7%K?6Z1
MLLL:HB[F#;]BF3>PW5]#44 >-_"#]B;X>?#/XJ0_'KQGX^\7?$?Q[9:(^C:3
MXP^(&H6]Q<Z7I\CJ\MO:Q6L%O;6_F,B&25(1++L022.%4#F_@A_P3:^%G[/?
M[0/Q'_:A^''Q>^(4?C3XLI#_ ,)]J5]JUG<1ZG+!#)%:3>0]H8HGMQ*QB$:*
MHQM960LA^B** /G/]F;_ ()@?LZ?LLZ#\3O!W@S6_%VM:#\8M3U+4_B)H?BK
M6TO+?5K^_39>79/E+)')+'E&".J$'[N54KQ?AK_@B5^R'X1_9(UO]B;1?&7Q
M./@3Q#;+8ZE:7_CV>\G72TE>5-+MY+A7^QV8D=G,=N(BY_UC..*^P** /EOX
MV?\ !)7]GW]H?]DGPS^Q!\6?B7\1=2^'7A-;)-+TJ/Q!!!.R62(EFDMS%;+-
M*L 0;=SY)P7+E5*]3XO_ &!= \2?&O3OVD]"_:2^*7AOQ]8>";?PI-XET/5]
M//\ :.FPW-S<HMU9W-E-93R"2ZE(D:#<O&TJ2Q;WNB@#SW]FS]F'X4?LJ>"=
M0\%_"NPNRVN^(KSQ!XGUG5;LW%_KFL7;A[F_NI2!YDTA"C@*BJB(BHB*HYW]
MN;]@C]F#_@HQ\#I_V?OVJ_A\-<T-KM+S3YX+EK>\TR\165+FVG3YHI &8=U9
M6965E)!]DHH ^8_V*?\ @E!^SA^P?::OJ/PE\9_$#7/%.K:,=(C\>>/O%9UK
M5]-L,AEM;-KB,P6\*NJ2>6L.UVCC,@<(H%C]FW_@E]\&_P!DKX=>/OA=\"_B
M[\1]*TKXDZW>:UXG^T:_;W4[:G=^6MU>Q2S6S/#-*D81BI"@'<H5PKK]*44
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MM:%JNL>(O!NBZ,NC:7I_C"XBOF@TM8%@2P+>6IF@6-=H$N]MK%2Q4*J^DT4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MHK'_ .$EU?\ Z%"]_P"^EH_X275_^A0O?^^EH V**Q_^$EU?_H4+W_OI:/\
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M_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\ WTM
M&Q16/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[_P!]
M+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM &Q
M16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]"A>_]]+1
M_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\ WTM
M&Q16/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[_P!]
M+7EOCO\ :V\3>&/B;>?"WPI^SQXA\2W]A80W=V-+O;<-%')G:61CN XZ]#0!
M[517D'@7]H_XL>+/%UAX<UO]DGQAH=I=SB.?5K^X@,-JN#\[A3G'T]:]?H *
M^;O&?_!3;X0^$/\ @H3X!_X)Q2?#7QPWBSQ]8ZI>V7B"\\.R66CQ0V%K//+Y
M<]QL:Z8F'8#"CQ_."9.@/TC7YV_MN@?\1$W[$+8Y/@;XB9/_ '"C0!]H?M3?
MM0?!S]C;X%:]^T3\=_$3Z=X<T"%#.;>W::XNYY'6*"UMXE^::>65TC1!U9QD
M@9(\Z\%_M]BU^-O@OX!?M+? +Q!\*=<^)MA<W/PZ;7M5L;VWU6:WC66?3I9+
M25UM=02)A)Y#;D=0_ERR,C*/D_\ X.&=;U77?V@/V$O@-=3-_P (YXK_ &KM
M#NM>M\X2Y-I<6RQQ/Z@K=3<'C(!Z@4__ (.B/$6H?#G]F?\ 9^^,_A61H/$7
MA+]J[PI?:%=0G$@E%OJ#&,$<D-L7*]]HH ^QOCY^VSX<^%'QU\-_LG?#?X?Z
MEX^^*GBG1+C7+3PCI%Y!;)INCP2"*34[^YG8+:VQE984(#R2RMM1&P[+J?LI
M_MA?#[]JNV\5Z)H^B:EX<\8?#[Q$^@_$'P/KWE?;]"OPHD0,8G>.:":)EEAN
M(V9)8VR"&#HOQ%_P3DUO5?B9_P '$O[<WC3Q5*SW'A/P[X0\-Z%%(<_9K!K7
MS&1,]%>2 2D="TA-/_9S\1:AX6_X.J/V@_A]H4C1Z7XL_9MT37=?AC.%EO[*
M?3;2WD<="RP7$B@GG#'WH _32BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .'_:3\1R^&?@7XIN
M[3POK>M75QH5W;6.E>'M(FO;JZGD@=8XU2)3C+8&]MJ+GYF YKY=_P"#>[X?
M_%3X$_\ !+'X;?LT_'?X1^)_!GC3P/;ZC!KND>(M&D@7]_JM[<0O#-@Q3@Q2
M(3L8E"<,%R,_;5% 'R#\%OVQ/&'[;OQT^.__  3T_:5_8F\7_#'3M.TC4K+0
M=<UC45FA\9^'Y)I=.FOH<1(( ^Y60!I599#A\QL#YG_P3F;]I+_@G#^Q'=_\
M$]_BK^S7XT\9^,?AI-JNG?#'6/#/AV2XT;QWIL]S/<6$K7P_T;3&7S_)FCO9
M(?+$6Y3(&&?MWP+\&/"?@7QIK_Q+CN;[5/$GB7R8M4UW5IUDG-I TK6UE&$5
M4AMX?.EV1HJ@M+)(^^2221NMH _+'5?^"&GQ0^#_ /P2 ^!7P!^#NI:;K?QN
M_9U\>Z?\3/#[FZ$-KK.NQ7TE[=Z8LT@ 2)Q,T,<C!06MX&?8"Y'J?[6_P?\
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M1110 4444 %%%% !1110 4444 %9OC'_ )%B]_ZX&M*LWQC_ ,BQ>_\ 7 T
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3P_:1QF2XU*^\C][*B?NXD@C(>2:XB&502.OL%% 'YL_"O\ ;H_X*@?L9?\
M!1GX:?L._P#!39?AUXZ\*?'.&^B^'/Q+^'.D3Z>]EJ=I")9;.ZMY&(*X,:C
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M<APRYP0* .JHKCA^T+\"W^-J_LV0_%SP]+\0&T:35F\&PZK$^I16,;1HUS)
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MB@ HHHH **** "BBB@ HHHH **** "O"_ /_ "D$\?\ _8B:5_Z,:O=*\+\
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M +'N7_TF:O=*\+_:P_Y+9\#_ /L>Y?\ TF:@#W2BBB@ HHHH **** "BBB@
MHHHH **** "O _C?\'?VP=._:?TW]I/]F#X@>"[K39/!R^'_ !;\.?'$5W:P
M:D(KJ6XM[V#4+43-;31F>:/:UM*K+*V>=I7WRB@#X1_8'_X)X_&F^\0?L\_M
M4_MG76D:;KGP/^"%IX5^&WP\T&.5SHEQ=:9;6VHWVH74H0S7CQ1"#R(XUBA
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MSYK.&3Z0HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M",AE8<$$<@B@"6BBB@ HHHH **** "BBB@ HHHH **** "O"_ /_ "D$\?\
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M,?\ 0:@_[ZH_X3'PQ_T&H/\ OJKG]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ%
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M#_OJKG]G:?\ \^,/_?H4?V=I_P#SXP_]^A0!3_X3'PQ_T&H/^^J/^$Q\,?\
M0:@_[ZJY_9VG_P#/C#_WZ%']G:?_ ,^,/_?H4 4_^$Q\,?\ 0:@_[ZH_X3'P
MQ_T&H/\ OJKG]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ% %/\ X3'PQ_T&H/\
MOJC_ (3'PQ_T&H/^^JN?V=I__/C#_P!^A1_9VG_\^,/_ 'Z% %/_ (3'PQ_T
M&H/^^J/^$Q\,?]!J#_OJKG]G:?\ \^,/_?H4?V=I_P#SXP_]^A0!3_X3'PQ_
MT&H/^^J/^$Q\,?\ 0:@_[ZJY_9VG_P#/C#_WZ%']G:?_ ,^,/_?H4 4_^$Q\
M,?\ 0:@_[ZH_X3'PQ_T&H/\ OJKG]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ%
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MLB?#;Q+_ ,+!\ _!#X?Z#XBG4M<ZYH_A.SM;V1F'SEIHHE=B23DD\Y.:[_\
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M?]?-I_Z41U\'5]X_MQ?\FWZU_P!?-I_Z41U\'4 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5ZY^P[_P G(:+_ ->UW_Z3
MR5Y'7KG[#O\ R<AHO_7M=_\ I/)0!]X4444 %%%% !1110 4444 %%%% !11
M10 5\^?MO?'#XH_"#4?#D'P[\3_V<E_#<M=C[%!-O*&(+_K4;&-QZ8ZU]!U\
MH_\ !2C_ )"WA'_KVO?_ $*&@#S3_AM7]IG_ **7_P"4:R_^,T?\-J_M,_\
M12__ "C67_QFO+** /4_^&U?VF?^BE_^4:R_^,T?\-J_M,_]%+_\HUE_\9KR
MRB@#U/\ X;5_:9_Z*7_Y1K+_ .,T?\-J_M,_]%+_ /*-9?\ QFO+** /4_\
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M%+_\HUE_\9KRRB@#U/\ X;5_:9_Z*7_Y1K+_ .,T?\-J_M,_]%+_ /*-9?\
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M :^A?^"O?P1^.W[2'_!,[XS? _\ 9HNY8_&WB/P7-;:-!!<")[T!T>>S5R0
MUQ LMN,D+F;D@9-<9^QSX/\ ^">7[*/_  36?QK\#?@-I\7A+P7X!DO/'&@V
M/A%)O$$MS:67G7EKJ-LZ">34>&#PSX?<P'"XH Z?_@DE\%/C7\"?V2?^$7^-
M7B+X>:FVH^+M5U?PC-\,9&FTN+P_<S>9I\27#(K76R$A5F;>QB$*EW*EC].5
M\J_\$??$G_"=?LM:I\2?"OP(UWX8?#[Q/X\U/5?A1X"\26"6=WI.@3+"1FV1
MF6UCFO!?7,<*DHD5S&$^3;7U50 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5\=_M_P#[+O\ P54^/'[1'AG4/V'_ /@HP?@IX$7P;<Q^
M)8'^'^EZZ&U:*Z0P,J72K*#-#<2@D2%$^PK\H,N3]B5Y5K?[._C[5OVR-%_:
M@M?VF_&-EX:TKP//H-U\);>5/[#U"ZDN&E74Y5/S?:%5A&#UPB891O5P#XU_
MX=I_\%\/^EAK_P UOT3_ ..UU_[,7[#?_!4_X.?M8^!/B?\ M@?\%1XOCEX-
MT\ZG#_PC$GPZT_PX;&]EL)EAO%^S.3=$*)8]A^91,6 V[R,KXQ?\$AOVV?C9
M^T=\1_BI8_\ !9/XZ_#WPMK?B@77@OP?X1UMGM].LGM+=I4/F2#8!=M=*D:J
M%6)8N220+W[-7_!,OXZ_LF?M@?#SXL_%C_@JS\4OC%9DZM86G@GXF:D9(C-+
MI\K?:[55=@98UC93N7A)GPZGY7 /O>BBB@ HHHH 1F55+,0 !DD]J^6=#_X*
M9W/Q&^"NN?M9? W]EWQ1XR^$&A'4)$\7V&L6,%YKEG8R21W5]IEA+(&N;=6A
MEV>:\$DPC)CC<-&7^H[JVM[VVDL[N(2131E)48<,I&"#^%?@6_[2'QW_ ."2
M7@SQY_P3<?XER:]^Q[J_C6]\&^'OVEM)\.W&HS?"\WSN^HZ1,J@17EQ#Y\D8
ME5F2&:1VQ*\4EC& ?LG\1OV^_P!EKX8_L:1?M[:]\1EG^&U[X?L]7TC5+"U>
M6?5([L)]D@MX,!WN)GECC6(@-O;#;<-CG?!?[?8M?C;X+^ 7[2WP"\0?"G7/
MB;87-S\.FU[5;&]M]5FMXUEGTZ62TE=;74$B82>0VY'4/Y<LC(RCX2_X*Y^#
MOA?\-]+_ .":O[&7P!U"*X^$-[^T#X473GM;Y;F'4M/L39I:,TR_+.)8KJ23
M?R'9M_I7H'_!T1XBU#X<_LS_ +/WQG\*R-!XB\)?M7>%+[0KJ$XD$HM]08Q@
MCDAMBY7OM% 'V-\?/VV?#GPH^.OAO]D[X;_#_4O'WQ4\4Z)<:Y:>$=(O(+9-
M-T>"012:G?W,[!;6V,K+"A >265MJ(V'9=3]E/\ ;"^'W[5=MXKT31]$U+PY
MXP^'WB)]!^(/@?7O*^WZ%?A1(@8Q.\<T$T3++#<1LR2QMD$,'1?B+_@G)K>J
M_$S_ (.)?VYO&GBJ5GN/"?AWPAX;T**0Y^S6#6OF,B9Z*\D E(Z%I":?^SGX
MBU#PM_P=4?M!_#[0I&CTOQ9^S;HFNZ_#&<++?V4^FVEO(XZ%E@N)%!/.&/O0
M!^FE%%% !7A?[6'_ "6SX'_]CW+_ .DS5W'Q!_:>^ 'PJ\1MX2^(GQ4TO2-2
M2%)6L[N1@X1N5;@'@UXA\<OVD/@9\4_CC\&X/A[\3--U9[#QLTEXMI(Q\I&@
M**3D#@L0* /JNBLW_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJ@#2HK-_X3'PQ_T&
MH/\ OJC_ (3'PQ_T&H/^^J -*BLW_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJ@#S
M;]N+_DV_6O\ KYM/_2B.O@ZON/\ ;6\1Z'J/[.^L6EEJ<4DC7%IM13R<7"&O
MAR@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "O7/V'?^3D-%_Z]KO_ -)Y*\CKU;]BF]M-._:(T>[O9UCC6WN]SMT&;>04
M ?>U%9O_  F/AC_H-0?]]4?\)CX8_P"@U!_WU0!I45F_\)CX8_Z#4'_?5'_"
M8^&/^@U!_P!]4 :5%9O_  F/AC_H-0?]]4?\)CX8_P"@U!_WU0!I45F_\)CX
M8_Z#4'_?5'_"8^&/^@U!_P!]4 :5%9O_  F/AC_H-0?]]4?\)CX8_P"@U!_W
MU0!I45F_\)CX8_Z#4'_?5'_"8^&/^@U!_P!]4 :5?*/_  4H_P"0MX1_Z]KW
M_P!"AKZ<_P"$Q\,?]!J#_OJOEK_@HQJ^F:MJOA-M-O$F"6]YOV'IEH<4 ?-5
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 ?5_\ P37_ .03XN_Z^;+_ -!FKZ=KY8_X)SZUI6DZ5XL74KY(2]Q9[-YZ
MX6;-?2O_  F/AC_H-0?]]4 :5%9O_"8^&/\ H-0?]]4?\)CX8_Z#4'_?5 &E
M16;_ ,)CX8_Z#4'_ 'U1_P )CX8_Z#4'_?5 &E7A?@'_ )2">/\ _L1-*_\
M1C5[%_PF/AC_ *#4'_?5>+_#2^M-1_;\\?7=C.LL;>!=* =>AQ(U 'O5%%%
M!1110 4444 %%%% !1110!XS_P %#?VP-%_8%_8J^(O[7VN>&Y-9C\$: UW;
M:3'+Y?VVZDD2"VA9\'8C3RQ*S@$JI8X.,'X.^'.@_P#!P/XR^"'A/]LOX[_\
M%*/"_P -[CQQXE\,P:=\'/#WP4TO4K+2+36=6LK.,7-U<,MRTD<=V':%92P*
M;//!+$??/[>UM^S/?_L?>/='_;)M8I/A=J.B_8?&TDSE$MK*>5(6N6<$-&(B
MZR^8IW)Y>]<LH%?&'QV_:1_8$^,__!/^Y_8FT_\ X+W?";P_K5I=Z)_PB?Q7
ML/%>EKK&FV^EZA97=N\RQ:A&D]X19[&N8_(7,@<0@J0X!]M?LF?&;QK\6O!6
MN:%\6+?1D\;>!/%-QX9\9OX;:0Z=<7L,4%PEQ;"0L\:36UU;3&%V9H6E>(O(
M8_,;U.OEK_@CGX;_ &3_  W^Q#IL7['OQ=U;XA>'I_%6N-KGQ \0ZH+W4?$^
MM1ZA-!?:E<3 GS#-)#OC;O T)YSD_4M !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!^3'Q'_ .":G[#7[1G[:_QP\2?\%@_VA-4E
M\4GQR+OX8:)KGQ8DT/2X/!DUK#]@-C$DT0)69;R&8 Y$D&YD E627T;]C/\
MX)R?\$:_V3/VVO /Q-_84^,-C<>/+FUU;3VT'3_B:?$/VO3GL9'GD:-[B5X
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MM^S%XAT3QQX462_"6NHZG97+W,NCK<28"Q%)3!'(P52UO 6V+NQWO[6_P?\
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MM/\ THCKX.H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_6O^OFT_]*(Z^#J "BBB@ HHHH **** "N,^,'[1?P'_ &?H;"X^-_Q=\/\
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ML_\ Q-U7]LC1?VE[/]I_Q39>$M+\#SZ'>?"."&(Z1J%Z]PTJZI(Q^<3JI$8
M'2-,,H+JX!\5>*OV=_\ @OOIO[:?QN\<_LA?%3]G[P?\/O$/C&VDTZ+QIX=U
M SZQMTVU*ZAY=O&Z-,L;QV,DV]#*=.&4&Q6;T+]FWP!_P7#\._M9^!=2_;O^
M.'P<\2?#,#4DFLOA;IE[970U(V$WV=[E;F,"2 *)@ K\2-&2IPK+A_&3_@E#
M_P %!OC1^T;\1OB9H/\ P6:^+WPY\):OXH%QX)\(>'$CN8;&Q>TMWE0L\J[
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M10 5ZY^P[_R<AHO_ %[7?_I/)7D=>N?L._\ )R&B_P#7M=_^D\E 'WA1110
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M\*CM-<\):KJ'AB&P6SC&HQ65M912V\%^VH"XGN0R+(XGMY!EI)&;[V_X*$_
M[_@GUI?PO\1?M??MM?#Y+OP_X&T^#6_$974[V*VU0:>_FV:7EC;SQP:J\<I
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MH **** /./VO/VEO!W['/[,OC;]I_P ?:9>WVE>"M FU*XL-.B+SW;* (X$
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M_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\
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MHOCG7X)(==\9Z3X4L[;5M2CDD221+B[CC$TRM(B.0[$%D4GD UV]% !1110
M4444 %%%% !1110 4444 %%%% !7A?[6'_);/@?_ -CW+_Z3-7NE>%_M8?\
M);/@?_V/<O\ Z3-0![I1110 4444 %%%% 'DG[<7_)M^M?\ 7S:?^E$=?!U?
M>/[<7_)M^M?]?-I_Z41U\'4 %%%% !1110 4444 %%%% !7#_$2PDM]:%]M^
M2XC&&_V@,$?EC\Z[BJVJZ59ZS9M97L>5/((ZJ?45]9P5Q%'AC/88NHKP:<9V
MWY7;5>::3MUM8^1XWX;EQ3D$\'3:51-2@WMS*^C\FFU?I>YYA1707_P[UJWD
M/V%H[A/X3N"M^(/'ZTEA\.]:N)!]N:.W3/S$L&;\ ./UK^EO]>.$OJOUCZY#
MEM>U_>_\ ^*_E8_F'_47B_ZW]7^I5.:]KV]W_P #^&WG</AWI\EQK1OMOR6\
M9RW^T1@#\L_E7<U6TK2K/1K-;*RCPHY8GJQ]35FOYIXUXBCQ/GT\7335-)1A
M??E5]7YMMORO8_I[@CAN7"V00P=1IU&W*=MN9VT7DDDK];7"BBBODSZX****
M "BBB@ HHHH *]<_8=_Y.0T7_KVN_P#TGDKR.O7/V'?^3D-%_P"O:[_])Y*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7A?[6'_ "6S
MX'_]CW+_ .DS5[I7A?[6'_);/@?_ -CW+_Z3-0![I1110 4444 %%%% 'DG[
M<7_)M^M?]?-I_P"E$=?!U?>/[<7_ ";?K7_7S:?^E$=?!U !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>N?L._P#)R&B_
M]>UW_P"D\E>1UZY^P[_R<AHO_7M=_P#I/)0!]X4444 %%%% !1110 4444 %
M%%% !1110 5\H_\ !2C_ )"WA'_KVO?_ $*&OJZOE'_@I1_R%O"/_7M>_P#H
M4- 'S#1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% 'U?_P $U_\ D$^+O^OFR_\ 09J^G:^8O^":_P#R"?%W_7S9?^@S
M5].T %%%% !1110 5X7X!_Y2">/_ /L1-*_]&-7NE>%^ ?\ E()X_P#^Q$TK
M_P!&-0![I1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?_(] 'V-17QS_P /*?VLO^D3_P 4_P#P+'_R/1_P\I_:R_Z1/_%/_P "Q_\
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M32M,\#>!]#@GL+"^U?69G;2X'$LLTL2):&.:8[BQ,<BKM+*!V7Q._:V_:/\
MV OCS\%O"/[8?Q+\.>-_!'QM\2KX.E\2Z1X5.COX8\531>991HOGRB:PN2DT
M0$A\Z%D5VED5F"^#_P#!??PZFA_M-?\ !/.UM=/2T\):9^U3H=I-!%&%MX)O
MM%F+-,=% 6.8 =@&JU_P=1+J5[^R'\"]!\,AFUW4/VK?"<.@)%_K#=FVU+84
MQSG/&1_>'K0!^G5%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'S-\9
M?V)O'6C_ +;VG?\ !1+]E/4O#]OXXN/!4GA#Q[X7\4SSVVF^*=*$RSVTAN;>
M.5[2[MY4&V;R9@\3&(JH"L-3]BO]A^?]G?XD?%+]I[XL^*K'Q)\6OC3KMKJ'
MC;6M-LV@LK*TM(!;:?I5FDC,_P!GMH1M\QSOF<L[!<JB?0M% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\Z?\
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MQIXONK<2-JNKZ1I#74]C8MGY4M)7MTFF (:8S0#:UO(#]^U^#7Q\_P""L?\
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MX+^,])T7P]9>#OM$L1AN(+F9I)+BXVO.[*D1SY<2C! 0<D_9]?G;_P $BO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV@Z<]KIGA[0H)WN5T^T65WEE:2XD:::XD8&5EC"QQ)&J5[A10 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 5@?%?6]3\-?"[Q+XCT2Y\B]T_0+RYM)MBMY<J0.R-A@0<$
M X((]:WZY;XY_P#)$O&/_8JZA_Z324 ?%_\ PVK^TS_T4O\ \HUE_P#&:/\
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M3KC43IYMC''9)-'(Y)N3<>2GF&!?N@ ^NZ*** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "N6^.?_)$O&/\ V*NH?^DTE=365XZ\,_\ ":>"=8\'?;?LW]K:5<67VGR]
M_E>;$R;]N1NQNSC(SCJ* /S(HKZF_P"':7_5:O\ RW/_ +IH_P"':7_5:O\
MRW/_ +IH ^6:_2/X&?\ )$O!W_8JZ?\ ^DT=>!?\.TO^JU?^6Y_]TU](^!?#
M/_"%^"='\'?;?M/]DZ5;V7VGR]GF^5$J;]N3MSMSC)QGJ: -6BBB@ KX?_X.
M%/\ @G7XY_X*6_\ !-O7O@[\(X$N/&WA?6[;Q7X-T^241C4+RUCFB>UW,0%>
M2WN;A$)(7S#'N*C+#[@HH ^6?^"6/_!2'X:?MV?L\:*FNZ['H7Q<\-Z;%IWQ
M6^&^N'[)K.AZQ @2Y\VTEVRK"[JTD<FW:5;!(=75?E/]DS4/#/CK_@ZU_:$\
M=>!+^QUG3;/]G'3M/OM8TF5+B""]^TZ,#;R2QDJLVV)OD)#8C/'RG'Z)_%K]
ME#]EKX^ZA%JWQV_9K\ >-;J! D%SXM\&V.I21J.@5KB)R!["NA\$_"KX7_#3
MPG_P@?PY^&^@^']#VLO]BZ)H\%I:8888>3$JIR.#QR* /SZ_X(H^,/">M?\
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M%E*=D$MU%")8Y6#HQG&%21I)1^F_[&OQ6\??'7]DGX9_&CXJ> /^$5\2^*_
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MG[2G[3_AC_@F3_P<,'X__M<ZA+H7PC^.GP/L_#6@>/[N%VL-(U>PNS*;2>0
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MRQS2ZE^S[\!=9\3/XTUCX(^$+O69+E;A]6N?#5K)<M,"")#*T9<L"!ALYX%
M'P?^R_XD\.S_ /!S3^TUHMOKEH]Y_P **\+*;5+A3)NC,!<;0<Y421DCL'7/
M45Y#_P $A_VT/AO^RO\ L:?M?^'!/8^(/BAX(^./Q0\31?">.XSJM[#9VZW
M:2W4-)%;.T)B-PR>7O81@M(RHWZG:/\ L^_ 3P]XDC\9:!\$?"%CJ\4[31:K
M9^&K6*Y21L[G$JQA@QR<G.3DUKZ/\/? /A[Q)JGC'0/ ^CV.KZV4.M:K9Z9%
M%<W^P83SY54-+M' W$X'2@#\$_V^OVK/V?OVF/\ @D#\(_VB_%/[75KXU^).
MI^.O!^L^)O"/AS5W@T;X>VWVL>=8?V1:-Y&GQ6[ VZ7-ZK3S%&VS,KA!]?\
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M_@I_"7AR^N M_K2-I,V7M8/]9<(BR(\CHI6*,^9(50%A]X?MG>+_ (4_#_\
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E** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>ew-20240331_g8.jpg
<TEXT>
begin 644 ew-20240331_g8.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH CO+2"_LY;&Z5C%/&T<@5RI*D8.""".#U!S7Y._L(?"U?C)_P6M_
M;/\ V=/B9\7_ (KZIX*^'S>&KCP7X>/QH\2P0:2U[:&:X$7DWZ':SGA22%
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MV\.J_"'P9?ZA%"@5;BY2)(UE8#JX4D9//- 'T''_ ,%BO^"8$\7A^XM/VVO
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M+;3-(^._QEM=+L85VQ6L*Z/&%CC4<*H & .!73>(B#_P: 1D'_FUVU_]$1T
M?1G[''_!2S]@WX6_!?\ 9Z_9%^('[4GA72_B-K7PM\*V6G^&;B\8R&ZETJT,
M5M)(JF*&=P\>R*1U=_,3:IWKGZ4^+W[3'P9^!NL:9X9^('B6\_MG6;>>XTO0
M-!T"^U?4KFWA*":X6SL(9I_(C,D8>;9Y:&1 S L ?RU_X*P>"/!O@K_@VQ^"
M%YX1\+:?ILFC-\-=6TQ[*T2,V]]*;4RW*E0,2N9IBTGWF,CDDEC7T;_P49^
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M%KWCM$_9]\4(CNVG>#-:\RXU.^$F-J-8V2W-PI_BO)'3/% &UX?_ &COCO\
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M_P"5<)87'Q(CB'D!44QR.RE4Z( PW #H>E?0'Q$\$:;\%?\ @V:TSXU?L_\
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M[\1]*TKXDZW>:UXG^T:_;W4[:G=^6MU>Q2S6S/#-*D81BI"@'<H5PKK]*44
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MM:%JNL>(O!NBZ,NC:7I_C"XBOF@TM8%@2P+>6IF@6-=H$N]MK%2Q4*J^DT4
M?#GP._X-Z_\ @GE^SY\6#\0?A_!\0?\ A'8]=76K'X4:AX_NYO"-KJ"R"2.X
M&G$@3,CJK*L[RJ"B_+\HQ[%\1?\ @G+\(OB9^V9X<_;RUKXD^.[?X@^$-+ET
MOPS<6&LVZ65A82AQ-;"V:W:.1)/,?<T@=R2,,-B;?H&B@#Y_\$_\$Y_A'X$_
M;5UO]OS2_B1XYG^(GB314T77;B\UBW:RN],C9&CLS:BW$<<:&*,AHPLF5)+D
MNY;U/X[_  9\*?M#_!WQ'\$/'.H:Q::1XGTN2PO[KP_K$UA>Q(X^]#<0L'C<
M'!!!P>A!!(/6T4 ?.?P8_P""9_PG^%UEX=TKQ]\;/BO\5[+PA?0WWA>P^+'C
MF35K?3[N$Y@N#$J1K<RQ$!HGN!*86"O'L958>\^,?#][XJ\-7?A[3O%NIZ%-
M=1A%U71_)^TP#<"3&9XY$!(!7)0D!B1A@&&G10!X3^PG_P $^/@U_P $[O =
M]\*OV?/%OB]_#%_J=QJ3Z'XDUE+^.*]G96FN$D:(3*SE>5W[,DG;N.:\H^ O
M_!/?PW\+_P#@K5\0OVZ?A'/X[TZR\8^&+VQ^(Y\3:K(;#7=6>:P^QII]K(JN
M(+2*TNF,[90F]1(&*+*J?9M% '&?M#?!#P_^TE\&/$'P,\6^*?$6C:5XEL39
MZG>^%-8?3[[[.Q'F1QW"#=&'4%&*X)1F&1FOBFU_X-H?^"?%CHD?AFR^)'QU
MATV&U6VAT^+XRZBL"0A=HB$8.T(%& H&,<5^A-% 'D_Q _8E_9O^)O[,FC_L
MB^*? >?!?AS3]-MO#-M97DEO<Z*^G",6-S:7$962WN(#%&R2HP8%><@D&'X.
M?L7_  U^%'Q:O?VA->\5>)?'?Q#O-#31%\;>.+^&XO+/2ED\P6-LEO##;VT1
MD^=_*B5YF"M*TA52/7J* /AOXJ_\&_G[%_QE^,'B?X[>-_BS\<&\2^+]1-[K
MM]8?%N^M1.X&U$"1;56.-,1QH!M1%"J !BO;_P!A?_@G=^SO_P $]?#/B/PY
M\!CXDNY?%>K1ZAKNL^+_ !'-JM_<O'"L449GF.[RT4,53H#(Y_BKW6B@#RG]
MK7]C7X)_MK>%O"O@_P".5CJ-Q9>#O'FF^+]%73=0:W9=3L3(;=G(!WH/,;*=
M#Q7JU%% 'S-\<?\ @D[^RU\=?VM[7]MC4-:^('A;QT=!31/$%Y\/_'U[H<?B
M/3D8%;6_^R.CRH,*/D="0B D[$VX7P[_ ."*_P"Q?\'?#'Q;\&?!]O&7A?2O
MC1=:B_BS3-(\4.MK:07Z!+VVL+=U:&Q294C5WB03;8HD$@2-%7ZVHH ^6M3_
M ."2'[.^L?L+1?\ !.#4/B-\0I/A+#;):+H/]O6XG-FDRSI:&[%MYYA65 P&
M_./D+%,(+/[0O_!)7]E']J;]FOP9^S5\;I?%.K0?#B2WE^'OC2'7!:^(O#LD
M"HD4EM?01H=RI'&I+J^\QHS[G17'TY10!\BZ7_P1<_9:/QT^'W[2_P 0/BG\
M9?&?CSX;65W;Z#XI\4?%C47O9!.H1C)+;O$P4)O3RHC'"XFE\R.0R.3]5^*]
M!/BKPOJ7A@:U?Z;_ &E836O]HZ5<>3=6OF(4\V&3!V2+G<K8.& .#BK]% 'Y
M]6'_  ;6?L!:5'+%IGQ1^/-LL]U-<S+!\:-20232R-++*V&Y=Y'9V8\LS$G)
M)-?47PD_8*_9A^#W['P_83TCX?C5_AM)IE]8ZCHWB.Y:]?4H[R:6:Y:XE?YY
M9)))I'+D[@2"""!CV.B@#P3X8?\ !.WX,?#[QWX0^(/B;QIXU\>7?PXLI+3X
M:0>/=?6^A\*Q/$(6:V58HS-/Y($7VJZ,]R$W*)0'?=YU^U=_P1._91_;+^/M
MY^TE\8OB7\7H_$MUIT>GP_\ "/?$R[TZVLK-,$6T$4.!%$7'F,H^\[,YR3FO
ML"B@#Y>_8W_X)$?LE_L0>+O$WCWX4ZAX\U;6_%7A[^P[_5O&7CJ\U.YM[ OY
MCPVTLC![<.X1F*$',49!!4&J7PC_ ."0GP-^%_@N;X2:_P#M _&WQYX!GG+R
M?#WX@?$N?4-)="V[[/(H1)9[8G[UM+(\,@R)$<,P/U=10!YE^UQ^R=\*OVT?
MV8_%/[)?Q:?5;3PIXNTV.QU(^'+_ .Q7,422QRH(I I"@-$H*E2K+E64J2#V
M'PM^'?A[X0?#+PY\)O"4EX^E>%]"L](TQM0NWN+@V]M"D,9EE<EI'V(NYVY8
MY)Y-;M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M .A0O?\ OI: -BBL?_A)=7_Z%"]_[Z6H[;Q??7D9EM?"UU(H8J6212,CJ.M
M&Y16/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[_P!]
M+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM &Q
M16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]"A>_]]+1
M_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\ WTM
M&Q16/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[_P!]
M+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM &Q
M16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]"A>_]]+1
M_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\ WTM
M&Q16/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[_P!]
M+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM &Q
M16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]"A>_]]+1
M_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\ WTM
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MH V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EH V**Q_P#A)=7_ .A0O?\
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M'[0?P^T*1H]+\6?LVZ)KNOPQG"RW]E/IMI;R..A98+B103SAC[T ?II1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% 'P_P#\%$?V5/BYH'[>?P&_X*J? 'P#?^,;WX6Q:CX:^)'@
MO2-C:AJ7AK4(I$-S9([*)I[26:2;R 0TP.U>5VM-XV_9]U_]O+_@I[\#?VP1
M\/\ Q#X<^'O[//A_Q#<:;J7BS0;C2;WQ+KFKPP6PMX[*[2.ZCM[6*$RM-+'&
M'ED18Q(HD9?MJB@#X#_9*^$?C[_@DO\ '?\ :"\")\$/&OC#X6_%3X@3_$;X
M9WG@#P\^J26^J7L21ZAHES%$<V962& P3S;;9HC\\R,C"N1^#W_!$SQ+\1/^
M"6'Q]_9X_:6NK#2/BE^T]XRUCQ[XMEMYQ=0>'M:N;M+S3[7S4XGCMI883(4X
M9GG",RE6/Z544 ?FI^TAX-_;#_;U_P""97AS_@E]JG[/_B[P?\2?$5EH/ASX
MO^+M8THIH6@6%A<6SW^IVU\3Y&I"Y6U(MX+=I)/])'G"'8Y'Z)?#GP#X9^%7
MP]T'X7^"K'[+HWAO1K72M(MMV?)M;>)88DSWPB*/PK9HH **** "O"_^">__
M "1/5O\ L>]9_P#2DU[I7A?_  3W_P"2)ZM_V/>L_P#I2: /=**** "BBB@
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M5FPHECBW%5W$>??M;_!_QW_P5M^-?[/W@@_!#QKX0^%WPL^(=M\1?B5?>/\
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M %%%% !1110 4444 %%%% !1110 5X7_ ,$]_P#DB>K?]CWK/_I2:]TKPO\
MX)[_ /)$]6_['O6?_2DT >Z4444 %%%% !1110 4444 %%%% !1110 4444
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M%*VTJ32?!D&GV#6VB>!M,DSYMOIL$CN[7$V2)[Z5O-E'RJL$?[JNH^(WP_\
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M0M?#7_"":YJ(\2>)Y($N(+R5K&RFB^RV$4B-"C-E[R0RE5^R0/)Y9_P;]?\
M!1+]C[XD_MN_M4_"OP7\5I[S7OB[^T#K7BKX>V3>%]3B&J:2ML9&N&DDMECM
MCL1CY4[1R<8V9(% 'LO_  41_:!_X+9_LX?!/Q5^W]\,+_X.:9X&\#PMJ]W\
M%M=T&ZN=6GT.-_WDEUJ:3B-;WRCYC00JL<>"BRSLFZ7[ ^"'[1'@S6OV1=*_
M:N^(3+X.T"^\'Q^*M9_MV81_V+:R6JW<HN&( !B1B&.!]P\5\_?\%N_V?/\
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M44 %>%^ ?^4@GC__ +$32O\ T8U>Z5X7X!_Y2">/_P#L1-*_]&-0![I1110
M44C,JJ68@ #))[5\LZ'_ ,%,[GXC?!77/VLO@;^R[XH\9?"#0CJ$B>+[#6+&
M"\URSL9)([J^TRPED#7-NK0R[/->"281DQQN&C+@'U/17C7Q&_;[_9:^&/[&
MD7[>VO?$99_AM>^'[/5](U2PM7EGU2.["?9(+># =[B9Y8XUB(#;VPVW#8YW
MP7^WV+7XV^"_@%^TM\ O$'PIUSXFV%S<_#IM>U6QO;?59K>-99].EDM)76UU
M!(F$GD-N1U#^7+(R,H /H>BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **\,@_X*"?!.*;XJZIXE\/\
MBK0?#'P::^7QQX[US1E@T:)[2-99DMY_,+7;!&!Q$C$-\C;7^2O,O^"?O_!8
M?X<?M^ZY86VD?LP?%GX>Z+XIBNKCX:^*_'_AR.VTWQ?#;Y:46DT4L@$PC5Y1
M$V-\<<C(SB.3: ?8%%%% !1110 4444 %%%% !1110 5X7_P3W_Y(GJW_8]Z
MS_Z4FO=*\+_X)[_\D3U;_L>]9_\ 2DT >Z4444 %%%% !1110!\D_P#!23_D
M:_"__8.N/_1BU\TU]+?\%)/^1K\+_P#8.N/_ $8M?-- !1110 4444 %%%%
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M;26TE[)+,LC(DD>Z-")5BQ)[1KGPL^)FA_M?_!7PHVJ_#GPI\(O ,.H1> /
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M!R:@0+>;5+61+JUAE)( CDFA2-B2 %<D\4 ?GW\9?^#C[]JCP5\(O%/C%/\
M@A-^U)X<.E>'KR['B'Q+X)N[;3M+\N!W^U74KV96."/&]V;@*I)XK]4O"%]=
M:IX3TO4[Z7S)[G3H)9GV@;G:-23@<#D]J_'?XH_\%=O^"CO_  4G\!ZM_P $
MQOAO_P $C/B)\-O'_P 1-+E\*_$;QCXP6<:+X3TVZ0V^H7RL]M'O7R'F\HLZ
M\LFSSFVJ_P"R>G6%MI>GP:99H5AMH5BB4G.%4  ?D* )J*** "BBB@ HHHH
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M'^WGI/Q#^#'_  3*M/C=\/? _AY'\ 32_&_2O#<5KKERDD=]J,MO=12R33I
MPM86(01)+=$;S<?N_EW_ ()._M!_MY:Y_P %R?VM9_&?_!/"VT*;QCJ?@*/X
MM0+\8-/NO^%=Q0:+=+9R*R0 :Q]I3Y]L'EF'&ULFOV2KRGX0_L:?!/X(?M)_
M%;]J[P)8:C'XN^,SZ,WC>:YU!I()3I=J]M:^3$1B+$<C!L9W'F@#XF_X-F?"
M6H?!/X2?M*_LN>,(6M_$W@/]JCQ''J=K(,.]O/:V/V:YP>2DJPNR-T95!&<U
M\!?&/]G+XB_M _\ !+W_ (*;?M)>!-+N+K2/$'[4]UK/AX1(2-0TS1=9,EW=
MIC[T:P7,CEAQFV<=5./V]^)_[!GPM\>_%W7/COX-\>^-/AYXK\6Z+;Z1XWU;
MX>ZW'8OXCLH PMTNA)%*!+$KND=U"(KF-'*K,%  [SX2?L\_!/X%?!/3/V<?
MA3\-=+TCP/I&EMIUEX;C@\RW^S/N\Q)!)N,QD+NTC2%FD9W9RQ8D@'Q3_P %
MG_C!X5UO_@W<\=_$S0;I+BP\8?"O0$T$6_SFZ.I3V$=NL8'+EO/4@#MSVKZP
M_8*^%'B3X#_L,_!CX'^,86CU?P;\*/#NAZK&YY2YM--MX)5_!XV%<-X*_P""
M6/[-/@U?"7AB75_%^M>!?A[K:ZQ\/?AAK^OBYT'P[>HS-!+#%Y8FG$!=C!%=
M33Q6_P IB2,HA7Z2H *R?'5GXQO_  C?V?P_UBTT_6I("-.O;ZW,L,,F1AG0
M?>&,\5K44 >%_P#" _\ !03_ *+_ .!/_"4D_P#BJQ/^">-CX\7X&ZDL^NV+
M2#QIJHE86IPT@FPY'/ +;B!V!%?1]>%_\$]_^2)ZM_V/>L_^E)H ]<^Q>-_^
M@W9?^ Q_QH^Q>-_^@W9?^ Q_QK8HH Q_L7C?_H-V7_@,?\:/L7C?_H-V7_@,
M?\:V** ,?[%XW_Z#=E_X#'_&C[%XW_Z#=E_X#'_&MBB@#X^_X*'0ZS#XH\-#
M6+R&9C83[##'MP-Z]:^=*^EO^"DG_(U^%_\ L'7'_HQ:^:: "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /O;]EZU\
M6/\  'PP]CJUK'"; [$> D@>8_4UWWV+QO\ ]!NR_P# 8_XURO[*/_)N_A7_
M +!Q_P#1CUZ%0!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8_P!B
M\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+Q
MO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8
M_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-
M'V+QO_T&[+_P&/\ C6Q10!\??\%#H=9A\4>&AK%Y#,QL)]AACVX&]>M?.E?2
MW_!23_D:_"__ &#KC_T8M?-- !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% 'WM^R]:^+'^ /AA['5K6.$V!V(\!) \
MQ^IKOOL7C?\ Z#=E_P" Q_QKE?V4?^3=_"O_ &#C_P"C'KT*@#'^Q>-_^@W9
M?^ Q_P :/L7C?_H-V7_@,?\ &MBB@#'^Q>-_^@W9?^ Q_P :/L7C?_H-V7_@
M,?\ &MBB@#'^Q>-_^@W9?^ Q_P :\<^&$=_%^WUX^34[B.6;_A!=*W/&FT']
MX^.*][KPOP#_ ,I!/'__ &(FE?\ HQJ /=**** "BBB@ HHHH **** "BBB@
M#PO_ (*8?M@W/[ W[!_Q-_:\T[PLFMWO@KPZ;G3-+F+"*>\EECM[<2[<-Y0F
MFC+X(.P-@@\U\)^ /V5O^"PE_P# /P?^V/\ M0_\%>/'>@^.?&OBCPI&G@'P
M-X:TJ/1/#UMK.L6%I]GDBG@DCNI(8;LDY0#>NTM* 7?] _V]?%?[/'@K]C[Q
M[KW[6OAR'5OAC_8GV;QY9W$3R)_9<\J07$A6/YSY:2&3]W^\^3Y,-M-?GS\;
MO^"@_P#P1<^-W[!E]^P3JO\ P6=NK#2_/TE/#_CBQBN(_$&E6FG7MI=VT0N4
MM5665#:",7!02%&!<R2!I' /T%_8V^,?C/XH^"_$WA#XG^(M(UOQ9\./&MWX
M2\3:_H%J;>SU2Y@A@N$N4A+OY#M!=0>;"&813B:-6*J#7KU?*/\ P1:N_P!B
M"X_8+T2T_P""?FL7NJ> +'Q)K=D=;U>[>?4=7OX=0FCN-1NY'1':6Z*K<C<B
M$1SQ (@ 4?5U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !7E6MZO^V6G[9.B:)X>\)^!'^!+^!IY=?UJZN[D>(H_$(N&$4,,8/DFU,.P
MDE=VXO\ ,NU5?U6OCS]O_P +?\%G/%'[0_AG2/\ @G)\9?A?X6\$7/@VYF\1
M7'Q"\.2W?D:I!=(JJDD2.W[Z&Y4JI  ^QRG.6 H X3XL_&C_ (.)=3_:3^(O
M@K]F7]G7]FZ;X>^&O$PLO"OB+Q]=:S:W6J6DEI;W22;8+EA(4%P(7D5%4RPR
M@ ;:V?V9_&W_  77U']K'P5H_P"WC\+_ (*:/\,I8M2:]O\ X.WFI3S/?BSD
M-M%=_;)&*6_$C JN#*L0+ E5;AO^%$_\'1?_ $?%^R__ .$1?_\ R-79_LN?
M!_\ X+E>'/VK/!/B/]O#]HSX4^,?AM:IJ8N],^&FBW%E/#?O92+;3W/FP)YD
M 'FI@-@22QDJW#( ?==%%% !1110 4444 %%%% !1110 5X7_P $]_\ DB>K
M?]CWK/\ Z4FO=*\+_P"">_\ R1/5O^Q[UG_TI- 'NE%%% !1110 4444 ?)/
M_!23_D:_"_\ V#KC_P!&+7S37TM_P4D_Y&OPO_V#KC_T8M?-- !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'Z%?LH
M_P#)N_A7_L''_P!&/7H5>>_LH_\ )N_A7_L''_T8]>A4 %%%% !1110 4444
M %%%% !1110 4444 ?)/_!23_D:_"_\ V#KC_P!&+7S37TM_P4D_Y&OPO_V#
MKC_T8M?-- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% 'Z%?LH_P#)N_A7_L''_P!&/7H5>>_LH_\ )N_A7_L''_T8
M]>A4 %%%% !1110 5X7X!_Y2">/_ /L1-*_]&-7NE?,-U\;/A1\(/V^?'5_\
M3/'-CHT-QX-TN"&2\<@/("7*C /.U@?QH ^GJ*\X\*?M=_LT^.?$=IX1\(_&
M/1[_ %*_E\JSLX)6+ROC.T97KQ7H] !7B7QI_;H^&_PR^-NG?LL^ /"6N?$7
MXJ:EIW]HGP-X.2!I=*T[.W^T-2N+B6.WT^VW$!6E?S)2<0QRM\M>@?'SXK:?
M\"/@7XT^.&K637-KX,\):EKMS;JV#+':6LEPR ]LB,C\:_(W_@DIXE_X*8_#
M7_@F?XU_X*E?#GX+?#7Q_P"-_BWKVJ_$#QP_BCQ)?IK?B:SMI988["T$-OY5
MFD,,$OV:%GE7,Q $8(6@#]2_CM^U=X(_9(_9FU/]I?\ :O-MX8L=$ME?4M/T
MB[?4WDGDE$5O:6Q$437-Q,[1(J!!\[XR5&^N,\%_M]BU^-O@OX!?M+? +Q!\
M*=<^)MA<W/PZ;7M5L;VWU6:WC66?3I9+25UM=02)A)Y#;D=0_ERR,C*/SJ_X
M*+_MX^"_^"EG@'_@F]\1OAG:7ECX(^+7[3^CWWB+0KV0%[>[TZ^BM9;&8C D
M"2RW*@X <*C@#(Q[1_P=$>(M0^'/[,_[/WQG\*R-!XB\)?M7>%+[0KJ$XD$H
MM]08Q@CDAMBY7OM% 'Z:4444 %%%% '+?&KX3_#;XX?#+4_A?\8-%MM2\,:D
M(6UK3KX*;>Z@BF28Q3!P5:)O+"NIX9"P/6OA/Q/_ ,%4_P#@VFT/QS-\"-?^
M*GP+DNF=K">*#X=BYTHC[C(U[%8M9>7@X),NS&>< U]"_P#!7OX(_';]I#_@
MF=\9O@?^S1=RQ^-O$?@N:VT:""X$3WH#H\]FKD@!KB!9;<9(7,W) R:XS]CG
MP?\ \$\OV4?^":S^-?@;\!M/B\)>"_ ,EYXXT&Q\(I-X@EN;2R\Z\M=1MG03
MR:CPP>&?#[F X7% '3_\$DO@I\:_@3^R3_PB_P :O$7P\U-M1\7:KJ_A&;X8
MR--I<7A^YF\S3XDN&16NMD)"K,V]C$(5+N5+'Z<KY5_X(^^)/^$Z_9:U3XD^
M%?@1KOPP^'WB?QYJ>J_"CP%XDL$L[O2= F6$C-LC,MK'->"^N8X5)1(KF,)\
MFVOJJ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KX[_;
M_P#V7?\ @JI\>/VB/#.H?L/_ /!1@_!3P(O@VYC\2P/\/]+UT-JT5TA@94NE
M64&:&XE!(D*)]A7Y09<G[$KRK6_V=_'VK?MD:+^U!:_M-^,;+PUI7@>?0;KX
M2V\J?V'J%U)<-*NIRJ?F^T*K",'KA$PRC>K@'QK_ ,.T_P#@OA_TL-?^:WZ)
M_P#':Z_]F+]AO_@J?\'/VL? GQ/_ &P/^"H\7QR\&Z>=3A_X1B3X=:?X<-C>
MRV$RPWB_9G)NB%$L>P_,HF+ ;=Y&5\8O^"0W[;/QL_:.^(_Q4L?^"R?QU^'O
MA;6_% NO!?@_PCK;/;Z=9/:6[2H?,D&P"[:Z5(U4*L2Q<DD@7OV:O^"9?QU_
M9,_; ^'GQ9^+'_!5GXI?&*S)U:PM/!/Q,U(R1&:73Y6^UVJJ[ RQK&RG<O"3
M/AU/RN ?>]%%% !1110 4444 %%%% !1110 5X7_ ,$]_P#DB>K?]CWK/_I2
M:]TKPO\ X)[_ /)$]6_['O6?_2DT >Z4444 %%%% !1110!\D_\ !23_ )&O
MPO\ ]@ZX_P#1BU\TU]+?\%)/^1K\+_\ 8.N/_1BU\TT %%%% !1110 4444
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M#;2'3KB]AB@N$N+82%GC2:VNK:8PNS-"TKQ%Y#'YC>IU\M?\$<_#?[)_AO\
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M10!\D_\ !23_ )&OPO\ ]@ZX_P#1BU\TU]+?\%)/^1K\+_\ 8.N/_1BU\TT
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M/?\ Y(GJW_8]ZS_Z4F@#W2BBB@ HHHH **** /DG_@I)_P C7X7_ .P=<?\
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M9_&;_@XC_:)\(^&2EI+X+FU3]HVSM--AE6W\M$TR>7;#E(I&C1H>B/@#:V"
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M\7OASX2U?Q0+CP3X0\.)'<PV-B]I;O*A9Y5V 7;72)&%PL4<9R2Q W/V5O\
M@EG^U_\ LY_M4>#_ (Z_%G_@J1\2/C;H&C0:E;W7A/QU L4%K)<6CQQWT/ER
MLK2H1Y6&7.RX<AEPP8 ^Z**** /,/B/^R#\#/C/\;=,^-_QH\#:9XON_#V@M
MIOA72_$FG17EGHKRRL]W=P12JRK<3J+>-I,;E2V55*AY WQ'^QG^RCX-^"7_
M  </_'CQ1^R;X7M?#/PTC^!NC0_$S0]"@%OI@\8WEZMQ;*D" 1I*+"%IV"#Y
M3>,Q \_)^@/^"DG_  58_9N_8%70_A9XR^-?A#0/B%XVW)X=A\4WI%GI%L,B
M35K]8SYGV:/:P2)</<R@1(4'FS0\I_P3[_;X_P""7=YXDT?]DK]CW]INV^*7
MCGQ;J&H:]XJU;2K>2XO-2O3$T]]K6IS^6D40=ECB51@)OMX(HUC150 \P_X-
M[_'U_P#M<:U^U;^WEX_ O-:\<?M":AX:T^6X&\VWA[2;2W&GV2Y^['&EW("H
MP&;<Q&6)KXUF_;Q^*'[%7_!)+]OW]FOX:>);JTE^"?Q\U/P/\++R&8K)HNB:
MQJS01P0L#F,P1"]>-ARC.H7 48^R?^"+&AZ#_P $ZO'/[5?[#'QT\1Z?X:_X
M1OXP:C\1_"^H:Y>I:PZAX0U2WA$%]')(0KQPFS>.=P2(I258CC/S%X2_X)C_
M !B_;8_X(_?MH_&70_"%]!XI_:7^,>I_$GX6Z)=6[17-YI%EJ7VS34\MP&5[
MJ,72Q!@ 4GA?.&S0!]._\%1/V>-"^!'_  ;JCPK\,$&@:O\ !3P)X7\0>"-8
MTX".XTK5M,FLY1>1.!\LS_OPS]6\^0G)8U]P_L?_ !INOVD?V2_A=^T/?6L<
M$_CSX=Z)XBG@B&%B>]L(;ED [ &0C'M7P/\ \%'/VG]&_;!_X(*:)X"^ ]U#
MKOQ&^/\ H'A_PEX2\&6LRF^DUF2XM1J5K)%]Z(V:17AN&8!8?(;>5'-?H+^S
M'\&;/]G']FWX>_L]:?>BYM_ ?@?2?#L%RJX$J65G%;!\'ID19_&@#N***R?'
M7@[2_B#X1O\ P7K=Q=PVFHP&&>2QN6AF520<HZ\J>.HH UJ\+_X)[_\ )$]6
M_P"Q[UG_ -*31_P[W^"?_0V^._\ PLKG_&L3_@GCX"T:#X&ZE;I=7Q6+QIJL
M2DWC$D)-L&3W.%&3W.30!]'T5C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;4
M ;%%8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;4 ;%%8__"#Z1_S\WO\ X%M1
M_P (/I'_ #\WO_@6U 'S#_P4D_Y&OPO_ -@ZX_\ 1BU\TU]%_P#!0[1K71_%
M'AJ.UDF8/83D^=*6_C7IFOG2@ HHHH **** "BBB@ KB_B+XD_9[\3ZQ_P ,
M_P#Q9UWP?J%_K.G?:O\ A#/$-S:RRWMKO9?-^RS$F2/<C#=M(RA]*[2N7\>_
M!#X+_%2_M=5^)_PA\+^)+JQ7;97.O:!;7DENN<X1I48H,\\8YH ^1_V=_P!D
M?3/^$;_:P^"/P(O1;_"[QK'_ &7X!A2X9[*VU.72I8M2-NQ)#1)<2PQEERH:
M!H\DQFLX?$%C_P $/3\/AITJ^+!X-/P[_P"$8V_Z<==W_P!F?8O*^]YV[Y]N
M,[/G^[S7W98V-CI=E%INF6<5O;V\:QP6\$81(T P%51P !P *QU^%_PS3QLW
MQ*3X=Z$/$;1[&U\:1#]M*[=NTS[?,QMXQGIQ0!P7P3U;X<_LQ?#?X2?LF^.O
M'^F6OBJ3PA:Z5HVFRW&)-3EL;.-;AHAW P6[9SQGI7CO[!WA:P^%/[5?[3/P
MJ^(=G!#KFO>/&\663WJ*/[2T&]5S$\9;_6Q1/YD3XR$<[3@FOJG5/!?@[6_$
M.F>+M:\)Z9>:MHOF_P!CZI=6$<EQ8>:NV7R9&!:+>H"MM(W 8.:J>,_A9\,?
MB/+:S?$/X<Z#KSV)8V3ZUH\-T;<L,-L,JMLR.N,9H ^:_P#@EA\'K+1_V;_'
MGA/6M"M[_P"'^M_%KQ#<_#_3=1MUFMIO#IG1+8K&X*F%WCED7C#!PXR&!KTG
MP7X3\+?%+XA0V7@[PUI^F?#;X=:M(NE:?I=FD%KJWB"-V\V81Q@*8;-RZKQA
MKLR-@-;(S>S16\$$"VL$2QQH@1$C&T*H& !CH,55\-^&_#_@_0;3PMX5T:VT
M[3;"!8;*QLX1'%#&HP%51P!0!\&>'/CA\9QX:\&_'FY\8:Y_PFNN_M7R^#]:
M\/R:I.UJFD-=7-J^F_9"WE(L5O$DX?8'5T,A;YW+?H!7,Q?!?X10>/C\4X/A
MGH2>)"[.=<72XA<^8T8B:3S-N=YC58R_WBBA2=H KIJ "BBB@ HHHH ****
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M*[#4$U_63X=TKX@R^-]-\&%X!86^NN&/V@,(O.\M9'DF6'S-BRN3]T*B^WT
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MEG;:MJ4<DB22)<7<<8FF5I$1R'8@LBD\@&NWHH **** "BBB@ HHHH ****
M"BBB@ KPO_@GO_R1/5O^Q[UG_P!*37NE>%_\$]_^2)ZM_P!CWK/_ *4F@#W2
MBBB@ HHHH **** /DG_@I)_R-?A?_L'7'_HQ:^::^EO^"DG_ "-?A?\ [!UQ
M_P"C%KYIH **** "BBB@ HHHH **** "N8^)L$C6=K<@?*DC*WU(&/Y&NGJ#
M4].MM6L9+"Z7*2#J.H/8BOH.%LWAD/$&'QTU>,'KWLTXNWFDVT?/<5Y///\
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MU^%_^P=<?^C%KYIH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MN?#[]H?2]!E:V4)]H\/:I:7,>HV!QC]W*EK"-O0% PP5!H _2"BBB@ HHHH
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M .C'KT*O/?V4?^3=_"O_ &#C_P"C'KT*@ HHHH **** "BBB@ HHHH ****
M"BBB@#Y)_P""DG_(U^%_^P=<?^C%KYIKZ6_X*2?\C7X7_P"P=<?^C%KYIH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH _0K]E'_DW?PK_ -@X_P#HQZ]"KSW]E'_DW?PK_P!@X_\ HQZ]"H ****
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M0?%6CW'AWQ/HEIJ6GWD1CN[&_MEFAG0]5='!5A[$8KB_^&3_ -EG_HVKX?\
M_A&V/_QJ@#\_O^"OFK:)^UO^R_\ LW_\%9_V;=,U?7_"OP,^.6E^.KPC2I8Y
M]0\)PWXCO;^& CS3&5MX;A<J&^SEI"JXQ6S_ ,%K?#VA?\%%O&?[*_[#/P+\
M26'B1_$7QCTSXB>*;S0[Q+J+3O"&FVT_G7\KQDK'%,;M(X&8@32X5"3G'Z/:
M5HNC:%H]OX>T32;:ST^TMUM[2QM8%CAAB50JQHB@*JA0 % P ,5A?#GX+_!W
MX/+?K\)/A/X9\+#5;CS]3'AS0;>Q^V2\_O)?)1?,;D_,V3R: .FHHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "O.?VNOVG?AO^QA^S-XV_:F^+<\J^'_  1H$VI7
MT5OCS;EE 6*WCS@>9+*T<29(&Z1<D#FO1J_.C_@ZQLO$MY_P1&^)YT!)6@AU
MCP])JRQ G-L-8M!DX["4Q'\,]J -/XC?MV_MR?LN?L/^$?\ @J7^T5/X7U#P
M9J1T;5?B/\)]#\-R1W'A?P_JDL,<4MG?&8R75[:?:;=IQ(@BFQ,$6 !6K[ZT
M+7-'\3Z)9^)?#VI0WFGZA:QW-C>6[AHYX9%#I(I'564@@]P:^&?^"UE]X9L?
M^" 'Q6N+5XO[-;X3:='8$8VD/):)!C\63'X5] _\$RK#Q'I7_!-W]GW3/&"R
M+JUO\$?"D6IK-G>+A=(M1(&SSNW Y]\T >WT45D^.O$.J>%/"-_XCT3PK=ZY
M=VD!D@TFQ91-=-D?(A;C/U]* -:O"_\ @GO_ ,D3U;_L>]9_]*31_P -8?&S
M_HQ_QW_X%6W_ ,57A7PR_::_:D_9;T2\^'&G?\$Z?B/XKCNM8N]5&IV++$B_
M:96?RL*D@)7C)W<YZ"@#[IHKXY_X>4_M9?\ 2)_XI_\ @6/_ )'H_P"'E/[6
M7_2)_P"*?_@6/_D>@#[&HKXY_P"'E/[67_2)_P"*?_@6/_D>C_AY3^UE_P!(
MG_BG_P"!8_\ D>@#[&HKXY_X>4_M9?\ 2)_XI_\ @6/_ )'H_P"'E/[67_2)
M_P"*?_@6/_D>@#0_X*2?\C7X7_[!UQ_Z,6OFFNK_ &DOVA/VLOVA-6TO5/\
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MC_Y'H ^QJ*^.?^'E/[67_2)_XI_^!8_^1Z/^'E/[67_2)_XI_P#@6/\ Y'H
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ KXE^*_[77[0WAKXH^)?#FB?$'R++3]?O+:TA_L
MFT;RXDG=47+1$G  &22?6OMJOS=^.?\ R6WQC_V-6H?^E,E '4_\-J_M,_\
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MK>$_@Q^Q!-^V#\<_@+XH\.:D/'EWX+L_ARMQ;W.H7.MQZO/I<-NLRLL 262
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M\4H)O"7BB^M_'?P?GU7481(+JXMXVO-.?8%47#(4*QA5RMB[!?W@%?K/X/\
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M\(?A/\7M-71OBS\,/#OBBS1'1+3Q%HD%[&JOMW@+,C !MJY'?:,]!0!\1_\
M!'SXA?MT>!_VD/CQ_P $_OVO?C3;_&/3_@V="/A;XQBQ$-[>17T$LW]FWY!;
M?=1((W(9GD7S"7=UDC(^_JP_AU\,/AK\'_"T/@;X2_#S0_"VB6S,UOH_AW28
M;&UB+'+%8H55%)/7 YK<H **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
)** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>ew-20240331_g9.jpg
<TEXT>
begin 644 ew-20240331_g9.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH CO+2"_LY;&Z5C%/&T<@5RI*D8.""".#U!S7Y._L(?"U?C)_P6M_
M;/\ V=/B9\7_ (KZIX*^'S>&KCP7X>/QH\2P0:2U[:&:X$7DWZ':SGA22%
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MV\.J_"'P9?ZA%"@5;BY2)(UE8#JX4D9//- 'T''_ ,%BO^"8$\7A^XM/VVO
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M+;3-(^._QEM=+L85VQ6L*Z/&%CC4<*H & .!73>(B#_P: 1D'_FUVU_]$1T
M?1G[''_!2S]@WX6_!?\ 9Z_9%^('[4GA72_B-K7PM\*V6G^&;B\8R&ZETJT,
M5M)(JF*&=P\>R*1U=_,3:IWKGZ4^+W[3'P9^!NL:9X9^('B6\_MG6;>>XTO0
M-!T"^U?4KFWA*":X6SL(9I_(C,D8>;9Y:&1 S L ?RU_X*P>"/!O@K_@VQ^"
M%YX1\+:?ILFC-\-=6TQ[*T2,V]]*;4RW*E0,2N9IBTGWF,CDDEC7T;_P49^
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M%KWCM$_9]\4(CNVG>#-:\RXU.^$F-J-8V2W-PI_BO)'3/% &UX?_ &COCO\
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M_P"5<)87'Q(CB'D!44QR.RE4Z( PW #H>E?0'Q$\$:;\%?\ @V:TSXU?L_\
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M[\1]*TKXDZW>:UXG^T:_;W4[:G=^6MU>Q2S6S/#-*D81BI"@'<H5PKK]*44
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MM:%JNL>(O!NBZ,NC:7I_C"XBOF@TM8%@2P+>6IF@6-=H$N]MK%2Q4*J^DT4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MT3PK=ZY=VD!D@TFQ91-=-D?(A;C/U]* -:BO"_\ AK#XV?\ 1C_CO_P*MO\
MXJNM^"7[0,WQK\%'QEIWPZU"Q"7\]I-:RW<4K1R1-M8%D)&<]NU 'H]%8_\
MPDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2T ;%%8__"2ZO_T*%[_WTM'_  DN
MK_\ 0H7O_?2T ;%%8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2T ;%%8_
M_"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2T ;%%8_\ PDNK_P#0H7O_ 'TM'_"2
MZO\ ]"A>_P#?2T ;%%8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2T ;%%8_\
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MH V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EH V**Q_P#A)=7_ .A0O?\
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M#86L\\OESW&QKIB8=@,*/'\X)DZ _2-?G;^VZ!_Q$3?L0MCD^!OB)D_]PHT
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M44 %%%% !6/X'_Y!$O\ U^S?^A5L5C^!_P#D$2_]?LW_ *%0!L4444 %%%%
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MPOJOQ673/#WP]\(ZJ4^WZ3X9T^WBC$UVJ,PBFO)HDN#!N+0JJ!\.61/M&B@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\+_P"">_\ R1/5O^Q[
MUG_TI->Z5X7_ ,$]_P#DB>K?]CWK/_I2: /=**** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *Q_ _P#R")?^OV;_ -"K8K'\#_\ ((E_Z_9O
M_0J -BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K'\#_ /((E_Z_
M9O\ T*MBL?P/_P @B7_K]F_]"H V**** "BBB@ HHHH **** "BBB@ HHHH
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MM)!I.G-(\4=U?7,S+%;+*\4R1)EGE:"3"X1F%7_@FU_P5.^!?_!2OP]XKMO
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MVT^RM[7Y(T6/S'9V)"K$J!/GW+]0?\)CX8_Z#4'_ 'U1_P )CX8_Z#4'_?5
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M1_PF/AC_ *#4'_?5 &E16;_PF/AC_H-0?]]4?\)CX8_Z#4'_ 'U0!I45F_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQZ%3P14M% &%_P *N^&?_1.]"_\ !1#_ /$UY#_P3VTW3E^"6JJNGP #QSK
M $0X N" .G8 #\*][KPO_@GO_P D3U;_ +'O6?\ TI- 'MW]G:?_ ,^,/_?H
M4?V=I_\ SXP_]^A4U% $/]G:?_SXP_\ ?H4?V=I__/C#_P!^A4U% $/]G:?_
M ,^,/_?H4?V=I_\ SXP_]^A4U% $/]G:?_SXP_\ ?H4?V=I__/C#_P!^A7R?
M_P %)/\ D:_"_P#V#KC_ -&+7S30!^HW]G:?_P ^,/\ WZ%']G:?_P ^,/\
MWZ%?ES10!^HW]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ%?ES10!^HW]G:?_P ^
M,/\ WZ%']G:?_P ^,/\ WZ%?ES10!^HW]G:?_P ^,/\ WZ%']G:?_P ^,/\
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M_9VG_P#/C#_WZ%']G:?_ ,^,/_?H5-10!#_9VG_\^,/_ 'Z%']G:?_SXP_\
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M;:%8HE)SA5  'Y"@":BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#\A_\ @H3XI_X)5?#C]MWX@^ _!'_!(+6_VN/CEXAU*SUSXBV7
MACP+'J5OX7+6%M!##<71BD%LTD<"3F,(V7GD=W4N%KV#_@E_H'_!-SQI\?-,
MUWX>?\$Q]?\ V5?C=X:TB\O8O"_B;P NA7&MZ5+&+:Y>VF1?*U&U1YH-Y7;)
M%((\JJL=^O\ $3]O#P9_P1X\9^/_  M^T?\ LE?$^\\+>,/B!JGB[1OBQ\._
M"*ZOI^K'49?/:WU!HY%DM+RW8FU19 5DM[:!D?JBU_V1/VV/B_\ \%:OVO\
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MP))8R5;AD /NNBBB@ HHHH **** "BBB@ HHHH *\+_X)[_\D3U;_L>]9_\
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MB[JWQ"\/3^*M<;7/B!XAU07NH^)]:CU":"^U*XF!/F&:2'?&W>!H3SG)^I:
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\F/B/_
M ,$U/V&OVC/VU_CAXD_X+!_M":I+XI/CD7?PPT37/BQ)H>EP>#)K6'[ ;&))
MH@2LRWD,P!R)(-S(!*LDOHW[&?\ P3D_X(U_LF?MM> ?B;^PI\8;&X\>7-KJ
MVGMH.G_$T^(?M>G/8R//(T;W$KP!'C@_>CY<L$()<%?"]2^'W_!O[H_[=7[2
M%Y_P4[^+/PP\8?$?5OBC)?V&I^./$<SG3M):U@BBTD1;PL$MI-#<Q%=I)B-N
MP8JP2/V[]B;2?^#?.P_;5\!R?\$RKCX>'XF_9]6$J_#B[DESI1L9?M'VK+%!
M'Y@M]O\ 'OQM^4R4 ?I/1110!\4_\%5/VK/VQ/A]J^A_ +]E_P#8?^+7CW1=
M;B\[X@>-/A\UO:S6E@=P.GV%Q-(IBNIL;7N5&;>)B8CYS+) O[#W[8W[5OQ,
M^)?A/]G/3?\ @D;XO^ _PWT'1IC?Z]XRU"T6UL[.W@\NVL+*WM3S*TKP\L=J
MQ1R_*Q(*_:M% 'P'^R5\(_'W_!)?X[_M!>!$^"'C7QA\+?BI\0)_B-\,[SP!
MX>?5)+?5+V)(]0T2YBB.;,K)# 8)YMMLT1^>9&1A7(_![_@B9XE^(G_!+#X^
M_L\?M+75AI'Q2_:>\9:QX]\6RV\XNH/#VM7-VEYI]KYJ<3QVTL,)D*<,SSA&
M92K']*J* /S4_:0\&_MA_MZ_\$RO#G_!+[5/V?\ Q=X/^)/B*RT'PY\7_%VL
M:44T+0+"PN+9[_4[:^)\C4A<K:D6\%NTDG^DCSA#L<C]$OASX!\,_"KX>Z#\
M+_!5C]ET;PWHUKI6D6V[/DVMO$L,29[X1%'X5LT4 %17UA8ZI:2:?J=E%<6\
MJ[98)XPZ./0J>"*EHH PO^%7?#/_ *)WH7_@HA_^)KR'_@GMING+\$M55=/@
M 'CG6  (AP!<$ =.P 'X5[W7A?\ P3W_ .2)ZM_V/>L_^E)H ]N_L[3_ /GQ
MA_[]"C^SM/\ ^?&'_OT*FHH A_L[3_\ GQA_[]"C^SM/_P"?&'_OT*FHH A_
ML[3_ /GQA_[]"C^SM/\ ^?&'_OT*FHH ^1O^"C]O!!XJ\,""%$!T^XR$4#/[
MQ:^;*^EO^"DG_(U^%_\ L'7'_HQ:^:: "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** /T%_94LK*3]GKPL\EI$S'3SD
MM&"3^\>O0?[.T_\ Y\8?^_0K@_V4?^3=_"O_ &#C_P"C'KT*@"'^SM/_ .?&
M'_OT*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\8?\ OT*/[.T__GQA_P"_0J:B@"'^
MSM/_ .?&'_OT*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\8?\ OT*/[.T__GQA_P"_
M0J:B@"'^SM/_ .?&'_OT*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\8?\ OT*/[.T_
M_GQA_P"_0J:B@#Y&_P""C]O!!XJ\,""%$!T^XR$4#/[Q:^;*^EO^"DG_ "-?
MA?\ [!UQ_P"C%KYIH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH _07]E2RLI/V>O"SR6D3,=/.2T8)/[QZ]!_L[3_
M /GQA_[]"N#_ &4?^3=_"O\ V#C_ .C'KT*@"'^SM/\ ^?&'_OT*/[.T_P#Y
M\8?^_0J:B@"'^SM/_P"?&'_OT*/[.T__ )\8?^_0J:B@"'^SM/\ ^?&'_OT*
M\/\ A[%'#_P4"\?QQ1JJCP+I6%48'^L:O=J\+\ _\I!/'_\ V(FE?^C&H ]T
MHHHH ***^;_^"HO_  4W^!?_  2I_9IF_:(^--A?:O)-?Q6.@>%M'=!>ZK<.
MZA@A?Y4CC4[WD;Y5^5>7D16 /I"BO._VH/VI?@W^QY\!-;_:/^.WB&33?#FA
MVT;S?9[=I[FZFE=8X+6WB7YIIY972-$'5G'(&2///!?[?8M?C;X+^ 7[2WP"
M\0?"G7/B;87-S\.FU[5;&]M]5FMXUEGTZ62TE=;74$B82>0VY'4/Y<LC(R@
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M7[Q.KI<1,2!,L9CD5E#%&4E_N"@ HHHH **** "BBB@ HHHH **** "BBB@
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M@#W2BBB@ HHHH **** /DG_@I)_R-?A?_L'7'_HQ:^::^EO^"DG_ "-?A?\
M[!UQ_P"C%KYIH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH _0K]E'_DW?PK_V#C_Z,>O0J\]_91_Y-W\*_P#8./\
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MAH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***\JUO\
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MHHH **** "O"_P#@GO\ \D3U;_L>]9_]*37NE>%_\$]_^2)ZM_V/>L_^E)H
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M7Q->>"C!'XGO)M6BLK:"YFA$R6<3,&,T_E,CL"%C7S$!DW;@OI]? G[3:_M
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M@ HHHH ^2?\ @I)_R-?A?_L'7'_HQ:^::^EO^"DG_(U^%_\ L'7'_HQ:^::
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M92Q(187(W?*&Z?X#_'_1OC<?$^AG1)=(\0>"O$<NB>)]&FG67[/<*B2))'(
M/-ADBD1T<JI()!52I ^+?V OV?/$_P"T?^R':_%GP\Z:5-9?M+WWQ%^'MIJN
MY+>:TBF$1M)&C#F..0?:DWH'VOA@' P?=/"_PR^(WPE\7^--'TOQ'8I\3?CG
MXJDU:\ET9FGMO"FC6\,5L;H/*B&9XHPJHS1J)+FXC79Y:.P /=O OQ/M/B'X
MG\1:7X?TF1]+\/7RZ<=;,H\J\ODW?:88EQ\RP'9&TF<>;YD>-T35U%> ?#3]
MK/X ^"H="^&7@OPMJ]CX.3QH_@'0?%3B)K&YUJ)7S!DRF=]\J2QBX9-LDRME
MOF5W]_H **** "BBB@ HHHH **** /T*_91_Y-W\*_\ 8./_ *,>O0J\]_91
M_P"3=_"O_8./_HQZ]"H **** "BBB@ KPOP#_P I!/'_ /V(FE?^C&KW2O"_
M /\ RD$\?_\ 8B:5_P"C&H ]THHHH **** "BBB@ HHHH **** /Q8_:_P#A
MEX?^$W_!"S]O._\ 'GAK3Y?&=S^T3XHO/$=W?VB//]IO/$%FNGS@N-R;M-N[
M1XL8Q'<#;C<<[GQC^$'_  0@_82^,5MHO_!4?X,V.@V4W@71O^%1VFN>$M5U
M#PQ#8+9QC48K*VLHI;>"_;4!<3W(9%D<3V\@RTDC-][?\%"?@=_P3ZTOX7^(
MOVOOVVOA\EWX?\#:?!K?B,KJ=[%;:H-/?S;-+RQMYXX-5>.4@01722A7D 4#
M<:^3/"/_  5C_P""DW[5'PXT3]I'P[_P1@\.R_!;7_$FDVG@^7XC_%"VM-6U
M@7]]#8V=Y%;M:2"!7DN8B&92FQRRR.IWT ?2G_!&3QI\$?B+^R/J'C;]D[PW
MJNC_  5OO'NJK\'M,U=I ]OI$)CM[@11RLTD$!U.+4WBA<YCC9%VH (U^M*\
M@_8<O_A1<_ <:?\ ";X:ZKX*CM?%&MOXD\%Z]<>;?:)KESJ-Q?:E!,WFRJVZ
MZNI9D:-VB>*:-XB8FCKU^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_@N^1G\::J[(67*%IMQ4^ZDE3[J: /H^BL?_ (275_\ H4+W_OI:/^$EU?\
MZ%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\
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M4+W_ +Z6@#8HK'_X275_^A0O?^^EH_X275_^A0O?^^EH ^8?^"DG_(U^%_\
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M:/\ A)=7_P"A0O?^^EH V*\+\ _\I!/'_P#V(FE?^C&KUS_A)=7_ .A0O?\
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MS^+GB7PQX@C\$)=QZ3XC\.R7"-?1W-]<W;":WFC'E%#.%#+(X<#)"8Y^GJ*
M/D[0_P!B/X[_ ++'[1WQ8^-W[#FL^"/[)^-MY#K/BKPEXZ>\AM]%\2(ACEUB
MT:T1S<+<*5:>T?RB\D09;B,,5&G\!/\ @E3^S]\)OV"?$_[!WCFXN?&.F_$4
M:M=_%#Q)>PK;W?B/5M3):\U$JF1!)NV>4%),2P0C<S)N/T]10!\+>(_^"9/[
M2OQV_94\%?\ !.7]J#XP>%=6^#?A&XTF#Q!KVD172Z_XYTC2I8Y+#3KJ!U$-
M@2;>V^T7$<T[3>2VQ(#(2OW+:VMK8VL=E96T<,,,82&&) JHH& H X  X %2
M44 %%%% !7A?_!/?_DB>K?\ 8]ZS_P"E)KW2O"_^">__ "1/5O\ L>]9_P#2
MDT >Z4444 %%%% !1110!\D_\%)/^1K\+_\ 8.N/_1BU\TU]+?\ !23_ )&O
MPO\ ]@ZX_P#1BU\TT %%%% !1110 4444 %%%% !4&IZC;:38R7]TV$C'0=2
M>P%3US'Q-GD6SM;8'Y7D9F^H Q_,U]!PME$,^X@P^!F[1F]>]DG)V\VDTCY[
MBO.)Y!P[B,?!7E".G;FDU%7\DVFS!UGQ7J^L2L7N6BBS\L,;8 'OZ_C5""\N
M[63S;:ZDC;^\CD&HZ*_KW"97EN!PBPV'HQC32MRI*WS[^;=V^I_'&,S;,\?B
MWBL16E*HW?F;=_EV\DK)=#L_!WC&74I1I6JL#,1^ZEQC?['WKI:\KL[B2UNX
MKF(G='(&7'J#7JE?SGXI<-X'(\TI5\)%0A64GRK92C:]ET3YEIT=[::'])^%
M/$V/S[*JN'QDG.=%Q7,]W&2=KOJTXO7=JU]=64445^7'ZJ%%%% !1110 444
M4 %%%% 'Z%?LH_\ )N_A7_L''_T8]>A5Y[^RC_R;OX5_[!Q_]&/7H5 !1110
M 4444 %%%% !1110 4444 %%%% 'R3_P4D_Y&OPO_P!@ZX_]&+7S37TM_P %
M)/\ D:_"_P#V#KC_ -&+7S30 4444 %%%% !1110 4444 %0:GJ-MI-C)?W3
M82,=!U)[ 5/7,?$V>1;.UM@?E>1F;Z@#'\S7T'"V40S[B##X&;M&;U[V2<G;
MS:32/GN*\XGD'#N(Q\%>4(Z=N:345?R3:;,'6?%>KZQ*Q>Y:*+/RPQM@ >_K
M^-4(+R[M9/-MKJ2-O[R.0:CHK^O<)E>6X'"+#8>C&--*W*DK?/OYMW;ZG\<8
MS-LSQ^+>*Q%:4JC=^9MW^7;R2LET.S\'>,9=2E&E:JP,Q'[J7&-_L?>NEKRN
MSN)+6[BN8B=T<@9<>H->J5_.?BEPW@<CS2E7PD5"%92?*ME*-KV71/F6G1WM
MIH?TGX4\38_/LJJX?&2<YT7%<SW<9)VN^K3B]=VK7UU91117Y<?JH4444 %%
M%% !1110 4444 ?H5^RC_P F[^%?^P<?_1CUZ%7GO[*/_)N_A7_L''_T8]>A
M4 %%%% !1110 5X7X!_Y2">/_P#L1-*_]&-7NE?*GB+0OCUK/[>OCB/X*>/-
M$T6X7P?I;7,FL:6URKP\@* ",-OW'/H0* /JNBO(/ O@W]M.P\76%Y\0/C/X
M/U#18YP=1LK#PX\4TL>#\J.6^4YQS7K] &5XZN/&%IX(UF[^'FG6=YK\6E7#
MZ'::C,8[>>\$3&%)7'*H9-H8CD DU^6/_!2[_@D]\2/V?/V1O'7_  4*^&O_
M  4H^.P^/?PX\/7'BZ\\7ZAXX==+U62T0W%S9+I:*(+>U=%D2&V3Y$'EH_FK
MN#?K'7RY^T9X9LO^"COB.Y_9-TB4S?"#0->A_P"%RZW$?W7B&XM9EE7PO:N/
MOIYR1F_E4X1$^R F26?[, ?/W[=?_!1_]H[0?^":/[,5MX0O&\'_ !J_:QU/
MP7X634;&W E\.3:O;V\FHWD$;@[9(_-\N,-DQM.C=8ZM_MYZUI__  1S^)O[
M._[0WP2U_P 0P^ _%_Q2LOAO\7_#^M>*;W4XM6MM1@E:WUF4WDLA%[;26SNU
MPI$DRR-'(S KMYW_ (+^:+80?$S]B?\ :ETB[M+GP?\ #']K#1;#Q7=V$JO#
MI<<U[!$TDA0[8Q#+9-$P.-LC*AP3BKG_  <T^$]7^-/P;_9M_9?\%PO<>(_'
MW[5'AR#3[:(9=;>*VOOM%QQT2(21LS=%4DG % 'Z7T444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !7A?_  3W_P"2)ZM_V/>L_P#I2:]TKPO_
M ()[_P#)$]6_['O6?_2DT >Z4444 %%%% !1110!\D_\%)/^1K\+_P#8.N/_
M $8M?--?2W_!23_D:_"__8.N/_1BU\TT %%%% !1110 4444 %%%% !6+XXT
M:75M(WVR%I;=MZJ.K#N/Z_A6U17HY1F>(R;,Z6-H?%3=UV?=/R:NGZGFYQE>
M&SK+*N!K_#45GW79KS3LUZ'D]%=]K/@?2-6E:Y3=;RL<LT?1CZD?X8JC!\,K
M19,W.JR.O]U(PI_,DU_2.$\5N$Z^$52M.5.=M8.,F[^32<7Y-M>:1_,^+\).
M+J&+=*C"-2%])J44K>:DU)>:2?DV8/A31I=9U>./83%$P>9L< #M^/2O1J@T
M[3+'2;86MA;B-!R<=2?4GO4]?B/''%DN+,T56$7&E!6@GOKNWYO31;)):[G[
MIP+PA'A'*G2G)2JU'>;6VFBBO):ZO5MMZ;(HHHKXL^V"BBB@ HHHH **** "
MBBB@#]"OV4?^3=_"O_8./_HQZ]"KSW]E'_DW?PK_ -@X_P#HQZ]"H **** "
MBBB@ HHHH **** "BBB@ HHHH ^2?^"DG_(U^%_^P=<?^C%KYIKZ6_X*2?\
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M/#EG,JI.MHL442":5$1)+J19+J1%"O,RD@^VT4 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 5X7_P3W_Y(GJW_ &/>L_\ I2:]TKPO_@GO
M_P D3U;_ +'O6?\ TI- 'NE%%% !1110 4444 ?)/_!23_D:_"__ &#KC_T8
MM?--?2W_  4D_P"1K\+_ /8.N/\ T8M?-- !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% 'Z%?LH_\ )N_A7_L''_T8
M]>A5Y[^RC_R;OX5_[!Q_]&/7H5 !1110 4444 %%%% !1110 4444 %%%% '
MR3_P4D_Y&OPO_P!@ZX_]&+7S37TM_P %)/\ D:_"_P#V#KC_ -&+7S30 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M!^A7[*/_ ";OX5_[!Q_]&/7H5>>_LH_\F[^%?^P<?_1CUZ%0 4444 %%%% !
M7A?@'_E()X__ .Q$TK_T8U>Z5X7X!_Y2">/_ /L1-*_]&-0![I1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %><_M=?M._#?]C#]F;QM^U-\
M6YY5\/\ @C0)M2OHK?'FW+* L5O'G \R65HXDR0-TBY('->C5^='_!UC9>);
MS_@B-\3SH"2M!#K'AZ35EB!.;8:Q:#)QV$IB/X9[4 :?Q&_;M_;D_9<_8?\
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M_ L?_(]'_#RG]K+_ *1/_%/_ ,"Q_P#(] 'V-17QS_P\I_:R_P"D3_Q3_P#
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M-/65%EC;:Z$CHP/!'8T =I17/^7^UE_T81\4_P#P3#_&CR_VLO\ HPCXI_\
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M^8MG;Y+8Z^IKH?\ AY3^UE_TB?\ BG_X%C_Y'H ^QJ*^.?\ AY3^UE_TB?\
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M);'7U-=#_P /*?VLO^D3_P 4_P#P+'_R/0!]C45\<_\ #RG]K+_I$_\ %/\
M\"Q_\CT?\/*?VLO^D3_Q3_\  L?_ "/0!]C45\<_\/*?VLO^D3_Q3_\  L?_
M "/1_P /*?VLO^D3_P 4_P#P+'_R/0!]C5X7X!_Y2">/_P#L1-*_]&-7EO\
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MQM(SM';PJBEB<EL #DGJ: )Z*** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ-/JFN:C*I;RH(E+-M4<NYX547+,S*H!) KY;_9-^+O_  4&_P""C/P<T_\
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M6>>[-RPN! T9N4MUB@^:)'$C211U]F?LH?'BQ_:D_9?^'7[2VF:%+I=O\0/
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MH\.:D/'EWX+L_ARMQ;W.H7.MQZO/I<-NLRLL 262 RB;=L$1W N=H;1\#_\
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MZ:C9:Q%=PO*EU9S"*)G@_=LF9(XWWI(I1=O(!ZY1110 4444 %%%% !1110
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MV8_^"?OQ=TSQCI^F^%!);:;X=9IYM#TZ"-1]HU3S-LEM+)*R(1,!/+-,S;6
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M&VGA75/%&D:3!I^I>+=2\3^$-1T?494C"/?2WMR9+QA,RF5]T,T^7.X2-DD
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>image_6.jpg
<TEXT>
begin 644 image_6.jpg
MB5!.1PT*&@H    -24A$4@  !ED    %" 8   #&\HI@    "7!(67,  $SE
M  !,Y0%USO"5    24E$051XG.W.L0D ,! #,>^_=#+#5\:@ _67) \
M ("S^@       ,"B^@       ,"B^@       , B29(D29(D29(D7?M[_4P4
0TLS&E     !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485961354448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COVER - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Apr. 25, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-15525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">EDWARDS LIFESCIENCES CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">36-4316614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One Edwards Way<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Irvine<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Zip Code</a></td>
<td class="text">92614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">250-2500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $1.00 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EW<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">602.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001099800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140486071119984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED CONDENSED BALANCE SHEETS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,224.6<span></span>
</td>
<td class="nump">$ 1,144.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments (Note&#160;5)</a></td>
<td class="nump">473.0<span></span>
</td>
<td class="nump">500.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowances of $13.5 and $8.3, respectively</a></td>
<td class="nump">817.6<span></span>
</td>
<td class="nump">775.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">59.3<span></span>
</td>
<td class="nump">61.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories (Note&#160;2)</a></td>
<td class="nump">1,207.3<span></span>
</td>
<td class="nump">1,168.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">138.1<span></span>
</td>
<td class="nump">146.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">250.6<span></span>
</td>
<td class="nump">239.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">4,170.5<span></span>
</td>
<td class="nump">4,035.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments (Note&#160;5)</a></td>
<td class="nump">455.6<span></span>
</td>
<td class="nump">583.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant, and equipment, net</a></td>
<td class="nump">1,767.9<span></span>
</td>
<td class="nump">1,749.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">98.4<span></span>
</td>
<td class="nump">94.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,252.8<span></span>
</td>
<td class="nump">1,253.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets, net</a></td>
<td class="nump">446.8<span></span>
</td>
<td class="nump">428.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income taxes</a></td>
<td class="nump">776.7<span></span>
</td>
<td class="nump">754.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets (Note 2)</a></td>
<td class="nump">767.6<span></span>
</td>
<td class="nump">463.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">9,736.3<span></span>
</td>
<td class="nump">9,363.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">212.3<span></span>
</td>
<td class="nump">201.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_AccruedAndOtherLiabilitiesCurrent', window );">Accrued and other liabilities (Note 2)</a></td>
<td class="nump">873.7<span></span>
</td>
<td class="nump">969.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">24.8<span></span>
</td>
<td class="nump">24.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,110.8<span></span>
</td>
<td class="nump">1,195.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">597.2<span></span>
</td>
<td class="nump">597.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrentAndNoncurrent', window );">Taxes payable</a></td>
<td class="nump">79.6<span></span>
</td>
<td class="nump">80.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="nump">77.2<span></span>
</td>
<td class="nump">73.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent', window );">Uncertain tax positions</a></td>
<td class="nump">336.6<span></span>
</td>
<td class="nump">339.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationReserveNoncurrent', window );">Litigation settlement accrual</a></td>
<td class="nump">82.0<span></span>
</td>
<td class="nump">94.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">266.5<span></span>
</td>
<td class="nump">264.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">2,549.9<span></span>
</td>
<td class="nump">2,643.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note&#160;11)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders' equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $1.00 par value, 1,050.0 shares authorized, 651.8 and 650.5 shares issued, and 602.4 and 601.1 shares outstanding, respectively</a></td>
<td class="nump">651.8<span></span>
</td>
<td class="nump">650.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">2,379.8<span></span>
</td>
<td class="nump">2,274.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">9,344.3<span></span>
</td>
<td class="nump">8,992.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss (Note 12)</a></td>
<td class="num">(233.3)<span></span>
</td>
<td class="num">(242.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury stock, at cost, 49.4 and 49.4 shares, respectively</a></td>
<td class="num">(5,024.7)<span></span>
</td>
<td class="num">(5,024.5)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Edwards Lifesciences Corporation stockholders' equity</a></td>
<td class="nump">7,117.9<span></span>
</td>
<td class="nump">6,650.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interest</a></td>
<td class="nump">68.5<span></span>
</td>
<td class="nump">69.4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity</a></td>
<td class="nump">7,186.4<span></span>
</td>
<td class="nump">6,719.4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 9,736.3<span></span>
</td>
<td class="nump">$ 9,363.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_AccruedAndOtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued And Other Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_AccruedAndOtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for uncertainty in income taxes classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUncertainTaxPositionsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482955/340-10-05-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481520/505-30-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140486049014768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED CONDENSED BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 13.5<span></span>
</td>
<td class="nump">$ 8.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">50,000,000.0<span></span>
</td>
<td class="nump">50,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">1,050,000,000<span></span>
</td>
<td class="nump">1,050,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">651,800,000<span></span>
</td>
<td class="nump">650,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">602,400,000<span></span>
</td>
<td class="nump">601,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">49,400,000<span></span>
</td>
<td class="nump">49,400,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485960801248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 1,598.2<span></span>
</td>
<td class="nump">$ 1,459.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">385.6<span></span>
</td>
<td class="nump">329.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">1,212.6<span></span>
</td>
<td class="nump">1,130.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general, and administrative expenses</a></td>
<td class="nump">489.7<span></span>
</td>
<td class="nump">436.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">285.2<span></span>
</td>
<td class="nump">261.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Intellectual property agreement and certain litigation expenses (Note 3)</a></td>
<td class="nump">8.9<span></span>
</td>
<td class="nump">43.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of contingent consideration liabilities (Note 7)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonrecurringIncomeExpense', window );">Separation costs (Note&#160;4)</a></td>
<td class="nump">41.3<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income, net</a></td>
<td class="nump">387.5<span></span>
</td>
<td class="nump">388.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest income, net</a></td>
<td class="num">(16.5)<span></span>
</td>
<td class="num">(8.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="num">(5.4)<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before provision for income taxes</a></td>
<td class="nump">409.4<span></span>
</td>
<td class="nump">398.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">58.4<span></span>
</td>
<td class="nump">58.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">351.0<span></span>
</td>
<td class="nump">340.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net loss attributable to noncontrolling interest</a></td>
<td class="num">(0.9)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Edwards Lifesciences Corporation</a></td>
<td class="nump">$ 351.9<span></span>
</td>
<td class="nump">$ 340.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 0.58<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 0.58<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average number of common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">601.6<span></span>
</td>
<td class="nump">607.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">604.1<span></span>
</td>
<td class="nump">610.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonrecurringIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense (income) that is infrequent in occurrence or unusual in nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483613/220-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonrecurringIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140486045805952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 351.0<span></span>
</td>
<td class="nump">$ 340.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive income (loss), net of tax (Note&#160;12):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="num">(26.1)<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Unrealized gain (loss) on hedges</a></td>
<td class="nump">26.9<span></span>
</td>
<td class="num">(17.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Unrealized pension credits (costs)</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain on available-for-sale investments</a></td>
<td class="nump">8.4<span></span>
</td>
<td class="nump">13.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">9.5<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">360.5<span></span>
</td>
<td class="nump">340.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Comprehensive loss attributable to noncontrolling interest</a></td>
<td class="num">(0.9)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to Edwards Lifesciences Corporation</a></td>
<td class="nump">$ 361.4<span></span>
</td>
<td class="nump">$ 340.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482739/220-10-55-15<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485961971808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 351.0<span></span>
</td>
<td class="nump">$ 340.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash (used in) provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">38.5<span></span>
</td>
<td class="nump">35.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Non-cash operating lease cost</a></td>
<td class="nump">7.7<span></span>
</td>
<td class="nump">6.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation (Note&#160;9)</a></td>
<td class="nump">44.6<span></span>
</td>
<td class="nump">38.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred income taxes</a></td>
<td class="num">(35.8)<span></span>
</td>
<td class="num">(51.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables', window );">Accounts and other receivables, net</a></td>
<td class="num">(55.0)<span></span>
</td>
<td class="num">(77.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(69.5)<span></span>
</td>
<td class="num">(32.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="num">(89.1)<span></span>
</td>
<td class="num">(45.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes</a></td>
<td class="num">(263.1)<span></span>
</td>
<td class="nump">87.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">27.1<span></span>
</td>
<td class="num">(23.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_IncreaseDecreaseInLegalSettlementAccrual', window );">Intellectual property agreement accrual</a></td>
<td class="num">(5.2)<span></span>
</td>
<td class="nump">29.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other</a></td>
<td class="num">(4.2)<span></span>
</td>
<td class="nump">6.2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash (used in) provided by operating activities</a></td>
<td class="num">(53.5)<span></span>
</td>
<td class="nump">314.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(65.3)<span></span>
</td>
<td class="num">(61.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireHeldToMaturitySecurities', window );">Purchases of held-to-maturity investments (Note 5)</a></td>
<td class="num">(0.8)<span></span>
</td>
<td class="num">(12.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities', window );">Proceeds from held-to-maturity investments (Note 5)</a></td>
<td class="nump">9.3<span></span>
</td>
<td class="nump">80.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchases of available-for-sale investments (Note 5)</a></td>
<td class="num">(1.8)<span></span>
</td>
<td class="num">(3.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities', window );">Proceeds from available-for-sale investments (Note 5)</a></td>
<td class="nump">157.3<span></span>
</td>
<td class="nump">183.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Investments in intangible assets</a></td>
<td class="num">(20.0)<span></span>
</td>
<td class="num">(13.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions', window );">Business combination, net of cash</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(141.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPaymentsToAcquireBusinesses', window );">Payment for acquisition options (Note 6)</a></td>
<td class="num">(10.8)<span></span>
</td>
<td class="num">(15.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireReceivables', window );">Issuances of notes receivable</a></td>
<td class="num">(2.5)<span></span>
</td>
<td class="num">(15.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="num">(2.3)<span></span>
</td>
<td class="num">(1.9)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">63.1<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchases of treasury stock</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(249.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Proceeds from stock plans</a></td>
<td class="nump">62.1<span></span>
</td>
<td class="nump">41.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">61.7<span></span>
</td>
<td class="num">(206.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash</a></td>
<td class="nump">9.7<span></span>
</td>
<td class="num">(4.2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash, cash equivalents, and restricted cash</a></td>
<td class="nump">81.0<span></span>
</td>
<td class="nump">103.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash at beginning of period</a></td>
<td class="nump">1,148.0<span></span>
</td>
<td class="nump">772.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash at end of period (Note 2)</a></td>
<td class="nump">$ 1,229.0<span></span>
</td>
<td class="nump">$ 876.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_IncreaseDecreaseInLegalSettlementAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Legal Settlement Accrual</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_IncreaseDecreaseInLegalSettlementAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments To Acquire Businesses, Net Of Cash Acquired, Excluding Options</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPaymentsToAcquireBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with other payments to acquire businesses including deposit on pending acquisitions and preacquisition costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPaymentsToAcquireBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireHeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow through purchase of long-term held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireHeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchase of all receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the sale or maturity of long-term held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485958813824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Total Edwards Lifesciences Corporation Stockholders' Equity</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Noncontrolling Interest</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, beginning balance (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">646.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">$ 5,806.7<span></span>
</td>
<td class="nump">$ 5,806.7<span></span>
</td>
<td class="nump">$ 646.3<span></span>
</td>
<td class="num">$ (4,144.0)<span></span>
</td>
<td class="nump">$ 1,969.3<span></span>
</td>
<td class="nump">$ 7,590.0<span></span>
</td>
<td class="num">$ (254.9)<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, beginning balance (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">340.5<span></span>
</td>
<td class="nump">340.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">340.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Common stock issued under stock plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Common stock issued under stock plans</a></td>
<td class="nump">41.9<span></span>
</td>
<td class="nump">41.9<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">38.9<span></span>
</td>
<td class="nump">38.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock</a></td>
<td class="num">(249.5)<span></span>
</td>
<td class="num">(249.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (249.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestPeriodIncreaseDecrease', window );">Changes to noncontrolling interest</a></td>
<td class="nump">84.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84.0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, ending balance (in shares) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">647.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Mar. 31, 2023</a></td>
<td class="nump">$ 6,062.0<span></span>
</td>
<td class="nump">5,978.0<span></span>
</td>
<td class="nump">$ 647.1<span></span>
</td>
<td class="num">$ (4,393.5)<span></span>
</td>
<td class="nump">2,049.3<span></span>
</td>
<td class="nump">7,930.5<span></span>
</td>
<td class="num">(255.4)<span></span>
</td>
<td class="nump">84.0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, beginning balance (in shares) at Dec. 31, 2023</a></td>
<td class="nump">601.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">650.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2023</a></td>
<td class="nump">$ 6,719.4<span></span>
</td>
<td class="nump">6,650.0<span></span>
</td>
<td class="nump">$ 650.5<span></span>
</td>
<td class="num">$ (5,024.5)<span></span>
</td>
<td class="nump">2,274.4<span></span>
</td>
<td class="nump">8,992.4<span></span>
</td>
<td class="num">(242.8)<span></span>
</td>
<td class="nump">69.4<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, beginning balance (in shares) at Dec. 31, 2023</a></td>
<td class="nump">49.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 351.0<span></span>
</td>
<td class="nump">351.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">351.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="nump">9.5<span></span>
</td>
<td class="nump">9.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Common stock issued under stock plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Common stock issued under stock plans</a></td>
<td class="nump">62.1<span></span>
</td>
<td class="nump">62.1<span></span>
</td>
<td class="nump">$ 1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">44.6<span></span>
</td>
<td class="nump">44.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock</a></td>
<td class="num">$ (0.2)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, ending balance (in shares) at Mar. 31, 2024</a></td>
<td class="nump">602.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">651.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Mar. 31, 2024</a></td>
<td class="nump">$ 7,186.4<span></span>
</td>
<td class="nump">$ 7,117.9<span></span>
</td>
<td class="nump">$ 651.8<span></span>
</td>
<td class="num">$ (5,024.7)<span></span>
</td>
<td class="nump">$ 2,379.8<span></span>
</td>
<td class="nump">$ 9,344.3<span></span>
</td>
<td class="num">$ (233.3)<span></span>
</td>
<td class="nump">$ 68.5<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Mar. 31, 2024</a></td>
<td class="nump">49.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485957280272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">BASIS OF PRESENTATION</a></td>
<td class="text">BASIS OF PRESENTATION<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim consolidated condensed financial statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") and should be read in conjunction with the consolidated financial statements and notes included in Edwards Lifesciences' Annual Report on Form&#160;10-K for the year ended December&#160;31, 2023. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") have been condensed or omitted.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The consolidated condensed financial statements include the accounts of all wholly-owned subsidiaries and variable interest entities for which the Company is the primary beneficiary. The Company attributes the net income or losses of its consolidated variable interest entities to controlling and noncontrolling interests using the hypothetical liquidation at book value method.  All intercompany accounts and transactions have been eliminated in consolidation.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements.  Actual results could differ from those&#160;estimates.  </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the unaudited interim consolidated condensed financial statements reflect all adjustments necessary for a fair statement of the results for the interim periods presented. All such adjustments, unless otherwise noted herein, are of a normal, recurring nature. The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for the full year.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to the Company's significant accounting policies from those described in the Company's Annual Report on Form 10-K for the year ended December 31, 2023.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, the Financial Accounting Standards Board ("FASB") issued an amendment to the accounting guidance on investments in tax credit structures to allow entities to elect to account for their tax equity investments, regardless of the tax credit program from which the income tax credits are received, using the proportional amortization method if certain conditions are met.   The guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years.  The Company adopted this guidance on January 1, 2024.  The adoption of this guidance did not have a material impact on the Company's consolidated financial statements.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Standards Not Yet Adopted</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2024, the SEC issued final climate-related disclosure rules that will require disclosure of material climate-related risks and material direct greenhouse gas emissions from operations owned or controlled (Scope 1) and/or material indirect greenhouse gas emissions from purchased energy consumed in owned or controlled operations (Scope 2). Additionally, the rules require disclosure in the notes to the financial statements of the effects of severe weather events and other natural conditions, subject to certain materiality thresholds. The new rules will be effective for annual reporting periods beginning in fiscal year 2025, except for the greenhouse gas emissions disclosures which will be effective for annual reporting periods beginning in fiscal year 2026. Subsequent to issuance, the rules became the subject of litigation, and the SEC has issued a stay to allow the legal process to proceed.  The Company is currently evaluating the impact the guidance will have on its consolidated financial statements.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued an amendment to the accounting guidance on income taxes which requires entities to provide additional information in the rate reconciliation and additional disaggregated disclosures about income taxes paid. This guidance requires public entities to disclose in their rate reconciliation table additional categories of information about federal, state, and foreign income taxes and to provide more details about the reconciling items in some categories if the items meet a quantitative threshold. The guidance is effective for annual periods beginning after December 15, 2024. The Company does not expect the adoption of this guidance to impact its financial statements, but the guidance will impact its income tax disclosures.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued an amendment to the accounting guidance on segment reporting. The amendments require disclosure of significant segment expenses and other segment items and requires entities to provide in interim periods</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">all disclosures about a reportable segment's profit or loss and assets that are currently required annually. The amendment also</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">requires disclosure of the title and position of the chief operating decision maker ("CODM") and an explanation of how the</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">resources. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">beginning after December 15, 2024. Retrospective application is required, and early adoption is permitted. The Company is</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">currently evaluating the impact the guidance will have on its consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 250<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//250/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485957255616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS</a></td>
<td class="text">OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Composition of Certain Financial Statement Captions</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of selected captions in the consolidated condensed balance sheets consisted of the following:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:75.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.191%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2024 and December&#160;31, 2023, $161.7 million and $164.6 million, respectively, of the Company's finished products inventories were held on consignment. </span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:75.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.191%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax receivable (Note 14)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes and other receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term prepaid royalties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued and other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and withholdings</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, payroll, and other taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued marketing expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal and insurance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued relocation costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued realignment reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued warranties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">969.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supplemental Cash Flow Information</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the year for:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes (Note 14)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts included in the measurement of operating lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash investing and financing transactions:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures accruals</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,224.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,144.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents, and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,229.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,148.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts included in restricted cash primarily represent funds placed in escrow related to litigation.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//210/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485960591808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTELLECTUAL PROPERTY AGREEMENT AND CERTAIN LITIGATION EXPENSES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LegalMattersAndContingenciesTextBlock', window );">INTELLECTUAL PROPERTY AGREEMENT AND CERTAIN LITIGATION EXPENSES</a></td>
<td class="text">INTELLECTUAL PROPERTY AGREEMENT AND CERTAIN LITIGATION EXPENSES<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 12, 2023, Edwards entered into an Intellectual Property Agreement (the "Intellectual Property Agreement") with Medtronic, Inc. ("Medtronic") pursuant to which the parties agreed to a 15-year global covenant not to sue ("CNS") for infringement of certain patents in the structural heart space owned or controlled by each other. In consideration for the global CNS and related mutual access to certain intellectual property rights, Edwards paid to Medtronic a one-time, lump sum payment of $300.0&#160;million and is paying annual royalties tied to net sales of certain Edwards products.  Based upon the terms of the Intellectual Property Agreement, the Company identified the relevant elements for accounting purposes and allocated the $300.0&#160;million upfront payment based on their respective fair values.  The Company recorded a $37.0&#160;million pre-tax charge in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intellectual Property Agreement and Certain Litigation Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in March 2023 related primarily to prior commercial sales incurred through March 31, 2023.  The Company recorded a prepaid royalty asset of $124.0&#160;million in April 2023 related to future commercial sales, which will be amortized to expense during the term of the Intellectual Property Agreement.  Separately, the Company recorded a $139.0&#160;million pre-tax charge in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intellectual Property Agreement and Certain Litigation Expenses</span> in April 2023 related to products currently in development.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalMattersAndContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalMattersAndContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485957764832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEPARATION COSTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock', window );">SEPARATION COSTS</a></td>
<td class="text">SEPARATION COSTS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 7, 2023, the Company announced its intention to complete a spin-off of its Critical Care product group as a separate publicly-traded company to Edwards Lifesciences' shareholders.  The proposed spin-off is intended to be a tax-free transaction for U.S. federal income tax purposes and is expected to be completed near the end of 2024, subject to the satisfaction of customary conditions including final approval by the Company's board of directors, receipt of a favorable opinion and Internal Revenue Service ruling with respect to the tax-free nature of the transaction, and the effectiveness of a registration statement on Form 10.  The Company incurred separation costs of $41.3&#160;million during the three months ended March 31, 2024, related primarily to consulting, legal, tax, and other professional advisory services associated with the planned spin-off.  The costs related primarily to the Company's United States segment.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for an event or transaction that is unusual in nature or infrequent in occurrence, or both.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//220-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485956269792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">INVESTMENTS</a></td>
<td class="text">INVESTMENTS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Securities</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in debt securities at the end of each period were as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:23.164%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.730%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Held-to-maturity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank time deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">553.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">658.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">898.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost and fair value of investments in debt securities, by contractual maturity, as of March&#160;31, 2024, were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held-to-Maturity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in 1&#160;year or less</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after 1&#160;year through 5&#160;years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments not due at a single maturity date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________</span></div><div style="padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)  &#160;&#160;&#160;&#160;Consists of mortgage-backed and asset-backed securities.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual maturities may differ from the contractual maturities due to call or prepayment rights.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present gross unrealized losses and fair values for those investments that were in an unrealized loss position as of March&#160;31, 2024 and December&#160;31, 2023, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.411%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">878.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews its investments in debt securities to determine if there has been an other-than-temporary decline in fair value.  Consideration is given to 1) the financial condition and near-term prospects of the issuer, including the credit quality of the security's issuer, 2) the Company's intent to sell the security, and 3) whether it is more likely than not the Company will have to sell the security before recovery of its amortized cost. The unrealized losses on the debt securities were largely due to changes in interest rates, not credit quality, and as of March&#160;31, 2024, the Company did not intend to sell the securities, and it was not more likely than not that it will be required to sell the securities before recovery of the unrealized losses, and, therefore, the unrealized losses are considered temporary.  </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments in Unconsolidated Entities</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a number of equity investments in unconsolidated entities.  These investments are recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the consolidated condensed balance sheets, and are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity method investments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of equity method investments</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of non-marketable equity securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total investments in unconsolidated entities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company makes equity investments in limited liability companies that invest in qualified community development entities ("CDEs") through the New Markets Tax Credit ("NMTC") program.  The NMTC program provides federal tax incentives to investors to make investments in distressed communities and promotes economic improvements through the development of successful businesses in these communities.  The NMTC is equal to 39% of the qualified investment and is taken over seven years. These limited liability companies are variable interest entities ("VIEs").  The Company determined that it is not the primary beneficiary of the VIEs because it does not have the power to direct the activities that most significantly impact the economic performance of the VIEs and, therefore, the Company does not consolidate these entities.  Instead, the NMTC investments are accounted for as equity method investments.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-marketable equity securities consist of investments in privately held companies without readily determinable fair values, and are reported at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer.  The Company recorded a downward adjustment of $2.4 million during the three months ended March 31, 2024 based on observable price changes.  As of March&#160;31, 2024, the Company had recorded cumulative upward adjustments of $8.8 million based on observable price changes, and cumulative downward adjustments of $5.5 million due to impairments and observable price changes.   </span></div>During the three months ended March 31, 2024, the gross realized gains or losses from sales of available-for-sale investments were not material.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//320/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-6B<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-6B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br> -Publisher SEC<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//946-320/tableOfContent<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 940<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//940-320/tableOfContent<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//942-320/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140486067064304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS IN VARIABLE INTEREST ENTITIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_VariableInterestEntitiesAbstract', window );"><strong>Variable Interest Entities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityDisclosureTextBlock', window );">INVESTMENTS IN VARIABLE INTEREST ENTITIES</a></td>
<td class="text">INVESTMENTS IN VARIABLE INTEREST ENTITIES <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews its investments in other entities to determine whether the Company is the primary beneficiary of a VIE. The Company would be the primary beneficiary of the VIE, and would be required to consolidate the VIE, if it has the power to direct the significant activities of the entity and the obligation to absorb losses or receive benefits from the entity that may be significant to the VIE.  The Company's maximum loss exposure to variable interest entities, prior to the exercise of options to acquire the entities, is limited to its investment in the variable interest entities, which include equity investments, options to acquire, and promissory notes.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidated VIEs</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, the Company acquired a majority equity interest in a medical technology company pursuant to a preferred stock purchase agreement, and amended and restated a previous option agreement to acquire the remaining equity interest.  Edwards concluded that it is the primary beneficiary and consolidated the VIE.  The total assets and liabilities of the Company's consolidated VIE was $266.9 million and $28.5 million, respectively, as of March&#160;31, 2024, and were $272.1 million and $31.5 million, respectively, as of December&#160;31, 2023.  The assets of the VIE can only be used to settle obligations of the VIE and general creditors have no recourse to the Company. </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.329%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unconsolidated VIEs</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Edwards has relationships with various VIEs that it does not consolidate as Edwards lacks the power to direct the activities that significantly impact the economic success of these entities.  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Company entered into a promissory note agreement, a preferred stock purchase agreement, and an option agreement with a privately-held medical device company (the "Investee").  The secured promissory note provides for borrowings up to $45.0&#160;million. At both March&#160;31, 2024 and December&#160;31, 2023, the Company had advanced $30.0&#160;million under the promissory note (included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). As of March&#160;31, 2024 and December&#160;31, 2023, the Company had invested $42.8&#160;million and $39.3&#160;million, respectively, in the Investee's preferred equity securities (included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and had paid $20.9&#160;million and $13.1&#160;million, respectively, for an option to acquire the Investee (included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).  Pursuant to the agreements, the Company may be required to invest up to an additional $3.0&#160;million in the Investee's preferred equity securities and up to an additional $6.6&#160;million for the option to acquire the Investee.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, the Company agreed to pay a medical device company up to $45.0&#160;million as consideration for an option</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to acquire that medical device company, of which $30.0&#160;million had been paid as of March&#160;31, 2024. Also, in March 2023, Edwards advanced $5.0&#160;million to the medical device company under a convertible promissory note. The option and the note</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the consolidated balance sheets.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, Edwards has made equity investments through the NMTC program in limited liability companies that are considered VIEs.  For more information, see Note 5.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_VariableInterestEntitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments in Variable Interest Entities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_VariableInterestEntitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//810/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485957764832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text">FAIR VALUE MEASUREMENTS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The Company prioritizes the inputs used to determine fair values in one of the following three categories:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Quoted market prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Inputs, other than quoted prices in active markets, that are observable, either directly or indirectly.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Unobservable inputs that are not corroborated by market data.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated condensed financial statements include financial instruments for which the fair market value of such instruments may differ from amounts reflected on a historical cost basis. Financial instruments of the Company consist of cash deposits, accounts and other receivables, investments, accounts payable, certain accrued liabilities, and borrowings under a revolving credit agreement. The carrying value of these financial instruments generally approximates fair value due to their </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">short-term nature. Financial instruments also include notes payable.  As of March&#160;31, 2024, the fair value of the notes payable, based on Level 2 inputs, was $584.6 million.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:47.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.220%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">March 31, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held for deferred compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">807.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,368.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale investments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held for deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,650.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Equivalents and Available-for-sale Investments</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents included money market funds for the periods presented above.  The Company estimates the fair values of its money market funds based on quoted prices in active markets for identical assets.  The Company estimates the fair values of its corporate debt securities, asset-backed securities, United States and foreign government and agency securities, and municipal securities by taking into consideration valuations obtained from third-party pricing services. The pricing services use industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. These inputs include reported trades and broker-dealer quotes on the same or similar securities, benchmark yields, credit spreads, prepayment and default projections based on historical data, and other observable inputs.  The Company independently reviews and validates the pricing received from the third-party pricing service by comparing the prices to prices reported by a secondary pricing source.  The Company&#8217;s validation procedures have not resulted in an adjustment to the pricing received from the pricing service.  </span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Compensation Plans</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds investments related to its deferred compensation plans.  The investments are in a variety of stock, bond and money market mutual funds.  The fair values of these investments are based on quoted market prices.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Instruments</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments in the form of foreign currency forward exchange contracts and cross-currency swap contracts to manage foreign currency exposures.  All derivatives contracts are recognized on the balance sheet at their fair value.  The fair value of the derivative financial instruments was measured using quoted foreign exchange rates, interest rates, yield curves, and cross-currency swap basis rates.  The estimates presented herein are not necessarily indicative of the amounts that the Company could realize in a current market exchange.  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration Liabilities</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company's acquisitions involve contingent consideration arrangements.  Payment of additional consideration is contingent upon the acquired company reaching certain performance milestones, such as attaining specified sales levels or obtaining regulatory approvals.  These contingent consideration liabilities are measured at estimated fair value using either a probability weighted discounted cash flow analysis or a Monte Carlo simulation model, both of which consider significant unobservable inputs.  As of March&#160;31, 2024, the probability of milestone achievement was determined to be 0% and, accordingly, the contingent consideration liability was zero.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the changes in fair value of Level 3 financial instruments measured at fair value on a recurring basis (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.174%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.675%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-670">Changes in fair value</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-680">Changes in fair value</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485959451760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</a></td>
<td class="text">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk as summarized below. Notional amounts are stated in United States dollar equivalents at spot exchange rates at the respective dates. The Company does not enter into these arrangements for trading or speculation purposes.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:76.319%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,772.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,786.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative financial instruments involve credit risk in the event the counterparty should default.  It is the Company's policy to execute such instruments with global financial institutions that the Company believes to be creditworthy.  The Company diversifies its derivative financial instruments among counterparties to minimize exposure to any one of these entities.  The Company also uses International Swap Dealers Association master-netting agreements.  The master-netting agreements provide for the net settlement of all contracts through a single payment in a single currency in the event of default, as defined by the agreements.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses foreign currency forward exchange contracts and cross-currency swap contracts to manage its exposure to changes in currency exchange rates from (a) future cash flows associated with intercompany transactions and certain local currency expenses expected to occur within approximately 1 year (designated as cash flow hedges), (b) its net investment in certain foreign subsidiaries (designated as net investment hedges) and (c) foreign currency denominated assets or liabilities (designated as fair value hedges).  The Company also uses foreign currency forward exchange contracts that are not </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">designated as hedging instruments to offset the transaction gains and losses associated with revaluation of certain assets and liabilities denominated in currencies other than their functional currencies (resulting principally from intercompany and local currency transactions). </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative financial instruments are recognized at fair value in the consolidated condensed balance sheets.  For each derivative instrument that is designated as a fair value hedge, the gain or loss on the derivative included in the assessment of hedge effectiveness is recognized immediately to earnings, and offsets the loss or gain on the underlying hedged item.  The Company reports in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the gain or loss on derivative financial instruments that are designated, and that qualify, as cash flow hedges.  The Company reclassifies these gains and losses into earnings in the same line item and in the same period in which the underlying hedged transactions affect earnings.  Changes in the fair value of net investment hedges are reported in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as a part of the cumulative translation adjustment and would be reclassified into earnings if the underlying net investment is sold or substantially liquidated.  The portion of the change in fair value related to components excluded from the hedge effectiveness assessment are amortized into earnings over the life of the derivative.  The gains and losses on derivative financial instruments for which the Company does not elect hedge accounting treatment are recognized in the consolidated statements of operations in each period based upon the change in the fair value of the derivative financial instrument.  Cash flows from net investment hedges are reported as investing activities in the consolidated statements of cash flows, and cash flows from all other derivative financial instruments are reported as operating activities.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the location and fair value amounts of derivative instruments reported in the consolidated condensed balance sheets (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:36.436%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.463%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet<br/>Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-695"><span style="-sec-ix-hidden:f-696">Assets</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-701"><span style="-sec-ix-hidden:f-702">Liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of master-netting agreements and rights of offset on the consolidated condensed balance sheets (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:29.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.889%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts <br/>Not Offset in<br/>the Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts<br/>Offset in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amounts<br/>Presented in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">March 31, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Amounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash<br/>Collateral<br/>Received</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the effect of derivative and non-derivative hedging instruments on the consolidated condensed statements of operations and consolidated condensed statements of comprehensive income (in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:28.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.879%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.726%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in OCI<br/>on Derivative<br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Reclassified from<br/>Accumulated OCI<br/>into Income<br/>(Effective Portion)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Location&#160;of&#160;Gain&#160;or<br/>(Loss)&#160;Reclassified&#160;from<br/>Accumulated&#160;OCI<br/>into&#160;Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:29.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.889%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:28.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.782%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.487%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.891%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.782%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.785%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in OCI<br/>on Derivative <br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in&#160;Income on Derivative (Amount Excluded from <br/>Effectiveness Testing)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Location&#160;of&#160;Gain&#160;or<br/>(Loss)&#160;Recognized in&#160;Income on Derivative (Amount Excluded from Effectiveness Testing)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:28.944%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.767%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.998%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.767%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.919%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The cross-currency swap contracts have an expiration date of June 15, 2028.  At the maturity of the cross-currency swap contracts, the Company will deliver the notional amount of &#8364;257.2 million and will receive $300.0 million from the counterparties.  The Company receives semi-annual interest payments from the counterparties based on a fixed interest rate until maturity of the agreements.</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:43.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.177%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:43.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.177%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:43.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.177%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the effect of fair value and cash flow hedge accounting on the consolidated condensed statements of operations (in millions):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:80.917%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.528%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31, 2024</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other income, net</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts of income and expense line items presented in the consolidated condensed statements of operations in which the effects of fair value or cash flow hedges are recorded</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(385.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The effects of fair value and cash flow hedging:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on fair value hedging relationships:</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized in earnings based on an amortization approach</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships:</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) reclassified from accumulated OCI into income</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:81.037%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31, 2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other income, net</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts of income and expense line items presented in the consolidated condensed statements of operations in which the effects of fair value or cash flow hedges are recorded</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(329.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The effects of fair value and cash flow hedging:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on fair value hedging relationships:</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized in earnings based on an amortization approach</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships:</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) reclassified from accumulated OCI into income</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects that during the next twelve months it will reclassify to earnings a $12.7 million gain currently recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-5C<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//815/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485960853776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK-BASED COMPENSATION</a></td>
<td class="text">STOCK-BASED COMPENSATION  <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense related to awards issued under the Company's incentive compensation plans for the three months ended March 31, 2024 and 2023 was as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.315%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.329%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separation costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense, net of tax</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2024, the total remaining compensation cost related to nonvested stock options, restricted stock units, market-based restricted stock units, and employee stock purchase plan ("ESPP") subscription awards amounted to $242.6 million, which will be amortized on a straight-line basis over each award's requisite service period.  The weighted-average remaining requisite service period is 30 months.  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Disclosures</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the weighted-average grant-date fair values of stock options granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Option Awards</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.7%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.3%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, per option</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the weighted-average grant-date fair values for ESPP subscriptions granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">ESPP</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.8%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, per share</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.52</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485960823424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCELERATED SHARE REPURCHASE<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">ACCELERATED SHARE REPURCHASE</a></td>
<td class="text">ACCELERATED SHARE REPURCHASE<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2023, the Company entered into an accelerated share repurchase ("ASR") agreement providing for the repurchase of the Company's common stock based on the volume-weighted average price ("VWAP") of the Company's common stock during the term of the agreement, less a discount.  The following table summarizes the terms of the ASR agreement (dollars and shares in millions, except per share data):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.730%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.437%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Initial Delivery</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Final Settlement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agreement Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount<br/>Paid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Received</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Price per<br/>Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value of<br/>Shares as %<br/>of Contract<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlement<br/>Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Shares<br/>Received</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price<br/>per Share</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.44&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ASR agreement was accounted for as two separate transactions: (1)&#160;the value of the initial delivery of shares was recorded as shares of common stock acquired in a treasury stock transaction on the acquisition date, and (2)&#160;the remaining amount of the purchase price paid was recorded as a forward contract indexed to the Company's own common stock and was initially recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Additional Paid-in Capital</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and subsequently, upon settlement, was transferred to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the consolidated condensed balance sheets. The initial delivery of shares resulted in an immediate reduction of the outstanding shares used to calculate the weighted-average common shares outstanding for basic and diluted earnings per share. The Company determined that the forward contract indexed to the Company's common stock met all the applicable criteria for equity classification and, therefore, was not accounted for as a derivative instrument.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485960901328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, the Company initiated an internal review and investigation into whether business activities in Japan and other markets violated certain provisions of the Foreign Corrupt Practices Act (&#8220;FCPA&#8221;).  The Company voluntarily notified the SEC and the United States Department of Justice (&#8220;DOJ&#8221;) during 2021 that it has engaged outside counsel to conduct this review and investigation. The Company has provided status updates to the SEC and DOJ since that time. Any determination that the Company&#8217;s operations or activities are not in compliance with existing laws, including the FCPA, could result in the imposition of fines, penalties, and equitable remedies. The Company cannot currently predict the final outcome of the investigation or any potential impact on its financial statements.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2021, Aortic Innovations LLC, a non-practicing entity, filed a lawsuit against Edwards Lifesciences Corporation and certain of its subsidiaries (&#8220;Edwards&#8221;) in the United States District Court for the District of Delaware alleging that Edwards&#8217; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SAPIEN 3 Ultra</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> product infringes certain of its patents.  The Company is unable to predict the ultimate outcome of this matter or estimate a range of possible exposure; therefore, no amounts have been accrued.  The Company intends to vigorously defend itself in this litigation.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The European Commission (the &#8220;Commission&#8221;) is investigating certain business practices of Edwards including its unilateral pro-innovation (anti-copycat) policy and patent practices.  The Company is cooperating with the Commission and believes its business practices support healthy competition.  The Company cannot predict the outcome of the investigation or the potential impact on our financial statements.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is or may be a party to, or may otherwise be responsible for, pending or threatened lawsuits including those related to products and services currently or formerly manufactured or performed, as applicable, by the Company, workplace and employment matters, matters involving real estate, Company operations or health care regulations, contingent considerations, or governmental investigations (the &#8220;Lawsuits&#8221;). The Lawsuits raise difficult and complex factual and legal issues and are subject to many uncertainties, including, but not limited to, the facts and circumstances of each particular case or claim, the jurisdiction in which each suit is brought, and differences in applicable law. Management does not believe that any loss relating to the Lawsuits would have a material adverse effect on the Company's overall financial condition, results of operations or cash flows. However, the resolution of one or more of the Lawsuits in any reporting period, could have a material adverse impact on the Company's financial results for that period. The Company is not able to estimate the amount or range of any loss for legal contingencies related to the Lawsuits for which there is no reserve or additional loss for matters already reserved.</span></div>The Company is subject to various environmental laws and regulations both within and outside of the United States. The Company's operations, like those of other medical device companies, involve the use of substances regulated under environmental laws, primarily in manufacturing and sterilization processes. While it is difficult to quantify the potential impact of continuing compliance with environmental protection laws, management believes that such compliance will not have a material impact on the Company's financial results. The Company's threshold for disclosing material environmental legal proceedings involving a governmental authority where potential monetary sanctions are involved is $1&#160;million.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485961072656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE LOSS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">ACCUMULATED OTHER COMPREHENSIVE LOSS</a></td>
<td class="text">ACCUMULATED OTHER COMPREHENSIVE LOSS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the activity for each component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.642%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain on Hedges</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Loss on Available-for-sale Investments</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Costs</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(242.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax expense </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.696%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain on Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Loss on Available-for-sale Investments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Pension<br/>Credits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(255.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about amounts reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.800%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.384%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Affected Line on Consolidated Condensed<br/>Statements of Operations</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Details about Accumulated Other</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Comprehensive Loss Components</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on hedges</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on available-for-sale investments</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//220/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140486071367616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS PER SHARE</a></td>
<td class="text">EARNINGS PER SHARE<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed by dividing net income by the weighted-average common shares outstanding during the period. Diluted earnings per share is computed based on the weighted-average common shares outstanding plus the effect of dilutive potential common shares outstanding during the period calculated using the treasury stock method. Dilutive potential common shares include employee equity share options, nonvested shares, and similar equity instruments granted by the Company. Potential common share equivalents have been excluded where their inclusion would be anti-dilutive. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Edwards Lifesciences Corporation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.6&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.5&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.58&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.56&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Edwards Lifesciences Corporation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.6&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.5&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock plans</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive weighted-average shares outstanding</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.58&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.56&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>Stock options, restricted stock units, and market-based restricted stock units to purchase an aggregate of 5.3 million and 5.2 million common shares for the three months ended March 31, 2024 and 2023, respectively, were outstanding, but were not included in the computation of diluted earnings per share for such periods because the effect would have been anti-dilutive.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140486052819920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's effective income tax rates were 14.3% and 14.6% for the three months ended March 31, 2024 and 2023, respectively.  The decrease in the effective rate between the three months ended March 31, 2024 and 2023 is primarily due </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to an increased tax benefit from employee share-based compensation.  In addition, the effective rates for the three months ended March 31, 2024 and 2023 were lower than the federal statutory rate of 21% primarily due to (1) foreign earnings taxed at lower rates, (2) Federal and California research and development credits, and (3) the tax benefit from employee share-based compensation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective rates include a tax benefit from employee share-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">based</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> compensation of $6.3 million and $2.9 million for the three months ended March 31, 2024 and 2023, respectively.   </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Internal Revenue Service ("IRS") and other taxing authorities are in different stages of examining various years of the Company's tax filings.  During these audits, the Company may receive proposed audit adjustments that could be material.  An adverse outcome in these audits could have a material effect on the Company's results of operations and financial condition.  The Company strives to resolve open matters with each tax authority at the examination level and could reach agreement with a tax authority at any time.  While the Company has accrued for matters it believes are more likely than not to require settlement, the final outcome with a tax authority may result in a tax liability that is materially different from that reflected in the consolidated financial statements.  Furthermore, the Company may later decide to challenge any assessments, if made, and may exercise its right to appeal. The uncertain tax positions are reviewed quarterly and adjusted as events occur that affect potential liabilities for additional taxes, such as lapsing of applicable statutes of limitations, proposed assessments by tax authorities, negotiations between tax authorities, identification of new issues, and issuance of new legislation, regulations, or case law.  </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2024 and December&#160;31, 2023, the gross liability recorded for income taxes associated with uncertain tax positions was $608.8 million and $583.9 million, respectively. The Company estimates that these liabilities would be reduced by $265.9 million and $250.7 million, respectively, from offsetting tax benefits associated with the correlative effects of potential transfer pricing adjustments, state income taxes, and timing adjustments. The net amounts of $342.9 million and $333.2 million, respectively, if not required, would favorably affect the Company's effective tax rate. Management believes that adequate amounts of tax and related penalty and interest have been provided for any adjustments that may result from these uncertain tax positions.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company executed an Advance Pricing Agreement (&#8220;APA&#8221;) in 2018 between the United States and Switzerland governments for tax years 2009 through 2020 covering various, but not all, transfer pricing matters.  The unagreed transfer pricing matters, namely Surgical Structural Heart and Transcatheter Aortic Valve Replacement (collectively "Surgical/TAVR") intercompany royalty transactions, then reverted to IRS examination for further consideration as part of the respective years' regular tax audits.  In addition, the Company executed other bilateral APAs as follows: during 2017, an APA between the United States and Japan covering tax years 2015 through 2019; and during 2018, APAs between Singapore and Japan and between Switzerland and Japan covering tax years 2015 through 2019.  The Company has filed to renew all three of the APAs with Japan for the years 2020 and forward.  An APA between Switzerland and Japan covering tax years 2020 through 2024 was executed in 2021.  An APA between the United States and Japan covering tax years 2020 through 2024 was executed in 2023.  The execution of some or all these APA renewals depends on many variables outside of Edwards' control.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The audits of the Company&#8217;s United States federal income tax returns through 2014 have been closed.  The IRS audit field work for the 2015 through 2017 tax years was completed during the second quarter of 2021, except for transfer pricing and related matters.  The IRS is currently examining the 2018 through 2020 tax years.  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The audits of the Company's material state, local, and foreign income tax matters have been concluded for years through 2015.  While not material, the Company continues to address matters in India for years since 2010. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, the Company received a Notice of Proposed Adjustment (&#8220;NOPA&#8221;) from the IRS for the 2015 through 2017 tax years relating to transfer pricing involving Surgical/TAVR intercompany royalty transactions between the Company's United States and Switzerland subsidiaries.  The NOPA proposed a substantial increase to the Company's United States taxable income, which could result in additional tax expense for this period of approximately $230 million and reflects a departure from a transfer pricing method the Company had previously agreed upon with the IRS.  The Company disagreed with the NOPA and pursued an administrative appeal with the IRS Independent Office of Appeals ("Appeals").  The Appeals process culminated in the third quarter of 2023 when the Company and Appeals concluded that a satisfactory resolution of the matter at the administrative level was not possible.  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2023, Appeals issued a notice of deficiency ("NOD") increasing the Company's 2015 through 2017 United States federal income tax in amounts resulting from the income adjustments previously reflected in the NOPA.  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The additional tax sought in excess of the Company's filing position is $269.3&#160;million before consideration of interest and a repatriation tax offset.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company plans to vigorously contest the additional tax claimed by the IRS through the judicial process.  Final resolution of this matter is not likely within the next 12 months.  The Company believes the amounts previously accrued related to this uncertain tax position are appropriate for a number of reasons, including the interpretation and application of relevant tax law and accounting standards to the Company's facts and, accordingly, has not accrued any additional amount based on the NOD and other proceedings to date.  Nonetheless, the outcome of the judicial process cannot be predicted with certainty, and it is possible that the outcome of that process could have a material impact on the Company's consolidated financial statements.  As noted below, similar material tax disputes may arise for the 2018 through 2023 tax years. While no payment of any amount related to the NOPA or NOD has yet been required, the Company made a partial deposit with the IRS of $75&#160;million in November 2022 to prevent the further accrual of interest on that portion of any additional tax the Company may ultimately be found to owe.  In March 2024, the Company made an additional deposit with the IRS of $305&#160;million to further mitigate interest on potential tax liabilities while the Company prepares to contest through the judicial process the IRS's entitlement to any of the additional tax claimed by the IRS. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Surgical/TAVR intercompany royalty transactions covering tax years 2018 through 2023 remain subject to IRS examination, and those transactions and related tax positions remain uncertain as of March&#160;31, 2024.  The Company has considered this information, as well as information regarding the NOPA, the rebuttal and Appeals discussions described above, in its evaluation of its uncertain tax positions.  The impact of these unresolved transfer pricing matters, net of any correlative tax adjustments, may be significant to the Company&#8217;s consolidated financial statements.  Based on the information currently available and numerous possible outcomes, the Company cannot reasonably estimate what, if any, changes in its existing uncertain tax positions may occur in the next 12 months and, therefore, has continued to record the uncertain tax positions as a long-term liability.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2024, the Company received a notice of assessment from the Israel Tax Authority (&#8220;ITA&#8221;) wherein the ITA claimed that the Company owes approximately $110&#160;million of tax excluding interest and penalties in connection with a claimed 2017 transfer of intellectual property. The Company maintains that it did not transfer intellectual property outside of Israel and intends to vigorously defend that position through administrative and, if necessary, judicial proceedings.  There can be no assurance that this matter will be resolved in the Company's favor and an adverse outcome could have a material effect on the Company's consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485958007792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT INFORMATION</a></td>
<td class="text">SEGMENT INFORMATION<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Edwards Lifesciences conducts operations worldwide and is managed in the following geographical regions: United States, Europe, Japan, and Rest of World. All regions sell products that are used to treat advanced cardiovascular disease.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's geographic segments are reported based on the financial information provided to the Chief Operating Decision Maker (the Chief Executive Officer). The Company evaluates the performance of its geographic segments based on net sales and operating income. Segment net sales and segment operating income are based on internally derived foreign exchange rates and do not include inter-segment profits. Because of the interdependence of the reportable segments, the operating profit as presented may not be representative of the geographical distribution that would occur if the segments were not interdependent. Net sales by geographic area are based on the location of the customer. There were no customers that represented 10% or more of the Company's total net sales.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain items are maintained at the corporate level and are not allocated to the segments. The non-allocated items include corporate research and development expenses, manufacturing variances, corporate headquarters costs, net interest income, global marketing expenses, special gains and charges, stock-based compensation, foreign currency hedging activities, certain litigation costs, changes in the fair value of contingent consideration liabilities, and most of the Company's amortization expense. Although most of the Company's depreciation expense is included in segment operating income, due to the Company's methodology for cost build-up, it is impractical to determine the amount of depreciation expense included in each segment and, therefore, a portion is maintained at the corporate level. The Company neither discretely allocates assets to its operating segments, nor evaluates the operating segments using discrete asset information.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents information about Edwards Lifesciences' reportable segments (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:71.801%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.715%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">940.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment net sales</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598.6&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,454.4&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Operating Income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945.5&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">879.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated pre-tax income (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:71.841%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.695%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales Reconciliation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment net sales</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,454.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,459.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pre-tax Income Reconciliation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">879.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate items</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(503.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(468.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separation costs (Note&#160;4)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intellectual property agreement and certain litigation expenses</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated operating income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated pre-tax income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Enterprise-wide Information</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated condensed financial statements.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:71.801%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.715%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Geographic Region</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">940.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,459.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Major Product Group</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transcatheter Aortic Valve Replacement</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,007.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">947.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transcatheter Mitral and Tricuspid Therapies</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Structural Heart</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Critical Care</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,459.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//280/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-26<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-34<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485956197600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="nump">$ 351.9<span></span>
</td>
<td class="nump">$ 340.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140486045775824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2024 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=ew_MichaelA.MussallemMember', window );">Michael A. Mussallem [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MtrlTermsOfTrdArrTextBlock', window );">Material Terms of Trading Arrangement</a></td>
<td class="text"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On February 12, 2024, Michael A. Mussallem, Chairman and Director, entered into a Plan providing for the potential sale of 276,900 shares of the Company&#8217;s stock commencing June 11, 2024.  Mr. Mussallem's Plan terminates on the earlier of May 1, 2025 or the date all shares are sold.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndName', window );">Name</a></td>
<td class="text">Michael A. Mussallem<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndTitle', window );">Title</a></td>
<td class="text">Chairman and Director<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrAdoptionDate', window );">Adoption Date</a></td>
<td class="text">February 12, 2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrDuration', window );">Arrangement Duration</a></td>
<td class="text">324 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrSecuritiesAggAvailAmt', window );">Aggregate Available</a></td>
<td class="nump">276,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=ew_ScottB.UllemMember', window );">Scott B. Ullem [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MtrlTermsOfTrdArrTextBlock', window );">Material Terms of Trading Arrangement</a></td>
<td class="text"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On February 15, 2024, Scott B. Ullem, Corporate Vice President, Chief Financial Officer, entered into a Plan providing for the potential sale of 67,500 shares of the Company&#8217;s stock commencing May 21, 2024.  Mr. Ullem's Plan terminates on the earlier of May 9, 2025 or the date all shares are sold.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndName', window );">Name</a></td>
<td class="text">Scott B. Ullem<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndTitle', window );">Title</a></td>
<td class="text">Corporate Vice President, Chief Financial Officer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrAdoptionDate', window );">Adoption Date</a></td>
<td class="text">February 15, 2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrDuration', window );">Arrangement Duration</a></td>
<td class="text">353 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrSecuritiesAggAvailAmt', window );">Aggregate Available</a></td>
<td class="nump">67,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=ew_BernardJ.ZovighianMember', window );">Bernard J. Zovighian [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MtrlTermsOfTrdArrTextBlock', window );">Material Terms of Trading Arrangement</a></td>
<td class="text"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On February 29, 2024, Bernard J. Zovighian, Chief Executive Officer and Director, entered into a Plan providing for the potential sale of 25,147 shares of the Company&#8217;s stock commencing May 30, 2024.  Mr. Zovighian's Plan terminates on the earlier of December 18, 2024 or the date all shares are sold.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndName', window );">Name</a></td>
<td class="text">Bernard J. Zovighian<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndTitle', window );">Title</a></td>
<td class="text">Chief Executive Officer and Director<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrAdoptionDate', window );">Adoption Date</a></td>
<td class="text">February 29, 2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrDuration', window );">Arrangement Duration</a></td>
<td class="text">202 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrSecuritiesAggAvailAmt', window );">Aggregate Available</a></td>
<td class="nump">25,147<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MtrlTermsOfTrdArrTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MtrlTermsOfTrdArrTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrAdoptionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrAdoptionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrDuration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrDuration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrIndName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrIndName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrIndTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrIndTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrSecuritiesAggAvailAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrSecuritiesAggAvailAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=ew_MichaelA.MussallemMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=ew_MichaelA.MussallemMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=ew_ScottB.UllemMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=ew_ScottB.UllemMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=ew_BernardJ.ZovighianMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=ew_BernardJ.ZovighianMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140486046002592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim consolidated condensed financial statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") and should be read in conjunction with the consolidated financial statements and notes included in Edwards Lifesciences' Annual Report on Form&#160;10-K for the year ended December&#160;31, 2023. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") have been condensed or omitted.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Consolidation</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The consolidated condensed financial statements include the accounts of all wholly-owned subsidiaries and variable interest entities for which the Company is the primary beneficiary. The Company attributes the net income or losses of its consolidated variable interest entities to controlling and noncontrolling interests using the hypothetical liquidation at book value method.  All intercompany accounts and transactions have been eliminated in consolidation.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements.  Actual results could differ from those&#160;estimates.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Standards and New Accounting Standards Not Yet Adopted</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, the Financial Accounting Standards Board ("FASB") issued an amendment to the accounting guidance on investments in tax credit structures to allow entities to elect to account for their tax equity investments, regardless of the tax credit program from which the income tax credits are received, using the proportional amortization method if certain conditions are met.   The guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years.  The Company adopted this guidance on January 1, 2024.  The adoption of this guidance did not have a material impact on the Company's consolidated financial statements.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Standards Not Yet Adopted</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2024, the SEC issued final climate-related disclosure rules that will require disclosure of material climate-related risks and material direct greenhouse gas emissions from operations owned or controlled (Scope 1) and/or material indirect greenhouse gas emissions from purchased energy consumed in owned or controlled operations (Scope 2). Additionally, the rules require disclosure in the notes to the financial statements of the effects of severe weather events and other natural conditions, subject to certain materiality thresholds. The new rules will be effective for annual reporting periods beginning in fiscal year 2025, except for the greenhouse gas emissions disclosures which will be effective for annual reporting periods beginning in fiscal year 2026. Subsequent to issuance, the rules became the subject of litigation, and the SEC has issued a stay to allow the legal process to proceed.  The Company is currently evaluating the impact the guidance will have on its consolidated financial statements.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued an amendment to the accounting guidance on income taxes which requires entities to provide additional information in the rate reconciliation and additional disaggregated disclosures about income taxes paid. This guidance requires public entities to disclose in their rate reconciliation table additional categories of information about federal, state, and foreign income taxes and to provide more details about the reconciling items in some categories if the items meet a quantitative threshold. The guidance is effective for annual periods beginning after December 15, 2024. The Company does not expect the adoption of this guidance to impact its financial statements, but the guidance will impact its income tax disclosures.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued an amendment to the accounting guidance on segment reporting. The amendments require disclosure of significant segment expenses and other segment items and requires entities to provide in interim periods</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">all disclosures about a reportable segment's profit or loss and assets that are currently required annually. The amendment also</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">requires disclosure of the title and position of the chief operating decision maker ("CODM") and an explanation of how the</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">resources. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">beginning after December 15, 2024. Retrospective application is required, and early adoption is permitted. The Company is</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">currently evaluating the impact the guidance will have on its consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140486048901808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Components of Selected Captions in the Consolidated Balance Sheets</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of selected captions in the consolidated condensed balance sheets consisted of the following:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:75.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.191%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued and Other Liabilities</a></td>
<td class="text"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:75.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.191%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax receivable (Note 14)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes and other receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term prepaid royalties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued and other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and withholdings</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, payroll, and other taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued marketing expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal and insurance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued relocation costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued realignment reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued warranties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">969.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Schedule of Supplemental Cash Flow Information</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supplemental Cash Flow Information</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the year for:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes (Note 14)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts included in the measurement of operating lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash investing and financing transactions:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures accruals</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Schedule of Cash and Cash Equivalents</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,224.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,144.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents, and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,229.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,148.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock', window );">Schedule of Restricted Cash</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,224.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,144.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents, and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,229.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,148.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140486045868624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock', window );">Schedule of Investments in Debt Securities</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in debt securities at the end of each period were as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:23.164%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.730%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Held-to-maturity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank time deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">553.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">658.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">898.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost and fair value of investments in debt securities, by contractual maturity, as of March&#160;31, 2024, were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held-to-Maturity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in 1&#160;year or less</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after 1&#160;year through 5&#160;years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments not due at a single maturity date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________</span></div><div style="padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)  &#160;&#160;&#160;&#160;Consists of mortgage-backed and asset-backed securities.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock', window );">Schedule of Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present gross unrealized losses and fair values for those investments that were in an unrealized loss position as of March&#160;31, 2024 and December&#160;31, 2023, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.411%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">878.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock', window );">Schedule of Investments in Unconsolidated Affiliates</a></td>
<td class="text">These investments are recorded in <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the consolidated condensed balance sheets, and are as follows:</span><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity method investments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of equity method investments</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of non-marketable equity securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total investments in unconsolidated entities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479081/326-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-6<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479106/326-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A tabular presentation of the information summarizing investments in and advances to majority-owned subsidiaries, other controlled companies, and other affiliates, as prescribed by the SEC. It reflects specified information about ownership, financial results from, and financial position in such entities. Includes the tabular presentations that disaggregate investments in and advances to majority-owned subsidiaries, other controlled companies, and other affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of unrealized gains and losses on investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485956186064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:47.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.220%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">March 31, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held for deferred compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">807.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,368.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale investments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held for deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,650.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Changes in Fair Value of Contingent Consideration and Other Liability</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the changes in fair value of Level 3 financial instruments measured at fair value on a recurring basis (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.174%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.675%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-670">Changes in fair value</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-680">Changes in fair value</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485961538944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock', window );">Schedule of Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk as summarized below. Notional amounts are stated in United States dollar equivalents at spot exchange rates at the respective dates. The Company does not enter into these arrangements for trading or speculation purposes.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:76.319%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,772.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,786.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock', window );">Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the location and fair value amounts of derivative instruments reported in the consolidated condensed balance sheets (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:36.436%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.463%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet<br/>Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-695"><span style="-sec-ix-hidden:f-696">Assets</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-701"><span style="-sec-ix-hidden:f-702">Liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsTableTextBlock', window );">Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of master-netting agreements and rights of offset on the consolidated condensed balance sheets (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:29.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.889%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts <br/>Not Offset in<br/>the Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts<br/>Offset in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amounts<br/>Presented in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">March 31, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Amounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash<br/>Collateral<br/>Received</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingLiabilitiesTableTextBlock', window );">Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Liabilities</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of master-netting agreements and rights of offset on the consolidated condensed balance sheets (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:29.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.889%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts <br/>Not Offset in<br/>the Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts<br/>Offset in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amounts<br/>Presented in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">March 31, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Amounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash<br/>Collateral<br/>Received</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the effect of derivative and non-derivative hedging instruments on the consolidated condensed statements of operations and consolidated condensed statements of comprehensive income (in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:28.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.879%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.726%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in OCI<br/>on Derivative<br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Reclassified from<br/>Accumulated OCI<br/>into Income<br/>(Effective Portion)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Location&#160;of&#160;Gain&#160;or<br/>(Loss)&#160;Reclassified&#160;from<br/>Accumulated&#160;OCI<br/>into&#160;Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:29.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.889%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:28.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.782%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.487%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.891%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.782%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.785%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in OCI<br/>on Derivative <br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in&#160;Income on Derivative (Amount Excluded from <br/>Effectiveness Testing)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Location&#160;of&#160;Gain&#160;or<br/>(Loss)&#160;Recognized in&#160;Income on Derivative (Amount Excluded from Effectiveness Testing)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:43.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.177%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:43.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.177%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:43.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.177%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Effect of Fair Value and Cash Flow Hedge Accounting on the Consolidated Condensed Statements of Operations</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the effect of fair value and cash flow hedge accounting on the consolidated condensed statements of operations (in millions):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:80.917%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.528%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31, 2024</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other income, net</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts of income and expense line items presented in the consolidated condensed statements of operations in which the effects of fair value or cash flow hedges are recorded</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(385.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The effects of fair value and cash flow hedging:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on fair value hedging relationships:</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized in earnings based on an amortization approach</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships:</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) reclassified from accumulated OCI into income</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:81.037%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31, 2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other income, net</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts of income and expense line items presented in the consolidated condensed statements of operations in which the effects of fair value or cash flow hedges are recorded</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(329.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The effects of fair value and cash flow hedging:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on fair value hedging relationships:</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized in earnings based on an amortization approach</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships:</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) reclassified from accumulated OCI into income</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffsettingAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative and other financial assets that are subject to offsetting, including master netting arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OffsettingAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffsettingLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative and other financial liabilities that are subject to offsetting, including master netting arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OffsettingLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4E<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the presentation of foreign exchange contracts on the statement of financial position, including the fair value amounts and location of such amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the notional amounts of outstanding derivative positions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485961095728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Stock-Based Compensation Expense</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense related to awards issued under the Company's incentive compensation plans for the three months ended March 31, 2024 and 2023 was as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.315%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.329%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separation costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense, net of tax</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Weighted-Average Assumptions for Options Granted</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the weighted-average grant-date fair values of stock options granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Option Awards</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.7%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.3%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, per option</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock', window );">Schedule of Weighted-Average Assumptions for ESPP Subscriptions Granted</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the weighted-average grant-date fair values for ESPP subscriptions granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">ESPP</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.8%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, per share</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.52</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485956182720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCELERATED SHARE REPURCHASE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesTextBlock', window );">Schedule of Accelerated Share Repurchases</a></td>
<td class="text">The following table summarizes the terms of the ASR agreement (dollars and shares in millions, except per share data):<div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.730%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.437%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Initial Delivery</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Final Settlement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agreement Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount<br/>Paid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Received</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Price per<br/>Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value of<br/>Shares as %<br/>of Contract<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlement<br/>Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Shares<br/>Received</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price<br/>per Share</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.44&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of accelerated share repurchase (ASR) programs. An ASR is a combination of transactions that permits an entity to purchase a targeted number of shares immediately with the final purchase price of those shares determined by an average market price over a fixed period of time. An accelerated share repurchase program is intended to combine the immediate share retirement benefits of a tender offer with the market impact and pricing benefits of a disciplined daily open market stock repurchase program. ASRs can be disclosed as part of stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481138/505-30-25-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140486068108448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the activity for each component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.642%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain on Hedges</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Loss on Available-for-sale Investments</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Costs</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(242.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax expense </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.696%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain on Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Loss on Available-for-sale Investments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Pension<br/>Credits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(255.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock', window );">Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about amounts reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.800%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.384%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Affected Line on Consolidated Condensed<br/>Statements of Operations</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Details about Accumulated Other</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Comprehensive Loss Components</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on hedges</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on available-for-sale investments</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485958007792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Computation of Basic and Diluted Earnings Per Share</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Edwards Lifesciences Corporation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.6&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.5&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.58&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.56&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Edwards Lifesciences Corporation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.6&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.5&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock plans</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive weighted-average shares outstanding</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.58&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.56&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140486048885200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Information about Reportable Segments and Reconciliation of Segment Net Sales and Pre-Tax Income</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents information about Edwards Lifesciences' reportable segments (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:71.801%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.715%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">940.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment net sales</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598.6&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,454.4&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Operating Income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945.5&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">879.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated pre-tax income (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:71.841%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.695%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales Reconciliation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment net sales</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,454.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,459.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pre-tax Income Reconciliation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">879.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate items</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(503.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(468.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separation costs (Note&#160;4)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intellectual property agreement and certain litigation expenses</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated operating income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated pre-tax income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock', window );">Schedule of Enterprise-Wide Information</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated condensed financial statements.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:71.801%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.715%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Geographic Region</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">940.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,459.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Major Product Group</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transcatheter Aortic Valve Replacement</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,007.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">947.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transcatheter Mitral and Tricuspid Therapies</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Structural Heart</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Critical Care</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,459.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485960313584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Components of Selected Captions in the Consolidated Balance Sheets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventories</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 280.0<span></span>
</td>
<td class="nump">$ 252.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">258.6<span></span>
</td>
<td class="nump">220.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished products</a></td>
<td class="nump">668.7<span></span>
</td>
<td class="nump">695.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories</a></td>
<td class="nump">1,207.3<span></span>
</td>
<td class="nump">1,168.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment', window );">Finished products inventories held on consignment</a></td>
<td class="nump">$ 161.7<span></span>
</td>
<td class="nump">$ 164.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount of inventory owned by the entity but in the hands of a customer, typically a reseller.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140486046037776">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Accrued and Other Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>Other assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReceivable', window );">Tax receivable</a></td>
<td class="nump">$ 286.4<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent', window );">Notes and other receivables</a></td>
<td class="nump">159.5<span></span>
</td>
<td class="nump">155.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_AcquisitionOptionsNoncurrent', window );">Acquisition options</a></td>
<td class="nump">172.1<span></span>
</td>
<td class="nump">161.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrentAndNoncurrent', window );">Long-term prepaid royalties</a></td>
<td class="nump">107.8<span></span>
</td>
<td class="nump">109.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsNoncurrent', window );">Fair value of derivatives</a></td>
<td class="nump">27.9<span></span>
</td>
<td class="nump">23.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneousNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">13.9<span></span>
</td>
<td class="nump">14.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets, noncurrent</a></td>
<td class="nump">767.6<span></span>
</td>
<td class="nump">463.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Accrued and other liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee compensation and withholdings</a></td>
<td class="nump">237.2<span></span>
</td>
<td class="nump">371.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Taxes payable</a></td>
<td class="nump">85.0<span></span>
</td>
<td class="nump">59.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent', window );">Property, payroll, and other taxes</a></td>
<td class="nump">71.2<span></span>
</td>
<td class="nump">63.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_ResearchAndDevelopmentAccruals', window );">Research and development accruals</a></td>
<td class="nump">75.7<span></span>
</td>
<td class="nump">74.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_AccruedRebates', window );">Accrued rebates</a></td>
<td class="nump">120.6<span></span>
</td>
<td class="nump">131.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Fair value of derivatives</a></td>
<td class="nump">4.9<span></span>
</td>
<td class="nump">15.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedMarketingCostsCurrent', window );">Accrued marketing expenses</a></td>
<td class="nump">14.1<span></span>
</td>
<td class="nump">15.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_AccruedLitigationAndInsuranceReserves', window );">Legal and insurance</a></td>
<td class="nump">32.9<span></span>
</td>
<td class="nump">30.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationReserveCurrent', window );">Litigation settlement</a></td>
<td class="nump">76.1<span></span>
</td>
<td class="nump">69.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_AccruedRelocationCostsCurrent', window );">Accrued relocation costs</a></td>
<td class="nump">19.3<span></span>
</td>
<td class="nump">19.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional services</a></td>
<td class="nump">15.7<span></span>
</td>
<td class="nump">8.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveCurrent', window );">Accrued realignment reserves</a></td>
<td class="nump">10.2<span></span>
</td>
<td class="nump">12.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualClassifiedCurrent', window );">Accrued warranties</a></td>
<td class="nump">10.5<span></span>
</td>
<td class="nump">10.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">100.3<span></span>
</td>
<td class="nump">89.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_AccruedAndOtherLiabilitiesCurrent', window );">Total accrued and other liabilities</a></td>
<td class="nump">$ 873.7<span></span>
</td>
<td class="nump">$ 969.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes, payroll taxes and other taxes, excluding income taxes payable. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_AccruedAndOtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued And Other Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_AccruedAndOtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_AccruedLitigationAndInsuranceReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Litigation And Insurance Reserves</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_AccruedLitigationAndInsuranceReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_AccruedRebates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount, as of the balance sheet date, of current obligations associated with sales rebates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_AccruedRebates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_AccruedRelocationCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Relocation Costs, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_AccruedRelocationCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_AcquisitionOptionsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquisition Options, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_AcquisitionOptionsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_ResearchAndDevelopmentAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount, as of the balance sheet date, of current obligations associated with research and development and clinical trials.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_ResearchAndDevelopmentAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedMarketingCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedMarketingCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of income taxes previously overpaid to tax authorities (such as U.S. Federal, state and local tax authorities) representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes. Also called income tax refund receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneousNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneousNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of receivable classified as other and noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(7)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualClassifiedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(5)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualClassifiedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485961319984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Supplemental Cash Flow Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Cash paid during the year for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes</a></td>
<td class="nump">$ 349.2<span></span>
</td>
<td class="nump">$ 21.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Amounts included in the measurement of operating lease liabilities</a></td>
<td class="nump">8.2<span></span>
</td>
<td class="nump">7.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non-cash investing and financing transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for new lease liabilities</a></td>
<td class="nump">13.4<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Capital expenditures accruals</a></td>
<td class="nump">$ 34.3<span></span>
</td>
<td class="nump">$ 26.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485959972480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,224.6<span></span>
</td>
<td class="nump">$ 1,144.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash included in other current assets</a></td>
<td class="nump">3.6<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash included in other assets</a></td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents, and restricted cash</a></td>
<td class="nump">$ 1,229.0<span></span>
</td>
<td class="nump">$ 1,148.0<span></span>
</td>
<td class="nump">$ 876.4<span></span>
</td>
<td class="nump">$ 772.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480632/954-210-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140486049105552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTELLECTUAL PROPERTY AGREEMENT AND CERTAIN LITIGATION EXPENSES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 12, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_IntellectualPropertyAgreementTerm', window );">Intellectual property agreement term</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Intellectual property litigation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.9<span></span>
</td>
<td class="nump">$ 43.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=ew_MedtronicIncMember', window );">Medtronic Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Payments for legal settlements</a></td>
<td class="nump">$ 300.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Intellectual property litigation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 139.0<span></span>
</td>
<td class="nump">$ 37.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidRoyalties', window );">Prepaid royalty asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 124.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_IntellectualPropertyAgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intellectual Property Agreement Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_IntellectualPropertyAgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for the settlement of litigation or for other legal issues during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for royalties that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(5)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483032/340-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482955/340-10-05-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=ew_MedtronicIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=ew_MedtronicIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485961535872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEPARATION COSTS (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Special charge</a></td>
<td class="nump">$ 41.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485959319328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVESTMENTS - Schedule of Investments in Debt Securities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAbstract', window );"><strong>Held-to-maturity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Fair Value</a></td>
<td class="nump">$ 56.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">767.7<span></span>
</td>
<td class="nump">$ 926.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(18.0)<span></span>
</td>
<td class="num">(27.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">749.8<span></span>
</td>
<td class="nump">898.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_BankTimeDepositsMember', window );">Bank time deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAbstract', window );"><strong>Held-to-maturity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Amortized Cost</a></td>
<td class="nump">56.0<span></span>
</td>
<td class="nump">64.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss', window );">Gross Unrealized Losses</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Fair Value</a></td>
<td class="nump">56.0<span></span>
</td>
<td class="nump">64.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember', window );">U.S. government and agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">63.8<span></span>
</td>
<td class="nump">72.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(2.4)<span></span>
</td>
<td class="num">(2.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">61.4<span></span>
</td>
<td class="nump">70.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">148.0<span></span>
</td>
<td class="nump">192.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(3.8)<span></span>
</td>
<td class="num">(7.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">144.2<span></span>
</td>
<td class="nump">184.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">553.1<span></span>
</td>
<td class="nump">658.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(11.7)<span></span>
</td>
<td class="num">(16.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">541.5<span></span>
</td>
<td class="nump">641.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember', window );">Municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 2.7<span></span>
</td>
<td class="nump">$ 2.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -SubTopic 10<br> -Topic 310<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrecognized gain on investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_BankTimeDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_BankTimeDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140486045941120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVESTMENTS - Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost', window );">Due in 1&#160;year or less</a></td>
<td class="nump">$ 56.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost', window );">Due after 1&#160;year through 5&#160;years</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount', window );">Instruments not due at a single maturity date</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss', window );">Amortized Cost</a></td>
<td class="nump">56.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue', window );">Due in 1&#160;year or less</a></td>
<td class="nump">56.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue', window );">Due after 1&#160;year through 5&#160;years</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Instruments not due at a single maturity date</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Fair Value</a></td>
<td class="nump">56.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis', window );">Due in 1&#160;year or less</a></td>
<td class="nump">422.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis', window );">Due after 1&#160;year through 5&#160;years</a></td>
<td class="nump">181.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost', window );">Instruments not due at a single maturity date</a></td>
<td class="nump">163.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">767.7<span></span>
</td>
<td class="nump">$ 926.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue', window );">Due in 1&#160;year or less</a></td>
<td class="nump">417.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue', window );">Due after 1&#160;year through 5&#160;years</a></td>
<td class="nump">174.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Instruments not due at a single maturity date</a></td>
<td class="nump">158.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 749.8<span></span>
</td>
<td class="nump">$ 898.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480832/942-320-50-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in second through fifth rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity), without single maturity date and not allocated over maturity grouping.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5B<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480832/942-320-50-3A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) without single maturity date and not allocated over maturity grouping.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480832/942-320-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following current statement of financial position date. For interim and annual periods when interim period is reported on rolling approach.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480832/942-320-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in second through fifth rolling fiscal year following current statement of financial position date. For interim and annual periods when interim period is reported on rolling approach.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480832/942-320-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485961202320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVESTMENTS - Schedule of Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair value, less than 12 months</a></td>
<td class="nump">$ 12.2<span></span>
</td>
<td class="nump">$ 35.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Gross unrealized losses, less than 12 months</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(1.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair value, 12 months or greater</a></td>
<td class="nump">622.1<span></span>
</td>
<td class="nump">843.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Gross unrealized losses, 12 months or greater</a></td>
<td class="num">(17.9)<span></span>
</td>
<td class="num">(25.6)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair value, total</a></td>
<td class="nump">634.3<span></span>
</td>
<td class="nump">878.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Gross unrealized losses, total</a></td>
<td class="num">(18.0)<span></span>
</td>
<td class="num">(27.5)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember', window );">U.S. government and agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair value, less than 12 months</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Gross unrealized losses, less than 12 months</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair value, 12 months or greater</a></td>
<td class="nump">58.5<span></span>
</td>
<td class="nump">67.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Gross unrealized losses, 12 months or greater</a></td>
<td class="num">(2.4)<span></span>
</td>
<td class="num">(2.8)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair value, total</a></td>
<td class="nump">58.5<span></span>
</td>
<td class="nump">67.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Gross unrealized losses, total</a></td>
<td class="num">(2.4)<span></span>
</td>
<td class="num">(2.8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair value, less than 12 months</a></td>
<td class="nump">12.2<span></span>
</td>
<td class="nump">10.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Gross unrealized losses, less than 12 months</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair value, 12 months or greater</a></td>
<td class="nump">130.7<span></span>
</td>
<td class="nump">172.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Gross unrealized losses, 12 months or greater</a></td>
<td class="num">(3.7)<span></span>
</td>
<td class="num">(6.0)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair value, total</a></td>
<td class="nump">142.9<span></span>
</td>
<td class="nump">182.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Gross unrealized losses, total</a></td>
<td class="num">(3.8)<span></span>
</td>
<td class="num">(7.8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair value, less than 12 months</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">25.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Gross unrealized losses, less than 12 months</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair value, 12 months or greater</a></td>
<td class="nump">430.3<span></span>
</td>
<td class="nump">601.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Gross unrealized losses, 12 months or greater</a></td>
<td class="num">(11.7)<span></span>
</td>
<td class="num">(16.6)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair value, total</a></td>
<td class="nump">430.3<span></span>
</td>
<td class="nump">626.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Gross unrealized losses, total</a></td>
<td class="num">(11.7)<span></span>
</td>
<td class="num">(16.7)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember', window );">Municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair value, less than 12 months</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Gross unrealized losses, less than 12 months</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair value, 12 months or greater</a></td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Gross unrealized losses, 12 months or greater</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair value, total</a></td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Gross unrealized losses, total</a></td>
<td class="num">$ (0.1)<span></span>
</td>
<td class="num">$ (0.2)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479081/326-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479106/326-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479106/326-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479081/326-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479106/326-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479106/326-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479081/326-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479106/326-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479106/326-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485960668160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract', window );"><strong>Equity method investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Carrying value of equity method investments</a></td>
<td class="nump">$ 34.1<span></span>
</td>
<td class="nump">$ 33.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract', window );"><strong>Equity securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Carrying value of non-marketable equity securities</a></td>
<td class="nump">88.7<span></span>
</td>
<td class="nump">87.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Total investments in unconsolidated entities</a></td>
<td class="nump">$ 122.8<span></span>
</td>
<td class="nump">$ 121.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482736/825-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAllOtherInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485961274800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems', window );"><strong>Debt and Equity Securities, FV-NI [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount', window );">Downward price adjustment, annual amount</a></td>
<td class="nump">$ 2.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount', window );">Increase in non-marketable equity securities due to observable price changes</a></td>
<td class="nump">8.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount', window );">Decrease in non-marketable equity securities due to observable price changes</a></td>
<td class="nump">$ 5.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_LimitedLiabilityCompanyMember', window );">Limited Liability Company</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems', window );"><strong>Debt and Equity Securities, FV-NI [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_EquityMethodInvestmentsInvestmentPeriod', window );">Investments taken period</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ew_NewMarketsTaxCreditMember', window );">New Markets Tax Credit | Limited Liability Company</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems', window );"><strong>Debt and Equity Securities, FV-NI [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Investment percentage (in percent)</a></td>
<td class="nump">39.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_EquityMethodInvestmentsInvestmentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investments, Investment Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_EquityMethodInvestmentsInvestmentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from downward price adjustment on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479536/321-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative loss from downward price adjustment on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479536/321-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative gain from upward price adjustment on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479536/321-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_LimitedLiabilityCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_LimitedLiabilityCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ew_NewMarketsTaxCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ew_NewMarketsTaxCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485957979728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS IN VARIABLE INTEREST ENTITIES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">13 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,736.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,736.3<span></span>
</td>
<td class="nump">$ 9,363.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,549.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,549.9<span></span>
</td>
<td class="nump">2,643.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Carrying value of non-marketable equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88.7<span></span>
</td>
<td class="nump">87.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPaymentsToAcquireBusinesses', window );">Payment for acquisition options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.8<span></span>
</td>
<td class="nump">$ 15.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ew_MedicalDeviceCompanyMember', window );">Investee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote', window );">Maximum secured promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_EquitySecuritiesFVNIPromissoryNoteOutstanding', window );">Investee drew additional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.0<span></span>
</td>
<td class="nump">30.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Carrying value of non-marketable equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42.8<span></span>
</td>
<td class="nump">39.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_EquitySecuritiesFVNIOptionToAcquireInvestment', window );">Investment option to acquire</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.9<span></span>
</td>
<td class="nump">13.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_EquitySecuritiesFVNIMaximumAdditionalRequired', window );">Maximum additional required investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment', window );">Maximum additional option to acquire investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">266.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">266.9<span></span>
</td>
<td class="nump">272.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28.5<span></span>
</td>
<td class="nump">$ 31.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ew_MedicalDeviceCompanyMember', window );">Investee | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_LoansReceivablesMaximumLendingCapacity', window );">Loans receivables, maximum lending amount</a></td>
<td class="nump">$ 45.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPaymentsToAcquireBusinesses', window );">Payment for acquisition options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ew_MedicalDeviceCompanyMember', window );">Investee | Variable Interest Entity, Not Primary Beneficiary | Convertible Promissory Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableGross', window );">Financing receivable</a></td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI, Maximum Additional Option To Acquire Investment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_EquitySecuritiesFVNIMaximumAdditionalRequired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI, Maximum Additional Required</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_EquitySecuritiesFVNIMaximumAdditionalRequired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI, Maximum Secured Promissory Note</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_EquitySecuritiesFVNIOptionToAcquireInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI, Option To Acquire Investment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_EquitySecuritiesFVNIOptionToAcquireInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_EquitySecuritiesFVNIPromissoryNoteOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI Promissory Note Outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_EquitySecuritiesFVNIPromissoryNoteOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_LoansReceivablesMaximumLendingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loans Receivables, Maximum Lending Capacity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_LoansReceivablesMaximumLendingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482736/825-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, before allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 80<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479294/326-20-55-80<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 79<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479294/326-20-55-79<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1405<br> -Paragraph (a)<br> -Subparagraph (1)<br> -Publisher SEC<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1405<br> -Paragraph (a)<br> -Subparagraph (2)<br> -Publisher SEC<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1404<br> -Paragraph (a)<br> -Publisher SEC<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-14<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -SubTopic 10<br> -Topic 310<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-7A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPaymentsToAcquireBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with other payments to acquire businesses including deposit on pending acquisitions and preacquisition costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPaymentsToAcquireBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481420/860-30-50-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481420/860-30-50-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481420/860-30-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ew_MedicalDeviceCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ew_MedicalDeviceCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ew_MedicalDeviceCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ew_MedicalDeviceCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ew_ConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ew_ConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485960790096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Narrative (Details)<br></strong></div></th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=ew_ContingentConsiderationLiabilityMember', window );">Contingent Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Financial instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liability</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=ew_MeasurementInputProbabilityOfMilestoneAchievementMember', window );">Probability of Milestone Achievement | Contingent Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Financial instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration liability measurement input</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Financial instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableFairValueDisclosure', window );">Notes payable fair value disclosure</a></td>
<td class="nump">$ 584,600,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-6<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479613/805-30-35-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of notes payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20,22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=ew_ContingentConsiderationLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=ew_ContingentConsiderationLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=ew_MeasurementInputProbabilityOfMilestoneAchievementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=ew_MeasurementInputProbabilityOfMilestoneAchievementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485959172896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">$ 749.8<span></span>
</td>
<td class="nump">$ 898.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">541.5<span></span>
</td>
<td class="nump">641.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">144.2<span></span>
</td>
<td class="nump">184.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember', window );">United States government and agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">61.4<span></span>
</td>
<td class="nump">70.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember', window );">Municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">2.7<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">430.0<span></span>
</td>
<td class="nump">579.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Investments held for deferred compensation plans</a></td>
<td class="nump">130.7<span></span>
</td>
<td class="nump">125.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivatives</a></td>
<td class="nump">57.5<span></span>
</td>
<td class="nump">47.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">1,368.0<span></span>
</td>
<td class="nump">1,650.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivatives</a></td>
<td class="nump">4.9<span></span>
</td>
<td class="nump">15.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Other</a></td>
<td class="nump">5.0<span></span>
</td>
<td class="nump">10.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">9.9<span></span>
</td>
<td class="nump">25.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">541.5<span></span>
</td>
<td class="nump">641.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">144.2<span></span>
</td>
<td class="nump">184.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | United States government and agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">61.4<span></span>
</td>
<td class="nump">70.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">2.7<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">430.0<span></span>
</td>
<td class="nump">579.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Investments held for deferred compensation plans</a></td>
<td class="nump">130.7<span></span>
</td>
<td class="nump">125.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivatives</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">560.7<span></span>
</td>
<td class="nump">705.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivatives</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Other</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 1 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 1 | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 1 | United States government and agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 1 | Municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Investments held for deferred compensation plans</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivatives</a></td>
<td class="nump">57.5<span></span>
</td>
<td class="nump">47.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">807.3<span></span>
</td>
<td class="nump">945.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivatives</a></td>
<td class="nump">4.9<span></span>
</td>
<td class="nump">15.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Other</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">4.9<span></span>
</td>
<td class="nump">15.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 2 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">541.5<span></span>
</td>
<td class="nump">641.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 2 | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">144.2<span></span>
</td>
<td class="nump">184.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 2 | United States government and agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">61.4<span></span>
</td>
<td class="nump">70.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 2 | Municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">2.7<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Investments held for deferred compensation plans</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivatives</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivatives</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Other</a></td>
<td class="nump">5.0<span></span>
</td>
<td class="nump">10.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">5.0<span></span>
</td>
<td class="nump">10.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 3 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 3 | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 3 | United States government and agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 3 | Municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485955429792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Schedule of Changes in Fair Value of Contingent Consideration and Other Liability (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList', window );">Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Change in fair value of contingent consideration liabilities (Note 7)<span></span>
</td>
<td class="text">Change in fair value of contingent consideration liabilities (Note 7)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value on a Recurring Basis | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value beginning balance</a></td>
<td class="nump">$ 10.3<span></span>
</td>
<td class="nump">$ 40.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Changes in fair value</a></td>
<td class="num">(5.3)<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value ending balance</a></td>
<td class="nump">5.0<span></span>
</td>
<td class="nump">40.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=ew_ContingentConsiderationLiabilityMember', window );">Contingent Consideration | Fair Value on a Recurring Basis | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value beginning balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">26.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Changes in fair value</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value ending balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">26.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_OtherLiabilitiesMember', window );">Other | Fair Value on a Recurring Basis | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value beginning balance</a></td>
<td class="nump">10.3<span></span>
</td>
<td class="nump">14.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Changes in fair value</a></td>
<td class="num">(5.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value ending balance</a></td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="nump">$ 14.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement in which net income is reported that includes gain (loss) from liability measured at fair value using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=ew_ContingentConsiderationLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=ew_ContingentConsiderationLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485959790832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk (Details) - Derivatives designated as hedging instruments - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Foreign currency forward exchange contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative Financial Instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 1,772.3<span></span>
</td>
<td class="nump">$ 1,786.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Cross-currency swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative Financial Instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 300.0<span></span>
</td>
<td class="nump">$ 300.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140486071123888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details)<br> &#8364; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative Financial Instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge', window );">Changes due to currency rate movements and expenses expected to occur, maximum term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Cash flow gain to be reclassified in the next twelve months</a></td>
<td class="nump">$ 12.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated as hedging instruments | Cross-currency swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative Financial Instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative liability, fair value</a></td>
<td class="nump">300.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net investment hedges | Derivatives designated as hedging instruments | Cross-currency swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative Financial Instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative liability, fair value</a></td>
<td class="nump">$ 300.0<span></span>
</td>
<td class="nump">&#8364; 257.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480870/815-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum period of time the entity is hedging its exposure to variability in future cash flows for forecasted transactions, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Excludes forecasted transactions related to payment of variable interest on existing financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 30<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480870/815-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140486052976464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration', window );">Derivative Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other current assets, Other assets (Note 2)<span></span>
</td>
<td class="text">Other current assets, Other assets (Note 2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration', window );">Derivative Liability, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Accrued and other liabilities (Note 2)<span></span>
</td>
<td class="text">Accrued and other liabilities (Note 2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Fair value of derivative assets</a></td>
<td class="nump">$ 29.6<span></span>
</td>
<td class="nump">$ 23.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Fair value of derivative liabilities</a></td>
<td class="nump">4.9<span></span>
</td>
<td class="nump">15.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Cross-currency swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Fair value of derivative assets</a></td>
<td class="nump">27.9<span></span>
</td>
<td class="nump">23.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated as hedging instruments | Foreign currency contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Fair value of derivative assets</a></td>
<td class="nump">29.6<span></span>
</td>
<td class="nump">23.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Fair value of derivative liabilities</a></td>
<td class="nump">4.9<span></span>
</td>
<td class="nump">15.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated as hedging instruments | Cross-currency swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Fair value of derivative assets</a></td>
<td class="nump">$ 27.9<span></span>
</td>
<td class="nump">$ 23.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes derivative asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes derivative liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485961963184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingDerivativeAssetsAbstract', window );"><strong>Derivative assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Gross Amounts</a></td>
<td class="nump">$ 29.6<span></span>
</td>
<td class="nump">$ 23.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetFairValueGrossLiability', window );">Gross Amounts Offset in the Consolidated Balance Sheet</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Net Amounts Presented in the Consolidated Balance Sheet</a></td>
<td class="nump">29.6<span></span>
</td>
<td class="nump">23.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_DerivativeFairValueOfDerivativeAssetGrossAmountsNotOffsetAbstract', window );"><strong>Gross Amounts Not Offset in the Consolidated Balance Sheet</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction', window );">Financial Instruments</a></td>
<td class="num">(4.9)<span></span>
</td>
<td class="num">(9.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeCollateralObligationToReturnCash', window );">Cash Collateral Received</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral', window );">Net Amount</a></td>
<td class="nump">24.7<span></span>
</td>
<td class="nump">14.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingDerivativeLiabilitiesAbstract', window );"><strong>Derivative liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Gross Amounts</a></td>
<td class="nump">4.9<span></span>
</td>
<td class="nump">15.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityFairValueGrossAsset', window );">Gross Amounts Offset in the Consolidated Balance Sheet</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Net Amounts Presented in the Consolidated Balance Sheet</a></td>
<td class="nump">4.9<span></span>
</td>
<td class="nump">15.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract', window );"><strong>Gross Amounts Not Offset in the Consolidated Balance Sheet</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction', window );">Financial Instruments</a></td>
<td class="num">(4.9)<span></span>
</td>
<td class="num">(9.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeCollateralRightToReclaimCash', window );">Cash Collateral Received</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral', window );">Net Amount</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">5.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Cross-currency swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingDerivativeAssetsAbstract', window );"><strong>Derivative assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Gross Amounts</a></td>
<td class="nump">27.9<span></span>
</td>
<td class="nump">23.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetFairValueGrossLiability', window );">Gross Amounts Offset in the Consolidated Balance Sheet</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Net Amounts Presented in the Consolidated Balance Sheet</a></td>
<td class="nump">27.9<span></span>
</td>
<td class="nump">23.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_DerivativeFairValueOfDerivativeAssetGrossAmountsNotOffsetAbstract', window );"><strong>Gross Amounts Not Offset in the Consolidated Balance Sheet</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction', window );">Financial Instruments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeCollateralObligationToReturnCash', window );">Cash Collateral Received</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral', window );">Net Amount</a></td>
<td class="nump">$ 27.9<span></span>
</td>
<td class="nump">$ 23.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_DerivativeFairValueOfDerivativeAssetGrossAmountsNotOffsetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative Fair Value of Derivative Asset Gross Amounts Not Offset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_DerivativeFairValueOfDerivativeAssetGrossAmountsNotOffsetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetFairValueGrossLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of liability associated with financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -SubTopic 20<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -SubTopic 20<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column F))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetFairValueGrossLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset, subject to master netting arrangement or similar agreement and not elected or qualified to offset, deducted from derivative asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 13<br> -SubTopic 20<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)(1)(i)<br> -SubTopic 20<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)(1)(ii)<br> -SubTopic 20<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeCollateralObligationToReturnCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to return cash collateral under master netting arrangements that have not been offset against derivative assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 13<br> -SubTopic 20<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-13<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-20<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeCollateralObligationToReturnCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeCollateralRightToReclaimCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of right to receive cash collateral under master netting arrangements that have not been offset against derivative liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 13<br> -SubTopic 20<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-13<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-20<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeCollateralRightToReclaimCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -SubTopic 20<br> -Topic 860<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481326/860-20-50-4D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after effect of master netting arrangement and deduction of obligation to return financial collateral not offset and financial instrument subject to master netting arrangement not offset, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset. Includes derivative not subject to master netting arrangement or similar agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 13<br> -SubTopic 20<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -SubTopic 20<br> -Topic 860<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481326/860-20-50-4D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after effect of master netting arrangement and deduction of obligation to return financial collateral not offset and financial instrument subject to master netting arrangement not offset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset. Includes derivative not subject to master netting arrangement or similar agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 13<br> -SubTopic 20<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityFairValueGrossAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of asset associated with financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -SubTopic 20<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -SubTopic 20<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column F))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-20<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityFairValueGrossAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset, subject to master netting arrangement or similar agreement and not elected or qualified to offset, deducted from derivative liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 13<br> -SubTopic 20<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)(1)(i)<br> -SubTopic 20<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)(1)(ii)<br> -SubTopic 20<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffsettingDerivativeAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OffsettingDerivativeAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffsettingDerivativeLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OffsettingDerivativeLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485961415744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency contracts | Derivatives not designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Amount of Gain or (Loss) Recognized in Income on Derivative</a></td>
<td class="nump">$ 12.4<span></span>
</td>
<td class="num">$ (5.4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash flow hedges | Foreign currency contracts | Derivatives designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)</a></td>
<td class="nump">36.2<span></span>
</td>
<td class="nump">3.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash flow hedges | Foreign currency contracts | Derivatives designated as hedging instruments | Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">29.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net investment hedges | Cross-currency swap contracts | Derivatives designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)</a></td>
<td class="nump">4.4<span></span>
</td>
<td class="num">(2.5)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net investment hedges | Cross-currency swap contracts | Derivatives designated as hedging instruments | Interest income, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Amount of Gain or (Loss) Recognized in&#160;Income on Derivative (Amount Excluded from Effectiveness Testing)</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair value hedges | Foreign currency contracts | Derivatives designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Amount of Gain or (Loss) Recognized in Income on Derivative</a></td>
<td class="nump">$ 4.8<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated value of gains (losses), net anticipated to be transferred in the future from accumulated other comprehensive income into earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480870/815-30-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480627/815-20-45-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4CCC<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485958621760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Fair Value and Cash Flow Hedge Accounting on the Consolidated Condensed Statements of Operations (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="num">$ (385.6)<span></span>
</td>
<td class="num">$ (329.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">5.4<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency contracts | Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract', window );"><strong>Gain (loss) on fair value hedging relationships:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1', window );">Hedged items</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax', window );">Amount excluded from effectiveness testing recognized in earnings based on an amortization approach</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract', window );"><strong>Gain (loss) on cash flow hedging relationships:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount of gain (loss) reclassified from accumulated OCI into income</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">29.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency contracts | Cost of sales | Derivatives designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract', window );"><strong>Gain (loss) on fair value hedging relationships:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1', window );">Derivatives designated as hedging instruments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency contracts | Other income, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract', window );"><strong>Gain (loss) on fair value hedging relationships:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1', window );">Hedged items</a></td>
<td class="num">(4.0)<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax', window );">Amount excluded from effectiveness testing recognized in earnings based on an amortization approach</a></td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract', window );"><strong>Gain (loss) on cash flow hedging relationships:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount of gain (loss) reclassified from accumulated OCI into income</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency contracts | Other income, net | Derivatives designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract', window );"><strong>Gain (loss) on fair value hedging relationships:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1', window );">Derivatives designated as hedging instruments</a></td>
<td class="nump">$ 4.0<span></span>
</td>
<td class="num">$ (1.2)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the increase (decrease) in fair value of derivative and nonderivative instruments designated as fair value hedging instruments recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -SubTopic 25<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480238/815-25-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the increase (decrease) in fair value of the hedged item in a fair value hedge recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -SubTopic 25<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480238/815-25-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of adjustments from accumulated other comprehensive income (AOCI) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-15<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485959656960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION - Schedule of Stock-Based Compensation Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Allocation of stock-based compensation expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 44.6<span></span>
</td>
<td class="nump">$ 38.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Income tax benefit</a></td>
<td class="num">(6.2)<span></span>
</td>
<td class="num">(4.7)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Total stock-based compensation expense, net of tax</a></td>
<td class="nump">38.4<span></span>
</td>
<td class="nump">34.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Allocation of stock-based compensation expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">8.2<span></span>
</td>
<td class="nump">7.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general, and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Allocation of stock-based compensation expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">24.6<span></span>
</td>
<td class="nump">22.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Allocation of stock-based compensation expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">11.2<span></span>
</td>
<td class="nump">9.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=ew_SeparationCostsMember', window );">Separation costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Allocation of stock-based compensation expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of expense for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=ew_SeparationCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=ew_SeparationCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485956462480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total remaining unrecognized compensation cost</a></td>
<td class="nump">$ 242.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost, recognition period</a></td>
<td class="text">30 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140486045779152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION - Schedule of Weighted-Average Assumptions for Options and ESPP Subscriptions Granted (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ew_EmployeeAndNonemployeeStockOptionsMember', window );">&#160;Option Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">4.30%<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">32.70%<span></span>
</td>
<td class="nump">31.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">5 years 3 months 18 days<span></span>
</td>
<td class="text">5 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value, per option/share (in dollars per share)</a></td>
<td class="nump">$ 32.91<span></span>
</td>
<td class="nump">$ 27.77<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">&#160;ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">5.10%<span></span>
</td>
<td class="nump">4.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">34.80%<span></span>
</td>
<td class="nump">31.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">7 months 6 days<span></span>
</td>
<td class="text">7 months 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value, per option/share (in dollars per share)</a></td>
<td class="nump">$ 25.52<span></span>
</td>
<td class="nump">$ 21.10<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ew_EmployeeAndNonemployeeStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ew_EmployeeAndNonemployeeStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485960340464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCELERATED SHARE REPURCHASE (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesDateAxis=ew_InitialDeliveryOfSharesSettledFebruary2023Member', window );">Initial Delivery of Shares Settled February2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Amount Paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares Received (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare', window );">Initial delivery, price per share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80.44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount', window );">Value of Shares as % of Contract Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesDateAxis=ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member', window );">February 2023 Stock Repurchase Program Shares Sold in March 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares Received (in shares)</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare', window );">Final settlement per share price (in dollars per share)</a></td>
<td class="nump">$ 79.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the value of the initial shares repurchased as a percentage of the contract amount under accelerated share repurchase agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Final price paid per share for the purchase of the targeted number of shares, determined by an average market price over a fixed period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481138/505-30-25-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price paid per share to immediately purchase the targeted number of shares on the date of executing the accelerated share repurchase agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481138/505-30-25-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesDateAxis=ew_InitialDeliveryOfSharesSettledFebruary2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesDateAxis=ew_InitialDeliveryOfSharesSettledFebruary2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesDateAxis=ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesDateAxis=ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485957362032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($) </div>
<div>lawsuit</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber', window );">Number of lawsuits that if settled could have a material adverse impact on net income or cash flows | lawsuit</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_AccrualForEnvironmentalLossContingenciesThresholdAmountForDisclosure', window );">Threshold of disclosing material environmental legal proceedings | $</a></td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_AccrualForEnvironmentalLossContingenciesThresholdAmountForDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrual For Environmental Loss Contingencies Threshold Amount For Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_AccrualForEnvironmentalLossContingenciesThresholdAmountForDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims That If Settled Could Have A Material Adverse Impact, Number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485962043552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">$ 6,650.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="nump">27.5<span></span>
</td>
<td class="nump">$ 20.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Amounts reclassified from accumulated other comprehensive loss</a></td>
<td class="num">(6.4)<span></span>
</td>
<td class="num">(27.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1', window );">Deferred income tax expense (benefit)</a></td>
<td class="num">(11.6)<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">7,117.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(242.8)<span></span>
</td>
<td class="num">(254.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(233.3)<span></span>
</td>
<td class="num">(255.4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(214.5)<span></span>
</td>
<td class="num">(218.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="num">(23.3)<span></span>
</td>
<td class="nump">4.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Amounts reclassified from accumulated other comprehensive loss</a></td>
<td class="num">(1.7)<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1', window );">Deferred income tax expense (benefit)</a></td>
<td class="num">(1.1)<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(240.6)<span></span>
</td>
<td class="num">(215.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Unrealized Gain on Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">23.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="nump">43.4<span></span>
</td>
<td class="nump">6.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Amounts reclassified from accumulated other comprehensive loss</a></td>
<td class="num">(7.2)<span></span>
</td>
<td class="num">(29.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1', window );">Deferred income tax expense (benefit)</a></td>
<td class="num">(9.3)<span></span>
</td>
<td class="nump">5.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">27.6<span></span>
</td>
<td class="nump">6.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Unrealized Loss on Available-for-sale Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(24.8)<span></span>
</td>
<td class="num">(65.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="nump">7.0<span></span>
</td>
<td class="nump">9.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Amounts reclassified from accumulated other comprehensive loss</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1', window );">Deferred income tax expense (benefit)</a></td>
<td class="num">(1.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(16.4)<span></span>
</td>
<td class="num">(52.6)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Unrealized Pension Credits (Costs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(4.2)<span></span>
</td>
<td class="nump">5.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Amounts reclassified from accumulated other comprehensive loss</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1', window );">Deferred income tax expense (benefit)</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">$ (3.9)<span></span>
</td>
<td class="nump">$ 5.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485959354272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Affected Line on Consolidated Condensed Statements of Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">$ 5.4<span></span>
</td>
<td class="nump">$ 1.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(58.4)<span></span>
</td>
<td class="num">(58.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net of tax</a></td>
<td class="nump">351.9<span></span>
</td>
<td class="nump">340.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="num">(385.6)<span></span>
</td>
<td class="num">(329.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest income, net</a></td>
<td class="nump">16.5<span></span>
</td>
<td class="nump">8.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Amount Reclassified from Accumulated Other Comprehensive Loss | Foreign currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Affected Line on Consolidated Condensed Statements of Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net of tax</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Amount Reclassified from Accumulated Other Comprehensive Loss | Gain on hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Affected Line on Consolidated Condensed Statements of Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">4.8<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(1.5)<span></span>
</td>
<td class="num">(7.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net of tax</a></td>
<td class="nump">5.7<span></span>
</td>
<td class="nump">22.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">29.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Total before tax</a></td>
<td class="nump">7.2<span></span>
</td>
<td class="nump">29.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Amount Reclassified from Accumulated Other Comprehensive Loss | Loss on available-for-sale investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Affected Line on Consolidated Condensed Statements of Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net of tax</a></td>
<td class="num">(1.9)<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest income, net</a></td>
<td class="num">$ (2.5)<span></span>
</td>
<td class="num">$ (4.0)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485960454528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income attributable to Edwards Lifesciences Corporation</a></td>
<td class="nump">$ 351.9<span></span>
</td>
<td class="nump">$ 340.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares outstanding (in shares)</a></td>
<td class="nump">601.6<span></span>
</td>
<td class="nump">607.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per share (in dollars per share)</a></td>
<td class="nump">$ 0.58<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net income attributable to Edwards Lifesciences Corporation</a></td>
<td class="nump">$ 351.9<span></span>
</td>
<td class="nump">$ 340.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares outstanding (in shares)</a></td>
<td class="nump">601.6<span></span>
</td>
<td class="nump">607.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of stock plans (in shares)</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Dilutive weighted-average shares outstanding (in shares)</a></td>
<td class="nump">604.1<span></span>
</td>
<td class="nump">610.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per share (in dollars per share)</a></td>
<td class="nump">$ 0.58<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480454/718-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-22<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-28A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485960591808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE - Narrative (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember', window );">Stock Compensation Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Anti-dilutive securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from the computation of earnings per share (in shares)</a></td>
<td class="nump">5.3<span></span>
</td>
<td class="nump">5.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485958816176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>agreement</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.30%<span></span>
</td>
<td class="nump">14.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Tax benefit from employee share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.3<span></span>
</td>
<td class="nump">$ 2.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Liability for income taxes associated with uncertain tax positions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">608.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 583.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Decrease in unrecognized tax benefits is reasonably possible</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">265.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Net amounts that would favorably affect effective tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">342.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">333.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_NumberOfAdvancePricingAgreementsRenewed', window );">Number of APAs renewed | agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_IncomeTaxAssessmentEstimateOfAdditionalTaxExpense', window );">Additional tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 230.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority', window );">Additional tax sought in excess of filing position</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 269.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_IncomeTaxExaminationAmountDepositedToMitigateInterestOnTaxLiabilities', window );">Additional deposit</a></td>
<td class="nump">$ 75.0<span></span>
</td>
<td class="nump">305.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_IsraelTaxAuthorityMember', window );">Israel Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss', window );">Estimate of additional tax owed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_IncomeTaxAssessmentEstimateOfAdditionalTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax Assessment, Estimate Of Additional Tax Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_IncomeTaxAssessmentEstimateOfAdditionalTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_IncomeTaxExaminationAmountDepositedToMitigateInterestOnTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax Examination, Amount Deposited To Mitigate Interest On Tax Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_IncomeTaxExaminationAmountDepositedToMitigateInterestOnTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_NumberOfAdvancePricingAgreementsRenewed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Advance Pricing Agreements Renewed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_NumberOfAdvancePricingAgreementsRenewed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated amount of loss resulting from an adverse tax position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the additional liability or refund received or expected based on a final settlement with a taxing authority.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_IsraelTaxAuthorityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_IsraelTaxAuthorityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485959355280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION - Schedule of Information about Reportable Segments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment Net Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment net sales</a></td>
<td class="nump">$ 1,598.2<span></span>
</td>
<td class="nump">$ 1,459.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment Net Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment net sales</a></td>
<td class="nump">1,598.6<span></span>
</td>
<td class="nump">1,454.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract', window );"><strong>Segment Operating Income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Total segment operating income</a></td>
<td class="nump">945.5<span></span>
</td>
<td class="nump">879.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment Net Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment net sales</a></td>
<td class="nump">940.7<span></span>
</td>
<td class="nump">849.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract', window );"><strong>Segment Operating Income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Total segment operating income</a></td>
<td class="nump">616.7<span></span>
</td>
<td class="nump">563.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment Net Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment net sales</a></td>
<td class="nump">363.0<span></span>
</td>
<td class="nump">335.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract', window );"><strong>Segment Operating Income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Total segment operating income</a></td>
<td class="nump">191.4<span></span>
</td>
<td class="nump">181.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Japan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment Net Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment net sales</a></td>
<td class="nump">112.9<span></span>
</td>
<td class="nump">104.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract', window );"><strong>Segment Operating Income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Total segment operating income</a></td>
<td class="nump">60.4<span></span>
</td>
<td class="nump">63.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment Net Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment net sales</a></td>
<td class="nump">182.0<span></span>
</td>
<td class="nump">165.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract', window );"><strong>Segment Operating Income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Total segment operating income</a></td>
<td class="nump">$ 77.0<span></span>
</td>
<td class="nump">$ 70.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ew_UnitedStatesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ew_UnitedStatesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ew_EuropeSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ew_EuropeSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ew_JapanSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ew_JapanSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ew_RestOfWorldSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ew_RestOfWorldSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140486071394720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION - Schedule of Reconciliation of Segment Net Sales and Pre-Tax Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Net Sales Reconciliation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 1,598.2<span></span>
</td>
<td class="nump">$ 1,459.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract', window );"><strong>Pre-tax Income Reconciliation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Consolidated operating income</a></td>
<td class="nump">387.5<span></span>
</td>
<td class="nump">388.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Unallocated amounts:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonrecurringIncomeExpense', window );">Separation costs (Note&#160;4)</a></td>
<td class="num">(41.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Intellectual property agreement and certain litigation expenses</a></td>
<td class="num">(8.9)<span></span>
</td>
<td class="num">(43.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of contingent consideration liabilities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before provision for income taxes</a></td>
<td class="nump">409.4<span></span>
</td>
<td class="nump">398.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Net Sales Reconciliation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,598.6<span></span>
</td>
<td class="nump">1,454.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract', window );"><strong>Pre-tax Income Reconciliation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Consolidated operating income</a></td>
<td class="nump">945.5<span></span>
</td>
<td class="nump">879.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember', window );">Reconciling items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Net Sales Reconciliation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="num">(0.4)<span></span>
</td>
<td class="nump">5.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Unallocated amounts:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonrecurringIncomeExpense', window );">Separation costs (Note&#160;4)</a></td>
<td class="num">(41.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Intellectual property agreement and certain litigation expenses</a></td>
<td class="num">(8.9)<span></span>
</td>
<td class="num">(43.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency</a></td>
<td class="num">(3.9)<span></span>
</td>
<td class="nump">22.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Non-operating income</a></td>
<td class="nump">21.9<span></span>
</td>
<td class="nump">10.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Unallocated amounts:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Corporate items</a></td>
<td class="num">$ (503.9)<span></span>
</td>
<td class="num">$ (468.9)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482014/830-20-35-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481956/830-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481926/830-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481839/830-10-45-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonrecurringIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense (income) that is infrequent in occurrence or unusual in nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483613/220-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonrecurringIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140485959987920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Enterprise-Wide Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 1,598.2<span></span>
</td>
<td class="nump">$ 1,459.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ew_TranscatheterAorticValveReplacementMember', window );">Transcatheter Aortic Valve Replacement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Enterprise-Wide Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,007.9<span></span>
</td>
<td class="nump">947.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ew_TranscatheterMitralAndTricuspidTherapiesMember', window );">Transcatheter Mitral and Tricuspid Therapies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Enterprise-Wide Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">72.9<span></span>
</td>
<td class="nump">41.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ew_SurgicalHeartValveTherapyMember', window );">Surgical Structural Heart</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Enterprise-Wide Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">266.1<span></span>
</td>
<td class="nump">248.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ew_CriticalCareMember', window );">Critical Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Enterprise-Wide Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">251.3<span></span>
</td>
<td class="nump">221.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Enterprise-Wide Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">940.7<span></span>
</td>
<td class="nump">849.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Enterprise-Wide Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">367.8<span></span>
</td>
<td class="nump">331.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_JP', window );">Japan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Enterprise-Wide Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">110.8<span></span>
</td>
<td class="nump">114.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=ew_RestOfWorldMember', window );">Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Enterprise-Wide Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 178.9<span></span>
</td>
<td class="nump">$ 165.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ew_TranscatheterAorticValveReplacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ew_TranscatheterAorticValveReplacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ew_TranscatheterMitralAndTricuspidTherapiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ew_TranscatheterMitralAndTricuspidTherapiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ew_SurgicalHeartValveTherapyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ew_SurgicalHeartValveTherapyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ew_CriticalCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ew_CriticalCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_JP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_JP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=ew_RestOfWorldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=ew_RestOfWorldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>93
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M%R*;B[.%XKMTM%QQA8-J^KC%_Q(@M "^7W-LEOE"_T#Q[V3T/U!+ P04
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MSI9<60'X?25A,JH+^X#]_UN8_P=02P,$%     @ Q8"=6#JLJE68"   ]4D
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M=)C9,(>9A!YFWBHI55;VH)31=Y&R;&Z8IKRPAABYTO:-U14DS(>$!9"P<,C
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MRQV)Z-&N,J"_?\BR\N=%]9TVYV]Z6OX%4$L#!!0    ( ,6 G5C1CW'P8 D
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M,HJ$0DWOHF8B*P%DFL;NN[8K$P !L:N[%C&CD"85JP[>$<&R/9 _8-@0I,@
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M^<.'TZ6_9L^TPZ7=OR[Q+TD8,L#\7&-#U1^TP/9_U^E_4$L#!!0    ( ,6
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MCQA=&$/A -YOC/''17#07#Y'_P%02P,$%     @ Q8"=6'%_.I+L P  3 @
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M*5]VU#?>+/F;Q-1X;S*^7"#2E:4->#XS@.OJA@YH/E+=_!M02P,$%     @
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M=E+DPH64MLE 7*#9QU9>92+)<""198I^<0F,NL&GSAX(H:8%IDI83.B:*>W
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M"4H)=/$<!@%G--4!+9%D-[FAJ:9#6>\#\39&51"5:<HT^%ZAO4.[-K5J%='
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M8C++DL"W@<JT-NQ<4%'H0*HEC*50KRN'TAK^G,DUJ%4A"5$>0Z'O[W8:-\M
MS1/:G"&JE83Y<H>P&^CB(7D%'T($-!0ZCT @]'/DNU#EL)4QP:&W5Y26JES*
MI&EDBZ\!Y(!T8EX(69 5Z+ T5I,;1%GH@DS=!G-G\A9'<IB8S1P%2. 5:J[X
M*>,8-@Q7<;@U<9U R,T!A=5!Q6UD3K_V]CAE&41 1RO,$6E"XB/B.JRU2&$S
MHLXSAF*/D3C Q+\1"G"2%@L\38$OGU#%)I_WL[.\"LJ8.@_HQ?>,1W*V.MC4
M/YK&!A%$T&V2;A];JPLB27F<\K ;'D.(H.U3!!P'K+Q)P0%%0\N%!&!L#EZ]
MDU+2"D5==E6V<%Q>00LD>F/W\IC&^#N /"L!A$7<[OU>SOP:G$ 6>N;'PW]E
M7AVZNR0&-!75&(;-8,V:GC=[-A!D!6*09$*OMAQ(!)5])('Q4MVYA*%/OA&1
MB:XM8JLOPZ*%\Q2W/W 3V$E"NZ(O&.HDN'A3D53*"(,(5 CT_;[FD'H4CET
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M]WNGSUS/\;HR$C-8VNN>'+7<C47^P:J4?K<S5=:JF!X7@L,9#B? ^YE2-O^
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MA"Q).VDTL[2^S";'YU>C(!\%;B7MW-X["Y:LC+D+BT_B,AL&0J2H\ &!X_%
M4U(J ('&?8.9=2K#P?WW%OU#M!VVK+BCJ5%?I?#;R^PL8X+6O%9^878?J;'G
M-. 51KGXSW9)-G^?L:)VWI3-83 HI4Y/_MCX8>_ V? '!_+F0!YY)T61Y37W
M?'QAS8[9( VT\!)-C:=!3NH0E*6W^"IQSH\GT^GL]]EB<C.[9LN/D\6,+6;S
M+XOIQ\ER=C'PT!#D!D6#=I70\A^@G;#/1ONM8S,M2#P_/P"SCE[>TKO*7P7\
MS&V?G1SW6#[,1Z_@G73FGD2\DQ_@S>YKZ9_8'Y.5\Q89\>=+-B:(T<L0H4K.
M7<4+NLQ0!H[L V7C7WXZ?CO\[16"HX[@Z#7T_QR/_X_&KFLK]29X]J3'_);8
MU)05UT^,M"=+@DGM#>.A<@I4D>4>>V[++:$:J]H66U0#.\@FRT5VR/C&$J%:
M/:NL>9 B0*-G1. ]<;/>5_6K8X4I2U0G$KVXB_4E&)9!YL&HNJ2C72PL;/,'
M<-@0\&41]-Y^G<RA^'5$D8P,$C"J;*4[MCVFR#G&F9"N,+7V?7:#[VNCT*[B
M2;Y2U/0L^1>Y#LJU6+!_S_H#@:/< E(WWG)P)$I7*70AUV/T6% %+Y%MG"E0
MMX?G[).67G+%KDFA3]DG]D%J+-$6O4K0DTX)2AUZR\"7+9..>?1*0+WEJHZ.
MWCMZ8WS 2J*3QI'IR =:V1K]."8">X/'L#]D.7YOV-FP/QKAG_W,4(G%-LGD
M_5-\>_>^GY]%9SUWP(Z[D#&!&X(64@ ;?F>8HXJ')&*H/.UX[,KNG!T<'Z9P
MM[3#0C;.$*TSL-\X,^!;*HP5(2=<NPV!9X'G!4H]93&BZW%AN1HXZ>,>@S;;
MHKR3<0L1H5X,X$%^V&1PN.!"/O#D]89GE]<I*2LNQ7<$>7#"CEL!@CIV'7 2
M](BOJ*_GN6MV^A]FZ 38.$0]?8.&81,A(F-X:@[51]B:\DJ&6,?TJU>.[FM$
M13WU6%T%U"XG>A$W>F)-UB8V-ZV?EE%[XQOP=D9)$3L %@*7,MY67'$-J^/M
MXU+AO!(X_'!5-A'13)8E"1GR ;KK)A;)JQ@>G(<!P=_-X=HE@@571:UB%D&P
M[0U';6]H?=?DQ!Y.2$2T%UE$SPBIZD"%N U1==_*,9G1MD)!H=315:%\RWU4
M^N^C^2R2)28L!# E6U4I6<3.4E@)%3(F":-T/16*.R?7D$B3BQ:Q06->,992
MW+3QWU<9NAB@'G@8=, *5UP=(MU_Z5X:[,T,)=E-G(P"92"F\:';[8:O29HY
MOHFGR0VM80-MZ*1K'!WVWYUFS*9I*"V\J>($LC(>\TQ\W6* )!L$\'UMC&\7
M04$WDH[_!E!+ P04    " #%@)U8%A=*T%\'  #.$   &0   'AL+W=O<FMS
M:&5E=',O<VAE970Q."YX;6RE6%UOVS84_2N$!W0=X,:)DVY%\P&X3K:E:-*@
M:;>'80^T=&USI4B-I.SXW^_<2TFVVZ3#L)=8HLC[><XAF;.U#Y_CDBBIA\JZ
M>#Y8IE2_'HUBL:1*QP-?D\.7N0^53G@-BU&L ^E2%E5V-#X\_'%4:>,&%V<R
M=A<NSGR3K'%T%U1LJDJ'S1NR?GT^.!IT Q_,8IEX8'1Q5NL%W5/Z5-\%O(UZ
M*Z6IR$7CG0HT/Q],CEZ_.>'Y,N$W0^NX\ZPXDYGWG_GENCP?'') 9*E(;$'C
M9T53LI8-(8R_6YN#WB4OW'WNK/\LN2.7F8XT]?9W4Z;E^>#50)4TUXU-'_SZ
M5VKS><GV"F^C_%7K//?E>*"*)B9?M8L1065<_M4/;1UV%KPZ?&+!N%TPEKBS
M(XGR4B=]<1;\6@6>#6O\(*G*:@1G'#?E/@5\-5B7+J;O;VZN/]Y<W7Z\5Y/;
M2S5]?_OQ^O:7J]OI]=7]V2C!!4\<%:VY-]G<^ ESQ^K&N[2,ZLJ55.ZO'R&T
M/KYQ%]^;\3<-WNAPH(Z/AFI\.#[YAKWC/M]CL7?\5+Z^JDP"JE)4VI5JBG"-
M6Y K#$5U:6)A?6P"J3\FLY@"0//G8U7(3DX>=\)$>AUK7=#Y $R)%%8TN'CV
MW=&/AZ??2.&D3^'D6];_>\O^ASEU[;CRJ']:$HI5U=IME'$F&9VH1 GQDB@X
M;4'1%;.0JVK<BF(R"RW,PPROUDN""5"HB0@@QLQ'V$'9C5-O-2S+6B_3H!"?
M"3U:&6_%4T$A06-4'?S*L"1$Y><2%=@)[CE$%T)3)W7'73,%[$Z*I)X_^^[5
M>'QX^O/T;B*/1Z<_'*B/.]FLO&U<TL'8C7(^F;F!.S9\?S65B/CY$U+&\'U"
M,, )U3H(BCB(MZ I_/6N+M^_[3RIL@F E]00=G12)JFECHK< IJ';)L434FJ
M\(V#5BE4JO"N;!!Y6IKX9%'W4V"+4AB03D7$V$35U*7$"HN[R2 XA0X@7 DG
M06$/U 0V2D(?H3"Y9_GCU@4G=/33*8I>4Y I> R[3=0@#<K'S2RPQAK-3M8F
M+14]F,@L4U:OXQ S"MN4_"[M0V.&G+\MD6V$FK()_F*JVD<CX:#*<X;-4&$W
MTI8=#B4=^KLQ2<\L86U%)<;W*U-HQT$530CH%CH,0I:FR+G!)'"+%B!@ZN"T
MCUW.$69JG[#<8#:"0M**80UXL@5(!\:YZB2Z<J#>.W5/-5YG0/+XU;"ET,0'
MX 24<G[5EO#=NRGR0-W<BSK#ELO"KM)F".N6.29E0YI*+\" F-15N=:AQ&HS
MIPCA<@QVP+_VN352F8XP2(LCC<T,0#. .>9V2&T-]6AM"_\%V-&\P"6;^B8D
MA8. 3.J'X>"2$"(#0%M+B]Q9W<?98D?=3^ZNKV[5L?IDH:P,6,&Y<7/F"#Q]
M$7*M4Z[G;D/!B<9)PP'LW68". :[-.WW$],Q"&1S)[FO,D6KH.&1IP!BT; Y
M>JA%^4_9&HX&4)4A&J-T!6HBFJ5>D9H1\4FB" V57\0%&72ET&UE%C[X)EHF
MU9R8N@G<GN?R(B)K]FE\U0302K.$87>*<N!YSCFU;=H.;SL5=X&*@G>UZ_6U
M[F4067:(V5*/"]PXP^(: %\TXX7I@:F>:T#P1>'K3:'3#RB2-<5&8)6;LK7^
M57<*WTH$G C[6Q7I$F,C,[*&5JS\B.*1B&-3 \M02@+7EQL1%$KF:^%KZ;V+
M@W^C,P\^1F> ^PDZ?Y&@Y]UI@QP (]X&-NCYL!N5W6MM(D.%Y:P&RP5>P).(
MEQ1?PL 9&E& 9RV]XYXP^LCK\]XG2!>RY$,+GRBD3EM9@T4^H5/ <Z5=,T=6
M '/)'] .^59":F"@AC87S*"AFFUV-7XH)^C:XN"2M14J[C>RRV4.07/;!RZK
MMRL.%6E89A8B'?9EVM\E<AO1K, Y+1J;/['JMZ>OQ(^\$8;N$Y8M_ HG"_;/
MC=KM8]RCQ[NV?OO;>S<*JG,[2C.?FX)W%Q%'WJ'H04F98)W'H%SL)\:&<IDY
M7,CF7\3(\ES6#2C3$BUO07W'4,LFR?YG365RT_*AB5UD>X4)15.A4JYE)>EB
M*1#BP'1 @1 H$B^L-E5>_1?.#Y&QG0]2.$89K)&%LB4 CS-H#:X>>3_D-*%>
MX@'3M\UFE!VH&^UP[)"6EAY3.."6C%FR.4><@&/&GD QGQ_Z<JYEIQ8UU P'
M"LP77:)7B)[@/O-I!UC?(]L5RXS=81@?<X31PW;;EY+L P<%6:HY+HY@X:]^
MC2A#+@M6X-36'0V\D[)5D.R.]N^VG)*< K&@<#YP8'S9G3B>RF.K"_MY;./O
M@L[[(4J7#7\E%USB;K_J-R VFC<6#KS?C/KJL]&,QV+O@K*C"'M9\OP,#=F\
MLE_5WCWD$%/F8L-B[Z#CLK9\G=]TT\N#QRXIHYT[)F1F(3?I*.?6E*^;_6A_
M69_D.^IV>K[IXTZ',P*V09ICZ>'!3R\'*N3;<WY)OI8;Z\PGW'_E$1("<> )
M^#[WT._VA1WT_\*X^ =02P,$%     @ Q8"=6*<2G>:C!   B@L  !D   !X
M;"]W;W)K<VAE971S+W-H965T,3DN>&ULM5;;;ALW$/V5P28(+"!9:2^29<<6
M("M*;2".#5_2AZ(/U.ZLM V75$C*=OKUG2%7LHS(;I&V+[N\S>&9*^?H7INO
M=H'HX*&1RAY'"^>6A]VN+1;8"!OK)2K:J;1IA*.IF7?MTJ HO5 CNVFO-^@V
MHE;1Z,BO79K1D5XY62N\-&!732/,]Q.4^OXX2J+UPE4]7SA>Z(Z.EF*.U^AN
MEY>&9MT-2EDWJ&RM%1BLCJ-Q<GB2\WE_X$N-]W9K#*S)3.NO/#DKCZ,>$T*)
MA6,$0;\[G*"4#$0TOK68T>9*%MP>K]$_>MU)EYFP.-'RU[ITB^-H&$&)E5A)
M=Z7O3['5I\]XA9;6?^$^G,WV(RA6UNFF%28&3:W"7SRT=M@2&/:>$4A;@=3S
M#A=YEA^$$Z,CH^_!\&E"XX%7U4L3N5JQ4ZZ=H=V:Y-QH/)G<GM]^&M],/\#%
MS>GT"B87YY=7T]/IY^NS+U/X='%]?=1U=!.?[Q8MZDE 39]!S>!<*[>P,%4E
MED_EN\1P0S-=TSQ)7P0\%R:&+'D+:2_-7\#+-FIG'B][!F_Z;56[[_#;>&:=
MH<CX?9>. 2+?#<'9<FB7HL#CB-+!HKG#:/3F53+HO7^!8+XAF+^$_M-^^?>H
M<+- J+2D=*W5')R82;1MTM9_(CC:]KG$!J2J "B*!12Z66J%RH&N8%P4JV8E
MA<,2+NB\@0EM&UQP,M\A?-+6PEZM**"EI-RTG4.@'*,,4G"KJ+9(NJB$7ZBF
M &7N*99SHK"UXP%H9WPG:LD$WQ&1=U9(A#-UA]91V7!/)"[;.C+1EC9NM!,2
M/F"!S8S8M8&5P6O82Y,\[G=HU(OW_3R/ASS=R^.T$Q927@EZ%4_TVI/$JP.U
MHF6$&1(II,I52&%M7=6%X$)$FJ=9G'4@S^(<]N,>W91#NA_W8=SH%?-^%"'F
ME=$-&?S1HGK'S=);-(GW.["WST13@GOS:I@FZ7O8&\1YA[2MT!B2;^DY\0#X
M0,7=(DLF)'G M-IQSW^3)!YT@+*/7+Q.OV"$'F^\9MX#7DC\'33(XH-@ILPK
M^3^[=;<CT^#(8? <67O("X-^H-QO'=O/F>HN/[86:MWYK!])'@8$=D ^#/9*
M>_^9%],#9I\3],:-'".[_3A#A57M*)(&I-[!1F3]'Q"M)TYL0[T?]]@B@^##
M?KHVT" 8J,\^W5$.8&GT75V2\VH5^@+_P,[HT0?QK/8_4Q5N%@;QR6,"XZJB
M%YVCA8H;^)165LNZ], T*3FD2[*3HRBR+:U_=/ED7<1L"'1OJ'4$%RNRNBJ^
M ST8RLI6Y_*/U3HL7T/B(XN_X8K@H;>@J+FB ,D[[?>2S>?+$=?/1S]B ,G:
M[V?TU90=O,Z91<@9"NJ8\Y"#Q)<T/L=YPD$YW+C]1Q94&X)02)PVM/D&"KN^
M+Q[)W_ +Z9.F]-LBN$Y=\6/JUENIRV$5RBO54XJ],^60'D_WA"1'<4*!_R(-
MXGO0%AS">62RZ^WM;O5'#9JY[P(M)1]%:FB5-JN;1G,<^JO'XZ%+I2R:UY3[
M$BL2I3>B'X$)G5^8.+WTW=9,.^K=_'!!S3(:/D#[E=9N/>$+-NWWZ"]02P,$
M%     @ Q8"=6*R>3V2X P  80D  !D   !X;"]W;W)K<VAE971S+W-H965T
M,C N>&ULQ5;;CMLV$/V5@1H4+;"1Y,LZ&]<V8&^<)D"S,.PV>2CZ0$MCBUB*
M5$C*6O]]AZ2M=1K;29[Z(MYF#L\,YZ)1H_2C*1 M/)5"FG%46%L-D\1D!9;,
MQ*I"22<;I4MF::FWB:DTLMPKE2+IIND@*1F7T63D]Q9Z,E*U%5SB0H.IRY+I
M_0R%:L91)SIN+/FVL&XCF8PJML45VK^JA:95TJ+DO$1IN)*@<3..IIWAK._D
MO<!'CHTYF8.S9*W4HUN\S\=1Z@BAP,PZ!$;##N]1" =$-#X?,*/V2J=X.C^B
MO_6VDRUK9O!>B4\\M\4XNHL@QPVKA5VJYAT>[+EU>)D2QG^A";*]-(*L-E:5
M!V5B4'(91O9T\,.)PMTEA>Y!H>MYAXL\RS?,LLE(JP:TDR8T-_&F>FTBQZ5[
ME)75=,I)ST[FT^7#^X??5["8+V'U;KJ<CQ)+N.XTR0X8LX#1O8#1@P]*VL+
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M^_\P#6WS63S\?%#'V5(&@< -J:;QJ]L(=&CH86%5Y9OH6EEJR7Y:T#\0:B=
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M985QE57BW].9\Q8)\9]C)@>)9\<E4I&\=&N9J3<]5(%3=J-ZES]\-WHV?/6
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M#O8&E D12;M)[D@CSG["=7<$8L->J^;@!.,8QEZT%G\S15B[Q^T@IYX'F"!
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MTH\;BEGE?7Q]EZ@!JC6KG&,=<^4RJV<$A#/XB2":U^6 W:)J&J._#_MC8TD
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M4J%G6[H!W\\-&FW\@PZH?S)W^3]02P,$%     @ Q8"=6%F5\&;9!P  AQ,
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M%N5[HLGEN13/(,UJU&8:UE0KC> 8-TZ9:(FS#.7TY>>OWV\G#W>W7Q\F</1
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MN^V=4</>1^0/6B3F8^I,:"TB4UPP"N<1[ #M@1 Z?\ )BJ_K1_\"4$L#!!0
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M_?$._9//'7.9,\MOM/PL$K<:!+T $KY@N71/>O,++_-I$UZLI?5/V!2VW2B
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MJGU 7G1?:"&UI0T.K U%976D+L,6T$;_8+< SLD&LR)?:9KO!$YC=Q>PY2]
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MZ3T'R2Z*"'_Y2$-VF%C0>OWB>_"T$>D7]G2\)4]T3L7#]I[+*[M 6041C9.
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MS=XX+I@0+,H^;BA949X&R-_7C(G7B_0E9O'2>OHO4$L#!!0    ( ,6 G5C
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M7'E#T&-V1[2A0M X>SQ@%&*F.LCO.TK%<T-=.Y77C,'_4$L#!!0    ( ,6
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MV98P+KY=SD"<[0\"=Y3%Y9?V]IIP'"?LG3C7_?0:O'WS#KPI1MS&22("V'C
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M=/"2>:1L[;HE\?WH]1EBW%4<;,B1LK4-D?L*W[RQZ,.0L\Z45#0=JBA/UW5
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MW, ]P3RH^HZH)T:NJS:[D :;=C5<X;4*R@;@^UQ*\SJQG;N]J)-_4$L#!!0
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MD%4#"7,@81@2YD+"/"!8I6J,?NE"]+4+RA7YR<)UF)WFJ8]6@H<LCKEX4?V
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M=5=,']U:KLG>'4-SW!W6U0)UUW+:4)O3;9B99=1'>5 SJ_X;26F(F7I#K+!
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M0&DGF/>I,,QUQUYLS7=)]!-02P,$%     @ Q8"=6.B!V[L "@  T%H  !D
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MG/V!(/0I4R1R)J48'%(,J$$8*/ R.9]:1R#46/E\:NM!:!I0YPTTWL<D*DH
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MZ@"7:EI5K4!M!CE^M [4/LWVUPP#J*H!7E4[0!&HK\<J@6FZ+]L#@P(:G+.
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M1;@46650_OXY38OW+]69QH=#K.?_!U!+ P04    " #%@)U85I6K3& $  "
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M>-$Q<IW?@J_2T)V:-U?TUX/*!M#\0DJSZ]B+M?J/"G\!4$L#!!0    ( ,6
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M<'_!X5,R'>C#PNQPN/\34$L#!!0    ( ,6 G5A"4QS[I@0   $8   9
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MV@#>1YRKYP>]0'X!/_D/4$L#!!0    ( ,6 G5CC1@:+_P0  .$7   9
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MU_4$7<'>1D=_,R&.RXH6@S;+016IG(D5]LC  M80A&^(-?SS#Z==_ZLLXXK
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M8^+<SIR!<M 6?R=D)RIMI$*9,_:F.@_QV+ 5(T)))!4$AI\MF1%*%1+P^+<
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M9U*R5#=7!,>$*P-XOF!,[CMJ@O(N*?@?4$L#!!0    ( ,6 G5@4,1YZ>P(
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M88.A4>\CTM*U^FO#JLHK;JTLZM=O2QR8H)T#WF^4L@?#)6A'</H74$L#!!0
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M3YS$RAUN[E$2&HH/"O][L$&L"4?1MZ4*11.R%QGM<4K;.T/;AR<6R[6 ASC
MH.AO*PER';R##F.O%O")\";X[D?P'*]5P6=RN;M?0\?/T^(;O%8UGCZ\=R(A
M"QQ8ZG0*Y%NTAC]\YW:<'U.E8;0C/*A4[MW(56%?":P@0BL7H670_7-[4V^.
MACZD 4Q8I"J7(&GL7&VG%:IJ(F&^AU.[*=F;:2,/_/&K@H1'B9'XLTJJUC6E
MNA)80:IV+E6[#GWX0L5K8\D1@:ISIO E<"*Q*N84R$UWLJ[RVZ'3=%IJUVY/
MHSECYN9F!9Z=G&>GEN?#6Z+JM\I30+<T0%4L]A3#H(IG"N0ZIP1*'&M-"ORZ
M.;_N9?RV+%1[+:1R7\6M6R6.[W5+_*K-7+^:8R_GV+N,HTIT!#=[)%Q\J&)9
M#],&XPD^1&DI=7L0D'U529E< ZD0ZVT>ZVTM]"=".6Q)N,&/D" '9HJ?;:X-
MN*$Q!"P,]=KZI9FM5")=Y/8D#[[7O'5+Z?J[E==M=KO5V7*=XPWKO/?DZYNR
M\O)[-V)5]JZ%5HS_Y O#_9_+>$;@6G)=":THEW>4R[M6*<^0RD6Z7=[89^Q:
MG3-;^_B5XM;>__^FG&=(M?6\WJ;(\?@1X=9>O)>6] RE7*Q;O3+':CNW?8;G
M\09WZZ_PB\OZ/^!T#U6X<[:<_Q>$8G3'>]^MO_BO5,BS50HUNMUL>^4D59BY
MS?*WBWW2-D7(5Z:;%+!@FUBFG4,^FW>L(].GE>;'NI,U[=@1)FV#55^PHJK_
M"7&I()UF5RG/T\XR'4B6F.9LSJ1J]<SC6G7CR+6!>K]D3!X&>H&\OQ_^!5!+
M P04    " #%@)U8YHI]DJ$#  !O#0  &0   'AL+W=O<FMS:&5E=',O<VAE
M970U.2YX;6RMEVUOXC@0Q[_**-<[M5*/A "%]@")IU4K;24$U[T7IWOA)@.)
MZL0YVY3=;W]C)Z2A"M%RX@W$=N;O^4WL\7BX%_)-18@:OB<\52,GTCI[<%T5
M1)@PU1(9IC2R$3)AFIIRZZI,(@NM4<)=W_/NW(3%J3,>VKZE' _%3O,XQ:4$
MM4L2)G],D8O]R&D[AXY5O(VTZ7#'PXQM<8WZ)5M*:KFE2A@GF*I8I"!Q,W(F
M[8=9VS<&]HUO,>Y5Y1D,RJL0;Z;Q%(X<SWB$' -M)!C]O>,,.3=*Y,>_A:A3
MSFD,J\\']2\6GF!>F<*9X'_%H8Y&SL"!$#=LQ_5*[!^Q .H9O4!P97]A7[SK
M.1#LE!9)84P>)'&:_[/O12 J!J13;^ 7!OYG@^X)@TYAT+&@N6<6:\XT&P^E
MV(,T;Y.:>;"QL=9$$Z?F,ZZUI-&8[/1X,ILMOBY6DS\7<U@_3E8+6"V6+ZO9
MXV2]@.LY:A9S=0._P\MZ#M=7-W %+JB(2500I_"2QEK=5CJ>8\[I\U#?5;4Y
M=#4Y:Z9T@\*Q:>Z8?\*Q-CR+5$<*%FF(X;&]2Y EJ7\@G?J-@L],MJ#3O@7?
M\SLU_LR:S;_@:PO\09WYD3N=,O =J]<]H?=$D8L9ASER6L?R!X@-K/,PTM[1
M'$.@*>6.]M8)AZ>-$YC]_Z R%N#(H0VN4+ZC,_[ME_:=]T<=_87$CF+1+6/1
MM>J=$[&8<::4#8 6P1O\_97&X4ECHOZIX^Y>DOM"8D?<O9*[U[@&)HG8I1J6
M+ [K.!N-S^7,Q?I6S.3V]S%E^J'[7N/^7>G^7:/[Q7)=88"TA$.XI@V?9X*;
M.IQ&L7-Q<K%!%:<>IE_"]']J/X;%?KR%3,8!0H8RA[)XH>"<2?716TO:.-.Y
MI+G8?85TX+6ZW7K:04D[:*3]QO@.*RF'*?C5-&>4<R4=K6!?J&-KU#V7+1=K
M>Q4XKS6H1[LOT>X;T0Y9TR;J(J.L,-O)(*+C'I92;"5+REPK>&@/*D;CIXZ&
M:>.,YT)?2.PH.&WOX[SW+IEK"[4+H5]*[9B]4NNT+YFP"K5>-<FT>N7J+) :
MI_R_2/X'DM^\VN.4DI:R%0-5U[J2K_+\]?-9JYBIFFGZ]RU_\!FXT:%S@=U*
MZ9J@W-J*7D%@#L:\MBM[RUO#Q-;*G_JGYC9A2^(/F?PJ0EM[&Z<*.&Y(TFOU
MZ8/*O+K/&UIDMD!^%9K*;?L8T8T(I7F!QC="Z$/#3%#>L<;_ 5!+ P04
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MS.>SU7RZ6"UAN)C ^&&QFBV^3A?CV70)EQ-TC M[!1? %<RY$%1*VP\=I?8
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M%7,RH8PS?4(;O<MORELY!5(2(/=HCX>,8N/#>6C(6SD/4E<@LZXXB)^19GO
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MR7F[3[>.EOA G[O(M7Y"CN4XZ,N3C]Z_^]!V87K,/6828Q>8O@;CGX]Q-9A
MC_$AKC&V!A.>C]'U)CH?8R&\9 !RSA,:\=S:Y&Y!=D^9/(]I!N@S?D$S:0N2
M+R&/7]%?'V4[="<@XW^W>;R$]MNAZAEQS=<XAIN.? AP8,_0F?SX@^U9O[3Y
MPB3,-PD+3,)"D[#($*SAF7[MF;Z./@D6"R@>DW(F+-PCI'L8%H#>8XXP6@.+
MI3O;?'ZK)5]JG!)FEZ-&51;/$ZMK]]UQ[WG?$B>:><UF@<FNA29AD2%80^Q!
M+?9 *[::&>:0PX((M& T0Y"M4_H*@/@*,_A9%3L)DC:0%2#'JH9JDUV;XU+9
M2YBW)Z?7/=3\N(W3O3H0W&2G0I.PR!"L(;A7"^YI!?](\)RD1+PB6<WOC7"0
M0YMS&A,YT!-9BHD5VN0Q,%D6Y<4,L*:<B%-%D3;GI08H88-] UBC[NC  B93
M!B9AH7=DSL'(/;1G9"AEPP3#V@1#K0EDP2'?WKB:X:7*#&*ZS,D_4G>QFPXX
M(ARI5C3'\_15Z<_)/(4V^;79+I5_>"2_XPT.;Y]O,F5@$A:V]']@=8<'\AM*
MV9!_5,L_TLK_(%_T<48WN119K+"0+\V;-$$+_$Q9H34N2@ $=27P5@*TB:_-
M=:GXHZ.;Y_:/IG;?9,K )"QLZ;_K=IT#\0VE;(A_58M_I1=_D\V!(;I T\>I
M&N$Y;.7(__?4>T<ILI9YJ<@F8;Y)6& 2%IJ$125LM&^LVE0-']C6;@'$TCIA
MFB3%$QVGQ?B&%U7CM0YQ/>A2^8W2?*.TH*(-]V=OUVH.W]!HRL@4K>F"O64P
M^Q(7<+I9KH0J#. E!L[51+&0!6.^K"O 5H=HDUSL$),TWR@M,$H+*UKC3<:[
M.GS?B4PE;7K$V7G$.=<C"10V:/6 <S1VAH/FA<RJ-HUYS#IHY.M[<[%@)FFA
M45IDBM;4=;<Z:&L7DB9WG&%(B^7!Z4:L*)/OA:W*&ET0-$KSC=("H[30*"TR
M16N:9;<L:/?_C[5DV^B:H%&:;Y06&*6%1FF1*5K3.[M51EN_S!AP03*UA"RK
M"=PL..BV=9_K5D^\V#>#HV>3;5N'SQV3*0.CM- H+3)%*^W0V]N%S8 MBPUV
MCF*UPE!N--9GZTW\:;%U?7!^9E_[Y5;\#E/^,N >LR7).4IA(9%6=R@O@)6;
M[>6!H.MBKW=.A:!9\7$%. &F&LCO%Y2*MP.5H/[)P^0_4$L#!!0    ( ,6
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M;+59;5.K.!3^*QGVSHYW9BT0H"]NVQFM>M</5<?J[N=(TY:Y0+I)VNJ_WQ-
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MB*MH0%,7R=@DV: FB%49%Y+#MP'DR>GBYL?\YOX9W=W?/CS-+Y_O'N[1.5K
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MF%D\/==.;R3;)D?#KTQ*%B67&TK@%ZP*@.]7#+;K[$:](/_OPO0_4$L#!!0
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M)"RAZ6Q;\P*'5E5HU;/80M.YMZX%&LW!&RH,C^4UA /_4(4]80B>>G_#UEE
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M>TJ"((K<"&!N!4& (? TX@BF #1@2!"4[\&M]Y&_>D_YS7\&AW\ 4$L#!!0
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M2P$"% ,4    " #%@)U86>^8C.\    K @  $0              @ &O
M9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " #%@)U8F5R<(Q &  "<)P
M$P              @ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0
M   ( ,6 G5A3WF&3TP4  , >   8              " @0X(  !X;"]W;W)K
M<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " #%@)U8&9_2D]0'  "S(0
M&               @($7#@  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L!
M A0#%     @ Q8"=6,=G*--8 P  (PL  !@              ("!(18  'AL
M+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( ,6 G5ACV&$LD04
M /\4   8              " @:\9  !X;"]W;W)K<VAE971S+W-H965T-"YX
M;6Q02P$"% ,4    " #%@)U8:$B:W/L#  "I#   &               @(%V
M'P  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ Q8"=6*#<
M6$IU!P  PR   !@              ("!IR,  'AL+W=O<FMS:&5E=',O<VAE
M970V+GAM;%!+ 0(4 Q0    ( ,6 G5@ZK*I5F @  /5)   8
M  " @5(K  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " #%
M@)U8T8]Q\& )  #A&0  &               @($@-   >&PO=V]R:W-H965T
M<R]S:&5E=#@N>&UL4$L! A0#%     @ Q8"=6-@X!(H/!@  @PT  !@
M         ("!MCT  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0
M   ( ,6 G5ADK6T9>P0  (@*   9              " @?M#  !X;"]W;W)K
M<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ Q8"=6'%_.I+L P  3 @
M !D              ("!K4@  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q0
M2P$"% ,4    " #%@)U8^4/YG\4)  "P&@  &0              @('03
M>&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( ,6 G5C:*BE[
M9@8  !D1   9              " @<Q6  !X;"]W;W)K<VAE971S+W-H965T
M,3,N>&UL4$L! A0#%     @ Q8"=6/!Z->YX"@  A!T  !D
M ("!:5T  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " #%
M@)U8:(^!8ML*  #4)0  &0              @($8:   >&PO=V]R:W-H965T
M<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( ,6 G5CQRT4SY 0  .0+   9
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M970R,"YX;6Q02P$"% ,4    " #%@)U8+FK(ASH.   ^)P  &0
M    @(&.C0  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    (
M ,6 G5A9E?!FV0<  (<3   9              " @?^;  !X;"]W;W)K<VAE
M971S+W-H965T,C(N>&UL4$L! A0#%     @ Q8"=6+?>CO1' @  H 4  !D
M             ("!#Z0  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"
M% ,4    " #%@)U8!)I68$4%  #+&0  &0              @(&-I@  >&PO
M=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( ,6 G5A2M3I%_P@
M #H9   9              " @0FL  !X;"]W;W)K<VAE971S+W-H965T,C4N
M>&UL4$L! A0#%     @ Q8"=6-]X@/0A!@  0!   !D              ("!
M/[4  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    " #%@)U8
M<<OW=& &  #2$@  &0              @(&7NP  >&PO=V]R:W-H965T<R]S
M:&5E=#(W+GAM;%!+ 0(4 Q0    ( ,6 G5B[VZ]SAP0  !D-   9
M      " @2["  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%
M  @ Q8"=6&KDG'-B!P  :1\  !D              ("![,8  'AL+W=O<FMS
M:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    " #%@)U8]*/:(7T$  #1"P
M&0              @(&%S@  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+
M 0(4 Q0    ( ,6 G5C"&H'9U0(  .\%   9              " @3G3  !X
M;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ Q8"=6/!RLS')
M!   5PP  !D              ("!1=8  'AL+W=O<FMS:&5E=',O<VAE970S
M,BYX;6Q02P$"% ,4    " #%@)U8-4Q7LP,#   Q!P  &0
M@(%%VP  >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( ,6
MG5@&=AZD1 4  +$,   9              " @7_>  !X;"]W;W)K<VAE971S
M+W-H965T,S0N>&UL4$L! A0#%     @ Q8"=6+A![;7U @  \ <  !D
M         ("!^N,  'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4
M    " #%@)U8^FQ9.$D%   ^%   &0              @($FYP  >&PO=V]R
M:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( ,6 G5@'HFC#:@,  $4)
M   9              " @:;L  !X;"]W;W)K<VAE971S+W-H965T,S<N>&UL
M4$L! A0#%     @ Q8"=6,F*POY, P  2PL  !D              ("!1_
M 'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"% ,4    " #%@)U8_ $<
M5>$#  #K$P  &0              @('*\P  >&PO=V]R:W-H965T<R]S:&5E
M=#,Y+GAM;%!+ 0(4 Q0    ( ,6 G5@U*1XO-0(  *,$   9
M  " @>+W  !X;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @
MQ8"=6,Z/&.Y<!0  P!X  !D              ("!3OH  'AL+W=O<FMS:&5E
M=',O<VAE970T,2YX;6Q02P$"% ,4    " #%@)U8P+[5>]<#  !R%   &0
M            @('A_P  >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4
M Q0    ( ,6 G5A/WVOVM 4  ,8A   9              " @>\# 0!X;"]W
M;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @ Q8"=6(SW]^*N @
MM <  !D              ("!V@D! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX
M;6Q02P$"% ,4    " #%@)U8E0N10T4#  !1"@  &0              @(&_
M# $ >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    ( ,6 G5A"
M@(9MI 8  %LV   9              " @3L0 0!X;"]W;W)K<VAE971S+W-H
M965T-#8N>&UL4$L! A0#%     @ Q8"=6"$NA2>X @  HP@  !D
M     ("!%A<! 'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ,6 G5CX+MB8;00  "@6   9              "
M@1<P 0!X;"]W;W)K<VAE971S+W-H965T-3(N>&UL4$L! A0#%     @ Q8"=
M6$)3'/NF!    1@  !D              ("!NS0! 'AL+W=O<FMS:&5E=',O
M<VAE970U,RYX;6Q02P$"% ,4    " #%@)U8,VUKM<0$  ",%P  &0
M        @(&8.0$ >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0
M   ( ,6 G5CC1@:+_P0  .$7   9              " @9,^ 0!X;"]W;W)K
M<VAE971S+W-H965T-34N>&UL4$L! A0#%     @ Q8"=6.1HP*SM P  5Q(
M !D              ("!R4,! 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q0
M2P$"% ,4    " #%@)U8%#$>>GL"  ".!0  &0              @('M1P$
M>&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4 Q0    ( ,6 G5C$OGGN
M!00  .L/   9              " @9]* 0!X;"]W;W)K<VAE971S+W-H965T
M-3@N>&UL4$L! A0#%     @ Q8"=6.:*?9*A P  ;PT  !D
M ("!VTX! 'AL+W=O<FMS:&5E=',O<VAE970U.2YX;6Q02P$"% ,4    " #%
M@)U8KB7[1K8"  #,!0  &0              @(&S4@$ >&PO=V]R:W-H965T
M<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    ( ,6 G5B?0NFG9 8  !0C   9
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M970V-2YX;6Q02P$"% ,4    " #%@)U8,EAVW(L$   !&P  &0
M    @(&4;0$ >&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    (
M ,6 G5ACT25Q$@4  &D8   9              " @59R 0!X;"]W;W)K<VAE
M971S+W-H965T-C<N>&UL4$L! A0#%     @ Q8"=6!KG<N65!   (!H  !D
M             ("!GW<! 'AL+W=O<FMS:&5E=',O<VAE970V."YX;6Q02P$"
M% ,4    " #%@)U8Q[,:!DP#   F%   #0              @ %K? $ >&PO
M<W1Y;&5S+GAM;%!+ 0(4 Q0    ( ,6 G5B7BKL<P    !,"   +
M      "  >)_ 0!?<F5L<R\N<F5L<U!+ 0(4 Q0    ( ,6 G5CQ<'[I004
M #4M   /              "  <N  0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M    " #%@)U8%MUK%"8"  !C*   &@              @ $YA@$ >&PO7W)E
M;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " #%@)U8X>Q>$?0!  "B
M)P  $P              @ &7B $ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
1    3 !, ,L4  "\B@$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>253</ContextCount>
  <ElementCount>347</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>71</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - COVER</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/COVER</Role>
      <ShortName>COVER</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED CONDENSED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED CONDENSED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME</Role>
      <ShortName>CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - BASIS OF PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/BASISOFPRESENTATION</Role>
      <ShortName>BASIS OF PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS</Role>
      <ShortName>OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - INTELLECTUAL PROPERTY AGREEMENT AND CERTAIN LITIGATION EXPENSES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSES</Role>
      <ShortName>INTELLECTUAL PROPERTY AGREEMENT AND CERTAIN LITIGATION EXPENSES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - SEPARATION COSTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/SEPARATIONCOSTS</Role>
      <ShortName>SEPARATION COSTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - INVESTMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/INVESTMENTS</Role>
      <ShortName>INVESTMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - INVESTMENTS IN VARIABLE INTEREST ENTITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIES</Role>
      <ShortName>INVESTMENTS IN VARIABLE INTEREST ENTITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/FAIRVALUEMEASUREMENTS</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - STOCK-BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/STOCKBASEDCOMPENSATION</Role>
      <ShortName>STOCK-BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - ACCELERATED SHARE REPURCHASE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASE</Role>
      <ShortName>ACCELERATED SHARE REPURCHASE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - EARNINGS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/EARNINGSPERSHARE</Role>
      <ShortName>EARNINGS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - SEGMENT INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/SEGMENTINFORMATION</Role>
      <ShortName>SEGMENT INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9954471 - Disclosure - BASIS OF PRESENTATION (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/BASISOFPRESENTATIONPolicies</Role>
      <ShortName>BASIS OF PRESENTATION (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9954472 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables</Role>
      <ShortName>OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9954473 - Disclosure - INVESTMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/INVESTMENTSTables</Role>
      <ShortName>INVESTMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.edwards.com/role/INVESTMENTS</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9954474 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/FAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.edwards.com/role/FAIRVALUEMEASUREMENTS</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9954475 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9954476 - Disclosure - STOCK-BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/STOCKBASEDCOMPENSATIONTables</Role>
      <ShortName>STOCK-BASED COMPENSATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.edwards.com/role/STOCKBASEDCOMPENSATION</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9954477 - Disclosure - ACCELERATED SHARE REPURCHASE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASETables</Role>
      <ShortName>ACCELERATED SHARE REPURCHASE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASE</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9954478 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9954479 - Disclosure - EARNINGS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/EARNINGSPERSHARETables</Role>
      <ShortName>EARNINGS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.edwards.com/role/EARNINGSPERSHARE</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9954480 - Disclosure - SEGMENT INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/SEGMENTINFORMATIONTables</Role>
      <ShortName>SEGMENT INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.edwards.com/role/SEGMENTINFORMATION</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9954481 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Components of Selected Captions in the Consolidated Balance Sheets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsintheConsolidatedBalanceSheetsDetails</Role>
      <ShortName>OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Components of Selected Captions in the Consolidated Balance Sheets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9954482 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Accrued and Other Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails</Role>
      <ShortName>OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Accrued and Other Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9954483 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Supplemental Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails</Role>
      <ShortName>OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Supplemental Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9954484 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails</Role>
      <ShortName>OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9954485 - Disclosure - INTELLECTUAL PROPERTY AGREEMENT AND CERTAIN LITIGATION EXPENSES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSESDetails</Role>
      <ShortName>INTELLECTUAL PROPERTY AGREEMENT AND CERTAIN LITIGATION EXPENSES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSES</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9954486 - Disclosure - SEPARATION COSTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/SEPARATIONCOSTSDetails</Role>
      <ShortName>SEPARATION COSTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.edwards.com/role/SEPARATIONCOSTS</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9954487 - Disclosure - INVESTMENTS - Schedule of Investments in Debt Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails</Role>
      <ShortName>INVESTMENTS - Schedule of Investments in Debt Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9954488 - Disclosure - INVESTMENTS - Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails</Role>
      <ShortName>INVESTMENTS - Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9954489 - Disclosure - INVESTMENTS - Schedule of Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails</Role>
      <ShortName>INVESTMENTS - Schedule of Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9954490 - Disclosure - INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails</Role>
      <ShortName>INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9954491 - Disclosure - INVESTMENTS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/INVESTMENTSNarrativeDetails</Role>
      <ShortName>INVESTMENTS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9954492 - Disclosure - INVESTMENTS IN VARIABLE INTEREST ENTITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails</Role>
      <ShortName>INVESTMENTS IN VARIABLE INTEREST ENTITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIES</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9954493 - Disclosure - FAIR VALUE MEASUREMENTS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9954494 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9954495 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Changes in Fair Value of Contingent Consideration and Other Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Schedule of Changes in Fair Value of Contingent Consideration and Other Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9954496 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9954497 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9954498 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9954499 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9954500 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9954501 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Fair Value and Cash Flow Hedge Accounting on the Consolidated Condensed Statements of Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Fair Value and Cash Flow Hedge Accounting on the Consolidated Condensed Statements of Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9954502 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION - Schedule of Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9954503 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9954504 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Weighted-Average Assumptions for Options and ESPP Subscriptions Granted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION - Schedule of Weighted-Average Assumptions for Options and ESPP Subscriptions Granted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9954505 - Disclosure - ACCELERATED SHARE REPURCHASE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails</Role>
      <ShortName>ACCELERATED SHARE REPURCHASE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASETables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9954506 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIESDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIES</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9954507 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9954508 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9954509 - Disclosure - EARNINGS PER SHARE - Schedule of Computation of Basic and Diluted Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails</Role>
      <ShortName>EARNINGS PER SHARE - Schedule of Computation of Basic and Diluted Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9954510 - Disclosure - EARNINGS PER SHARE - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails</Role>
      <ShortName>EARNINGS PER SHARE - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9954511 - Disclosure - INCOME TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/INCOMETAXESDetails</Role>
      <ShortName>INCOME TAXES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.edwards.com/role/INCOMETAXES</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>9954512 - Disclosure - SEGMENT INFORMATION - Schedule of Information about Reportable Segments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails</Role>
      <ShortName>SEGMENT INFORMATION - Schedule of Information about Reportable Segments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>9954513 - Disclosure - SEGMENT INFORMATION - Schedule of Reconciliation of Segment Net Sales and Pre-Tax Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails</Role>
      <ShortName>SEGMENT INFORMATION - Schedule of Reconciliation of Segment Net Sales and Pre-Tax Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="ew-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>9954514 - Disclosure - SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails</Role>
      <ShortName>SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 3 fact(s) appearing in ix:hidden were eligible for transformation: ecd:TrdArrDuration -  ew-20240331.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="ew-20240331.htm">ew-20240331.htm</File>
    <File>ew-20240331.xsd</File>
    <File>ew-20240331_cal.xml</File>
    <File>ew-20240331_def.xml</File>
    <File>ew-20240331_lab.xml</File>
    <File>ew-20240331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>ew-20240331_g1.jpg</File>
    <File>ew-20240331_g10.jpg</File>
    <File>ew-20240331_g11.jpg</File>
    <File>ew-20240331_g12.jpg</File>
    <File>ew-20240331_g2.jpg</File>
    <File>ew-20240331_g3.jpg</File>
    <File>ew-20240331_g4.jpg</File>
    <File>ew-20240331_g5.jpg</File>
    <File>ew-20240331_g6.jpg</File>
    <File>ew-20240331_g7.jpg</File>
    <File>ew-20240331_g8.jpg</File>
    <File>ew-20240331_g9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="943">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/ecd/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>100
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ew-20240331.htm": {
   "nsprefix": "ew",
   "nsuri": "http://www.edwards.com/20240331",
   "dts": {
    "inline": {
     "local": [
      "ew-20240331.htm"
     ]
    },
    "schema": {
     "local": [
      "ew-20240331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "ew-20240331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "ew-20240331_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "ew-20240331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ew-20240331_pre.xml"
     ]
    }
   },
   "keyStandard": 324,
   "keyCustom": 23,
   "axisStandard": 27,
   "axisCustom": 0,
   "memberStandard": 48,
   "memberCustom": 22,
   "hidden": {
    "total": 14,
    "http://xbrl.sec.gov/ecd/2023": 3,
    "http://fasb.org/us-gaap/2023": 6,
    "http://xbrl.sec.gov/dei/2023": 5
   },
   "contextCount": 253,
   "entityCount": 1,
   "segmentCount": 71,
   "elementCount": 657,
   "unitCount": 7,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 943,
    "http://xbrl.sec.gov/dei/2023": 29,
    "http://xbrl.sec.gov/ecd/2023": 24
   },
   "report": {
    "R1": {
     "role": "http://www.edwards.com/role/COVER",
     "longName": "0000001 - Document - COVER",
     "shortName": "COVER",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
     "longName": "0000002 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS",
     "shortName": "CONSOLIDATED CONDENSED BALANCE SHEETS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:ShortTermInvestments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical",
     "longName": "0000003 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS (Parenthetical)",
     "shortName": "CONSOLIDATED CONDENSED BALANCE SHEETS (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS",
     "longName": "0000004 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS",
     "shortName": "CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GrossProfit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME",
     "longName": "0000005 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME",
     "shortName": "CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS",
     "longName": "0000006 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS",
     "shortName": "CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "longName": "0000007 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "shortName": "CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-29",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-29",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.edwards.com/role/BASISOFPRESENTATION",
     "longName": "0000008 - Disclosure - BASIS OF PRESENTATION",
     "shortName": "BASIS OF PRESENTATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS",
     "longName": "0000009 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS",
     "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSES",
     "longName": "0000010 - Disclosure - INTELLECTUAL PROPERTY AGREEMENT AND CERTAIN LITIGATION EXPENSES",
     "shortName": "INTELLECTUAL PROPERTY AGREEMENT AND CERTAIN LITIGATION EXPENSES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.edwards.com/role/SEPARATIONCOSTS",
     "longName": "0000011 - Disclosure - SEPARATION COSTS",
     "shortName": "SEPARATION COSTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.edwards.com/role/INVESTMENTS",
     "longName": "0000012 - Disclosure - INVESTMENTS",
     "shortName": "INVESTMENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIES",
     "longName": "0000013 - Disclosure - INVESTMENTS IN VARIABLE INTEREST ENTITIES",
     "shortName": "INVESTMENTS IN VARIABLE INTEREST ENTITIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.edwards.com/role/FAIRVALUEMEASUREMENTS",
     "longName": "0000014 - Disclosure - FAIR VALUE MEASUREMENTS",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES",
     "longName": "0000015 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.edwards.com/role/STOCKBASEDCOMPENSATION",
     "longName": "0000016 - Disclosure - STOCK-BASED COMPENSATION",
     "shortName": "STOCK-BASED COMPENSATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASE",
     "longName": "0000017 - Disclosure - ACCELERATED SHARE REPURCHASE",
     "shortName": "ACCELERATED SHARE REPURCHASE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIES",
     "longName": "0000018 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS",
     "longName": "0000019 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.edwards.com/role/EARNINGSPERSHARE",
     "longName": "0000020 - Disclosure - EARNINGS PER SHARE",
     "shortName": "EARNINGS PER SHARE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.edwards.com/role/INCOMETAXES",
     "longName": "0000021 - Disclosure - INCOME TAXES",
     "shortName": "INCOME TAXES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.edwards.com/role/SEGMENTINFORMATION",
     "longName": "0000022 - Disclosure - SEGMENT INFORMATION",
     "shortName": "SEGMENT INFORMATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R24": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:NonRule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:Rule10b51ArrTrmntdFlag",
       "ecd:NonRule10b51ArrTrmntdFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:NonRule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:Rule10b51ArrTrmntdFlag",
       "ecd:NonRule10b51ArrTrmntdFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.edwards.com/role/BASISOFPRESENTATIONPolicies",
     "longName": "9954471 - Disclosure - BASIS OF PRESENTATION (Policies)",
     "shortName": "BASIS OF PRESENTATION (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables",
     "longName": "9954472 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables)",
     "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.edwards.com/role/INVESTMENTSTables",
     "longName": "9954473 - Disclosure - INVESTMENTS (Tables)",
     "shortName": "INVESTMENTS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSTables",
     "longName": "9954474 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables",
     "longName": "9954475 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONTables",
     "longName": "9954476 - Disclosure - STOCK-BASED COMPENSATION (Tables)",
     "shortName": "STOCK-BASED COMPENSATION (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASETables",
     "longName": "9954477 - Disclosure - ACCELERATED SHARE REPURCHASE (Tables)",
     "shortName": "ACCELERATED SHARE REPURCHASE (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AcceleratedShareRepurchasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AcceleratedShareRepurchasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables",
     "longName": "9954478 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.edwards.com/role/EARNINGSPERSHARETables",
     "longName": "9954479 - Disclosure - EARNINGS PER SHARE (Tables)",
     "shortName": "EARNINGS PER SHARE (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.edwards.com/role/SEGMENTINFORMATIONTables",
     "longName": "9954480 - Disclosure - SEGMENT INFORMATION (Tables)",
     "shortName": "SEGMENT INFORMATION (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsintheConsolidatedBalanceSheetsDetails",
     "longName": "9954481 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Components of Selected Captions in the Consolidated Balance Sheets (Details)",
     "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Components of Selected Captions in the Consolidated Balance Sheets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails",
     "longName": "9954482 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Accrued and Other Liabilities (Details)",
     "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Accrued and Other Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:IncomeTaxReceivable",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:IncomeTaxReceivable",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails",
     "longName": "9954483 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Supplemental Cash Flow Information (Details)",
     "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Supplemental Cash Flow Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxesPaid",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxesPaid",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails",
     "longName": "9954484 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details)",
     "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:RestrictedCashCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSESDetails",
     "longName": "9954485 - Disclosure - INTELLECTUAL PROPERTY AGREEMENT AND CERTAIN LITIGATION EXPENSES (Details)",
     "shortName": "INTELLECTUAL PROPERTY AGREEMENT AND CERTAIN LITIGATION EXPENSES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-50",
      "name": "ew:IntellectualPropertyAgreementTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-50",
      "name": "ew:IntellectualPropertyAgreementTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.edwards.com/role/SEPARATIONCOSTSDetails",
     "longName": "9954486 - Disclosure - SEPARATION COSTS (Details)",
     "shortName": "SEPARATION COSTS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RestructuringCostsAndAssetImpairmentCharges",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RestructuringCostsAndAssetImpairmentCharges",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails",
     "longName": "9954487 - Disclosure - INVESTMENTS - Schedule of Investments in Debt Securities (Details)",
     "shortName": "INVESTMENTS - Schedule of Investments in Debt Securities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:HeldToMaturitySecuritiesFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails",
     "longName": "9954488 - Disclosure - INVESTMENTS - Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details)",
     "shortName": "INVESTMENTS - Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails",
     "longName": "9954489 - Disclosure - INVESTMENTS - Schedule of Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position (Details)",
     "shortName": "INVESTMENTS - Schedule of Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails",
     "longName": "9954490 - Disclosure - INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details)",
     "shortName": "INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:EquityMethodInvestments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:EquityMethodInvestments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.edwards.com/role/INVESTMENTSNarrativeDetails",
     "longName": "9954491 - Disclosure - INVESTMENTS - Narrative (Details)",
     "shortName": "INVESTMENTS - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails",
     "longName": "9954492 - Disclosure - INVESTMENTS IN VARIABLE INTEREST ENTITIES (Details)",
     "shortName": "INVESTMENTS IN VARIABLE INTEREST ENTITIES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:Assets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-69",
      "name": "ew:EquitySecuritiesFVNIMaximumSecuredPromissoryNote",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
     "longName": "9954493 - Disclosure - FAIR VALUE MEASUREMENTS - Narrative (Details)",
     "shortName": "FAIR VALUE MEASUREMENTS - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-117",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-117",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails",
     "longName": "9954494 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis (Details)",
     "shortName": "FAIR VALUE MEASUREMENTS - Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-79",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails",
     "longName": "9954495 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Changes in Fair Value of Contingent Consideration and Other Liability (Details)",
     "shortName": "FAIR VALUE MEASUREMENTS - Schedule of Changes in Fair Value of Contingent Consideration and Other Liability (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-120",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-120",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails",
     "longName": "9954496 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk (Details)",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-136",
      "name": "us-gaap:DerivativeNotionalAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-136",
      "name": "us-gaap:DerivativeNotionalAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails",
     "longName": "9954497 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details)",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails",
     "longName": "9954498 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets (Details)",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-142",
      "name": "us-gaap:DerivativeAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OffsettingLiabilitiesTableTextBlock",
       "us-gaap:OffsettingAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-140",
      "name": "us-gaap:DerivativeAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails",
     "longName": "9954499 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets and Liabilities (Details)",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-142",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OffsettingLiabilitiesTableTextBlock",
       "us-gaap:OffsettingAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-142",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OffsettingLiabilitiesTableTextBlock",
       "us-gaap:OffsettingAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails",
     "longName": "9954500 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income (Details)",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-157",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-157",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails",
     "longName": "9954501 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Fair Value and Cash Flow Hedge Accounting on the Consolidated Condensed Statements of Operations (Details)",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Fair Value and Cash Flow Hedge Accounting on the Consolidated Condensed Statements of Operations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-159",
      "name": "us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails",
     "longName": "9954502 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Stock-Based Compensation Expense (Details)",
     "shortName": "STOCK-BASED COMPENSATION - Schedule of Stock-Based Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
     "longName": "9954503 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details)",
     "shortName": "STOCK-BASED COMPENSATION - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails",
     "longName": "9954504 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Weighted-Average Assumptions for Options and ESPP Subscriptions Granted (Details)",
     "shortName": "STOCK-BASED COMPENSATION - Schedule of Weighted-Average Assumptions for Options and ESPP Subscriptions Granted (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-175",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-175",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails",
     "longName": "9954505 - Disclosure - ACCELERATED SHARE REPURCHASE (Details)",
     "shortName": "ACCELERATED SHARE REPURCHASE (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-179",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-179",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIESDetails",
     "longName": "9954506 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ew:LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber",
      "unitRef": "lawsuit",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ew:LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber",
      "unitRef": "lawsuit",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails",
     "longName": "9954507 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss (Details)",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails",
     "longName": "9954508 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss (Details)",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherNonoperatingIncomeExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-206",
      "name": "us-gaap:OtherNonoperatingIncomeExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails",
     "longName": "9954509 - Disclosure - EARNINGS PER SHARE - Schedule of Computation of Basic and Diluted Earnings Per Share (Details)",
     "shortName": "EARNINGS PER SHARE - Schedule of Computation of Basic and Diluted Earnings Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails",
     "longName": "9954510 - Disclosure - EARNINGS PER SHARE - Narrative (Details)",
     "shortName": "EARNINGS PER SHARE - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c-212",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-212",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.edwards.com/role/INCOMETAXESDetails",
     "longName": "9954511 - Disclosure - INCOME TAXES (Details)",
     "shortName": "INCOME TAXES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails",
     "longName": "9954512 - Disclosure - SEGMENT INFORMATION - Schedule of Information about Reportable Segments (Details)",
     "shortName": "SEGMENT INFORMATION - Schedule of Information about Reportable Segments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-226",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails",
     "longName": "9954513 - Disclosure - SEGMENT INFORMATION - Schedule of Reconciliation of Segment Net Sales and Pre-Tax Income (Details)",
     "shortName": "SEGMENT INFORMATION - Schedule of Reconciliation of Segment Net Sales and Pre-Tax Income (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-226",
      "name": "us-gaap:OperatingIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails",
     "longName": "9954514 - Disclosure - SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details)",
     "shortName": "SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-240",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20240331.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AOCI Attributable to Parent, Net of Tax",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AcceleratedShareRepurchasesDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AcceleratedShareRepurchasesDateAxis",
     "presentation": [
      "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accelerated Share Repurchases, Date [Axis]",
        "label": "Accelerated Share Repurchases, Date [Axis]",
        "documentation": "Information by date of execution of accelerated share repurchases."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "us-gaap_AcceleratedShareRepurchasesDateDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AcceleratedShareRepurchasesDateDomain",
     "presentation": [
      "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accelerated Share Repurchases, Date [Domain]",
        "label": "Accelerated Share Repurchases, Date [Domain]",
        "documentation": "Date upon which the accelerated share repurchase agreement was executed."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AcceleratedShareRepurchasesFinalPricePaidPerShare",
     "presentation": [
      "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Final settlement per share price (in dollars per share)",
        "label": "Accelerated Share Repurchases, Final Price Paid Per Share",
        "documentation": "Final price paid per share for the purchase of the targeted number of shares, determined by an average market price over a fixed period of time."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AcceleratedShareRepurchasesInitialPricePaidPerShare",
     "presentation": [
      "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial delivery, price per share (in dollars per share)",
        "label": "Accelerated Share Repurchases, Initial Price Paid Per Share",
        "documentation": "The price paid per share to immediately purchase the targeted number of shares on the date of executing the accelerated share repurchase agreement."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "us-gaap_AcceleratedShareRepurchasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AcceleratedShareRepurchasesTextBlock",
     "presentation": [
      "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASETables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accelerated Share Repurchases",
        "label": "Accelerated Share Repurchases [Table Text Block]",
        "documentation": "Tabular disclosure of accelerated share repurchase (ASR) programs. An ASR is a combination of transactions that permits an entity to purchase a targeted number of shares immediately with the final purchase price of those shares determined by an average market price over a fixed period of time. An accelerated share repurchase program is intended to combine the immediate share retirement benefits of a tender offer with the market impact and pricing benefits of a disciplined daily open market stock repurchase program. ASRs can be disclosed as part of stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount",
     "presentation": [
      "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Value of Shares as % of Contract Value",
        "label": "Accelerated Share Repurchases, Value Of Shares Repurchased As Percentage Of Contract Amount",
        "documentation": "Represents the value of the initial shares repurchased as a percentage of the contract amount under accelerated share repurchase agreement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Policies [Abstract]",
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r866"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable, net of allowances of $13.5 and $8.3, respectively",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r350",
      "r351"
     ]
    },
    "ew_AccrualForEnvironmentalLossContingenciesThresholdAmountForDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "AccrualForEnvironmentalLossContingenciesThresholdAmountForDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Threshold of disclosing material environmental legal proceedings",
        "label": "Accrual For Environmental Loss Contingencies Threshold Amount For Disclosure",
        "documentation": "Accrual For Environmental Loss Contingencies Threshold Amount For Disclosure"
       }
      }
     },
     "auth_ref": []
    },
    "ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": {
       "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, payroll, and other taxes",
        "label": "Accrual for Property Payroll and Other Taxes Other than Income Taxes Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes, payroll taxes and other taxes, excluding income taxes payable. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": []
    },
    "ew_AccruedAndOtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "AccruedAndOtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued and other liabilities (Note 2)",
        "totalLabel": "Total accrued and other liabilities",
        "label": "Accrued And Other Liabilities, Current",
        "documentation": "Accrued And Other Liabilities, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedIncomeTaxesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": {
       "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Taxes payable",
        "label": "Accrued Income Taxes, Current",
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r186"
     ]
    },
    "ew_AccruedLitigationAndInsuranceReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "AccruedLitigationAndInsuranceReserves",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": {
       "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legal and insurance",
        "label": "Accrued Litigation And Insurance Reserves",
        "documentation": "Accrued Litigation And Insurance Reserves"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedMarketingCostsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedMarketingCostsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": {
       "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued marketing expenses",
        "label": "Accrued Marketing Costs, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedProfessionalFeesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": {
       "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued professional services",
        "label": "Accrued Professional Fees, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "ew_AccruedRebates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "AccruedRebates",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": {
       "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued rebates",
        "label": "Accrued Rebates",
        "documentation": "Aggregate carrying amount, as of the balance sheet date, of current obligations associated with sales rebates."
       }
      }
     },
     "auth_ref": []
    },
    "ew_AccruedRelocationCostsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "AccruedRelocationCostsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": {
       "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued relocation costs",
        "label": "Accrued Relocation Costs, Current",
        "documentation": "Accrued Relocation Costs, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized Pension Credits (Costs)",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r18",
      "r45",
      "r976",
      "r977",
      "r978"
     ]
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails",
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized Gain on Hedges",
        "verboseLabel": "Gain on hedges",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r253",
      "r261",
      "r262",
      "r557",
      "r840",
      "r976"
     ]
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails",
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized Loss on Available-for-sale Investments",
        "verboseLabel": "Loss on available-for-sale investments",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]",
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r249",
      "r250",
      "r251",
      "r253",
      "r261",
      "r262",
      "r976"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accumulated Other Comprehensive Loss",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r260",
      "r261",
      "r600",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive loss (Note 12)",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r45",
      "r143",
      "r236",
      "r681",
      "r719",
      "r720"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r260",
      "r261",
      "r600",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails",
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Loss",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r18",
      "r45",
      "r569",
      "r572",
      "r613",
      "r715",
      "r716",
      "r976",
      "r977",
      "r978",
      "r987",
      "r988",
      "r989"
     ]
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedTranslationAdjustmentMember",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails",
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Currency Translation Adjustments",
        "verboseLabel": "Foreign currency translation adjustments",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r18",
      "r45",
      "r261",
      "r262",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r976"
     ]
    },
    "ew_AcquisitionOptionsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "AcquisitionOptionsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisition options",
        "label": "Acquisition Options, Noncurrent",
        "documentation": "Acquisition Options, Noncurrent"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r916"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital, Common Stock",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-in Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r527",
      "r528",
      "r529",
      "r730",
      "r987",
      "r988",
      "r989",
      "r1034",
      "r1051"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r922"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r922"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r922"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r922"
     ]
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net income to net cash (used in) provided by operating activities:",
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation expense",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r81",
      "r492"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r887",
      "r898",
      "r908",
      "r933"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r890",
      "r901",
      "r911",
      "r936"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r922"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r929"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r894",
      "r902",
      "r912",
      "r929",
      "r937",
      "r941",
      "r949"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r947"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails": {
       "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r522",
      "r530"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllocatedShareBasedCompensationExpenseNetOfTax",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stock-based compensation expense, net of tax",
        "label": "Share-Based Payment Arrangement, Expense, after Tax",
        "documentation": "Amount, after tax, of expense for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for doubtful accounts",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r237",
      "r352",
      "r397"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Anti-dilutive securities excluded from the computation of earnings per share (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r310"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities [Axis]",
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Anti-dilutive securities",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_AssetBackedSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetBackedSecuritiesMember",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset-backed securities",
        "label": "Asset-Backed Securities [Member]",
        "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans."
       }
      }
     },
     "auth_ref": [
      "r858",
      "r996",
      "r999",
      "r1002"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "terseLabel": "Assets",
        "label": "Assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r229",
      "r275",
      "r320",
      "r335",
      "r341",
      "r394",
      "r434",
      "r435",
      "r437",
      "r438",
      "r439",
      "r441",
      "r443",
      "r445",
      "r446",
      "r553",
      "r558",
      "r594",
      "r677",
      "r764",
      "r866",
      "r878",
      "r1025",
      "r1026",
      "r1039"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ASSETS",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r223",
      "r241",
      "r275",
      "r394",
      "r434",
      "r435",
      "r437",
      "r438",
      "r439",
      "r441",
      "r443",
      "r445",
      "r446",
      "r553",
      "r558",
      "r594",
      "r866",
      "r1025",
      "r1026",
      "r1039"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Assets",
        "label": "Assets, Fair Value Disclosure",
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsFairValueDisclosureAbstract",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Assets, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross Unrealized Gains",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r361"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gross Unrealized Losses",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r362"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Amortized Cost",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r358",
      "r404",
      "r676"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesAbstract",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Available-for-sale",
        "label": "Debt Securities, Available-for-Sale [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAbstract",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Available-for-Sale",
        "label": "Available-for-Sale Securities, Debt Maturities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortized Cost",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Rolling Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value",
        "label": "Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due in 1\u00a0year or less",
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date."
       }
      }
     },
     "auth_ref": [
      "r997"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due in 1\u00a0year or less",
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value",
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date."
       }
      }
     },
     "auth_ref": [
      "r997"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due after 1\u00a0year through 5\u00a0years",
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date."
       }
      }
     },
     "auth_ref": [
      "r998"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due after 1\u00a0year through 5\u00a0years",
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value",
        "documentation": "Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date."
       }
      }
     },
     "auth_ref": [
      "r998"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Instruments not due at a single maturity date",
        "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping."
       }
      }
     },
     "auth_ref": [
      "r995",
      "r996"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Instruments not due at a single maturity date",
        "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value",
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping."
       }
      }
     },
     "auth_ref": [
      "r364",
      "r674",
      "r995"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value",
        "totalLabel": "Fair Value",
        "verboseLabel": "Available-for-sale investments:",
        "label": "Debt Securities, Available-for-Sale",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r359",
      "r404",
      "r665",
      "r993"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r944"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r945"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r940"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r940"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r940"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r940"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r940"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r940"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r943"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r942"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r941"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r941"
     ]
    },
    "us-gaap_BankTimeDepositsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BankTimeDepositsMember",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bank time deposits",
        "label": "Bank Time Deposits [Member]",
        "documentation": "Certificates of deposit (CD) or savings accounts with a fixed term or understanding the customer can only withdraw by giving advanced notice with a bank or other financial institution. A CD is a short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest."
       }
      }
     },
     "auth_ref": [
      "r195"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.edwards.com/role/BASISOFPRESENTATIONPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "ew_BernardJ.ZovighianMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "BernardJ.ZovighianMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bernard J. Zovighian [Member]",
        "documentation": "Bernard J. Zovighian"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS",
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in fair value of contingent consideration liabilities (Note 7)",
        "negatedLabel": "Change in fair value of contingent consideration liabilities",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement."
       }
      }
     },
     "auth_ref": [
      "r551",
      "r981"
     ]
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent consideration liability",
        "label": "Business Combination, Contingent Consideration, Liability",
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r84",
      "r550"
     ]
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent consideration liability measurement input",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input",
        "documentation": "Value of input used to measure contingent consideration liability from business combination."
       }
      }
     },
     "auth_ref": [
      "r585"
     ]
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital expenditures accruals",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r55",
      "r56"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r225",
      "r828"
     ]
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash equivalents",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS",
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of period",
        "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of period (Note 2)",
        "totalLabel": "Total cash, cash equivalents, and restricted cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r158",
      "r273"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net increase in cash, cash equivalents, and restricted cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r158"
     ]
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flow gain to be reclassified in the next twelve months",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months",
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months."
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "us-gaap_CashFlowHedgingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashFlowHedgingMember",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash flow hedges",
        "label": "Cash Flow Hedging [Member]",
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk."
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash investing and financing transactions:",
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivatives designated as hedging instruments",
        "label": "Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments",
        "documentation": "Amount of gain (loss) from the increase (decrease) in fair value of derivative and nonderivative instruments designated as fair value hedging instruments recognized in the income statement."
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedged items",
        "label": "Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge",
        "documentation": "Amount of the increase (decrease) in fair value of the hedged item in a fair value hedge recognized in the income statement."
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r920"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Line Items]",
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r232",
      "r233",
      "r234",
      "r315",
      "r465",
      "r466",
      "r467",
      "r469",
      "r472",
      "r477",
      "r479",
      "r722",
      "r723",
      "r724",
      "r725",
      "r855",
      "r955",
      "r984"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r921"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r921"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies (Note\u00a011)",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r125",
      "r678",
      "r750"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]",
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "COMMITMENTS AND CONTINGENCIES",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r428",
      "r429",
      "r815",
      "r1016"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r868",
      "r869",
      "r870",
      "r872",
      "r873",
      "r874",
      "r875",
      "r987",
      "r988",
      "r1034",
      "r1049",
      "r1051"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r751"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical",
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares outstanding (in shares)",
        "periodStartLabel": "Common stock, beginning balance (in shares)",
        "periodEndLabel": "Common stock, ending balance (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r130",
      "r751",
      "r770",
      "r1051",
      "r1052"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common stock, $1.00 par value, 1,050.0 shares authorized, 651.8 and 650.5 shares issued, and 602.4 and 601.1 shares outstanding, respectively",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r680",
      "r866"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r926"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r925"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r927"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r924"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive income attributable to Edwards Lifesciences Corporation",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r257",
      "r259",
      "r266",
      "r669",
      "r694"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Comprehensive loss attributable to noncontrolling interest",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r87",
      "r96",
      "r257",
      "r259",
      "r265",
      "r668",
      "r693"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive income",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r177",
      "r257",
      "r259",
      "r264",
      "r667",
      "r692"
     ]
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ACCUMULATED OTHER COMPREHENSIVE LOSS",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r263",
      "r666",
      "r690"
     ]
    },
    "srt_ConsolidatedEntitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidatedEntitiesAxis",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated Entities [Axis]",
        "label": "Consolidated Entities [Axis]"
       }
      }
     },
     "auth_ref": [
      "r279",
      "r553",
      "r554",
      "r558",
      "r559",
      "r617",
      "r825",
      "r1024",
      "r1027",
      "r1028"
     ]
    },
    "srt_ConsolidatedEntitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidatedEntitiesDomain",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated Entities [Domain]",
        "label": "Consolidated Entities [Domain]"
       }
      }
     },
     "auth_ref": [
      "r279",
      "r553",
      "r554",
      "r558",
      "r559",
      "r617",
      "r825",
      "r1024",
      "r1027",
      "r1028"
     ]
    },
    "srt_ConsolidationItemsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidationItemsAxis",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails",
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation Items [Axis]",
        "label": "Consolidation Items [Axis]"
       }
      }
     },
     "auth_ref": [
      "r279",
      "r322",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r339",
      "r343",
      "r434",
      "r435",
      "r436",
      "r437",
      "r439",
      "r440",
      "r442",
      "r444",
      "r445",
      "r1025",
      "r1026"
     ]
    },
    "srt_ConsolidationItemsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidationItemsDomain",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails",
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation Items [Domain]",
        "label": "Consolidation Items [Domain]"
       }
      }
     },
     "auth_ref": [
      "r279",
      "r322",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r339",
      "r343",
      "r434",
      "r435",
      "r436",
      "r437",
      "r439",
      "r440",
      "r442",
      "r444",
      "r445",
      "r1025",
      "r1026"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.edwards.com/role/BASISOFPRESENTATIONPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation",
        "label": "Consolidation, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r841"
     ]
    },
    "ew_ContingentConsiderationLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "ContingentConsiderationLiabilityMember",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent Consideration",
        "label": "Contingent Consideration Liability [Member]",
        "documentation": "Contingent Consideration Liability"
       }
      }
     },
     "auth_ref": []
    },
    "ew_ConvertiblePromissoryNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "ConvertiblePromissoryNoteMember",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Promissory Note",
        "label": "Convertible Promissory Note [Member]",
        "documentation": "Convertible Promissory Note"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CorporateDebtSecuritiesMember",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate debt securities",
        "verboseLabel": "Corporate debt securities",
        "netLabel": "Corporate debt securities",
        "label": "Corporate Debt Securities [Member]",
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment."
       }
      }
     },
     "auth_ref": [
      "r858",
      "r860",
      "r1048"
     ]
    },
    "us-gaap_CorporateNonSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CorporateNonSegmentMember",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate items",
        "label": "Corporate, Non-Segment [Member]",
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r334",
      "r335",
      "r336",
      "r337",
      "r343",
      "r992"
     ]
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfGoodsAndServicesSold",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails",
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of sales",
        "negatedTerseLabel": "Cost of sales",
        "negatedLabel": "Cost of sales",
        "label": "Cost of Goods and Services Sold",
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities."
       }
      }
     },
     "auth_ref": [
      "r150",
      "r651"
     ]
    },
    "us-gaap_CostOfSalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfSalesMember",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails",
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of sales",
        "label": "Cost of Sales [Member]",
        "documentation": "Primary financial statement caption encompassing cost of sales."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostsAndExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Corporate items",
        "label": "Costs and Expenses",
        "documentation": "Total costs of sales and operating expenses for the period."
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Axis]",
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r277",
      "r278",
      "r450",
      "r467",
      "r616",
      "r836",
      "r839"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "ew_CriticalCareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "CriticalCareMember",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Critical Care",
        "label": "Critical Care [Member]",
        "documentation": "This element represents the critical care product line."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrencySwapMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrencySwapMember",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cross-currency swap contracts",
        "terseLabel": "Cross-currency swap contracts",
        "label": "Currency Swap [Member]",
        "documentation": "Swap involving the exchange of principal and interest in one currency for another currency."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Axis]",
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r127",
      "r128",
      "r185",
      "r187",
      "r279",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r607",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r985"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Name [Domain]",
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r279",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r607",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r985"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails": {
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value, 12 months or greater",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r205",
      "r408",
      "r847"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails": {
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gross unrealized losses, 12 months or greater",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss",
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r205",
      "r408"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails": {
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value, less than 12 months",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r205",
      "r408",
      "r847"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails": {
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gross unrealized losses, less than 12 months",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r205",
      "r408"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Securities, Available-for-sale [Table]",
        "label": "Debt Securities, Available-for-Sale [Table]",
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Fair value, total",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss."
       }
      }
     },
     "auth_ref": [
      "r203",
      "r406",
      "r847"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Gross unrealized losses, total",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss",
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r204",
      "r407"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]",
        "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r202",
      "r847",
      "r1010"
     ]
    },
    "us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Amortized Cost",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss",
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity)."
       }
      }
     },
     "auth_ref": [
      "r354",
      "r372",
      "r374",
      "r665"
     ]
    },
    "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/INCOMETAXESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Decrease in unrecognized tax benefits is reasonably possible",
        "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible",
        "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "us-gaap_DeferredCompensationPlanAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredCompensationPlanAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments held for deferred compensation plans",
        "label": "Deferred Compensation Plan Assets",
        "documentation": "Carrying amount as of the balance sheet date of assets held under deferred compensation agreements."
       }
      }
     },
     "auth_ref": [
      "r970"
     ]
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income taxes",
        "label": "Deferred Income Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r534",
      "r535"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r325"
     ]
    },
    "us-gaap_DerivativeAssetFairValueGrossLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeAssetFairValueGrossLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DerivativeAssets",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gross Amounts Offset in the Consolidated Balance Sheet",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, Liability Offset",
        "documentation": "Fair value of liability associated with financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r30",
      "r108",
      "r807",
      "r808"
     ]
    },
    "us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeAssetNotOffsetPolicyElectionDeduction",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Financial Instruments",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, Deduction of Financial Instrument Not Offset",
        "documentation": "Fair value of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset, subject to master netting arrangement or similar agreement and not elected or qualified to offset, deducted from derivative asset."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r28",
      "r212"
     ]
    },
    "us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]",
        "label": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes derivative asset."
       }
      }
     },
     "auth_ref": [
      "r560"
     ]
    },
    "us-gaap_DerivativeAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails",
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivatives",
        "verboseLabel": "Fair value of derivative assets",
        "totalLabel": "Net Amounts Presented in the Consolidated Balance Sheet",
        "label": "Derivative Asset",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r246",
      "r593",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r757",
      "r758",
      "r800",
      "r803",
      "r806",
      "r807",
      "r809",
      "r810",
      "r839",
      "r870",
      "r1050"
     ]
    },
    "us-gaap_DerivativeAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeAssetsAbstract",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Derivative Asset [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of derivatives",
        "label": "Derivative Asset, Noncurrent",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r243"
     ]
    },
    "us-gaap_DerivativeCollateralObligationToReturnCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeCollateralObligationToReturnCash",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cash Collateral Received",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, Collateral, Obligation to Return Cash Not Offset",
        "documentation": "Amount of obligation to return cash collateral under master netting arrangements that have not been offset against derivative assets."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r116",
      "r244",
      "r837"
     ]
    },
    "us-gaap_DerivativeCollateralRightToReclaimCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeCollateralRightToReclaimCash",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cash Collateral Received",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, Collateral, Right to Reclaim Cash Not Offset",
        "documentation": "Amount of right to receive cash collateral under master netting arrangements that have not been offset against derivative liabilities."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r116",
      "r244",
      "r837"
     ]
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeContractTypeDomain",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Contract [Domain]",
        "label": "Derivative Contract [Domain]",
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "auth_ref": [
      "r740",
      "r742",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r765",
      "r766",
      "r767",
      "r768",
      "r778",
      "r779",
      "r780",
      "r781",
      "r784",
      "r785",
      "r786",
      "r787",
      "r800",
      "r801",
      "r806",
      "r809",
      "r868",
      "r870"
     ]
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DerivativeAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross Amounts",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset",
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r108",
      "r141",
      "r242",
      "r839"
     ]
    },
    "us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Amount",
        "label": "Derivative Asset, Including Not Subject to Master Netting Arrangement, after Offset and Deduction",
        "documentation": "Fair value, after effect of master netting arrangement and deduction of obligation to return financial collateral not offset and financial instrument subject to master netting arrangement not offset, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset. Includes derivative not subject to master netting arrangement or similar agreement."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r115"
     ]
    },
    "ew_DerivativeFairValueOfDerivativeAssetGrossAmountsNotOffsetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "DerivativeFairValueOfDerivativeAssetGrossAmountsNotOffsetAbstract",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross Amounts Not Offset in the Consolidated Balance Sheet",
        "label": "Derivative Fair Value of Derivative Asset Gross Amounts Not Offset [Abstract]",
        "documentation": "Derivative Fair Value of Derivative Asset Gross Amounts Not Offset"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DerivativeLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross Amounts",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset",
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r108",
      "r141",
      "r242",
      "r839"
     ]
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Amount",
        "label": "Derivative Liability, Including Not Subject to Master Netting Arrangement, after Offset and Deduction",
        "documentation": "Fair value, after effect of master netting arrangement and deduction of obligation to return financial collateral not offset and financial instrument subject to master netting arrangement not offset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset. Includes derivative not subject to master netting arrangement or similar agreement."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r115"
     ]
    },
    "ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross Amounts Not Offset in the Consolidated Balance Sheet",
        "label": "Derivative Fair Value of Derivative Liability Gross Amounts Not Offset [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeGainLossOnDerivativeNet",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount of Gain or (Loss) Recognized in Income on Derivative",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement."
       }
      }
     },
     "auth_ref": [
      "r1033"
     ]
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentRiskAxis",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instrument [Axis]",
        "label": "Derivative Instrument [Axis]",
        "documentation": "Information by type of derivative contract."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r109",
      "r110",
      "r112",
      "r740",
      "r742",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r765",
      "r766",
      "r767",
      "r768",
      "r778",
      "r779",
      "r780",
      "r781",
      "r784",
      "r785",
      "r786",
      "r787",
      "r800",
      "r801",
      "r806",
      "r809",
      "r839",
      "r868",
      "r870"
     ]
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts."
       }
      }
     },
     "auth_ref": [
      "r179",
      "r566",
      "r575"
     ]
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Relationship [Axis]",
        "label": "Hedging Relationship [Axis]",
        "documentation": "Information by type of hedging relationship."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r106",
      "r110"
     ]
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r106",
      "r110",
      "r112",
      "r117",
      "r118",
      "r565"
     ]
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments, Gain (Loss)",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r565"
     ]
    },
    "us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount of Gain or (Loss) Recognized in\u00a0Income on Derivative (Amount Excluded from Effectiveness Testing)",
        "label": "Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred",
        "documentation": "The estimated value of gains (losses), net anticipated to be transferred in the future from accumulated other comprehensive income into earnings."
       }
      }
     },
     "auth_ref": [
      "r574"
     ]
    },
    "us-gaap_DerivativeLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": {
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails",
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivatives",
        "verboseLabel": "Fair value of derivative liabilities",
        "totalLabel": "Net Amounts Presented in the Consolidated Balance Sheet",
        "label": "Derivative Liability",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r246",
      "r593",
      "r732",
      "r733",
      "r734",
      "r735",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r765",
      "r767",
      "r768",
      "r801",
      "r802",
      "r803",
      "r806",
      "r807",
      "r809",
      "r810",
      "r839",
      "r1050"
     ]
    },
    "us-gaap_DerivativeLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLiabilitiesAbstract",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities",
        "label": "Derivative Liability [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": {
       "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of derivatives",
        "label": "Derivative Liability, Current",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r243"
     ]
    },
    "us-gaap_DerivativeLiabilityFairValueGrossAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLiabilityFairValueGrossAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DerivativeLiabilities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gross Amounts Offset in the Consolidated Balance Sheet",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, Asset Offset",
        "documentation": "Fair value of asset associated with financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r30",
      "r108",
      "r807",
      "r808",
      "r837"
     ]
    },
    "us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLiabilityNotOffsetPolicyElectionDeduction",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Financial Instruments",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, Deduction of Financial Instrument Not Offset",
        "documentation": "Fair value of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset, subject to master netting arrangement or similar agreement and not elected or qualified to offset, deducted from derivative liability."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r28",
      "r212"
     ]
    },
    "us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]",
        "label": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes derivative liability."
       }
      }
     },
     "auth_ref": [
      "r560"
     ]
    },
    "us-gaap_DerivativeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLineItems",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Financial Instruments",
        "label": "Derivative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r575"
     ]
    },
    "us-gaap_DerivativeNotionalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeNotionalAmount",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notional Amount",
        "verboseLabel": "Derivative liability, fair value",
        "label": "Derivative, Notional Amount",
        "documentation": "Nominal or face amount used to calculate payment on derivative."
       }
      }
     },
     "auth_ref": [
      "r1031",
      "r1032"
     ]
    },
    "us-gaap_DerivativeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeTable",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative [Table]",
        "label": "Derivative [Table]",
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r97",
      "r98",
      "r100",
      "r104",
      "r107",
      "r110",
      "r113",
      "r114",
      "r118",
      "r575"
     ]
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativesFairValueLineItems",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivatives designated as hedging instruments",
        "label": "Derivatives, Fair Value [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DesignatedAsHedgingInstrumentMember",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Derivatives designated as hedging instruments",
        "terseLabel": "Derivatives designated as hedging instruments",
        "label": "Designated as Hedging Instrument [Member]",
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "STOCK-BASED COMPENSATION",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r490",
      "r495",
      "r523",
      "r524",
      "r526",
      "r861"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement [Abstract]",
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Quarterly Report",
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r915"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings per share:",
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS",
      "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (in dollars per share)",
        "verboseLabel": "Basic earnings per share (in dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r267",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r294",
      "r297",
      "r307",
      "r308",
      "r309",
      "r313",
      "r578",
      "r579",
      "r670",
      "r695",
      "r842"
     ]
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasicAbstract",
     "presentation": [
      "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic:",
        "label": "Earnings Per Share, Basic [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS",
      "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in dollars per share)",
        "verboseLabel": "Diluted earnings per share (in dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r267",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r297",
      "r307",
      "r308",
      "r309",
      "r313",
      "r578",
      "r579",
      "r670",
      "r695",
      "r842"
     ]
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDilutedAbstract",
     "presentation": [
      "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted:",
        "label": "Earnings Per Share, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.edwards.com/role/EARNINGSPERSHARE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EARNINGS PER SHARE",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r293",
      "r310",
      "r311",
      "r312"
     ]
    },
    "us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectOfCashFlowHedgesOnResultsOfOperationsAbstract",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Gain (loss) on cash flow hedging relationships:",
        "label": "Effect of Cash Flow Hedges on Results of Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r599"
     ]
    },
    "us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectOfFairValueHedgesOnResultsOfOperationsAbstract",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain (loss) on fair value hedging relationships:",
        "label": "Effect of Fair Value Hedges on Results of Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "presentation": [
      "http://www.edwards.com/role/INCOMETAXESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effective income tax rate (as a percent)",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r537"
     ]
    },
    "ew_EmployeeAndNonemployeeStockOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "EmployeeAndNonemployeeStockOptionsMember",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Option Awards",
        "label": "Employee and Nonemployee Stock Options [Member]",
        "documentation": "An arrangement whereby an employee or nonemployee (including a member of the entity's Board of Directors) is entitled to receive in the future, subject to vesting and other restrictions, a number of shares in the entity at a specified price, as defined in the agreement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": {
       "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee compensation and withholdings",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allocation of stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total remaining unrecognized compensation cost",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r525"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation cost, recognition period",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r525"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails": {
       "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Income tax benefit",
        "label": "Share-Based Payment Arrangement, Expense, Tax Benefit",
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r522"
     ]
    },
    "us-gaap_EmployeeStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeStockMember",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ESPP",
        "label": "Employee Stock [Member]",
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock Option",
        "label": "Employee Stock Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r954"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity [Abstract]",
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails",
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails",
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r219",
      "r260",
      "r261",
      "r262",
      "r280",
      "r281",
      "r282",
      "r284",
      "r290",
      "r292",
      "r314",
      "r395",
      "r396",
      "r480",
      "r527",
      "r528",
      "r529",
      "r543",
      "r544",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r577",
      "r600",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r613",
      "r715",
      "r716",
      "r717",
      "r730",
      "r791"
     ]
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails",
      "http://www.edwards.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Name [Domain]",
        "label": "Investment, Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r391",
      "r392",
      "r393"
     ]
    },
    "us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentFinancialStatementReportedAmountsAbstract",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity method investments",
        "label": "Equity Method Investment, Financial Statement, Reported Amounts [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment percentage (in percent)",
        "label": "Equity Method Investment, Ownership Percentage",
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r391"
     ]
    },
    "us-gaap_EquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails": {
       "parentTag": "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Carrying value of equity method investments",
        "label": "Equity Method Investments",
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized."
       }
      }
     },
     "auth_ref": [
      "r330",
      "r390",
      "r969",
      "r1007"
     ]
    },
    "ew_EquityMethodInvestmentsInvestmentPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "EquityMethodInvestmentsInvestmentPeriod",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments taken period",
        "label": "Equity Method Investments, Investment Period",
        "documentation": "Equity Method Investments, Investment Period"
       }
      }
     },
     "auth_ref": []
    },
    "ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum additional option to acquire investment",
        "label": "Equity Securities, FV-NI, Maximum Additional Option To Acquire Investment",
        "documentation": "Equity Securities, FV-NI, Maximum Additional Option To Acquire Investment"
       }
      }
     },
     "auth_ref": []
    },
    "ew_EquitySecuritiesFVNIMaximumAdditionalRequired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "EquitySecuritiesFVNIMaximumAdditionalRequired",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum additional required investment",
        "label": "Equity Securities, FV-NI, Maximum Additional Required",
        "documentation": "Equity Securities, FV-NI, Maximum Additional Required"
       }
      }
     },
     "auth_ref": []
    },
    "ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "EquitySecuritiesFVNIMaximumSecuredPromissoryNote",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum secured promissory note",
        "label": "Equity Securities, FV-NI, Maximum Secured Promissory Note",
        "documentation": "Equity Securities, FV-NI, Maximum Secured Promissory Note"
       }
      }
     },
     "auth_ref": []
    },
    "ew_EquitySecuritiesFVNIOptionToAcquireInvestment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "EquitySecuritiesFVNIOptionToAcquireInvestment",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment option to acquire",
        "label": "Equity Securities, FV-NI, Option To Acquire Investment",
        "documentation": "Equity Securities, FV-NI, Option To Acquire Investment"
       }
      }
     },
     "auth_ref": []
    },
    "ew_EquitySecuritiesFVNIPromissoryNoteOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "EquitySecuritiesFVNIPromissoryNoteOutstanding",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investee drew additional amount",
        "label": "Equity Securities, FV-NI Promissory Note Outstanding",
        "documentation": "Equity Securities, FV-NI Promissory Note Outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquitySecuritiesFvNi",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails": {
       "parentTag": "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Carrying value of non-marketable equity securities",
        "label": "Equity Securities, FV-NI, Current",
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current."
       }
      }
     },
     "auth_ref": [
      "r230",
      "r591",
      "r830"
     ]
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Downward price adjustment, annual amount",
        "label": "Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount",
        "documentation": "Amount of loss from downward price adjustment on investment in equity security without readily determinable fair value."
       }
      }
     },
     "auth_ref": [
      "r388"
     ]
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Decrease in non-marketable equity securities due to observable price changes",
        "label": "Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount",
        "documentation": "Amount of cumulative loss from downward price adjustment on investment in equity security without readily determinable fair value."
       }
      }
     },
     "auth_ref": [
      "r388"
     ]
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in non-marketable equity securities due to observable price changes",
        "label": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount",
        "documentation": "Amount of cumulative gain from upward price adjustment on investment in equity security without readily determinable fair value."
       }
      }
     },
     "auth_ref": [
      "r389"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r923"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r887",
      "r898",
      "r908",
      "r933"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r884",
      "r895",
      "r905",
      "r930"
     ]
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Estimate of Fair Value Measurement",
        "label": "Estimate of Fair Value Measurement [Member]",
        "documentation": "Measured as an estimate of fair value."
       }
      }
     },
     "auth_ref": [
      "r455",
      "r593",
      "r851",
      "r852"
     ]
    },
    "srt_EuropeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "EuropeMember",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Europe",
        "label": "Europe [Member]"
       }
      }
     },
     "auth_ref": [
      "r1053",
      "r1054",
      "r1055",
      "r1056"
     ]
    },
    "ew_EuropeSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "EuropeSegmentMember",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Europe",
        "label": "Europe Segment [Member]",
        "documentation": "Represents the Europe reportable segment of the entity."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r929"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of financial instruments measured on a recurring basis",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r581",
      "r582",
      "r587"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r581",
      "r582",
      "r587"
     ]
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial instruments",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByBalanceSheetGroupingTable",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r122",
      "r123"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails",
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r455",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r582",
      "r621",
      "r622",
      "r623",
      "r851",
      "r852",
      "r858",
      "r859",
      "r860"
     ]
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByLiabilityClassAxis",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability Class [Axis]",
        "label": "Liability Class [Axis]",
        "documentation": "Information by class of liability."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r181"
     ]
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByMeasurementBasisAxis",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Basis [Axis]",
        "label": "Measurement Basis [Axis]",
        "documentation": "Information by measurement basis."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r120",
      "r455",
      "r851",
      "r852"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails",
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Axis]",
        "label": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r581",
      "r582",
      "r584",
      "r585",
      "r588"
     ]
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosureItemAmountsDomain",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurement [Domain]",
        "label": "Fair Value Measurement [Domain]",
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value."
       }
      }
     },
     "auth_ref": [
      "r455",
      "r851",
      "r852"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Disclosures [Abstract]",
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "FAIR VALUE MEASUREMENTS",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r580"
     ]
    },
    "us-gaap_FairValueHedgingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueHedgingMember",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value hedges",
        "label": "Fair Value Hedging [Member]",
        "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r455",
      "r483",
      "r488",
      "r582",
      "r621",
      "r858",
      "r859",
      "r860"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r455",
      "r483",
      "r488",
      "r582",
      "r622",
      "r851",
      "r852",
      "r858",
      "r859",
      "r860"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails",
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 3",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r455",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r582",
      "r623",
      "r851",
      "r852",
      "r858",
      "r859",
      "r860"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value by Liability Class [Domain]",
        "label": "Fair Value by Liability Class [Domain]",
        "documentation": "Represents classes of liabilities measured and disclosed at fair value."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r121"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Changes in Fair Value of Contingent Consideration and Other Liability",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r121"
     ]
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails",
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Domain]",
        "label": "Measurement Frequency [Domain]",
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in fair value",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3)."
       }
      }
     },
     "auth_ref": [
      "r586"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Fair value beginning balance",
        "periodEndLabel": "Fair value ending balance",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails",
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r455",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r621",
      "r622",
      "r623",
      "r851",
      "r852",
      "r858",
      "r859",
      "r860"
     ]
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails",
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value on a Recurring Basis",
        "label": "Fair Value, Recurring [Member]",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r580",
      "r588"
     ]
    },
    "us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "label": "Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "documentation": "Indicates line item in statement in which net income is reported that includes gain (loss) from liability measured at fair value using unobservable input (level 3)."
       }
      }
     },
     "auth_ref": [
      "r586"
     ]
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r107",
      "r117"
     ]
    },
    "ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "February2023StockRepurchaseProgramSharesSoldInMarch2023Member",
     "presentation": [
      "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "February 2023 Stock Repurchase Program Shares Sold in March 2023",
        "label": "February 2023 Stock Repurchase Program Shares Sold In March 2023 [Member]",
        "documentation": "February 2023 Stock Repurchase Program Shares Sold In March 2023"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instrument [Axis]",
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r405",
      "r409",
      "r410",
      "r463",
      "r477",
      "r575",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r691",
      "r847",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r1003",
      "r1004",
      "r1005",
      "r1006"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Foreign currency",
        "label": "Gain (Loss), Foreign Currency Transaction, before Tax",
        "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction."
       }
      }
     },
     "auth_ref": [
      "r595",
      "r596",
      "r597",
      "r598",
      "r788"
     ]
    },
    "us-gaap_ForeignExchangeContractMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignExchangeContractMember",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency contracts",
        "label": "Foreign Exchange Contract [Member]",
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates."
       }
      }
     },
     "auth_ref": [
      "r839",
      "r858",
      "r864"
     ]
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignExchangeForwardMember",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency forward exchange contracts",
        "label": "Foreign Exchange Forward [Member]",
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate."
       }
      }
     },
     "auth_ref": [
      "r757",
      "r761",
      "r767",
      "r780",
      "r786",
      "r804",
      "r805",
      "r806",
      "r870"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r891",
      "r902",
      "r912",
      "r937"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r891",
      "r902",
      "r912",
      "r937"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r891",
      "r902",
      "r912",
      "r937"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r891",
      "r902",
      "r912",
      "r937"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r891",
      "r902",
      "r912",
      "r937"
     ]
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Goodwill",
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r413",
      "r664",
      "r849",
      "r866",
      "r1012",
      "r1013"
     ]
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross profit",
        "label": "Gross Profit",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r275",
      "r320",
      "r334",
      "r340",
      "r343",
      "r394",
      "r434",
      "r435",
      "r437",
      "r438",
      "r439",
      "r441",
      "r443",
      "r445",
      "r446",
      "r594",
      "r844",
      "r1025"
     ]
    },
    "us-gaap_HedgingDesignationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HedgingDesignationAxis",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Designation [Axis]",
        "label": "Hedging Designation [Axis]",
        "documentation": "Information by designation of purpose of derivative instrument."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r565"
     ]
    },
    "us-gaap_HedgingDesignationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HedgingDesignationDomain",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Designation [Domain]",
        "label": "Hedging Designation [Domain]",
        "documentation": "Designation of purpose of derivative instrument."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_HedgingRelationshipDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HedgingRelationshipDomain",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Relationship [Domain]",
        "label": "Hedging Relationship [Domain]",
        "documentation": "Nature or intent of a hedge."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_HeldToMaturitySecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldToMaturitySecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Amortized Cost",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss",
        "documentation": "Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity)."
       }
      }
     },
     "auth_ref": [
      "r214",
      "r370",
      "r400",
      "r1009"
     ]
    },
    "us-gaap_HeldToMaturitySecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldToMaturitySecuritiesAbstract",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Held-to-maturity",
        "label": "Debt Securities, Held-to-Maturity, Fair Value to Amortized Cost, after Allowance for Credit Loss [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": {
       "parentTag": "us-gaap_HeldToMaturitySecurities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross Unrealized Gains",
        "label": "Debt Securities, Held-to-Maturity, Accumulated Unrecognized Gain",
        "documentation": "Amount of accumulated unrecognized gain on investment in debt security measured at amortized cost (held-to-maturity)."
       }
      }
     },
     "auth_ref": [
      "r199",
      "r380"
     ]
    },
    "us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": {
       "parentTag": "us-gaap_HeldToMaturitySecurities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gross Unrealized Losses",
        "label": "Debt Securities, Held-to-Maturity, Accumulated Unrecognized Loss",
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at amortized cost (held-to-maturity)."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r381"
     ]
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesAbstract",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Held-to-Maturity",
        "label": "Debt Securities, Held-to-Maturity, Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value",
        "label": "Debt Securities, Held-to-Maturity, Fair Value, Rolling Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": {
       "parentTag": "us-gaap_HeldToMaturitySecuritiesFairValue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due in 1\u00a0year or less",
        "label": "Debt Securities, Held-to-Maturity, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value",
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": {
       "parentTag": "us-gaap_HeldToMaturitySecuritiesFairValue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due after 1\u00a0year through 5\u00a0years",
        "label": "Debt Securities, Held-to-Maturity, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value",
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in second through fifth rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": {
       "parentTag": "us-gaap_HeldToMaturitySecuritiesFairValue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Instruments not due at a single maturity date",
        "label": "Debt Securities, Held-to-Maturity, Maturity, without Single Maturity Date, Fair Value",
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), without single maturity date and not allocated over maturity grouping."
       }
      }
     },
     "auth_ref": [
      "r201",
      "r382",
      "r674"
     ]
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": {
       "parentTag": "us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Instruments not due at a single maturity date",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, without Single Maturity Date",
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) without single maturity date and not allocated over maturity grouping."
       }
      }
     },
     "auth_ref": [
      "r374",
      "r673"
     ]
    },
    "us-gaap_HeldToMaturitySecuritiesFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldToMaturitySecuritiesFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": {
       "parentTag": "us-gaap_HeldToMaturitySecurities",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value",
        "totalLabel": "Fair Value",
        "label": "Debt Securities, Held-to-Maturity, Fair Value",
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity)."
       }
      }
     },
     "auth_ref": [
      "r198",
      "r379",
      "r665",
      "r676"
     ]
    },
    "us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortized Cost",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Rolling Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": {
       "parentTag": "us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due in 1\u00a0year or less",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Rolling within One Year",
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following current statement of financial position date. For interim and annual periods when interim period is reported on rolling approach."
       }
      }
     },
     "auth_ref": [
      "r1000",
      "r1042"
     ]
    },
    "us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": {
       "parentTag": "us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due after 1\u00a0year through 5\u00a0years",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Rolling after One through Five Years",
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in second through fifth rolling fiscal year following current statement of financial position date. For interim and annual periods when interim period is reported on rolling approach."
       }
      }
     },
     "auth_ref": [
      "r1001",
      "r1043"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS",
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income before provision for income taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r145",
      "r192",
      "r320",
      "r334",
      "r340",
      "r343",
      "r671",
      "r686",
      "r844"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails",
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total before tax",
        "verboseLabel": "Total segment operating income",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments."
       }
      }
     },
     "auth_ref": [
      "r320",
      "r334",
      "r340",
      "r343",
      "r696",
      "r844"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails",
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Operating Income",
        "verboseLabel": "Pre-tax Income Reconciliation",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement [Abstract]",
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails",
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Axis]",
        "label": "Income Statement Location [Axis]",
        "documentation": "Information by location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r423",
      "r425",
      "r775"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails",
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Domain]",
        "label": "Income Statement Location [Domain]",
        "documentation": "Location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r425",
      "r775"
     ]
    },
    "ew_IncomeTaxAssessmentEstimateOfAdditionalTaxExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "IncomeTaxAssessmentEstimateOfAdditionalTaxExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/INCOMETAXESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional tax expense",
        "label": "Income Tax Assessment, Estimate Of Additional Tax Expense",
        "documentation": "Income Tax Assessment, Estimate Of Additional Tax Expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityNameAxis",
     "presentation": [
      "http://www.edwards.com/role/INCOMETAXESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Authority, Name [Axis]",
        "label": "Income Tax Authority, Name [Axis]",
        "documentation": "Information by name of taxing authority."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityNameDomain",
     "presentation": [
      "http://www.edwards.com/role/INCOMETAXESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Authority, Name [Domain]",
        "label": "Income Tax Authority, Name [Domain]",
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxContingencyLineItems",
     "presentation": [
      "http://www.edwards.com/role/INCOMETAXESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Contingency [Line Items]",
        "label": "Income Tax Contingency [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxContingencyTable",
     "presentation": [
      "http://www.edwards.com/role/INCOMETAXESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Contingency [Table]",
        "label": "Income Tax Contingency [Table]",
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r83",
      "r174",
      "r175"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Disclosure [Abstract]",
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.edwards.com/role/INCOMETAXES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INCOME TAXES",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
       }
      }
     },
     "auth_ref": [
      "r276",
      "r532",
      "r538",
      "r541",
      "r542",
      "r545",
      "r547",
      "r548",
      "r549",
      "r727"
     ]
    },
    "ew_IncomeTaxExaminationAmountDepositedToMitigateInterestOnTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "IncomeTaxExaminationAmountDepositedToMitigateInterestOnTaxLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/INCOMETAXESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional deposit",
        "label": "Income Tax Examination, Amount Deposited To Mitigate Interest On Tax Liabilities",
        "documentation": "Income Tax Examination, Amount Deposited To Mitigate Interest On Tax Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExaminationEstimateOfPossibleLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/INCOMETAXESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimate of additional tax owed",
        "label": "Income Tax Examination, Estimate of Possible Loss",
        "documentation": "Estimated amount of loss resulting from an adverse tax position."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/INCOMETAXESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional tax sought in excess of filing position",
        "label": "Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority",
        "documentation": "The amount of the additional liability or refund received or expected based on a final settlement with a taxing authority."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails",
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Provision for income taxes",
        "negatedLabel": "Provision for income taxes",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r215",
      "r291",
      "r292",
      "r328",
      "r536",
      "r546",
      "r697"
     ]
    },
    "us-gaap_IncomeTaxReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReceivable",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax receivable",
        "label": "Income Taxes Receivable",
        "documentation": "Carrying amount as of the balance sheet date of income taxes previously overpaid to tax authorities (such as U.S. Federal, state and local tax authorities) representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes. Also called income tax refund receivable."
       }
      }
     },
     "auth_ref": [
      "r973"
     ]
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/INCOMETAXESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Tax benefit from employee share-based compensation",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount",
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1030"
     ]
    },
    "us-gaap_IncomeTaxesPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxesPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes",
        "label": "Income Taxes Paid",
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r53"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsAndOtherReceivables",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts and other receivables, net",
        "label": "Increase (Decrease) in Accounts and Other Receivables",
        "documentation": "The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable and accrued liabilities",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Deferred income taxes",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Inventories",
        "label": "Increase (Decrease) in Inventories",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ew_IncreaseDecreaseInLegalSettlementAccrual": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "IncreaseDecreaseInLegalSettlementAccrual",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intellectual property agreement accrual",
        "label": "Increase (Decrease) In Legal Settlement Accrual",
        "documentation": "Increase (Decrease) In Legal Settlement Accrual"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other current assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "calculation": {
      "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dilutive effect of stock plans (in shares)",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method."
       }
      }
     },
     "auth_ref": [
      "r298",
      "r299",
      "r300",
      "r309",
      "r494"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r894",
      "r902",
      "r912",
      "r929",
      "r937",
      "r941",
      "r949"
     ]
    },
    "ew_InitialDeliveryOfSharesSettledFebruary2023Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "InitialDeliveryOfSharesSettledFebruary2023Member",
     "presentation": [
      "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial Delivery of Shares Settled February2023",
        "label": "Initial Delivery Of Shares Settled February 2023 [Member]",
        "documentation": "Initial Delivery Of Shares Settled February 2023"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r947"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r883",
      "r953"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r883",
      "r953"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r883",
      "r953"
     ]
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other intangible assets, net",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r68"
     ]
    },
    "ew_IntellectualPropertyAgreementTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "IntellectualPropertyAgreementTerm",
     "presentation": [
      "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intellectual property agreement term",
        "label": "Intellectual Property Agreement Term",
        "documentation": "Intellectual Property Agreement Term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestIncomeExpenseNet",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails",
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest income, net",
        "verboseLabel": "Interest income, net",
        "label": "Interest Income (Expense), Net",
        "documentation": "The net amount of operating interest income (expense)."
       }
      }
     },
     "auth_ref": [
      "r194"
     ]
    },
    "us-gaap_InterestIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestIncomeMember",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income, net",
        "label": "Interest Income [Member]",
        "documentation": "Primary financial statement caption in which reported facts about interest income have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsintheConsolidatedBalanceSheetsDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsintheConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Finished products",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r833"
     ]
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryNet",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsintheConsolidatedBalanceSheetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsintheConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories (Note\u00a02)",
        "totalLabel": "Total inventories",
        "label": "Inventory, Net",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r238",
      "r829",
      "r866"
     ]
    },
    "us-gaap_InventoryNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryNetAbstract",
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsintheConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Inventories",
        "label": "Inventory, Net [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryRawMaterialsNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsintheConsolidatedBalanceSheetsDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsintheConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Raw materials",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r835"
     ]
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryWorkInProcessNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsintheConsolidatedBalanceSheetsDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsintheConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Work in process",
        "label": "Inventory, Work in Process, Net of Reserves",
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r834"
     ]
    },
    "us-gaap_InvestmentsAllOtherInvestmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsAllOtherInvestmentsAbstract",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity securities",
        "label": "Investments, All Other Investments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]",
        "label": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total investments in unconsolidated entities",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate."
       }
      }
     },
     "auth_ref": [
      "r971"
     ]
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INVESTMENTS",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "documentation": "The entire disclosure for investments in certain debt and equity securities."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r196",
      "r197",
      "r216",
      "r353",
      "r356",
      "r589",
      "r590"
     ]
    },
    "us-gaap_IsraelTaxAuthorityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IsraelTaxAuthorityMember",
     "presentation": [
      "http://www.edwards.com/role/INCOMETAXESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Israel Tax Authority",
        "label": "Israel Tax Authority [Member]",
        "documentation": "Designated tax department of the government of Israel."
       }
      }
     },
     "auth_ref": []
    },
    "country_JP": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "JP",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Japan",
        "label": "JAPAN"
       }
      }
     },
     "auth_ref": []
    },
    "ew_JapanSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "JapanSegmentMember",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Japan",
        "label": "Japan Segment [Member]",
        "documentation": "Represents the Japan reportable segment of the entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LegalMattersAndContingenciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LegalMattersAndContingenciesTextBlock",
     "presentation": [
      "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INTELLECTUAL PROPERTY AGREEMENT AND CERTAIN LITIGATION EXPENSES",
        "label": "Legal Matters and Contingencies [Text Block]",
        "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies."
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "terseLabel": "Liabilities",
        "label": "Liabilities",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r275",
      "r394",
      "r434",
      "r435",
      "r437",
      "r438",
      "r439",
      "r441",
      "r443",
      "r445",
      "r446",
      "r554",
      "r558",
      "r559",
      "r594",
      "r749",
      "r843",
      "r878",
      "r1025",
      "r1039",
      "r1040"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r135",
      "r189",
      "r684",
      "r866",
      "r986",
      "r1008",
      "r1035"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r224",
      "r275",
      "r394",
      "r434",
      "r435",
      "r437",
      "r438",
      "r439",
      "r441",
      "r443",
      "r445",
      "r446",
      "r554",
      "r558",
      "r559",
      "r594",
      "r866",
      "r1025",
      "r1039",
      "r1040"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Liabilities",
        "label": "Liabilities, Fair Value Disclosure",
        "documentation": "Fair value of financial and nonfinancial obligations."
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities",
        "label": "Liabilities, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilityForUncertainTaxPositionsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilityForUncertainTaxPositionsNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Uncertain tax positions",
        "label": "Liability for Uncertainty in Income Taxes, Noncurrent",
        "documentation": "Amount recognized for uncertainty in income taxes classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_LimitedLiabilityCompanyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LimitedLiabilityCompanyMember",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Limited Liability Company",
        "label": "Limited Liability Company [Member]",
        "documentation": "Legal form of business company offering limited liability to its owners (denoted by L.L.C. or LLC in the U.S.)."
       }
      }
     },
     "auth_ref": []
    },
    "srt_LitigationCaseAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "LitigationCaseAxis",
     "presentation": [
      "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Litigation Case [Axis]",
        "label": "Litigation Case [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_LitigationCaseTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "LitigationCaseTypeDomain",
     "presentation": [
      "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Litigation Case [Domain]",
        "label": "Litigation Case [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LitigationReserveCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LitigationReserveCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": {
       "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Litigation settlement",
        "label": "Estimated Litigation Liability, Current",
        "documentation": "Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r1017"
     ]
    },
    "us-gaap_LitigationReserveNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LitigationReserveNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Litigation settlement accrual",
        "label": "Estimated Litigation Liability, Noncurrent",
        "documentation": "Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r1017"
     ]
    },
    "us-gaap_LitigationSettlementExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LitigationSettlementExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS",
      "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSESDetails",
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intellectual property agreement and certain litigation expenses (Note 3)",
        "verboseLabel": "Intellectual property litigation expense",
        "negatedLabel": "Intellectual property agreement and certain litigation expenses",
        "label": "Litigation Settlement, Expense",
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees."
       }
      }
     },
     "auth_ref": []
    },
    "ew_LoansReceivablesMaximumLendingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "LoansReceivablesMaximumLendingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loans receivables, maximum lending amount",
        "label": "Loans Receivables, Maximum Lending Capacity",
        "documentation": "Loans Receivables, Maximum Lending Capacity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term debt",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r231"
     ]
    },
    "us-gaap_LongTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term investments (Note\u00a05)",
        "label": "Long-Term Investments",
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle)."
       }
      }
     },
     "auth_ref": [
      "r226"
     ]
    },
    "us-gaap_LossContingenciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LossContingenciesLineItems",
     "presentation": [
      "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingencies [Line Items]",
        "label": "Loss Contingencies [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r430",
      "r431",
      "r432",
      "r433",
      "r1018",
      "r1019"
     ]
    },
    "us-gaap_LossContingenciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LossContingenciesTable",
     "presentation": [
      "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingencies [Table]",
        "label": "Loss Contingencies [Table]",
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations."
       }
      }
     },
     "auth_ref": [
      "r430",
      "r431",
      "r432",
      "r433",
      "r1018",
      "r1019"
     ]
    },
    "ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber",
     "presentation": [
      "http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of lawsuits that if settled could have a material adverse impact on net income or cash flows",
        "label": "Loss Contingency, Claims That If Settled Could Have A Material Adverse Impact, Number",
        "documentation": "Loss Contingency, Claims That If Settled Could Have A Material Adverse Impact, Number"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MaterialReconcilingItemsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MaterialReconcilingItemsMember",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciling items",
        "label": "Segment Reconciling Items [Member]",
        "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MaximumLengthOfTimeForeignCurrencyCashFlowHedge",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes due to currency rate movements and expenses expected to occur, maximum term",
        "label": "Maximum Length of Time, Foreign Currency Cash Flow Hedge",
        "documentation": "Maximum period of time the entity is hedging its exposure to variability in future cash flows for forecasted transactions, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Excludes forecasted transactions related to payment of variable interest on existing financial instruments."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r921"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r921"
     ]
    },
    "ew_MeasurementInputProbabilityOfMilestoneAchievementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "MeasurementInputProbabilityOfMilestoneAchievementMember",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Probability of Milestone Achievement",
        "label": "Measurement Input, Probability Of Milestone Achievement [Member]",
        "documentation": "Measurement Input, Probability Of Milestone Achievement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input Type [Axis]",
        "label": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r583"
     ]
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputTypeDomain",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input Type [Domain]",
        "label": "Measurement Input Type [Domain]",
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": []
    },
    "ew_MedicalDeviceCompanyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "MedicalDeviceCompanyMember",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Medical Device Company",
        "verboseLabel": "Investee",
        "label": "Medical Device Company [Member]",
        "documentation": "Medical Device Company"
       }
      }
     },
     "auth_ref": []
    },
    "ew_MedtronicIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "MedtronicIncMember",
     "presentation": [
      "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Medtronic Inc",
        "label": "Medtronic Inc [Member]",
        "documentation": "Medtronic Inc"
       }
      }
     },
     "auth_ref": []
    },
    "ew_MichaelA.MussallemMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "MichaelA.MussallemMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Michael A. Mussallem [Member]",
        "documentation": "Michael A. Mussallem"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MinorityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncontrolling interest",
        "label": "Equity, Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r188",
      "r275",
      "r394",
      "r434",
      "r437",
      "r438",
      "r439",
      "r445",
      "r446",
      "r594",
      "r683",
      "r753"
     ]
    },
    "us-gaap_MinorityInterestPeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterestPeriodIncreaseDecrease",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes to noncontrolling interest",
        "label": "Noncontrolling Interest, Period Increase (Decrease)",
        "documentation": "Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r940"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r948"
     ]
    },
    "us-gaap_MunicipalBondsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MunicipalBondsMember",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Municipal securities",
        "verboseLabel": "Municipal securities",
        "netLabel": "Municipal securities",
        "label": "Municipal Bonds [Member]",
        "documentation": "Long-term debt securities issued by state, city or local governments or the agencies operated by state, city or local governments."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r922"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by (used in) financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r272"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r272"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash (used in) provided by operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r159",
      "r160"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income attributable to Edwards Lifesciences Corporation",
        "terseLabel": "Net Income (Loss)",
        "label": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r160",
      "r193",
      "r222",
      "r255",
      "r258",
      "r262",
      "r275",
      "r283",
      "r285",
      "r286",
      "r287",
      "r288",
      "r291",
      "r292",
      "r305",
      "r320",
      "r334",
      "r340",
      "r343",
      "r394",
      "r434",
      "r435",
      "r437",
      "r438",
      "r439",
      "r441",
      "r443",
      "r445",
      "r446",
      "r579",
      "r594",
      "r689",
      "r772",
      "r789",
      "r790",
      "r844",
      "r876",
      "r1025"
     ]
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss attributable to noncontrolling interest",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r178",
      "r255",
      "r258",
      "r291",
      "r292",
      "r688",
      "r978"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails",
      "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "Net of tax",
        "terseLabel": "Net income attributable to Edwards Lifesciences Corporation",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r268",
      "r285",
      "r286",
      "r287",
      "r288",
      "r294",
      "r295",
      "r306",
      "r309",
      "r320",
      "r334",
      "r340",
      "r343",
      "r844"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net income attributable to Edwards Lifesciences Corporation",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r268",
      "r296",
      "r301",
      "r302",
      "r303",
      "r304",
      "r306",
      "r309"
     ]
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetInvestmentHedgingMember",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net investment hedges",
        "label": "Net Investment Hedging [Member]",
        "documentation": "Hedges of a net investment in a foreign operation."
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.edwards.com/role/BASISOFPRESENTATIONPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recently Adopted Accounting Standards and New Accounting Standards Not Yet Adopted",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "ew_NewMarketsTaxCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "NewMarketsTaxCreditMember",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New Markets Tax Credit",
        "label": "New Markets Tax Credit [Member]",
        "documentation": "New Markets Tax Credit"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r921"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r891",
      "r902",
      "r912",
      "r929",
      "r937"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r919"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r918"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r929"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r948"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r948"
     ]
    },
    "us-gaap_NoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncontrollingInterestMember",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncontrolling Interest",
        "label": "Noncontrolling Interest [Member]",
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r480",
      "r987",
      "r988",
      "r989",
      "r1051"
     ]
    },
    "us-gaap_NondesignatedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NondesignatedMember",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivatives not designated as hedging instruments",
        "label": "Not Designated as Hedging Instrument [Member]",
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-operating income",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "us-gaap_NotesPayableFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NotesPayableFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes payable fair value disclosure",
        "label": "Notes Payable, Fair Value Disclosure",
        "documentation": "Fair value portion of notes payable."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_NotesReceivableGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NotesReceivableGross",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing receivable",
        "label": "Financing Receivable, before Allowance for Credit Loss",
        "documentation": "Amortized cost, before allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r214",
      "r217",
      "r218",
      "r235",
      "r400",
      "r403",
      "r845",
      "r846",
      "r966",
      "r1009"
     ]
    },
    "ew_NumberOfAdvancePricingAgreementsRenewed": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "NumberOfAdvancePricingAgreementsRenewed",
     "presentation": [
      "http://www.edwards.com/role/INCOMETAXESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of APAs renewed",
        "label": "Number Of Advance Pricing Agreements Renewed",
        "documentation": "Number Of Advance Pricing Agreements Renewed"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OciBeforeReclassificationsBeforeTaxAttributableToParent",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive (loss) income before reclassifications",
        "label": "OCI, before Reclassifications, before Tax, Attributable to Parent",
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss) attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "us-gaap_OffsettingAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OffsettingAssetsLineItems",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offsetting Assets [Line Items]",
        "label": "Offsetting Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OffsettingAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OffsettingAssetsTable",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offsetting Assets [Table]",
        "label": "Offsetting Assets [Table]",
        "documentation": "Disclosure of information about derivative and financial assets that are subject to offsetting, including enforceable master netting arrangements."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r140"
     ]
    },
    "us-gaap_OffsettingAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OffsettingAssetsTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets",
        "label": "Offsetting Assets [Table Text Block]",
        "documentation": "Tabular disclosure of derivative and other financial assets that are subject to offsetting, including master netting arrangements."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r245"
     ]
    },
    "us-gaap_OffsettingDerivativeAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OffsettingDerivativeAssetsAbstract",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative assets",
        "label": "Offsetting Derivative Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OffsettingDerivativeLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OffsettingDerivativeLiabilitiesAbstract",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative liabilities",
        "label": "Offsetting Derivative Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OffsettingLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OffsettingLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Liabilities",
        "label": "Offsetting Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of derivative and other financial liabilities that are subject to offsetting, including master netting arrangements."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r245"
     ]
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS",
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating income, net",
        "terseLabel": "Consolidated operating income",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r320",
      "r334",
      "r340",
      "r343",
      "r844"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r609"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r609"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amounts included in the measurement of operating lease liabilities",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r610",
      "r611"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r608"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash operating lease cost",
        "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r982"
     ]
    },
    "us-gaap_OperatingSegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingSegmentsMember",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails",
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating segments",
        "label": "Operating Segments [Member]",
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r343"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.edwards.com/role/BASISOFPRESENTATION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BASIS OF PRESENTATION",
        "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles."
       }
      }
     },
     "auth_ref": [
      "r161",
      "r162",
      "r163",
      "r176"
     ]
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": {
       "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other accrued liabilities",
        "label": "Other Accrued Liabilities, Current",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_OtherAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsAbstract",
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets",
        "label": "Other Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other current assets",
        "label": "Other Assets, Current",
        "documentation": "Amount of current assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r240",
      "r866"
     ]
    },
    "us-gaap_OtherAssetsMiscellaneousNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsMiscellaneousNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other long-term assets",
        "label": "Other Assets, Miscellaneous, Noncurrent",
        "documentation": "Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 8.0
      },
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets (Note 2)",
        "totalLabel": "Other assets, noncurrent",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r228"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized gain (loss) on hedges",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r247",
      "r252"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r247",
      "r252",
      "r561",
      "r562",
      "r567"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount of gain (loss) reclassified from accumulated OCI into income",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r252",
      "r254"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r252",
      "r254"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Amount excluded from effectiveness testing recognized in earnings based on an amortization approach",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, after Tax",
        "documentation": "Amount, after tax, of adjustments from accumulated other comprehensive income (AOCI) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method."
       }
      }
     },
     "auth_ref": [
      "r248",
      "r252",
      "r254",
      "r563"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation adjustments",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge."
       }
      }
     },
     "auth_ref": [
      "r564"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Other comprehensive income (loss), net of tax",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r29",
      "r256",
      "r259",
      "r263",
      "r600",
      "r601",
      "r606",
      "r666",
      "r690",
      "r976",
      "r977"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive loss, net of tax",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r17",
      "r177",
      "r256",
      "r259"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other comprehensive income (loss), net of tax (Note\u00a012):",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Unrealized pension credits (costs)",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r143"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossTaxPortionAttributableToParent1",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Deferred income tax expense (benefit)",
        "label": "Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent",
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r17",
      "r177"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized gain on available-for-sale investments",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale."
       }
      }
     },
     "auth_ref": [
      "r249",
      "r252",
      "r387"
     ]
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherIncomeAndExpensesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsintheConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finished products inventories held on consignment",
        "label": "Other Inventory, Materials, Supplies and Merchandise under Consignment, Gross",
        "documentation": "Gross amount of inventory owned by the entity but in the hands of a customer, typically a reseller."
       }
      }
     },
     "auth_ref": [
      "r974"
     ]
    },
    "us-gaap_OtherLiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": {
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Liabilities, Fair Value Disclosure",
        "documentation": "Fair value portion of other liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesMember",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Liabilities [Member]",
        "documentation": "Primary financial statement caption encompassing other liabilities."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r117"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other liabilities",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNoncashIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other",
        "label": "Other Noncash Income (Expense)",
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other."
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails",
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other income, net",
        "verboseLabel": "Other income, net",
        "terseLabel": "Other income, net",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other income, net",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNonrecurringIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonrecurringIncomeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS",
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Separation costs (Note\u00a04)",
        "negatedTerseLabel": "Separation costs (Note\u00a04)",
        "label": "Other Nonrecurring (Income) Expense",
        "documentation": "Amount of other expense (income) that is infrequent in occurrence or unusual in nature."
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "us-gaap_OtherPaymentsToAcquireBusinesses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherPaymentsToAcquireBusinesses",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS",
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payment for acquisition options (Note 6)",
        "terseLabel": "Payment for acquisition options",
        "label": "Other Payments to Acquire Businesses",
        "documentation": "The cash outflow associated with other payments to acquire businesses including deposit on pending acquisitions and preacquisition costs."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r921"
     ]
    },
    "us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherReceivableAfterAllowanceForCreditLossNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes and other receivables",
        "label": "Other Receivable, after Allowance for Credit Loss, Noncurrent",
        "documentation": "Amount, after allowance for credit loss, of receivable classified as other and noncurrent."
       }
      }
     },
     "auth_ref": [
      "r970"
     ]
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherReceivablesNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other receivables",
        "label": "Other Receivables, Net, Current",
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r889",
      "r900",
      "r910",
      "r935"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r892",
      "r903",
      "r913",
      "r938"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r892",
      "r903",
      "r913",
      "r938"
     ]
    },
    "us-gaap_ParentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ParentMember",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Edwards Lifesciences Corporation Stockholders' Equity",
        "label": "Parent [Member]",
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PayablesAndAccrualsAbstract",
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued and other liabilities",
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForLegalSettlements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForLegalSettlements",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments for legal settlements",
        "label": "Payments for Legal Settlements",
        "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other."
       }
      }
     },
     "auth_ref": [
      "r956",
      "r979"
     ]
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of treasury stock",
        "label": "Payments for Repurchase of Common Stock",
        "documentation": "The cash outflow to reacquire common stock during the period."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of available-for-sale investments (Note 5)",
        "label": "Payments to Acquire Debt Securities, Available-for-Sale",
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r269",
      "r355"
     ]
    },
    "ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Business combination, net of cash",
        "label": "Payments To Acquire Businesses, Net Of Cash Acquired, Excluding Options",
        "documentation": "Payments To Acquire Businesses, Net Of Cash Acquired, Excluding Options"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToAcquireHeldToMaturitySecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireHeldToMaturitySecurities",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of held-to-maturity investments (Note 5)",
        "label": "Payments to Acquire Held-to-Maturity Securities",
        "documentation": "Amount of cash outflow through purchase of long-term held-to-maturity securities."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r355"
     ]
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Investments in intangible assets",
        "label": "Payments to Acquire Intangible Assets",
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill."
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Capital expenditures",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "us-gaap_PaymentsToAcquireReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireReceivables",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Issuances of notes receivable",
        "label": "Payments to Acquire Receivables",
        "documentation": "The cash outflow for the purchase of all receivables."
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r920"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r920"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r919"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r929"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r922"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r918"
     ]
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Portion at Fair Value Measurement",
        "label": "Portion at Fair Value Measurement [Member]",
        "documentation": "Measured at fair value for financial reporting purposes."
       }
      }
     },
     "auth_ref": [
      "r592"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, par value (in dollars per share)",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r465"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares authorized (in shares)",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r751"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares outstanding (in shares)",
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r751",
      "r770",
      "r1051",
      "r1052"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding",
        "label": "Preferred Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r679",
      "r866"
     ]
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses",
        "label": "Prepaid Expense, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r239",
      "r411",
      "r412",
      "r831"
     ]
    },
    "us-gaap_PrepaidExpenseCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseCurrentAndNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term prepaid royalties",
        "label": "Prepaid Expense",
        "documentation": "Carrying amount as of the balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r239",
      "r763",
      "r1044"
     ]
    },
    "us-gaap_PrepaidRoyalties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidRoyalties",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid royalty asset",
        "label": "Prepaid Royalties",
        "documentation": "Amount of asset related to consideration paid in advance for royalties that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r832",
      "r848",
      "r1011"
     ]
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other."
       }
      }
     },
     "auth_ref": [
      "r957",
      "r980"
     ]
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from available-for-sale investments (Note 5)",
        "label": "Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale",
        "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r269",
      "r270",
      "r994"
     ]
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from held-to-maturity investments (Note 5)",
        "label": "Proceeds from Sale and Maturity of Held-to-Maturity Securities",
        "documentation": "Amount of cash inflow from the sale or maturity of long-term held-to-maturity securities."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r994"
     ]
    },
    "us-gaap_ProceedsFromStockPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromStockPlans",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from stock plans",
        "label": "Proceeds from Stock Plans",
        "documentation": "The cash inflow associated with the amount received from the stock plan during the period."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]"
       }
      }
     },
     "auth_ref": [
      "r345",
      "r651",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r826",
      "r856",
      "r867",
      "r958",
      "r1020",
      "r1021",
      "r1029",
      "r1047"
     ]
    },
    "us-gaap_ProductWarrantyAccrualClassifiedCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProductWarrantyAccrualClassifiedCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": {
       "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued warranties",
        "label": "Product Warranty Accrual, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r1022",
      "r1023"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Domain]",
        "label": "Product and Service [Domain]"
       }
      }
     },
     "auth_ref": [
      "r345",
      "r651",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r826",
      "r856",
      "r867",
      "r958",
      "r1020",
      "r1021",
      "r1029",
      "r1047"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS",
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS",
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income",
        "terseLabel": "Net income",
        "verboseLabel": "Net income",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r222",
      "r255",
      "r258",
      "r271",
      "r275",
      "r283",
      "r291",
      "r292",
      "r320",
      "r334",
      "r340",
      "r343",
      "r394",
      "r434",
      "r435",
      "r437",
      "r438",
      "r439",
      "r441",
      "r443",
      "r445",
      "r446",
      "r552",
      "r555",
      "r556",
      "r579",
      "r594",
      "r671",
      "r687",
      "r729",
      "r772",
      "r789",
      "r790",
      "r844",
      "r862",
      "r863",
      "r877",
      "r978",
      "r1025"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant, and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r675",
      "r685",
      "r866"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Affected Line on Consolidated Condensed Statements of Operations",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r262"
     ]
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Amounts reclassified from accumulated other comprehensive loss",
        "label": "Reclassification from AOCI, Current Period, before Tax, Attributable to Parent",
        "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Axis]",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]",
        "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r262"
     ]
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Domain]",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]",
        "documentation": "Item reclassified out of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r262"
     ]
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount Reclassified from Accumulated Other Comprehensive Loss",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]",
        "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r262"
     ]
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r262"
     ]
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]",
        "documentation": "Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Unallocated amounts:",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r884",
      "r895",
      "r905",
      "r930"
     ]
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party [Domain]",
        "label": "Related Party, Type [Domain]",
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r489",
      "r614",
      "r615",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r769",
      "r771",
      "r796"
     ]
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party [Axis]",
        "label": "Related Party, Type [Axis]",
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r489",
      "r614",
      "r615",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r769",
      "r771",
      "r796",
      "r1038"
     ]
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Domain]",
        "label": "Counterparty Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r277",
      "r278",
      "r450",
      "r467",
      "r616",
      "r838",
      "r839"
     ]
    },
    "ew_ResearchAndDevelopmentAccruals": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "ResearchAndDevelopmentAccruals",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": {
       "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development accruals",
        "label": "Research And Development Accruals",
        "documentation": "Aggregate carrying amount, as of the balance sheet date, of current obligations associated with research and development and clinical trials."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development expenses",
        "label": "Research and Development Expense",
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r531",
      "r1041"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development expenses",
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "ew_RestOfWorldMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "RestOfWorldMember",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rest of World",
        "label": "Rest of World [Member]",
        "documentation": "Represents the geographic areas of the world other than the United States, Europe and Japan."
       }
      }
     },
     "auth_ref": []
    },
    "ew_RestOfWorldSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "RestOfWorldSegmentMember",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rest of World",
        "label": "Rest of World Segment [Member]",
        "documentation": "Represents the reportable segment of the entity comprised of regions other than the United States, Europe and Japan (Rest of World)."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r885",
      "r896",
      "r906",
      "r931"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r886",
      "r897",
      "r907",
      "r932"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r893",
      "r904",
      "r914",
      "r939"
     ]
    },
    "us-gaap_RestrictedCashCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCashCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash included in other current assets",
        "label": "Restricted Cash, Current",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r968",
      "r983"
     ]
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCashNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash included in other assets",
        "label": "Restricted Cash, Noncurrent",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r207",
      "r970",
      "r983"
     ]
    },
    "us-gaap_RestructuringCostsAndAssetImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringCostsAndAssetImpairmentCharges",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/SEPARATIONCOSTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Special charge",
        "label": "Restructuring Costs and Asset Impairment Charges",
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_RestructuringReserveCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringReserveCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": {
       "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued realignment reserves",
        "label": "Restructuring Reserve, Current",
        "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset."
       }
      }
     },
     "auth_ref": [
      "r972",
      "r1014",
      "r1015"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retained earnings",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r132",
      "r171",
      "r682",
      "r718",
      "r720",
      "r726",
      "r752",
      "r866"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retained Earnings",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r280",
      "r281",
      "r282",
      "r284",
      "r290",
      "r292",
      "r395",
      "r396",
      "r527",
      "r528",
      "r529",
      "r543",
      "r544",
      "r568",
      "r570",
      "r571",
      "r573",
      "r577",
      "r715",
      "r717",
      "r730",
      "r1051"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS",
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails",
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails",
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net sales",
        "verboseLabel": "Total segment net sales",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r321",
      "r322",
      "r333",
      "r338",
      "r339",
      "r345",
      "r347",
      "r349",
      "r481",
      "r482",
      "r651"
     ]
    },
    "us-gaap_RevenuesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenuesAbstract",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails",
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Net Sales",
        "verboseLabel": "Net Sales Reconciliation",
        "label": "Revenues [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Enterprise-Wide Information",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets obtained in exchange for new lease liabilities",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r612",
      "r865"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r948"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r948"
     ]
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accrued and Other Liabilities",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r1036",
      "r1037"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368"
     ]
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Cash and Cash Equivalents",
        "label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
        "documentation": "Tabular disclosure of the components of cash and cash equivalents."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Effect of Fair Value and Cash Flow Hedge Accounting on the Consolidated Condensed Statements of Operations",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Supplemental Cash Flow Information",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r110",
      "r565"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/EARNINGSPERSHARETables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Computation of Basic and Diluted Earnings Per Share",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r990"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock-Based Compensation Expense",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails",
      "http://www.edwards.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Name [Axis]",
        "label": "Investment, Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r391",
      "r392",
      "r393"
     ]
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r581",
      "r582"
     ]
    },
    "us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets",
        "label": "Schedule of Foreign Exchange Contracts, Statement of Financial Position [Table Text Block]",
        "documentation": "Tabular disclosure of the presentation of foreign exchange contracts on the statement of financial position, including the fair value amounts and location of such amounts."
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Components of Selected Captions in the Consolidated Balance Sheets",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r136",
      "r137",
      "r138"
     ]
    },
    "us-gaap_ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Investments in Unconsolidated Affiliates",
        "label": "Schedule of Investments in and Advances to Affiliates, Schedule of Investments [Table Text Block]",
        "documentation": "A tabular presentation of the information summarizing investments in and advances to majority-owned subsidiaries, other controlled companies, and other affiliates, as prescribed by the SEC. It reflects specified information about ownership, financial results from, and financial position in such entities. Includes the tabular presentations that disaggregate investments in and advances to majority-owned subsidiaries, other controlled companies, and other affiliates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk",
        "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]",
        "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions."
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restricted Cash",
        "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]",
        "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r183",
      "r1046"
     ]
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Enterprise-Wide Information",
        "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]",
        "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r148"
     ]
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r144"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails",
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r62",
      "r63",
      "r66"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Information about Reportable Segments and Reconciliation of Segment Net Sales and Pre-Tax Income",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r62",
      "r63",
      "r66"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r491",
      "r493",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Weighted-Average Assumptions for ESPP Subscriptions Granted",
        "label": "Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Weighted-Average Assumptions for Options Granted",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock by Class [Table]",
        "label": "Schedule of Stock by Class [Table]",
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r70",
      "r71",
      "r72",
      "r73",
      "r74",
      "r75",
      "r169",
      "r170",
      "r171",
      "r232",
      "r233",
      "r234",
      "r315",
      "r465",
      "r466",
      "r467",
      "r469",
      "r472",
      "r477",
      "r479",
      "r722",
      "r723",
      "r724",
      "r725",
      "r855",
      "r955",
      "r984"
     ]
    },
    "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSNarrativeDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt and Equity Securities, FV-NI [Line Items]",
        "label": "Debt and Equity Securities, FV-NI [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSNarrativeDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]",
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security with change in fair value recognized in net income (FV-NI)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Variable Interest Entities [Table]",
        "label": "Schedule of Variable Interest Entities [Table]",
        "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r90",
      "r91",
      "r92",
      "r93",
      "r553",
      "r554",
      "r558",
      "r559",
      "r632",
      "r633",
      "r634"
     ]
    },
    "ew_ScottB.UllemMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "ScottB.UllemMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scott B. Ullem [Member]",
        "documentation": "Scott B. Ullem"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r879"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r881"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentDomain",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Domain]",
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r317",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r343",
      "r349",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r426",
      "r427",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r849",
      "r958",
      "r1047"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Domain]",
        "label": "Geographical [Domain]"
       }
      }
     },
     "auth_ref": [
      "r347",
      "r348",
      "r734",
      "r737",
      "r739",
      "r797",
      "r798",
      "r799",
      "r811",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r827",
      "r857",
      "r870",
      "r1029",
      "r1047"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting [Abstract]",
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEGMENT INFORMATION",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r332",
      "r337",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r349"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails",
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting Information [Line Items]",
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling, general, and administrative expenses",
        "label": "Selling, General and Administrative Expense",
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc."
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling, general, and administrative expenses",
        "label": "Selling, General and Administrative Expenses [Member]",
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "ew_SeparationCostsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "SeparationCostsMember",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Separation costs",
        "label": "Separation Costs [Member]",
        "documentation": "Separation Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation (Note\u00a09)",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected dividend yield",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r519"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r518"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free interest rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r520"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r491",
      "r493",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value, per option/share (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r513"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521"
     ]
    },
    "ew_ShareInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "ShareInformationAbstract",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share information (Note 13)",
        "label": "Share Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Expected term (years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r517"
     ]
    },
    "us-gaap_ShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term investments (Note\u00a05)",
        "label": "Short-Term Investments",
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current."
       }
      }
     },
     "auth_ref": [
      "r190",
      "r191",
      "r975"
     ]
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Axis]",
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r221",
      "r317",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r343",
      "r349",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r424",
      "r426",
      "r427",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r849",
      "r958",
      "r1047"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails",
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails",
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r41",
      "r219",
      "r260",
      "r261",
      "r262",
      "r280",
      "r281",
      "r282",
      "r284",
      "r290",
      "r292",
      "r314",
      "r395",
      "r396",
      "r480",
      "r527",
      "r528",
      "r529",
      "r543",
      "r544",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r577",
      "r600",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r613",
      "r715",
      "r716",
      "r717",
      "r730",
      "r791"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Axis]",
        "label": "Geographical [Axis]"
       }
      }
     },
     "auth_ref": [
      "r347",
      "r348",
      "r734",
      "r737",
      "r739",
      "r797",
      "r798",
      "r799",
      "r811",
      "r814",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r827",
      "r857",
      "r870",
      "r1029",
      "r1047"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r280",
      "r281",
      "r282",
      "r314",
      "r651",
      "r721",
      "r731",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r751",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r771",
      "r773",
      "r774",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r791",
      "r871"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position [Abstract]",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Comprehensive Income [Abstract]",
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Stockholders' Equity [Abstract]",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r280",
      "r281",
      "r282",
      "r314",
      "r651",
      "r721",
      "r731",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r751",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r771",
      "r773",
      "r774",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r791",
      "r871"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r888",
      "r899",
      "r909",
      "r934"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockCompensationPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockCompensationPlanMember",
     "presentation": [
      "http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Compensation Plan",
        "label": "Share-Based Payment Arrangement [Member]",
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares."
       }
      }
     },
     "auth_ref": [
      "r991"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issued under stock plans (in shares)",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r129",
      "r130",
      "r171"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issued under stock plans",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r129",
      "r130",
      "r171"
     ]
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount Paid",
        "label": "Stock Repurchase Program, Authorized Amount",
        "documentation": "Amount of stock repurchase plan authorized."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails",
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Edwards Lifesciences Corporation stockholders' equity",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r133",
      "r134",
      "r164",
      "r753",
      "r770",
      "r792",
      "r793",
      "r866",
      "r878",
      "r986",
      "r1008",
      "r1035",
      "r1051"
     ]
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders' equity",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r86",
      "r94",
      "r219",
      "r220",
      "r261",
      "r280",
      "r281",
      "r282",
      "r284",
      "r290",
      "r395",
      "r396",
      "r480",
      "r527",
      "r528",
      "r529",
      "r543",
      "r544",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r577",
      "r600",
      "r602",
      "r606",
      "r613",
      "r716",
      "r717",
      "r728",
      "r753",
      "r770",
      "r792",
      "r793",
      "r812",
      "r877",
      "r986",
      "r1008",
      "r1035",
      "r1051"
     ]
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders' equity",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ACCELERATED SHARE REPURCHASE",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r274",
      "r464",
      "r466",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r478",
      "r480",
      "r576",
      "r794",
      "r795",
      "r813"
     ]
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity."
       }
      }
     },
     "auth_ref": [
      "r967"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid during the year for:",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ew_SurgicalHeartValveTherapyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "SurgicalHeartValveTherapyMember",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Surgical Structural Heart",
        "label": "Surgical Heart Valve Therapy [Member]",
        "documentation": "This element represents the surgical heart valve therapy product line."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "us-gaap_TaxesPayableCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TaxesPayableCurrentAndNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Taxes payable",
        "label": "Taxes Payable",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r186",
      "r1045"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r920"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r927"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r947"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r949"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ew_TranscatheterAorticValveReplacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "TranscatheterAorticValveReplacementMember",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transcatheter Aortic Valve Replacement",
        "label": "Transcatheter Aortic Valve Replacement [Member]",
        "documentation": "Transcatheter Aortic Valve Replacement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ew_TranscatheterMitralAndTricuspidTherapiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "TranscatheterMitralAndTricuspidTherapiesMember",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transcatheter Mitral and Tricuspid Therapies",
        "label": "Transcatheter Mitral And Tricuspid Therapies [Member]",
        "documentation": "Transcatheter Mitral And Tricuspid Therapies [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instruments [Domain]",
        "label": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r463",
      "r477",
      "r575",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r691",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r1003",
      "r1004",
      "r1005",
      "r1006"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r950"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r951"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r949"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r949"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r952"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r950"
     ]
    },
    "us-gaap_TreasuryStockCommonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonMember",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury Stock",
        "label": "Treasury Stock, Common [Member]",
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical",
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury stock (in shares)",
        "periodStartLabel": "Treasury stock, beginning balance (in shares)",
        "periodEndLabel": "Treasury stock, ending balance (in shares)",
        "label": "Treasury Stock, Common, Shares",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "us-gaap_TreasuryStockCommonValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonValue",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Treasury stock, at cost, 49.4 and 49.4 shares, respectively",
        "label": "Treasury Stock, Common, Value",
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r76",
      "r77"
     ]
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockSharesAcquired",
     "presentation": [
      "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails",
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchases of treasury stock (in shares)",
        "verboseLabel": "Shares Received (in shares)",
        "label": "Treasury Stock, Shares, Acquired",
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r130",
      "r171"
     ]
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of treasury stock",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r76",
      "r171"
     ]
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "US",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States",
        "label": "UNITED STATES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_USTreasuryAndGovernmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "USTreasuryAndGovernmentMember",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.S. government and agency securities",
        "verboseLabel": "U.S. government and agency securities",
        "netLabel": "United States government and agency securities",
        "label": "US Treasury and Government [Member]",
        "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac)."
       }
      }
     },
     "auth_ref": [
      "r672",
      "r858",
      "r1048"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r946"
     ]
    },
    "ew_UnitedStatesSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "UnitedStatesSegmentMember",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States",
        "label": "United States Segment [Member]",
        "documentation": "Represents the United States reportable segment of the entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrealizedGainLossOnInvestmentsTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Investments in Debt Securities",
        "label": "Unrealized Gain (Loss) on Investments [Table Text Block]",
        "documentation": "Tabular disclosure of unrealized gains and losses on investments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefits",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/INCOMETAXESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability for income taxes associated with uncertain tax positions",
        "label": "Unrecognized Tax Benefits",
        "documentation": "Amount of unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r533",
      "r539"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/INCOMETAXESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net amounts that would favorably affect effective tax rate",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate."
       }
      }
     },
     "auth_ref": [
      "r540"
     ]
    },
    "us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnusualOrInfrequentItemsDisclosureTextBlock",
     "presentation": [
      "http://www.edwards.com/role/SEPARATIONCOSTS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEPARATION COSTS",
        "label": "Unusual or Infrequent Items, or Both, Disclosure [Text Block]",
        "documentation": "The entire disclosure for an event or transaction that is unusual in nature or infrequent in occurrence, or both."
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.edwards.com/role/BASISOFPRESENTATIONPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r59",
      "r60",
      "r208",
      "r209",
      "r210",
      "r211"
     ]
    },
    "ew_VariableInterestEntitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.edwards.com/20240331",
     "localname": "VariableInterestEntitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Interest Entities [Abstract]",
        "documentation": "Investments in Variable Interest Entities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableInterestEntityDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityDisclosureTextBlock",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INVESTMENTS IN VARIABLE INTEREST ENTITIES",
        "label": "Variable Interest Entity Disclosure [Text Block]",
        "documentation": "The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss."
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityLineItems",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Interest Entity [Line Items]",
        "label": "Variable Interest Entity [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r553",
      "r554",
      "r558",
      "r559",
      "r632",
      "r633",
      "r634"
     ]
    },
    "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Interest Entity, Not Primary Beneficiary",
        "label": "Variable Interest Entity, Not Primary Beneficiary [Member]",
        "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Interest Entity, Primary Beneficiary",
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r553",
      "r554",
      "r558",
      "r559"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "calculation": {
      "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS",
      "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Dilutive weighted-average shares outstanding (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r296",
      "r309"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average number of common shares outstanding:",
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "calculation": {
      "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS",
      "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted-average shares outstanding (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r294",
      "r309"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "940",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479613/805-30-35-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a),(b),(c)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(i),(j),(k)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(i-k)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "30",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480870/815-30-50-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c),(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "SubTopic": "20",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(1)(i)",
   "SubTopic": "20",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "280",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-4"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(c)(2)",
   "SubTopic": "20",
   "Topic": "860",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4D"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13",
   "SubTopic": "20",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-13"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "SubTopic": "20",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-8"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19,20,22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.24)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.25)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.30)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "((a)(1),(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(CFRR 211.02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482663/740-10-55-217"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "25",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-6"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-21"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-6"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-9"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a),(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-8"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-8"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-8"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "182",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480401/815-10-55-182"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "25",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480238/815-25-50-1"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480870/815-30-50-1"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-11"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-12"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.10)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.17)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "985",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-4"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-7"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//220/tableOfContent"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//220-20/tableOfContent"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483613/220-20-50-1"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "250",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//250/tableOfContent"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//275/tableOfContent"
  },
  "r164": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r165": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2"
  },
  "r166": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//440/tableOfContent"
  },
  "r167": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450/tableOfContent"
  },
  "r168": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//505/tableOfContent"
  },
  "r169": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6"
  },
  "r170": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7"
  },
  "r171": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r172": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481138/505-30-25-5"
  },
  "r173": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r174": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r175": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r176": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//810/tableOfContent"
  },
  "r177": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r178": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r179": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//815/tableOfContent"
  },
  "r180": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "25",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480238/815-25-50-1"
  },
  "r181": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r182": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "940",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//940-320/tableOfContent"
  },
  "r183": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r184": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r185": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r186": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r187": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r188": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r189": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r190": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r191": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r192": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r193": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r194": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.10)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r195": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "b.",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481160/942-230-45-1"
  },
  "r196": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//942-320/tableOfContent"
  },
  "r197": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//946-320/tableOfContent"
  },
  "r198": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r199": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r200": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r201": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r202": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-6"
  },
  "r203": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-6"
  },
  "r204": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-6"
  },
  "r205": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-7"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "210",
   "Topic": "954",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480632/954-210-45-5"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(1)(ii)",
   "SubTopic": "20",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "SubTopic": "10",
   "Topic": "310",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-7A"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1403",
   "Paragraph": "(b)",
   "Publisher": "SEC"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1405",
   "Paragraph": "(a)",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1405",
   "Paragraph": "(a)",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-4"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(dd)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-11"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//260/tableOfContent"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//280/tableOfContent"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//320/tableOfContent"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-1"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-10"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-5"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//718/tableOfContent"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//740/tableOfContent"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-10B"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-4"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4CCC",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4CCC"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5C"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480627/815-20-45-3"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480870/815-30-50-6"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6B"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6B"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-1A"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-2"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-17"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-1"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-2"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3A"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-12"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(7)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5A",
   "Subparagraph": "(SX 210.12-13A(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-20"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "79",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-79"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "80",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-80"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii",
   "Section": "6"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r952": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r953": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r954": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r955": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3"
  },
  "r956": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r957": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r958": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4H",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H"
  },
  "r959": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r960": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r961": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r962": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r963": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r964": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r965": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r966": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1404",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r967": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//210/tableOfContent"
  },
  "r968": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r969": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r970": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r971": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r972": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r973": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r974": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r975": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r976": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r977": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r978": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r979": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r980": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r981": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r982": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r983": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r984": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r985": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r986": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r987": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r988": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r989": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r990": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r991": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-1"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r999": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450/tableOfContent"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480109/944-80-50-1"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>101
<FILENAME>0001099800-24-000039-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001099800-24-000039-xbrl.zip
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MA>?5'Q]=9TB&I@43Z(V^F1;U?,>F'7UL@JHX4F3CWHS>>&,1SYL/[08(#/(
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M)^\=/0%(-X[G]T9]8F57;4\(4#X%Z%PK ;<!3"% 0H!RL +5<AX'/L8.P*'
M>:#^G?U"/1\?3(<>+B0KIVM +>=1; %A?B!\+BW,;0P^E1ES!Y-Q 2QAX]-:
M,D)Z^)&><RT W.Z@".D1TL/]VI/SK3 !85Y.)1RT01O89@A)&KAS0$["P]YM
MTW,T16Y<=[\_Q8_'/\5_X_/K$)ZKS<9=<+8XI)XMQ@H?1,JKI9.K'5R!Y!P@
M^5Q6![=;N-N8]>#8QIQ?>8!I7G4=MWNC B&<Z!"Q^9<CD)Q)C=2YW>!*!1)V
M[Q@4BC-E=^/1,,"GNF]3Z.[$P:++P@VWNTI%5"Z%,*7/A=1\;Q[E7\,)\!X
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M_E>R8[&D0&&%<WI.F?*D0 &&\WE.F7*D0/&%TR\A2H8^;*M 484S+B&9LJ1
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M/T?S0@4^=8' YI18$GVC.BLH!5^#.H'7$=N0_FU.)8PTKW=6\JL59$:,]*!
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M.5^L^P?F"C!]=A^.*5GXPHK_1AUM.5Z ]VT[0R?P\>+-#^I+3Z;W0RC>PH!
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M#"87)Z(RLD0O&''I#T7MBCB\5'95U]3,#HCSE:\C?S;MC3.9F%&]/+QLAD"
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M"[B:;-MX+KH&."!(MDF:M5*[=?Q3 7GS6@J%LI/'RS;AK<:R$AWNI7!47N]
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MFY?<,?X5>#XKPCIP.D:<CA^S\=_942Y^MJ /WR_H3_2OP/1,G_:I^V+J-+0
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MM>)CU:^XROY'XZFAC!G:<S9J#6$IXU7]'9Z(FY\9+)X837\$EH@A+$!X(5(
M\SFNP"H;_A.NQZNYP0F0\,?A:]%BF?L!K)_WCH >\7XKD2,/MU8LU@5&XPSF
M!MHSVJ"Q5?F+KPQ=H T^9V3!WAFX'FS<\ NS9EQ5,4#Q?G4]GE_E E4BNPJ%
MOX=/_@FB#I@(-F3OU0+#UYO;^%KN/0C5]VCD"\(Y!M<8PLT^1D9Q',LI,!X+
MQ=]!8Y</Q&,O%EC;@B/\ !9=&*J. @;+5%&;:YK80F\+,8*WF:X?^(55L*R2
M+?$>U;?XAAMGQ(M4W,-(+ ^'><LW\>+*61ODI)H:WA6I"G$UBK<QF+J\C8$
M[FJ"T%6R\HNNB+F-]N:58J/U=X7K)19$1"4!@H!_?'@? FKT:ODN@,X7Z^ZC
M=NN"]H</YHO/74$VL'V,G\(5$JN0.(Q5</X!BP)7/.%B^_"JEW!'S70DY_('
M7F*#HWYZ@Z,"FD9_H6F<25>DE>U8ZZYOQ_C)B;2@=JH6M(LN=,\+-7*7S;WS
MA0T#D$3 _K\8/^C"L\/@_8F!7.1%Q_ L0"CHS[!I GVXT-JN.'42%*=.TN'
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MUFRE*A:=!:>S1*'J[\>SD-M-ZAU*P#N]A=QNZH1#PN'A+.1VLX6A@=2]]ES
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M?SM#GG?X2)9E*2)@$\(GD)TXM\R @8PT6V\'(ZVKI8+DFPN3^<ECG]!;Y(<
M^<:X,G]KS P30%04#(#*'*89^BW,E<8%*^)Z8S%/LV(K&,40L,1EN4)M6@10
M%5N:C*!Y+O]_&.^B_GC$II\7^7^%5T9-,;=65P9U'=Z(@BL\J8$08$;8OLM5
MSSBJ(V?4CA9S1H(Q&IPQR/[-X^U4"I)!PPR +"J$^UP:(W(+U,#1\_-ZD1:P
M8HN*6,G(MQ,&(N(7DF ;T[1(]\D:1V+)^-5"\9L[5N%M*=;?X@2;4J1_+)D7
MO=)3(S$0=#75.IX\G2?'>ZT1"+JW0;G\BNE_+L>C8&4^&!^T<^1WI=TX9()-
MSE2%7BUA#>5-!^B6F@ZP3,I:9 #XFRD N)^MIP!T]<T4@*\W]S^5/V^^_7&G
M?+^[>?KCYQU/!SAMO+\8:,+P-4FS +XN\FXQ&'7$QCPUW%C$I9JASA(+NN=1
M[LNF/VAZH(#%$'B^U^.>ATFT8[ZW+9G8$DVI-O-LX;'!&ZH*(N,8GH*Q:Q90
M \3B2JX CVRWL/.2&*#ES.8@3*+PO&5F0BR=F"<Q.(L\<M&#0Z2786J9";+X
MQ<6:(M<'M1GTSLG6^!M6@1 ,J_[O_]735.W3_SMW4<)&!,=UYH3BQWLL_%R<
M[BQSGZ,822\>;)QN:65E3'V2CSQ:2)Y[CJNK,/F%-\#ZEZ!8&JFNECO3,L?S
M2F$6?X(X0 74(SV=Z*]\1JH<E-%#ROSAQ%)80_9;S%R<*GN>.W0]H>*\1Q #
ME<>HME%N@@9O "Y,@[<T2Q!/4V;P])VE<.*.KK%AV^(P>&2-06CBV:V-E%\$
M%\=NF%A@Z8*=]-Y0X)W^'"RFV OY;9$3*>DN?B@,WPL[<^VJ<'Q1L@^F_R#K
M>RP0@_27W05C9406J>)\ .X;>NFB<<#TP[@#/RGC*=^[*PR;Y_0V4LMVBSP9
M)<K'$YE5RR\MQP=U2'R+TGIM84/N6]2>Y8")WX, %+ 3Z6H&3X?':)*Q#4)*
MK*P! ,)J17P7X(4X8-$MV)N_)HYC-?TD7BH$H#H![/!,92PA($JMA*GQ7%)Z
M2T?2U6KFV.+BF?$NA&O$<? -:(0K*3 B*B(>F!":VAY[=>U7W/[#GHH+%[30
M-,R-<KTB:"69XF&T/PAV8P8&S&\+4\;].*[#.@#P$/BH@ %RD>G@6GHZN,R9
MW>FV@)9H"^BU$SIL_(GK!>)LU#&P8EX:%QNV[RX$#L_)C#@ON])*C %"8;#R
M@*OEIL%5#$4+M\JKXHEIW78.7]\/\=X$ [2PVZ]5&[1[K81CBBCYZ+RWJX+1
MEC?+!,180I?R7>SFO' 3MS#_%%C K>0G'B?Q^AZ?<1,IJ5/ICHT\%X@0$[EQ
M1K%I1+-X=!9CYD-.:>*)2%QU44BK<\2,8)%T-I^"S%N8U<O$T>1M3R@9J/%/
M8PL=9WJ';[710G-M05EI)99N;)^XIV6_W^@VNT73XEK=1DLOK7NDII:7%D>#
M.OZ@*M#\,T]W0#&R$592XXK/-5>R\:I8_TRE8._,L^B**+06M<"T<B9KGM'L
MM8N>O7ZAL^<M(BZN#^CJ"?(NS9UV[0@K7Z'WTS>Z(EH2+8F6<G5GVR3*F/^7
MV.[@+-JV^1,>MP(&[98FMKFF7;76)DE3E!O/A1R*G>T.143&C3/"?^Z6^$AT
M+6YZ#SNU06M+\.0^2W#(#D%KK\O5(8@8X=P9(:.06@%&B/O8Q]9O-JK_FWEN
M$H-T<?/AD0;$(L0BTK-(1I&[@[!(CUB$6.1\6"2EO$,IZE1?+G6J)%?8N=A(
M-UO[*%R?TA2G^TN^7_J"5;)>59+?)+<@2,MPZ,3DR4GSA81[Q?5F/$88]H9A
M$,MI7HNO6A<=6C'"5;"'>B^C\LE"*']UO2<0R<OL[2] Z>5?!31.>&7U-$Z"
MU!)2&05I\D-J$SIJ;=!N)=7J)N!4 #@I50$.*8LTDD65AE1&-8-]9)$NERPZ
M=N#$>6B&/-2BCI/'HI=EZ(4)9*LBXV34O#B$+&Z5)HNW.$(.(8OS6,D$J5Y&
M:L4^LKA=&ZBM5D,CX%01.!E'Z(>011V2196&5%;_L3UD45<N672$2*MU74\J
M6/SA\.H_3P'/I7UQ86P.SPOGA<Y?F&.^)RF&Y"K<X)FL9G$'$,-5/)PF2"TA
ME7&:NX\8QO*?:J-%N*D@;OK'/[7HTZE%M2%UN%,+>+1,HHC.WJO:94O6J\@U
MG22=OH,XPK*$-OFE"XCIXY\1]LL[(R1?D(R0.MP9(3QZH#6Z!)LJPN;X)V1]
M.B&K-J0.=T(&CY9($I$F?=KPWW-)"8BU6U-XNU&L23J*.AAA&7_F^*)*(I#)
M(>_][GG(7T*JWL:(^@-H*FJ5)$F4#O8_:^XO4\@=)B-<,@Y(L^"27Z>I8HHN
M 2EW3FMY0**SPFH#*>.LL/@&UI=K [NP=,\OC'>2MUYW#+JX#),P6VV+J%A4
M8'::Y9UHDC=!1NADJG#KT-F$".9;=?=/<2!\R(B/3,UL=]%"1R;5ADZF+I8M
M6G2I1,N^CK4BU6=R%W:L:&F:_/.O$,=DY3!P/LE5IZ;3Q*8AG?(,ER*%1F6L
MYD3\=('\E)7 482?VK5!K]EMZ,1/Q$^7RD]9R1WI_)3?*B@OJ8XXC3A-HHF7
M:3OEY+3,WG*=)B8B7NF=7FD%#0_*;I?0^"/6#:ZD[A\Z4'KDSK&E655: QRY
M-B$1DXA)Q#P^,2\LE&W+<>?>!_O239:J51<]O8UI!D4LJBK&O! [5)8=<I](
MK[##)NRQ4'NC3Y GR$L/^=R'[+OM &H5RQ(0.U26'7('#FS? 515IAV TIFH
MHH)4A*M:K/!C,&$>10GO;&=R^L4DZG[G>"I%]U4;31EF6LEHT@E-E493A@64
M"TV;J,$8N/T/-@DQ,B(FPTC8$3%MF1!#\<8497)*C;"\[9N"NHC=B-TR5.;B
MNU6W3 <7L914R"*6*L%N*,Y2O5(40&(I8BF))EZF856<I?JU0?\\=JFS#B_N
MY8@N%B.#Y<5&R+ (US 7YN%5&'QFLNF0>8JN7BE:4],I^IAB/(F81,R+)69)
MT<>2Z$3)V28BDV@G#$D]V](Y9HL:3=0B:DE.K6K*V_,.6+DU_(G"_C6W7L%B
M<C:%\-XG?-+-.+\!GC1%N?%<J(9[QL$+(N/&&>$_=TM\Y#.WM2;63.I+TUJT
M!(V4&*&RC)!Q)%* $7(?1FIJ!6.)B$4JRR(91QP'89$J!F\2BU2613*.+/92
MIW2YU*D+RXA?=#.J@_"J^[ XBK7L]W(M@[5-]Y=T/R7Z4.O4,MTKKC?#8TX&
M>\,PH/ZI^?=3N./8;0L[&K4MK#BF#M8[O:.U:X-.2VWT"#F51,[1VSEWM/("
MU@E34F+J8/V<.UI7+FET["B&\] .>=Q#'2?/1N7HA@EDJR3G'+VE=4>K8@4S
MPE0,4P?K:=W1L(%?KU5:W7Y"CES(R6J94KXTTJM838LP%<-45MN0W:61KLHE
MC8X0<;6N[TF%BS\ !Z#_/05&  ]]<6%L#IXL*(8S4HP7YICO2<HAN0PWF2:K
M-\@!!'$53ZD)4S%,977!V$,0Z[5!MRE-I0\"3JG 48]_?J'3^47%,76X\PN]
M+94PHG-XJE0J%>$NU$7]'>21:<T,F_S31>3T\4\+]=++6Y%'2"Y,'>ZT4._6
M!EJC0[BI)&Z.?U:FTUE9Q3%UN+,RO2^3+")MFNK^Y^&>^V4^@#)A]@AE)7#(
MF'D>0P),9\SQ>;4C!<CDD!=_][SD+R%5;V-$_0$T%45$$B1*JUD;J%I;FE@H
M\HD=,WLW"RZYE9I6%5-V"4BY<US+ Q(=&58;2)FMPXIN8+I<&]B%I7]N:8A,
M-F$!M2VB8G&!6=ZQ)KD39(1.[FZ[Z2*R71NTN@V5\%%%?.1N35M<M-"I2;6A
MD[N-:[IHZ4HE6O9UK!6I1G.QI?<+S[]"').5S,#Y)%_=FE8/8XK*ZV4F12L+
MXB?BIQ*5VT+\A%TL6N4Y HB?I((5\5,)QL 6?LIM%;3+RZXC3B-.DVCB9=I.
M.3G-F4_K(Y<W_,%');$;)B1> =>=Q\9V"1TY8@VV]BEO6.W6+$>N54C$)&(2
M,8]/S L+9=MRW+GWP;YTDZ7JU45/;V.:01&+JHHQ+\0.E66'W"?2*^RP"7N,
MW&E+4[>=,$^8+^&4?<<MH(K%"8@=*LL.N2,',K: ME1; "4T45T%J0A7M6CA
MQV#"/(H3WMG2Y/2+B=0]3_(HOJ_::,HPU$I&4Y?05&DT99A N="TB9H>:(!-
M:<JM$F2.:2;L")F^5) Y0<RQ>/GZ<5+ZP?XE6-JED*9"K)>A29:V[7<.%0ZV
MUTI*ZO$B_B7^+4=W+[QK=M1276W$I,2DQ*09)E%Q)M7*46V)28E)B4GS&:'%
MF52O#;1VHWWF3,KMUK\&6(AP4:U83.AA/H5E,5>J,,<K+FO-AM9>%%T>_-?0
MP\>%L^8/2KM1:[0/6:R9/_':"F"JYG84:;S_M.%/E+M_S:U76&$L3H<]91+Z
MV<?JU^6:9JPBM43$R28%BY'"<DQ[/F(C9>HZ[%V9&MXO%BAC@*_/R_<%$Z;,
MX%TN_#WSF \WP<7&T'UE#45YAF^Q@H_AO"M .N ][-Z#]XR!Q917Y#%?<<>*
M!:]*>,/0\.%IP-C_FKOXW!G D>&@%&2U5Q9>+89B(?D0XHK!DRZ*OM],:T-^
M)1ZXV8/R2EEM2X2X@9$ 09W,%D57_.-I0N5P9?BN!,8OX&F8:."B&/-A;IZH
MC(ACYK_!N(>! 2L([_3<*<S*\D;UF>$%[YQ.>#^@X!4IUN"46/]4F?L,7C&:
M^X$'0PM@0(8W6KX!5F3$;!BI  '>"F)C@G^Z4R;&S^E?%^MDS&:>:Y@3G!PN
MR-O$,B>*8</D@"+6&-8&J&$YLSGRF,=@ C@49+(KA5GH!%1&EL?,P'Y7<$&=
MZ*\K!>@0+6!L[?B\^"3X,T.P*AZ#A<1U"3QC%*[+T'-_@0 =,0"V)_#D([(0
M##YL!/A"WP*6,KR551K"NDUPFLJ[Q>P1?&)Z;&0!/@#N!OX-_\Z,]\5*C]C8
MF-L!?.S^DYEBI18XGEA^X'H<I",C, 0(7#[S)3'"Z:SA%\7#C'$9 >3QV*O%
MWL34@!36:('L:)6!<@Q89($.M@TAB#DLP&EX^&'T&'RB&_VV("I<:B")7(1+
M[$GNW#/7F)X[A+J?_&B(O+2GYYIL!%NJKTP,8&''#>#9/I ,GHV<#?\;_7,N
M!"V^?_NDUB8"[\\G92NR=T5UTI1XH33EQTKYU+.DP]99Q_EBX@)7 G"6M64]
M9AN<^UTNU[=4F W1&K\9Y1*B$"#K60PX!78'X%GS%X@"%P6YL[873N?!'-B9
M;UCA\]8VER"44:LO6=_;PL<);FNLM8\ A0RU6<L1DKD$E2.D9TL3T2(SU[?P
MR=><>,!BG]ZL43")].S8C:&"VES>8@Q!'9T'Z;?$E%$3%03O1+!1]36RQGY.
MO&@T,]BKZT,0[K_JQA@&>VW8;\:[C[IR;$Y3RZFOT3!M^K"R+W!U2#CLK!A^
M@MK\]@43/]=6/S1 VEV]KB<06E9!%84"@AX-"L<\OQY]_C(*%"V40PL*C"W'
M<$P+Q(:UI 6*':Z:NMX4Q4:D28(NXG'E$3YX0P6-_38GAO/"N(&+1J=0 TS/
M]?WZXFK_S9C%K@!A"%,":&\^E_V><1L7Q=<-:&O+@?KQ5WBH6)DN:'+_%H(+
M!SLT0(Z"_N!/& @O(\ /0?C%5;0UD1A*Q&QRO!E@$S #1S8""N(F'XK*: 8+
M0J#6SO548%<0LM'?7&/#>;Y&^G82C4 06[ZX)1SLTE18FC2@HC'<%SRAL3B@
MB/@^;!$VU\Q H^,S">=F3,' 1Z)/!$460##=.8P(9(L-1!3[C!A,$,G_:$ZY
M%9DXQB7BC:(V.)=O+TB(VQ5[)RG)^ASIL7WVS$-3+H)/B):_ -.98(N+;9;K
M.*[]*M@^I-6J;6AX'D*'LP_@YT=HE<!3T4>$EP"+K=YB^?''S6<A6_/W1CH3
M A<@:TZ0!<UPJ&#T\[-A9'Z@"+ ,*$7 9?X<;3X8>8"7<<U\QDPP_M!R!MO+
M5VSV"E8EVEO"@!5Z_<L<] X7[ EN18*D")G1WS)?>XD-SI@+:0%<%_'P*"YZ
MA!0)34T#39&A>,*[(M8'+A]9OHG<BY-';\C8=M] =ACV.XH)%^_[CHY%Y=;P
M;!=M1ASYPER^$C8RT%R8O]&(5VS@N9-D[=UP;?&[X9D3X4+4U2M%:VJMJ]#2
M68X6KEL07<&5 9KRM4:A.6(@!J?<,P!2?\B45#>I,Y\.01O;Z%RR$C2@K7M*
M/R,90?H!3(<@N?&12_9=X=Z(>=^_BY7!(=[C=!?NU+JV]*>V:H/-(FC_B7(;
MA+=INAZZ(+@S8)(#%.^<%L4ZMJP<MMX_?"UAYIDA%,TE =JU 7ZU08-&.9)O
MQ:N[/O?UJ2Y\X#$!'*[BZ-'YB1X2]!5\QLWSCQB<^?+^1.^ "7=Q6CS#:S[;
M8$(M9PH 8S#_&4[!F[/3:;&9*MS8M4$ <*\(3L\' 3>%K1JW;PY#OEESW6U5
MQ?F&4D[14W2;N*2*WX<*@1?1-M1,/L"S87(V[@$?KZ,EY:-9VF3\= #H8ALS
MGUU'OWR*\@PLA\^.W_1IU1YI;W9ZYPL@OEX:-8VF,&S"$+?PS>'7#?CJKYN?
M=[H-M=M*_*K94!,_3WN4"E_HQ1Z5_GE/TTL95+?1Z19]]S'&U-[ZI(Q(Q7,J
MP9.[K,>620F7Q'&FU<LUJS1EN, \,ZJ4G!4YMF<+57ONSRY84(>HM%*D!>]I
M#O<_AZX%V"*_@+6-FJH2:L3K?KS2"]15.B+DH@KTJ6I&<-9"T8W9*/\ "W%#
MJ?57M5I_50=>*/S\644"I\O+EZ(ZFL2F$DV\&)MFA&<=B$TWV;&D1#3B1>)%
MB29>B!>UIB2\6%*&GP0%;T]?8H+J?)RV-H?4<G'EI? 0LV[]KD^LT8@YU\"(
MW69M<)ODZ5RP()7R2!6FZF&$:8HL_9MA.=]<W[\/ W?OG3O#PS.V(F7(NN6U
M\:6$_".!\D,Q5&KKJ,3S2?CMA/#<A*%6&[03MO^/A+XS1Y]^#NC3)4$?:5L'
M=&^?V+/-HSTBMW:K-(OFHDWSZMKE+;E=V=W2J]=6(3>9N/-"N+,MA]>LVT:]
MY>#M1(D#B0-EX\",8E='X\#.>7!@J&NOI82I(N!RKQB;?,V.<@;JG.^[<D;:
M52E@B6+7*':-8M>VQ*YI%+M&!_%Y%9J,ZG]'4VBZM8'6*;MH( 7%R %)XL5<
MO'B:.-)-7L0 M=;AK0OB1>)%:7E1DF#1;K\V:#7/8U^D4T29!D@!:J4&J/4H
M0&UG8:H?*-JWC!B,GEH;-!M="D*K)/#.,#*R5UZ/;@*EE*#<"(R42!KJ,DE#
MTK$N)"Q-W]&.22YEWLQ=S;S:%OO>U*F2T-V(!SZ-/=]K<3]W_Q@E_?.OM-R>
M-^)RXO*<7'Z:\-5-+F\?PH-.7$Y<3EP.7"Y)&&ROPWWS%=C+<W3HR5T@OI3R
MN&GW(>4MM:6:/7W,6'MDM,8M?=AI]77#[+;U_I"UM>[_8 ?"S9>%1*JC3+C6
MNI&@"%]?QT^.7V..5X'L-01BXC\5I5@US67U\UCQ\QMG]'<V>H%9WV W&UYB
M<]EQ:K-J9J];"\N>SMGH)@@_PY>MUM+\<O?S_L^;Y_L_[Y3[AZ?GGW]\OWMX
M?E)N'KXH?[_[\K?[A[\I-[?P]?WS_=W3)I12T)!_@5)JCR:4L ^'GS IK5:P
M7NF3.6&CN<T>QP^NJ'1\(XIP/XX?099@<QL8_7(=?H3="_QGY*L$8O?.ID1I
ML2KSRT+PO.G1L@A\K):ZXEG^+UXPW>)UZ6-EU<.O8G501\J0V>Y;0XD(ORA_
MCC69_< (&[NL]DH:88E2;Z77E(%-==Q@K:Q[6%0>>\3,F.CZ-!*UVN-S'[EP
M)19FYU&0HG&2Z+L1+XHM6E9Y!N]EA U_X(E1]>;9W)NY_D;KC<T^#BCAPQ#I
MH]9@[?<;W6:W: G6;J>AJ_UR2K V&\U6L2*EZ9^W]7+*G?8;G2:5.Q63ZI]G
MG/!";@B)721B6(K%RS?+W*5JBT2!R+VPVY.;=YUZOA2-4+)N/J8ZY$VOBGI1
MG-.O(.>LU'P_:0K%*?P-7_-W/BIJQE^ 3ZJRCJ6,[,ZE;;=J :Y&=SCS:7WD
M!O7P24F.(ZPZ>-7M:J45'CP#-R_QA4QS*\87&4E"9?%%O\GYHE=>'M"!(U#.
M:<N[W=:\+T?T:N7#LC*R;])!OHECM3;0L9]-,10?1HCG#,>K_/)F)'0465[M
M),LK?31<CE.DO9L*2^,6_Y+E!5_T4A3-W+E3.^R_REYYXW'>8P[[ 'JB8[H_
MX;T[P_;N#46Y#[![XFJ_QAF8G""^L5O];V;. R;Z(:ZT-;6"B?)BNT-L&KTR
M-BN8BT:/&VU#A\S&#G]^V,]/#/K-]8+)^UJ7>%@,YOG8;M$/FU]G$,*8NMC5
M<3E32[QF:CG6%+N<1=UA\4-\ W8<7#2UAD?P8ZNU40 7N^(XXAX?*SKEP8N?
M<%O[PH!C/5^Y\7W7M,+6B88/U]4=%F#Q",5X\=BBC24^./5[[(KX:HV8\.S#
ME7")XL-E-EOTOK3MY58*UX F\C+!%O;P))LIL[!+)F_&&GZVV(=7( '/"E?_
M2N%M%L>\Q^+P7;3,7(XY%W^<(5=M'#8=JD4Q(C>.NUB7O>0#*QB*YTZ5#\9'
M93P/\*Y%[TYX<P@T6"O.?/P\*VIL"N]V?+%!A&,,&YS:KHG=4F--DIF#<\9?
MS+"]O&O"]_RAB!YL7/J;-QVUWPN>#W\WX,;Y]!MS7H+)XQA7+72"W(8#N(7Y
M?(7IX(GQ:DT^S(:Z'LV]=V9XRUU0!V5]7< K>(GR8<2PVBJG!\!XV>1T@H_V
M/UXI'X8?^1(@+RW;UG/JA\2)%MZ?#WUK9!D>2HVU!Z_='3Z=T_B#^7$3.X!O
M=VI%MP,/\VZK\1ZO:R^(-4X,'YXJAHH E4O?J,_S6K&.;6$6:]W@9^$!\[7'
M;"Z 4_O#AZ[JYO(68^B[-NP>J;=L."]/)!'4UAJ!8C\GWE*W>F'UH<>,7W5C
M#(.]-NPWX]U'K21^O&HY]34:IDU_]?047:JQL]GM<C4K'$%+#$?03U1,AA-Y
M%?43$3*R?J;OCL? ,GPGBHDTY06X5<@U&T0OVQ2&'D,.$E2 #2YB\) !^8TQ
M#HSSZ%(8XS<N[ZD,O.-$+>#GCAFUG%Y>]L%C/FR@.(&99\%G,]B>WX7T7I'+
M8L@K(C@NJH'5J]L._ 8TEFS%S<.8"--]<7@,QFHCV5!OP<[(> C"UPO^&.$6
M!AI+F.CA3QCC*A;L-0HV^(Z_=?DN(1$M7/TX$(T- 2PZ,[_P3N8>!YP2]A-?
M>:[(=(K&B$CS_4A9X\]1V'@L0CVPV3*^.391:SH%[5=LLJAGA^E25QPQ@@N$
M5B[>[X7C$2^; PD\^QWAQ]^$ 2YLNK9M>&P&JC77-B*L' @%_(G75@"2W,R#
M"U W>+=Q&#<O+,:'[+$)+"N2%A/)#CSBK>-+7/[L@*1HOUW"2RPF_^)?<R#.
M^/TJ25796#?3!C0)XT?8)QOBCP<&19B)(.B#+J;@=#@:1-Q3[)L9S,#E'XF6
M[LE 6E4D.8 7+X*!QK+3\?[59M&)JE+(X8A%P2T$QD)@Y"(*+=K07%7"\>+@
M^&*%@5_&Z)_SD/"X\F_<S!^R.)Q&Z[@9KX-@757V\?1YQ&/,0$4.#- H^$9G
M6_^:"WD<@A>7-]Q[E_W$U]J)<PU26!RX/8(%[G #*12D?//$FY.$9TR\(I[
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M"XNKM&*+E2C SIV1,QI![L[(+5"@6_M70I4P5H)@HW8S^@_N#ILVP$9KZ)+
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MH8V(ACHB PN56[[B F<HS, X&1SY7WQ8G7_-+=\*8 G$C)493]]M* J6NA
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MGP PU9I5E6"*\ UCIU6","'&B+DN/Y=B@58J+@II+GL%IR :P&7BJE1+ '\
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M6<XK<-#?G5=8I5L5S3&H*X_0V1>&6@1EI<(L"[ILL]>+;[#WR%4PN\*3\)X
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M SKLT.X!Q6#SA&!3 =B-QUU[E<MF.RN-8FGVVG;BI$MR&TI,+3BFMK>.J7W
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M)>QTC5Z>@$N>V W*1 -QR'1&_:Q=!RQ3E'-X(0CGOP(QWAN%J8^;YKVA >L
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MW/RU4?T'3,15.PI8Y@G;#^$UXE8+63BF(>Q0U..GN%YA=4>DRV'[BU"47:&
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M^M\K[/4<#[+>;*K_'JNUOZ;CBJ)9_M\K\"*U,F<O-9O-Z=M[7(#-5F/ZAN9
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MXZO(@4,1$_IFR*UK,*!VX%VH10/'!'@"HW$"'P?((Y=\;[P!QY.L*9'W$XS
MQPQT !^W(T&YM W--0Y=FX@-"4>O.)Z\%NW2D[M$N0/H:@4&M^W(,%!+P^ #
MD-]@W&%-$FOM/Z2W-)Y:>!):Q!EBO>/F9G$68-'9V'=F8"(C%R7"F>!]DLO>
M;08D*!&U.E<D\J1 =MKK#!@O9&Y.@:]:#_2U?BO[E_=DC.9[TF&MJ=YI%FY-
MG7;['8FU:F.-S-IB%3(<W.SS75W5KX#-\LH_-]8YQ.(- '\BS\-W[GFX1N\[
M:0NA!W[9^2[9>R%2PP^.\M8[LH,GO V=_J&3WCV/P*%'W1XGFR.4"%QH!-YH
MX?0[A\87#Y_1:;U.@^AU-KRJ2?0Q :VY!M!RLLR#V'H&W]M,Z==1=,Y))"*6
MO'(CUO@ZO>5/J\8\]_Z+74+>;]5KW?=U="E$'X4E38-*%#X-%.ZU^C6U1.$2
MA0\7A?MJK7.<&!S>OT;GMH]A<_%.%6=J%^U4]P.)G[<QN8<VWN5)047F:KPB
MJC1(-G35&NU_CXV1-#O=W)SD0.9DGO2Q-M7<BFMYK,4_UDYNB_H(3_4 #TY]
M-SF>GDJVI*OO :AD5)Q>:F0[T,@.MRFW^G[S[<#L[H,\G-9[?7[EX6S[<,Z:
MM>:G\E@*=RR-6F^WQW*0FLUA.YL2O79*#6=W/J<#9 AJMU?KE_/ "GHXG7:M
M61Y.00^GF3M>5Y[-KM(!:HW2B7.T27YW@>]ALT+1=*+,^=N30^?8G/:==K?6
M+EJPODS!^/"QJO7R6(_O6%O=6KT\U0,\N.Y[DXU/3SD[;#_4D^-K5M1VJU3-
M/G;5FID#Y4S DY\)*(9I'N(\O0WX-DHZ*>ED73JA090EG91T4M+)4E=W[V2I
MY,@]Y?W<KI&C\I2G1A3*-1W\=(3;L-NQL\1=+MMJTB]\&A%>EYI;P-YTZCN0
M-<" 3S!XS[V\YV?8E=E3;,>'+[ ;.!^C (#$GK?8%5:L7KZ'WPBK=R9,3EN@
MIK0.O-6;.KSE-A,CP'*OBJ;5V)H85@.'$>!X,3YB*3E#C 8?\/:XV&3ZF1G4
MWQ9'6K]0 _BCF/"U1N_)>S'!X3><X%"DM;^C!>6B097[&M-=-JDLT%7K@;Z0
M#2&+N*8C:E+9*GJGL;))9=FDLFQ26?;XV]I599/*LDGE02-PV:2R;%)9-JDL
MFU1N-2]BK2'6)1/=4KI$V3?MJ/JFJ=5ZO9N[ANE 4@%+)#X-).ZW2A0N4?B@
M4;A3+_.QCR_+OI.[ +5L7[E^UD2A.5G23/D>36=^"J<S/\GQK*6QLJ&KCC/+
MJ-LHFPP4]6Q:^?M.EV>SH[-IJF7_AZ*>3;==-ADX8B?M8^".:03]H^]B;B J
M/[\SS2W]LKM0=0ZWNK71Z91="0M[.*W\97'EX>RL%=E[7:#EV6Q=V=D+V1RD
MKG. GIXKUZ2U*%>:6PXI*5TY2T5HN[1)BWLX#;5TM!7V</JU5GDVQ3P;M;D7
MIG:0"LYAC_THFQ+M(\NN;"*Q P 5F^N\KRG1QJ%4["RHDDY*.GE74Z*23DHZ
M.3$Z>4=3HF.ADB/W-N=O2G14WN944Z*UNL*(I[8:W :;.IZ)[6LN7&91!YVH
ME0BV$8G=*,B@'MVB#0'C W_Q+:GBLSTU<6ETD^"(__L<UMA.M3$['[I,^W&N
MC6"Q%YKUJLT\I*5XBQ?3/I^#X:+M)SNX8$E<K#],;VD;GT6=9;*?A67!$JG/
M439=-#N2>$43G7.UN=TN.O3$"Q.L9E-?7OK76+^XC;<-6M5NYP- Z14()(K<
MISD9*YZK_[W"7L^QI+;>;*K_'C=K?TW'%46S_+]7VIU.98Z@F\WF].T]38-:
MG?[TC6HJ"]N$*=:D;*0\#?[UH$QY%REJ3 84ZS$#6W=1:R^?^EE,'.IGP;"?
MA1+VLE 0G(KA I^SL1G5,[P$T"]\-MXO3V'72)&]]6OC57,-3WD<W-]<WVY[
M<4N7 E3I Y GV H+X5B%4S GO -;X0'75/ZP?%=3'JX?;[[=#/8)1^6%V!Q
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M(H.6_T&U)8Z- 3 Y1P*((1-$1V,V?:7D[7#>H1&Q,,$'0)H1XLB9L5&)@TM
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MD$L6YY!K)D!KH=?LG!B7> I-9AB6V9G!66;/E#+)GI%"'N\CR9XA$]:Z)HL
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MX;A1$9./O@M-UYZ27UU_T+_]'U!+ P04    " #%@)U8QH^3?>82  #"NP
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M&K)+9.N105 "=8:&X[J/9R_@4N?9>J25?#\%\LHOKO/J3;X[S#)S6=7N\B4
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MA[%P6>K<1%"LG,H,/385"R;/,#MP9;0QFA&&%XIE%B59"0Q<GR\L9T4(3'G
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M76'9DR^CR1G  8S:T= 26*X:DRLBDA':M5P?6E\!T6[\!<@Z.$-N1A\%U8>
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MAN/69O-FT\TGNG%/?1"!>T8B(Y';=;?MT>TG7U2A:X7&9O/7<39$]A6A7=;
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M"@2P:<.BNQ!:3N5P?#HYG2T'\QYFLU9P4,@+M^[.F!8I8_$F,A-;$SGG6Y4
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M4I\-?/:98(XFDTM([R['Y5R%<7^4YGOC[.L;%& J"\35S<I >UX&E3EEA$=
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M@QN]X[Z4M3,B@V0D4*91E()SYREWNO;P@]60[:KTICXAEC.NEF(:E%[<0/L
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MOT\@34<?_-!_@K>XD)*0./PSSGI-3G'G/NU/_N6'R+@IC&$RO7YIXTZ<?5O
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M-HZAY[NMUJW]HOX1;7Z?S+<Q;D7&8]GIFUR?_WEV+A,3$C0G#F(F,@+^5)Z
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M^:TJ1X:EF.SPCPW]ND\NXX!$+L'1/*HJN1X''@BD93!C&<B;ERG)]^IDG=F
MB-MR^(&0%FO+HM=U*5K3>._>K&+<N/,C6CJL>UCY>3"O2B@82C=' Z#EN#8E
MN=$\)L7A0:["+A7;SZWU#3J[/W'6OT)(,U^S@6M(\6])HU*4P>8@J476HEG2
MP.OVIJP;3IR3RYN"#^^.@<PIK(4(7Y8*9:UGLH3A6[!=UV'TV6#-E_DD\"1Z
M'QLX\A*Y\ I)WD=I86Y*9P-U+SE/_+O4OTO]WY0JROEV^]2K>=DTK/2[T#T"
MRR(<UV.4TS?\08$E(L>R<!3+>,A?<%V D9UBZ[3 8_I@^(1;&_DC^NQM@V</
M;NQ7Z,</:'P-2CF<+Z1(_-2^T?AT0,FQ=FP]@@UXQ(.*GZ>B-;%#*K3#S!?S
M=;O\IYJJ(C+P_GE6/05?WM3TX4^:'::5Y79.9EEP7[VG:!&<.C\6HQ4G>G:6
M(('F!F6H?#8(.2J$RWA>UY0[T8XZPRV1;H77E D^?JWAK_??U+B3@@UA<3/$
M0+=7=;64!3)W^#+?S/:])H'/0<SP@%54XN7P<0-%$TL%)\G3@;P I8,TC*6I
MLX$0'*A$"V&&(+C1Z-X5G.",+'Q 3YS*>2JF_>LNS5RUL3>O'SQZ+Z7:H/#L
MLN0.M3L/MU6>9]1"6$QBYGA[#,%9FP\60AYI)8 [DB6/!KIKCHUUBOD?_>HC
M'FH7XXJ;&[%QI/=J??&R3;T5'%VS\M'&"^6"EF3>9^RCT&DID$>[$$"&\4X/
MLX$837+V,4>RJNH.\^*[N6J*U=5/C;:-.GQJ[:Y)T+TC111Q?9/_T'0ZA5!O
M'NJP'0QWI'HX@*;DU 71F0=KMSVB%S2W!?CP'9^:C)F\WR;QA9*OFP(P+E)1
M#&&="?$Y TAE+V8L2]N5Q5^':T*5()ME=,:=FF0V#7_.JBSK4=>2#WC9,IF^
MI\>NV<U*7R,\Q/>#6-TSJ(,&P,"CT']W_3MIULP(#!>80&R,'U>/O>W4:"XR
MZNP7[2.61N;7'L;JLJQC$^_MBALVXMRWP>7F2Y,/2),T(0/E64F;BR'[-Q>Z
MDCOKL:$$[B0F1@BM1.D,C\CSG)IU)*;PU\:/*$ZM)JPIUSG>PEQK^]+%74_@
MQ,AVT,6P]0U(R16<C'&*7SCVNGEDRJF2L:!K,PWVGUQOZRK6?G\D\YJ_,VGQ
M0MB"L)!&:3#AM3C1%#\,8_$%T$]AZT_H:7=XC?$C&]91#0N<_B'"5:0+SSZK
M[NS/JO!L?'#$[_KK@)@3&@M 0BPW"2O DF!H@]7D7#U)*HK\/7(\2-96S,0;
M)S"S=W3D$/ZSHTA[J_&<9Y.+\VVQ:'*<U""Q3JJ[0',>T<P5T=[0_/E2Q*BB
MQ+GC^J(B6Z$ 1%_LY?,8H*._1G"L]C9E5FHJ3+-Z)"3CY.IM]*V#G.F?VD^I
M-&)=4%O\78E(J3H^? 3CL&/.7?RVUN2CS=UR2X_LBWCI^I\T/O '<3F(TVVP
M;3= .!MP_$18/]G',4\:&L8R0"(;P(3#_WQJ9@ <8Z;EL('.6.3JM,6?3\_U
MG=Z(_%<4V02/*G"[W._]*&98"^9[+%R?D[\65N"*=7)A TL3,.:Z:.HX:HUO
MF@VLK&.7A>U%.& T7QP;0.QE Z0,H[\X/VNA+\ &_KN<R%_<0NO?I7Y9*M+)
M]?KH_IH[!9G*Y0\2CX8"7Y9B!E@?>MG 5#.<OJRBW<$R"B2M+]Y=2_F8OAE;
M4LH&UJB1+"8O\L^G*3% )/V0.1O 26 7NC+_?)K[\G^M2$Z3FQO'3C[OH[<?
MZ6N80_1,^7\H%,(PD67J])8-T&4GV4#/-;PWGH^9C_Q2CH:Q@:+O*.;.Z\#J
MB;]2?!_#E WL"(*S".:L$-?+1;_\^G=KLV^.\,4/\A1X9<*3@IB68C;P8'25
M5?.<=:W\?R\4_%5S5T_\JE/28=Y_+8J$-Q(6Q;O9P+=E-C"]LUSEI^]_?U@J
M^Q>FEQ^HOB:S@/W6KO[U'^C.?QO!_YH1O%F(8@/P.B&T0O_V;LP._Q(ZXNM7
M4F>(^NOSIE6'F[P>9UX\R!WB=7Z!H8V?@QBG <2;E <)C&O!AT_%+':";JBA
M5%8,BF6!QX+OX91A0HD.4X3 R'1@ ]048$57I0-)+L->\UC?A5TSA#IC0A-+
MO,YZ1UH^PP86XP+90+,S9]\T?@\;B.AG/B%,9[.!2:E5-A +61Y_'ET#VPT-
M0KO6 AN03-^Z\).)-I=UCHC3/&OZO(?FZ^2^FP8F+,'G[M:7NC4'1.(:2@D_
MU<PQZVV=]*OJ?U5S%W=NMX/MKZK/9&VSIEUC \^3V< C5Q)+0U\VQR# Z>=^
MB?]EEP"WTT0G<3_UR[+'5O]((ZI[J,NX!VPTZ'DSZ[-3*:[C"FG;EM"R8/E[
MC9SZXLX0A5#^'?F%/:G\Y5S[P]S^]X07LYVZ]0[YL-!"X^BNP3W+[[4;/N?4
M]6GQ/8K@\W]T-2O!:(>%_I<$?=$X2NB$4@-^F),\&=E$"$$):.)%0$?+@,&3
M@\N'FMZ45B\Z)?!L.5-H92#4)/?]S)&1^\9?7Q.NXR-06^M4,9T.ZI3X)MB&
M&=D=O7!B14]0J%WOY:HP8]7L#?H)NSC>.D9(QSZ56K-F\:=!O2Z+YF8#KZ^5
ML8&<SX;!B#F\ CA/#V0U(HM7[XZ!6+HQ9A"Y58^G\--'Q96Z^'&2I*W+ZAE[
MC:H]#;NRK)3M#HIH[SVQ=\YUH)/SP'N,/,.4F8ZCH9A9>K:0@^)K@5BR!F4@
M=XP0A17(?F@.+KV<L=.)32;:!:[Y5KGC/"5B)N;**2--FW<G[ A KYV1E+7:
MR$ES)*+$,.)@"SFQHAG'RSC>[0/C'G5!#B?5*9?UC0<A[&7"67T5'#4E6]_:
MO_OPN69*M)TA_"/-<)4-#.O8O:&0ZF'W$'#JS@R/G!?I-TKI75=3FD:N.QS/
MYW@VE#II'[5ZO"6X<; !3G%0CT;(]"%$6&W8UW[U3[Q'S"/90"FL!<;G'W@F
ME)@A5U1)>:1A+U82?"S,WLFVP/C<VDG/.4[7R^78,3),]CRK30Q73)HG4A;<
M<85H!#-CN7:35?EIG#.%ENOB)9MYT3/^<WO2Z[A:#GTBUY%T6'6=!JN+L)'@
M%"?78@_V4]5-*<MVV0L?EZ/P.4Q6IE=IQ4,WWE#5QM1C^XS['^].D@=2>L +
M5$<RKGEAHRW#!#PV\5ZE,86?177)<Q[,U5-K;9+1V77 V^?*E0-7K^Y^*V"
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M$VNC=5 H%'(/VW:ZBS#'P0;*ON#3IG\_V/K9BV.\!J=;YJ;8@ *\ 4D#RME
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M.^=[2MR6>'4JT3G78-DI^]&4Y(MC\1$Z:@6[+1U+GP^[5O5ZK^=DVFFB9]C
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M&H>%ZTXUCO"EXB+-\-?+=<K7\P>H^24S/6TN*@6%Z0_V/FQU:YV%=R09&EJ
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MV1WV3]="UC2U;(E3::,7T5-/!^]CZRL(BV'X8"Q-?1:^[EN;#GM!N &#,PQ
M"[HBPP+,IF#:!Z::ZJ1 OX+9.O&*NK"V+55QM6&]]GNB-N^).*=_3O"^<2O^
M,4+PQ_O#S\0/:_QX80&W':A$5N<D4B/'2<2/:)-QE"18W#RI=YC< =O-3;<H
M#WZRL^KI!?LHM]#=PE,'=^S8C?G<[UV+M.]5\[Y@UZVFZK'=7^WB_:M7XOKR
M=M&V/P 'G$)J9,;P8?"MR[A(%JR7W*-WD!PD1C+OF=\RYUA<7![N&*W3VCAO
MW&WX58%\R^2;/IP3TXJJ2&:(G!W+88@4=K!X B&;.M2#YA\W)4G[&RXT8GE9
MRFC=URD?^(^HAM8V9??7A(7Y&$\>Y#@A<AI=O[N*SCT?"0$&5Q@8G@N&0&&8
M&-6O@0#,(+;%/=0OIGX/1^1@)[9EZ7^P,YZT*1TY\Z5)ULKD?,:#V.OMNPES
M$+M+00Z3:$MO?N#-M_5 (S)\B[^:^28&3XQ_>UV.JQ[+-W-<3]9*)8G'PY5)
M=TY!N[V)C3=GUK%@K$&"#-;)+)"</'>5;N2,W*)G\6HF68S8J-L2GM5WA?BB
MZ_Z)9![:3OF;&FMGB]VW1$D>V2X]R! Z1"-1_1@B]BR>M3'8\ 04C<'D*,V5
MXZ:!K5IQ:KW8(;/WV5\&$LP\:I(6KSCSO2JZ7!TC%E0=WZ-%Y68(R-.2P41J
M)TVIKP[&N X:9/BK-&,!1N!+M!I5[0$Y4*NBUR%([8!VAX<0HRCDH=SKLZ55
M&B\M?2QHS']*>NEO"1HY;O[QT$3.'(R:,XZ=?PA-B?KN90^!)JH,&RA';&=U
M8A3KM,5T1PM3'Y-F=$,BI-P^53_5N]6B(*RQ>'DX'"U,,P0SN1GB$Q.O(VG?
M*1_!:Z02?-Q92^S0_G5),\;Z\^UB*1\*O&X^T)K/QUR)EA:T;[S3$5 @UQI#
MRO-I9!@SGV*X&.>I.U,GL%%PON74!8'I5];'J;I'OERONGCPDRH^0\73?>LI
M=*7XP8/O 7BI1SA+$9P:PT6CN2E)A[>XVM'B?'+L/X$1WYT+"HY3:JY=$VB>
MWW7F[1IVYW?#%;PL9"BFF%:D).&B^<?D!E119]."H+^3PX\750T'!JDT.D@G
MD1$DD4$_<:7W(<XM"6U?7X44'\"<$I9 FM@,->4,';ODOEAZ\WA1IOFA]B_*
M;_=\-STXD7391"_!S%2?"YT!V?)Q9C+!@S \0M05ASCHD,Y$"Y'$Y6_I;M 9
ME\^X1*87'&$<%2R1"<L5WAT4-29Y^> 2&^BON[S?2+U_^31W$YP#>\T#5-5%
MNU">9=.M,20<_XIZI*YVEKK6 L0.0/3Z!5J^7%Q<;5'EK>8#>E0^X[SX_9K.
M'RP_PDM]^*[5OG[VWF97DIA^2_F1'ZM+2RB&D#Q-\L>KL;U8/*MCJ(\CS:.Z
MO0S37/#$!<OO6FF[AXTOOJ$[Y/CX5Y\Q?^QF'YQSN"]E_<P?>)*#_.-5)_4D
M&>1%;!Q2F W<P($[M\9G^D>H1RTPBZC<M$"J*O5UT<"*]Z=FB'_WB>SM=9_\
M1)Y(.KC]">ZA6)_*&*Y8ITD".4: RX0A*_PB6HC:S#3T]90\5EMR5[O'5+\@
M4#K@XYH:%HUW<UQ2,!Z+&578:O_>1>RX%=.^4&G<:&Z"HCX^%:U)VL;0!U%9
M)/](@S-52M$],'G+7HX/9+<@'ON[-V]Y3;96MGUP!IB9:'6J>@MR(\-T#!E6
M-.UH-UCJ6J [.M6HXV7@=ETI?$)C;X2.RXDD[HXUG5LZ!?ZK#"%[VA'P/7T#
MIK%.B'D/H^Y_EZB[RM@^T#LRXR!'^5+!0P-?5+^I1-P0-M1+,M<Z)_J N'CS
M<?WZB>8/JHCV;7Q^B9G_K[WOBFJJZ]H-@B(@O4D11)I*4VF*0&ST%V.C"Q&0
M7B(B$B0D](X(2A&$H%0%1*G2$D)5$&E*"4(*B@@$=@3#EH1PXO>-<:[^BS/^
M<_YS]5W,,9)<[+'VFG,^\WG66IDK5C5#-F+>0<F<R^>NTXA\@YC5MVQ_9XC&
M=V'PN/IJ)S.*/3DO,XJ39G_ *Y@J@!K=U7>U44$^"\+"<_["5)&,_%55RZ?7
M5RT@0Z(C6';MAFCV&70=1WX=!068NAB"W\0"+/XWIX(Q6"#B)>K,6)-21!TR
M@$+J^3&^WN0N$1A$RQC*/4GXD>QL=C,BJ]3\[NNN+1+P$$-PNY?Y$'U"-KQW
M)/H!OB?J^K4(E+1V78G_:("L8+MP[C%J+$R-Z2.SLZKY3;SM!,'A9\%1[B',
M;=B,2S>FWJ)';GVO[X/OGUIJP,S>[<Q48P0U;>G:L=^T^VQ/_;F%?JS*N>;/
MEGG)U%2]O<UKIN7_=TN/_['_.>/:4*25,B^P;H&V=/.>'JPP"[Z#]3*-D?SX
MAL.O9X?:KALONYPR[[V3>O)9R.^Z(__J'UN!^7?_V*%=2/J4'0?UI'8AV;.<
MGZ:K>=E/OD[%7.%]N0OI\6=/0/_=>I93Y?L#IC >ZT3I!=X^;*HA6QZ,X<@M
MFL!1/;Y@CR2FZ;Q6?0KYRLQ#??4D]_0%;#D*Z\;DU)^??Q_\"C-=#64_F;W"
M.[/YMU3-5*02I=\5GWLIFWO?!,*M,E%5(JS/4;1>[ ]P.9R*/X;75)@]CN.E
M&Z8UNGB_^\+2>8$L)BY<K4]QLBO+G9/_()MXCZ<^6J#*Q.P>5@JMRU(#A<E_
MV$HH?Y #8 [GFWCF HS8);G-;R!\JM\?)9R#J*O$P'/P@,/(-):1 S9PWOC<
M9TP@%%0?2/Z41A\B9W:1#H#8'J)74]M^EHM$ 0Z_=[$H)%VFV :IG,%]Z/4K
M]]-"=8JCZ+^MP+)0?^O0W^Y-4CA=5B!@EC_^>Q8:;ZH^SE9"*OQN"*/0G/32
MLO0;7W5)9;3Z?CN,N/C>P<$,PG2AY/7!$TFRQHH!=%Z*SL-[>#%?AT'9(<>Q
M.C$JD6*=*"B?;-V6<^L\3ZP@8BINA&D!&C*\=G+9$@*T/5M.4\8.E4O%AP##
M^'M71=HFFXX%7DKA\;:WI%Y*E*G(=O"RI,::G^FZWHT,9?-'52,]&7,3>#(6
MWR2]NA!"1BB +=TM1NL]&K7*?8^6MV&I"RU6"I&6:\X:/BUM5R62AG+UKXD4
ML2H X9JEND_KH,H(;809R/Z\"VFJHQTJ8P6!>Q$^9:#/@D2Q])-I<)ROMD-)
M,"/Y4I/ES,5YO>PXY:&#=CIG1?94764HTNJ %6H=AY%/KU KNS-CBI6,8.DL
M&V#=:9RE\5(@4WUU.YYQK8\[(BX?CQQB$@:C*.]+A.S7V?QQG)#9G&"YAI [
M+S((@%;G\.L*8M PK;\YI;+O06U3K?.?M_[J@K_R.^8HN)L^J0QA".H< .N#
M\3JB+H AU#0MQ,4O[AN-PRZ7G]D@PA2HN-O!I\-4Y$^\5WYD>:9N$ JJ^+ D
MVQG'L PDL,42[6'SBP/%0^2Z7@0/Z"&\-P"]%TPI5VW.H-H]5.(V^G!4E"\8
M,VD<&K3AYC%F/+L!]T2V4),(Z^ 1#$N\L+M ,66U"2;R$RT2!.TV%1K;O'$]
MK-KUYM?\0*V+'P>3+;U(FNE[XN__>2@9;?JZ[A@8RKS#*132NQ#?3%'TH**
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M;78ZV+;)EEKIE\7.\\&R]5KC:AX-J#FZ&]!\%CL$F&B4)]W[,9!&#5I?3?<
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MQS=,S(,H10%07.JMQ$9-$+FT]O3R,WRG=D=G'G%EC05[D:H!Z&[O_[M3]B>
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M+$. Q#@-5I:AKG[6E_/3^;V"%SS[03I1[ZU "Q%Q^R1UWDI-Y%SN)WL?/YO
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M&B^QZ![ _<_012*A8U*X@' $;/!"Z<)Y/V&LXU$$63=A-NK42T'@F<A]R-A
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M3-UB>B3(==NQG G@"<YD"_:7VBSO(,'K>Y8TV.Z)8-C^0)'_SJ_77Q*Y6;E
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MRI4[\^>II#;2QF5;*5LA,W&9B6&S&^]%+DI$N(^^E?_;-N=_M/_#5>$?/=)
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MHWPJR)6<,(+Y?/WMU==:@@W@W]G>\^_-?CL7!S P?V_[,OCW5M^&85B!MW6
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M3(MZT4M5_WGPZO_Q/Q&J&Y/_ E!+ P04    " #%@)U80 /7]Z8_  "83
M$P   &5W+3(P,C0P,S,Q7V<Q,2YJ<&?MNPDX5/_?-WYDR[X38F2)0K*K9)1L
MJ5!V,2%[3)N,3#,D^S*EHBA3J)28[(6,727)DF7(F%&D+#/*.,SV/WV?W_U[
M?LOW?]_W[[Z?Z_]_KN=ZCNL]EW.=\_F<SWM_O3XSASO&G08D#]LYV@$\FWB
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MCEPK,$A_[GB5,[@GQB(@5[/(TD'C=('UB7V.9V;4I*ADFAUV?(@A">9#RCB
M6O1RQ@>:2"1'$TRD_L"+<('H7NJ^,=.CASEK7;$%P<6: R=[MAEVN]S/?A78
M$ (L$%!<(*D2^W4S60:^L(="9EN2/-\C:(=PH)9]&Y(4R1%R9&IB1C=4"Y_Y
MLHZ <?138 :)R9'VK0D]%QHYL^]6<_*BYJT)[8VMT>\&NG,5U9WO+)UMW2K!
MVKJ'J?F=2#M&!#4D.G \*,\>G\G&RD2FXW<S*V7ZF<9)PC.\!.)Q$Y;_WMIA
MFS=RQX=W6\HGF/%CRK\1Z\D+RTQIR+][6J189]C/,#J5F4_(H$1'GL>^BMGF
MED^K0K7@85]?WW:"Z?LE&Y6RTFGY,X #&,N1\.0"MWQ9<"Y0S7S$!>9O^A(*
MH:)6Y3@S3HR0 +6R_+6,<4#]70K/&00\A!GW>M!JO*E^66/A=7SH5 (\U J
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MQEM>7,7IFL%NB(UCIPVY@)+5WYX 8__2U8]#0<.!=4+/3MKK->7X:Y(,)S*
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M7-DYY;=T0S-9Y Z>7V5+CV)8L..V*TGHJ(RU1A#B &S()$]! VB9N(_-VH_
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M^LAUL':D, K6%K^KV9#B+(_:NWPBW-0O:>_]C^)5;TT.-;;N]I!$MUI.[F7
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M9*_<_T=6]@_[TIZ-GLF@(.>XT P78$J9$-A;AGF6;O^$L^00G*,=1Z&@;IF
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M>^K8,*?&O"E.I,/I3799DD.Z1D]1B]ZWY$[K;_!P 5$\4P_"K75H. 1HS?Y
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M1655=4WMN_=US2VM;>T=GSJ[^@<&AX9'1L?&IRDSWV:_S_V87Z#]6EU;IV]
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M0JD(VO+EXNGCSC8[B]?*=<^L>%^V.>(9*ME>@A8"]Q#)<T5@2PK1"]R<R^$
M"T;PVC<%!P7=PD#:*4R)&WKJXV9G:T"A_#JW'*MXB0L#=.W(CSQE.S5YZ'$S
M(\N55!YZ"!29@Y.GX>O?!#2:T\X]V\ K4&7NKMDEGW$FUMR5T/M86VN][W"]
M<VC_PZ1'VK*U4E_P;6CJ:0XPID+G +T-3J_Q7SR,!O>LH[G1U2G)YFI%?B'2
M\E\2;XA$6!UZ^0FIEIMJZ=[E:O+'S_..5!)3LI""6'J2#YN)Q?- ON2"R)-O
M&&X>/P0<^IBV% ?Q"VY8M^;-,TWXQ>OA@1*ZF1O*,A_VN=JH*I]1O?1-X0$2
M@,-PR:<1175!3]PVXP#21TM.C--?C<A_+K)5=$U,$7/WF143/.>D^D[H.!=5
M4))K4SB( P@@P":M:@%:R9.7S%LC5]=+XRB7* XB5M1%5_?3&C'?;%/U//HN
M/VCU3/^\*^BNEK^<3-9&Z6@ZG<IZ3"2_('!-L_*(WH1[1R]0N]'V7J%J;2\S
M*D?=6Z5>UKY+."5O<N[65:SV0M>),@U:-'O;@4N7KG, /ALXL/?=O[JT_LJA
M';/5:1?6Q123,D_=B3A18G.TRC>GA(>]#?T:YU@!>X1!!<U;[.B^;?3NU9 \
M:>G8[S>"?4$Q S:U#YJ_GK!4G+4^P!V!\L#9P=-^@Z<-@&Q.]^L;K21N%ED@
M1G!H5$Q5:8)&<V9!\\C!!M/5H/33OY@%0K9_+CZVL+'P$;OWNX,M%'B)L1W+
M =C"<8R]"QQ %H5QN =N;U3%HAS[!YI1(DOFHF\^%V"+2XRDC9>WY]S36^X/
M373]VGC913G)>LJC?^@[B7J8&$V@.A A;0WF#K<FN XREUVF135:;Z/X&X+>
M3D(I=N^&OY=EVM<%+D[\T/>P"_5,50YSFU?9X^;%^S#X:&T/!R#7]O\P@*/?
MP0'*SK*ELX?=]TTT+1?8>2LWZ%_%V9MD>'F37URX>'];NR;/VLQ,#U/Z)EMP
M@J'/'KC&_H2JDFE?) I""]^GS!(#1='-KL]N#WQ<6$K+'ZW=>] D8T'NPNQ@
MSN]&UUJ&%-CD#B,0:6*%LI+(YL;W$'<8W9Q!\:K8%T.!K6R9AGY]J[JN<J/F
MHR'R!ZQ2^YQW[!2)?^]T8VY5@BV4Z.L;#B=-*+Y[!]JU;3]"V$^<]Q$/,!]6
M5&&,N-;DK-3*?? LL6SU*0B9Y]$C$_A'*[#6S(.E7,3>JM@#3&M\%=>F-TV!
M+;3.D,8*S&@DXWGF+51H&DGF1ZD]UIGGH"<R$4R5T,*6:;OC[9?#.G..1(Z(
MULG^F2Y:).3MMA.U= X.]!Y6$HJ<*WVGI("!9)X9Q#GYYEDI9HZL0AK._<N?
M0E)ENC)/545J[,Z]UJP\>X+Y\;+OKU4Z%^L)VQ1LL@"#'"8ZIFLC&V4#B#N7
M&Y5=#?RR5B)*BJ]:M+S],A[3>M"B:,/@6$WME:P$PY>5VF\%/,U;!99Z(),0
MMF UK8<M"'( 7A8'B%%A6$.QPS-M^-VT9%(\9BW<8G59>E,V>VJ8K\+%IEN%
M*^B[F49GXWDA9]$EKD&PZ2:17!#'%K1G; L@*C48O'(-4#(:,3)M0)$5A&?U
MN 9?W;>UZ-L?)6PELL].RX-G?ZYX_2\+7SBG]<$F_48E]ABZ(B063I,7).HY
MOGJ(1CM*>7DZ\/91RJ$!TOP4<L##2;IL;+2<8>@V([Q/1W;L.V^2\IM)-!LA
MS'J(5V/"88NZZD>0:93_L7'P 71FQFC8W,8K4.ZVO7:@_\6L1;].92T1D:^7
MO/P5'^S(VM1GBXZP7C0@&,? )B6V\!1TU+DV>[%923:E.8OU[#2/6O+W;%S*
MGL,6B^9V(A^5WNQ76N.JIJZR!5N*\%](5$<' 286DJ )M[VA/C'G*O7/(K38
MGVD;<<JRB:MVR2\+"RL^./7=EW'PL^*9O#9903DK3<GCS55L$[@ _%"7")%X
M)5K(_6J4&%3:FBT-A5&,>O&[H.XF#\'&(4-P>X!:WOF:]PVQ!F*I\G[GAM4?
MM/?GEIV_B.B704DV[AQCGH@F+_<D5:W3[+]$6]1*Q] CKH*5+[(T5>NTF/OB
M?9-YC$W$#W\9[E@MF"$@V=T>^[86!S]Y!\,49_R1V(SDK6*A3Q+:ZD;N&XT%
MZWFUNSX;^:'W8D!OZIC]_J8CGR@NQS8DDA/O:D\Y"ZP@X,:MB5FZ22V@'ZMA
MU9L[T8CVF)CQF)CJX52*O8765;"JL;=I5^R4[,-NW2]SO@\E[I1=;+IMK,-4
M9+T'X0"/GZ%DYS/VVDRC9>:5]L8U.Q0OXD5H'""B]-9[IQ.AI[^>( 7<.WI=
M,5G+8=(\6DNY<?AT]6]'A@&^Q4("MOL!O&2%J,J-I=)"W.5*JF]"=8I,0"73
M<+#:<7=E_4CQ>G(XI>*=IJ#S;*W,<86WC<TO1G4Q _!)/,0KI(GN9I!Z2A3-
M%KP$%Y8MY&N<#_?]N9;Z&7+/O3N)@NNF5=&'TCO]C?K%,^GIH;=_M=VP?6"H
M)O>X<0?/1Q0YFD0]A8PFE/4LWV3X+8)5F:T<0 RY_<?!^5KJ2-R5XI7JQ.J:
MZL%J!X.EX53!G9=BI8ZJOM1UU#S],Z<$O,$!O% 33G0,B]C(YXSO(U9TM$K2
M9&)62KRK_3\79:R.NUNE&$]AO<]A\]V[KMEH=W6YN#BSD;#IW$6&C)3Q,VPA
MM[!#S_3W^\L/VAILM9'08IE3=V(\[QW_<;ODCM"F#%LD)_L\O$88G%V-O^ Q
M:/)VUQ.R1-[\14('SZ\<Q)B09F[$_WC\0DX@Z!)P'\2 <03J&S" Q!<PI49M
ML5>L]#.>,ARJJK>+2]YH'["Y%,S]Y[F/E[[S-P'W#Y=ZY$:8)](/L6) 'X=1
MC>E1R):A!>F?IX[$BONKU?;NP?D7!F1D]*@\4=W; 08?;'G?Z?.K^5NY1MK-
MYXP@L.D O&HKD";Q[AJ!"S^&%-%ON)3K=R=E8FUR-^Y2H7]-WV0H1O9Y7EE=
MS.4'JFG:E;':JM>VB=Q<'CPET,T!E$!R,D@]V3,.DE<B&P$<#M(KA@APPQ)=
M:BN-6CMTE(*Y=_<.[A)O8(:]I8>/\\=DC_.WCRE(QE!R(9CZ\GK BWD3WYMM
M3'5H34DB\N,L2Q9)VPV[=1 \"[4H*=R)=#_JN&D:0BMOT&DC8:'(^T#J$TL?
M3[YP.RL U\0X!3;)@^2GZ)J0#G=A^@/6*P[@$X:0AFI;-F\9&X^,QY;>4:Z/
MDM83<F].UPUY*FQBH/-3(/#J*> ]U8XMB( -H+*>@?X$,?P(D1?E:X<2A5;:
MQ+[NR7OC?Z=ZZ=HQ7]X_Z/1<C/(024-/:+?[YZJ2[SW]MV#/4?P@.9% /8D>
M6VE7,H$BJ8%P?AONQ%"L,T,+H+FS-5 AQ8G@'#O_9_KO8O7<CC]]?3!&UY4S
MU)S% ]^R$D#R8T*Y#%.BWFJ$:<108BK543,R*?'B]B%VF>WR-06!P<HE31KI
M<+A4EG_;:4=U :H1?&&SDEPTF6@8LB=1D*I^I(5Y#\,2ZT4_&TLZ]:Z!<08"
MV>+"W_O,)Z=_#_PY=;2CX?+AKMXD$6L N(->AO4!;S(K$A50.FYRA%7,-F,B
MAX-+[V7+!!I31^)W0RD488U^^Z+VL)N!4L5KURTK/"\KB-WX5MZI.M)_]I3
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M(Q)L3F)@Z.JEU[WH/9!M ]&L*S4=WU-I_'7&M+/]3E83!XB#\VJH@0/,3G"
MKX_H:[@#,P?7\LYG2]/2[,/6Z'=*:W!Z&/%W.@C7LV\]BS5KLKZ]J>MC12]K
M=\"L-G5J@]V0R_9IM/KGB4XB(!V3].*>(A@"(GN>"W7,PC^<&]BY2G<=8.\F
MP.#>J\$^F\\!.I]P@%8',F93&-:/P>!OGN4%'0H)"EMAN?6PW8FL3AOFH0UV
M\1P'V$-B?\O[QW/CF,?8_!P@A\@L@''V@45_;N.Q+=G&=P:&WL6.+(THU/2Q
M\$R&KU--.<.)J:; )!B?2\&3*I)')Y]=]MUI%1Z"/O3\VL_K+4.['?;F?_I>
M\N%'USP80VS=U$V_]^NJ2O[!)\$>P0*^/[N,,4Q;/,PZG!+"(K>XATLC7-2I
MGAOL=_+]1219#O"I' :Y"Z+ A0'B-Z0 ZSKZFW9 W$G8*AQRO0U\\.;U?V?K
MG><72*>P2N"PQTY)P:D6%6"A2\N$];G,C$.[0^SX9%7V[F$+&2:J?JAH+=G#
MM/?8B"/KE8+MBLIQ"GI?7NI E]64O-Z;$78GJK9CZ1+#%\Z*D^9("I$;WTJL
MTHAAJTW^.-AO,X-*&A[/CR5XO=(K"UTV9+@8R16GSCXXW*82<U;;('SY5;GY
M 88/?AQ9H;&<SSC.W+-%,,G)%F90S+09!T@@3!PLJ7P)??DR+&C4_=RX\^<>
MY0P_P.]G$+[IVJ5NP_W=>_=T+:2&"2PMPS$18-6 ?N#XS/1*,VI<@RUH2R%$
MU?'V!V12H8XV"^7J(:^,GSL/!M__(L&[RU+G9;H%I2GAR *72"L0/O87UL?O
MFVSN.^T09[%]"+\+6FF5KCL9]\*_<D&^O3!\[WUA,V<O?[4L:W-M;9U]&CG\
MC>Z]L,7%2@(8;JP^/0&*HTJT38E!>C09EZH!G K-SCV[SQ-U)3Q#IG8X4"N[
MN6NY9IOO \70/KDTX+?2.0X@<()YE&;30H*4X]K.3-N]"?HV_'/-7?T717IW
MQG#0Z8DO%S8/:MW;++H;4DBBPB#@(=6/(D]AXM$(BTX9^M4X:N+Q^\UZ>0$*
M!W2S2#MCE30_;0H!C%\)-"*DX9#2X$!S8PNN4W4H<<DE^007&K*I1V0AJV$U
MS<.M,%E[W,4]_EO:SX[LT-++<#OLH:$3F ?(F.WN4&U;78.Q?-!==;?NSB_B
MJO/O9FJ-YI#4KQR@ L62*19@<P!8X$L<ED7_,TI ]?3CK ;B94044;1:?QOS
M++3QXD?6PRG=(7W/JH90$Z.&6A&O!Y>.MVRWNI/)/(1B"\+!LW&:3F'\UH>Q
M]C!2B#V(^G5#R9P#E->?X@#]<27B=83[2OK4D59$4J,V;23:Z%ZUJ(HSC6_R
M^Q.0__8%2]4_YY7G!/B.JRQ>J :O>B-_:;7 .8W</(&*-4CYK4!!+7Z#.<4K
M24>K.P+/X%<@F 0#*S,S!0;WT<E7'&#^;/#F,CH%%&RP>X$UH!3$XBY1DD^:
MZ1G8TO@>?<\+-;YMR7LFKU/%J^)M&O[1%I0@'. KA(%]0Y 7FPTWZE:GU;DD
M&$'W-8-1Z"Q4;@/<CE*OZC.OPPZXK*PY18 M UL@2UH+QL/%3$SC #3)?_$W
M*:B<<?V_\7Y)KI7UIS/(W]+ZX&)D*7S1N *X% \1?RPP8?P U3@ 13LNGDA^
M3:0Z+"YS+_2/T%]1NSM5CRG'J\&+0I+D6K-^#JL4"+68P %VGW'JN8VFGNV!
MX(YSW4IC^<ST@V[Q6*7+#8K@^],<X%]>_[]E[+]^LQ3,^;99&.%T( 9Y$(JF
MWFP?QN_J\_A^7,*Q7-=KO[I)Z9]<GS[E;,_]K]@</!!?B/<;X<!&P<2[R:;Q
M +:KA7Z:5;:6,I9'+HUN< R9GD#N\,^63'&FR209F<DPC-8'"AL\IX;-'L_6
M).EV]=!O^YSGVS</9_IDYO(<0Y'I1067EAE7V,/R,ATIVZ%-MT4'7NQR@XQT
M=,E\5G'QLY%77Q:VJ:4IO%:MC)K/^":5JK2S1/&/?"WV$%B^P91<:6HTIPFT
M$B"UN&603!!Q@6I8ZWIAT[5M*2+5W]/Y"Y3YLC;;?TZ9O*M>38A7C7B96M5N
M:SV@$AW/0+";4=5SD2A_/15Z'>Q2*7YB/*1U)0'I^:'/0@Y[M'D<6TY=B;U+
M?8)1J[YG)7'A0B>O2*QOO)SG]J++NOF Q=)?,;^%2'X)%U5L' R6@JPX"Q5\
MQ^;W0J7LJ7V]#<7ZIQ\)JV6\$'EST]>,J_/8^UCIBP>T9;=7_])?WDTF32#H
MZ_#UO;$WV8+A;_$][#U4L)4@YN)GH0@1*<M>)[1>^$E+RTCW@&\FT!+? H[,
M!AVOC9I\F<Y2#6W>>=]FWEV2*YDZ]]%"#CI'W;"$T.1"9,6/*86^XEO%RA.W
M<4_=L!FRZ8>H]_*HQ5F:.=M*BW2#[6P-62>[=!)#G:Z4.<C>NO[C+/5OC+\$
M@KO-L94C<'B/H9CV5_L.(XWPS03!1BF(,,U?^!K*G";$K2O$T&I*Q7O"\RP-
M[KJE284<E(@<O26UC*+FL/DX0)\T-9,MD4%D7FT@L057.("JPWEX:59<X')-
M]Y@_K$A@:J(BP36K!KB"[L["HD,ACRV)_$C<5)Z"BZSYQ@@'2!YQL0)N@/\\
M884NFP\GAI'S.$P2,-=V#%+1CFL9'A70>':E]&A1F/[OG2O@8I?^=S\>_?\P
M(2QPA!!D-$L,(PA.'PCD .V+1;D1!U#0*9 ;UH2)6!AH!+O1;!.;_V!=244"
M -?SM"43!J=<O6E]IH8>"$TB_]FZNBY-GF\]D%9*"R(V6Y1%*#)";\.9]U85
MOJ+9-]C??#6_MVGW4;XF;1=)17&NCI,"^;B=Z!=$ZCG,;V.6&;M]$</2>%_:
MH\U^07W*MI5B'V#'_:I-)/YR1FUN( 8U<Q-8NLR/\#= YR<:4D>T.,0I&4(:
MQ0L>^R P-V!$#/OJ>-Z[P;77OK<<*MV>OWANRZ/Z[%:G$74('P$V::"^1<,"
MF&X"N_FR9N@W,8'TRZ:'>8W9,V .T]NT+B29\"VLXS_X7KR"P'JU>(@-Q*9,
M.R"<YV]'=B>Z'^S;E;1OX78.C\9PJ2.ZVW?]HJ.5)/"?#:=$[ 3])NM9+JO:
M4'_"JQVU [.VLO,'GIO0O(E_CDK\W/AL\]:(GL%QNG=4P]/NR-WDB/V"]_=G
M#Z %X%2TYP">*9 R87DWPQ%RH*"9D@,45$LB2NR'!]^[@2H.((IMH7CZ27BX
M?,:JUM3OUM>;355.,UO[XV=RUG<T)>DBSR,(;DJ\A^$RNX/O15;YMF+&%2@;
MRZ@9ZW<T8GSFV;*^!A/:5?N#/7;65;6V><XS>%>[E^^?/2,+/CJ2_,0,6='!
M%(]F"\XQI-ACV0#4S;# ]WIH$6D/Z9LUF4$YV'2*\&)AN*_:P[23?>V,+!X%
M*PFY&Q("E[K-L;]0T&U?IKP>![!,&>, '$#\(,B^X)2+;R.6KS!W(,F(Y:=D
M$$;K)E-S%[(:E'D]\.TX!_"%!"A)V;L#GQN.'1]X^MB#?9TWH%M0@D^TX>T-
MQ4< 2WX+>=[B=]&V1TX?$E]IG=(:T5W[;-P\6= X:"3\,%88^]#[99K-;L?#
MW](.2]UHV*"_A;RIBY21I758,F]CGJ+N2:7LW,<T"]<8-2HVUGE]+&K\E*J@
M\@-%?M-+GSJ;<D1)=Y%R%E+P<B%T+?28XE!D/K:@1;[P2YT/\<647EL^*=W\
MP7'/1S<J-#.T9&ZD;?\:96/T!7>%58;RT1_K=JFFSK6O)(\+Q 4K= OJ4P9*
M2U:OU3C6C.DK&?+EUEB;!L8)BV?+Q>#@5L+_!=8/" L>F#$8N'* @9]Y%TR8
M"J09.&''9UQ9A2!&'QD96HR=H=\=-#<JZ+YF\A2#\#?.F'&HN, :G;%[S^48
M\?G]O6Z)P\@\5^GZ%U#!L4J:26SP4WL;^\$@K_<#Z\+",5G"C]V/JI9_NEN8
MI\6[5W6'I=1W]@Y6+7@9@\2=1/(S91A'(;?3-,7,6NGS=>&O7B?M^;G<9"+=
M:\<NH6"C:I^(7.FW*:]]NVS*]'I*IT$OMAY/4R5B2&.ETP7Q5XO5( W:ZADJ
MJKG[DX^.>F)NH'REI>*.L@-)33L^8$=O)"W(<%E;=,()F(OOD9?YF *9G,4Z
M34>)\CA!6F0'82BZ2;[]&6^(_/GB5_:^F@WQ'W_[@*18?/'<IY-V\@!+/;=A
MD8Z"!H(9Q]F=H##1+VS1F4SH(&Q?<Q!SX#TJ+#$U>O3&)X&+(G>]QC](_WU_
M0/]?H*^'#%P'&W#!:Q2"HQNPPINW+;WU]_Y>OD3\%O*! Y1J$I\4)_Q5(D88
M;\'.OXW?>6RA8@Z@3BH 1R>#8#C9,/H]^S\#LC4>MN !V$0D&C:Q#LU2JRGM
MV63!-1)U$NP4@&%[Z6HFK+V#"E=!*>*W% (T_9OP"FO+ =0>HII0GS;3$C1+
M9RLWR_YJWK\:.M^(X[7T 'C>T^PA4FU<%%N1/=PH275(LM!WP9D,:E!)D4S[
M@%I$<&YGJ()"I<2;\[_R:Y][=7X2__K@);?3XHG?F?0&5CV*3""6<8!E-3+K
M*+UQA*E")NZ TIO&TR"OCLV?SRSZ@XI+@G"L WO.2V/[LKX?N"USSO/ELNIE
M %=-.SW!%K6$=M.0KI 5+7 :]FTL!YO94G<WX^!4\FNLA636%XI!7')'ZB#R
MY"&=?%8"$Y;%_!N+I!I,U$78\J!1G"DZ@7O@[#YB,TMCJ?Y6GZ_&N,78O2%Y
MO?:=>2S?)V6EGU3YMO9,(\&F*OA<\0876G0KJ,#F"<2KT6H*I5]01'T]>B]^
M>)?EO+1<U'?>MOA)QCZI(IN+9B&9N*NW-4I8SXB!6SC;OC+.^*B$8,6D-"_?
MI)C:GYXV0L1-(1/:PU%_V G&-&4Y%S^TE:@_',4]H]N]J^>A)<"HV6*'J1P@
M8.NF\O(YAB43,V2AC8-51U0Y[@+DDDMJNI(Q)41]1?!22TZW$;+^F;P_4]WZ
MC,IEUIPIY4-MVYU#'<T.HQNGJ"NMB'@3^26V H31*ZFDL(+S$H).'-<5L@N[
M9BWF87T^E1;#=]^TU*Z(*(M%-J%W5'E-DY!8E-V(X:KRIRO!L,!];%<Z&92F
M=2'IF>+UPT@$C*SEFR5/WL#?$6R!MH* O2>',^X,FMB)O$C:+WKSE)HLHFYT
M%WDU"G%G!B0GRBM%PR6R0.M9=F*(X&[1E C3I9 U>V\ 2HRI_SHP\TW@]A?3
MHJ>GQ/C6;AP_TG#MJ<G]$-Y[^6K.]PTV1<F8NT2A1EFC 9PAY O'>/O3WJBU
M'ZZ&T@2_L7H?#J E@Y_\G#2G</]@5AP%MCX:E/$>F(/*J9DM%AKARC,]_>A6
M5]$/\Q69*5/'?*Q_341VD:F'-'EHB<UHZA]@$KJF@RG&H/=!W2^@(YL(278_
M!Y!=1\6CA&_9%=Y.^+YZO&*P<>Q5009Y_X=!SWE/$4#+7/^9<> /#*0YMXS*
MPX^BJ);V$A_17#]?C.!5<&"O.6I:7Q"[?]C;I#]P_P77Y!/#QQO7K#\K-YB(
M?-2U.(K1/E ZT O(\@"WN-\G"Y,+FDJ%(<8IJ'BZ]&ZV[$"#8^&KSTZM&0=%
M&TPV"A]<UVO>E6;YP-0'-MF,[@49^#),V9^)"-"WV&+MP@2$^+CI$'?Q_;F/
MCW2+*#6(Z %E7;;15U@T7H86F\;1K<AM)$C?[5U][(!C1(MYAHF>2-?+Z(?!
MLPX[K4(13#,2F< 2;32#*5W7'#-P$LZX9RARM@5W7PZD\,8M?XCFW.#_MO7E
MU#Y5U0E^AYLQ<H>^V(<1F;LV;9C,*5@7N3FE;@DX#O M?H%$/[2(VCP-S\*#
M9.\(5V'C,2!5[S7,>Y#'.0#A*8DI'#":&P$+O6F!?M3<=Q@SN<<K]7 Z!;:4
MIX7\V7.7;_=5I%Z;J+!=""S\*_<$_F$*U%_.KM',$0$AR[64W[]AF/U8D_?O
MURWT3  Z_K,3$1DH\FL/Q;)^E&^8<*%_B5Q*PO+#>%_=?=\NT%$G("'B49#\
MEO0K:#.$E3Q,VG2XB<X^QSHZ;<),TV'>9"%F,3+@MS)P_2?RM:.5U*;+[XB_
ML;(I%-4.L7T45H@\U1.);TJD,MMN:(J=/.NU-#R7LSG2-+3)!=?",[A=($JW
MY+P^.VW"Z3M;!^Q$HF@MJZ@_J.EL.TTP"DQ=\_W+,I^/?5I@F>^::!>2^G#?
M@4?=2N&?G7.)&3T+'__+3ZWPLNI!\A-".8$I&=TB[Q2WA2AWS]?-CL1ENY@;
ME+1.N?],58T1?DS@VRG;(>?G;;L[/!H7E+!1!Q'90BQ8?+V!8,SA3>EMT,B'
M6J9O?YAQD,,=9KA"!BWCWG]*WZZHKC]2832YU!%4=?&KM0GO@U\G>[DN<LVV
ML 7=IS%C1Y-]V8+1<-+V-PK6+H:^PLE2VR-G$DWC0B*+\P:,?( ;7D&'OAP6
M^W1G4V;)( ?.)ED+ ^:5 ;P6NPF]W4(6BZ"@(]2)5323&)P).<Q!%!O[Y<"E
ML+!$O:,.SB^>>G9Y8?;FJ4.';7;'HT1-6M'COFRA"K *).=Q *KK2B2Z,J6Y
M?B83TJ':S6Q/&&^;?;\HRLZGUYYR.?[5I$=NU_=M/0[5(/G9UIW3J)WL#@\+
MZMS2+.PP>9@MA8UN9ZO7UKFQSC1GZU>,K'^OK*T-S7_?4&?K_63WGO*<),D4
M7)XG4!R!J/^QU11C6"^(_J2Q.;H==&=KI\X?3)K:247%I05'!CN(+5R?L-']
M4]#9Z^M-W;LZ.^X)[W@Y XP$>URB(>F6D!R-,'/U"8TX8Q-9U2,S"859!IDT
MUZ'C#7^4ZJXY99P/JW^G_,CE/"58FE;U^.N;*V_SCWZ2Y5Y9FF2XX#\C:Q!1
MJE *0Q]W@SIRO\IYCT5/</CTY]-FD4'&!K-_O TY NU:OO8R:OM>R]=X8_PH
MLE)F:;9H'+HY$]*^S--2ESQ[-Y/F/S(2^LY-<^)*9HH\=Y^;BJ)12TR\@TAS
MHR(KB0-XPXP.UG[1<6QS;![=GOJA-!8O;T,UL8ZC^,2].*RWUC2CT#WTKN9L
M))"L)KVC:FD'[A7M<>3<M\];31?:A*72NV%B &FBNX/L$>AARGIAA!#U__55
M]/M$R[A]_KN!I4S4;=/^GX?/7C2XZKF_M5?@QW!,R0^\5I\NTW[ZN<^ XT"P
M@O//6ZPCS=,^4=]E3G7JWMBM_:/+4D20=X=5*/$N*H@TIM!!DHAK(O*Q>]G2
M@PTV:LMMCTH(_F]5A.OKK]FW5<'V%[[+WE7\_:B"8>I2T$+]293L=U8#7G/K
MTSNV^A,;]$#(G^)6:(L79.(&F0AJQ2^YA,[<'UGM1;TVO+K;O?8>T_<P5LP[
M&//1,:4")+\F5+;'4%78HD-*4M#%Z,-#;"&L1#-[%]6ZO(!K9_NC0O]TERY]
MY6L6+H2-:4)AZ"^)M/8(E.WKTH.L%+;A)+X?58%N7AE7VAPVU:#-M7R0:#W3
MM*.Y=:-FQ]<*KE&>W;+T4JN_WR82WKJ!QP$Z)8:(2V'#X-K+D3JGF'\!O7^K
M^;^ 9Z#G7TEHCFC"7QYWL?"#)RT$.VOG2703-W#^T&=\J-,/#%/*C6U//+G%
M'R=@JO@S<+6+^!JG#D.6%7@??,$LIJPP,Q#L#RWK\"1$.]3>O\WW+SDFFW@8
M14XG_+)<YP ,A7R8,+L%,$EMF-\J<VQ3O.]\MCC8Z8V@.ORR>)F;H//["KOH
MOWQ,YS>#_I0&+@U10V9(,>S][*%LZ;ZU9:DJP351'HK)/<_XM4FEGPO?M=0J
M&S+.3ES<8YZ(T9X>M5)IIYFI/);&Y 3$)>!TIE,4H:N,ID8CZFQL^<N C-+
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M_+=G3"6Y:!I+>0P3G/[6LW_+S#.L2N+EP$/&R#@#YHX:*JE5]$S+B6C;8?/
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M"RN%"FO8G-?))V9Y1E*N2?;U3W(=?7M,^C89<^KR\"KK;BPU>*L?^*L(RR]
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M>]Q<^!!Z\?%PW1$N"\F?BW,CY U2SRRS7\CU%Q,V<(!795"]DR+ R0'<1Y@
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M;N@VN3N.P<'>;PI*5/K+<[GG"O4L;;@&AY6IHG02*QGM^^ J X*GPHIB1^4
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M5_8P?\G_]_(_-]N$/ 1N\?/TG.R)-_Z<J9V?. _;7S-0I8DV%K&TUOZ<6O+
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M>57B)]R2!7J!S &^^@*K60DK7FQ%5PYPW(D#;(.S/^?]W;>'HL\*L!GH'^O
M_VP#13],8ZQT_MW5PHOH9@OF@PL17FS)K\@OCG =MKCBW7E,1:_ T'&G;CAU
M@;":BUNYQ &6#6 _?@$B;"V0%5#6I\T!"C4Y0":, URQ_]WW(P*#@_\]C62A
MWN(JK9CZ:K<+?3'46 YP%GWN@Y5T#T6T,BS[SOVI[D,>BDO3@7]J%7&EB^'
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MGSY!/ABS\-FR)LUYD\1YE4=G"FFREE+L-Y#@T>QW,.HQQ'HHRY5J5$ U!7.
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M#Y%=YI,_>W2/Y8/PB N>,;)ZV]]=GU_KE;   _>@)Q]B%A%,00YPXS&&Z0#
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MPRO$MIID%Y4#[&85O6W&QN4QZJ635][Y?9T?^1+#2D5)Z]V_3B7O:X8M$?D
M%!KBTT5_I@T1!VKDSUD1<?S($S3(GP5BXSF ]+9%!&S:; ,87S2=@7^?5GU?
MVDBYJC;Y>$':'EGNFOEUUF28'3($ZE($<YW<X=C'S-T@@6;5C-)KI$GAF$HN
MB<B+-(<V)R=ZX>IU%YN G8]4#-=W!7A>5+$6B\U0Z9"76L R%>0GQP5(, H#
MH@A(-4Q0KO,W<01'"US=2V[F[;[?8>BOM;.+,JX:7]:7FAY[1G/6M0=4P\[5
M4//(L5!BAR>W&O?$Z9L0HC/K2A^%AY,"XNHZGGGC@SI2PGTN%M<E?^PSKWPK
MV7&*2YAGV\6.R-U>9$/*::KPI$R\/H87>9#V)A6,=:O.FK*D-L;GN?OBJR@-
MN[Z5*I<]C_&+B3%-7HBC;]DD+2N53@P8:Z7KTU+F5@PIKGFH 3,11*SC@#7?
M?&*5R 5-$QLCLC\VP.3PD>;_K[UK_V>Z?_]S*(3F3,3D5$(Z.%1D**?<&I5S
MS'T[QW*KG#);B#%)1THQ)2GGV%IEC,T0:45.F]CF+N5&6VK>M8/ON\\_\/WA
M^_@^OK]\?[C>/[ZOQ^MU7=?SNIZO]_NZ7GN?R12ZMLNZL@>9(]7&P'U^"J],
MK-T AD!TF2QK$6Y($&83RQA(-4IL1HY1*9>@&'%:*2L1*@Q)^$CIKLSP<;['
MUBK[^@:WAEH%TS[3DTJ4E/Z^'$9-$"AIJ;<A+QL*@I2_1+7I"-<TL/$F1[]L
M7% WO;6_[!Q*[]2]N(LN<R!(<-K@_#\BPOMF=?EH^+/)BYSWSK'<GVE,*./Q
M:6JLSW=@(BBIV.Q.H,W[IKWMQ7>4&W3\Z95U/"I@HR#6&.M%JMI1+[N82)ZA
M=74+?W0=7Z1[O^>\*$_-LJ$\V#)KAW?(*##;YM>#W&[M@O%$4Z6J/P 8'P7G
M7)OKJ+^"Y,;C/DY:BVW/8>.;9Q+5AK-2TLY9OT/8G7MY1[W:/.1VHTH_GI#F
M7E9)Y5S&*KL8D,4&PX)I9BZQ^=<,4GV9E(6AW5WA%J1H[/@G.?:6UM6&S%/7
M=_L,*GR@\H_#]+"]3MWF&-I+9N$ZY R<I>GVUD5=?'@4567_G!+YS*:AQ\A@
M,*P_Y';7*]2U_=[Y/XO^#KQ5= B+IR8CIQJ%D:,NAF([P=RR*O>#+%+7HRX1
M"[7S"PY-M+?Y\XR^4])A+>LP7M3K@#]>/Y0]NW3 _F>)X';5.:G*\_:*D'6(
M3T*WVF=WA[N?=II,HN0SF7[WM:!^#[J<I,I8;HHJT"%TE^1_+]/XG$X6DN=(
M2+J3P>"NFLTWPOWJ9ZW;V@X%]$!:#^,A(AP'K 8[A"J2!R[.BX0.6"^,54&K
MMA!,E*58KUW87'$AXN$5![:IVZYWVH.'K\[Z=L]LG=\(PC2>0 KN(>1'VCX#
M,N93]&9\>+Y=%A%!,!4 >[AKPAZ^!+"C9^WK+NT[5LX=1!RXZD59_M")!VY(
M-R%K/E?__I@QA>T]F 97^:+#0L\' /F/LLK]K9&?DQZ$72+_=)6PBLU87;K9
M42J579P2A %F&,Z/A)<A== GN,OG^F>U@%9^*VTM:+);=;1^XHQ8V_Q22J)V
MP7)=.T4HB'3..$$WN>^5\,\;!^\AF1\5O6#1"UW:(_(Y-$+N0;"5N?4E+4MV
M7A/VAQS=!<TWURIS\K0T3LVPK;M1Q(11D\ZC#>I5AZ.N[J3FP3DUA':O/GB1
MD2[P)[<5?V(=D@S\\P8-W5C'K3K:;ZMAYC!Z:MB!<&B$DHIT;SOR+>NMTP!9
MWO'U"V =(OS=/W(V"2,C*8 G=<&$#:G\#D])K7/V?&DZC8[6B "LZ"^)GGI'
MEC7MDG8.%$=N.*=_L:'/@4]!]")9)X0?)9?6(8DI%PE/=<7:JYP,G#B5^P4=
MNQG'UQ26\:V;BM+NV(FJ#K+F DC)>BOFI,Y*C2FWU0Z9_5YW7.&!)!N7R: Q
MD,Q\C,O[I(./]0G5:Y3=O,4[=O\A-_ET^Y^_VXXX@%*** #;>PQ^YFONG)[T
MD!A%X2_0X5L2'*C0Y/-?RS"6;?KR&<,-/OOSEUAY&W\V<UEFF]4\(1 =A1^+
M5!,LYS:85@WFO<0Z8 )VJA\09/=+U1VD!_E-J%1.\_E0GX.^&UOT#NQY/CCE
M\%QF[!SJSQNN1KF@YNV2%GCB5S7I!)5D*]:\.S_7;QC.*RSE:_;[)'&81=7&
MM^+&]=^$WWU<4/6#EBLL/NGZT DMFOC;QQ]/B***M8:%VOD\BP)^_U<A?A35
M*@YH<+C#S7%?&5TTM KK"F*ADG\X%H5&^%&2O_'NW"8/;5RQ^O2572MT @)
M[:] P]A(1P_&+QERLC] 0\>=M9^<QA@+M"JK&"M/&Q![ERC=+[JJ9A/-0XPR
M5)\KOOGD_\+^3JN41F@'=1.D2H&<5U)+S!Q58P$P=C:LR\2_\=N1>91FN-E
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M8!S;:3K7 <='<"^.3[KR5PC:Y;=TR#R#D>.9-:6R)EEKUU]9!@;*!*>/0S9
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MF;X.ZX2C#T_KV*DP3NJ>G1WYW[G4\?_E_^7_4K#KT_\%4$L#!!0    ( ,6
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M8I*Z<?H*6=4>$R\.Q)G14BE?XK&\F(,SW0<P;C/^1*LQW:)OISHR)GS397F
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M2."AMZT/,(+8(_C6X+XW;!/V6Z2R,5(>?7'B1[@SR[//TSK8XKB28[63AXJ
MT#"4=V8C,"I).GW%%=)&K>.H2 4HN*=#<* Z?%/Y@[&*8-$FL2B[!9_N'1#K
MW;S87C>QS#ZH9/2GX(=CL?W&G"H^B7"1L(-I03/8^,MJ9R!S*DX6UZ=%?A7@
MW>QWT[-9;4^5#:X,&=?QYZ9.<M#=MBOM)O? -NK0Q@@7]N>A=E"=OHN;<XU,
M!7"K'Y_B0GVE0\3QXD((O$TVFCGU']\$/NY]NF"VS\A:IW_T!R;E=,>7B!P
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M4W7ZKVPCXHR2UWK[A5#0S+JM.6=B6-0&JS45T)"\XY'CAG34CYZ]YE*6ZV@
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M=U.":3=NH4,-/^K@BG=TW;5TSKHBM&W=GTX\D4%VVIUTNE4L5RJ]^.)GY-V
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M%-IY5&76??+WT?U&5[8;_2(8NZZG/1S5)#I+]==L966^5E3/!)$;=#VL*61
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MS0J)T A_GQ,M"T<:;EZNBC_4HF&5^NY9M&3T$TK\)B)79N_@Y$0*TZ$6Q71
MB7!7=]2@CU&6Y.LUW6&BZYJ$L1*R=WS'/M\7D"[SW'STC ?Q^L[4245>SQ&
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M%A\0EL:;\:[.*)EK</#S!]C[&D8K]Q7U;GZ)VS/@_J;08T-K^H. $QJ5^_G
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ME@=I&O,IN 38)G*L-NXJ$-(/XJE9U[5Q-<'YS%4($YGN W/FQ&@29,,'9DV
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MA3:O+/^69MNQL"__\C<&Y43+RG1U)_.4TRC% [Z"[9C!C_86=#X023G ,4S
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MBM*&2$]&<7:A9^I55-\,^LE=/*@[K=Y_:NG"]LNB%1E?!G7M 1PY!E/MOEC
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MD<?Y]O\(L>>X-;L=## [HFA;8.>J(B32":6?6/(_?T,Z:<81TL0N$NF8+5!
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M4>&#H7> )I^J:]05=DBI^^/X0T+$APQ+*4<MN_=N)UIV&R;S@*?$2O<E$6(
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M,A<ZOA1G3(GR3WB&B;$*L=O\+3=L*<66?WN$>%B/AM=KAY SF(G#A*D&))R
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MM6>3#UX_DWF9L998@5$>GV?D<U4:[)=%#:7;=E2Y?%?5>EP=6FY@=O1&J2?
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M,@L"3=H5T:WDA*MOV]825M,OY'?JG!\3SKX4HBU_8?OEW?3EG2,V G)N MQ
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ML&ZKH$;=.]JJ:UYFAMSRG;"4-?:T,I"#$7OMYY4TTL@[C@U0BRK9@%03+&P
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ME>.$R&3!KI,G AK''(.2><N_M'?V9#^-&W'F3%*=S 7\)DL#3].Y,5MH2L_
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MDTYM,T700[YU+2^VJ#RKZWY+1B6?##7=VFO>WQ,3XB3@,-&OV*'7@5MPL9,
M<$V84JI6!UZ0?0"=9J$+9CR=P#A>NM"BJOYFU$_^BI7>O.;(6=KEG==$:K.^
MC.HY 1A"+*K!8Z6498T]/F8ARMX'ULAR#8<N9:V[T7$UQ7/!AU_*O[3T)E3-
MD\0'172+/IS>DWT.=X'0E^]$=>,!MWC !<B21G!I"[VE @GZUM(7BW0PM:L^
M-("$'/4=*IBWBY)@RTQO<?0/V!HTZ6+[5:)"J8E#I2) +=/V4/@TB0S9:)!1
MQ.P$2RK8CG32.0RZ[?KX-ZOZAD]97P?6/%^6IIX8)F=1C!-IIZZ0U>RP,1)
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MW?3[IDY\P/V&*XW&#^@-U!Y:/Y3V)\%&NCIS!Q1SU6Q%^D8G(<&9^E:'A!?
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MK+R20HK^-09YG_R'U@_^1QY?7WLJ1CW<:S0N+G:LW95X_>GA13RY %[;0T-
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M%Y8EHF?N_034.IMS?-0X.:5[9]T]EUO9016G#+=+2V<81EDV/6VYPBZ"]$,
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M #HTU&RNZ9S??<$P9&+T0+< (U'E>:+'^1/)0R\RXMZ9:[AV&A*BX?5!KGB
M]48.IC%<6&EHY=,EQ]&;09P[_0)UY1,^5Z:06;&(?%@:T5V;OZ[,F>=<?+/_
M]LCF )^E0MH]1$^02+YMKS"]FTP"M[CB$D<EHQ," ]5#C^QR;,M\I9"J54E,
M"GO"W!FO=7O+FW=8;=E&?W?1.@[@2AQ,9,R!KI1/M*6B.DA8=U0O0XN>7+:^
M1@[$T46/=V6',*T>;Z\?N)O5^_9A1=2^4ZM"<JQI<MO]W6)*N>?&H@\(KN%=
M*]'R<D^MPKCI'ZY)^/UA<PO3A>"MV0)=?NVI+^IWE'KF#IDD,)%P$.U% ,_/
M#4YJV.4[EN\X<H4=W96\V317_[1E<^L:.WD3"O"),)#(YN>"UZR5%0.9JH=@
MW1&#ZG65*ZL\!WVT^ /O:0OLZUXT\SJ=: JC5I"--F**".M&+&S1)]G]3HJA
MM<22O.D[Y.$+3I5!R?8"/2\KO>8'L9>E [O#[7#HS<4MNV%SY\.2;V%I!U%7
M?"U!!<K"E"\MH,^Z>=T\4M .-=&WO(CJ\KA*Q/&0<:O(Q\:W&6_[ME)1_8GL
M5>[,(Y!Y+_8,/^DJO@07I1>89<@!!MB2KZ?F(J']N5,;?^( !P9]/9\=_*AT
M[([R;1%%[LD)Y5=85Y^K&"U0.'L$K5P#AMX#L^M3?XX$=2SI6[(6 I[F/EDM
M4S]&F5WPX#TV6W3ZS*U.LX04M^KQ(*D?LG&YTA';4HJ??\D!E*!R0G<: 60D
MLI_@WZ&2N[_'!W%-P.19';I=$4&<3'_/3C!#!?35H;ZX\OI/N6.+LU+>Z05[
MRBOOXE>\--$[JN(KS&,IY_W(D"R\D-3C:&[Q8E7=LKS_A?UCY$]$<J;4^Q94
MOPVUO=DG!E_B"XFV-L'>!J,#'>F\R%(GOV\D\?E9CRSV-3!&#T>_'"0YELQT
M-3TE#<SPN@@?5CMY!(Q[>1PQ18(5>AJ$46SY+.C/W,UN&Y%DI>@94$DXF(8(
MSR'70,8@/1>M5U.),TPJLIZT]I\?]2F9FAWDC]M^TL[?-%$N/S<==X_=C=D&
M:WHMII,#5+3@D"[8-SA&&$T=1OA5:&U:^)7[R,AJ(W)C;YFZZ//[_-EC=>LG
M.N2KS5VUE@>O2M!L_=CH/R+ NHXE5^H+@15D];6PG=*.85=!!B V%UPPP3=A
M!#LQZ\87Q1;#B .61[U>6A9L2-0ZLK9"_::LDHZ(<##RP(<?4Y.P[A('D.G$
M]FE"!;,#Q"/>Q-$!\\4Q;!+&X;LX'4\!NY$X>WY$A@,4^>(73;2#)E$K,%]>
M^GW,TKA\^LKPX57[]D);YUK_QT3V()9S@(:S["[DW!'XX>)<.$"S&P<([V'=
MQ7[(Y0#OI%HY0&Q?LN4>&3@ $"A@'N( ':8<X(5V"@=8E\V6MF'<X@!9\(<;
M'NIL32<[ R  #^T@3,..QT"= RCVHJ S.- +->#*CD:Q+1\0P39_%]C$L+0!
M8FD[2XP(9=MAZ:E(2AG6';^X%?O9\!$'&-5^=\."Y][_>\GN/&$58]TFG]_)
M>$]5>U\11,-/Q6PO'5U'E<%*?5)2Y.Z&W<T_"::%_4(DCU;%3*&C7\G5\;5(
M!)6LX-WF7\IE]*5(U8^B@7GD/\\8XI\G:_;%?T(RIU"F*KN+N!XCB_ZY T*,
MJDNS2@Y7FB:>\V&E><E,)\_N@IY+/6Q0U)/I^>080)R";Z>@2IE9?._/ 7(2
M+7A&2BT- +$_.3 >,%$X0G1."\0.W%]@#(*#L.M+HQ.F!LGBM+!D7*;]AQ'U
MZ-KRK$Y3QH<3G])8QZ\/CG=^%E9.29(_O[)'^R4;QJ[BW@CZ E4G5!]&(3P-
M18CD *4[XLCF4N,#A,AJ?@(XQL^4CCQRZ-38*EN3U9&\J4CM5:YA/_,(UJ31
M4QCG8?@)@. P*03OUVH+_Y/D")JCZ!)7**S-ZB$C*\&4>XV5^SZ(.(17U925
M/'8)F:6:&3LV;7>YGFWJ<6)?Q+XA4M,&(S;O5IHOXSFH0,:!"KBK;'%W$D(;
M%6DMX7P81)QTYB:$1[TJO72Q"X@<*,HHV:7:\G*+J6\L9NI1,":AXUMQT5<E
M$A[#7V.2%M?'&[^938U)]NX<&!M</]N\*\/D#/_&37Y7+8R0#2L*^_9=-2S'
M\1GD7,)99F\-WU>7?M_AN/1!@2;P?VR?S>M2^Q\X!# .WQ4H?@F'_@8_0@G%
MWZ'6$SU($5@ LP-2!@6HI%5@)0>P!JL*2.XC,C6O]73EA^-BRQ^J=&K/O3CG
M&79\A=R.G]]S6?8'6=><A;4%5K8Z@X\<X(0D;</3E*E N@-UNATW;]JF>_@A
M:'6G)?_XX-!@K9K>DTT:RNFT![/+[@0[V)F* Z>YWZ- 9<+T4]B#WNJN46IG
MKL;6[<,ZJ\M YCU:CDJ#]H\<12FE ]?*RZN6JS;E#I?>T^-*U8E*U;CE9F>B
MZ_$<IM8<H-P&$DYAG ;[*>97\+3#,Z "LA$'@ 5PW#>M)4'7B45S!P&FOM@=
M5BE'NKVWX%U31)/"; N,UR35JNP^2V+SGZ,+=C5)8K3+X4?AP[RA3_0Q)!@Z
ME2'05DL51N^,WK7&MK'9_ 6=U=G%,%A4>Q@U$&EVB"C4>K8JI ]NHB)!.9MI
M ;(R4MP/)F\E:<U(";WEO0$[DLHI9^RDK,XT-F7Q2QS$;;\!O7E3B[CSM^6Q
M>44L]XE%^N!%P:(&,F**RX5<R&,=),MT:,**Z,OV#PV-+^XN>49WL!^PKPOU
M]==LTMWP4C9DYWE*JEN8GRLD&LI@L1X7(7V$$-@Z9=@F<IV$:;$D83UU\C/(
MA2*$\%O&>Z(+;7)'N]%Z:F9USLUW=F>LGO'QQELI,Q_. D%, [0+K9U1Q<K"
M^A &3$>-&K#]HE3SB&HALL^519!VFZW<#:FSBI%1>L>NWU*CO'&-.E%<MF7G
M;?69N[[R\E''O)=*)&BVN/"E+>F0BV@C5AD;"5Y&"DQBN>=5G1M(DFB%NT/K
M#/(B+_8OU["W+[VI4B&B)W.8C7<[YISDO ?A:HG"8X6)WB0XSCG.BH!D8=0S
M967ET6KND-N,/PP0&K%7%Q'A;^-'Z]F('OGPG;DE-9KKU A>^EW>75%K#'9L
M6?40*$0%N=F/X:A!(NV--3+==ZJ[YOEM/WKZJ YI76C8'&$B%G__Q5Z>QUI<
M9[^_K(TK!46?5F!=0+X@JA;,;_DMOOQIK%\:7YFLS4@9S>:K:Z6_"P-'?\$1
M_5N_\*U\[MF![RGU>XIBP N8F$Q;8%VHAF?$I."%<@\'.(7Z_)./$+9/MYTE
MEQJL/_^G2]Y2D.0<4KGK-#]S\P1B]4D6GDC&[\*U/#5M8F^J*2XK[X2L5J;L
MB L4CTTTI-PM3\(&>E:0:SXP'AQZXJ/)/;%K%A>?L9U5J(>D$RGF$>SE:!':
M^RBT0,&DSG.Z0Z-]<XVJ6O5/;M>VEJ=VBK8U/)<U?@"<VI&_D4=C(\\S6#'G
M$: *BJ7\9%0(0MK#/$/V6,92<VHRMLZ\.HA^@0+S+/,X!,UP=R#%Z"ID,-JF
MU.I$9Q/HB,-]7G./S>H?C8V,#(F[R]M23-;=D#V8LX'B4<PJX@!G":"*3RC2
M(\Z9C)LR9ZY$(^D<(/0B!^ ?3ZUV4J/KQ LF[W?4?FGF_6**^]FC_I?&L3NZ
M_6*<_=H5R'!4Z<'F)^6C3])67F'N9=<1!:K%X>C^*+TFW6,41@_3EI@"IS?]
M>K4G3Z@)]LO-4GWYF$<,=Z)J,A&9W;#F6-!MHJNUR3ZK)_2UZ!E$UUQW*;,;
M%:EW\_*/JVRS=V@.>YML=$I<^)B$RF%@>5\KJ3BB-LB5ZCOM0>=A\Z70]S?H
MV!OFCA($[?SV4RY'W'/0TDE%A1;*>X1EO%N[,CJ0F>=1PAU,:U3MJ'\F;WE]
M*?_'2L2286TO,\*A%7R8:I@.[&KT!C)J]9#!O1'0MUE?HK)[\'B/[*G7SR_G
MMZZ_MJ=.+EJ$[_,+^:"FS;/O64D<P!4+*H^DT!>,Z!731.9%4+21S=.AZGW7
MG!?2H^T?-[^'JC9<:]9=9*HG_"#A^;L0KNNG3@G6!0MQP[-J\V!>0(=A 3+O
M^MW<1A<@3CM3GT$'2E8?5&LJ3T5@_%_MA2[,H-)195X1<?.X-_QLOGL$T/HG
M4H,7\Y1=8<,>WKB73IN0[GH_8_T8GN;,G+[IE1%,8<B7E8QTFXE!2!-/MKG6
M(?J1TCZ;>M%6%/4-N]_N6%2/$EY]?E(BSBW>6X)RL)2!>R>9L+'UW-I3V>9D
M!4@DCX$!S9C+03Q#D-[6U!Y[D129;5T%WJ&:OK$>F6D,*+]KZG16_NAF7AW/
MV9"$4[:;I&\EG@-F2:"JRT*X)Y8<C! O4G52G^H%S?*,3ACNN#9K+[<6LML.
MVKQ&T@X5" F/HVAFI/Z%0_209Y5EQ#H$G\&]!_TC:I+&92(KVW4KN/'HOA 0
MQ^9-9!Z$+K.2],27CMMAY>MO\[.Q!G4HTG%;A-9X#!RP,26 [XT[<^--!79-
M\%@*7-DR,C@M*=RF:_:VO#'XV4%6JX>'A[/'AJ2DTI\;5I_<%"['EY]Y0I$[
M&"!S[1&Q-H^OWG_?[VB]#ENV0T_9M\AQ8,_I4)-B%U'''4;/PAZW]W66Y6<*
M\<-,^R'8SP$,D:-$B _VG]0"43;O*#7]#.I*Y0T"N>JM*_WN_:FP%$5[KR;S
MRH1CS'N$[,EO4+C)?VJ!,_JU3:FW28P+]T]M3MC?=CAY6NY9"UO[[W\WX@+5
M\?B@,9*RIIH9 :9T$C4G?P2$1TQY7-+&3TMF#CGT/VVX[TA5?-:*S7JAR[ZT
MH/"K 'V-7Z505OY>^U99L0'PK]JW',0L_AN^V^VK+]_35AK*%N9O?XR-"E(^
M_P-<T'Z&=F5J.R/FM;?JU BE1XTN=MJ%V.&R@0/LFEV<Q[Y)81]V:"#-O_K$
M 4RV9 I58'^G^[)PJ<[\][HOWV0%;__=OLTOONFQWZPZ8[';_-Q)^1()V1<W
M8EE^!7\@8X%"P$3X--*--%C%, %5*4(#0@QAUFV"OM*$E&3,;;^N.L;U]JUI
M1@GUXX=&K*IX3V\?"DH/[TGTD2O2:)CB4^2>U23;0.*C;,&5K#P]"?U-F'82
MS43]JI-:!]2UNB] H65:T*?DD/Z<YL;NBCJE#*FMRRJO[;7PJ*+Y3B\5'B_2
MD2WJX4Y\+'@MR;<PZT$SVJ@#&)-K[U?27",#1KD6''?8YRJP7E=5_;1;IWNR
MHN,M/HT7SLA)Y3=$<EX%D7;0O/\);EJ9:0UYEX'J]!730@R;>(BK2/\6=7+.
M:9G*CNC.L\7+MK\=:CCGK?EIXZ23&8P^,4NUOVP2LOQ]8RMAM1^>L9>.C&$O
M?T U7XUYG:']NE!/&>LO!="?[TA]9+(RL]E VO71[/7+!5K&_19<BZ@?MY77
M^FL2M&<Q\;>9J._*$^[^BAG-V(/*7U_[W?KUK;\01_PA.)["N2,G;[&/<7WV
M^J[=30)3!'[V5K] ]I,1[+A<SSOQ+W.V>Q !WPJC_V5$V8*EV442R;D92J Z
MF12*I9EBI<9'UM'[XO1.,7:1HK01\I)FG;)=']^G&B3;OIT]_GR]X@;AG!7-
MPWECB%,VM]D=& %P^/Z'9"<]5EJU:9X]V-Y0J)(LA8P<2[H8%\"[['.OY)F-
M;8*LR([AS:77C*,'3\?=#;<0>DEX,\I>]82.8KC24R!U\U@B[3!A.>0/%E_0
M&)I B>AO9W=)2I4U#,5B9J7]T7JO&_<"!8\33M<VEC%L8FIV8^O,"B$KLI=L
M$[(XY0I:GK+;J*5R=TJ,GCE,[6+/>^@$!,6F&#\VU>E4W:_RR-]",XKW0%)\
MPT)*2\T6V$@;48(<P&6WH?DJ-@E!,R<-\%,,*SPOMY_/$*OH+55.?J7I>M_A
M^*J/*<A&X<!E7,^$(2V8D,34K,/T2-W "+-"8 /#<X!2]:9T[[=A(1=I<>77
MLP:+R=)/#X^16]QNM;QZ8=1-7B/4<5:Y#7N&M KMUS6G2XI$EO9%EO97NU(U
M18<_Z$L_3IK#"CD853U_6.J^K*Q!;<'=>]CJ_?6HP?4FJ[<'6'T=J'^9?%TX
M^-76 1"8^YL,Z.I?],[JLQ?JGLZOD4S^]W2R<'\9&=3,$T*(7USY?:#_U57<
M^VTZ-KG[.USP5]KO9/FEB71S+13^^5VN%UC:$2$<6Y<6$:\OBFE'"M0H@LS:
M%!E-^J&^# 6Z;S![K2,8S5"5>/5BS-U+55QK\MF*EUTQ%^6S+T<C-/;='##F
MZ;EA,X:$Q$79_ I49#!BM9XF4P)35TY: ]DQC2!CY9.4<+IO??JI7GC!'NI"
MK,L./UU\8S_9:OMN8%/%Q95;-UQ/EHC[/!,<$-&" !50D6@A^M$F(LT",8 =
M=<(3P$2SUS7*?BAJ19V0N'9,3?8N>X/ K.?Z-^6*$Z2?9#85?=;OD-ZE]#G#
M-E.H)U5IPZY%@:/FH4?+39)U;UK;]H[U4ZXI WO<WG)U//2WYKI"#C94.OO_
M8_+_%YIW=/P7) Y&JN9_3P_4EXI?G?55X)S//6/_9]W,+'Z R;!\3?3 AO=F
M"*=1C:+UA*D"_-9FJ+H179IUIFJ9&;>E;6Y$>]@MNPU.Z]Z'&Z?;R46['EFY
M7\@Z*UA?;ZE"%ENW ;,.TX22UCO*M(<.@>.CB#C4.LC14X7 ED?ONR4S]JK1
MBP,8E$:=W[A/G/O\X6XKQZ@D_0)Z ^,8>)T^,[H0# 52VP<$IM@(D+_Q-1@B
M%"%E$WY$LV!BS=[-@R:!Z$^:SZX-[7QL/!JO/;P^,/2&X.[*'];%^I?2_&FE
M^<$]L/]=6\F_84J+O^;.,X5:SW[/='P9/! 4"5_F\P%F[[_1*LN'V4@7O$+9
M+3+3.+*U3V6N;4?]<%Y-MS;_C7!^OQLN.0E&FRSWO$W8(QY'"QU5J"<,<%/>
M13010U!KM ABH+.5?]^AOCG=IL>E5;.N";RKCQ19&X@T;?YX9._@->.QA\2S
MA'"48(TJIMU)G89K$EHV+K.I"]%0T1D4:M]UJO*JL6KNLCT)6[EJG</7Q]Z6
M^FS#%DCG #=DEHX2>GBFC /D#1L&Z^> _<P3F)>HDN02#TI['$FZ5$AP0B=9
M!-64AW(<HWAF>SURTG/C-_",_;E/4$)>3Y-OYJ*J[W[ZX2A7JL_JR1VI\6GY
M RT7\B8D)/FU)+=5AILX7^>U,3RRZH3QQA#E3REL@1GZ/ >8/E>(Z2%6I.!J
MJWNKSS'WG961ZGKW6+JM(J(TS?1<7K\:9NI<[E!P?NV9H4:7*$+<&58U1A'&
M+3C"&5Q@>(#N5(<"$PPOA.Z&A&B/9M=%/\_ZD-K\X+71<A5!YVT'U)UVK,_>
M%59K&2S4W[X*,TA\I(.K41 *Q?"S[D"J]_SB30=CE!WUNXX92OI>)J?%N,&&
M9G-.;Z_#R_ =[K)O!GLNWPY(QWC"Y,\2Z1K'3S:"I._K*=/J5EXI@,1H"F'0
M7G*<\^%ENG'*UEU;2FXX'2"C2Y S#4CK3V\5Y.."&I@(R+V2E8,]30PCE>Z>
M?_"S^6A[1(!"9%[(IK"H&<]-3TYS/URY;_OT'IF8OT*8_V (\UOH>8X.ZKG8
MQD]&Q<ZG>UB$=';VU:=>K=#1T;@:+R?1*?*R)1CXZ#&* W<@K;JTD> F#E +
MEDX;\@YTMMN'CY^\L3U\;]'9Y=E<"P[+U\O\O'<&];-?0RV;#PS+1@B"S+I%
MIR=YMR3V.S]PIP_5.V(F/:\??'N:/!J=1_:Y2N2K6:O=A=8"7>$ 1##M=<C<
M!WLM";Q;?]49#K!5$C/<%OM>.GY7*@ MO2=6Q2U "!(M:$&6H::VT[L: [#A
M1(HT6)</&=%J[A0YY3[8%7%5V]3O@&3'\TU\]'K/D9^&1#;?2#JUL_VED\C2
MBXFA4ZQR)!E'*L<U.PK52[[VRV.D@"WW(!/0(<O1H=1&!X[7<AEMVGH57$D?
MLR5-UYS@,J&@*26H$N(:-A\D#5:IX9%-N*LUZ^BZXY(RF 3VYM=>,V8WJC&S
MLAHZR4."-CQ7QAVW :NY@G=Q[4'<1-$LVP>PAJR'6')(JD)P#??P_B+($.0
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M<Y7&]7]&.]F,TE87?=%7L^H5W&HK@1.&6V80WVOS?^&Y(CP ,AX#3CP/N$0
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M5\+P@).C7&UVX,N/QIFJ8#%%_N-Z2"IZ3T_]"8>JPC+$F6U6!KX)LKH.=74
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M=O9$QUV/"P^DK23D&FN\J_^RM_&>&.8T+< T<KJ-EVX7PUJ#U,=G'<J_UGF
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M[[W?6.ZCQF4LC7SM^CG]"Z]L%^>\(E)<[WE]N_]&,$V&OL966J]:)DKC WC
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M)?._[;+-]DZJ_/GJ/_3G_XK(9?XU//Q5%2)!_Z#3_(OX^+%.8'>#!8SIHR]
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M0YM@JEV]-KG9>21F3AFJW,O8,TW5"?HPGCQK:*@0(W,[^R:Z76VES.:)# L
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M4)7+/V/TJ[?IF]=B2RW^G^TWL"/(\:,"1^*@GVQY@"HZB0<T/211,N'/)<B
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M.(Z]8JPE.-GDNAMQK=KRXHGJEM<'=/KSNUPL-KOLJGA0P7R_Y/[ICK//,+-
M*U\3/+-*; QK_SLRW0$Q$M&(+/=JSNDOYZQ#1ARL2/0*5ITZ+^+F@T[&Y@QF
M*2T[^M&!3[?/AQVO%?O>=[Z1I A2;I#+U&<G'X -9TF^6D1Y^'E&A65:<7)D
MW')4C$,[(\*V&@;Z<Z+;U::]UI>8+2UFWOC";)BX19CV^(@I^==[<*$G,6W$
MX2)JSNSBT=CSJ5QA)-V6>KR20HS@ :)XA3I-:(X:)_S.UK-@6F*W3L>#")\+
MXA*.EA:C-1WZVJ4;/KJC(^_H+6AB$H@EP1'E>D-&W!6YT.=Q5/3N_B 062?;
M\ "_I??!H[WVLU?B'Y5'II=8O7:;V/'$YD@ST&Z&W,T=PM#W^2(NDTI)475;
MP 9C8T]J9SA1ABV=Z>+K)O^XIQ:3.^;HV^/4W*-L=*BT)OVP'O7GU7%G<[M5
M-U4_'#8/!NF[P9'IO?"BNPLVH&IU6'93*XEBT^<[[K;>IEXPV9"5IGHX]%;.
MAB_/WAU**VU66['%1NY4VRG3!M9^O!L=6X\<JFDC*1)6O;-S\JZ3HH??R3^Q
MV66KR$23_WMT^OW!Y5)GGM<#UDOJ9'A V '2\:)(8FD<6T*V*1DE,5\0:SI'
M140'(F0/^WSV=MAUTE]BF<ZMO+=KH_N\,(?2;,\#7;!<6WQ!Z1[N<F%6 -X
MNLT8:34UJJ0G-\<AAMX:IF_LX_;HW+V?%!RPS-W^4+24(*-$HXM@=SK==WX?
MR0BDQ&,^W.B$--"<FRA1'C!50B7]E,O_L9VY"D*PO(:((QBS+L*VZ?-!5=2Y
MX6O<@8;AL<J@ 2(]UKM2_+#+TV!WJ8DL"0LO_+0 [L/SI(?AKJ$#BZUNK5''
MD-$@?9<(-H)8R0-FU%G'V"<&C/>0I/1=A5K'1* 8QA*:2QFCI>[.Z=>W)JZ9
M;3;:QG\Q5*GVF&&L-2?RT:/*LLH+-57=&ID[/[2K"AZRVV2M'@K,8?0&H2U-
MW.4(1N?BR1_#2,HHW7?<[>%P9Y.1SX P#;%2&RM%6+6:--':;WCS9"K7^:G6
M*&)T;>DSOC%"/UBRG#O8-<5= D4PDEL5A$(+,Q+V.C>E"PY,=KTO;[^WRE*W
MJ/"VETQ7[K%5L==W?5AZ_6'L(39L@@*>D EK!_<%JFQ@UIRUC=2*DH6F*<@P
M8_?L(;9J?^WI@J>YKLYD:P^OOGE(UZ/=1NQ^28L_S<CA\"U1Z\EH5G)SM5"8
MJ0%^:^I/J<[5U2_QYCE9Z^Z,D\1=AJQ-:D.W/Q6<N%K\++K]DHKFT@F37<;<
M4XL_R<<#/!&28(,!2"D'Q4G'2$,LJFR4 2:4JP<I(YMWC!-7^FXBQXGZ)DRC
MW ]W.]H8SB495;YJP^=G7=AU1-0,9?L]NP,_>GP@#R<R#3A$'G#21&A7CZD!
MSM(G$"GZSOP '8P^Z[?36<R]J9*FZ'\?>\0S96Q/?H)TA>E+95=+K8]95*^9
MG$4.#GFRCDVEJ+.EFEI4-G(*41[AMZRSUX5E[:PD*#^^=BBAF^;6=?;6FD27
M\#79VX8"Y(V\-M[!K"<Y>6>((H2@I@:D)%Z>DT>O:0T*=L+'&SQ^S(W1/A 2
MWWBQ3-/A4/PF5-#TA^O\>B<8I"$8G!KH$<S]T$<::7CS>$XS2>45%$$EW%6&
MB;KT@,$CW<+RFEO=]M%6D2,7^>(Z_#+Y5];;K\H8P>SH,A,\ES,;P-+&"3%?
M0N+WN2] *;8--<2PB;#:/L9917( N:^JMG(RL+1#;O0UR6I'Z/2'BD,/39,M
M  +>!6PH(]-M+W VENF@J<@VHX[MNVIOEXT47:U.'&F7V7#,8_32Y5-6=PFA
M/DYNJ7>F@H;7Q1Z5+DQ+J][AXRMP5#5<S2X_.BLT P"4@;RW&0A-R)JE@)>$
M-%DV;'O.?;;8T=PV&N(J:9!,3]T;D*N?] %>6\/EA3F)XG(QXC5+6X-5?/MR
M?\ ^SW?/=F]N!N(I-HI80H3CJ/'DV9A[WD3Z0804KHU9QDE0.+KN>LJ*V.6C
M4!!SVP$;F]@+%MU'HO>>D8N^/NGYW&/VY]8K^'S.;CIXU5B<8=A '":*U'IY
M!>8\E70>(;\M:5$?4M)0W'G3TUI2];,_21/8Q"Q<T."?[/R7)MP"^)X)1ZU^
M]<].=EB7&=*4\'*Q]U!<! IIJ@F9T];%,@:HG4U^V 8GS6[]FQ"&EMP],U$R
M^FB'2:J53FV^<-O&2V9VULLNALA2L#-#]"8F0>%%%F4DQ)+EPM!YCE;19& B
MRZVQGUR/'T[TL*2^.78XV^?F->D1J1VW+".%A>I^X*;?7^.O\=?XKQPHWM#_
M 5!+ P04    " #%@)U8.MLM]%F_  !^\0  $@   &5W+3(P,C0P,S,Q7V<W
M+FIP9^R\=U137_LO>) .:NBA1P0%I E2E!8;342*2H>(@#0A7T0D2$B07D50
M0$$("(I(DZX8B704$2F"! 424! IB4HXFC;']\[,O3-W[KJ_N7/7_#'S;M:3
M!8OL?9YG/^WSV><DW(_<!4#LE+6=-<"S@P>X /T W U@][$ ],5 (!" !@]W
M%C@![.#Y._Z^[O@[^'C_OO+S\?'R"? +"/Q+!(6%(!$4$! 2%1(6^3N@WW:*
MBNS\^\??1?[3U!W\O+S\(H("@B+_MP?W%2 NM,.4]Q<OSUY@AS@/KS@/MP]
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M7TJ^V8OH$VK:QW@F;>M2TIR?>UPYPA>),F)!G2[1%;OK[SV<4#P<-X/?C3O
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M=6I<VL7B>B8 HJF-+(7?3#@K$.RFXF_.F8 M]&ZB/95]<NY[QQ1"9K/^Y(;
MY-&\\/,W#?LBRQ6<I0XD"&C-<@$_/*@>L[8)>62+-IK..D*3!?,W4-*K8ZOR
M&RU0518?>3+_B?A/G;-UT-V-'V,GI,\D#"V#M9^#RV&:['J\/RH1W]Z10M1:
MX (W74US^HN2B+&/0)*5CXE3V#6?,WU#X3-#@M=A^LVE,.G52>>CB$/82"C@
MSG"&44KXL#C4K+_35-<>C->@S3$'R3XX <:*CZL8I%H<D95N(S%5*]\DB5C:
M'#^^1VW-X1EJ-^1_",PWX;OG=V*]:$'=#'I1RJ_&'+AG%MAR>MS<Z7M8"/\?
MOI?M3SNB@R^[!-I^F%.3#,]4D^#+D<:U0]GE.0FMD(]HZ6IB_NM$>6'24A5[
M_#9%V_AU<">,L?7L_DS5L*FG0E/X\EW7<SL%6(M+VF>%M#GO230[U(P-XQ&[
MF"7'-,)&%/6;MB)VJW44439S5*;Y&].)9FHB&5*%T^^MTZY41=;H-A('LIFE
MTH,3=YP$ASI1+/$HAB=2R1*!&X?*Z-]#,#HAUU+!PV=VQ5*3;M.?8[49(/G8
MVL ^@G[0J63B3?J@:,;#GZJWAI;8;M27?&!MSY^B5($V_",N$.+N$,:N?.@=
M:^+:=5'JI]]MP8"LTC<?#U_8O?L 6XKG]Y8?5 >F<*\\SUWI?X1U!G]>;OGL
M$&703:]T.:8V/C0^K.7W/"9O9B97^ZW=:[7I290P\D+C3-K"]AH6Z6>A2@$_
M<!3L'J'<5TU-TC<\M[8T-O<7AA4^*^#$!N3;55U9VN!+%-KC_Q'BFWP@="F^
M=5"?QAS$B8%)5+0\9GJP"+];NZH5#!',C=[J2NMI,C\N$Q;H7GG(<>D&G-R0
MO:UBHG%','XNFNF&[Y8D!2)F]1;7E]?WT;.HJ/X5EGUTM4TUQ)R$MON&7YJ2
MWXP<M&H5/W%#RFKP[AO+GRU'7A]I? HU_2*2/QY4LUDK8HIA7O3-68!G'V-^
MNDZQSE,VU\S87@.^IL3)C? UT=^YNUJ;#\;]LR%^MT)0W_H8_[$G* BJ+-PB
M\.+@H"XZN9@+0-BV8[",I^S*#ZP%>(.N&W_"[JK.B[4?&B<+XR[BMEJ;S0UV
M9HCW'D2Z08 ZD.F->STO0@I'S.3V(YM1_=4?PLTUJ>O&9DJVX!4NL.:F?S)_
M\(!0E<CQA#&- ^=J=<_?J=G#0(CBE, XBF"OWF[L?MJ=HMR'&-3QEG'#@4G=
M.>K"[.SQ6P.!!:]#$!=UER/<E\H<(L:.\DLY_UO^+?^6_XFB&#-(RNF28Y=R
MI,,0<*P/95Y\M5W>Z'['H8_@V=X.^=*U6L5P%>&=(GW8Q[B@ PF+V@9:M]@W
MN,#E1EZ(PQ]#!I"$<=-0H\;J/%GIA&47,AP..4R;D]KZI5]N]9<;I-_+\\CF
M9]0>5&BZG3T=3:\2 (]0/_C=PA["W\)_GSL%+G-VE7*!.\I802[P]%(;%ZC^
M;)U@N=8H 4XPKV)-P$!ZQQEV(9:'HA-%U>MWL#_#&;,4H%TY.O[-\QI$5H)#
MW> 2@^CJV8@]6J<X 554V2_HPI>\B\O]X<@%FU<D>>P_'^J*OTYWETE,MLV6
M1%^6\V]MRZ?<4IX1SP.GE] LB;-])-I91"J)=IH+R$,FN70ILF3 ,(A4*+"\
MIMM0Z<J'\5*8?+812=)CUEY;_Z.G4#BKUC!5=A_34/M'PZ4]0MVB1Q$U>"52
MZ"8?[C6BQ;B::<_Y\'6V5\9T7W/7P^IO<'0-\?9KC<RY\8_I#\)*,DH?6!U-
M6L8&/)[W#H(P/;HIC-[1C0=((>@$WSW@V0:LP]/GS\&K9$:M?QSZR0A:?MBR
M5+LPOY.\*BPI;)[ZZ68%ZWE 0""B%$5SQL\.=N-I+J/ W_/Y+E7LH59B$\VF
MOY&,M^FBRZ3$[=%#QU2CK,)TLOLNV$IX1)Q3!"C.K^1D&;F@J6J?9UHO88;
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M46437WW /?Z9IT[ZGT]U/. J2M@2G4_)6RB+VAKL1B=ERO-CDUM4$?;)II*
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M6)?LMR,/PW=A(584.<WK0O[THT\U$R[V>2Y/SOTVOA&%G T]E'GHW#JI=YQ
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MU=!R9$R!PP!3)SC,Q/A>44C6$9*6\X/3T'VWOP6_X20$6"R9H,*4(3,NH.2
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MBLBT7E+TUWX4O@4"[46.-(B#_-5@(.C33%76$_ V#9ZS$:SX@G$Q\\'BT/W
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M>\)>*3#RX_UKRE]'*S;)J8DJB]G%W]D@D!!A%WVXM[!J9G?2YHS54A%+;U0
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M$KQE3,M2E.Z^7J>;'<Z$@<:F'#E#JA*]BVT!YM*P;4S5?GLYYFQ/H^!:KX8
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ME76E?!Z96I#7NIH9D)[E^IN^O:UDQ2!@KU9,@Z2F]EXZY;*=1LX Q$9+??E
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MJI+^WTL'*^9#@G;M7!:51_/.'KDK\,>1;(.+>8^@:<5]2F]^S;#J/8)GIZL
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M7G4VO3D:@E#AW OMD&B5THPV\>J#\:'7WFRO&/&O+G\E;/Z2'NR+<IN/F]Q
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MN^_';_L=&H@M1\$YTB2>4VG-.LAOMF$=5*X=;SORWTEH'I;\ /?-'(#SNB;
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MSVP4:6S%*BR,;UJ,,PX0\+^A8>+X+"M@=->[[#4A"3WF=YYH#UL,V^7()[:
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M+F]OE& <;ZC#A[UW1$;?(S>A##B[ @[!DL@\P6MIA!J+-&^Z=.PKE8P^!>M
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M$N15V[<@B62%6B-M22M_QC.JC>'^32?WH!&?ZCI7U4L#87>B[3R1VIRQ%ET
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MR+>1F9%_ND?F7_K33/[[R.JE\;%L",S1_HH%\P1G&"D&UV2=H:^U$Y*1D 5
MOX%BE'I*.61RU+YZXE!3[%>;,L,']L?;F/7G>N71[Y0<DAL(E__S<O/_=^AO
M>!)9Z+01FD:D$&! ;MCT)3J>I3E8@T,%-$@3?3BMY*_AU34K7Q92/WU)H?@J
M\$$PB6:1MEN0W2-;D)?C6Y"LA2U(\/!?CH<$G+C^;7$+DJ'\$O=I',')='=I
M<>%AGL3LWH+$\E#R*@5P[?;L"L83IS7L*$-;\>:WY[9YH2VX\07#M=&TB*5_
M^Y>JB&9K'JG8T?"[[F5IUD2?:\%N'6%U*1G&^\IXEAQ=D2-XC:L$-*[MQ/C!
M==@%DUR/E%"A HRY7#E<-:9WHD(/QA?@P\>\X.HZ$<%OQ7/=MLTK1<-[]B9V
M.7??S8,1$0E9EG,.K](:1:"\>^XE;0S"L.\1U;Y=J%7$1;" J8TY25<>R!2Y
MM1@JRWW&#>W] R=:+XVHY*H<>QFU,[85(G)!8 [/$I_F""[0T8Q^[F\D."/(
MU^9/Z%I;D,L 7T^7;< DXRH]/B'G<<@IC?/-,;3N>?UNJ>Z(,L\--9+Q<DS!
M/LF?9-:>/,;7(58X\S#HPI!A/]\'RLVNM06*D=NO:(.W::'N'M9^-SRE& T,
M>B/_=\' $16=KL;0[W-EBHB9N_KZ;MZ/3M[,\Y5\5]=L(_FN>>\#RW1S22<+
M(0@$<@+BHD@/8MQBY\,1;7P-/?BH&6%Z[=T"J6&PJ9V1F]%^G/#HLCDS?"$)
MPJ* :Z4@LH<(W#5HM1GD6]*7'<N781/T$C F6MDZEY^H.X1$)=[R5'U_7?4"
M#X6@Z[DFLLX%TZOI *P3!EQ&D!;:$8 C4C8LM..*\E 63(0E,=JBC#3Q+VZC
M\C!BFVP4@YV5(S[E#M"NA'[,T-=)H&#+65K@80!%N9O D0$U@.P..'34XSZ<
M0 WD)]M%_R&RTS-:TJJGS@?CP/X#X5.9YC:.3X3K8P?W\]/C"HJUONAO0;K@
M8C5CJK4RJGN-Z4;F.E:_+.>&!"CX-GP*3!1'R277\E=QO=Q9L*$4103LH(DX
MR>XB*CKQ81AV:=/Z^.GG\[80Y.R'W+;O9K4NQ\\L].C>K8Z=7O#X8POB_P,/
M'MZ"K)C1[![ ]B#\D *8VR,AE?%$4=W:MW3IM!]Y+^9'O/[H.M+O&7A++K!K
MY)"IFU(O_Q(O;Y,DTI,>WTZ.0^YIWJO:@8!A3@[5#8KV[S31CO^9>D@N3SKU
M6)6(V.&4EY2K@:VM73[N7)P 687#/F%4ZD 8!6S6*+*9]\?*X#N<RTJFB!\-
MS&XJKL\BC-9?0@=FBJ/@Y]BQN.MK$JR+H"B*Z1R6S&@""=0U"<RM)C0,K#D/
M:">N2)]O:!Q33'U:E_"NL*BK(L-UBG^F-?FT!7^++U=-SX+D5AQ@@P,UD#UD
M4%&?2+<6;%:F)2_C%%@P@M/8-3'ALN0PTL;YR&C'RSH2&ON<^CXU\;$IDK\'
M*5L0GC -ZO<T8R,*5&#QWOY\97^^-'Q)3^"NN\S^:CWAS.C,E#]=#,.9Q[']
MO],JM-Z]P ZV[,K_'1'W)I^!%G*MK;;N;RST/397==WJ^AT[W1W3?\G,V3%'
M;CB?4QI K@Y-U0Q^[*GN3S]'M8 [ANZU4J56R<''?_DC:TAI3SS+%C<63Q85
M!DU[G!WZ?$;]JU=JM+.#48P@;\3D FS5@LF+.0>>HLE5!%'GHR,J03=761O7
M\NO'+[L>-%R?-Y-K0?[ZML,!HNI_HO(S1I%FW"1@_LHU(?=!D598_4I1<&8J
M\UNNQ\T5[-Y9 5&?2Z0?0>=TY6?WK5LIA\KICY6_A?OD+7H'+9"&@.*<4M25
MPZ/!@3*NE5H_=UVK=93/\6A_=6K=3"6':B>!NO?'<#!:E/QE1HJDJ7ECQLKJ
M!^GIGQQ)AN^*(G,72&B'<T=]DEYFS93LRE[3U12Z(>/@<"+_VK#0_?62&=%>
MDB//[QZQVRKN'8TWEB=SYVN^IO[,_)8Q\V6F%Y8.#(K,8RQRVF-WP=U?^;M;
MOJIX5QF8M4KP&C:39-W ^<=N;T5_3 1"%I)8L.=8KHVJR7I"B[S7_HE JND(
M'6D+/ZEU@U(S9KHAZ?G1?[Y;YBWT6-"8RZ)O-%:,)0\HC,T<X,9X@QTGCY!2
MK@Y&/O.K9_3?B1<Q,+84OM\V1W"+[R+OP/)C3D_D=6*-06WJ*;1]V/C^+8@+
M\+7BX\>71U]>,3UR6H$_K&)0.,RNO85_Z"G0$--\O.3;;^]7:S7^)(\,][;=
M\UK3GBE\EVN.R^^V$1\;$IBSZ.0&",BJ[!5NK,4W =(+<&W.+7O!,RQ)^JP%
M,-$$)-/L\,TP_H*2::N2Q?1/5R[IKG<<:/A0R51OL9;N>2(#KV3:@@L,/KH=
M2\R$T0ZF,_DQ8@ TSI@'!]0XOLZC2=_':*(*7,$.)W>CVK#98V>DIQT$<M4R
M9K7P>IUTU7[Q[VQA\!G7-FU!NMD[C _32ZAV<<W(HIX3N:<,NF0E6Y[=K(XZ
M?5O^6]^^G>'=X24!6Q ![-ZP^^WZ,.C/M=A\^9:AX'>$J5SE^7BT9E%QIUJ^
MXY%815)YGWYTE*6\+ 2TMHN#'V67$2F37WBHVJW"Z67@_<OL#%T;!97)<W\8
MS7BT/9\6/.+BOP5Q6Q/)^FIG<;U$?L*%)5[#$:YA"H8M,X3 VU1;]Y[7A.2W
M!K&U6Q#A&8Q8W/!@@C;K#$K(+=G(_6QC2)9?FQ5NO+LRQPVA94MXUB($AE.@
M<6\OYZIV$'C\?O,]FN0/O_'#5D?#,M_A9?'9=/68+B=SRP&)W>W5P;@I;JR-
MB&]1GL'X#\$%0?.>[I,Q.F2P>K#C;E5 J/H7TVR;?8_;O@O+#PE\C5]%TVT8
M*'8R@M)(JNQ$;O=IP0E?P1P!EX%,DQH GV;L1/7[^42C@S3_AY?5"J;WJ:<0
M(G=E0 )7T>"[PT8GXC-Y+X*2-Z/'?L@UO5N01"1@MQ9#$*TE"KEB%"8",79T
MS]89\9J1\I"\M97E>GW!VZ+-N$"F<<1^*X-:O\ECS[-P1RTV89V$6*0P1P>\
M8L?#0H+HIV&59KEF&1ZPSEQCZ8E7RW\>2PKQ4O*BI'<'2(''@/!F/A10VB(1
MY@=>Z52K!J:&*CAM-R4RGFDRPOUCK/;9I^1"6 _IZ(1F.!GP<31 3M_U402<
M^X:L&+&DF_RE$ECGH,W-U*9[W_<M>UBP)(@]+4( K@T&JH3V0"7 2KM1ED(!
MRP>P':B@)3?5V@BKR5D[B]L8&BGB XRDKTOP7K>$Y++U$#4&*S/!Z4]A4YMM
ML&O2_!177/MAW[G$I%6=&^N,[R0(-_"Z7MD/F%#>]43C.X3Q#^#2F1WFUXX!
M&]^DNCO?RX7A#I1D-]T2?=(X>,J/AX(FE7"$PH'L3@+@@(LC5M<W,2V_X80X
M>\ \RM?-%&BW]]C5T2(Z"N=WJMJO7O9=JZ!WP.*-3=L@'D%5I_CW64?IO:HY
MN#8IXTBFY@SV$ZP!W9K0[*HWD$?#)>SU\">IE 7A;I<NG91F>'TXM2S\9/+.
M6:<H QW?"#OI@7[=B"W(16,D<)^JW2GWY-!F#U&XV:BBG\K$(TYGNPP?: S4
MO[QCWCUGSQ_N0G"O-LH]%QFF#4813(X$$+00\DHH++99E1[1E;\OGVQ*C^5D
M)3?97Q*Y6^-A)7]C/1S#ZRO&V_IKW\Y"'OHDPYY=@//$;7? L$(10!4E[@='
MZ'WX7M";)FIRH6HDA"R_;#[:?5(U3G7\ZQLI:6<Q=;=WR^:NV!'5O9W5E=^]
M/@E'-+"D5)#1L!H/P@J"Z;.(@^I6)N&J-]N:V!8=^9I) Q/0/?[+SY?</%X]
MN?8B/?'0&TN^)IW>]SKA ;O\I4_AVZ"\&-_,5I) &PY/  )+8D/L)/QES\EB
MBVA?;#HY>\:"(\T=4Q3)-A%WO)JO'3_\>--$]U?0&\LIU94MR*</C+, 8:6+
M>1P:9= B!GQTELTJ*UNZ5Q);*XJX&5ORQ'H=51J\?$+I M^?5VXGGC'=+=&8
M=NJK!$\;T6LM%0F8V^%AM?$/;FYO_$/P8'>#'=WZSJ$&O^-3,7S [[Z)V;9<
M3]) ?G!#LE]EX)'UDVX5KW[D3(3G^5L655[FQ@$U+"CX;+M5C1Y<GR4*:LI7
M@R6=.&B(<*#4@!1ILSIADYUN=^[CRZ$4BL\52YE*).B^73NE]8L46I0E 5I1
M\0*+D]+\$<E083_]WQBQOC =G=,)Y>35O;F+WW@VT Q/=@/1Y]]F\\W1@"OJ
M=)\\_R J(NHX".UN$7^7XTFLF]34+1Z%G8MP9E/RP].=U:S7'MKMNQ J! R2
M-BFAJ3A/!'B\'1F%W/\=5X.YZ$\)5$#K?C&_D#G]928L;>;G#:&JWBR)O ]J
MQ_'*35JHGXE<($B<&K!+XIG%$" 8L1E=Z)NP9M#YXU)T50J[[,-&4-KQMW68
M("";BNS<"""+<2-/7*?Y>\2GM*:",Z&,2&;HRH9]_4U28_?Q6M^G3T4&IP8O
M#[-LF7!0KA.^?UQS[08: RON]P]'J648%J N];U]38F!VB,%N9#W#L:*NBK'
M&&!'!X9$WAF9<&$741Z+T:@7'NU5\FX\9= KNS ^%BKY&TJIC,^'@*BBWN<8
M0T ?_]35]I9O[J#IZ*':Q*_J+[T.B[TXXN3HE4(]O:)AT(W<R1'$F(WW), /
ML!2 5TW8@Y=B&374953I@ZL9XI@7_;5BMXY'9YZ&\6&G.$K SVR6/)XI[^]R
M[VNABRTPV+W,"->2@'M59W^0LQK\Z/E0N]2\^Q9J0?M3QVPE2QS%,&:7X_QA
MGX@<H56@C$J,9X5PG4E3YWX=P#>M135,?80&$P-QCF\,CNI<&>1A]87J3UR%
MYMK?H;\76.Y:6"$SC0-.5B__CF]%\@UBXW0::L+<AHOY]83^"-J_]D@]>G#'
M:05U9"*Q9K,5F>J2BWU&SZ3@'QB[WRZT1%H3.F=DZX@1*DIBP[KTJI0YGL<]
MUA!6-5<U^_J91@%$X#1:BF6R[1-\;:6IF^U36%40YSSDT@$7PULTC/^@OYPR
M)0U7)^U*.:P;E3 U&?RZ4&Q.T,GEIP5EH<?N/KG6X &T$Q:-$]/%2X&8+WJU
M)SG180W.!CKJI;=%VWT,V[,^]<OIE)5U6P:'>*P&=6 5Z/#[052DV#<IM[3L
M\)L3F[F!/U_:HHU-KW;3WZCW6?!9=A\.AD*_P26&-3%ZU$"Q0=O1\JN7;M2R
MX5,'8V;T]CF:GI:4V!T%X<)D 6[P(L7&(WSLIJ<9"W5@"-<PNW<2>1$!Z'B<
MR$H(<2?F+)!5,_>%[#<9^O:!#\DF\!LZ\%D^R3E#S\N;Z?:UODD#\W.[%\H=
M=FW+=@*^RBK\ ';T0MCYM:YZ9)TK:/8"$XCO6 QYKI*'OM..E+6X\?+UX-=>
M7GKWV7);8^NO]SK)94AQ[LN#3BW,!I<ANKD 4(0>\?R0!EC Q7_10K%):L>[
M/Q\./7!7Z],2RMT1]  &W0%!T+Z"BUDJC8],^/O-R+X=.9AII[^<6A7YY%'/
MZZO7[E*NWNZ"8$W#.F9]5] 4**A=LM)!A[;AZA[,&(UHP>7"7G4X@<GE8=T>
M 627\<*H<N>LAEVV>><'^F)Z[!R=LKS,8J^8.6\BHN$J -<* L%V/0IB"G>'
M*Z49/D,T_;);Q;:+$6A%K<\+!Y52$Y9X[@]-DB=P BUB_NO?Q"]A-($Y*-6R
M$-^^MCOQ9HF%E81&1:D@)TWF-*]%[1Z(GL,@ PN*EH0]#9NU Y6I^_2*F@QL
MRDVH34YOQ;..>&^81FQF6&G^.;>@NP,<WX+PUK&?$BF/R-79,<;AW$,V5_D:
M,6J@"]4NF3L1,*&5RM^;Z!:MSD$-23\^E"VN'6RVZ:WX/&#]6=+11_G9NMNI
M/DOD"X0_,AH!G*LD;5!<6BNG?+N)(@1&Y&MZ=U4EBECSJH;R@@K4S2>_<.N7
MS]J8/OVPLWZ4//TY\K7[^^BTG:_=HYJP&W3RRD] F):=5#NH@#D/*G!#S[W+
M]PX+F$^$K(F09CPN[>F*CG/U]$WFS=!/[^V_ B8"\51$UZI>,#H9(6)L1$O6
MM3"MI4LE\JT$5#:$">L<W5'_RB*RX!17%2VX@F' 6&9P&(SQ$*1SCSCL2JSN
M-,MSE"/Z9!?H/KNO:L_,C%DD;PW.A_S0/7+,4O&.3+[9AF!H2(8.G%..B$>*
MP&59,* 6S@_: !LF0'WBC8\3OQ'QP7_<"+Q^Y$[7]5@GB<Q)GMS/_W\7M_Y%
M_Z)_T;_HORE!MZ;^!U!+ P04    " #%@)U8(<1[AB6T  "<[   $@   &5W
M+3(P,C0P,S,Q7V<Y+FIP9^R\=U13W]LO>) J17I'(DU FB)%:;'11*2H5"$B
MT@6^B$B0D"A(;X(" DI F@@8.@HQD8XBHH @("5!!9% HA*.I,WQ?6?FWEES
MUUWOW/N;^>/.NUD["U:R]WF>\WSV\WP^^^S ^<19 L1.V]C; %R[N(!+T _
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MD$.I11[V^J5O;$[:;U+I,:,WVHLEX_,F+)SYIE,Y0/!F#@?H@#&58JBOPCB
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MINP]YB",YC2($'_V.U+T-55MH 27MH&W)X^DC/^F[3K3^$]=]*&441Y,_(A
M;83=.WLZ(AD+D02(D';R,\6]2;[)M-J^$I-ZJJT3Z%\1)F%C[-E0,<X!6J^^
M'QXU;LA[+?F*=B;_UJNO5]S>V>%T6?46EB08#.)50\264C"SSQDQ.T2U[>]*
M+GA6[X_=CYSYDG)2*4E'/;R]2.V:6>+!-P( PY3NS'KY5]O/Y8_X$ECWT1:K
MA,/*LB\=G,1Z:O\TC]6^873$-;U-5ZU?3\!UAEU-J*(<^8W9^YUM\!$O71_B
M"]!$.O*>7?S^R[IJ;?H&(B3C#>ENVDIPK$&)>%KXG5MS_]CQ&_]A,8[.S*YB
MJ=%.%-&P*N]J_$WB^B:IGF*OXOSXVU?]R\D!J(1OXLP7%LL9+-ERT3>X.8B1
MDF@.]!/@"E5RF0.LRS/.H8(^LO7!TN6SQ95@ZVD:IM_\I>_80(E1NN[LHP%*
M0^J;##F5.]T/\H]</GG'&J..^[[2#]N]9G64FK"=;(13#K.2+Z$;Z(;Y*IN0
M?WZ6?)WV^:11J-WP9^>\AW5N0.ZH$W@DFBXRWB9Z>[:6*1U&OP&V+N,$4-?!
MX\9E%:1LUXG!V&V3SCR'!![#D)$@BQ9KP=??F,W>CW5Q:?,^".[?8SW3)>Q*
MTEX=9YKOP\*;53M7)4+=\AXVR(HH%(M=0PK;,;6XES@ :%(_A)4DJ&%Z3#=0
MMK0D\@WB\EX4RIUF^7(E#>7XU#XN+N:K[WW7G\,.ROS<Y:N DONJ"/H&%-0F
M[,]L'0[ T"V#=,M$IOMJVO5 K6="!@O 3RWN(G FA.;M KH\^X[@;O?>:S[0
MV2$25K[6]7"7A]',5]5#2)KR?C&^PW&>RD%%K6HW;+]L,Z5+V;N_TG38NU,9
M^FL8ZGGXC!"=#:Y$T1Q([W UOF :R!@:7^M0/I0"\9-QA_C2$W5BO"LV'GFG
MXL\/BDED89LO_)S.QFM40\;9LP\$RXP_G4<)@F'DX?:X#8%YT5R\;8"*"<UZ
M%F+*,;]\S[I]V]#Z&+T7G^(L"DFAQ"KT-$:& Y#\V"/8)M&^1[$7J$[IQ! #
MV2>TCKK'OA9F.9FD.3F_%Q_U*+5G+-O['SMIZ,L*9^07](4'O -_+7^"5DHA
MANJ*FQEZQ0&$C"U=%TD&%-'8)Z#!@)78I'%WZ5RX.2+]4L+A\VVRAN8GC<8.
M=3[4.3!<X5-0Y?QQ"#+:N6TN',86LO[W#;G&\"W%^$W^B\C2_C*1(K?V1U<Z
M,ET)S<'KE;^D"O1T\&_*E;[-IX:V0[FRG5J&HQ6Q!2%-PK,-:I $RI;/=X)S
M<<LZPR3Y@R&SII\B5@IHV^>?MB0BU2]=H1U3;F8X8'K4C.%S8P,$33"3X8R>
MQLKBX;'[*Z,CJ1#!$K&XMN-61 H3**YL?^'A?]'']XS4Q5'=N:8 L2<7TB3O
M0=ENFQG)>L+60P^R#U%AE(#E'[GR4''9C39"II+8CY;KQT?A:>O7)W95?\[I
M+RY]FQ^,[W4X>"<B\)^WZ#16+=L(^4UG&*J<N3-/-V:=,M":$R4.8=])OQI1
M*K7F1I'/$ 8GGIS,C+]VTN==F<><PD5'T4+455"/AJ ?A8(5-<]^C:$Z..W*
ME4#^.CZN2VDP>H'W#ZH-'>6E+&=2_#:>$6\4M5YF7RD[=<54Y8'MOJS^8U8N
MT, E]B0'V$M0"24*;J)W(=F,8^ %4N1L?:^OV/26I3Z)C)'[D1VKXS-GJRKF
MF)W>^5-]K=7G]0$E137B5@F1'XIQ P>0^[NQ927/N@\IJ,W$LL/0O$;?%P50
M:DN+L_P]0SV!$_3D\?;F)XMSK"JO[UE-<SK]01HC/L,>.MI!P@ACA@_#"CFQ
MS-_OE'13-MO*BBGIE&IUD-@1.VTA"4NOF'(_?==NK3GSD[@:5DM\^\ MT^4G
M1EP%M")Z!PO+WH6L/4.5[<<HO2&H3>D&$B8L#"J"B[H(]5$ANW=Y5[<TI83E
MJNSFJOG);%??]6K*-XD1QQY45F,](I(:KV_.QO9$,4T\U3,0<HMAS5XS)PT/
MN2?:/*C(^>=57?*K>Q;AKP=06\LP::8)39,IH]./EF'EX[EKQVC;#J!.0"W3
M#DPFLVPV'&7[K/86,B@FA<W?/]AE/_%UT/8\K3.G.BC5_LK_:^?((O5,H_*:
M**B1RY3*["7LQW=.EDTL+PX*A16KM8CU'1:1F?')W_M6U<8\[<S=%X-.7@"C
MOA].]8#RT7[1.Z4]#N3(.8>>0DVR=/7+Z62KB1A5UN,%4D:/T0NGWW9?]E'B
M<_4\M/?=W6/91]X>Q"0C +QH%$USV2#7:'%/<.&$M=#B6O0=]Q+WW5*'< N%
MGDI/U>WDYQ\<J%,79-X!4ZES)%8N4[Y<9JBGY,K^7Z0]N?7S;6YVC9;@9*/'
MQ1?<>OH7;'Z]DQ)>XO+-I=U;WE-=!RU.3RCF#XD"5@9K06RQ;FQR5U':]8))
M&$N! PS8GD)>RG=<U+W7WXUZC [(__'UST-G;BMM9@"H38ME[[%C%6X9W+&"
MTXQ'J=38K*%,O 'YJ'&FMM'K"9O2]7%,0.AEDV8)6_5D'Y7L *X<C\2P+7>/
MYY/A1IGUC;"SWMW/&Q]1PA7\Y$J.53V5/2IT[W;9S"CZ!GOVIE5N."0W]K$'
M%E0RG9(--MA*('V6O+Y/PD'*ZRI.*:"KX)QNU9Y!FRWC'=-CL")X9RI3_!<Y
MAKA.7,;.!6ZR!4UIST;HR=2BY$B\5]F!"8M8RYK;O%^KN^>M'H77E'M0VM;5
M^C-VQ[@JV]S?="^E0X!/;&!/< !1S%(2C \>XH!I_8Y0(EAZ(2-["4J3V1E_
M;NP\>Y)U]DF3?Z3)^Y$HA>5+^78I@LS:-<1L_=DB.ITX!?=#<*U%VRZ=+S-'
MY+!UFN\_S525L:6.-F1.;6P8UE][@_G0J'XI2J__R!]_]IXS5$SJ;^*,[=+?
M1V+<)R]9Z% UZ8741]N9X48OL4$?K@]O>Y,^'KEC,^&UOY=/)F#UT%T1(JC-
MU0%9:L T!NT984P)&C%3__J\*%F_@#26_1YY;R"VZRXM)1F-DQY@?7I1T!<J
M?K9Y5+HW.<! _<H?QY:7#/IS:/CU'_#.E?[N+58Y/)B81E $HRN]CH>38+PH
M0QJJQ SQV>BR0_8YYQ+I7YIWS=/\;F'U-3I##HX>G?FUS=QK7;[& 20AS)1:
M*;/*+&3Y9_&V-(=E1(K%85*FUN"W%_@2SP!KYZ-J8OE.?HA(% I<X7^%$ JQ
MDJ"B$Q>T:(MIG2%L;BHJUNIB5^/;8%,'HP?PH-;DTZ^CKAWWN ?PYY$SCHEF
M$I?29FLIEE0'>C6K[N_%8+)61Y!)Y-0D B^8U$>A;@X2]+O#'MF8^W@->O?4
M.OT3]V! ]B[\4^1A+I<\64@6)$*>]IBR59#<](O3Q/#<%$P'8K".&!*N>1X2
M5-IUJVCC[HRA\Q_U#2H2+65&;&Q-:%XOBBLS>%Q9PF/P30?6*$.)/4J09>4S
M8;$DA!BX,'81S*3Q^Q!H0;E,ZWT>FC299NU<RKD^KLNOPW8]T".GR8CUWJW3
M2 ^DB8)Z!DQ)'9(LI8=A#&:2T>TTQ4$K2=IB7^.N7_W*7#2;O.5')V8G;"?U
M]+Z4'/6:>,<XD.BL\[:YH>>:F[7J+:LL6M#0F C[+;RE'Z[, <)%]WY7ENVD
MKJ0T/+-(:'PT^&Z*5JCU]9/88</VOG5K9P<99RYU]\@EC"+2B8Q(;,.DL7=-
M4]K#A?H5? C5C]<*([L41^R7/?V*%;O,#)LL>Z1_+3(E.W[T0^I)DRF!(RE7
M,,)!M;,TM\IE3(K9E07#<>:%*NL8OB;U9/G %YW%9R("CBN]K8YZ\1-8$JW\
M[2-K0UW(#B$M[OEN,J60D-QV8TI&QEG7>>Y$AK1:MA3OJ0M<)VX! -<QF>#'
M&8#6_T<]U;FCA-X;;QY^(LQ>(SG?O#OFI+KN<:Y)NX;D5)<7GM>.\D0AC)E0
MI4MT0XG\?883BI%%SV#VH \P;3G G4VR\ =XSF8[7*PG.O)9PU5!6^-N[S]1
M3Y-G":<'/]0=2.;"U3PI%]AH#(]LO-+RLB,G.#"KZOV;VP636=+[J,>5Q,*^
MB@I@>A0Q@;!47PD:K"<W95&,H(&,)1ED&CS3AZ1?XHYMYAU?I0<7]TX?/"6\
M_^?X[&7OMYV=+S)D]ZR="Y/&-:R6BY9AKL+!_9'K%$8X4K('*XC66BO3^H#7
MIG* \RV33$W2&&]H\W>W#MF.8-KLV;+SWCTIIEII<C:5<L=LPA90YE7SP5[2
M-=GQ9*%Y-^]@&=/)&'%9[#^VM-=?5?<O+X8^H=>W.?-GLN>(34&OG.88)';2
M$BPG'>?5F6SA'D)&"(:QI:8#)HPM%<]W?%9]T?D\\YLMU^?8P9/"AO4&TC11
M]N[C# NF-5A![2:SMOMA:1U>TSTI+^Z1!@9P&7=J'9]W"=%'ZKR^:?ONQ!?Z
M_'*X/F&4-7HOT3K!W!I ,2"&T7,4+1&VV+%0 +$[GDGV?B2%K;;:)?Z^[4?U
M1TKA&TN5ZCB$D\GC3S8?#MM]:>:[>+?WV)L&BTIZ!G3[N-$0_VRSI1@_04_5
MF_;# )#8+X*5<Z#V#1U>O0MF/8PT#1/3-+B-[_\@>S10(]V?/BK%E40EDE+[
MH-'$/6V(.T1!O'9(!3*RK^NZFX)^WN72R^V=V2>>"G\IX]>U#U3/MU>?OL>>
M@5'/+L[\H)-HMM! &-.KBQ:81T:D*#2.;B>A7)8P,O/!706YLRYJ7<D1>L4^
M_L5JV8@0D3M_/*]%;TPZ\X]NPZ@.F[=JZ3@JCE)<!2X/*41FX45),=3I9)DA
M[SL>WV>UA/>4Z97QV:NIS!GL_V._[T]I@5U1+Y;JB$@N$V UH!#0>D0LP_H=
M(M,6S-Y/V-+V-\6$'54I>Z-AG:C1'G^2!^U>)&]S2J3@J-[+[019:P"IN0[1
M1YYU$-+I/'^::":I5,E!7Z/2TS0T,1H75N*>'O.1F.+CAC%X]](->2==+6WR
MH+O _.E\+F5;ACVF9Q<'N$2</4DO)K :2S!I5ERTPN< +7RQEP,H.3VV)>O?
M)DPU[[JV)$(1SWZ8_=9!8HAR4XN[EVV&Z3&!7UZ<U:$?ZV E6VF@Q":JP9":
MF;F>BM5"5PO1*KS@*5.9">U?:H]B33=C91(V8,B\OFNPIEBFA";][W&)A+!\
ML(]4V+T\)O/C1XU)4?6/10D40K\YJO+[VS>C 5<:)'3L/*KB[P3+X]N%^[6D
MM_9*<:73U'H0U&;F[J=($?RYIZMU]5[&;;-EJ;I1\WV*_[#/O59\>EC?_<;\
M&[F" Z\._OE!0C E8NEH4(\A$<H!J$X&J3!QMDH(!Q#<*C6?T_[M1/D1MS_E
MW>]WTQW-%U\VEQRI#4N7?Q7^BC5X[!UL35"+^^NF.(3=_1 M7I1!]\DL4L\Z
MQI/A_=ILR=G9D_[*Z:R7$:WM609*=V?:WW=(ROGG:UPRW8!?;SXF%LZ\!#EY
M!3V*@6&",'SL=XNRFC03G&Q?:;T#,77AL,+T#.HD::3>N3X\*BPA(J]E1.&Q
M_C<1XN5BTZ9YQ$F78\JFU"3Z?C"..D:N@BOC@Y8W92$]2RE,VS&YMRR:II#\
M<N!=4>WPVL^YV8$PWI?MQ ?#*?:NXKK=8O9JR<Y'B8DPJB,N&=NZ2.&FP>@5
M8!0MGBR%-@);[G* WH0Z1.A4K/C:M1[A/"_'+Y85&9J=$LUI-AF5BIZ>0BH[
MJAG GS%Z(.3!)?0[;,N[))IYSX+P%-.G,1@NUV[I< Y,KP#KO1U&$KS8+!-?
MGWM?=?->Z\;9"*S=@747N.(1*<2E=$0+[ [F2G8D??\'5 #M""C9;S+B7^>%
M .GQKZ<=['W/CU.^/'=G['V0-_/V!EEUA>5_A$QX]?B6E3<X Z&Y@(7%!&-F
M-/O@S?P#V'2,>(Q!JJ^DM_KX[R?,XSR2+9ZJ&B4.T=(MHP=>B85__J/).U+@
M^M(I$P*T#W<_5N'WYJS3"58501L9.32EO+N36K6@\7XKP8(#!']O^OSY\^-Y
MS\\SC@$6B0YU=GGEG_'A!QQDMKNTN,<P@6,SJ23;];JE1R=[,(+K^B-A!%4\
MC3]]ZY';^F?$CY*!N=07Q*[[M[\YJ@@>$<QXDI:1EE'YB/6">"EW)HDM>(AJ
MAIEAT.M!E/&HR+/Q7TYE0H6=^ D#<4_7;[/7_SR^R^<W[^E94'#_;D(^=)MS
MZ=K0;79&OX,U)=3@GC U:-A^D>@!LXZLZVG,N.5-Z4=A[A-7#>7#K\Z2#_/B
M#ZSEQX7MF0Y>-N07*/=@E6*6BA;Y., 57*JO%>A#-2!O]B?HG ;O-2Z$^6HR
M;(B1,>:AL6BO>=\!W:FWU-$#-N(9=\OWOI'N[6)I0[FYFSK'%N  ##FF)2ME
M"PYJBG" U':<%&KO) \QB%J;T>X2S2KY>=%RXF5CKZJ3)*OB;4]G?NZ;\)&@
ML1@XN$]T/8X,%5%?&7 OS7_9:<A)$1G=8Z7:^A&O&4#.S33-QUS)/)^GTM[Y
M\P[ZS&EUP(SW$4]PG:'^U\@76N6B4#6(P()JN>N0&.'EF\"KP0<;-0?,8M/Q
M_((])'B:E1S-9X"8INO''UL8&6#X\M7\KV^1AY)D B[YC-S@ *U$IF0GW9M5
M2@QB8>C_4%>2-BUL*\#!H]-#L0MF'S6FC$6EY"O$[*:W37G:_MP1Z*5F5 H^
M/>R[##FNZ0])_BWV@ F,"V7+T!Z"K+^*%8J9$9I!F3T':Z/WYU9\(P6ION-S
M/?3"2;(XL<A07V-N'X-_"=.#X4:/P03;G))@(ICVE&32#X&&MN=;1#'?T"+Q
M'H4[ITQE\T=T#CP!M*]J 5H EX^/%!=YP9R5CC^TS %FPXZQ&MIAV1@Q/8L+
M)!]#QAGJEYOHNN!"&1/3;"$?;Z' ]N"OGEX+NT:UX@X+7SGRZ?G:)B;0(%$A
MEV+LQ_#S1<I\9*M\)PAC>SO*5(X:[B_0>W.Q3>Y[_Q.[B'+[?>^4,C:?E(L^
MP&.@!50':M TZ>_><X!(#B#&] 'SB5)X@YK7-6"83]LTI3+5L3GJB$GS;$+1
M^J:,?B"/O6+A8J'N*X7,(035#C-C.H1IWVADA%K5+5,D!WRUQRD-%G&UX+FA
MHA*W8O)JXP>UM% W>@,VF$O-6DO>/^:BV<' ^2UI*2[:2B)$W5,QS?"^R)EM
MLNAZ#_7;KZ&;FDE6^T/=[X%%]JVTZUEYLSXFW]M^&.?)ZX;[)$;*_%#*3ZOT
M5,]S.;:-FUFA7P03&$?9[W:"UMLK0KN&TO"*CU='*D-N8K+T50G!1NVW+SGL
M6O J+O>8#I;8#&\XW^S\E' /"NM1JCE;Y >TH.+08U@9T7Y8*A5U' +H#<N8
MF'I8LD)J[L8W:O:S\I;=:L\5HO:=&5YKJ#=_4_Z82=0::D990P.O,57!8D8@
M,IK^<XJ@#FXLDD7O&+VX3A3^[!%F\CW ST\KRKBI(^Q&SJE[;Q-&]\6J9QW\
M5(J^#:4M#-6)*8DEP6[#PWTBZ<QQMCKR&R:M3/W#.>OI" /CS!LMW1-J5X+7
M1Y]TB@\IR%6J5 KM/Y__I;MP"PX)%SZ4-N,D<R]$($65UA0&:O+("?H.0@R<
MZ ])#]_^'*O?IF)-R,]*8L=[5H_S)$U]. 8[RI2#[ UB:H(^ :1YG:%%12L=
MIGL+-?FWZ8)L$]B\7&P<EF"U(?E 7_AT7N/;9C$%S><2#SQTAIH+/.+'LE#P
M>#).Q >,/TN+J*UPC)&S_G@=HTDY*/+JGGS943$)KHOWU?G4_6[YU4(TPVE=
M$T(4"!I#KQO4O=N]N)E? P0#C#!B+5;AWBI:?<J5?007%!#R3,(F[4S#US@?
MAJ']W/-O^,HE2!(M]F&$($@T(L2($=@[T>#FV19:;HK!5;0:5C*T15$DUBVN
MP6JP)*$AX]F^MHSQ[UF4^_NW)/BT6IXFE%H#4=@VTQY14?8X@L_B./7P $&;
M)I-=C2SLGUF+)4A-P9P(#'/Q;[9[>T4^I#J[9"S=#Y27QV6$8Y9F8:#F0$XZ
M+.4J01T5D^J8\C&\8H(,CCQIV"W@\UA%SOP$KYP@WZ$!])T/QY2=:-QT#58I
M>S_[;0E\/9.,Y5KI02M-_)Z+%)[S]+6/C'Y,>*@F8VI2)%Z0OT#FEKJ:7\G'
M&S>L+H?>@X:DO A:"N7UDE5AO"F-+!K"B&T:&7V0'5PX0DPA_QP[[6G1XW^U
MD-H7&2Y^;P5S0"/N@<[I<6E7RYL9 !A)QC$5_S!DF0%@#QF3LV *MM)Z\ YD
MUJF%'YU3,)G-QE,;?)/'\L(OY!CU1Y4KND@=N,6G,\<!_#"@9NSZ)A21+>I8
M&O,H50[,WT!(KWU84]AHA;*R^.C3Q<_X?QI<;((>;/S\<%+Z[*WA%;!^/KA<
M5)O5B/%')&(Z.I/Q.DL<(,?-+'N@* D?5P,2K7U,G<-N^)SM'PZ?&>:_*7JH
MY9&H]-JDRS'88504!+BS[!'$7DQ8/&+.WWF*L _I/61[W%&R7Q8KRDR(KQ@B
M6QZ5DVXG,M0JWR0)6MF>.+%/?=WQ.6(/%'^(S#=C>A:%4=[4H!XZK2CY-RY;
MUBL3;#TS;N'\(RR$=X?G94=39TSP5=< NX\+ZI+A&>H2/-G2Z YH=7E-0C/D
MPUH)S8Q_VU%>FK120YVX1](U>1W<)4K?>OYPIFK$S$NQ.7SE@=MY83[F\A?=
M<P*Z[/=$JCUBQI9>PRIARC.,41%% V9ML#WJG46DS6R5:5Y<&MY<73!=JG#Z
MO4WJM:JH.GT<?C"+\4AZ:.*^,_]P%X(I'DWW@N^U@J''H33Z=Q.,ALVU4O3T
MF5NUTJ;9#F1;;UZ1?&)CZ!!!.^A<.O$F;4@HO?J7VMWA+RQW\DL>L+YWIRB%
MKQU3PP%"/!S#6)75%^-,W0B7I7[YW>._DOGHS:<CE_;L.<"2XOJSY0?E@2GT
M*Z_SUP9J4"[@KZNM\X[1ACVT2M?CZN/#XR,Z?B]B\V9F<G7?VK]6GYY$[(9?
MPLVD+FVOH^!^EFHD\"-;T;X&X;%F9IJVX;6UI;6YOS"L\'D!.^Y*OGW5M2\;
M/(D"^_P_07J3!X0NQ4,!#U$90V@Q,(D<J8"<'BK"[-&M:@-#^'-CM@BIO<T6
M)V3" CPJ#SM]N2T[^RQK6\54ZSY_PD(,PQW3(TD,@,T9+%-6*!JT3#)B8)7I
M$%-K6PLI)X'M_I&79K-O1@]:MXF?O"UE/?3@C=6OUJ.OC^*:H*)?1/3'@.JV
MZT4,,61W_X(E>.X)\I?;%/,":7/=G.4]Z&N&G]P(7Q?ZDRO2UG(P_I\-\0<5
M_(=LCO,>?XJ J,K272PW6A;4C[Q3P@$@;MLY5,95=NTGRA*\3=-/.&E_7:][
M_:?6J<+XR^BMMA8+0^%T\;Z#<'>(4 <P+J)?+PH2PV$SN0/P%L1 [<=P"VTR
MQ<1\KQUXC0.LNQ\ZE3]T0*!*\,2M#UH'SM?K7[A?MX\.$T+O!>-)_'T&>U#[
MJ?>+<JN1B!.MXT:#D_H+Y*6YN1-W!P,*7H? +NNO1'A\*7.,^'",5\KE/_N_
MNJ/F&(J0&'.RXD5_QK2M#'* F:&E%&Q"#.P58UYUS(WFT*6HYQO_L?NSWK$_
M)4=*/DR\A>L6"Q>?.1S,GK(Z1(L<=%+R1/<B>)DG8VO6RM0FW)W!4G*VOK_2
M@@RUN_O4POFD![C-&8WV#C41A>J/P]\^7F![_<UW2)U>!$2+E]J(G1R@;Y$+
M>6/"[OUOG<AD$P6K C^!'"%S#Y1YM)+S8&7R!>L+W$U27%O\6<3()YM6ED@B
M/9)58L43MBAMX4!==FS'@VG7?=S>#$Y8YW]5< BW<(H]H+O]L[_&^O8_&=VH
MF<NZY70X-SP</C-!3V05J;*:49++PXTHP:X+\W3<DS![NKV12PC>M^]F[BB^
M@R)5?Z!S_E#^;CE-TB)H_,/[(UJ=/<8!VH*&L')G)L#<04Q[;(9^>V;Z683J
M0D^AVJIT]3WN<I';MQ%86%OL($*)J?=W7QC3XTH0!F5VXGWX%NDO9*;"N,4Z
M\D*]9KP_G6NIU'@8)?V]X^2/8[!F,QA3NO(59<F)E_T!(<;>A>SNA?,25'^8
ME$3>06N'M<[JVE)R6WKI.Z,!AS]Y^G3T"/_DSC53,SP&4_OA!8JRA8Y3?_1V
MV3(51VDZI)495?;H>[9XB/@GZ[;PDT$:][R7F_H&Y&''$6<P/6:H!#(F8Y'J
MA+N-D+((C]'=&4MC[T$&G?^X\C#_Y_S%$+?Q-^M.ZD4W+'Z- O$:4FY..?B3
M3Y'G>DW9:A\L=&*?^<P>NY)DWQP@Z6-B.YS\?&QZ_);Q$QS$0E*:_JI+&_@R
MD2G8P0'(]8V@!N/8* W78SOH%=O7>*)?@TF_YS42*]6HE&<RQ7LW[R&=<DPY
MUQH2#+T.]1S@?44\!TC0@U'SUSC ;RU?#K#H<$Q1R@W.5.\BL@1EB=OC'SC
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MOE^R?9I*!#6)S#Q+;_;0RR .<-H1B*_^C_!M?Q#&/B[! :;7%W>DK[K!;W.
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M"0!_[556U@"M*_V_$[QC,_T12"'!P@@WX I !3.;OEA7TQ9O.-,SVR5WRX9
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MU:6#UJ$Q77_55AKV^X[2CPPUBC%_Z4>=\[M>U/PW_C\'0EW_C*_F"(#&_9R
M@J"<-KN 7%N?RZUWI&Y D2\?W&CR_^M \0XYZ="<>1@HI,MW$(39@ISG:5P-
M.HV9J%OUL'!?Q.AMWR]/^ECOIE]K-2CB=)>6= +U[04ST3WP'2A?.IP92,>T
M$)2:TG26GC28>>;H?$L*4$FZUN6[Y52%F(J7V\V)9-P!R,Q1B@DXC*O2P"DR
M &/1&DUE*;9E](MRX"?:KYY->HG6Z-PML-5P%XXXJ9BL.X9,_9P21VE4B@&1
MV0&YZ $'C(RI="'*A&$7J6,JAF N 6=_T4Y_M&QJF-XE1? (6'.X]4+G'1XR
M,W\5'L8#'A<!648.1; =_,2&S$&: _%O3A;#YZ%[1O/?9MB.) N$6B1<*?DA
M,-!3UCDE:]_9\O;* 1':4WO!W]"]&Z"*E<A%(GWL>^L!>$=P2!$0>VZ\JI"F
MTQ EQV229Y/VQ*5\;<UXXO4ZI8I/7664& ;9:7J<W!V C"+L5JW&=2IIO'0?
MS1PZJ6)H6)8J58<2;1:7T%BTN1Z<W*M?[_!ATN2-!O\7'64F'X#+GY^1 V0F
MF^),1<C8!%^&,/&:]%#&&BV5XOS>GXK\NG5W2/;Y$J,,['Y^OMIJ_'CE/Y(J
M\)3;.\G,1= %VZ3HP,T%#^<M @6]$1SJKU+6/ZY0_VE-_/]CX#?(GYA"4RQ/
MX2-]C)PB8TSU5YTNCN7>4N>[J?QM;3Q/:_;T7\?7"$XN2H@*B\'Q-3C3\<V8
MB6@,!;N3Z+WENT-=LH;OY6\S5F>(]?&3)^I;)I9_<)?'_<Q!P;.+N?3Q3N+6
M#9 G1I MS_@^?V\&L&D;>W!HQEOZO+7DY_L#*C8'=UM$&/J^V/^3CT/-5'[+
MP]0V_9,5]L J)?:[K/X49.OQ5\")'J%K>8]Z[XW+/1F*.%;@?G!B'^WFFF_W
MD8]:@W.O=D*ZG!QH6P,982T/TMH($L"]X18IPNW-%[Z>'2G^\O![WR ?@ND
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MO];#6[DWL+=BZQ)]]K?)IZ'O[>0X,85@VBS@+7Q:JV<8QU 7J+O+B?C8B*\
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MD-FQ3^H73_#>O&D/5ZIPETTO%K?G:R/4-:P@.$XF#FACP"QH'.SMO!I*#>U
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MRA+N;#SU9?;K0,\CPV'P_:Z5FAM[KM5>ELOV:*\P6;= ]SIW$]YB5PZ1,7N
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M* F064"=.<FQW7EK.^C\]KR49I(F:FS?FN)VU 4P AJ6+KX:B!L)1,T":'@
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M3C"Q/>(U4#3YD#75LSILQF'$X%'1'.TFA^E,NI<<%7=W)SG^PJG7>#JA:-V
MX$;\/%_*;_L<+V[S<JXL.M5*1%J"\NQYN5P]-^4?9BD17LKC! :!KSHT13[$
M/HMA$DAE@!(:!V)@<L$PAD;>E3JA)9J_,[#F4!=*:7D$+9/@CPV;H,/GX)O
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M$WJ8#*7M *"'[P4L^661,$4AS((DA@A3:;CPD,,PCEF2,D+C,+:+J7**T_<
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M(8. .'@I8C?:5#<C@V3L7(\,>__$4,$/KYTJE*JV2.WH)"CV Q01Z*=4ZM>
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MRM>Q(3IV1,\Z81)T_1W#;LJ,0+3T^CB"QFY]#D5EN ?(0$S7;J ^DN_C"S(
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M<?/6$1%VV0%V##:G;R,[(MA[>]&.2<]E#.'/*G195336,7&<!6&:8"9-:Y)
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M?'S4'6 MUE+/$&/[9A\?"UW-=].UUGP5]4E^?#4Y$MIN53T46#??W8KIW/
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MZ/1(>PI [HZX@[B8^LA["E1[CL G#3<T5>7^B2\6*K8,+U]G@1\GOE!M[:-
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MET_J?RJIX0M>*%M8^2**.97CJP_.EVS[#YTG9QF.PQ1[,60X9G(_QG(_3H(
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M?OT1_'KY\9>KZU_ ^87\^.KAZO+>UM%^PA28>MBG =;6M;XNWMUA2_N@&L;
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MRT>-1^%4BZ)M:_%ZG5=ULXNZ?=7E0@5LY\N/G*WT#S/$4P^KY$D>Q5@:$DC
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M550^-@$*#_+5681)G.+$@SQ1)\$TYA"K/J H"\/(8SB*D)&?<W?@L0,N&U)
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M3;L44!2'* D(C:R.0LW$CNS&:B5T:'/7L$,ZE*L:PF?FJOR#8N>1-GAL-;@
MC73P9_OO*$[)SG!/OL=0Z*0NQ@Z(UY[$\FXWAU&G/]\H<TCUT"0^=WWW A:%
MB#,"12#5RB?"&)*$IA )1CG-@Y!P2R;)05FC'_TX4&@, V,V^\\SUFG"-R4.
MK<Q-U7HK=KB)FO7\/FF:IRD]+&?267S2W-<3]_0-CK0X7;!0MN<]KYNA;C=-
M],[:3.].)+D((!.Q>LO'80+S,"4PBW/.4,H("6.[&6RIP;1'NF2GG7"EM %%
M72S:D,,TW01CRV:"MIB;.8<Q<'1CTNFH<U9E=^P+#/HT>V32<4/"%Y..I?1I
MF73<H-ECTG$<QLU';;K9]_9TOM3'U8+?JD60SEY4H4P=V_R^*&DEEL]:E^O%
MT[HNV5XP=5<=NC>%B91%A&<\@"+*51A"(@QS%F<PQ23)9):&H<ALEBJ^%9QB
MT[;-R^AI##J5=9W31FE0:ZV;J&_U!K7B8%=SMPI3[\_6S%F^Y1.S\Z9O]+"L
MG>Y8B'KRRM[5F]1MCP7N:[\^FIPS'?][HN:$IN\08O7;LEP_*24VW/'?5BK(
MTZ^C#Z3NE5DG-5YKRNP9)CDG$9,P8C2 ."$J6I4!@SF721Y$<9!**WZ <Q4:
MV[%OZ/0+UQ8&9T-NZ7\G -+=W[;*@5H[T*EWT6M;L-$0="J"/[62H-9R#/=Z
M)F"^W:FK.F_C/L\$;]!=GCNN-17 C?CQA2S_)50(3O[ZH+QST75%Q2Q&*.48
M9BJ6A9BE I(@9"K43;,PB0B246!8W#\H9&0WIN2"5K!F1 2-:./*[F%LCOLF
M7Q;;^9O#QIZN3#*WVKA"W8OU;C7GEH_<IFC\I%6#9>##=TY5V'U2]UZI]NEK
M'=.VY_/RA_9N:FG_L5S3E5S/V_.#2H5\HJ@CP$UN4Y8R3K( !IF@$,>8PSR)
M!4R3B$9YG.:2,*L<;AOI(_NEC2XUXSYOM=%MW6IU+#.YK6 UBZI& \O.I74B
MP5;F!=@%K_5RFEY@A'0I)QQ\98!;R9XV'=P%EKW<<*=!SLVB;/9V8BI3%"4Y
M#% 8ZN-#!DD:8<@E)0D*PA13QX[64VR[]7(%G;;*7J-AYA/.L-%NUEN8=T;^
MXQA[0Z]'?Z,LQZ,[,T.7N;(N5JMEP73N$*D>]+%B^Y[)XB .PQQ!@N,48B02
M2&@<028R(6A&,I$9K1Y."1IYJFW%-A1=Q8+-UUS]5BQ 69]HDZH2MJ_L0=3,
M9J(/+.RF9 \&+;(F6F:^7[:GS/+&.3@@9F(ZP>/&[C,%GKC^_&8V^KCM<L&[
M(H=;.53T,,M%F <QR2 ),UU?J:9Y+D4*>2## !%$!;+*T'/28N29O]O&Y:&M
M_7ELU?!Q>.\$O9F'&!U0._>QBZ56J.[7V*F@\R->%U?USOC'Z8QC#<L(_7',
M=7BS+CG6,!WKE6,_F)M7NUXP784N/HKFW^M%M["X(R\ZZE%*J$^6:\%[YU.S
MG),\0(F$B4!J58#"'*K?*<PDUB15ZD-I53;NIL;8>P_=FOJIT:&>B:31 LRW
M:M@Y,T?$S;S9^#C:N;-.'_"NT^@7'0]ND+WK(=OJU3]Q]^?/S@/&DT-S5&)2
MCW8>4*]=VIFC.>Z>,B;F0G=QYG6%QE?QU.47Z@.B^9V*#L4=*73/P_J"F61Q
M'B0D@GE"$,0A36">QK$*V@1A61CP6%@MP:PUF."0>M[R+M<GIT]J.59IP>!)
MJP+>J4G)R_F<+*OMWRRC-'O8#7=8QP33>I>U4P74HD!/F>:,>@YJ?8!62#>+
M;:[SN,_JBH:OO59K^=/NM[K"L[?GZCS0>04<RR[A9[=8 2=9$B99"%$6*P^%
M*(54QA&,D<B#-(UEG%F=\1P7-[([^B:>R'+;#*Q=%O[G?P0)^B]LZ75.X,:9
MI DA.4PB?30?,@%I'F H5<@:A'$<!3+J<N?O)X5O-U_^_J=&T<Q1^_M.V7GE
M3;W,1C!XUXC^!;3"_1?-'#?2<^7,@+ W*9\Y;OA0#<V)NYP7KVJL3:[/):UJ
M#MT9PTG"DB2$$6$QQ*F,8)9&&>0B5^$<YTE*K,*Y 3DC>\FV\&N;[O9G)]CR
M$&L()N,EY;G&6Z\9K>UV60\>L\K?@N^@E*E7=,=,/;!D.WJYZU1]5H.5RY>O
MY$?7M*"JF[M^%3JC652S$+&$913!/)0<8L'5^HN2 ":AD+$,.(N#R([Z_+10
MFV^Q$Q6ZDKQI;6.]4702,M,9[!,&V\G<RKX &HJ-^$W[Y4X%GU/;U%QOL_RD
MP(DGO"D ^W/?^$Y[.O%VS_HE".E]L9J+64"C/,0D@3)0RQDL"5.Q.5:_QE&.
M99@B:O::/C3XR._F6H;^^@;A._I+=P+S8LX9O@?&\:E\KHEVD];6.BMB\"$S
MG/C ]P:;C 9\R(P^^_?@-?8M>:X75:&NO%_RFC>B$)4^+;KDY9-:/'Z:D^^F
MK7E.#C1Z5%O+!_=+HGG_0*=%?010GX#QM;H=M!J9M^\YC=#Q*>8='-L7I14N
MX$^MCJ<N/\9F.W7[.3WZ9%U_C WM=_\QO\FQ"Q"I'BX7=;+*U;_7Q3.9ZU2)
M39W+EHAJEH@<!X$@,%.!,<28IY#D0033@.51'-,HB:Q(+(TEC^P3M ) ;#6P
M[(%CC)]9N#P**G;.H 9$3_SZAYX6%V!;*P>VFGCLI6-KO*\6.\9RI^V\8PO'
M7D,>ZP%<LTMK6KH[LER]M+3T5.0\(9A I%-*,1<AS((4P8QQ%LA("A%8-NI^
M+6)DM] *!+5$1_+^ [B8>8'SK+6;[CN&7@#=XGT$6OYAB[REB^X)F#A1=,C
M_131P2L]<D_/..)I&,0<4IXGNA2>0,I("A-)9)8A1-(H.9MT>N1)^-$KO_0,
MH8 1(A'D,@@5).JG#$<9C+B,,YY$&<E"NTV^LT%QVM<;(N%VSPL[C%>2IQR3
M!$.&(PHQ0Q3F.980!RR+"0HQ8RKD*U=D/M57:"/+&"N]TW?YV"9\-9R>35G
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M6VF><;.I;"[::G)O%##^HNOC;:8T 4^M*H"^M+7V.B(F&SWL)KP%M&8N8!S
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MNJ[JI^G3&"$N<ZQ"QBR'N@0"DB -(9$A1CA  E&K19QG_4;V.UM%=-U1W9L
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M/,!QD <T3$*KV6^KP,C^0!-YU&S49:<7F->'<ZRL+*OHK*$UC'Y&!,PRT-E
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M# :\=XBWL-Z- -M@_.EXL,V-W:'#MKC-<>.B[L/7+;@I#Q$+X@#&04QT0J:
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MN7*./(1!GK*$"4%0:L6TY:##R"'35CQ@??E@WBE@YPA=4#9S?R-C9^?T.F5
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ML:V)R&G9:RU V*.HM;G7U6&HM>)#.5=W5,T1U R'*9$B83"F4KD'F0N8<1K
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M@4"0JA>C^E7B),U1$*#,0Q/U$VJ,/($UG4:3T5B!E=($_-"J $F>56!&YR^
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MORVJ]>-JEHJ,9+A D.0DAB@-I>_,.8-9% 4X$$F "BU\KS/Y\.PB%5= 2+;
M@V1)U; 0#I8=CE0+D=SE9(SV<PW6-6/@J>;,$"K?\C/H.=$)E&OF-6N]*HY
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MAVIF<"I@$08AS**,!90C%!)A-B_%&6^>#;:+X//[4K(#.H5PBKVV_7I7=]M
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M+,Z <5Y'A,'!31/80A VR^B\I'Z3&(XO.]U8AK.B/9O1</YIYW'?;9GG^[:
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MH2HO3Y&:MI[20NB]*DF;=X[MZ>'W^JS_]N-?NI_H/QBMY(]_^3]02P,$%
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MQ;8.E1JR;0(D!RFA"F;7?[P=CH$-DE*!9A $8D:DFZB(LTR2: Q3)GK/<JP
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MMV\&C>93D!5$VP1$CL?X-!3'\ N\]G-_S=8@,ZF]$X90Q0'YT(KX;% XQKK
MH_16[W;^_=S;-X-(\XG("J)M B+E&'=ZZ.=P.9E^'U@>%$V@B;<<$2X4@ML$
M2Y /BG;0A5@EW73OI9N5336?@]Q>D$W@X/R3'XU>7<V&8YC-!L*#8U0S(J$<
MR*6(,/99$"\E"H<GZJFI@(-[+]T,!\UG&[<79!,X./H$TTO<\GZ;3K[./QY.
M/GWVX^^#Q"-HS=$[UA*=(\_*"7]@)/&<;7;6&UX##VM?OADNFD\S[B[8)O!Q
M_A%&HQOJ*5"I53(D\Y"(M!2(0R>:,!JB85%EJ7<+/QZ_<S,T-)QSW%&,38
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MPB*/@APL%V66.3LE'!'"%59\( %=,P(I4NZ$IHG73CJMIZ3?;'[3T*R@N@8
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MS3&?HZ>UT5$5@?!T*FDWK313:_)85K<%8*=E-C#J<#Z?#L/5O&P)%Y/U3L#
M)&5S HV;/@4B@_#$9W1;023E;3:4Z]H#?NI0WMH0JNZPVX.FFT'YFJ3><OT.
M3&E:GV0B+EF,LD%#F7:MB(C6HS1]H'(/&=0E,:T-G^H.BW7TT0R\3J>3/)R7
MMO<#+K@6"NF/J;@TCC%BC<E$2<J]="!8KEUF<_?VU@9%=0>@+26^-6*^P#1,
M:G:16I.1*=PL.F==^&]K+?(R/33P2F20@A&TM9E(BS&\C502YPP52>@@3.U
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M:B6[^6#(%G#&0VD]P%S)\#*&04=@G  -,FBKA=>UX[W:D]4>UN"_G\QAG0O
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MR3<@J]^,;/_XJZ.OIC;^M4*].0D_'J^U_C#-D^FGDIQ>O99OM;81+;XLPY/
M6.)I&0*>7&32&9\?3M"JN/M78J+?VJW^78 ^L-"$17Y<(UR$#LAS'%UA_'T\
M/HCQZM/5H@OZ8LSKFGY[14@/CR&S,,QR39PN!T-&:1)LY$1[3V647$K9W:*H
MRLI&2T/_>9=&?[AH-%FW?F#'MIFY9Y_6W7R1+G-NNTUQ<"HS )<(DRD0&<J
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M@X3*A'HH0\RNQZ@-9&1,^6A(7(PG,KE,+@B<4!LA9DNI\[5O6:VGI.>^L'L
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MJ%T0^30U_2:V*FXDE07?K\TX'L]A5 ;K7OG135^D@\LIP'+*^?330&C+J&!
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M;=U0446-VJ/C]W\<G5^4 YV5 KAE#>?"T1N.7T.8GT-$>>PT?'3;%]4YR*K
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M=1VO$5&0OVP+*.L#>*2CF>C;TA219%*/^WF/_?KQ\-)2=;/&<NP@>GV?E_G
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ML@OG/DOKO$=(PKM(T9RV*8/*40'F1&?->U.22HK^; "AK0D:KV#B<)W/AE;
MN(^9;W*:1+SX+7\C3^_'')>,S)I(<F'1<E#)U D!Q(FH^R2C9LIG]Z2U?OCW
MCP>*@?0X:RW4T:W3;:OUC26OYT<:KEEF B1F\OJU=Q#H ($0RL:DO8K;M3D_
M::$V?WXO;]U#6:D&4N\0.>L3I7ABLA#T$Z^)<X(\U)HUT"[J:(QGS+8P30]3
M,*8M:J'9)Z"RAY@[>+[:>)2^OYM/ON#\^XL\S642)_3E]24:<C29>$(6$JC
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M+YW#E_@5(PGB/!<96>!TC+2B U6< ">B!2T32A/0!H=/XFR[S]H*3_Z9X6D
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M08(JK-0>4EUGK!JMHXS.#L=]!QT[QT+.P_WCN^NA P=J+9[?\F+R:;I25DW
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MK[9-K0_7:F'S#_,AKMV)G-[A]_J/3^9SG'[*JW?Q.OL#<TZ 6=;%X#&!=R&
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MMN.8=F3%LDLT>Z@'^^$">!.?BDDESE0LD**GR9/=9A8:NHU]EVUF%N$-F]Q
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M2I,XP97V<_3KFJQ(G!2C.T0,&A#N^E>F.8CBJI9),#>6HE6E\)?E"_^D"YM
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M_YN#WAC/4:S<E!WA/=.*/V:S=SNKB7DUA^M;(G"MJ1PJ"EQTC:EG'Q9D)E1
MX#<9R7& I31MDC=5+T.IZU]^WCM\ ][^4(VT0;3V=6+8J:.$.WW*,ZSLY2T&
MW[++Q!7F@G-UTQF3@JC Q7<4PQ]\HR*<A\JA:P:U1^@0+@F"115G+3A$6R9*
MWZ@NYH&B]#LF]RXHE=<:8>J9'&.]S2_O9@F&DS1*!LD'3!7X XM:'%X*/T^T
MTON<Q)DDU,1G#6YY?$EW+;9ET'9L2QL!OP;EZP=@,N5T##5ZADD<RIY"</6J
M:%\*AN<@9HF"<X'-!=*7YHE56F(RP:)60G%8*#"6RPI\L(M,0WQO1#B,#$M2
MA0/&(S!84"EKY3R5 7WT\%B>SC("<90P81'CNU2XWIO :T:5=+T&8'$U[8B(
M$%,%62;-RU5!1*[R(/JF$<R*)=X0U7#N?<D49[O5E##U$;Z&&Q[GTA0H&4(3
M6V]T0P7 .*GV?C*@=:FKC*H4-2&<@?BLN#::DB_7B%N0#DI\#!.=<#YFE@]A
M;9#K*!$^4=APQ-I4/^,VG4G:JSI/L\$&/L<V&#^!^1Z<-I,B(@J4AIMO8N*I
M3LPG7---C&"P$([:KB! X&M2@GWOG8+YB)LX\(52B7Z<#T%7VJFQ@RW<@R(S
M[G."<:^:M*HS $M+!GNE8$1BME]I:6:1J=^[N$9:B*3W!VZ SR#-!/+L%:47
MM_<4^8;@34404L!;,V;I/(.ICU-L6?,X9P8E_BD.F<)-^.@GT-6]R.*.EL*=
MRYQ5B<2\9:6$42FFH4!N&$3#>6$\$OIPD'>:9VX<C'&'[F]O>O 6,'ZC"LWU
M99R<A5K!8Y&\+_3^C(?.]8E2&5XP124/DHI(:%W"20+%FIC(%^2,8'SJ17";
M);#)0HWPJG!T:46+KA:^"1TMSJD#SR+BI92^H.1P_?"IGA.-)KS.WE8]'331
MA-XG?1"(=^G:IF6*UCL<;Y.M W*2LX]>HL5H%%:'X(1V (7)#(RP&#33"  \
M-_E,3,74*2L&L4>@'\@J[Q:$KV*F%O[_,Z!&.]#H\J#1=E;C7\>W2'W4 CRM
MJ?.T17C6TD&U"09;GAFFY!I'6(%FBPZCTMTJNI;@?LF"%$,=BDSGKEP5HL0E
M+6S>IY9ME.M(BD$[S55&_ (VW*(MLI(Q21:=F:11* )E BZ<I9Z>)ET'HU^M
M0V%8%,9NA\+H4!@O"H7Q L_JGWZM+;RS*FUQJ9ME3*.?U6OEMI#JGR NCH.2
M+6 4VBR6)MHS+R$R-RKYP"@M3J[QMFH"N@XU^4A=;6M@U)H63ZGF>$BO<;F+
M9V1-=6/I%VYYXU+9B;KN*8]EG-[?6U_OD/IX*EY!YH+:%M*E<4:WMAJ44D$E
MKDJKH1HW-Z_R*=2P*2@"A;Y7/T#+6N^,J];D4PD##P'9%#"\%5A,BW) ;YF6
M@=8]LB;=BF9[.Y0G]\V?!S*]3+Y@W1FNUE0\%3)<;NRQ-2DNUD "G"86.\PI
MO(5SB/BV=@?47F??L-US2-_@2%QCF\KA0RKMC^*<(N_XM0Z'4X13[4)R+):M
MB?F.P)B#UI15%>2RFF-LDVQFMS)$"IS!SN;6%'YWK<Y!EP\0\V VYD\RRKD7
M3>JJA/;A$))2;NP'K#\9M*:0JR"T];BU-HCN@VM('PRF6TZVENLQLU;1:DUM
M4T&TN.7/^@7)ZD!=>O2P*CO-]YE=P[\G"/9T[R/25!*1EB:&4-]1EQM%^J"3
MR7 !_85P!54 6-2>O0<.C9XXBJ=#[=4J1,&R)D&5WJE]B+W6E%Y4A/O[0XTV
MBDT[9*3^=7?Z>U6DJWAB;Z$7R]:]T\XJD=9O%=OHHS)0ULI-.[ZGN7<6@<D?
M9?\N::"TWV';:6>YB;-.%,N\Y-Z([9++:E@L+0U;M71$"7,XP[&)W&@4)PP3
MH_!7A2K&8*H<JBH"[1'Z3QDX5PF!*.?>!;4N86AMD&+D@<T-2A9_1S4".^VL
M55$*JCW2";:NQF@^S*1><<!JT'[]UYK6+P6)6F?::\%QVX(TF/>DPJO=6G/T
MJ;54Z^]AN-/8PW#!*CZPE^&K_E'I--C:'?2_!92P_MUWVM,O;W# \W"A\W8M
MVSNK;>2ZA%9?8T;U^:MIZ([+$JV6."+V&7.Z0,?VUVH_%$EM#3258F,A1WA5
M^SJGNL7!V2UX,>PZI^+$]3J9N^,DBAQ:4EL<?3_J4%WIGA-A"7=SB?>&*'7:
M=>+1FYSQ:R>RLT.]O@34:P/ AK>*:J&X<$.X32^8G-C9%:#'-A6K-.-PL&'D
M+.::N.(^4$55JB.UHBMW>+Y,<T=O H].".@>2E571!A40QB+L6]/9!D3LS.3
M'KJO[90%C;L[7J<T>!LM,-HO>$%;8*!O:DQ8ATVVV&13D-YADSML\G>%3:YW
M!M9D^V>WL,?G6\A"L+$S4%#4#:1Y!PMPOC6F3E-[^^J+0$%1D<T,SEX%N@E2
M6S/(AW*Q6X#&X0:58QBQ7XF\B;\:?+/2RH^.JCTVT=460&L1FEKG1"PRC\KV
M?@V&V19B&B=$(V93!DTY[3Z'<DR\%(G3=Z6,#$,"8N8O\)4!97V0C6+7;>[[
M@#C43:>S=C.QA3?,,Y?;H%+?7>_%K,%W)_#!=UL@_13W?:]_Q/Y[0\;QA3OO
M#6_5Y+GO+?3<A6(&Z-SVSFU_>6Y[TU98Y+/O/8O/KHP(4VKS ]@X2P [UWM*
M/=3*:9*FUI@X.,#5VS??QJ99 F6S9IOFV4DOGI:2.*"I60226FORRGNJ7;/H
MS9IL&T/1J;B\JLQ8UC% JP=WOV%:4K5WA6(,7?A85X/1V4F=G?0R[:2%6VN1
MK;3?V4H/Q9A^_]&@A=+4#ENIHM<764TK-)F<.C\>;AV]X_.$BBQ2;W>-8)_V
M0#^/&,-1OT[KMY2*K+R*M;-"QDN&3&KY&VJ$D[>K4\LOVL#*T;YI5XG/IQ$7
M;_?W%]-7?&/,7>NIB@>O6!W5L5<&T4T<YE&&K'R9V_-AR2,$^;!/1)[*IY,T
M;E<P]+B"WW-\??D5/.SO&P+2ZIHT+F$S%<IJ#\#E.I!^BS.Q?BF1<GB6)[,X
ME6F5X[_7[#C6428_9IL4+*WA7-D]1'PL17;=\VP7K)ZSG!'Q:,#5F2+W8T_6
M%HZC4SZF4AG;LIUH566*^( @16Q2DH?26%QE!9")NZU_T\LC&;CS)&Q2M>FR
M#3H<@XW.-.P9D^E YO*L[QUW\!8'WK+?P5LZ>,MW"6]I%?7>O>J<3/]BJ))9
M#IYB$)6HD/'()=MHI1F?NC9LZ_0VV].,2'F;;RE,/=.KUM(BK;YW5HF3%X-B
M0SF*\8$/! ,U]6E+X7P>4 #.<LST"O+*NV,FYCIZ8\;"@3MUT](PT;R!^\3(
MA;<(HR31RJ <&CRD[&0O[Q$VN0Z/953JO,22EWCLA?ETMI7F4T],XQR[B.B5
MJU> >303@>_RN_>P:CO!VNH;H7H2@%3UX$H0NNDP3Y"YW1#^R[N9C%)J=J/Z
MUJM&)IF<IDA'%W&>"+^-;WD?E%HM:%(;S V95O8UO/)%^M1'J^4F>5NN?=):
MY:U5/NW!SA("I_JH>_$P$X$2A2EV#YJ%<TWX5B^8(HKP/B 1J$)OJ P6;O.G
MD@CUL W3.0?._(G,JC_C"TOL%YN]@H]EW2_U\V$<Y2EW^@UTA\U2TE)WP!!H
MO <S;C@_5D0<SN_GL =*-UDDUJ9?)TR4HK\;)V+$H7'\=91/)6AG:A.B;LIC
MP6^&' (=YQ30!-M&8IR3R/9,Z4MY;'K_W3NTGB%K@+T0TZ?E45B&/XS1PB>J
M=IE)(ZGW@Q<&,C=]U&CI]$7<=&4J?%G5$BM>(I'9&7A\-*4QFMEZ3=*>]B3+
MG%RWL;>QLZD5A]/WK%%M)$I\Z_N64/YU52?,LD*Q1)AMS4+AMT<HECE>'BX5
MSW28M/PL6;5^V^,KVRW+LCVRK!3<*3?K<OV[H00'BL]ED &W*!8M%#2F$:.Q
MI6A&C1!R:\1)(B*' -T@ <HGIVD=AA\W)=VMX6UZW*C'C.*(.E"2-PK_B-0H
M36#<\.NJ1YB>8O8>2,83YYGIQDC. &ZT6^3:S^$!*3V@KN'9HE&SSXN__D8H
MI_HP"NQ,7' <$ZHF:P1IRVN=H0K&&L4)=R,%M0<F%JPA^&X4)(NI]:<^&-5\
M@P,H0YEHV:A9ELT%Z])!\I9N)M6XO;5-S7FK%$%:1,L.5VUQ5\*-P$J=;I_&
M7VW2C@C*C:6<S2)2.%"UEZW.NE!2X[ZQ^RCO%@\Z[&AZ(_V^=YG%HZ]>/..
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M/9QKU1;WA[.)OE\5U6YM]*K-VL@T$L6=4<Y<>Y]H-:\P*%!J\MU^755433+
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MI^=7R[P]X9 >GJMY),YA=WUH)LK4M+,\O*FAR'J!ZT>[;[XQGO^A\V80/:U
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MDO@H1^@)M83F)%G"LD2$>30TD!])4EPAB2*! +"H !@WG''VA-Q,6)RHF5D
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MNG;TZ$5'<*L-%>I(%^[YL3?)(/Q!6E#YG7Q[N\1&\\+>+T@1YF"^CZ<!WBH
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M 0!E=RTR,#(T,#,S,2YX<V102P$"% ,4    " #%@)U8\%U_2=DK   /LP$
M$P              @ %N8 $ 97<M,C R-# S,S%?8V%L+GAM;%!+ 0(4 Q0
M   ( ,6 G5AK3RF7$5T  )<O!  3              "  7B, 0!E=RTR,#(T
M,#,S,5]D968N>&UL4$L! A0#%     @ Q8"=6,'J[-*[:@  H9<  !(
M         ( !NND! &5W+3(P,C0P,S,Q7V<Q+FIP9U!+ 0(4 Q0    ( ,6
MG5A"&T:2(4P  )!9   3              "  :54 @!E=RTR,#(T,#,S,5]G
M,3 N:G!G4$L! A0#%     @ Q8"=6$ #U_>F/P  F$P  !,
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M,C0P,S,Q7V<T+FIP9U!+ 0(4 Q0    ( ,6 G5B-N%PF26X  &.J   2
M          "  <1K! !E=RTR,#(T,#,S,5]G-2YJ<&=02P$"% ,4    " #%
M@)U8C(M#%+!M  #&J0  $@              @ $]V@0 97<M,C R-# S,S%?
M9S8N:G!G4$L! A0#%     @ Q8"=6#K;+?19OP  ?O$  !(
M ( !'4@% &5W+3(P,C0P,S,Q7V<W+FIP9U!+ 0(4 Q0    ( ,6 G5C9/L8Z
MLK(  *GF   2              "  :8'!@!E=RTR,#(T,#,S,5]G."YJ<&=0
M2P$"% ,4    " #%@)U8(<1[AB6T  "<[   $@              @ &(N@8
M97<M,C R-# S,S%?9SDN:G!G4$L! A0#%     @ Q8"=6(,Q-3C,+@$ OG(+
M !,              ( !W6X' &5W+3(P,C0P,S,Q7VQA8BYX;6Q02P$"% ,4
M    " #%@)U8_?CE\#*N  "Z$@@ $P              @ ':G0@ 97<M,C R
M-# S,S%?<')E+GAM;%!+ 0(4 Q0    ( ,6 G5B=:)"#M4<   UP @ 4
M          "  3U,"0!E>"TQ,#$Q,'AQ<3$R,#(T+FAT;5!+ 0(4 Q0    (
M ,6 G5@_?4<Y'P@  *\J   4              "  224"0!E>"TS,3$Q,'AQ
M<3$R,#(T+FAT;5!+ 0(4 Q0    ( ,6 G5A/ RM>$@@  +4J   4
M      "  76<"0!E>"TS,3(Q,'AQ<3$R,#(T+FAT;5!+ 0(4 Q0    ( ,6
MG5CGIMBW^00  !@6   3              "  ;FD"0!E>"TS,C$P>'%Q,3(P
<,C0N:'1M4$L%!@     6 !8 B 4  ..I"0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>ew-20240331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2023"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2023"
  xmlns:ew="http://www.edwards.com/20240331"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="ew-20240331.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
        </entity>
        <period>
            <instant>2024-04-25</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
        </entity>
        <period>
            <startDate>2023-04-12</startDate>
            <endDate>2023-04-12</endDate>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ew:MedtronicIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-12</startDate>
            <endDate>2023-04-12</endDate>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ew:MedtronicIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ew:MedtronicIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ew:MedtronicIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ew:NewMarketsTaxCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:LimitedLiabilityCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:LimitedLiabilityCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ew:MedicalDeviceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ew:MedicalDeviceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ew:MedicalDeviceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ew:MedicalDeviceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ew:MedicalDeviceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ew:MedicalDeviceCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ew:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ew:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ew:MeasurementInputProbabilityOfMilestoneAchievementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ew:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ew:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ew:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ew:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ew:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ew:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ew:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ew:SeparationCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ew:SeparationCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ew:EmployeeAndNonemployeeStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ew:EmployeeAndNonemployeeStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">ew:InitialDeliveryOfSharesSettledFebruary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">ew:InitialDeliveryOfSharesSettledFebruary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">ew:February2023StockRepurchaseProgramSharesSoldInMarch2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="c-217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:IsraelTaxAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:JapanSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:JapanSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ew:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ew:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:TranscatheterAorticValveReplacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:TranscatheterAorticValveReplacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:TranscatheterMitralAndTricuspidTherapiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:TranscatheterMitralAndTricuspidTherapiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:SurgicalHeartValveTherapyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:SurgicalHeartValveTherapyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:CriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:CriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ew:MichaelA.MussallemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ew:MichaelA.MussallemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ew:ScottB.UllemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-251">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ew:ScottB.UllemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ew:BernardJ.ZovighianMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ew:BernardJ.ZovighianMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="lawsuit">
        <measure>ew:lawsuit</measure>
    </unit>
    <unit id="agreement">
        <measure>ew:agreement</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-25">0001099800</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-26">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-27">2024</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-28">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag contextRef="c-1" id="f-29">false</dei:AmendmentFlag>
    <us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList contextRef="c-1" id="f-670">http://fasb.org/us-gaap/2023#BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList>
    <us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList contextRef="c-5" id="f-680">http://fasb.org/us-gaap/2023#BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList>
    <us-gaap:DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration contextRef="c-3" id="f-695">http://fasb.org/us-gaap/2023#OtherAssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent</us-gaap:DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration contextRef="c-4" id="f-696">http://fasb.org/us-gaap/2023#OtherAssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent</us-gaap:DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration contextRef="c-4" id="f-701">http://www.edwards.com/20240331#AccruedAndOtherLiabilitiesCurrent</us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration contextRef="c-3" id="f-702">http://www.edwards.com/20240331#AccruedAndOtherLiabilitiesCurrent</us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration>
    <ecd:TrdArrDuration contextRef="c-248" id="f-1031">P324D</ecd:TrdArrDuration>
    <ecd:TrdArrDuration contextRef="c-250" id="f-1032">P353D</ecd:TrdArrDuration>
    <ecd:TrdArrDuration contextRef="c-252" id="f-1033">P202D</ecd:TrdArrDuration>
    <dei:DocumentType contextRef="c-1" id="f-1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c-1" id="f-2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2024-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">1-15525</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-6">EDWARDS LIFESCIENCES CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-7">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-8">36-4316614</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-9">One Edwards Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-10">Irvine</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-11">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-12">92614</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-13">949</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-14">250-2500</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-15">Common Stock, par value $1.00 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-16">EW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-17">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-18">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-19">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-20">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-21">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-22">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="c-1" id="f-23">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-2" decimals="-5" id="f-24" unitRef="shares">602600000</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-5" id="f-30" unitRef="usd">1224600000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-5" id="f-31" unitRef="usd">1144000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments contextRef="c-3" decimals="-5" id="f-32" unitRef="usd">473000000.0</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c-4" decimals="-5" id="f-33" unitRef="usd">500500000</us-gaap:ShortTermInvestments>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c-3" decimals="-5" id="f-34" unitRef="usd">13500000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c-4" decimals="-5" id="f-35" unitRef="usd">8300000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-3" decimals="-5" id="f-36" unitRef="usd">817600000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-4" decimals="-5" id="f-37" unitRef="usd">775100000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent contextRef="c-3" decimals="-5" id="f-38" unitRef="usd">59300000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent contextRef="c-4" decimals="-5" id="f-39" unitRef="usd">61800000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:InventoryNet contextRef="c-3" decimals="-5" id="f-40" unitRef="usd">1207300000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c-4" decimals="-5" id="f-41" unitRef="usd">1168200000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseCurrent contextRef="c-3" decimals="-5" id="f-42" unitRef="usd">138100000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="c-4" decimals="-5" id="f-43" unitRef="usd">146800000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c-3" decimals="-5" id="f-44" unitRef="usd">250600000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c-4" decimals="-5" id="f-45" unitRef="usd">239300000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-3" decimals="-5" id="f-46" unitRef="usd">4170500000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="-5" id="f-47" unitRef="usd">4035700000</us-gaap:AssetsCurrent>
    <us-gaap:LongTermInvestments contextRef="c-3" decimals="-5" id="f-48" unitRef="usd">455600000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments contextRef="c-4" decimals="-5" id="f-49" unitRef="usd">583900000</us-gaap:LongTermInvestments>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-3" decimals="-5" id="f-50" unitRef="usd">1767900000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-5" id="f-51" unitRef="usd">1749400000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-3" decimals="-5" id="f-52" unitRef="usd">98400000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-5" id="f-53" unitRef="usd">94000000.0</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill contextRef="c-3" decimals="-5" id="f-54" unitRef="usd">1252800000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-4" decimals="-5" id="f-55" unitRef="usd">1253500000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-3" decimals="-5" id="f-56" unitRef="usd">446800000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-4" decimals="-5" id="f-57" unitRef="usd">428400000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-3" decimals="-5" id="f-58" unitRef="usd">776700000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-4" decimals="-5" id="f-59" unitRef="usd">754600000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-3" decimals="-5" id="f-60" unitRef="usd">767600000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-4" decimals="-5" id="f-61" unitRef="usd">463700000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-3" decimals="-5" id="f-62" unitRef="usd">9736300000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-4" decimals="-5" id="f-63" unitRef="usd">9363200000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-3" decimals="-5" id="f-64" unitRef="usd">212300000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-4" decimals="-5" id="f-65" unitRef="usd">201400000</us-gaap:AccountsPayableCurrent>
    <ew:AccruedAndOtherLiabilitiesCurrent contextRef="c-3" decimals="-5" id="f-66" unitRef="usd">873700000</ew:AccruedAndOtherLiabilitiesCurrent>
    <ew:AccruedAndOtherLiabilitiesCurrent contextRef="c-4" decimals="-5" id="f-67" unitRef="usd">969100000</ew:AccruedAndOtherLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-3" decimals="-5" id="f-68" unitRef="usd">24800000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-5" id="f-69" unitRef="usd">24900000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-3" decimals="-5" id="f-70" unitRef="usd">1110800000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="-5" id="f-71" unitRef="usd">1195400000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-3" decimals="-5" id="f-72" unitRef="usd">597200000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-4" decimals="-5" id="f-73" unitRef="usd">597000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:TaxesPayableCurrentAndNoncurrent contextRef="c-3" decimals="-5" id="f-74" unitRef="usd">79600000</us-gaap:TaxesPayableCurrentAndNoncurrent>
    <us-gaap:TaxesPayableCurrentAndNoncurrent contextRef="c-4" decimals="-5" id="f-75" unitRef="usd">80600000</us-gaap:TaxesPayableCurrentAndNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-3" decimals="-5" id="f-76" unitRef="usd">77200000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-5" id="f-77" unitRef="usd">73000000.0</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent contextRef="c-3" decimals="-5" id="f-78" unitRef="usd">336600000</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
    <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent contextRef="c-4" decimals="-5" id="f-79" unitRef="usd">339300000</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
    <us-gaap:LitigationReserveNoncurrent contextRef="c-3" decimals="-5" id="f-80" unitRef="usd">82000000.0</us-gaap:LitigationReserveNoncurrent>
    <us-gaap:LitigationReserveNoncurrent contextRef="c-4" decimals="-5" id="f-81" unitRef="usd">94200000</us-gaap:LitigationReserveNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-3" decimals="-5" id="f-82" unitRef="usd">266500000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-4" decimals="-5" id="f-83" unitRef="usd">264300000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-3" decimals="-5" id="f-84" unitRef="usd">2549900000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-4" decimals="-5" id="f-85" unitRef="usd">2643800000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-3" id="f-86" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-4" id="f-87" unitRef="usd" xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-88"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-89"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-90" unitRef="shares">50000000.0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-91" unitRef="shares">50000000.0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-92" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-93" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="c-3" decimals="-5" id="f-94" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-4" decimals="-5" id="f-95" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-96"
      unitRef="usdPerShare">1.00</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-97"
      unitRef="usdPerShare">1.00</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-98" unitRef="shares">1050000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-99" unitRef="shares">1050000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c-3" decimals="-5" id="f-100" unitRef="shares">651800000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="-5" id="f-101" unitRef="shares">650500000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-3" decimals="-5" id="f-102" unitRef="shares">602400000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="-5" id="f-103" unitRef="shares">601100000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c-3" decimals="-5" id="f-104" unitRef="usd">651800000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="-5" id="f-105" unitRef="usd">650500000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-3" decimals="-5" id="f-106" unitRef="usd">2379800000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-4" decimals="-5" id="f-107" unitRef="usd">2274400000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-3" decimals="-5" id="f-108" unitRef="usd">9344300000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-5" id="f-109" unitRef="usd">8992400000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-3" decimals="-5" id="f-110" unitRef="usd">-233300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-4" decimals="-5" id="f-111" unitRef="usd">-242800000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockCommonShares contextRef="c-3" decimals="-5" id="f-112" unitRef="shares">49400000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares contextRef="c-4" decimals="-5" id="f-113" unitRef="shares">49400000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue contextRef="c-3" decimals="-5" id="f-114" unitRef="usd">5024700000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue contextRef="c-4" decimals="-5" id="f-115" unitRef="usd">5024500000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-5" id="f-116" unitRef="usd">7117900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-5" id="f-117" unitRef="usd">6650000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest contextRef="c-3" decimals="-5" id="f-118" unitRef="usd">68500000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="c-4" decimals="-5" id="f-119" unitRef="usd">69400000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-3" decimals="-5" id="f-120" unitRef="usd">7186400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-4" decimals="-5" id="f-121" unitRef="usd">6719400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-3" decimals="-5" id="f-122" unitRef="usd">9736300000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-5" id="f-123" unitRef="usd">9363200000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-5" id="f-124" unitRef="usd">1598200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-5" id="f-125" unitRef="usd">1459600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-1" decimals="-5" id="f-126" unitRef="usd">385600000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-5" decimals="-5" id="f-127" unitRef="usd">329500000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit contextRef="c-1" decimals="-5" id="f-128" unitRef="usd">1212600000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-5" decimals="-5" id="f-129" unitRef="usd">1130100000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-1" decimals="-5" id="f-130" unitRef="usd">489700000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-5" decimals="-5" id="f-131" unitRef="usd">436300000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-5" id="f-132" unitRef="usd">285200000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-5" decimals="-5" id="f-133" unitRef="usd">261200000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:LitigationSettlementExpense contextRef="c-1" decimals="-5" id="f-134" unitRef="usd">8900000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense contextRef="c-5" decimals="-5" id="f-135" unitRef="usd">43500000</us-gaap:LitigationSettlementExpense>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-1" decimals="-5" id="f-136" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-5" decimals="-5" id="f-137" unitRef="usd">700000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:OtherNonrecurringIncomeExpense contextRef="c-1" decimals="-5" id="f-138" unitRef="usd">41300000</us-gaap:OtherNonrecurringIncomeExpense>
    <us-gaap:OtherNonrecurringIncomeExpense contextRef="c-5" decimals="-5" id="f-139" unitRef="usd">0</us-gaap:OtherNonrecurringIncomeExpense>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-5" id="f-140" unitRef="usd">387500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-5" decimals="-5" id="f-141" unitRef="usd">388400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet contextRef="c-1" decimals="-5" id="f-142" unitRef="usd">16500000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet contextRef="c-5" decimals="-5" id="f-143" unitRef="usd">8600000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-5" id="f-144" unitRef="usd">5400000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-5" decimals="-5" id="f-145" unitRef="usd">1600000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-5" id="f-146" unitRef="usd">409400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-5" decimals="-5" id="f-147" unitRef="usd">398600000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-148" unitRef="usd">58400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-5" decimals="-5" id="f-149" unitRef="usd">58100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-5" id="f-150" unitRef="usd">351000000.0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-5" decimals="-5" id="f-151" unitRef="usd">340500000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-1" decimals="-5" id="f-152" unitRef="usd">-900000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-5" decimals="-5" id="f-153" unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-154" unitRef="usd">351900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-5" id="f-155" unitRef="usd">340500000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-156"
      unitRef="usdPerShare">0.58</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-157"
      unitRef="usdPerShare">0.56</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-158"
      unitRef="usdPerShare">0.58</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-159"
      unitRef="usdPerShare">0.56</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-5" id="f-160" unitRef="shares">601600000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="-5" id="f-161" unitRef="shares">607500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-5" id="f-162" unitRef="shares">604100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="-5" id="f-163" unitRef="shares">610900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-5" id="f-164" unitRef="usd">351000000.0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-5" decimals="-5" id="f-165" unitRef="usd">340500000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-1" decimals="-5" id="f-166" unitRef="usd">-26100000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-5" decimals="-5" id="f-167" unitRef="usd">3800000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax contextRef="c-1" decimals="-5" id="f-168" unitRef="usd">26900000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax contextRef="c-5" decimals="-5" id="f-169" unitRef="usd">-17200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="c-1" decimals="-5" id="f-170" unitRef="usd">-300000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="c-5" decimals="-5" id="f-171" unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-1" decimals="-5" id="f-172" unitRef="usd">8400000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-5" decimals="-5" id="f-173" unitRef="usd">13000000.0</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-1" decimals="-5" id="f-174" unitRef="usd">9500000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-5" decimals="-5" id="f-175" unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="c-1" decimals="-5" id="f-176" unitRef="usd">360500000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="c-5" decimals="-5" id="f-177" unitRef="usd">340000000.0</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="c-1" decimals="-5" id="f-178" unitRef="usd">-900000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="c-5" decimals="-5" id="f-179" unitRef="usd">0</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-5" id="f-180" unitRef="usd">361400000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-5" decimals="-5" id="f-181" unitRef="usd">340000000.0</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-5" id="f-182" unitRef="usd">351000000.0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-5" decimals="-5" id="f-183" unitRef="usd">340500000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="-5" id="f-184" unitRef="usd">38500000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-5" decimals="-5" id="f-185" unitRef="usd">35200000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-1" decimals="-5" id="f-186" unitRef="usd">7700000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-5" decimals="-5" id="f-187" unitRef="usd">6800000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-5" id="f-188" unitRef="usd">44600000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-5" decimals="-5" id="f-189" unitRef="usd">38900000</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes contextRef="c-1" decimals="-5" id="f-190" unitRef="usd">35800000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes contextRef="c-5" decimals="-5" id="f-191" unitRef="usd">51800000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-1" decimals="-5" id="f-192" unitRef="usd">500000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-5" decimals="-5" id="f-193" unitRef="usd">-1100000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables contextRef="c-1" decimals="-5" id="f-194" unitRef="usd">55000000.0</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
    <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables contextRef="c-5" decimals="-5" id="f-195" unitRef="usd">77500000</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-1" decimals="-5" id="f-196" unitRef="usd">69500000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-5" decimals="-5" id="f-197" unitRef="usd">32800000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-1" decimals="-5" id="f-198" unitRef="usd">-89100000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-5" decimals="-5" id="f-199" unitRef="usd">-45200000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable contextRef="c-1" decimals="-5" id="f-200" unitRef="usd">-263100000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable contextRef="c-5" decimals="-5" id="f-201" unitRef="usd">87200000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-1" decimals="-5" id="f-202" unitRef="usd">-27100000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-5" decimals="-5" id="f-203" unitRef="usd">23800000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <ew:IncreaseDecreaseInLegalSettlementAccrual contextRef="c-1" decimals="-5" id="f-204" unitRef="usd">-5200000</ew:IncreaseDecreaseInLegalSettlementAccrual>
    <ew:IncreaseDecreaseInLegalSettlementAccrual contextRef="c-5" decimals="-5" id="f-205" unitRef="usd">29300000</ew:IncreaseDecreaseInLegalSettlementAccrual>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet contextRef="c-1" decimals="-5" id="f-206" unitRef="usd">4200000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet contextRef="c-5" decimals="-5" id="f-207" unitRef="usd">-6200000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-5" id="f-208" unitRef="usd">-53500000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-5" decimals="-5" id="f-209" unitRef="usd">314100000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-5" id="f-210" unitRef="usd">65300000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-5" decimals="-5" id="f-211" unitRef="usd">61500000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireHeldToMaturitySecurities contextRef="c-1" decimals="-5" id="f-212" unitRef="usd">800000</us-gaap:PaymentsToAcquireHeldToMaturitySecurities>
    <us-gaap:PaymentsToAcquireHeldToMaturitySecurities contextRef="c-5" decimals="-5" id="f-213" unitRef="usd">12500000</us-gaap:PaymentsToAcquireHeldToMaturitySecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities contextRef="c-1" decimals="-5" id="f-214" unitRef="usd">9300000</us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities contextRef="c-5" decimals="-5" id="f-215" unitRef="usd">80500000</us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt contextRef="c-1" decimals="-5" id="f-216" unitRef="usd">1800000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt contextRef="c-5" decimals="-5" id="f-217" unitRef="usd">3200000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities contextRef="c-1" decimals="-5" id="f-218" unitRef="usd">157300000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities contextRef="c-5" decimals="-5" id="f-219" unitRef="usd">183400000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="c-1" decimals="-5" id="f-220" unitRef="usd">20000000.0</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="c-5" decimals="-5" id="f-221" unitRef="usd">13100000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <ew:PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions contextRef="c-1" decimals="-5" id="f-222" unitRef="usd">0</ew:PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions>
    <ew:PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions contextRef="c-5" decimals="-5" id="f-223" unitRef="usd">141200000</ew:PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions>
    <us-gaap:OtherPaymentsToAcquireBusinesses contextRef="c-1" decimals="-5" id="f-224" unitRef="usd">10800000</us-gaap:OtherPaymentsToAcquireBusinesses>
    <us-gaap:OtherPaymentsToAcquireBusinesses contextRef="c-5" decimals="-5" id="f-225" unitRef="usd">15000000.0</us-gaap:OtherPaymentsToAcquireBusinesses>
    <us-gaap:PaymentsToAcquireReceivables contextRef="c-1" decimals="-5" id="f-226" unitRef="usd">2500000</us-gaap:PaymentsToAcquireReceivables>
    <us-gaap:PaymentsToAcquireReceivables contextRef="c-5" decimals="-5" id="f-227" unitRef="usd">15000000.0</us-gaap:PaymentsToAcquireReceivables>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="c-1" decimals="-5" id="f-228" unitRef="usd">2300000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="c-5" decimals="-5" id="f-229" unitRef="usd">1900000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-5" id="f-230" unitRef="usd">63100000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-5" decimals="-5" id="f-231" unitRef="usd">500000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-1" decimals="-5" id="f-232" unitRef="usd">200000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-5" decimals="-5" id="f-233" unitRef="usd">249300000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromStockPlans contextRef="c-1" decimals="-5" id="f-234" unitRef="usd">62100000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans contextRef="c-5" decimals="-5" id="f-235" unitRef="usd">41900000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="c-1" decimals="-5" id="f-236" unitRef="usd">-200000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="c-5" decimals="-5" id="f-237" unitRef="usd">800000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-5" id="f-238" unitRef="usd">61700000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-5" decimals="-5" id="f-239" unitRef="usd">-206600000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-1" decimals="-5" id="f-240" unitRef="usd">9700000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-5" id="f-241" unitRef="usd">-4200000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-5" id="f-242" unitRef="usd">81000000.0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-5" decimals="-5" id="f-243" unitRef="usd">103800000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-5" id="f-244" unitRef="usd">1148000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-6" decimals="-5" id="f-245" unitRef="usd">772600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="-5" id="f-246" unitRef="usd">1229000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-7" decimals="-5" id="f-247" unitRef="usd">876400000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-8" decimals="-5" id="f-248" unitRef="shares">650500000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-8" decimals="-5" id="f-249" unitRef="usd">650500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares contextRef="c-9" decimals="-5" id="f-250" unitRef="shares">49400000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-9" decimals="-5" id="f-251" unitRef="usd">-5024500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-10" decimals="-5" id="f-252" unitRef="usd">2274400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-11" decimals="-5" id="f-253" unitRef="usd">8992400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-12" decimals="-5" id="f-254" unitRef="usd">-242800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-13" decimals="-5" id="f-255" unitRef="usd">6650000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-14" decimals="-5" id="f-256" unitRef="usd">69400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-4" decimals="-5" id="f-257" unitRef="usd">6719400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss contextRef="c-15" decimals="-5" id="f-258" unitRef="usd">351900000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-16" decimals="-5" id="f-259" unitRef="usd">351900000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-17" decimals="-5" id="f-260" unitRef="usd">-900000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-5" id="f-261" unitRef="usd">351000000.0</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-18" decimals="-5" id="f-262" unitRef="usd">9500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-16" decimals="-5" id="f-263" unitRef="usd">9500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-5" id="f-264" unitRef="usd">9500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="c-19" decimals="-5" id="f-265" unitRef="shares">1300000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-19" decimals="-5" id="f-266" unitRef="usd">1300000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-20" decimals="-5" id="f-267" unitRef="usd">60800000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-16" decimals="-5" id="f-268" unitRef="usd">62100000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-1" decimals="-5" id="f-269" unitRef="usd">62100000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-20" decimals="-5" id="f-270" unitRef="usd">44600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-16" decimals="-5" id="f-271" unitRef="usd">44600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="-5" id="f-272" unitRef="usd">44600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-21" decimals="-5" id="f-273" unitRef="usd">200000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-16" decimals="-5" id="f-274" unitRef="usd">200000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-1" decimals="-5" id="f-275" unitRef="usd">200000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-22" decimals="-5" id="f-276" unitRef="shares">651800000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-22" decimals="-5" id="f-277" unitRef="usd">651800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares contextRef="c-23" decimals="-5" id="f-278" unitRef="shares">49400000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-23" decimals="-5" id="f-279" unitRef="usd">-5024700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-24" decimals="-5" id="f-280" unitRef="usd">2379800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-25" decimals="-5" id="f-281" unitRef="usd">9344300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-26" decimals="-5" id="f-282" unitRef="usd">-233300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-27" decimals="-5" id="f-283" unitRef="usd">7117900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-28" decimals="-5" id="f-284" unitRef="usd">68500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-3" decimals="-5" id="f-285" unitRef="usd">7186400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-29" decimals="-5" id="f-286" unitRef="shares">646300000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-29" decimals="-5" id="f-287" unitRef="usd">646300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares contextRef="c-30" decimals="-5" id="f-288" unitRef="shares">38000000.0</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-30" decimals="-5" id="f-289" unitRef="usd">-4144000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-31" decimals="-5" id="f-290" unitRef="usd">1969300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-32" decimals="-5" id="f-291" unitRef="usd">7590000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-33" decimals="-5" id="f-292" unitRef="usd">-254900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-34" decimals="-5" id="f-293" unitRef="usd">5806700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-35" decimals="-5" id="f-294" unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-6" decimals="-5" id="f-295" unitRef="usd">5806700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss contextRef="c-36" decimals="-5" id="f-296" unitRef="usd">340500000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-37" decimals="-5" id="f-297" unitRef="usd">340500000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-5" decimals="-5" id="f-298" unitRef="usd">340500000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-38" decimals="-5" id="f-299" unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-37" decimals="-5" id="f-300" unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-5" decimals="-5" id="f-301" unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="c-39" decimals="-5" id="f-302" unitRef="shares">800000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-39" decimals="-5" id="f-303" unitRef="usd">800000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-40" decimals="-5" id="f-304" unitRef="usd">41100000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-37" decimals="-5" id="f-305" unitRef="usd">41900000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-5" decimals="-5" id="f-306" unitRef="usd">41900000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-40" decimals="-5" id="f-307" unitRef="usd">38900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-37" decimals="-5" id="f-308" unitRef="usd">38900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-5" decimals="-5" id="f-309" unitRef="usd">38900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-41" decimals="-5" id="f-310" unitRef="shares">3100000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-41" decimals="-5" id="f-311" unitRef="usd">249500000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-37" decimals="-5" id="f-312" unitRef="usd">249500000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-5" decimals="-5" id="f-313" unitRef="usd">249500000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease contextRef="c-42" decimals="-5" id="f-314" unitRef="usd">84000000.0</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease contextRef="c-5" decimals="-5" id="f-315" unitRef="usd">84000000.0</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-43" decimals="-5" id="f-316" unitRef="shares">647100000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-43" decimals="-5" id="f-317" unitRef="usd">647100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares contextRef="c-44" decimals="-5" id="f-318" unitRef="shares">41100000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-44" decimals="-5" id="f-319" unitRef="usd">-4393500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-45" decimals="-5" id="f-320" unitRef="usd">2049300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-46" decimals="-5" id="f-321" unitRef="usd">7930500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-47" decimals="-5" id="f-322" unitRef="usd">-255400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-48" decimals="-5" id="f-323" unitRef="usd">5978000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-49" decimals="-5" id="f-324" unitRef="usd">84000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-7" decimals="-5" id="f-325" unitRef="usd">6062000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock contextRef="c-1" id="f-326">BASIS OF PRESENTATION&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying interim consolidated condensed financial statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") and should be read in conjunction with the consolidated financial statements and notes included in Edwards Lifesciences' Annual Report on Form&#160;10-K for the year ended December&#160;31, 2023. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") have been condensed or omitted.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The consolidated condensed financial statements include the accounts of all wholly-owned subsidiaries and variable interest entities for which the Company is the primary beneficiary. The Company attributes the net income or losses of its consolidated variable interest entities to controlling and noncontrolling interests using the hypothetical liquidation at book value method.  All intercompany accounts and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements.  Actual results could differ from those&#160;estimates.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the opinion of management, the unaudited interim consolidated condensed financial statements reflect all adjustments necessary for a fair statement of the results for the interim periods presented. All such adjustments, unless otherwise noted herein, are of a normal, recurring nature. The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for the full year.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There have been no material changes to the Company's significant accounting policies from those described in the Company's Annual Report on Form 10-K for the year ended December 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2023, the Financial Accounting Standards Board ("FASB") issued an amendment to the accounting guidance on investments in tax credit structures to allow entities to elect to account for their tax equity investments, regardless of the tax credit program from which the income tax credits are received, using the proportional amortization method if certain conditions are met.   The guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years.  The Company adopted this guidance on January 1, 2024.  The adoption of this guidance did not have a material impact on the Company's consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;New Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2024, the SEC issued final climate-related disclosure rules that will require disclosure of material climate-related risks and material direct greenhouse gas emissions from operations owned or controlled (Scope 1) and/or material indirect greenhouse gas emissions from purchased energy consumed in owned or controlled operations (Scope 2). Additionally, the rules require disclosure in the notes to the financial statements of the effects of severe weather events and other natural conditions, subject to certain materiality thresholds. The new rules will be effective for annual reporting periods beginning in fiscal year 2025, except for the greenhouse gas emissions disclosures which will be effective for annual reporting periods beginning in fiscal year 2026. Subsequent to issuance, the rules became the subject of litigation, and the SEC has issued a stay to allow the legal process to proceed.  The Company is currently evaluating the impact the guidance will have on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued an amendment to the accounting guidance on income taxes which requires entities to provide additional information in the rate reconciliation and additional disaggregated disclosures about income taxes paid. This guidance requires public entities to disclose in their rate reconciliation table additional categories of information about federal, state, and foreign income taxes and to provide more details about the reconciling items in some categories if the items meet a quantitative threshold. The guidance is effective for annual periods beginning after December 15, 2024. The Company does not expect the adoption of this guidance to impact its financial statements, but the guidance will impact its income tax disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2023, the FASB issued an amendment to the accounting guidance on segment reporting. The amendments require disclosure of significant segment expenses and other segment items and requires entities to provide in interim periods&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;all disclosures about a reportable segment's profit or loss and assets that are currently required annually. The amendment also&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;requires disclosure of the title and position of the chief operating decision maker ("CODM") and an explanation of how the&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;resources. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;beginning after December 15, 2024. Retrospective application is required, and early adoption is permitted. The Company is&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;currently evaluating the impact the guidance will have on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-327">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying interim consolidated condensed financial statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") and should be read in conjunction with the consolidated financial statements and notes included in Edwards Lifesciences' Annual Report on Form&#160;10-K for the year ended December&#160;31, 2023. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") have been condensed or omitted.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c-1" id="f-328">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The consolidated condensed financial statements include the accounts of all wholly-owned subsidiaries and variable interest entities for which the Company is the primary beneficiary. The Company attributes the net income or losses of its consolidated variable interest entities to controlling and noncontrolling interests using the hypothetical liquidation at book value method.  All intercompany accounts and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-329">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements.  Actual results could differ from those&#160;estimates.</us-gaap:UseOfEstimates>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-330">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2023, the Financial Accounting Standards Board ("FASB") issued an amendment to the accounting guidance on investments in tax credit structures to allow entities to elect to account for their tax equity investments, regardless of the tax credit program from which the income tax credits are received, using the proportional amortization method if certain conditions are met.   The guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years.  The Company adopted this guidance on January 1, 2024.  The adoption of this guidance did not have a material impact on the Company's consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;New Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2024, the SEC issued final climate-related disclosure rules that will require disclosure of material climate-related risks and material direct greenhouse gas emissions from operations owned or controlled (Scope 1) and/or material indirect greenhouse gas emissions from purchased energy consumed in owned or controlled operations (Scope 2). Additionally, the rules require disclosure in the notes to the financial statements of the effects of severe weather events and other natural conditions, subject to certain materiality thresholds. The new rules will be effective for annual reporting periods beginning in fiscal year 2025, except for the greenhouse gas emissions disclosures which will be effective for annual reporting periods beginning in fiscal year 2026. Subsequent to issuance, the rules became the subject of litigation, and the SEC has issued a stay to allow the legal process to proceed.  The Company is currently evaluating the impact the guidance will have on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued an amendment to the accounting guidance on income taxes which requires entities to provide additional information in the rate reconciliation and additional disaggregated disclosures about income taxes paid. This guidance requires public entities to disclose in their rate reconciliation table additional categories of information about federal, state, and foreign income taxes and to provide more details about the reconciling items in some categories if the items meet a quantitative threshold. The guidance is effective for annual periods beginning after December 15, 2024. The Company does not expect the adoption of this guidance to impact its financial statements, but the guidance will impact its income tax disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2023, the FASB issued an amendment to the accounting guidance on segment reporting. The amendments require disclosure of significant segment expenses and other segment items and requires entities to provide in interim periods&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;all disclosures about a reportable segment's profit or loss and assets that are currently required annually. The amendment also&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;requires disclosure of the title and position of the chief operating decision maker ("CODM") and an explanation of how the&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;resources. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;beginning after December 15, 2024. Retrospective application is required, and early adoption is permitted. The Company is&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;currently evaluating the impact the guidance will have on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock contextRef="c-1" id="f-331">OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Composition of Certain Financial Statement Captions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Components of selected captions in the consolidated condensed balance sheets consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.586%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.190%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.191%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;668.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,207.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,168.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2024 and December&#160;31, 2023, $161.7 million and $164.6 million, respectively, of the Company's finished products inventories were held on consignment. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:22.5pt;text-indent:-22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.586%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.190%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.191%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax receivable (Note 14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes and other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term prepaid royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;767.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee compensation and withholdings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, payroll, and other taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued rebates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued marketing expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal and insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Litigation settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued relocation costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued realignment reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued warranties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;873.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;969.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Supplemental Cash Flow Information&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.706%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.631%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid during the year for:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes (Note 14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts included in the measurement of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash investing and financing transactions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for new lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital expenditures accruals&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash, Cash Equivalents, and Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,224.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,144.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash included in other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash included in other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents, and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,229.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,148.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts included in restricted cash primarily represent funds placed in escrow related to litigation.&lt;/span&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="c-1" id="f-332">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Components of selected captions in the consolidated condensed balance sheets consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.586%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.190%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.191%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;668.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,207.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,168.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="c-3" decimals="-5" id="f-333" unitRef="usd">280000000.0</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="c-4" decimals="-5" id="f-334" unitRef="usd">252600000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="c-3" decimals="-5" id="f-335" unitRef="usd">258600000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="c-4" decimals="-5" id="f-336" unitRef="usd">220100000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="c-3" decimals="-5" id="f-337" unitRef="usd">668700000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="c-4" decimals="-5" id="f-338" unitRef="usd">695500000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet contextRef="c-3" decimals="-5" id="f-339" unitRef="usd">1207300000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c-4" decimals="-5" id="f-340" unitRef="usd">1168200000</us-gaap:InventoryNet>
    <us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment contextRef="c-3" decimals="-5" id="f-341" unitRef="usd">161700000</us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment>
    <us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment contextRef="c-4" decimals="-5" id="f-342" unitRef="usd">164600000</us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="c-1" id="f-343">&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.586%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.190%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.191%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax receivable (Note 14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes and other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term prepaid royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;767.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee compensation and withholdings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, payroll, and other taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued rebates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued marketing expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal and insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Litigation settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued relocation costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued realignment reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued warranties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;873.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;969.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:IncomeTaxReceivable contextRef="c-3" decimals="-5" id="f-344" unitRef="usd">286400000</us-gaap:IncomeTaxReceivable>
    <us-gaap:IncomeTaxReceivable contextRef="c-4" decimals="-5" id="f-345" unitRef="usd">0</us-gaap:IncomeTaxReceivable>
    <us-gaap:OtherReceivableAfterAllowanceForCreditLossNoncurrent contextRef="c-3" decimals="-5" id="f-346" unitRef="usd">159500000</us-gaap:OtherReceivableAfterAllowanceForCreditLossNoncurrent>
    <us-gaap:OtherReceivableAfterAllowanceForCreditLossNoncurrent contextRef="c-4" decimals="-5" id="f-347" unitRef="usd">155100000</us-gaap:OtherReceivableAfterAllowanceForCreditLossNoncurrent>
    <ew:AcquisitionOptionsNoncurrent contextRef="c-3" decimals="-5" id="f-348" unitRef="usd">172100000</ew:AcquisitionOptionsNoncurrent>
    <ew:AcquisitionOptionsNoncurrent contextRef="c-4" decimals="-5" id="f-349" unitRef="usd">161300000</ew:AcquisitionOptionsNoncurrent>
    <us-gaap:PrepaidExpenseCurrentAndNoncurrent contextRef="c-3" decimals="-5" id="f-350" unitRef="usd">107800000</us-gaap:PrepaidExpenseCurrentAndNoncurrent>
    <us-gaap:PrepaidExpenseCurrentAndNoncurrent contextRef="c-4" decimals="-5" id="f-351" unitRef="usd">109900000</us-gaap:PrepaidExpenseCurrentAndNoncurrent>
    <us-gaap:DerivativeAssetsNoncurrent contextRef="c-3" decimals="-5" id="f-352" unitRef="usd">27900000</us-gaap:DerivativeAssetsNoncurrent>
    <us-gaap:DerivativeAssetsNoncurrent contextRef="c-4" decimals="-5" id="f-353" unitRef="usd">23400000</us-gaap:DerivativeAssetsNoncurrent>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent contextRef="c-3" decimals="-5" id="f-354" unitRef="usd">13900000</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent contextRef="c-4" decimals="-5" id="f-355" unitRef="usd">14000000.0</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-3" decimals="-5" id="f-356" unitRef="usd">767600000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-4" decimals="-5" id="f-357" unitRef="usd">463700000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-3" decimals="-5" id="f-358" unitRef="usd">237200000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-4" decimals="-5" id="f-359" unitRef="usd">371200000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="c-3" decimals="-5" id="f-360" unitRef="usd">85000000.0</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="c-4" decimals="-5" id="f-361" unitRef="usd">59300000</us-gaap:AccruedIncomeTaxesCurrent>
    <ew:AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent contextRef="c-3" decimals="-5" id="f-362" unitRef="usd">71200000</ew:AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent>
    <ew:AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent contextRef="c-4" decimals="-5" id="f-363" unitRef="usd">63000000.0</ew:AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent>
    <ew:ResearchAndDevelopmentAccruals contextRef="c-3" decimals="-5" id="f-364" unitRef="usd">75700000</ew:ResearchAndDevelopmentAccruals>
    <ew:ResearchAndDevelopmentAccruals contextRef="c-4" decimals="-5" id="f-365" unitRef="usd">74100000</ew:ResearchAndDevelopmentAccruals>
    <ew:AccruedRebates contextRef="c-3" decimals="-5" id="f-366" unitRef="usd">120600000</ew:AccruedRebates>
    <ew:AccruedRebates contextRef="c-4" decimals="-5" id="f-367" unitRef="usd">131400000</ew:AccruedRebates>
    <us-gaap:DerivativeLiabilitiesCurrent contextRef="c-3" decimals="-5" id="f-368" unitRef="usd">4900000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent contextRef="c-4" decimals="-5" id="f-369" unitRef="usd">15200000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:AccruedMarketingCostsCurrent contextRef="c-3" decimals="-5" id="f-370" unitRef="usd">14100000</us-gaap:AccruedMarketingCostsCurrent>
    <us-gaap:AccruedMarketingCostsCurrent contextRef="c-4" decimals="-5" id="f-371" unitRef="usd">15000000.0</us-gaap:AccruedMarketingCostsCurrent>
    <ew:AccruedLitigationAndInsuranceReserves contextRef="c-3" decimals="-5" id="f-372" unitRef="usd">32900000</ew:AccruedLitigationAndInsuranceReserves>
    <ew:AccruedLitigationAndInsuranceReserves contextRef="c-4" decimals="-5" id="f-373" unitRef="usd">30700000</ew:AccruedLitigationAndInsuranceReserves>
    <us-gaap:LitigationReserveCurrent contextRef="c-3" decimals="-5" id="f-374" unitRef="usd">76100000</us-gaap:LitigationReserveCurrent>
    <us-gaap:LitigationReserveCurrent contextRef="c-4" decimals="-5" id="f-375" unitRef="usd">69100000</us-gaap:LitigationReserveCurrent>
    <ew:AccruedRelocationCostsCurrent contextRef="c-3" decimals="-5" id="f-376" unitRef="usd">19300000</ew:AccruedRelocationCostsCurrent>
    <ew:AccruedRelocationCostsCurrent contextRef="c-4" decimals="-5" id="f-377" unitRef="usd">19200000</ew:AccruedRelocationCostsCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-3" decimals="-5" id="f-378" unitRef="usd">15700000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-4" decimals="-5" id="f-379" unitRef="usd">8800000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:RestructuringReserveCurrent contextRef="c-3" decimals="-5" id="f-380" unitRef="usd">10200000</us-gaap:RestructuringReserveCurrent>
    <us-gaap:RestructuringReserveCurrent contextRef="c-4" decimals="-5" id="f-381" unitRef="usd">12300000</us-gaap:RestructuringReserveCurrent>
    <us-gaap:ProductWarrantyAccrualClassifiedCurrent contextRef="c-3" decimals="-5" id="f-382" unitRef="usd">10500000</us-gaap:ProductWarrantyAccrualClassifiedCurrent>
    <us-gaap:ProductWarrantyAccrualClassifiedCurrent contextRef="c-4" decimals="-5" id="f-383" unitRef="usd">10000000.0</us-gaap:ProductWarrantyAccrualClassifiedCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-3" decimals="-5" id="f-384" unitRef="usd">100300000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-4" decimals="-5" id="f-385" unitRef="usd">89800000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <ew:AccruedAndOtherLiabilitiesCurrent contextRef="c-3" decimals="-5" id="f-386" unitRef="usd">873700000</ew:AccruedAndOtherLiabilitiesCurrent>
    <ew:AccruedAndOtherLiabilitiesCurrent contextRef="c-4" decimals="-5" id="f-387" unitRef="usd">969100000</ew:AccruedAndOtherLiabilitiesCurrent>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock contextRef="c-1" id="f-388">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Supplemental Cash Flow Information&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.706%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.631%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid during the year for:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes (Note 14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts included in the measurement of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash investing and financing transactions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for new lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital expenditures accruals&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:IncomeTaxesPaid contextRef="c-1" decimals="-5" id="f-389" unitRef="usd">349200000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="c-5" decimals="-5" id="f-390" unitRef="usd">21700000</us-gaap:IncomeTaxesPaid>
    <us-gaap:OperatingLeasePayments contextRef="c-1" decimals="-5" id="f-391" unitRef="usd">8200000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-5" decimals="-5" id="f-392" unitRef="usd">7100000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-1" decimals="-5" id="f-393" unitRef="usd">13400000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-5" decimals="-5" id="f-394" unitRef="usd">2200000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-1" decimals="-5" id="f-395" unitRef="usd">34300000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-5" decimals="-5" id="f-396" unitRef="usd">26500000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock contextRef="c-1" id="f-398">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash, Cash Equivalents, and Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,224.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,144.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash included in other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash included in other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents, and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,229.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,148.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock contextRef="c-1" id="f-397">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash, Cash Equivalents, and Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,224.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,144.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash included in other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash included in other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents, and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,229.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,148.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-5" id="f-399" unitRef="usd">1224600000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-5" id="f-400" unitRef="usd">1144000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent contextRef="c-3" decimals="-5" id="f-401" unitRef="usd">3600000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent contextRef="c-4" decimals="-5" id="f-402" unitRef="usd">3300000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-3" decimals="-5" id="f-403" unitRef="usd">800000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-4" decimals="-5" id="f-404" unitRef="usd">700000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="-5" id="f-405" unitRef="usd">1229000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-5" id="f-406" unitRef="usd">1148000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:LegalMattersAndContingenciesTextBlock contextRef="c-1" id="f-407">INTELLECTUAL PROPERTY AGREEMENT AND CERTAIN LITIGATION EXPENSES&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 12, 2023, Edwards entered into an Intellectual Property Agreement (the "Intellectual Property Agreement") with Medtronic, Inc. ("Medtronic") pursuant to which the parties agreed to a 15-year global covenant not to sue ("CNS") for infringement of certain patents in the structural heart space owned or controlled by each other. In consideration for the global CNS and related mutual access to certain intellectual property rights, Edwards paid to Medtronic a one-time, lump sum payment of $300.0&#160;million and is paying annual royalties tied to net sales of certain Edwards products.  Based upon the terms of the Intellectual Property Agreement, the Company identified the relevant elements for accounting purposes and allocated the $300.0&#160;million upfront payment based on their respective fair values.  The Company recorded a $37.0&#160;million pre-tax charge in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intellectual Property Agreement and Certain Litigation Expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in March 2023 related primarily to prior commercial sales incurred through March 31, 2023.  The Company recorded a prepaid royalty asset of $124.0&#160;million in April 2023 related to future commercial sales, which will be amortized to expense during the term of the Intellectual Property Agreement.  Separately, the Company recorded a $139.0&#160;million pre-tax charge in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intellectual Property Agreement and Certain Litigation Expenses&lt;/span&gt; in April 2023 related to products currently in development.</us-gaap:LegalMattersAndContingenciesTextBlock>
    <ew:IntellectualPropertyAgreementTerm contextRef="c-50" id="f-408">P15Y</ew:IntellectualPropertyAgreementTerm>
    <us-gaap:PaymentsForLegalSettlements contextRef="c-51" decimals="-5" id="f-409" unitRef="usd">300000000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:PaymentsForLegalSettlements contextRef="c-51" decimals="-5" id="f-410" unitRef="usd">300000000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:LitigationSettlementExpense contextRef="c-52" decimals="-5" id="f-411" unitRef="usd">37000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:PrepaidRoyalties contextRef="c-53" decimals="-5" id="f-412" unitRef="usd">124000000</us-gaap:PrepaidRoyalties>
    <us-gaap:LitigationSettlementExpense contextRef="c-54" decimals="-5" id="f-413" unitRef="usd">139000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock contextRef="c-1" id="f-414">SEPARATION COSTS&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 7, 2023, the Company announced its intention to complete a spin-off of its Critical Care product group as a separate publicly-traded company to Edwards Lifesciences' shareholders.  The proposed spin-off is intended to be a tax-free transaction for U.S. federal income tax purposes and is expected to be completed near the end of 2024, subject to the satisfaction of customary conditions including final approval by the Company's board of directors, receipt of a favorable opinion and Internal Revenue Service ruling with respect to the tax-free nature of the transaction, and the effectiveness of a registration statement on Form 10.  The Company incurred separation costs of $41.3&#160;million during the three months ended March 31, 2024, related primarily to consulting, legal, tax, and other professional advisory services associated with the planned spin-off.  The costs related primarily to the Company's United States segment.&lt;/span&gt;&lt;/div&gt;</us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges contextRef="c-1" decimals="-5" id="f-415" unitRef="usd">41300000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock contextRef="c-1" id="f-416">INVESTMENTS&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:20.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investments in debt securities at the end of each period were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.164%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.730%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Held-to-maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bank time deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;553.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;541.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;658.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;767.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;749.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;898.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cost and fair value of investments in debt securities, by contractual maturity, as of March&#160;31, 2024, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:54.016%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.578%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Held-to-Maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Available-for-Sale&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due in 1&#160;year or less&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after 1&#160;year through 5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments not due at a single maturity date&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;767.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;749.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:22.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(a)  &#160;&#160;&#160;&#160;Consists of mortgage-backed and asset-backed securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Actual maturities may differ from the contractual maturities due to call or prepayment rights.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present gross unrealized losses and fair values for those investments that were in an unrealized loss position as of March&#160;31, 2024 and December&#160;31, 2023, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.282%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.270%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.703%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.270%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.996%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.270%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.996%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.270%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.703%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.270%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.996%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.274%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less than 12 Months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12 Months or Greater&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;430.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;430.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;622.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;634.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.700%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.992%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.992%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.700%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.992%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.411%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less than 12 Months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12 Months or Greater&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;843.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;878.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews its investments in debt securities to determine if there has been an other-than-temporary decline in fair value.  Consideration is given to 1) the financial condition and near-term prospects of the issuer, including the credit quality of the security's issuer, 2) the Company's intent to sell the security, and 3) whether it is more likely than not the Company will have to sell the security before recovery of its amortized cost. The unrealized losses on the debt securities were largely due to changes in interest rates, not credit quality, and as of March&#160;31, 2024, the Company did not intend to sell the securities, and it was not more likely than not that it will be required to sell the securities before recovery of the unrealized losses, and, therefore, the unrealized losses are considered temporary.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments in Unconsolidated Entities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:20.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a number of equity investments in unconsolidated entities.  These investments are recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-term Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; on the consolidated condensed balance sheets, and are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.438%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value of equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value of non-marketable equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total investments in unconsolidated entities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company makes equity investments in limited liability companies that invest in qualified community development entities ("CDEs") through the New Markets Tax Credit ("NMTC") program.  The NMTC program provides federal tax incentives to investors to make investments in distressed communities and promotes economic improvements through the development of successful businesses in these communities.  The NMTC is equal to 39% of the qualified investment and is taken over seven years. These limited liability companies are variable interest entities ("VIEs").  The Company determined that it is not the primary beneficiary of the VIEs because it does not have the power to direct the activities that most significantly impact the economic performance of the VIEs and, therefore, the Company does not consolidate these entities.  Instead, the NMTC investments are accounted for as equity method investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-marketable equity securities consist of investments in privately held companies without readily determinable fair values, and are reported at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer.  The Company recorded a downward adjustment of $2.4 million during the three months ended March 31, 2024 based on observable price changes.  As of March&#160;31, 2024, the Company had recorded cumulative upward adjustments of $8.8 million based on observable price changes, and cumulative downward adjustments of $5.5 million due to impairments and observable price changes.   &lt;/span&gt;&lt;/div&gt;During the three months ended March 31, 2024, the gross realized gains or losses from sales of available-for-sale investments were not material.</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock contextRef="c-1" id="f-417">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investments in debt securities at the end of each period were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.164%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.730%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Held-to-maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bank time deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;553.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;541.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;658.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;767.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;749.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;898.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock>
    <us-gaap:HeldToMaturitySecurities contextRef="c-55" decimals="-5" id="f-418" unitRef="usd">56000000.0</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain contextRef="c-55" decimals="-5" id="f-419" unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss contextRef="c-55" decimals="-5" id="f-420" unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue contextRef="c-55" decimals="-5" id="f-421" unitRef="usd">56000000.0</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecurities contextRef="c-56" decimals="-5" id="f-422" unitRef="usd">64500000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain contextRef="c-56" decimals="-5" id="f-423" unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss contextRef="c-56" decimals="-5" id="f-424" unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue contextRef="c-56" decimals="-5" id="f-425" unitRef="usd">64500000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-57" decimals="-5" id="f-426" unitRef="usd">63800000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-57" decimals="-5" id="f-427" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-57" decimals="-5" id="f-428" unitRef="usd">2400000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-57" decimals="-5" id="f-429" unitRef="usd">61400000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-58" decimals="-5" id="f-430" unitRef="usd">72700000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-58" decimals="-5" id="f-431" unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-58" decimals="-5" id="f-432" unitRef="usd">2800000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-58" decimals="-5" id="f-433" unitRef="usd">70000000.0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-59" decimals="-5" id="f-434" unitRef="usd">148000000.0</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-59" decimals="-5" id="f-435" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-59" decimals="-5" id="f-436" unitRef="usd">3800000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-59" decimals="-5" id="f-437" unitRef="usd">144200000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-60" decimals="-5" id="f-438" unitRef="usd">192100000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-60" decimals="-5" id="f-439" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-60" decimals="-5" id="f-440" unitRef="usd">7800000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-60" decimals="-5" id="f-441" unitRef="usd">184300000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-61" decimals="-5" id="f-442" unitRef="usd">553100000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-61" decimals="-5" id="f-443" unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-61" decimals="-5" id="f-444" unitRef="usd">11700000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-61" decimals="-5" id="f-445" unitRef="usd">541500000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-62" decimals="-5" id="f-446" unitRef="usd">658500000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-62" decimals="-5" id="f-447" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-62" decimals="-5" id="f-448" unitRef="usd">16700000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-62" decimals="-5" id="f-449" unitRef="usd">641800000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-63" decimals="-5" id="f-450" unitRef="usd">2800000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-63" decimals="-5" id="f-451" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-63" decimals="-5" id="f-452" unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-63" decimals="-5" id="f-453" unitRef="usd">2700000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-64" decimals="-5" id="f-454" unitRef="usd">2800000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-64" decimals="-5" id="f-455" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-64" decimals="-5" id="f-456" unitRef="usd">200000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-64" decimals="-5" id="f-457" unitRef="usd">2600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-3" decimals="-5" id="f-458" unitRef="usd">767700000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-3" decimals="-5" id="f-459" unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-3" decimals="-5" id="f-460" unitRef="usd">18000000.0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-3" decimals="-5" id="f-461" unitRef="usd">749800000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-4" decimals="-5" id="f-462" unitRef="usd">926100000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-4" decimals="-5" id="f-463" unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-4" decimals="-5" id="f-464" unitRef="usd">27500000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-4" decimals="-5" id="f-465" unitRef="usd">898700000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock contextRef="c-1" id="f-466">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cost and fair value of investments in debt securities, by contractual maturity, as of March&#160;31, 2024, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:54.016%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.578%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Held-to-Maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Available-for-Sale&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due in 1&#160;year or less&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after 1&#160;year through 5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments not due at a single maturity date&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;767.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;749.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:22.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(a)  &#160;&#160;&#160;&#160;Consists of mortgage-backed and asset-backed securities.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost contextRef="c-3" decimals="-5" id="f-467" unitRef="usd">56000000.0</us-gaap:HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue contextRef="c-3" decimals="-5" id="f-468" unitRef="usd">56000000.0</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis contextRef="c-3" decimals="-5" id="f-469" unitRef="usd">422800000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue contextRef="c-3" decimals="-5" id="f-470" unitRef="usd">417000000.0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue>
    <us-gaap:HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost contextRef="c-3" decimals="-5" id="f-471" unitRef="usd">0</us-gaap:HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue contextRef="c-3" decimals="-5" id="f-472" unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis contextRef="c-3" decimals="-5" id="f-473" unitRef="usd">181600000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue contextRef="c-3" decimals="-5" id="f-474" unitRef="usd">174800000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount contextRef="c-3" decimals="-5" id="f-475" unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue contextRef="c-3" decimals="-5" id="f-476" unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost contextRef="c-3" decimals="-5" id="f-477" unitRef="usd">163300000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue contextRef="c-3" decimals="-5" id="f-478" unitRef="usd">158000000.0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss contextRef="c-3" decimals="-5" id="f-479" unitRef="usd">56000000.0</us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue contextRef="c-3" decimals="-5" id="f-480" unitRef="usd">56000000.0</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-3" decimals="-5" id="f-481" unitRef="usd">767700000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-3" decimals="-5" id="f-482" unitRef="usd">749800000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock contextRef="c-1" id="f-483">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present gross unrealized losses and fair values for those investments that were in an unrealized loss position as of March&#160;31, 2024 and December&#160;31, 2023, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.282%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.270%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.703%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.270%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.996%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.270%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.996%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.270%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.703%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.270%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.996%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.274%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less than 12 Months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12 Months or Greater&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;430.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;430.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;622.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;634.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.700%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.992%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.992%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.700%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.992%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.411%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less than 12 Months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12 Months or Greater&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;843.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;878.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months contextRef="c-57" decimals="-5" id="f-484" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="c-57" decimals="-5" id="f-485" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger contextRef="c-57" decimals="-5" id="f-486" unitRef="usd">58500000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="c-57" decimals="-5" id="f-487" unitRef="usd">2400000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition contextRef="c-57" decimals="-5" id="f-488" unitRef="usd">58500000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c-57" decimals="-5" id="f-489" unitRef="usd">2400000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months contextRef="c-59" decimals="-5" id="f-490" unitRef="usd">12200000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="c-59" decimals="-5" id="f-491" unitRef="usd">100000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger contextRef="c-59" decimals="-5" id="f-492" unitRef="usd">130700000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="c-59" decimals="-5" id="f-493" unitRef="usd">3700000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition contextRef="c-59" decimals="-5" id="f-494" unitRef="usd">142900000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c-59" decimals="-5" id="f-495" unitRef="usd">3800000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months contextRef="c-61" decimals="-5" id="f-496" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="c-61" decimals="-5" id="f-497" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger contextRef="c-61" decimals="-5" id="f-498" unitRef="usd">430300000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="c-61" decimals="-5" id="f-499" unitRef="usd">11700000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition contextRef="c-61" decimals="-5" id="f-500" unitRef="usd">430300000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c-61" decimals="-5" id="f-501" unitRef="usd">11700000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months contextRef="c-63" decimals="-5" id="f-502" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="c-63" decimals="-5" id="f-503" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger contextRef="c-63" decimals="-5" id="f-504" unitRef="usd">2600000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="c-63" decimals="-5" id="f-505" unitRef="usd">100000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition contextRef="c-63" decimals="-5" id="f-506" unitRef="usd">2600000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c-63" decimals="-5" id="f-507" unitRef="usd">100000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months contextRef="c-3" decimals="-5" id="f-508" unitRef="usd">12200000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="c-3" decimals="-5" id="f-509" unitRef="usd">100000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger contextRef="c-3" decimals="-5" id="f-510" unitRef="usd">622100000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="c-3" decimals="-5" id="f-511" unitRef="usd">17900000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition contextRef="c-3" decimals="-5" id="f-512" unitRef="usd">634300000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c-3" decimals="-5" id="f-513" unitRef="usd">18000000.0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months contextRef="c-58" decimals="-5" id="f-514" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="c-58" decimals="-5" id="f-515" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger contextRef="c-58" decimals="-5" id="f-516" unitRef="usd">67100000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="c-58" decimals="-5" id="f-517" unitRef="usd">2800000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition contextRef="c-58" decimals="-5" id="f-518" unitRef="usd">67100000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c-58" decimals="-5" id="f-519" unitRef="usd">2800000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months contextRef="c-60" decimals="-5" id="f-520" unitRef="usd">10200000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="c-60" decimals="-5" id="f-521" unitRef="usd">1800000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger contextRef="c-60" decimals="-5" id="f-522" unitRef="usd">172700000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="c-60" decimals="-5" id="f-523" unitRef="usd">6000000.0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition contextRef="c-60" decimals="-5" id="f-524" unitRef="usd">182900000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c-60" decimals="-5" id="f-525" unitRef="usd">7800000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months contextRef="c-62" decimals="-5" id="f-526" unitRef="usd">25000000.0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="c-62" decimals="-5" id="f-527" unitRef="usd">100000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger contextRef="c-62" decimals="-5" id="f-528" unitRef="usd">601300000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="c-62" decimals="-5" id="f-529" unitRef="usd">16600000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition contextRef="c-62" decimals="-5" id="f-530" unitRef="usd">626300000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c-62" decimals="-5" id="f-531" unitRef="usd">16700000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months contextRef="c-64" decimals="-5" id="f-532" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="c-64" decimals="-5" id="f-533" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger contextRef="c-64" decimals="-5" id="f-534" unitRef="usd">2600000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="c-64" decimals="-5" id="f-535" unitRef="usd">200000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition contextRef="c-64" decimals="-5" id="f-536" unitRef="usd">2600000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c-64" decimals="-5" id="f-537" unitRef="usd">200000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months contextRef="c-4" decimals="-5" id="f-538" unitRef="usd">35200000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="c-4" decimals="-5" id="f-539" unitRef="usd">1900000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger contextRef="c-4" decimals="-5" id="f-540" unitRef="usd">843700000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="c-4" decimals="-5" id="f-541" unitRef="usd">25600000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition contextRef="c-4" decimals="-5" id="f-542" unitRef="usd">878900000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c-4" decimals="-5" id="f-543" unitRef="usd">27500000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock contextRef="c-1" id="f-544">These investments are recorded in &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-term Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; on the consolidated condensed balance sheets, and are as follows:&lt;/span&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.438%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value of equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value of non-marketable equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total investments in unconsolidated entities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock>
    <us-gaap:EquityMethodInvestments contextRef="c-3" decimals="-5" id="f-545" unitRef="usd">34100000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments contextRef="c-4" decimals="-5" id="f-546" unitRef="usd">33600000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-3" decimals="-5" id="f-547" unitRef="usd">88700000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-4" decimals="-5" id="f-548" unitRef="usd">87600000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-3" decimals="-5" id="f-549" unitRef="usd">122800000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-4" decimals="-5" id="f-550" unitRef="usd">121200000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-65" decimals="2" id="f-551" unitRef="number">0.39</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <ew:EquityMethodInvestmentsInvestmentPeriod contextRef="c-66" id="f-552">P7Y</ew:EquityMethodInvestmentsInvestmentPeriod>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount contextRef="c-1" decimals="-5" id="f-553" unitRef="usd">2400000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount contextRef="c-3" decimals="-5" id="f-554" unitRef="usd">8800000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount contextRef="c-3" decimals="-5" id="f-555" unitRef="usd">5500000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount>
    <us-gaap:VariableInterestEntityDisclosureTextBlock contextRef="c-1" id="f-556">INVESTMENTS IN VARIABLE INTEREST ENTITIES &lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews its investments in other entities to determine whether the Company is the primary beneficiary of a VIE. The Company would be the primary beneficiary of the VIE, and would be required to consolidate the VIE, if it has the power to direct the significant activities of the entity and the obligation to absorb losses or receive benefits from the entity that may be significant to the VIE.  The Company's maximum loss exposure to variable interest entities, prior to the exercise of options to acquire the entities, is limited to its investment in the variable interest entities, which include equity investments, options to acquire, and promissory notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Consolidated VIEs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2023, the Company acquired a majority equity interest in a medical technology company pursuant to a preferred stock purchase agreement, and amended and restated a previous option agreement to acquire the remaining equity interest.  Edwards concluded that it is the primary beneficiary and consolidated the VIE.  The total assets and liabilities of the Company's consolidated VIE was $266.9 million and $28.5 million, respectively, as of March&#160;31, 2024, and were $272.1 million and $31.5 million, respectively, as of December&#160;31, 2023.  The assets of the VIE can only be used to settle obligations of the VIE and general creditors have no recourse to the Company. &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.315%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.329%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Unconsolidated VIEs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Edwards has relationships with various VIEs that it does not consolidate as Edwards lacks the power to direct the activities that significantly impact the economic success of these entities.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2021, the Company entered into a promissory note agreement, a preferred stock purchase agreement, and an option agreement with a privately-held medical device company (the "Investee").  The secured promissory note provides for borrowings up to $45.0&#160;million. At both March&#160;31, 2024 and December&#160;31, 2023, the Company had advanced $30.0&#160;million under the promissory note (included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). As of March&#160;31, 2024 and December&#160;31, 2023, the Company had invested $42.8&#160;million and $39.3&#160;million, respectively, in the Investee's preferred equity securities (included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-term Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) and had paid $20.9&#160;million and $13.1&#160;million, respectively, for an option to acquire the Investee (included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).  Pursuant to the agreements, the Company may be required to invest up to an additional $3.0&#160;million in the Investee's preferred equity securities and up to an additional $6.6&#160;million for the option to acquire the Investee.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2023, the Company agreed to pay a medical device company up to $45.0&#160;million as consideration for an option&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;to acquire that medical device company, of which $30.0&#160;million had been paid as of March&#160;31, 2024. Also, in March 2023, Edwards advanced $5.0&#160;million to the medical device company under a convertible promissory note. The option and the note&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;are included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, Edwards has made equity investments through the NMTC program in limited liability companies that are considered VIEs.  For more information, see Note 5.&lt;/span&gt;&lt;/div&gt;</us-gaap:VariableInterestEntityDisclosureTextBlock>
    <us-gaap:Assets contextRef="c-67" decimals="-5" id="f-557" unitRef="usd">266900000</us-gaap:Assets>
    <us-gaap:Liabilities contextRef="c-67" decimals="-5" id="f-558" unitRef="usd">28500000</us-gaap:Liabilities>
    <us-gaap:Assets contextRef="c-68" decimals="-5" id="f-559" unitRef="usd">272100000</us-gaap:Assets>
    <us-gaap:Liabilities contextRef="c-68" decimals="-5" id="f-560" unitRef="usd">31500000</us-gaap:Liabilities>
    <ew:EquitySecuritiesFVNIMaximumSecuredPromissoryNote contextRef="c-69" decimals="-5" id="f-561" unitRef="usd">45000000</ew:EquitySecuritiesFVNIMaximumSecuredPromissoryNote>
    <ew:EquitySecuritiesFVNIPromissoryNoteOutstanding contextRef="c-70" decimals="-5" id="f-562" unitRef="usd">30000000</ew:EquitySecuritiesFVNIPromissoryNoteOutstanding>
    <ew:EquitySecuritiesFVNIPromissoryNoteOutstanding contextRef="c-71" decimals="-5" id="f-563" unitRef="usd">30000000</ew:EquitySecuritiesFVNIPromissoryNoteOutstanding>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-70" decimals="-5" id="f-564" unitRef="usd">42800000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-71" decimals="-5" id="f-565" unitRef="usd">39300000</us-gaap:EquitySecuritiesFvNi>
    <ew:EquitySecuritiesFVNIOptionToAcquireInvestment contextRef="c-70" decimals="-5" id="f-566" unitRef="usd">20900000</ew:EquitySecuritiesFVNIOptionToAcquireInvestment>
    <ew:EquitySecuritiesFVNIOptionToAcquireInvestment contextRef="c-71" decimals="-5" id="f-567" unitRef="usd">13100000</ew:EquitySecuritiesFVNIOptionToAcquireInvestment>
    <ew:EquitySecuritiesFVNIMaximumAdditionalRequired contextRef="c-70" decimals="-5" id="f-568" unitRef="usd">3000000</ew:EquitySecuritiesFVNIMaximumAdditionalRequired>
    <ew:EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment contextRef="c-70" decimals="-5" id="f-569" unitRef="usd">6600000</ew:EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment>
    <ew:LoansReceivablesMaximumLendingCapacity contextRef="c-72" decimals="-5" id="f-570" unitRef="usd">45000000</ew:LoansReceivablesMaximumLendingCapacity>
    <us-gaap:OtherPaymentsToAcquireBusinesses contextRef="c-73" decimals="-5" id="f-571" unitRef="usd">30000000</us-gaap:OtherPaymentsToAcquireBusinesses>
    <us-gaap:NotesReceivableGross contextRef="c-74" decimals="-5" id="f-572" unitRef="usd">5000000</us-gaap:NotesReceivableGross>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c-1" id="f-573">FAIR VALUE MEASUREMENTS&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The Company prioritizes the inputs used to determine fair values in one of the following three categories:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1&#x2014;Quoted market prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;2&#x2014;Inputs, other than quoted prices in active markets, that are observable, either directly or indirectly.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;3&#x2014;Unobservable inputs that are not corroborated by market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated condensed financial statements include financial instruments for which the fair market value of such instruments may differ from amounts reflected on a historical cost basis. Financial instruments of the Company consist of cash deposits, accounts and other receivables, investments, accounts payable, certain accrued liabilities, and borrowings under a revolving credit agreement. The carrying value of these financial instruments generally approximates fair value due to their &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;short-term nature. Financial instruments also include notes payable.  As of March&#160;31, 2024, the fair value of the notes payable, based on Level 2 inputs, was $584.6 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:20.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.433%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.216%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.216%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.216%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.220%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;430.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;430.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;541.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;541.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments held for deferred compensation plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;807.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,368.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;579.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;579.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments held for deferred compensation plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;945.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,650.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:20.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash Equivalents and Available-for-sale Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents included money market funds for the periods presented above.  The Company estimates the fair values of its money market funds based on quoted prices in active markets for identical assets.  The Company estimates the fair values of its corporate debt securities, asset-backed securities, United States and foreign government and agency securities, and municipal securities by taking into consideration valuations obtained from third-party pricing services. The pricing services use industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. These inputs include reported trades and broker-dealer quotes on the same or similar securities, benchmark yields, credit spreads, prepayment and default projections based on historical data, and other observable inputs.  The Company independently reviews and validates the pricing received from the third-party pricing service by comparing the prices to prices reported by a secondary pricing source.  The Company&#x2019;s validation procedures have not resulted in an adjustment to the pricing received from the pricing service.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:20.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred Compensation Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:20.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company holds investments related to its deferred compensation plans.  The investments are in a variety of stock, bond and money market mutual funds.  The fair values of these investments are based on quoted market prices.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivative Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:20.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses derivative financial instruments in the form of foreign currency forward exchange contracts and cross-currency swap contracts to manage foreign currency exposures.  All derivatives contracts are recognized on the balance sheet at their fair value.  The fair value of the derivative financial instruments was measured using quoted foreign exchange rates, interest rates, yield curves, and cross-currency swap basis rates.  The estimates presented herein are not necessarily indicative of the amounts that the Company could realize in a current market exchange.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingent Consideration Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of the Company's acquisitions involve contingent consideration arrangements.  Payment of additional consideration is contingent upon the acquired company reaching certain performance milestones, such as attaining specified sales levels or obtaining regulatory approvals.  These contingent consideration liabilities are measured at estimated fair value using either a probability weighted discounted cash flow analysis or a Monte Carlo simulation model, both of which consider significant unobservable inputs.  As of March&#160;31, 2024, the probability of milestone achievement was determined to be 0% and, accordingly, the contingent consideration liability was zero.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the changes in fair value of Level 3 financial instruments measured at fair value on a recurring basis (in millions):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.174%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.671%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.675%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-670"&gt;Changes in fair value&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-680"&gt;Changes in fair value&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:NotesPayableFairValueDisclosure contextRef="c-75" decimals="-5" id="f-574" unitRef="usd">584600000</us-gaap:NotesPayableFairValueDisclosure>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="c-1" id="f-575">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.433%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.216%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.216%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.216%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.220%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;430.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;430.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;541.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;541.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments held for deferred compensation plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;807.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,368.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;579.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;579.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments held for deferred compensation plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;945.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,650.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-76" decimals="-5" id="f-576" unitRef="usd">430000000.0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-77" decimals="-5" id="f-577" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-78" decimals="-5" id="f-578" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-79" decimals="-5" id="f-579" unitRef="usd">430000000.0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-80" decimals="-5" id="f-580" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-81" decimals="-5" id="f-581" unitRef="usd">541500000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-82" decimals="-5" id="f-582" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-83" decimals="-5" id="f-583" unitRef="usd">541500000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-84" decimals="-5" id="f-584" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-85" decimals="-5" id="f-585" unitRef="usd">144200000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-86" decimals="-5" id="f-586" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-87" decimals="-5" id="f-587" unitRef="usd">144200000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-88" decimals="-5" id="f-588" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-89" decimals="-5" id="f-589" unitRef="usd">61400000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-90" decimals="-5" id="f-590" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-91" decimals="-5" id="f-591" unitRef="usd">61400000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-92" decimals="-5" id="f-592" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-93" decimals="-5" id="f-593" unitRef="usd">2700000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-94" decimals="-5" id="f-594" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-95" decimals="-5" id="f-595" unitRef="usd">2700000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DeferredCompensationPlanAssets contextRef="c-76" decimals="-5" id="f-596" unitRef="usd">130700000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets contextRef="c-77" decimals="-5" id="f-597" unitRef="usd">0</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets contextRef="c-78" decimals="-5" id="f-598" unitRef="usd">0</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets contextRef="c-79" decimals="-5" id="f-599" unitRef="usd">130700000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DerivativeAssets contextRef="c-76" decimals="-5" id="f-600" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-77" decimals="-5" id="f-601" unitRef="usd">57500000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-78" decimals="-5" id="f-602" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-79" decimals="-5" id="f-603" unitRef="usd">57500000</us-gaap:DerivativeAssets>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-76" decimals="-5" id="f-604" unitRef="usd">560700000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-77" decimals="-5" id="f-605" unitRef="usd">807300000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-78" decimals="-5" id="f-606" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-79" decimals="-5" id="f-607" unitRef="usd">1368000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DerivativeLiabilities contextRef="c-76" decimals="-5" id="f-608" unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-77" decimals="-5" id="f-609" unitRef="usd">4900000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-78" decimals="-5" id="f-610" unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-79" decimals="-5" id="f-611" unitRef="usd">4900000</us-gaap:DerivativeLiabilities>
    <us-gaap:OtherLiabilitiesFairValueDisclosure contextRef="c-76" decimals="-5" id="f-612" unitRef="usd">0</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure contextRef="c-77" decimals="-5" id="f-613" unitRef="usd">0</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure contextRef="c-78" decimals="-5" id="f-614" unitRef="usd">5000000.0</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure contextRef="c-79" decimals="-5" id="f-615" unitRef="usd">5000000.0</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-76" decimals="-5" id="f-616" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-77" decimals="-5" id="f-617" unitRef="usd">4900000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-78" decimals="-5" id="f-618" unitRef="usd">5000000.0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-79" decimals="-5" id="f-619" unitRef="usd">9900000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-96" decimals="-5" id="f-620" unitRef="usd">579200000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-97" decimals="-5" id="f-621" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-98" decimals="-5" id="f-622" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-99" decimals="-5" id="f-623" unitRef="usd">579200000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-100" decimals="-5" id="f-624" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-101" decimals="-5" id="f-625" unitRef="usd">641800000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-102" decimals="-5" id="f-626" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-103" decimals="-5" id="f-627" unitRef="usd">641800000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-104" decimals="-5" id="f-628" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-105" decimals="-5" id="f-629" unitRef="usd">184300000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-106" decimals="-5" id="f-630" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-107" decimals="-5" id="f-631" unitRef="usd">184300000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-108" decimals="-5" id="f-632" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-109" decimals="-5" id="f-633" unitRef="usd">70000000.0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-110" decimals="-5" id="f-634" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-111" decimals="-5" id="f-635" unitRef="usd">70000000.0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-112" decimals="-5" id="f-636" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-113" decimals="-5" id="f-637" unitRef="usd">2600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-114" decimals="-5" id="f-638" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-115" decimals="-5" id="f-639" unitRef="usd">2600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DeferredCompensationPlanAssets contextRef="c-96" decimals="-5" id="f-640" unitRef="usd">125800000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets contextRef="c-97" decimals="-5" id="f-641" unitRef="usd">0</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets contextRef="c-98" decimals="-5" id="f-642" unitRef="usd">0</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets contextRef="c-99" decimals="-5" id="f-643" unitRef="usd">125800000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DerivativeAssets contextRef="c-96" decimals="-5" id="f-644" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-97" decimals="-5" id="f-645" unitRef="usd">47100000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-98" decimals="-5" id="f-646" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-99" decimals="-5" id="f-647" unitRef="usd">47100000</us-gaap:DerivativeAssets>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-96" decimals="-5" id="f-648" unitRef="usd">705000000.0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-97" decimals="-5" id="f-649" unitRef="usd">945800000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-98" decimals="-5" id="f-650" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-99" decimals="-5" id="f-651" unitRef="usd">1650800000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DerivativeLiabilities contextRef="c-96" decimals="-5" id="f-652" unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-97" decimals="-5" id="f-653" unitRef="usd">15200000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-98" decimals="-5" id="f-654" unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-99" decimals="-5" id="f-655" unitRef="usd">15200000</us-gaap:DerivativeLiabilities>
    <us-gaap:OtherLiabilitiesFairValueDisclosure contextRef="c-96" decimals="-5" id="f-656" unitRef="usd">0</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure contextRef="c-97" decimals="-5" id="f-657" unitRef="usd">0</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure contextRef="c-98" decimals="-5" id="f-658" unitRef="usd">10300000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure contextRef="c-99" decimals="-5" id="f-659" unitRef="usd">10300000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-96" decimals="-5" id="f-660" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-97" decimals="-5" id="f-661" unitRef="usd">15200000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-98" decimals="-5" id="f-662" unitRef="usd">10300000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-99" decimals="-5" id="f-663" unitRef="usd">25500000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput contextRef="c-116" decimals="2" id="f-664" unitRef="number">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-117" decimals="INF" id="f-665" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="c-1" id="f-666">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the changes in fair value of Level 3 financial instruments measured at fair value on a recurring basis (in millions):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.174%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.671%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.675%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-670"&gt;Changes in fair value&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-680"&gt;Changes in fair value&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-118" decimals="-5" id="f-667" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-119" decimals="-5" id="f-668" unitRef="usd">10300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-120" decimals="-5" id="f-669" unitRef="usd">10300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="c-121" decimals="-5" id="f-671" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="c-122" decimals="-5" id="f-672" unitRef="usd">-5300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="c-123" decimals="-5" id="f-673" unitRef="usd">-5300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-124" decimals="-5" id="f-674" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-125" decimals="-5" id="f-675" unitRef="usd">5000000.0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-126" decimals="-5" id="f-676" unitRef="usd">5000000.0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-127" decimals="-5" id="f-677" unitRef="usd">26200000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-128" decimals="-5" id="f-678" unitRef="usd">14000000.0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-129" decimals="-5" id="f-679" unitRef="usd">40200000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="c-130" decimals="-5" id="f-681" unitRef="usd">700000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="c-131" decimals="-5" id="f-682" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="c-132" decimals="-5" id="f-683" unitRef="usd">700000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-133" decimals="-5" id="f-684" unitRef="usd">26900000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-134" decimals="-5" id="f-685" unitRef="usd">14000000.0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-135" decimals="-5" id="f-686" unitRef="usd">40900000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="c-1" id="f-687">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk as summarized below. Notional amounts are stated in United States dollar equivalents at spot exchange rates at the respective dates. The Company does not enter into these arrangements for trading or speculation purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:76.319%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.043%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.605%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,772.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,786.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Derivative financial instruments involve credit risk in the event the counterparty should default.  It is the Company's policy to execute such instruments with global financial institutions that the Company believes to be creditworthy.  The Company diversifies its derivative financial instruments among counterparties to minimize exposure to any one of these entities.  The Company also uses International Swap Dealers Association master-netting agreements.  The master-netting agreements provide for the net settlement of all contracts through a single payment in a single currency in the event of default, as defined by the agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses foreign currency forward exchange contracts and cross-currency swap contracts to manage its exposure to changes in currency exchange rates from (a) future cash flows associated with intercompany transactions and certain local currency expenses expected to occur within approximately 1 year (designated as cash flow hedges), (b) its net investment in certain foreign subsidiaries (designated as net investment hedges) and (c) foreign currency denominated assets or liabilities (designated as fair value hedges).  The Company also uses foreign currency forward exchange contracts that are not &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;designated as hedging instruments to offset the transaction gains and losses associated with revaluation of certain assets and liabilities denominated in currencies other than their functional currencies (resulting principally from intercompany and local currency transactions). &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All derivative financial instruments are recognized at fair value in the consolidated condensed balance sheets.  For each derivative instrument that is designated as a fair value hedge, the gain or loss on the derivative included in the assessment of hedge effectiveness is recognized immediately to earnings, and offsets the loss or gain on the underlying hedged item.  The Company reports in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the gain or loss on derivative financial instruments that are designated, and that qualify, as cash flow hedges.  The Company reclassifies these gains and losses into earnings in the same line item and in the same period in which the underlying hedged transactions affect earnings.  Changes in the fair value of net investment hedges are reported in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; as a part of the cumulative translation adjustment and would be reclassified into earnings if the underlying net investment is sold or substantially liquidated.  The portion of the change in fair value related to components excluded from the hedge effectiveness assessment are amortized into earnings over the life of the derivative.  The gains and losses on derivative financial instruments for which the Company does not elect hedge accounting treatment are recognized in the consolidated statements of operations in each period based upon the change in the fair value of the derivative financial instrument.  Cash flows from net investment hedges are reported as investing activities in the consolidated statements of cash flows, and cash flows from all other derivative financial instruments are reported as operating activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the location and fair value amounts of derivative instruments reported in the consolidated condensed balance sheets (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:36.436%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:37.463%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.897%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.605%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet&lt;br/&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-695"&gt;&lt;span style="-sec-ix-hidden:f-696"&gt;Assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-701"&gt;&lt;span style="-sec-ix-hidden:f-702"&gt;Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the effect of master-netting agreements and rights of offset on the consolidated condensed balance sheets (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.296%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.032%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.822%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.234%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.032%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.325%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.889%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amounts &lt;br/&gt;Not Offset in&lt;br/&gt;the Consolidated&lt;br/&gt;Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amounts&lt;br/&gt;Offset in the&lt;br/&gt;Consolidated&lt;br/&gt;Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Amounts&lt;br/&gt;Presented in the&lt;br/&gt;Consolidated&lt;br/&gt;Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial&lt;br/&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash&lt;br/&gt;Collateral&lt;br/&gt;Received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the effect of derivative and non-derivative hedging instruments on the consolidated condensed statements of operations and consolidated condensed statements of comprehensive income (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:28.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.879%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.726%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain or (Loss)&lt;br/&gt;Recognized in OCI&lt;br/&gt;on Derivative&lt;br/&gt;(Effective Portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain or (Loss)&lt;br/&gt;Reclassified from&lt;br/&gt;Accumulated OCI&lt;br/&gt;into Income&lt;br/&gt;(Effective Portion)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;Location&#160;of&#160;Gain&#160;or&lt;br/&gt;(Loss)&#160;Reclassified&#160;from&lt;br/&gt;Accumulated&#160;OCI&lt;br/&gt;into&#160;Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.002%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.738%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.444%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.919%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.738%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.889%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:28.988%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.782%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.487%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.891%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.782%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.785%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain or (Loss)&lt;br/&gt;Recognized in OCI&lt;br/&gt;on Derivative &lt;br/&gt;(Effective Portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain or (Loss)&lt;br/&gt;Recognized in&#160;Income on Derivative (Amount Excluded from &lt;br/&gt;Effectiveness Testing)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;Location&#160;of&#160;Gain&#160;or&lt;br/&gt;(Loss)&#160;Recognized in&#160;Income on Derivative (Amount Excluded from Effectiveness Testing)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:28.944%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.767%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.325%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.998%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.767%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.919%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The cross-currency swap contracts have an expiration date of June 15, 2028.  At the maturity of the cross-currency swap contracts, the Company will deliver the notional amount of &#x20ac;257.2 million and will receive $300.0 million from the counterparties.  The Company receives semi-annual interest payments from the counterparties based on a fixed interest rate until maturity of the agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.980%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:30.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain or (Loss)&lt;br/&gt;Recognized in Income on&lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of Gain or (Loss)&lt;br/&gt;Recognized in Income on&lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair value hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.980%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:30.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.980%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:30.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain or (Loss)&lt;br/&gt;Recognized in Income on&lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of Gain or (Loss)&lt;br/&gt;Recognized in Income on&lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the effect of fair value and cash flow hedge accounting on the consolidated condensed statements of operations (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:80.917%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.528%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amounts of income and expense line items presented in the consolidated condensed statements of operations in which the effects of fair value or cash flow hedges are recorded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(385.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;The effects of fair value and cash flow hedging:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) on fair value hedging relationships:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedged items&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount excluded from effectiveness testing recognized in earnings based on an amortization approach&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) on cash flow hedging relationships:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount of gain (loss) reclassified from accumulated OCI into income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:81.037%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.393%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amounts of income and expense line items presented in the consolidated condensed statements of operations in which the effects of fair value or cash flow hedges are recorded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(329.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;The effects of fair value and cash flow hedging:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) on fair value hedging relationships:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedged items&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount excluded from effectiveness testing recognized in earnings based on an amortization approach&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) on cash flow hedging relationships:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount of gain (loss) reclassified from accumulated OCI into income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company expects that during the next twelve months it will reclassify to earnings a $12.7 million gain currently recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock contextRef="c-1" id="f-688">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk as summarized below. Notional amounts are stated in United States dollar equivalents at spot exchange rates at the respective dates. The Company does not enter into these arrangements for trading or speculation purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:76.319%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.043%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.605%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,772.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,786.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock>
    <us-gaap:DerivativeNotionalAmount contextRef="c-136" decimals="-5" id="f-689" unitRef="usd">1772300000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-137" decimals="-5" id="f-690" unitRef="usd">1786200000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-138" decimals="-5" id="f-691" unitRef="usd">300000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-139" decimals="-5" id="f-692" unitRef="usd">300000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge contextRef="c-1" id="f-693">P1Y</us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge>
    <us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock contextRef="c-1" id="f-694">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the location and fair value amounts of derivative instruments reported in the consolidated condensed balance sheets (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:36.436%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:37.463%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.897%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.605%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet&lt;br/&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-695"&gt;&lt;span style="-sec-ix-hidden:f-696"&gt;Assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-701"&gt;&lt;span style="-sec-ix-hidden:f-702"&gt;Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock>
    <us-gaap:DerivativeAssets contextRef="c-140" decimals="-5" id="f-697" unitRef="usd">29600000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-141" decimals="-5" id="f-698" unitRef="usd">23700000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-138" decimals="-5" id="f-699" unitRef="usd">27900000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-139" decimals="-5" id="f-700" unitRef="usd">23400000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities contextRef="c-140" decimals="-5" id="f-703" unitRef="usd">4900000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-141" decimals="-5" id="f-704" unitRef="usd">15200000</us-gaap:DerivativeLiabilities>
    <us-gaap:OffsettingAssetsTableTextBlock contextRef="c-1" id="f-706">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the effect of master-netting agreements and rights of offset on the consolidated condensed balance sheets (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.296%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.032%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.822%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.234%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.032%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.325%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.889%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amounts &lt;br/&gt;Not Offset in&lt;br/&gt;the Consolidated&lt;br/&gt;Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amounts&lt;br/&gt;Offset in the&lt;br/&gt;Consolidated&lt;br/&gt;Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Amounts&lt;br/&gt;Presented in the&lt;br/&gt;Consolidated&lt;br/&gt;Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial&lt;br/&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash&lt;br/&gt;Collateral&lt;br/&gt;Received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OffsettingAssetsTableTextBlock>
    <us-gaap:OffsettingLiabilitiesTableTextBlock contextRef="c-1" id="f-705">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the effect of master-netting agreements and rights of offset on the consolidated condensed balance sheets (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.296%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.032%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.822%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.234%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.032%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.325%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.889%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amounts &lt;br/&gt;Not Offset in&lt;br/&gt;the Consolidated&lt;br/&gt;Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amounts&lt;br/&gt;Offset in the&lt;br/&gt;Consolidated&lt;br/&gt;Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Amounts&lt;br/&gt;Presented in the&lt;br/&gt;Consolidated&lt;br/&gt;Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial&lt;br/&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash&lt;br/&gt;Collateral&lt;br/&gt;Received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OffsettingLiabilitiesTableTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-142" decimals="-5" id="f-707" unitRef="usd">29600000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeAssetFairValueGrossLiability contextRef="c-142" decimals="-5" id="f-708" unitRef="usd">0</us-gaap:DerivativeAssetFairValueGrossLiability>
    <us-gaap:DerivativeAssets contextRef="c-142" decimals="-5" id="f-709" unitRef="usd">29600000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction contextRef="c-142" decimals="-5" id="f-710" unitRef="usd">4900000</us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeCollateralObligationToReturnCash contextRef="c-142" decimals="-5" id="f-711" unitRef="usd">0</us-gaap:DerivativeCollateralObligationToReturnCash>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral contextRef="c-142" decimals="-5" id="f-712" unitRef="usd">24700000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-143" decimals="-5" id="f-713" unitRef="usd">27900000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeAssetFairValueGrossLiability contextRef="c-143" decimals="-5" id="f-714" unitRef="usd">0</us-gaap:DerivativeAssetFairValueGrossLiability>
    <us-gaap:DerivativeAssets contextRef="c-143" decimals="-5" id="f-715" unitRef="usd">27900000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction contextRef="c-143" decimals="-5" id="f-716" unitRef="usd">0</us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeCollateralObligationToReturnCash contextRef="c-143" decimals="-5" id="f-717" unitRef="usd">0</us-gaap:DerivativeCollateralObligationToReturnCash>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral contextRef="c-143" decimals="-5" id="f-718" unitRef="usd">27900000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-142" decimals="-5" id="f-719" unitRef="usd">4900000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityFairValueGrossAsset contextRef="c-142" decimals="-5" id="f-720" unitRef="usd">0</us-gaap:DerivativeLiabilityFairValueGrossAsset>
    <us-gaap:DerivativeLiabilities contextRef="c-142" decimals="-5" id="f-721" unitRef="usd">4900000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction contextRef="c-142" decimals="-5" id="f-722" unitRef="usd">4900000</us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeCollateralRightToReclaimCash contextRef="c-142" decimals="-5" id="f-723" unitRef="usd">0</us-gaap:DerivativeCollateralRightToReclaimCash>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral contextRef="c-142" decimals="-5" id="f-724" unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-144" decimals="-5" id="f-725" unitRef="usd">23700000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeAssetFairValueGrossLiability contextRef="c-144" decimals="-5" id="f-726" unitRef="usd">0</us-gaap:DerivativeAssetFairValueGrossLiability>
    <us-gaap:DerivativeAssets contextRef="c-144" decimals="-5" id="f-727" unitRef="usd">23700000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction contextRef="c-144" decimals="-5" id="f-728" unitRef="usd">9400000</us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeCollateralObligationToReturnCash contextRef="c-144" decimals="-5" id="f-729" unitRef="usd">0</us-gaap:DerivativeCollateralObligationToReturnCash>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral contextRef="c-144" decimals="-5" id="f-730" unitRef="usd">14300000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-145" decimals="-5" id="f-731" unitRef="usd">23400000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeAssetFairValueGrossLiability contextRef="c-145" decimals="-5" id="f-732" unitRef="usd">0</us-gaap:DerivativeAssetFairValueGrossLiability>
    <us-gaap:DerivativeAssets contextRef="c-145" decimals="-5" id="f-733" unitRef="usd">23400000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction contextRef="c-145" decimals="-5" id="f-734" unitRef="usd">0</us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeCollateralObligationToReturnCash contextRef="c-145" decimals="-5" id="f-735" unitRef="usd">0</us-gaap:DerivativeCollateralObligationToReturnCash>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral contextRef="c-145" decimals="-5" id="f-736" unitRef="usd">23400000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-144" decimals="-5" id="f-737" unitRef="usd">15200000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityFairValueGrossAsset contextRef="c-144" decimals="-5" id="f-738" unitRef="usd">0</us-gaap:DerivativeLiabilityFairValueGrossAsset>
    <us-gaap:DerivativeLiabilities contextRef="c-144" decimals="-5" id="f-739" unitRef="usd">15200000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction contextRef="c-144" decimals="-5" id="f-740" unitRef="usd">9400000</us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeCollateralRightToReclaimCash contextRef="c-144" decimals="-5" id="f-741" unitRef="usd">0</us-gaap:DerivativeCollateralRightToReclaimCash>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral contextRef="c-144" decimals="-5" id="f-742" unitRef="usd">5800000</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock contextRef="c-1" id="f-743">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the effect of derivative and non-derivative hedging instruments on the consolidated condensed statements of operations and consolidated condensed statements of comprehensive income (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:28.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.879%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.726%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain or (Loss)&lt;br/&gt;Recognized in OCI&lt;br/&gt;on Derivative&lt;br/&gt;(Effective Portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain or (Loss)&lt;br/&gt;Reclassified from&lt;br/&gt;Accumulated OCI&lt;br/&gt;into Income&lt;br/&gt;(Effective Portion)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;Location&#160;of&#160;Gain&#160;or&lt;br/&gt;(Loss)&#160;Reclassified&#160;from&lt;br/&gt;Accumulated&#160;OCI&lt;br/&gt;into&#160;Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.002%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.738%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.444%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.919%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.738%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.889%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:28.988%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.782%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.487%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.891%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.782%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.785%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain or (Loss)&lt;br/&gt;Recognized in OCI&lt;br/&gt;on Derivative &lt;br/&gt;(Effective Portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain or (Loss)&lt;br/&gt;Recognized in&#160;Income on Derivative (Amount Excluded from &lt;br/&gt;Effectiveness Testing)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;Location&#160;of&#160;Gain&#160;or&lt;br/&gt;(Loss)&#160;Recognized in&#160;Income on Derivative (Amount Excluded from Effectiveness Testing)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.980%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:30.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain or (Loss)&lt;br/&gt;Recognized in Income on&lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of Gain or (Loss)&lt;br/&gt;Recognized in Income on&lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair value hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.980%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:30.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.980%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:30.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain or (Loss)&lt;br/&gt;Recognized in Income on&lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of Gain or (Loss)&lt;br/&gt;Recognized in Income on&lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-146" decimals="-5" id="f-744" unitRef="usd">36200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-147" decimals="-5" id="f-745" unitRef="usd">3700000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-148" decimals="-5" id="f-746" unitRef="usd">2400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-149" decimals="-5" id="f-747" unitRef="usd">29800000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax contextRef="c-150" decimals="-5" id="f-748" unitRef="usd">4400000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax contextRef="c-151" decimals="-5" id="f-749" unitRef="usd">-2500000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred contextRef="c-152" decimals="-5" id="f-750" unitRef="usd">1700000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred contextRef="c-153" decimals="-5" id="f-751" unitRef="usd">1700000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeNotionalAmount contextRef="c-154" decimals="-5" id="f-752" unitRef="eur">257200000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-154" decimals="-5" id="f-753" unitRef="usd">300000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-155" decimals="-5" id="f-754" unitRef="usd">4800000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-156" decimals="-5" id="f-755" unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-157" decimals="-5" id="f-756" unitRef="usd">12400000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-158" decimals="-5" id="f-757" unitRef="usd">-5400000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock contextRef="c-1" id="f-758">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the effect of fair value and cash flow hedge accounting on the consolidated condensed statements of operations (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:80.917%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.528%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amounts of income and expense line items presented in the consolidated condensed statements of operations in which the effects of fair value or cash flow hedges are recorded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(385.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;The effects of fair value and cash flow hedging:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) on fair value hedging relationships:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedged items&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount excluded from effectiveness testing recognized in earnings based on an amortization approach&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) on cash flow hedging relationships:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount of gain (loss) reclassified from accumulated OCI into income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:81.037%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.393%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amounts of income and expense line items presented in the consolidated condensed statements of operations in which the effects of fair value or cash flow hedges are recorded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(329.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;The effects of fair value and cash flow hedging:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) on fair value hedging relationships:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedged items&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount excluded from effectiveness testing recognized in earnings based on an amortization approach&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) on cash flow hedging relationships:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount of gain (loss) reclassified from accumulated OCI into income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-1" decimals="-5" id="f-759" unitRef="usd">385600000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-5" id="f-760" unitRef="usd">5400000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1 contextRef="c-159" decimals="-5" id="f-761" unitRef="usd">0</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1 contextRef="c-160" decimals="-5" id="f-762" unitRef="usd">-4000000.0</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1 contextRef="c-161" decimals="-5" id="f-763" unitRef="usd">0</us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1>
    <us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1 contextRef="c-162" decimals="-5" id="f-764" unitRef="usd">4000000.0</us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax contextRef="c-159" decimals="-5" id="f-765" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax contextRef="c-160" decimals="-5" id="f-766" unitRef="usd">800000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-159" decimals="-5" id="f-767" unitRef="usd">2400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-160" decimals="-5" id="f-768" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-5" decimals="-5" id="f-769" unitRef="usd">329500000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-5" decimals="-5" id="f-770" unitRef="usd">1600000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1 contextRef="c-163" decimals="-5" id="f-771" unitRef="usd">0</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1 contextRef="c-164" decimals="-5" id="f-772" unitRef="usd">1200000</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1 contextRef="c-165" decimals="-5" id="f-773" unitRef="usd">0</us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1>
    <us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1 contextRef="c-166" decimals="-5" id="f-774" unitRef="usd">-1200000</us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax contextRef="c-163" decimals="-5" id="f-775" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax contextRef="c-164" decimals="-5" id="f-776" unitRef="usd">1200000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-163" decimals="-5" id="f-777" unitRef="usd">29800000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-164" decimals="-5" id="f-778" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths contextRef="c-1" decimals="-5" id="f-779" unitRef="usd">12700000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-780">STOCK-BASED COMPENSATION  &lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense related to awards issued under the Company's incentive compensation plans for the three months ended March 31, 2024 and 2023 was as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.315%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.329%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general, and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Separation costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2024, the total remaining compensation cost related to nonvested stock options, restricted stock units, market-based restricted stock units, and employee stock purchase plan ("ESPP") subscription awards amounted to $242.6 million, which will be amortized on a straight-line basis over each award's requisite service period.  The weighted-average remaining requisite service period is 30 months.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Disclosures&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table includes the weighted-average grant-date fair values of stock options granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.730%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Option Awards&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.7%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.3%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value, per option&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table includes the weighted-average grant-date fair values for ESPP subscriptions granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.730%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;ESPP&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.8%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.5%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value, per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.52&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c-1" id="f-781">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense related to awards issued under the Company's incentive compensation plans for the three months ended March 31, 2024 and 2023 was as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.315%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.329%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general, and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Separation costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-167" decimals="-5" id="f-782" unitRef="usd">8200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-168" decimals="-5" id="f-783" unitRef="usd">7000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-169" decimals="-5" id="f-784" unitRef="usd">24600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-170" decimals="-5" id="f-785" unitRef="usd">22300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-171" decimals="-5" id="f-786" unitRef="usd">11200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-172" decimals="-5" id="f-787" unitRef="usd">9600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-173" decimals="-5" id="f-788" unitRef="usd">600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-174" decimals="-5" id="f-789" unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-5" id="f-790" unitRef="usd">44600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-5" decimals="-5" id="f-791" unitRef="usd">38900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="c-1" decimals="-5" id="f-792" unitRef="usd">6200000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="c-5" decimals="-5" id="f-793" unitRef="usd">4700000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax contextRef="c-1" decimals="-5" id="f-794" unitRef="usd">38400000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax contextRef="c-5" decimals="-5" id="f-795" unitRef="usd">34200000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="c-3" decimals="-5" id="f-796" unitRef="usd">242600000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-1" id="f-797">P30M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c-1" id="f-798">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table includes the weighted-average grant-date fair values of stock options granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.730%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Option Awards&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.7%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.3%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value, per option&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-175" decimals="3" id="f-799" unitRef="number">0.043</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-176" decimals="3" id="f-800" unitRef="number">0.041</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-175"
      decimals="INF"
      id="f-801"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-176"
      decimals="INF"
      id="f-802"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-175" decimals="3" id="f-803" unitRef="number">0.327</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-176" decimals="3" id="f-804" unitRef="number">0.313</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-175" id="f-805">P5Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-176" id="f-806">P5Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-175"
      decimals="2"
      id="f-807"
      unitRef="usdPerShare">32.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-176"
      decimals="2"
      id="f-808"
      unitRef="usdPerShare">27.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock contextRef="c-1" id="f-809">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table includes the weighted-average grant-date fair values for ESPP subscriptions granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.730%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;ESPP&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.8%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.5%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value, per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.52&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-177" decimals="3" id="f-810" unitRef="number">0.051</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-178" decimals="3" id="f-811" unitRef="number">0.046</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-177"
      decimals="INF"
      id="f-812"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-178"
      decimals="INF"
      id="f-813"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-177" decimals="3" id="f-814" unitRef="number">0.348</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-178" decimals="3" id="f-815" unitRef="number">0.315</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-177" id="f-816">P0Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-178" id="f-817">P0Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-177"
      decimals="2"
      id="f-818"
      unitRef="usdPerShare">25.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-178"
      decimals="2"
      id="f-819"
      unitRef="usdPerShare">21.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c-1" id="f-820">ACCELERATED SHARE REPURCHASE&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2023, the Company entered into an accelerated share repurchase ("ASR") agreement providing for the repurchase of the Company's common stock based on the volume-weighted average price ("VWAP") of the Company's common stock during the term of the agreement, less a discount.  The following table summarizes the terms of the ASR agreement (dollars and shares in millions, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.730%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.063%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.356%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.502%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.174%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.437%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Initial Delivery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Final Settlement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Agreement Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;br/&gt;Paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;br/&gt;Received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Price per&lt;br/&gt;Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Value of&lt;br/&gt;Shares as %&lt;br/&gt;of Contract&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Settlement&lt;br/&gt;Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Shares&lt;br/&gt;Received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average Price&lt;br/&gt;per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ASR agreement was accounted for as two separate transactions: (1)&#160;the value of the initial delivery of shares was recorded as shares of common stock acquired in a treasury stock transaction on the acquisition date, and (2)&#160;the remaining amount of the purchase price paid was recorded as a forward contract indexed to the Company's own common stock and was initially recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Additional Paid-in Capital&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and subsequently, upon settlement, was transferred to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Treasury Stock&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; on the consolidated condensed balance sheets. The initial delivery of shares resulted in an immediate reduction of the outstanding shares used to calculate the weighted-average common shares outstanding for basic and diluted earnings per share. The Company determined that the forward contract indexed to the Company's common stock met all the applicable criteria for equity classification and, therefore, was not accounted for as a derivative instrument.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:AcceleratedShareRepurchasesTextBlock contextRef="c-1" id="f-821">The following table summarizes the terms of the ASR agreement (dollars and shares in millions, except per share data):&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.730%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.063%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.356%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.502%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.174%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.437%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Initial Delivery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Final Settlement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Agreement Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;br/&gt;Paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;br/&gt;Received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Price per&lt;br/&gt;Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Value of&lt;br/&gt;Shares as %&lt;br/&gt;of Contract&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Settlement&lt;br/&gt;Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Shares&lt;br/&gt;Received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average Price&lt;br/&gt;per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AcceleratedShareRepurchasesTextBlock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1 contextRef="c-179" decimals="-5" id="f-822" unitRef="usd">200000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-180"
      decimals="-5"
      id="f-823"
      unitRef="shares">2000000.0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:AcceleratedShareRepurchasesInitialPricePaidPerShare
      contextRef="c-180"
      decimals="2"
      id="f-824"
      unitRef="usdPerShare">80.44</us-gaap:AcceleratedShareRepurchasesInitialPricePaidPerShare>
    <ew:AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount contextRef="c-180" decimals="2" id="f-825" unitRef="number">0.80</ew:AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-181"
      decimals="-5"
      id="f-826"
      unitRef="shares">2500000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare
      contextRef="c-181"
      decimals="2"
      id="f-827"
      unitRef="usdPerShare">79.28</us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-828">COMMITMENTS AND CONTINGENCIES&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2021, the Company initiated an internal review and investigation into whether business activities in Japan and other markets violated certain provisions of the Foreign Corrupt Practices Act (&#x201c;FCPA&#x201d;).  The Company voluntarily notified the SEC and the United States Department of Justice (&#x201c;DOJ&#x201d;) during 2021 that it has engaged outside counsel to conduct this review and investigation. The Company has provided status updates to the SEC and DOJ since that time. Any determination that the Company&#x2019;s operations or activities are not in compliance with existing laws, including the FCPA, could result in the imposition of fines, penalties, and equitable remedies. The Company cannot currently predict the final outcome of the investigation or any potential impact on its financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 28, 2021, Aortic Innovations LLC, a non-practicing entity, filed a lawsuit against Edwards Lifesciences Corporation and certain of its subsidiaries (&#x201c;Edwards&#x201d;) in the United States District Court for the District of Delaware alleging that Edwards&#x2019; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;SAPIEN 3 Ultra&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; product infringes certain of its patents.  The Company is unable to predict the ultimate outcome of this matter or estimate a range of possible exposure; therefore, no amounts have been accrued.  The Company intends to vigorously defend itself in this litigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The European Commission (the &#x201c;Commission&#x201d;) is investigating certain business practices of Edwards including its unilateral pro-innovation (anti-copycat) policy and patent practices.  The Company is cooperating with the Commission and believes its business practices support healthy competition.  The Company cannot predict the outcome of the investigation or the potential impact on our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is or may be a party to, or may otherwise be responsible for, pending or threatened lawsuits including those related to products and services currently or formerly manufactured or performed, as applicable, by the Company, workplace and employment matters, matters involving real estate, Company operations or health care regulations, contingent considerations, or governmental investigations (the &#x201c;Lawsuits&#x201d;). The Lawsuits raise difficult and complex factual and legal issues and are subject to many uncertainties, including, but not limited to, the facts and circumstances of each particular case or claim, the jurisdiction in which each suit is brought, and differences in applicable law. Management does not believe that any loss relating to the Lawsuits would have a material adverse effect on the Company's overall financial condition, results of operations or cash flows. However, the resolution of one or more of the Lawsuits in any reporting period, could have a material adverse impact on the Company's financial results for that period. The Company is not able to estimate the amount or range of any loss for legal contingencies related to the Lawsuits for which there is no reserve or additional loss for matters already reserved.&lt;/span&gt;&lt;/div&gt;The Company is subject to various environmental laws and regulations both within and outside of the United States. The Company's operations, like those of other medical device companies, involve the use of substances regulated under environmental laws, primarily in manufacturing and sterilization processes. While it is difficult to quantify the potential impact of continuing compliance with environmental protection laws, management believes that such compliance will not have a material impact on the Company's financial results. The Company's threshold for disclosing material environmental legal proceedings involving a governmental authority where potential monetary sanctions are involved is $1&#160;million.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <ew:LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber
      contextRef="c-1"
      decimals="INF"
      id="f-829"
      unitRef="lawsuit">1</ew:LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber>
    <ew:AccrualForEnvironmentalLossContingenciesThresholdAmountForDisclosure contextRef="c-3" decimals="-6" id="f-830" unitRef="usd">1000000</ew:AccrualForEnvironmentalLossContingenciesThresholdAmountForDisclosure>
    <us-gaap:ComprehensiveIncomeNoteTextBlock contextRef="c-1" id="f-831">ACCUMULATED OTHER COMPREHENSIVE LOSS&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the activity for each component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.282%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.642%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gain on Hedges&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Loss on Available-for-sale Investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;br/&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(214.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(242.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax expense &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(240.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(233.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.282%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.696%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gain on Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Loss on Available-for-sale Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Pension&lt;br/&gt;Credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;br/&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(218.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(254.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax benefit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(215.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(255.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about amounts reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.800%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.478%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.478%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Affected Line on Consolidated Condensed&lt;br/&gt;Statements of Operations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Details about Accumulated Other&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Comprehensive Loss Components&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on hedges&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total before tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on available-for-sale investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock contextRef="c-1" id="f-832">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the activity for each component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.282%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.642%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gain on Hedges&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Loss on Available-for-sale Investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;br/&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(214.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(242.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax expense &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(240.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(233.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.282%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.696%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gain on Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Loss on Available-for-sale Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Pension&lt;br/&gt;Credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;br/&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(218.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(254.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax benefit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(215.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(255.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity contextRef="c-182" decimals="-5" id="f-833" unitRef="usd">-214500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-183" decimals="-5" id="f-834" unitRef="usd">700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-184" decimals="-5" id="f-835" unitRef="usd">-24800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-185" decimals="-5" id="f-836" unitRef="usd">-4200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-12" decimals="-5" id="f-837" unitRef="usd">-242800000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-186" decimals="-5" id="f-838" unitRef="usd">-23300000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-187" decimals="-5" id="f-839" unitRef="usd">43400000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-188" decimals="-5" id="f-840" unitRef="usd">7000000.0</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-189" decimals="-5" id="f-841" unitRef="usd">400000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-1" decimals="-5" id="f-842" unitRef="usd">27500000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-186" decimals="-5" id="f-843" unitRef="usd">1700000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-187" decimals="-5" id="f-844" unitRef="usd">7200000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-188" decimals="-5" id="f-845" unitRef="usd">-2500000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-189" decimals="-5" id="f-846" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-1" decimals="-5" id="f-847" unitRef="usd">6400000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-186" decimals="-5" id="f-848" unitRef="usd">1100000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-187" decimals="-5" id="f-849" unitRef="usd">9300000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-188" decimals="-5" id="f-850" unitRef="usd">1100000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-189" decimals="-5" id="f-851" unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-1" decimals="-5" id="f-852" unitRef="usd">11600000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:StockholdersEquity contextRef="c-190" decimals="-5" id="f-853" unitRef="usd">-240600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-191" decimals="-5" id="f-854" unitRef="usd">27600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-192" decimals="-5" id="f-855" unitRef="usd">-16400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-193" decimals="-5" id="f-856" unitRef="usd">-3900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-26" decimals="-5" id="f-857" unitRef="usd">-233300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-194" decimals="-5" id="f-858" unitRef="usd">-218800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-195" decimals="-5" id="f-859" unitRef="usd">23800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-196" decimals="-5" id="f-860" unitRef="usd">-65600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-197" decimals="-5" id="f-861" unitRef="usd">5700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-33" decimals="-5" id="f-862" unitRef="usd">-254900000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-198" decimals="-5" id="f-863" unitRef="usd">4900000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-199" decimals="-5" id="f-864" unitRef="usd">6700000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-200" decimals="-5" id="f-865" unitRef="usd">9000000.0</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-201" decimals="-5" id="f-866" unitRef="usd">-100000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-5" decimals="-5" id="f-867" unitRef="usd">20500000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-198" decimals="-5" id="f-868" unitRef="usd">1700000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-199" decimals="-5" id="f-869" unitRef="usd">29800000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-200" decimals="-5" id="f-870" unitRef="usd">-4000000.0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-201" decimals="-5" id="f-871" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-5" decimals="-5" id="f-872" unitRef="usd">27500000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-198" decimals="-5" id="f-873" unitRef="usd">-600000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-199" decimals="-5" id="f-874" unitRef="usd">-5900000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-200" decimals="-5" id="f-875" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-201" decimals="-5" id="f-876" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-5" decimals="-5" id="f-877" unitRef="usd">-6500000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:StockholdersEquity contextRef="c-202" decimals="-5" id="f-878" unitRef="usd">-215000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-203" decimals="-5" id="f-879" unitRef="usd">6600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-204" decimals="-5" id="f-880" unitRef="usd">-52600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-205" decimals="-5" id="f-881" unitRef="usd">5600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-47" decimals="-5" id="f-882" unitRef="usd">-255400000</us-gaap:StockholdersEquity>
    <us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock contextRef="c-1" id="f-883">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about amounts reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.800%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.478%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.478%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Affected Line on Consolidated Condensed&lt;br/&gt;Statements of Operations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Details about Accumulated Other&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Comprehensive Loss Components&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on hedges&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total before tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on available-for-sale investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-206" decimals="-5" id="f-884" unitRef="usd">1700000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-207" decimals="-5" id="f-885" unitRef="usd">1700000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-206" decimals="-5" id="f-886" unitRef="usd">400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-207" decimals="-5" id="f-887" unitRef="usd">400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-206" decimals="-5" id="f-888" unitRef="usd">1300000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-207" decimals="-5" id="f-889" unitRef="usd">1300000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-208" decimals="-5" id="f-890" unitRef="usd">-2400000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-209" decimals="-5" id="f-891" unitRef="usd">-29800000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-208" decimals="-5" id="f-892" unitRef="usd">4800000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-209" decimals="-5" id="f-893" unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-208" decimals="-5" id="f-894" unitRef="usd">7200000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-209" decimals="-5" id="f-895" unitRef="usd">29800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-208" decimals="-5" id="f-896" unitRef="usd">1500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-209" decimals="-5" id="f-897" unitRef="usd">7100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-208" decimals="-5" id="f-898" unitRef="usd">5700000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-209" decimals="-5" id="f-899" unitRef="usd">22700000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:InterestIncomeExpenseNet contextRef="c-210" decimals="-5" id="f-900" unitRef="usd">-2500000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet contextRef="c-211" decimals="-5" id="f-901" unitRef="usd">-4000000.0</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-210" decimals="-5" id="f-902" unitRef="usd">-600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-211" decimals="-5" id="f-903" unitRef="usd">-1000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-210" decimals="-5" id="f-904" unitRef="usd">-1900000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-211" decimals="-5" id="f-905" unitRef="usd">-3000000.0</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-906">EARNINGS PER SHARE&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share is computed by dividing net income by the weighted-average common shares outstanding during the period. Diluted earnings per share is computed based on the weighted-average common shares outstanding plus the effect of dilutive potential common shares outstanding during the period calculated using the treasury stock method. Dilutive potential common shares include employee equity share options, nonvested shares, and similar equity instruments granted by the Company. Potential common share equivalents have been excluded where their inclusion would be anti-dilutive. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.730%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to Edwards Lifesciences Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;607.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to Edwards Lifesciences Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;607.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive weighted-average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Stock options, restricted stock units, and market-based restricted stock units to purchase an aggregate of 5.3 million and 5.2 million common shares for the three months ended March 31, 2024 and 2023, respectively, were outstanding, but were not included in the computation of diluted earnings per share for such periods because the effect would have been anti-dilutive.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-907">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.730%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to Edwards Lifesciences Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;607.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to Edwards Lifesciences Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;607.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive weighted-average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-1" decimals="-5" id="f-908" unitRef="usd">351900000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-5" decimals="-5" id="f-909" unitRef="usd">340500000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-5" id="f-910" unitRef="shares">601600000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="-5" id="f-911" unitRef="shares">607500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-912"
      unitRef="usdPerShare">0.58</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-913"
      unitRef="usdPerShare">0.56</us-gaap:EarningsPerShareBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c-1" decimals="-5" id="f-914" unitRef="usd">351900000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c-5" decimals="-5" id="f-915" unitRef="usd">340500000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-5" id="f-916" unitRef="shares">601600000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="-5" id="f-917" unitRef="shares">607500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-1" decimals="-5" id="f-918" unitRef="shares">2500000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-5" decimals="-5" id="f-919" unitRef="shares">3400000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-5" id="f-920" unitRef="shares">604100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="-5" id="f-921" unitRef="shares">610900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-922"
      unitRef="usdPerShare">0.58</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-923"
      unitRef="usdPerShare">0.56</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-212"
      decimals="-5"
      id="f-924"
      unitRef="shares">5300000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-213"
      decimals="-5"
      id="f-925"
      unitRef="shares">5200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-926">INCOME TAXES&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's effective income tax rates were 14.3% and 14.6% for the three months ended March 31, 2024 and 2023, respectively.  The decrease in the effective rate between the three months ended March 31, 2024 and 2023 is primarily due &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;to an increased tax benefit from employee share-based compensation.  In addition, the effective rates for the three months ended March 31, 2024 and 2023 were lower than the federal statutory rate of 21% primarily due to (1) foreign earnings taxed at lower rates, (2) Federal and California research and development credits, and (3) the tax benefit from employee share-based compensation. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effective rates include a tax benefit from employee share-&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;based&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; compensation of $6.3 million and $2.9 million for the three months ended March 31, 2024 and 2023, respectively.   &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, the Internal Revenue Service ("IRS") and other taxing authorities are in different stages of examining various years of the Company's tax filings.  During these audits, the Company may receive proposed audit adjustments that could be material.  An adverse outcome in these audits could have a material effect on the Company's results of operations and financial condition.  The Company strives to resolve open matters with each tax authority at the examination level and could reach agreement with a tax authority at any time.  While the Company has accrued for matters it believes are more likely than not to require settlement, the final outcome with a tax authority may result in a tax liability that is materially different from that reflected in the consolidated financial statements.  Furthermore, the Company may later decide to challenge any assessments, if made, and may exercise its right to appeal. The uncertain tax positions are reviewed quarterly and adjusted as events occur that affect potential liabilities for additional taxes, such as lapsing of applicable statutes of limitations, proposed assessments by tax authorities, negotiations between tax authorities, identification of new issues, and issuance of new legislation, regulations, or case law.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2024 and December&#160;31, 2023, the gross liability recorded for income taxes associated with uncertain tax positions was $608.8 million and $583.9 million, respectively. The Company estimates that these liabilities would be reduced by $265.9 million and $250.7 million, respectively, from offsetting tax benefits associated with the correlative effects of potential transfer pricing adjustments, state income taxes, and timing adjustments. The net amounts of $342.9 million and $333.2 million, respectively, if not required, would favorably affect the Company's effective tax rate. Management believes that adequate amounts of tax and related penalty and interest have been provided for any adjustments that may result from these uncertain tax positions.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company executed an Advance Pricing Agreement (&#x201c;APA&#x201d;) in 2018 between the United States and Switzerland governments for tax years 2009 through 2020 covering various, but not all, transfer pricing matters.  The unagreed transfer pricing matters, namely Surgical Structural Heart and Transcatheter Aortic Valve Replacement (collectively "Surgical/TAVR") intercompany royalty transactions, then reverted to IRS examination for further consideration as part of the respective years' regular tax audits.  In addition, the Company executed other bilateral APAs as follows: during 2017, an APA between the United States and Japan covering tax years 2015 through 2019; and during 2018, APAs between Singapore and Japan and between Switzerland and Japan covering tax years 2015 through 2019.  The Company has filed to renew all three of the APAs with Japan for the years 2020 and forward.  An APA between Switzerland and Japan covering tax years 2020 through 2024 was executed in 2021.  An APA between the United States and Japan covering tax years 2020 through 2024 was executed in 2023.  The execution of some or all these APA renewals depends on many variables outside of Edwards' control.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The audits of the Company&#x2019;s United States federal income tax returns through 2014 have been closed.  The IRS audit field work for the 2015 through 2017 tax years was completed during the second quarter of 2021, except for transfer pricing and related matters.  The IRS is currently examining the 2018 through 2020 tax years.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The audits of the Company's material state, local, and foreign income tax matters have been concluded for years through 2015.  While not material, the Company continues to address matters in India for years since 2010. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2021, the Company received a Notice of Proposed Adjustment (&#x201c;NOPA&#x201d;) from the IRS for the 2015 through 2017 tax years relating to transfer pricing involving Surgical/TAVR intercompany royalty transactions between the Company's United States and Switzerland subsidiaries.  The NOPA proposed a substantial increase to the Company's United States taxable income, which could result in additional tax expense for this period of approximately $230 million and reflects a departure from a transfer pricing method the Company had previously agreed upon with the IRS.  The Company disagreed with the NOPA and pursued an administrative appeal with the IRS Independent Office of Appeals ("Appeals").  The Appeals process culminated in the third quarter of 2023 when the Company and Appeals concluded that a satisfactory resolution of the matter at the administrative level was not possible.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2023, Appeals issued a notice of deficiency ("NOD") increasing the Company's 2015 through 2017 United States federal income tax in amounts resulting from the income adjustments previously reflected in the NOPA.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The additional tax sought in excess of the Company's filing position is $269.3&#160;million before consideration of interest and a repatriation tax offset.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company plans to vigorously contest the additional tax claimed by the IRS through the judicial process.  Final resolution of this matter is not likely within the next 12 months.  The Company believes the amounts previously accrued related to this uncertain tax position are appropriate for a number of reasons, including the interpretation and application of relevant tax law and accounting standards to the Company's facts and, accordingly, has not accrued any additional amount based on the NOD and other proceedings to date.  Nonetheless, the outcome of the judicial process cannot be predicted with certainty, and it is possible that the outcome of that process could have a material impact on the Company's consolidated financial statements.  As noted below, similar material tax disputes may arise for the 2018 through 2023 tax years. While no payment of any amount related to the NOPA or NOD has yet been required, the Company made a partial deposit with the IRS of $75&#160;million in November 2022 to prevent the further accrual of interest on that portion of any additional tax the Company may ultimately be found to owe.  In March 2024, the Company made an additional deposit with the IRS of $305&#160;million to further mitigate interest on potential tax liabilities while the Company prepares to contest through the judicial process the IRS's entitlement to any of the additional tax claimed by the IRS. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Surgical/TAVR intercompany royalty transactions covering tax years 2018 through 2023 remain subject to IRS examination, and those transactions and related tax positions remain uncertain as of March&#160;31, 2024.  The Company has considered this information, as well as information regarding the NOPA, the rebuttal and Appeals discussions described above, in its evaluation of its uncertain tax positions.  The impact of these unresolved transfer pricing matters, net of any correlative tax adjustments, may be significant to the Company&#x2019;s consolidated financial statements.  Based on the information currently available and numerous possible outcomes, the Company cannot reasonably estimate what, if any, changes in its existing uncertain tax positions may occur in the next 12 months and, therefore, has continued to record the uncertain tax positions as a long-term liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2024, the Company received a notice of assessment from the Israel Tax Authority (&#x201c;ITA&#x201d;) wherein the ITA claimed that the Company owes approximately $110&#160;million of tax excluding interest and penalties in connection with a claimed 2017 transfer of intellectual property. The Company maintains that it did not transfer intellectual property outside of Israel and intends to vigorously defend that position through administrative and, if necessary, judicial proceedings.  There can be no assurance that this matter will be resolved in the Company's favor and an adverse outcome could have a material effect on the Company's consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-1" decimals="3" id="f-927" unitRef="number">0.143</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-5" decimals="3" id="f-928" unitRef="number">0.146</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-1" decimals="-5" id="f-929" unitRef="usd">-6300000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-5" decimals="-5" id="f-930" unitRef="usd">-2900000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-3" decimals="-5" id="f-931" unitRef="usd">608800000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-4" decimals="-5" id="f-932" unitRef="usd">583900000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible contextRef="c-3" decimals="-5" id="f-933" unitRef="usd">265900000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible contextRef="c-4" decimals="-5" id="f-934" unitRef="usd">250700000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="c-3" decimals="-5" id="f-935" unitRef="usd">342900000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="c-4" decimals="-5" id="f-936" unitRef="usd">333200000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <ew:NumberOfAdvancePricingAgreementsRenewed
      contextRef="c-214"
      decimals="INF"
      id="f-937"
      unitRef="agreement">3</ew:NumberOfAdvancePricingAgreementsRenewed>
    <ew:IncomeTaxAssessmentEstimateOfAdditionalTaxExpense contextRef="c-215" decimals="-6" id="f-938" unitRef="usd">230000000</ew:IncomeTaxAssessmentEstimateOfAdditionalTaxExpense>
    <us-gaap:IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority contextRef="c-4" decimals="-5" id="f-939" unitRef="usd">269300000</us-gaap:IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority>
    <ew:IncomeTaxExaminationAmountDepositedToMitigateInterestOnTaxLiabilities contextRef="c-216" decimals="-6" id="f-940" unitRef="usd">75000000</ew:IncomeTaxExaminationAmountDepositedToMitigateInterestOnTaxLiabilities>
    <ew:IncomeTaxExaminationAmountDepositedToMitigateInterestOnTaxLiabilities contextRef="c-1" decimals="-6" id="f-941" unitRef="usd">305000000</ew:IncomeTaxExaminationAmountDepositedToMitigateInterestOnTaxLiabilities>
    <us-gaap:IncomeTaxExaminationEstimateOfPossibleLoss contextRef="c-217" decimals="-6" id="f-942" unitRef="usd">110000000</us-gaap:IncomeTaxExaminationEstimateOfPossibleLoss>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-943">SEGMENT INFORMATION&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Edwards Lifesciences conducts operations worldwide and is managed in the following geographical regions: United States, Europe, Japan, and Rest of World. All regions sell products that are used to treat advanced cardiovascular disease.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's geographic segments are reported based on the financial information provided to the Chief Operating Decision Maker (the Chief Executive Officer). The Company evaluates the performance of its geographic segments based on net sales and operating income. Segment net sales and segment operating income are based on internally derived foreign exchange rates and do not include inter-segment profits. Because of the interdependence of the reportable segments, the operating profit as presented may not be representative of the geographical distribution that would occur if the segments were not interdependent. Net sales by geographic area are based on the location of the customer. There were no customers that represented 10% or more of the Company's total net sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain items are maintained at the corporate level and are not allocated to the segments. The non-allocated items include corporate research and development expenses, manufacturing variances, corporate headquarters costs, net interest income, global marketing expenses, special gains and charges, stock-based compensation, foreign currency hedging activities, certain litigation costs, changes in the fair value of contingent consideration liabilities, and most of the Company's amortization expense. Although most of the Company's depreciation expense is included in segment operating income, due to the Company's methodology for cost build-up, it is impractical to determine the amount of depreciation expense included in each segment and, therefore, a portion is maintained at the corporate level. The Company neither discretely allocates assets to its operating segments, nor evaluates the operating segments using discrete asset information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents information about Edwards Lifesciences' reportable segments (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.801%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.712%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.715%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;940.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;849.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,454.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment Operating Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;945.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;879.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated pre-tax income (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.841%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales Reconciliation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,454.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,459.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pre-tax Income Reconciliation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;945.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;879.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unallocated amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(503.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(468.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Separation costs (Note&#160;4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intellectual property agreement and certain litigation expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of contingent consideration liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;388.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated pre-tax income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Enterprise-wide Information&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated condensed financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.801%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.712%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.715%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales by Geographic Region&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;940.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;849.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,459.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales by Major Product Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transcatheter Aortic Valve Replacement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,007.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;947.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transcatheter Mitral and Tricuspid Therapies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Surgical Structural Heart&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Critical Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,459.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c-1" id="f-944">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents information about Edwards Lifesciences' reportable segments (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.801%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.712%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.715%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;940.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;849.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,454.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment Operating Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;945.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;879.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated pre-tax income (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.841%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales Reconciliation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,454.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,459.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pre-tax Income Reconciliation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;945.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;879.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unallocated amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(503.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(468.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Separation costs (Note&#160;4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intellectual property agreement and certain litigation expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of contingent consideration liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;388.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated pre-tax income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-218" decimals="-5" id="f-945" unitRef="usd">940700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-219" decimals="-5" id="f-946" unitRef="usd">849100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-220" decimals="-5" id="f-947" unitRef="usd">363000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-221" decimals="-5" id="f-948" unitRef="usd">335400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-222" decimals="-5" id="f-949" unitRef="usd">112900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-223" decimals="-5" id="f-950" unitRef="usd">104300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-224" decimals="-5" id="f-951" unitRef="usd">182000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-225" decimals="-5" id="f-952" unitRef="usd">165600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-226" decimals="-5" id="f-953" unitRef="usd">1598600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-227" decimals="-5" id="f-954" unitRef="usd">1454400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-218" decimals="-5" id="f-955" unitRef="usd">616700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-219" decimals="-5" id="f-956" unitRef="usd">563400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-220" decimals="-5" id="f-957" unitRef="usd">191400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-221" decimals="-5" id="f-958" unitRef="usd">181700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-222" decimals="-5" id="f-959" unitRef="usd">60400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-223" decimals="-5" id="f-960" unitRef="usd">63400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-224" decimals="-5" id="f-961" unitRef="usd">77000000.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-225" decimals="-5" id="f-962" unitRef="usd">70500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-226" decimals="-5" id="f-963" unitRef="usd">945500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-227" decimals="-5" id="f-964" unitRef="usd">879000000.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-226" decimals="-5" id="f-965" unitRef="usd">1598600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-227" decimals="-5" id="f-966" unitRef="usd">1454400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-228" decimals="-5" id="f-967" unitRef="usd">-400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-229" decimals="-5" id="f-968" unitRef="usd">5200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-5" id="f-969" unitRef="usd">1598200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-5" id="f-970" unitRef="usd">1459600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss contextRef="c-226" decimals="-5" id="f-971" unitRef="usd">945500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-227" decimals="-5" id="f-972" unitRef="usd">879000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:CostsAndExpenses contextRef="c-230" decimals="-5" id="f-973" unitRef="usd">503900000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-231" decimals="-5" id="f-974" unitRef="usd">468900000</us-gaap:CostsAndExpenses>
    <us-gaap:OtherNonrecurringIncomeExpense contextRef="c-228" decimals="-5" id="f-975" unitRef="usd">41300000</us-gaap:OtherNonrecurringIncomeExpense>
    <us-gaap:OtherNonrecurringIncomeExpense contextRef="c-229" decimals="-5" id="f-976" unitRef="usd">0</us-gaap:OtherNonrecurringIncomeExpense>
    <us-gaap:LitigationSettlementExpense contextRef="c-228" decimals="-5" id="f-977" unitRef="usd">8900000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense contextRef="c-229" decimals="-5" id="f-978" unitRef="usd">43500000</us-gaap:LitigationSettlementExpense>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-1" decimals="-5" id="f-979" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-5" decimals="-5" id="f-980" unitRef="usd">700000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-228" decimals="-5" id="f-981" unitRef="usd">-3900000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-229" decimals="-5" id="f-982" unitRef="usd">22500000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-5" id="f-983" unitRef="usd">387500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-5" decimals="-5" id="f-984" unitRef="usd">388400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-228" decimals="-5" id="f-985" unitRef="usd">21900000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-229" decimals="-5" id="f-986" unitRef="usd">10200000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-5" id="f-987" unitRef="usd">409400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-5" decimals="-5" id="f-988" unitRef="usd">398600000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock contextRef="c-1" id="f-989">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated condensed financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.801%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.712%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.715%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales by Geographic Region&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;940.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;849.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,459.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales by Major Product Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transcatheter Aortic Valve Replacement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,007.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;947.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transcatheter Mitral and Tricuspid Therapies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Surgical Structural Heart&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Critical Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,459.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-232" decimals="-5" id="f-990" unitRef="usd">940700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-233" decimals="-5" id="f-991" unitRef="usd">849100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-234" decimals="-5" id="f-992" unitRef="usd">367800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-235" decimals="-5" id="f-993" unitRef="usd">331100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-236" decimals="-5" id="f-994" unitRef="usd">110800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-237" decimals="-5" id="f-995" unitRef="usd">114100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-238" decimals="-5" id="f-996" unitRef="usd">178900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-239" decimals="-5" id="f-997" unitRef="usd">165300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-5" id="f-998" unitRef="usd">1598200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-5" id="f-999" unitRef="usd">1459600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-240" decimals="-5" id="f-1000" unitRef="usd">1007900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-241" decimals="-5" id="f-1001" unitRef="usd">947900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-242" decimals="-5" id="f-1002" unitRef="usd">72900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-243" decimals="-5" id="f-1003" unitRef="usd">41600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-244" decimals="-5" id="f-1004" unitRef="usd">266100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-245" decimals="-5" id="f-1005" unitRef="usd">248200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-246" decimals="-5" id="f-1006" unitRef="usd">251300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-247" decimals="-5" id="f-1007" unitRef="usd">221900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-5" id="f-1008" unitRef="usd">1598200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-5" id="f-1009" unitRef="usd">1459600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-1" id="f-1010">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-1" id="f-1011">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-1" id="f-1012">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:MtrlTermsOfTrdArrTextBlock contextRef="c-248" id="f-1013">&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On February 12, 2024, Michael A. Mussallem, Chairman and Director, entered into a Plan providing for the potential sale of 276,900 shares of the Company&#x2019;s stock commencing June 11, 2024.  Mr. Mussallem's Plan terminates on the earlier of May 1, 2025 or the date all shares are sold.&lt;/span&gt;&lt;/div&gt;</ecd:MtrlTermsOfTrdArrTextBlock>
    <ecd:TrdArrAdoptionDate contextRef="c-248" id="f-1014">February 12, 2024</ecd:TrdArrAdoptionDate>
    <ecd:TrdArrIndName contextRef="c-248" id="f-1015">Michael A. Mussallem</ecd:TrdArrIndName>
    <ecd:TrdArrIndTitle contextRef="c-248" id="f-1016">Chairman and Director</ecd:TrdArrIndTitle>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-248" id="f-1017">true</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:TrdArrSecuritiesAggAvailAmt
      contextRef="c-249"
      decimals="INF"
      id="f-1018"
      unitRef="shares">276900</ecd:TrdArrSecuritiesAggAvailAmt>
    <ecd:MtrlTermsOfTrdArrTextBlock contextRef="c-250" id="f-1019">&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On February 15, 2024, Scott B. Ullem, Corporate Vice President, Chief Financial Officer, entered into a Plan providing for the potential sale of 67,500 shares of the Company&#x2019;s stock commencing May 21, 2024.  Mr. Ullem's Plan terminates on the earlier of May 9, 2025 or the date all shares are sold.&lt;/span&gt;&lt;/div&gt;</ecd:MtrlTermsOfTrdArrTextBlock>
    <ecd:TrdArrAdoptionDate contextRef="c-250" id="f-1020">February 15, 2024</ecd:TrdArrAdoptionDate>
    <ecd:TrdArrIndName contextRef="c-250" id="f-1021">Scott B. Ullem</ecd:TrdArrIndName>
    <ecd:TrdArrIndTitle contextRef="c-250" id="f-1022">Corporate Vice President, Chief Financial Officer</ecd:TrdArrIndTitle>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-250" id="f-1023">true</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:TrdArrSecuritiesAggAvailAmt
      contextRef="c-251"
      decimals="INF"
      id="f-1024"
      unitRef="shares">67500</ecd:TrdArrSecuritiesAggAvailAmt>
    <ecd:MtrlTermsOfTrdArrTextBlock contextRef="c-252" id="f-1025">&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On February 29, 2024, Bernard J. Zovighian, Chief Executive Officer and Director, entered into a Plan providing for the potential sale of 25,147 shares of the Company&#x2019;s stock commencing May 30, 2024.  Mr. Zovighian's Plan terminates on the earlier of December 18, 2024 or the date all shares are sold.&lt;/span&gt;&lt;/div&gt;</ecd:MtrlTermsOfTrdArrTextBlock>
    <ecd:TrdArrAdoptionDate contextRef="c-252" id="f-1026">February 29, 2024</ecd:TrdArrAdoptionDate>
    <ecd:TrdArrIndName contextRef="c-252" id="f-1027">Bernard J. Zovighian</ecd:TrdArrIndName>
    <ecd:TrdArrIndTitle contextRef="c-252" id="f-1028">Chief Executive Officer and Director</ecd:TrdArrIndTitle>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-252" id="f-1029">true</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:TrdArrSecuritiesAggAvailAmt
      contextRef="c-253"
      decimals="INF"
      id="f-1030"
      unitRef="shares">25147</ecd:TrdArrSecuritiesAggAvailAmt>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
